action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value,target_name
,,2247145,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCc1ccc(-c2ccc(Cl)cc2)n1CC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '17.54', 'le': '0.35', 'lle': '2.49', 'sei': '6.79'}",CHEMBL503254,,CHEMBL503254,5.40,0,http://www.openphacts.org/units/Nanomolar,748200,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.0,PIM1 kinase
,,2247146,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCc1ccc(-c2cccs2)n1CC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '18.06', 'le': '0.36', 'lle': '2.73', 'sei': '6.34'}",CHEMBL504500,,CHEMBL504500,5.05,0,http://www.openphacts.org/units/Nanomolar,748201,=,1,1,=,,IC50,nM,,9000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,9.0,PIM1 kinase
,,2247147,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCSc1nnc(SCCC(=O)O)s1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '16.20', 'le': '0.38', 'lle': '3.10', 'sei': '4.75'}",CHEMBL455496,,CHEMBL455496,4.77,0,http://www.openphacts.org/units/Nanomolar,748202,=,1,1,=,,IC50,nM,,17000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,17.0,PIM1 kinase
,,2247148,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2c(c1)c1nnc(SCc3ccc(CC(=O)O)cc3)nc1n2C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '11.81', 'le': '0.23', 'lle': '1.09', 'sei': '4.08'}",CHEMBL460982,,CHEMBL460982,4.82,0,http://www.openphacts.org/units/Nanomolar,748203,=,1,1,=,,IC50,nM,,15000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,15.0,PIM1 kinase
,,2247149,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)Cc1cc(S(=O)(=O)c2ccc(Sc3ccc(C(=O)O)cc3)cc2)ccc1C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '11.42', 'le': '0.23', 'lle': '1.71', 'sei': '3.70'}",CHEMBL517724,,CHEMBL517724,5.40,0,http://www.openphacts.org/units/Nanomolar,748278,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.0,PIM1 kinase
,,2247150,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCn1c(=S)n(CCC(=O)O)c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '16.39', 'le': '0.33', 'lle': '2.70', 'sei': '5.71'}",CHEMBL460563,,CHEMBL460563,4.82,0,http://www.openphacts.org/units/Nanomolar,748279,=,1,1,=,,IC50,nM,,15000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,15.0,PIM1 kinase
,,2247151,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)Cn1c(=O)n(CC(=O)O)c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '19.17', 'le': '0.36', 'lle': '4.83', 'sei': '4.72'}",CHEMBL509657,,CHEMBL509657,4.80,0,http://www.openphacts.org/units/Nanomolar,748280,=,1,1,=,,IC50,nM,,16000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,16.0,PIM1 kinase
,,2247152,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1oc(C(=O)O)cc1CSCC(C)C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '18.03', 'le': '0.37', 'lle': '2.42', 'sei': '5.31'}",CHEMBL448958,,CHEMBL448958,4.66,0,http://www.openphacts.org/units/Nanomolar,748281,=,1,1,=,,IC50,nM,,22000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,22.0,PIM1 kinase
,,2247153,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(C(=O)O)c(CSCc2cc(C(=O)O)oc2C)o1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '15.14', 'le': '0.31', 'lle': '1.38', 'sei': '4.66'}",CHEMBL512761,,CHEMBL512761,4.70,0,http://www.openphacts.org/units/Nanomolar,748282,=,1,1,=,,IC50,nM,,20000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,20.0,PIM1 kinase
,,2247154,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCN1C(=O)/C(=C2/C(=O)N(CC(=O)O)c3ccccc32)SC1=S,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.31', 'le': '0.27', 'lle': '4.06', 'sei': '4.53'}",CHEMBL462690,,CHEMBL462690,5.22,0,http://www.openphacts.org/units/Nanomolar,748283,=,1,1,=,,IC50,nM,,6000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.0,PIM1 kinase
,,2247155,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCCN1C(=O)/C(=C2/C(=O)N(CC(=O)O)c3ccccc32)SC1=S,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '12.11', 'le': '0.25', 'lle': '3.37', 'sei': '4.27'}",CHEMBL462261,,CHEMBL462261,4.92,0,http://www.openphacts.org/units/Nanomolar,748443,=,1,1,=,,IC50,nM,,12000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,12.0,PIM1 kinase
,,2247156,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(Oc1cc(OC(C)C(=O)O)c2c(c1)oc(=O)c1ccccc12)C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.69', 'le': '0.26', 'lle': '2.45', 'sei': '4.13'}",CHEMBL460782,,CHEMBL460782,5.10,0,http://www.openphacts.org/units/Nanomolar,748444,=,1,1,=,,IC50,nM,,8000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,8.0,PIM1 kinase
,,2247157,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CC1OC(=O)c2cc3c(cc21)C(=O)OC3CC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '16.19', 'le': '0.31', 'lle': '3.90', 'sei': '3.90'}",CHEMBL460783,,CHEMBL460783,4.96,0,http://www.openphacts.org/units/Nanomolar,748445,=,1,1,=,,IC50,nM,,11000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,11.0,PIM1 kinase
,,2247158,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc2ccc(C(=O)O)cc2c(O)c1CCC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '17.07', 'le': '0.32', 'lle': '2.74', 'sei': '4.36'}",CHEMBL448036,,CHEMBL448036,4.70,0,http://www.openphacts.org/units/Nanomolar,748446,=,1,1,=,,IC50,nM,,20000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,20.0,PIM1 kinase
,,2247159,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CSc1cc(-c2ccccc2)nc(SCC(=O)O)n1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '14.04', 'le': '0.29', 'lle': '2.22', 'sei': '4.70'}",CHEMBL460784,,CHEMBL460784,4.72,0,http://www.openphacts.org/units/Nanomolar,748447,=,1,1,=,,IC50,nM,,19000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,19.0,PIM1 kinase
,,2247160,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1oc(C)c(C(=O)NCC(=O)O)c1C(=O)NCC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '15.37', 'le': '0.30', 'lle': '5.06', 'sei': '3.14'}",CHEMBL510354,,CHEMBL510354,4.58,0,http://www.openphacts.org/units/Nanomolar,748448,=,1,1,=,,IC50,nM,,26000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,26.0,PIM1 kinase
,,2247161,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1oc(C)c(C(=O)O)c1COc1ccccc1C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '17.99', 'le': '0.34', 'lle': '2.35', 'sei': '5.39'}",CHEMBL467436,,CHEMBL467436,5.22,0,http://www.openphacts.org/units/Nanomolar,748534,=,1,1,=,,IC50,nM,,6000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.0,PIM1 kinase
,,2247162,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CN1C(=O)/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)SC1=S,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.41', 'le': '0.27', 'lle': '2.29', 'sei': '4.83'}",CHEMBL512260,,CHEMBL512260,5.22,0,http://www.openphacts.org/units/Nanomolar,748535,=,1,1,=,,IC50,nM,,6000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.0,PIM1 kinase
,,2247163,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccc2c(c1)C(=O)N(c1ccccc1C(=O)O)C2=O)c1ccc2c(c1)C(=O)N(c1ccccc1C(=O)O)C2=O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '9.09', 'le': '0.17', 'lle': '1.18', 'sei': '3.06'}",CHEMBL449985,,CHEMBL449985,5.10,0,http://www.openphacts.org/units/Nanomolar,748536,=,1,1,=,,IC50,nM,,8000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,8.0,PIM1 kinase
,,2247164,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)Cn1c(CCCCc2nc3ccccc3n2CC(=O)O)nc2ccccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.28', 'le': '0.25', 'lle': '2.28', 'sei': '4.90'}",CHEMBL467435,,CHEMBL467435,5.40,0,http://www.openphacts.org/units/Nanomolar,748537,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.0,PIM1 kinase
,,2247165,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ncnc2[nH]c(SCCC(=O)O)nc12,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '19.64', 'le': '0.40', 'lle': '4.20', 'sei': '3.99'}",CHEMBL510282,,CHEMBL510282,4.70,0,http://www.openphacts.org/units/Nanomolar,748538,=,1,1,=,,IC50,nM,,20000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,20.0,PIM1 kinase
,,2247166,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2ccc(CCC(=O)O)n2CC(=O)O)cc1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '17.13', 'le': '0.32', 'lle': '2.35', 'sei': '6.19'}",CHEMBL512261,,CHEMBL512261,4.92,0,http://www.openphacts.org/units/Nanomolar,748539,=,1,1,=,,IC50,nM,,12000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,12.0,PIM1 kinase
,,2247167,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCc1ccc(-c2ccc(F)cc2)n1CC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '17.32', 'le': '0.33', 'lle': '2.65', 'sei': '6.34'}",CHEMBL466401,,CHEMBL466401,5.05,0,http://www.openphacts.org/units/Nanomolar,748540,=,1,1,=,,IC50,nM,,9000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,9.0,PIM1 kinase
,,2247168,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1ccc(S(=O)(=O)c2ccc(Sc3ccc(C(=O)O)c(C(=O)O)c3)cc2)cc1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '11.39', 'le': '0.23', 'lle': '1.45', 'sei': '3.58'}",CHEMBL460348,,CHEMBL460348,5.22,0,http://www.openphacts.org/units/Nanomolar,748205,=,1,1,=,,IC50,nM,,6000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.0,PIM1 kinase
,,2247169,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1ccc(Oc2ccc(S(=O)(=O)c3ccc(C(=O)O)c(C(=O)O)c3)cc2)cc1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '11.30', 'le': '0.22', 'lle': '1.59', 'sei': '3.22'}",CHEMBL460347,,CHEMBL460347,5.00,0,http://www.openphacts.org/units/Nanomolar,748206,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.0,PIM1 kinase
,,2247170,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CN1C(=O)/C(=C2/C(=O)N(CC(=O)O)c3ccccc32)SC1=S,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '12.91', 'le': '0.27', 'lle': '4.12', 'sei': '4.24'}",CHEMBL517107,,CHEMBL517107,4.89,0,http://www.openphacts.org/units/Nanomolar,748207,=,1,1,=,,IC50,nM,,13000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,13.0,PIM1 kinase
,,2247171,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CN1C(=O)/C(=C2\SC(=S)N(C(Cc3ccccc3)C(=O)O)C2=O)c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '11.79', 'le': '0.24', 'lle': '3.13', 'sei': '4.79'}",CHEMBL409315,,CHEMBL409315,5.52,0,http://www.openphacts.org/units/Nanomolar,748208,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,2247172,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CN1C(=O)/C(=C2\SC(=S)N(NC(=O)c3ccccc3O)C2=O)c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '10.89', 'le': '0.22', 'lle': '3.22', 'sei': '3.90'}",CHEMBL517857,,CHEMBL517857,4.96,0,http://www.openphacts.org/units/Nanomolar,748284,=,1,1,=,,IC50,nM,,11000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,11.0,PIM1 kinase
,,2247173,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CN1C(=O)/C(=C2\SC(=S)N(c3ccc(Br)cc3)C2=O)c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '10.99', 'le': '0.25', 'lle': '1.56', 'sei': '6.70'}",CHEMBL459501,,CHEMBL459501,5.22,0,http://www.openphacts.org/units/Nanomolar,748285,=,1,1,=,,IC50,nM,,6000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.0,PIM1 kinase
,,2247174,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CN1C(=O)/C(=C2\SC(=S)NC2=O)c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '15.75', 'le': '0.33', 'lle': '4.07', 'sei': '5.82'}",CHEMBL462260,,CHEMBL462260,5.05,0,http://www.openphacts.org/units/Nanomolar,748442,=,1,1,=,,IC50,nM,,9000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,9.0,PIM1 kinase
,,2247175,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1oc(CSCCSCc2cc(C(=O)O)c(C)o2)cc1C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '14.31', 'le': '0.30', 'lle': '1.25', 'sei': '5.25'}",CHEMBL461840,,CHEMBL461840,5.30,0,http://www.openphacts.org/units/Nanomolar,748286,=,1,1,=,,IC50,nM,,5000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.0,PIM1 kinase
,,2247176,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(CSCc2cc(C(=O)O)c(C)o2)oc1C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '16.83', 'le': '0.34', 'lle': '1.90', 'sei': '5.18'}",CHEMBL512049,,CHEMBL512049,5.22,0,http://www.openphacts.org/units/Nanomolar,748287,=,1,1,=,,IC50,nM,,6000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.0,PIM1 kinase
,,2247177,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(OCc2ccoc2C(=O)O)cc1C,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '20.14', 'le': '0.38', 'lle': '1.79', 'sei': '8.31'}",CHEMBL447111,,CHEMBL447111,4.96,0,http://www.openphacts.org/units/Nanomolar,748541,=,1,1,=,,IC50,nM,,11000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,11.0,PIM1 kinase
,,2247178,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1oc2ccccc2c1CSc1ccccn1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '16.01', 'le': '0.31', 'lle': '0.75', 'sei': '7.21'}",CHEMBL448841,,CHEMBL448841,4.57,0,http://www.openphacts.org/units/Nanomolar,748542,=,1,1,=,,IC50,nM,,27000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,27.0,PIM1 kinase
,,2247179,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1oc(CSCC2CCCO2)cc1C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '18.71', 'le': '0.39', 'lle': '2.10', 'sei': '8.04'}",CHEMBL505863,,CHEMBL505863,4.80,0,http://www.openphacts.org/units/Nanomolar,748543,=,1,1,=,,IC50,nM,,16000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,16.0,PIM1 kinase
,,2247180,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCNc1ccc(Br)cc1C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '15.60', 'le': '0.38', 'lle': '2.46', 'sei': '5.19'}",CHEMBL500760,,CHEMBL500760,4.50,0,http://www.openphacts.org/units/Nanomolar,748544,=,1,1,=,,IC50,nM,,32000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,32.0,PIM1 kinase
,,2247181,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCC1(CCC(=O)O)c2ccccc2-c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.86', 'le': '0.26', 'lle': '0.62', 'sei': '5.77'}",CHEMBL511379,,CHEMBL511379,4.30,0,http://www.openphacts.org/units/Nanomolar,748545,=,1,1,=,,IC50,nM,,50000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,50.0,PIM1 kinase
,,2247182,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(O)c12)c1ccccc1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '10.79', 'le': '0.22', 'lle': '2.28', 'sei': '2.89'}",CHEMBL145352,,CHEMBL145352,4.57,0,http://www.openphacts.org/units/Nanomolar,748546,=,1,1,=,,IC50,nM,,27000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,27.0,PIM1 kinase
,,2247183,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1([N+](=O)[O-])CN(CCC(=O)O)CN(CCC(=O)O)C1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '14.87', 'le': '0.29', 'lle': '4.75', 'sei': '3.46'}",CHEMBL468905,,CHEMBL468905,4.30,0,http://www.openphacts.org/units/Nanomolar,748547,=,1,1,=,,IC50,nM,,50000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,50.0,PIM1 kinase
,,2247184,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCn1c(=O)[nH]c(=O)n(CCC(=O)O)c1=O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '16.40', 'le': '0.32', 'lle': '6.83', 'sei': '2.96'}",CHEMBL469106,,CHEMBL469106,4.48,0,http://www.openphacts.org/units/Nanomolar,748631,=,1,1,=,,IC50,nM,,33000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,33.0,PIM1 kinase
,,2247185,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCS(=O)(=O)CCC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '20.92', 'le': '0.46', 'lle': '5.05', 'sei': '4.04'}",CHEMBL498855,,CHEMBL498855,4.40,0,http://www.openphacts.org/units/Nanomolar,748632,=,1,1,=,,IC50,nM,,40000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,40.0,PIM1 kinase
,,2247186,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CC[S+]([O-])CCC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '22.65', 'le': '0.50', 'lle': '4.72', 'sei': '4.50'}",CHEMBL509918,,CHEMBL509918,4.40,0,http://www.openphacts.org/units/Nanomolar,748633,=,1,1,=,,IC50,nM,,40000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,40.0,PIM1 kinase
,,2247187,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CSc1cccc(C(=O)O)c1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '21.12', 'le': '0.44', 'lle': '2.92', 'sei': '6.01'}",CHEMBL500208,,CHEMBL500208,4.48,0,http://www.openphacts.org/units/Nanomolar,748634,=,1,1,=,,IC50,nM,,33000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,33.0,PIM1 kinase
,,2247188,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cccc(NC(=O)C2CCCCC2C(=O)O)c1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '14.62', 'le': '0.28', 'lle': '2.05', 'sei': '4.11'}",CHEMBL468074,,CHEMBL468074,4.26,0,http://www.openphacts.org/units/Nanomolar,748635,=,1,1,=,,IC50,nM,,55000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,55.0,PIM1 kinase
,,2247189,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(N(CCC(=O)O)CCC(=O)O)sc1C(C)(C)C,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.43', 'le': '0.27', 'lle': '1.72', 'sei': '4.65'}",CHEMBL467863,,CHEMBL467863,4.22,0,http://www.openphacts.org/units/Nanomolar,748636,=,1,1,=,,IC50,nM,,60000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,60.0,PIM1 kinase
,,2247190,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CNS(=O)(=O)c1ccc2c(c1)C(=O)c1cc(S(=O)(=O)NCC(=O)O)ccc1-2,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '9.46', 'le': '0.20', 'lle': '4.68', 'sei': '2.34'}",CHEMBL468072,,CHEMBL468072,4.30,0,http://www.openphacts.org/units/Nanomolar,748637,=,1,1,=,,IC50,nM,,50000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,50.0,PIM1 kinase
,,2247191,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1oc(C(=O)O)cc1CSCc1cc(C(=O)O)oc1C,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '14.17', 'le': '0.29', 'lle': '1.08', 'sei': '4.36'}",CHEMBL503504,,CHEMBL503504,4.40,0,http://www.openphacts.org/units/Nanomolar,748210,=,1,1,=,,IC50,nM,,40000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,40.0,PIM1 kinase
,,2247192,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCC(=O)NC(Cc1ccccc1)C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '16.58', 'le': '0.32', 'lle': '3.74', 'sei': '4.24'}",CHEMBL446487,,CHEMBL446487,4.40,0,http://www.openphacts.org/units/Nanomolar,748211,=,1,1,=,,IC50,nM,,40000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,40.0,PIM1 kinase
,,2247193,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(S(=O)(=O)N2CCC(C(=O)O)CC2)cc1C(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.17', 'le': '0.27', 'lle': '3.64', 'sei': '3.73'}",CHEMBL462689,,CHEMBL462689,4.52,0,http://www.openphacts.org/units/Nanomolar,748212,=,1,1,=,,IC50,nM,,30000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,30.0,PIM1 kinase
,,2247194,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCn1c(=O)oc2cc(S(=O)(=O)O)ccc21,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '14.26', 'le': '0.29', 'lle': '3.78', 'sei': '3.23'}",CHEMBL442876,,CHEMBL442876,4.10,0,http://www.openphacts.org/units/Nanomolar,748213,=,1,1,=,,IC50,nM,,80000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,80.0,PIM1 kinase
,,2247195,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CC(CC(=O)Nc1nnn[nH]1)c1ccccc1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '16.43', 'le': '0.31', 'lle': '3.73', 'sei': '3.74'}",CHEMBL461633,,CHEMBL461633,4.52,0,http://www.openphacts.org/units/Nanomolar,748214,=,1,1,=,,IC50,nM,,30000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,30.0,PIM1 kinase
,,2247196,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCc1nc2cc(C(=O)O)ccc2[nH]1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '17.49', 'le': '0.33', 'lle': '2.82', 'sei': '3.97'}",CHEMBL461842,,CHEMBL461842,4.10,0,http://www.openphacts.org/units/Nanomolar,748289,=,1,1,=,,IC50,nM,,80000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,80.0,PIM1 kinase
,,2247197,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cccc(S(=O)(=O)N2CCCC(c3nc(O)c4nnn(Cc5ccc(F)cc5)c4n3)C2)c1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '8.74', 'le': '0.17', 'lle': '2.10', 'sei': '2.96'}",CHEMBL462049,,CHEMBL462049,4.48,0,http://www.openphacts.org/units/Nanomolar,748290,=,1,1,=,,IC50,nM,,33000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,33.0,PIM1 kinase
,,2247198,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cccc(S(=O)(=O)N2CCCC(c3nc(O)c4nnn(Cc5ccccc5Cl)c4n3)C2)c1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '7.68', 'le': '0.15', 'lle': '1.16', 'sei': '2.68'}",CHEMBL460570,,CHEMBL460570,4.06,0,http://www.openphacts.org/units/Nanomolar,748291,=,1,1,=,,IC50,nM,,87000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,87.0,PIM1 kinase
,,2247199,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)c1ccc(-c2noc(C3CCN(S(=O)(=O)c4cccc(C(=O)O)c4)CC3)n2)cc1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '9.63', 'le': '0.19', 'lle': '1.33', 'sei': '3.76'}",CHEMBL460571,,CHEMBL460571,4.40,0,http://www.openphacts.org/units/Nanomolar,748292,=,1,1,=,,IC50,nM,,40000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,40.0,PIM1 kinase
,,2247200,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1nnc(NS(=O)(=O)c2ccc(NC(=O)CCC(=O)O)cc2)s1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '10.66', 'le': '0.22', 'lle': '2.40', 'sei': '2.96'}",CHEMBL512214,,CHEMBL512214,4.10,0,http://www.openphacts.org/units/Nanomolar,748293,=,1,1,=,,IC50,nM,,80000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,80.0,PIM1 kinase
,,2247201,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(CCc1ccc2c(c1)OCO2)=N\N=C1/NC(=O)CC(C(=O)O)S1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '11.84', 'le': '0.23', 'lle': '2.51', 'sei': '3.93'}",CHEMBL461841,,CHEMBL461841,4.30,0,http://www.openphacts.org/units/Nanomolar,748288,=,1,1,=,,IC50,nM,,50000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,50.0,PIM1 kinase
,,2247202,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cccc(S(=O)(=O)N2CCS(=O)(=O)CC2)c1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '12.83', 'le': '0.28', 'lle': '4.30', 'sei': '3.76'}",CHEMBL450862,,CHEMBL450862,4.10,0,http://www.openphacts.org/units/Nanomolar,748638,=,1,1,=,,IC50,nM,,80000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,80.0,PIM1 kinase
,,2247203,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCS(=O)(=O)c1cccc2c(S(=O)(=O)CCC(=O)O)cccc12,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '11.13', 'le': '0.23', 'lle': '3.12', 'sei': '3.12'}",CHEMBL468073,,CHEMBL468073,4.46,0,http://www.openphacts.org/units/Nanomolar,748639,=,1,1,=,,IC50,nM,,35000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,35.0,PIM1 kinase
,,2247204,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1ccccc1C(=O)NCc1ccc(CNC(=O)c2ccccc2C(=O)O)cc1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '10.46', 'le': '0.19', 'lle': '1.58', 'sei': '3.41'}",CHEMBL467237,,CHEMBL467237,4.52,0,http://www.openphacts.org/units/Nanomolar,748640,=,1,1,=,,IC50,nM,,30000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,30.0,PIM1 kinase
,,2247205,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(-c2ccc(N)c(S(=O)(=O)O)c2)cc1S(=O)(=O)O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467238,,CHEMBL467238,,0,http://www.openphacts.org/units/Nanomolar,748641,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247206,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(O)CCSc1nnc(SCCS(=O)(=O)O)s1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467239,,CHEMBL467239,,0,http://www.openphacts.org/units/Nanomolar,748642,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247207,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(O)c1cc(O)c2c(S(=O)(=O)O)cc(S(=O)(=O)O)cc2c1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL453929,,CHEMBL453929,,0,http://www.openphacts.org/units/Nanomolar,748643,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247208,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)C(CCc1nn[nH]n1)(CCc1nn[nH]n1)C(=O)OCC,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL500986,,CHEMBL500986,,0,http://www.openphacts.org/units/Nanomolar,748714,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247209,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(O)CCCSc1sc2ccccc2[n+]1CCCS(=O)(=O)O.[Cl-],,,CHEMBL1139343,J Med Chem,2009,,CHEMBL541931,,CHEMBL466820,,0,http://www.openphacts.org/units/Nanomolar,748715,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247210,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=P(O)(O)c1ccccc1OCCOc1ccccc1P(=O)(O)O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL469118,,CHEMBL469118,,0,http://www.openphacts.org/units/Nanomolar,748716,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247211,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(O)c1ccccc1Nc1ccnc(Nc2ccccc2S(=O)(=O)O)n1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL466002,,CHEMBL466002,,0,http://www.openphacts.org/units/Nanomolar,748717,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247212,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(C(=O)O)c(CSCc2cc(C(=O)O)c(C)o2)o1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL511372,,CHEMBL511372,,0,http://www.openphacts.org/units/Nanomolar,748718,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247213,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCC1(CCC(=O)O)CCCCC1=O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL466003,,CHEMBL466003,,0,http://www.openphacts.org/units/Nanomolar,748719,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247214,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(-c2nn[nH]n2)ccc1OCC(=O)O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461634,,CHEMBL461634,,0,http://www.openphacts.org/units/Nanomolar,748216,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247215,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(c1cc(S(=O)(=O)N2CCOCC2)c2n[n+]3c4cc(S(=O)(=O)N5CCOCC5)cc(S(=O)(=O)N5CCOCC5)c4[n-]n3c2c1)N1CCOCC1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL508178,,CHEMBL508178,,0,http://www.openphacts.org/units/Nanomolar,748217,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247216,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)c1cnc(SC(C)C(=O)O)nc1N,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461635,,CHEMBL461635,,0,http://www.openphacts.org/units/Nanomolar,748218,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247217,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCS(=O)(=O)N1CCN(S(=O)(=O)c2ccc(C(=O)O)cc2)CC1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461839,,CHEMBL461839,,0,http://www.openphacts.org/units/Nanomolar,748219,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247218,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(NC(=O)c2ccco2)sc1C(=O)O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL512048,,CHEMBL512048,,0,http://www.openphacts.org/units/Nanomolar,748220,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247219,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(c1ccc(C(=O)O)cc1)S(=O)(=O)c1cccs1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL511180,,CHEMBL511180,,0,http://www.openphacts.org/units/Nanomolar,748221,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247220,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCc1nc(-c2ccc(Cl)cc2)no1)Nc1nnn[nH]1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460572,,CHEMBL460572,,0,http://www.openphacts.org/units/Nanomolar,748294,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247221,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1C(=O)c2ccccc2S1(=O)=O)Nc1ccc(Cl)c(C(=O)O)c1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459300,,CHEMBL459300,,0,http://www.openphacts.org/units/Nanomolar,748295,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247222,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)c1cc(S(=O)(=O)NCc2ccc(C(=O)O)cc2)c(C)s1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL448408,,CHEMBL448408,,0,http://www.openphacts.org/units/Nanomolar,748296,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247223,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCNC(=O)c1cc(S(=O)(=O)NCCC(=O)O)c(C)s1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459301,,CHEMBL459301,,0,http://www.openphacts.org/units/Nanomolar,748297,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247224,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)Nc1nc(CC(=O)O)cs1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL502103,,CHEMBL502103,,0,http://www.openphacts.org/units/Nanomolar,748298,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247225,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cccc(NS(=O)(=O)c2cccc3nsnc23)c1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459302,,CHEMBL459302,,0,http://www.openphacts.org/units/Nanomolar,748299,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247226,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C(=O)O)cc2)nn1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL462051,,CHEMBL462051,,0,http://www.openphacts.org/units/Nanomolar,748441,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247227,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)O)cc1S(=O)(=O)NCc1cccnc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL466004,,CHEMBL466004,,0,http://www.openphacts.org/units/Nanomolar,748720,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247228,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCCNc1n[nH]c(=O)[nH]c1=O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL447958,,CHEMBL447958,,0,http://www.openphacts.org/units/Nanomolar,748721,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247229,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CNC(=O)c1cc(=O)[nH]c(=O)[nH]1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460593,,CHEMBL460593,,0,http://www.openphacts.org/units/Nanomolar,748722,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247230,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1ccc(NS(=O)(=O)c2cccs2)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460801,,CHEMBL460801,,0,http://www.openphacts.org/units/Nanomolar,748723,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247231,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cccc(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc([N+](=O)[O-])c2)c1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL516484,,CHEMBL516484,,0,http://www.openphacts.org/units/Nanomolar,748724,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247232,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(O)CC(O)CSc1nc2ccccc2s1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.10', 'le': '0.30', 'lle': '2.36', 'sei': '4.57'}",CHEMBL460802,,CHEMBL460802,4.00,0,http://www.openphacts.org/units/Nanomolar,748725,=,1,1,=,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247233,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CSC1CCS(=O)(=O)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL475281,,CHEMBL475281,,0,http://www.openphacts.org/units/Nanomolar,748726,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247234,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CSc1ccc(C(=O)O)cc1[N+](=O)[O-],,,CHEMBL1139343,J Med Chem,2009,"{'bei': '15.55', 'le': '0.32', 'lle': '2.53', 'sei': '3.40'}",CHEMBL466206,,CHEMBL466206,4.00,0,http://www.openphacts.org/units/Nanomolar,748787,=,1,1,=,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247235,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CNC1CS(=O)(=O)CC1O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL447590,,CHEMBL447590,,0,http://www.openphacts.org/units/Nanomolar,748788,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247236,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,C=CCN1C(=S)S/C(=C/C=C2\Sc3ccccc3N2CCCS(=O)(=O)O)C1=S,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461009,,CHEMBL461009,,0,http://www.openphacts.org/units/Nanomolar,748789,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247237,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CC1S/C(=N/N=C/c2ccco2)NC1=O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL505114,,CHEMBL505114,,0,http://www.openphacts.org/units/Nanomolar,748790,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247238,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1(C)C(C(=O)O)N2C(=O)C(NC(=O)C(C(=O)O)c3ccccc3)C2[S+]1[O-],,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460803,,CHEMBL460803,,0,http://www.openphacts.org/units/Nanomolar,748791,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247239,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)CSc1nc2ccc(NC(=O)c3ccccc3C(=O)O)cc2s1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '11.79', 'le': '0.24', 'lle': '1.75', 'sei': '3.73'}",CHEMBL460804,,CHEMBL460804,4.57,0,http://www.openphacts.org/units/Nanomolar,748792,=,1,1,=,,IC50,nM,,27000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,27.0,PIM1 kinase
,,2247240,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1NC(=O)c1cccc(NC(=O)CCC(=O)O)c1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '13.65', 'le': '0.25', 'lle': '1.41', 'sei': '4.67'}",CHEMBL460353,,CHEMBL460353,4.46,0,http://www.openphacts.org/units/Nanomolar,748223,=,1,1,=,,IC50,nM,,35000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,35.0,PIM1 kinase
,,2247241,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=[N+]([O-])c1ccccc1-c1nnc(CSc2nnc(-c3ccccc3O)o2)o1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460354,,CHEMBL460354,,0,http://www.openphacts.org/units/Nanomolar,748224,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247242,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=[N+]([O-])c1ccccc1-c1nnc(CSc2nc(-c3ccccc3O)n[nH]2)o1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL462696,,CHEMBL462696,,0,http://www.openphacts.org/units/Nanomolar,748225,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247243,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,N#C/C(=C\c1ccc(-c2ccccc2[N+](=O)[O-])o1)S(=O)(=O)c1ccccc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL518673,,CHEMBL518673,,0,http://www.openphacts.org/units/Nanomolar,748226,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247244,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cc2c(=O)c(-c3nc4ccccc4s3)c(C)oc2cc1OS(C)(=O)=O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461208,,CHEMBL461208,,0,http://www.openphacts.org/units/Nanomolar,748300,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247245,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1O)c1cc(S(=O)(=O)N2CCCCCC2)ccc1Cl,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL518188,,CHEMBL518188,,0,http://www.openphacts.org/units/Nanomolar,748301,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247246,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1O)c1cccc(S(=O)(=O)N2CCCC2)c1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461209,,CHEMBL461209,,0,http://www.openphacts.org/units/Nanomolar,748302,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247247,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(NCc1ccccc1)c1ccc(S(=O)(=O)N(Cc2ccc(Cl)cc2)Cc2ccco2)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461424,,CHEMBL461424,,0,http://www.openphacts.org/units/Nanomolar,748303,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247248,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1C(=O)NCC(C)(C)CNC1=NS(=O)(=O)c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL518634,,CHEMBL518634,,0,http://www.openphacts.org/units/Nanomolar,748304,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247249,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Nc1ccc(NS(=O)(=O)c2cccs2)cc1)c1cccs1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461010,,CHEMBL461010,,0,http://www.openphacts.org/units/Nanomolar,748793,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247250,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)CCc2nnc(NC(=O)CC3CC4CCC3C4)s2)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459744,,CHEMBL459744,,0,http://www.openphacts.org/units/Nanomolar,748794,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247251,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)S(=O)(=O)c1ccc(OC)c(NC(=O)C2CCCO2)c1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459529,,CHEMBL459529,,0,http://www.openphacts.org/units/Nanomolar,748795,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247252,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)NS(=O)(=O)c1ccc2oc3ccc(S(=O)(=O)NC(C)(C)C)cc3c2c1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459743,,CHEMBL459743,,0,http://www.openphacts.org/units/Nanomolar,748796,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247253,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2nnc3c4ccccc4c(C)nn23)cc1S(=O)(=O)N1CCOCC1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL516778,,CHEMBL516778,,0,http://www.openphacts.org/units/Nanomolar,748797,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247254,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)COc1ccc(S(=O)(=O)N2CCCCC2)cc1C,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL452994,,CHEMBL452994,,0,http://www.openphacts.org/units/Nanomolar,748868,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247255,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)C1C(=O)C2=C(CC1C)NC(C)=C(C(=O)OC1CCCC1)C2c1ccccc1C,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467217,,CHEMBL467217,,0,http://www.openphacts.org/units/Nanomolar,748869,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247256,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Cn1cc(C(=O)c2ccco2)c2ccccc21)NCc1cccnc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL511913,,CHEMBL511913,,0,http://www.openphacts.org/units/Nanomolar,748870,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247257,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)C1C(=O)c2c([nH]c(C(=O)OC3CCCCC3)c2C)CC1C,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467423,,CHEMBL467423,,0,http://www.openphacts.org/units/Nanomolar,748871,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247258,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)C1C(=O)c2c([nH]c(C(=O)OCC3CCCO3)c2C)CC1C,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL448847,,CHEMBL448847,,0,http://www.openphacts.org/units/Nanomolar,748872,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247259,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(S(=O)(=O)N2CCOCC2)ccc1OCC(=O)N1CCCC1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL448142,,CHEMBL448142,,0,http://www.openphacts.org/units/Nanomolar,748228,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247260,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,C=CCn1c(Cc2ccccc2)nnc1SCC(=O)Nc1nnc(C)s1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460993,,CHEMBL460993,,0,http://www.openphacts.org/units/Nanomolar,748229,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247261,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)S(=O)(=O)c1cccc(C(=O)Nc2ccccc2C(=O)O)c1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '10.63', 'le': '0.21', 'lle': '1.33', 'sei': '3.85'}",CHEMBL460994,,CHEMBL460994,4.00,0,http://www.openphacts.org/units/Nanomolar,748230,=,1,1,=,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247262,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(OS(=O)(=O)c2ccccc2)cccc1OS(=O)(=O)c1ccccc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460995,,CHEMBL460995,,0,http://www.openphacts.org/units/Nanomolar,748231,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247263,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,C=CCN1C(=O)C(Cc2ccccc2)S/C1=N/c1ccc(C(=O)O)cc1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '10.92', 'le': '0.21', 'lle': '0.25', 'sei': '5.72'}",CHEMBL459939,,CHEMBL459939,4.00,0,http://www.openphacts.org/units/Nanomolar,748305,=,1,1,=,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247264,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1nnc(CCS(=O)(=O)c2ccc3ccccc3c2)s1)c1ccccc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL517101,,CHEMBL517101,,0,http://www.openphacts.org/units/Nanomolar,748306,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247265,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1nnc(CCS(=O)(=O)c2ccc3ccccc3c2)s1)c1ccccc1Cl,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459940,,CHEMBL459940,,0,http://www.openphacts.org/units/Nanomolar,748307,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247266,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(Nc1ccccc1O)c1cc(S(=O)(=O)N2CCCCC2)ccc1Cl,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461852,,CHEMBL461852,,0,http://www.openphacts.org/units/Nanomolar,748308,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247267,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(c1ccc(C(O)(C(=O)OC)C(F)(F)F)cc1)S(=O)(=O)c1ccc(C)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL462059,,CHEMBL462059,,0,http://www.openphacts.org/units/Nanomolar,748309,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247268,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(/C=C/C(=O)O)cc1S(=O)(=O)NC1CCS(=O)(=O)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL448868,,CHEMBL448868,,0,http://www.openphacts.org/units/Nanomolar,748873,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247269,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCC(=O)N(Cc1ccc(S(N)(=O)=O)cc1)C1CC(=O)N(c2ccccc2)C1=O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL466178,,CHEMBL466178,,0,http://www.openphacts.org/units/Nanomolar,748874,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247270,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOC(=O)C(=Cc1c[nH]c2ccc(S(=O)(=O)N(C)C)cc12)C(=O)OCC,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL466179,,CHEMBL466179,,0,http://www.openphacts.org/units/Nanomolar,748875,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247271,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,C(=C/CSc1nnnn1-c1ccccc1)\CSc1nnnn1-c1ccccc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL511207,,CHEMBL511207,,0,http://www.openphacts.org/units/Nanomolar,748876,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247272,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1nnc(NC(=O)c2cc(S(=O)(=O)N(CC)CC)ccc2Cl)s1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468471,,CHEMBL468471,,0,http://www.openphacts.org/units/Nanomolar,748877,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247273,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(C=C2C(=O)OC3(CCCC3)OC2=O)cc(I)c1OCc1ccccc1C#N,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468683,,CHEMBL468683,,0,http://www.openphacts.org/units/Nanomolar,748946,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247274,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(NC(=O)COc1ccccc1)C1=NS(=O)(=O)c2ccccc21,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL513348,,CHEMBL513348,,0,http://www.openphacts.org/units/Nanomolar,748947,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247275,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN1/C(=C2/SC(=S)N(NC(C)=O)C2=O)Sc2ccc(S(=O)(=O)C(F)(F)F)cc21,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468890,,CHEMBL468890,,0,http://www.openphacts.org/units/Nanomolar,748948,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247276,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(NC(=O)CCC(=O)O)ccc1NC(=O)c1cccs1,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '12.03', 'le': '0.24', 'lle': '0.89', 'sei': '4.19'}",CHEMBL468891,,CHEMBL468891,4.00,0,http://www.openphacts.org/units/Nanomolar,748949,=,1,1,=,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247277,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(c1ccc(C(=O)Nc2ccc(F)cc2)cc1)S(=O)(=O)c1ccccc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467848,,CHEMBL467848,,0,http://www.openphacts.org/units/Nanomolar,748950,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247278,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)Nc2ccc(NC(=O)CN3CCCCC3)c(Cl)c2)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459727,,CHEMBL459727,,0,http://www.openphacts.org/units/Nanomolar,748233,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247279,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(C)nc(SCc2nnc(SCC(=O)N3CCCCC3)n2-c2ccccc2)n1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459728,,CHEMBL459728,,0,http://www.openphacts.org/units/Nanomolar,748234,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247280,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCOC(=O)c1ccc(NC(=O)CSc2nnnn2CC)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459938,,CHEMBL459938,,0,http://www.openphacts.org/units/Nanomolar,748235,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247281,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,C=CCSc1nnc(-c2ccc(NS(C)(=O)=O)cc2)n1C,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL512561,,CHEMBL512561,,0,http://www.openphacts.org/units/Nanomolar,748236,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247282,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(SCC(N)=O)nnc1-c1ccc(NS(C)(=O)=O)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL452114,,CHEMBL452114,,0,http://www.openphacts.org/units/Nanomolar,748310,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247283,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)CSc1nnc(-c2ccc(NS(C)(=O)=O)cc2)n1C,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL504860,,CHEMBL504860,,0,http://www.openphacts.org/units/Nanomolar,748311,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247284,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)CSc1nnc(-c2ccc(S(=O)(=O)N3CCCCC3)cc2)n1Cc1ccccc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL518027,,CHEMBL518027,,0,http://www.openphacts.org/units/Nanomolar,748312,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247285,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CSc1nnc(-c2ccc(S(=O)(=O)N3CCOCC3)cc2)n1Cc1ccco1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460792,,CHEMBL460792,,0,http://www.openphacts.org/units/Nanomolar,748313,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247286,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(SCC(=O)c2cccs2)nnc1-c1ccc(NS(C)(=O)=O)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL506724,,CHEMBL506724,,0,http://www.openphacts.org/units/Nanomolar,748314,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247287,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CCCCC1N(Cc1ccccc1F)S(=O)(=O)c1ccc(S(=O)(=O)N(C)C)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467849,,CHEMBL467849,,0,http://www.openphacts.org/units/Nanomolar,748951,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247288,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(S(=O)(=O)N(Cc2cccnc2)Cc2ccccc2Cl)ccc1-n1cnnn1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL512985,,CHEMBL512985,,0,http://www.openphacts.org/units/Nanomolar,748952,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247289,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(S(=O)(=O)N(Cc2ccc(Br)cc2)Cc2ccco2)ccc1-n1cnnn1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468059,,CHEMBL468059,,0,http://www.openphacts.org/units/Nanomolar,748953,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247290,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(S(=O)(=O)NC2CCCC2)ccc1-n1cnnn1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL513144,,CHEMBL513144,,0,http://www.openphacts.org/units/Nanomolar,748954,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247291,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cc(-n2cnnn2)c(OCC)cc1NC(=O)c1cc2cccc(OC)c2oc1=O,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL511935,,CHEMBL511935,,0,http://www.openphacts.org/units/Nanomolar,749057,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247292,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cc(S(=O)(=O)NCc2ccc3c(c2)OCO3)c(OCC)cc1-n1cnnn1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468480,,CHEMBL468480,,0,http://www.openphacts.org/units/Nanomolar,749058,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247293,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(S(=O)(=O)NC2CCCCC2C)ccc1-n1cnnn1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468481,,CHEMBL468481,,0,http://www.openphacts.org/units/Nanomolar,749059,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247294,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN(Cc1cccs1)S(=O)(=O)c1ccc(S(=O)(=O)NC2CC2)cc1)Nc1ccccc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468691,,CHEMBL468691,,0,http://www.openphacts.org/units/Nanomolar,749060,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247295,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CCc2c(sc3nc(C4CC4)n4c(SCC(=O)Nc5nccs5)nnc4c23)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461850,,CHEMBL461850,,0,http://www.openphacts.org/units/Nanomolar,748238,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247296,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(S(=O)(=O)CCc2nnc(NC(=O)CCc3ccccc3)s2)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL461851,,CHEMBL461851,,0,http://www.openphacts.org/units/Nanomolar,748239,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247297,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)NCc1nnc(SCC(=O)N2CCCCCC2)n1-c1ccc(F)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL517894,,CHEMBL517894,,0,http://www.openphacts.org/units/Nanomolar,748240,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247298,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1nnc(NC(=O)C2CCCN2S(=O)(=O)c2ccc(F)cc2)s1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL517260,,CHEMBL517260,,0,http://www.openphacts.org/units/Nanomolar,748241,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247299,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(Cn2nnc3c(O)nc(C4CCCN(S(=O)(=O)c5ccccc5)C4)nc32)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL518797,,CHEMBL518797,,0,http://www.openphacts.org/units/Nanomolar,748315,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247300,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(c1ccc(F)cc1)N1CCCC(c2nc(O)c3nnn(Cc4ccc(F)cc4)c3n2)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459310,,CHEMBL459310,,0,http://www.openphacts.org/units/Nanomolar,748316,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247301,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCS(=O)(=O)N1CCCC(c2nc(O)c3nnn(Cc4ccccc4)c3n2)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL459311,,CHEMBL459311,,0,http://www.openphacts.org/units/Nanomolar,748317,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247302,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(c1ccccc1)N1CCCC(c2nc(-c3ccc(F)cc3)no2)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL516612,,CHEMBL516612,,0,http://www.openphacts.org/units/Nanomolar,748318,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247303,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCS(=O)(=O)N1CCCC(c2nc(-c3ccc(C(C)C)cc3)no2)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467645,,CHEMBL467645,,0,http://www.openphacts.org/units/Nanomolar,749061,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247304,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(Cc1ccccc1)S(=O)(=O)c1ccc(S(=O)(=O)NC2CCC(C)CC2)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467646,,CHEMBL467646,,0,http://www.openphacts.org/units/Nanomolar,749062,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247305,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(N(CC(=O)NC2CCCC2)C(=O)C2CSC(=O)C2)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467858,,CHEMBL467858,,0,http://www.openphacts.org/units/Nanomolar,749063,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247306,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(c1ccc(OC(F)(F)F)cc1)N1CCCC(c2nc(O)c3nnn(Cc4ccccc4Cl)c3n2)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL467859,,CHEMBL467859,,0,http://www.openphacts.org/units/Nanomolar,749064,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247307,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1c(SCCN2CCCC2)nnc1C1CCCN(S(C)(=O)=O)C1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL513482,,CHEMBL513482,,0,http://www.openphacts.org/units/Nanomolar,749065,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247308,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(CCNS(=O)(=O)c2ccccc2)nnc1SCc1cccnc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468909,,CHEMBL468909,,0,http://www.openphacts.org/units/Nanomolar,749165,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247309,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(S(=O)(=O)N2CCc3ccccc32)ccc1OCC(=O)NCc1ccccn1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL513531,,CHEMBL513531,,0,http://www.openphacts.org/units/Nanomolar,749166,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247310,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(S(=O)(=O)N2CCOCC2)ccc1OCC(=O)O,,,CHEMBL1139343,J Med Chem,2009,"{'bei': '12.68', 'le': '0.26', 'lle': '3.52', 'sei': '4.29'}",CHEMBL469109,,CHEMBL469109,4.00,0,http://www.openphacts.org/units/Nanomolar,749167,=,1,1,=,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247311,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(-c2noc(CNC(=O)CN(C)S(=O)(=O)c3ccc4ccccc4c3)n2)cc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468490,,CHEMBL468490,,0,http://www.openphacts.org/units/Nanomolar,749168,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247312,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNS(=O)(=O)c1ccc(OCC(=O)NCC2CCCO2)c(C)c1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL468491,,CHEMBL468491,,0,http://www.openphacts.org/units/Nanomolar,749169,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247313,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(S(=O)(=O)N2CCOCC2)ccc1OCC(=O)NCc1ccncc1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460581,,CHEMBL460581,,0,http://www.openphacts.org/units/Nanomolar,748243,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247314,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCS(=O)(=O)Nc1cc2c(C(C)=O)c(C)n(S(=O)(=O)CC)c2cc1C,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL460582,,CHEMBL460582,,0,http://www.openphacts.org/units/Nanomolar,748244,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2247315,[],CHEMBL1021377,Inhibition of purified human recombinant APE1 expressed in Escherichia coli M15 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCS(=O)(=O)Nc1cc2c(cc1C)C(S(=O)(=O)CC)C1=C2CCC1,,,CHEMBL1139343,J Med Chem,2009,,CHEMBL506221,,CHEMBL506221,,0,http://www.openphacts.org/units/Nanomolar,748245,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,2989559,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '13.21', 'le': '0.25', 'lle': '0.89', 'sei': '5.56'}",CHEMBL578390,APX-3330,CHEMBL578390,5.00,0,http://www.openphacts.org/units/Nanomolar,861675,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.0,PIM1 kinase
,,2989560,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,COC1=C(OC)C(=O)C(/C=C/C(=O)O)=C(C)C1=O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '17.44', 'le': '0.33', 'lle': '3.80', 'sei': '4.89'}",CHEMBL569384,,CHEMBL569384,4.40,0,http://www.openphacts.org/units/Nanomolar,861676,=,1,1,=,,IC50,nM,,40000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,40.0,PIM1 kinase
,,2989561,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,COC1=C(OC)C(=O)C(/C=C(\C)C(=O)O)=C(C)C1=O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '20.74', 'le': '0.40', 'lle': '4.53', 'sei': '6.14'}",CHEMBL571611,,CHEMBL571611,5.52,0,http://www.openphacts.org/units/Nanomolar,861497,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,2989562,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '15.65', 'le': '0.30', 'lle': '2.66', 'sei': '5.37'}",CHEMBL571827,,CHEMBL571827,4.82,0,http://www.openphacts.org/units/Nanomolar,861498,=,1,1,=,,IC50,nM,,15000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,15.0,PIM1 kinase
,,2989563,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,COC1=C(OC)C(=O)C(/C=C(\C)C(=O)O)=C(Cl)C1=O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '19.27', 'le': '0.40', 'lle': '4.35', 'sei': '6.14'}",CHEMBL571828,,CHEMBL571828,5.52,0,http://www.openphacts.org/units/Nanomolar,861499,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,2989564,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,COCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '16.11', 'le': '0.31', 'lle': '3.99', 'sei': '5.04'}",CHEMBL577095,,CHEMBL577095,5.00,0,http://www.openphacts.org/units/Nanomolar,861507,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.0,PIM1 kinase
,,2989565,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)NCCO,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '11.86', 'le': '0.23', 'lle': '1.87', 'sei': '4.91'}",CHEMBL583347,,CHEMBL583347,5.00,0,http://www.openphacts.org/units/Nanomolar,861528,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.0,PIM1 kinase
,,2989566,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(=C\C1=CC(=O)c2ccccc2C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '22.80', 'le': '0.42', 'lle': '3.50', 'sei': '7.73'}",CHEMBL572065,,CHEMBL572065,5.52,0,http://www.openphacts.org/units/Nanomolar,861529,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,2989567,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1=C(/C=C(\C)C(=O)O)C(=O)c2ccccc2C1=O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '18.82', 'le': '0.35', 'lle': '2.41', 'sei': '6.75'}",CHEMBL571874,,CHEMBL571874,4.82,0,http://www.openphacts.org/units/Nanomolar,861559,=,1,1,=,,IC50,nM,,15000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,15.0,PIM1 kinase
,,2989568,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,COC1=C(/C=C(\C)C(=O)O)C(=O)c2ccccc2C1=O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '22.04', 'le': '0.41', 'lle': '4.00', 'sei': '7.44'}",CHEMBL577297,,CHEMBL577297,6.00,0,http://www.openphacts.org/units/Nanomolar,861604,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.0,PIM1 kinase
,,2989569,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,CSC1=C(/C=C(\C)C(=O)O)C(=O)c2ccccc2C1=O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '20.81', 'le': '0.41', 'lle': '3.29', 'sei': '8.40'}",CHEMBL572060,,CHEMBL572060,6.00,0,http://www.openphacts.org/units/Nanomolar,861605,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.0,PIM1 kinase
,,2989570,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(=C\C1=C(F)C(=O)c2ccccc2C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '20.74', 'le': '0.39', 'lle': '3.08', 'sei': '7.56'}",CHEMBL570986,,CHEMBL570986,5.40,0,http://www.openphacts.org/units/Nanomolar,861624,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.0,PIM1 kinase
,,2989571,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(=C\C1=C(Cl)C(=O)c2ccccc2C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '21.69', 'le': '0.43', 'lle': '3.41', 'sei': '8.40'}",CHEMBL568994,,CHEMBL568994,6.00,0,http://www.openphacts.org/units/Nanomolar,861625,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.0,PIM1 kinase
,,2989572,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(=C/C1=C(Cl)C(=O)c2ccccc2C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '20.60', 'le': '0.41', 'lle': '3.11', 'sei': '7.98'}",CHEMBL568995,,CHEMBL568995,5.70,0,http://www.openphacts.org/units/Nanomolar,861640,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.0,PIM1 kinase
,,2989573,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(=C\C1=C(Br)C(=O)c2ccccc2C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '17.75', 'le': '0.41', 'lle': '2.95', 'sei': '7.98'}",CHEMBL568996,,CHEMBL568996,5.70,0,http://www.openphacts.org/units/Nanomolar,861666,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.0,PIM1 kinase
,,2989574,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,COCC/C(=C\C1=C(C)C(=O)c2ccccc2C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '16.65', 'le': '0.31', 'lle': '2.57', 'sei': '6.20'}",CHEMBL569164,,CHEMBL569164,5.00,0,http://www.openphacts.org/units/Nanomolar,861677,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.0,PIM1 kinase
,,2989575,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,COCC/C(=C\C1=C(Cl)C(=O)c2ccccc2C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '17.22', 'le': '0.34', 'lle': '2.91', 'sei': '6.85'}",CHEMBL569165,,CHEMBL569165,5.52,0,http://www.openphacts.org/units/Nanomolar,861678,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,2989576,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,COCC/C(=C\C1=C(Br)C(=O)c2ccccc2C1=O)C(=O)O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '16.43', 'le': '0.37', 'lle': '3.24', 'sei': '7.44'}",CHEMBL570293,,CHEMBL570293,6.00,0,http://www.openphacts.org/units/Nanomolar,861508,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.0,PIM1 kinase
,,2989577,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(=C\C1=C(Cl)C(=O)c2ccccc2C1=O)C(=O)NCCO,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '18.77', 'le': '0.37', 'lle': '4.39', 'sei': '7.19'}",CHEMBL570294,,CHEMBL570294,6.00,0,http://www.openphacts.org/units/Nanomolar,861509,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.0,PIM1 kinase
,,2989578,[],CHEMBL1043577,Inhibition of Ape1/ref-1 redox activity in presence of 0.02 mM DTT and human Hey-C2 cells nuclear extracts by EMSA,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)CCC1=C(Br)C(=O)c2ccccc2C1=O,,,CHEMBL1156823,J Med Chem,2010,"{'bei': '17.15', 'le': '0.40', 'lle': '2.72', 'sei': '7.42'}",CHEMBL568769,,CHEMBL568769,5.30,0,http://www.openphacts.org/units/Nanomolar,861510,=,1,1,=,,IC50,nM,,5000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.0,PIM1 kinase
,,10954685,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '15.34', 'le': '0.31', 'lle': '0.95', 'sei': '12.60'}",CHEMBL1617574,,CHEMBL1617574,5.70,0,http://www.openphacts.org/units/Nanomolar,1657597,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.0,PIM1 kinase
,,10954686,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '16.81', 'le': '0.34', 'lle': '1.91', 'sei': '10.25'}",CHEMBL1721230,,CHEMBL1721230,5.54,0,http://www.openphacts.org/units/Nanomolar,1657598,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.9,PIM1 kinase
,,10954687,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C(=O)OC(C)(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL1879618,,CHEMBL1879618,,0,http://www.openphacts.org/units/Nanomolar,1657599,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954688,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '15.78', 'le': '0.32', 'lle': '1.45', 'sei': '11.98'}",CHEMBL1719929,,CHEMBL1719929,5.42,0,http://www.openphacts.org/units/Nanomolar,1657600,=,1,1,=,,IC50,nM,,3800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.8,PIM1 kinase
,,10954689,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1cccc3ccccc13)CCNC2,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2059403,,CHEMBL2059403,,0,http://www.openphacts.org/units/Nanomolar,1657606,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954690,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1csc3ccccc13)CCNC2,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2059407,,CHEMBL2059407,,0,http://www.openphacts.org/units/Nanomolar,1657610,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954691,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1cc3ccccc3[nH]1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2057929,,CHEMBL2057929,,0,http://www.openphacts.org/units/Nanomolar,1655697,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954692,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3o1)CCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '13.20', 'le': '0.26', 'lle': '0.41', 'sei': '8.04'}",CHEMBL1719251,,CHEMBL1719251,4.69,0,http://www.openphacts.org/units/Nanomolar,1655702,=,1,1,=,,IC50,nM,,20400.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,20.4,PIM1 kinase
,,10954693,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc(-c3ccccc3)cs1)CCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '13.93', 'le': '0.28', 'lle': '0.28', 'sei': '12.24'}",CHEMBL1700271,,CHEMBL1700271,5.54,0,http://www.openphacts.org/units/Nanomolar,1655703,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.9,PIM1 kinase
,,10954694,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)C(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2057934,,CHEMBL2057934,,0,http://www.openphacts.org/units/Nanomolar,1655705,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954695,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2)C1CC1,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '14.69', 'le': '0.30', 'lle': '1.20', 'sei': '9.67'}",CHEMBL2057935,,CHEMBL2057935,5.22,0,http://www.openphacts.org/units/Nanomolar,1655706,=,1,1,=,,IC50,nM,,6000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.0,PIM1 kinase
,,10954696,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCc1ccccc1)Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2057938,,CHEMBL2057938,,0,http://www.openphacts.org/units/Nanomolar,1655709,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954697,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2)C(F)(F)F,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.40', 'le': '0.26', 'lle': '0.58', 'sei': '8.80'}",CHEMBL1882023,,CHEMBL1882023,4.75,0,http://www.openphacts.org/units/Nanomolar,1655710,=,1,1,=,,IC50,nM,,17600.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,17.6,PIM1 kinase
,,10954698,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '14.34', 'le': '0.29', 'lle': '1.10', 'sei': '7.83'}",CHEMBL2057939,,CHEMBL2057939,4.96,0,http://www.openphacts.org/units/Nanomolar,1655711,=,1,1,=,,IC50,nM,,11100.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,11.1,PIM1 kinase
,,10954699,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2)C(F)F,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '14.83', 'le': '0.31', 'lle': '1.55', 'sei': '10.03'}",CHEMBL1720543,,CHEMBL1720543,5.42,0,http://www.openphacts.org/units/Nanomolar,1655712,=,1,1,=,,IC50,nM,,3800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.8,PIM1 kinase
,,10954700,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCCC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '13.39', 'le': '0.27', 'lle': '0.90', 'sei': '9.11'}",CHEMBL1876662,,CHEMBL1876662,4.92,0,http://www.openphacts.org/units/Nanomolar,1655713,=,1,1,=,,IC50,nM,,12000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,12.0,PIM1 kinase
,,10954701,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCc2c(sc(NC(=O)C(F)F)c2-c2nc3ccccc3s2)C1,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.95', 'le': '0.27', 'lle': '0.29', 'sei': '11.66'}",CHEMBL2057941,,CHEMBL2057941,5.28,0,http://www.openphacts.org/units/Nanomolar,1655715,=,1,1,=,,IC50,nM,,5300.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.3,PIM1 kinase
,,10954702,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCc2c(sc(NC(=O)C3CCCCC3)c2-c2nc3ccccc3s2)C1,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '11.56', 'le': '0.23', 'lle': '-1.23', 'sei': '11.23'}",CHEMBL2057942,,CHEMBL2057942,5.08,0,http://www.openphacts.org/units/Nanomolar,1655716,=,1,1,=,,IC50,nM,,8300.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,8.3,PIM1 kinase
,,10954703,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.19', 'le': '0.25', 'lle': '-0.88', 'sei': '11.15'}",CHEMBL2057943,,CHEMBL2057943,5.04,0,http://www.openphacts.org/units/Nanomolar,1655717,=,1,1,=,,IC50,nM,,9100.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,9.1,PIM1 kinase
,,10954704,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2sc(-c3csc4c3CCNC4)nc2c1,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '16.88', 'le': '0.35', 'lle': '0.93', 'sei': '18.45'}",CHEMBL2057216,,CHEMBL2057216,4.60,0,http://www.openphacts.org/units/Nanomolar,1655719,=,1,1,=,,IC50,nM,,25200.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,25.2,PIM1 kinase
,,10954705,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1sc2c(c1-c1nc3ccccc3s1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2057944,,CHEMBL2057944,,0,http://www.openphacts.org/units/Nanomolar,1655720,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954706,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1sc2c(c1-c1nc3ccccc3s1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2057945,,CHEMBL2057945,,0,http://www.openphacts.org/units/Nanomolar,1655721,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954707,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(-c2sc3c(c2-c2nc4ccccc4s2)CCNC3)o1,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2057946,,CHEMBL2057946,,0,http://www.openphacts.org/units/Nanomolar,1655722,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954708,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(-c2sc3c(c2-c2nc4ccccc4s2)CCNC3)n1,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2057947,,CHEMBL2057947,,0,http://www.openphacts.org/units/Nanomolar,1655723,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954709,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(Nc2sc3c(c2-c2nc4ccccc4s2)CCNC3)o1,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.78', 'le': '0.26', 'lle': '0.61', 'sei': '6.22'}",CHEMBL2057948,,CHEMBL2057948,4.72,0,http://www.openphacts.org/units/Nanomolar,1655724,=,1,1,=,,IC50,nM,,19000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,19.0,PIM1 kinase
,,10954710,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(Nc2sc3c(c2-c2nc4ccccc4s2)CCNC3)n1,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.83', 'le': '0.26', 'lle': '0.63', 'sei': '6.25'}",CHEMBL2057949,,CHEMBL2057949,4.74,0,http://www.openphacts.org/units/Nanomolar,1655725,=,1,1,=,,IC50,nM,,18200.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,18.2,PIM1 kinase
,,10954711,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2cnccc2c1-c1nc2ccccc2s1,,,CHEMBL2057080,J Med Chem,2012,,CHEMBL2057951,,CHEMBL2057951,,0,http://www.openphacts.org/units/Nanomolar,1655729,>,1,1,>,,IC50,nM,,57000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,57.0,PIM1 kinase
,,10954712,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '15.41', 'le': '0.31', 'lle': '0.80', 'sei': '12.18'}",CHEMBL1698064,,CHEMBL1698064,5.51,0,http://www.openphacts.org/units/Nanomolar,1655730,=,1,1,=,,IC50,nM,,3100.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.1,PIM1 kinase
,,10954713,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CNC2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '17.38', 'le': '0.36', 'lle': '1.89', 'sei': '10.15'}",CHEMBL1706858,,CHEMBL1706858,5.48,0,http://www.openphacts.org/units/Nanomolar,1655731,=,1,1,=,,IC50,nM,,3300.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.3,PIM1 kinase
,,10954714,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.68', 'le': '0.26', 'lle': '-0.25', 'sei': '10.81'}",CHEMBL1705313,,CHEMBL1705313,4.89,0,http://www.openphacts.org/units/Nanomolar,1656102,=,1,1,=,,IC50,nM,,12900.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,12.9,PIM1 kinase
,,10954715,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C(C)C)CC2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.33', 'le': '0.25', 'lle': '-0.04', 'sei': '10.51'}",CHEMBL1716096,,CHEMBL1716096,4.75,0,http://www.openphacts.org/units/Nanomolar,1656103,=,1,1,=,,IC50,nM,,17600.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,17.6,PIM1 kinase
,,10954739,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '13.24', 'le': '0.27', 'lle': '0.17', 'sei': '10.88'}",CHEMBL1617574,,CHEMBL1617574,4.92,0,http://www.openphacts.org/units/Nanomolar,1657597,=,1,1,=,,IC50,nM,,12000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,12.0,PIM1 kinase
,,10954740,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '16.09', 'le': '0.33', 'lle': '1.67', 'sei': '9.81'}",CHEMBL1721230,,CHEMBL1721230,5.30,0,http://www.openphacts.org/units/Nanomolar,1657598,=,1,1,=,,IC50,nM,,5000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.0,PIM1 kinase
,,10954741,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '15.43', 'le': '0.31', 'lle': '1.33', 'sei': '11.72'}",CHEMBL1719929,,CHEMBL1719929,5.30,0,http://www.openphacts.org/units/Nanomolar,1657600,=,1,1,=,,IC50,nM,,5000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.0,PIM1 kinase
,,10954742,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3o1)CCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '13.75', 'le': '0.27', 'lle': '0.61', 'sei': '8.37'}",CHEMBL1719251,,CHEMBL1719251,4.89,0,http://www.openphacts.org/units/Nanomolar,1655702,=,1,1,=,,IC50,nM,,13000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,13.0,PIM1 kinase
,,10954743,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc(-c3ccccc3)cs1)CCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '13.89', 'le': '0.28', 'lle': '0.26', 'sei': '12.21'}",CHEMBL1700271,,CHEMBL1700271,5.52,0,http://www.openphacts.org/units/Nanomolar,1655703,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,10954744,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1sc2c(c1-c1nc3ccccc3s1)CCNC2)C(F)F,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '14.77', 'le': '0.31', 'lle': '1.53', 'sei': '9.99'}",CHEMBL1720543,,CHEMBL1720543,5.40,0,http://www.openphacts.org/units/Nanomolar,1655712,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.0,PIM1 kinase
,,10954745,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '15.10', 'le': '0.31', 'lle': '0.69', 'sei': '11.93'}",CHEMBL1698064,,CHEMBL1698064,5.40,0,http://www.openphacts.org/units/Nanomolar,1655730,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.0,PIM1 kinase
,,10954746,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CNC2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '19.02', 'le': '0.39', 'lle': '2.41', 'sei': '11.11'}",CHEMBL1706858,,CHEMBL1706858,6.00,0,http://www.openphacts.org/units/Nanomolar,1655731,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.0,PIM1 kinase
,,10954747,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCCN(C(C)C)C2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.59', 'le': '0.25', 'lle': '-0.29', 'sei': '10.73'}",CHEMBL1705313,,CHEMBL1705313,4.85,0,http://www.openphacts.org/units/Nanomolar,1656102,=,1,1,=,,IC50,nM,,14000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,14.0,PIM1 kinase
,,10954748,[],CHEMBL2061059,Inhibition of recombinant APE1 using [35P]-5'-AP-DNA as substrate incubated for 15 mins prior to substrate addition measured after 5 mins by PAGE analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C(C)C)CC2,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '12.67', 'le': '0.26', 'lle': '0.10', 'sei': '10.80'}",CHEMBL1716096,,CHEMBL1716096,4.89,0,http://www.openphacts.org/units/Nanomolar,1656103,=,1,1,=,,IC50,nM,,13000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,13.0,PIM1 kinase
,,10955353,[],CHEMBL2061145,Inhibition of human APE1 expressed in Escherichia coli rosetta using fluorescein-dabcyl-containing oligonucleotide as substrate after 5 mins by fluorescence spectrophotometry,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(C)c2c(N)c3cccc(C)c3nc2n1,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '24.54', 'le': '0.44', 'lle': '2.53', 'sei': '11.24'}",CHEMBL1453126,,CHEMBL1453126,5.82,0,http://www.openphacts.org/units/Nanomolar,1657595,=,1,1,=,,IC50,nM,,1500.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.5,PIM1 kinase
,,10955362,[],CHEMBL2061057,Inhibition of human recombinant APE1 after 15 mins by fluorescence based HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)c2c(N)c3cccc(C)c3nc2n1,,,CHEMBL2057080,J Med Chem,2012,"{'bei': '18.94', 'le': '0.34', 'lle': '1.20', 'sei': '8.68'}",CHEMBL1453126,,CHEMBL1453126,4.50,0,http://www.openphacts.org/units/Nanomolar,1657595,=,1,1,=,,IC50,nM,,32000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,32.0,PIM1 kinase
,,13427189,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3cccc(-c4nnn[nH]4)c3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420480,,CHEMBL2420480,,0,http://www.openphacts.org/units/Nanomolar,1916680,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427190,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3cccc4[nH]ncc34)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420479,,CHEMBL2420479,,0,http://www.openphacts.org/units/Nanomolar,1916679,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427191,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3ccc4cn[nH]c4c3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420478,,CHEMBL2420478,,0,http://www.openphacts.org/units/Nanomolar,1916678,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427192,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3cccc(S(N)(=O)=O)c3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420477,,CHEMBL2420477,,0,http://www.openphacts.org/units/Nanomolar,1916677,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427193,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)Nc1cccc(-n2c3nc(=O)[nH]c(=O)c-3cc3cc(Cl)ccc32)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420476,,CHEMBL2420476,,0,http://www.openphacts.org/units/Nanomolar,1916676,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427194,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)Nc1cccc(-n2c3nc(=O)[nH]c(=O)c-3cc3ccccc32)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420475,,CHEMBL2420475,,0,http://www.openphacts.org/units/Nanomolar,1916675,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427195,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)Nc1cccc(-n2c3nc(=O)[nH]c(=O)c-3cc3ccc(C#N)cc32)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420474,,CHEMBL2420474,,0,http://www.openphacts.org/units/Nanomolar,1916674,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427196,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3cccc(CC(N)=O)c3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420473,,CHEMBL2420473,,0,http://www.openphacts.org/units/Nanomolar,1916673,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427197,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3cccc(N)c3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420472,,CHEMBL2420472,,0,http://www.openphacts.org/units/Nanomolar,1916672,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427198,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3ccc(Br)cc3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420471,,CHEMBL2420471,,0,http://www.openphacts.org/units/Nanomolar,1916671,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427199,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3cccc(F)c3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420470,,CHEMBL2420470,,0,http://www.openphacts.org/units/Nanomolar,1916670,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427200,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2c3nc(=O)[nH]c(=O)c-3cc3ccc(C#N)cc32)cc1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420469,,CHEMBL2420469,,0,http://www.openphacts.org/units/Nanomolar,1916669,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427201,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2c3nc(=O)[nH]c(=O)c-3cc3ccc(C#N)cc32)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420468,,CHEMBL2420468,,0,http://www.openphacts.org/units/Nanomolar,1916668,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427202,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-n2c3nc(=O)[nH]c(=O)c-3cc3ccc(C#N)cc32)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420467,,CHEMBL2420467,,0,http://www.openphacts.org/units/Nanomolar,1916667,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427203,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3cccc(CO)c3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420466,,CHEMBL2420466,,0,http://www.openphacts.org/units/Nanomolar,1916666,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427204,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3ccc(O)cc3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420465,,CHEMBL2420465,,0,http://www.openphacts.org/units/Nanomolar,1916665,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427205,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3cccc(O)c3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420507,,CHEMBL2420507,,0,http://www.openphacts.org/units/Nanomolar,1916711,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427206,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2cc3c(=O)[nH]c(=O)nc-3n(-c3ccccc3)c2c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420506,,CHEMBL2420506,,0,http://www.openphacts.org/units/Nanomolar,1916710,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427207,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3ccccc3)c3cc(C(F)(F)F)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420505,,CHEMBL2420505,,0,http://www.openphacts.org/units/Nanomolar,1916709,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427208,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3ccccc3O)c3cc(Cl)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420504,,CHEMBL2420504,,0,http://www.openphacts.org/units/Nanomolar,1916708,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427209,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3cccc(O)c3)c3cc(Cl)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420503,,CHEMBL2420503,,0,http://www.openphacts.org/units/Nanomolar,1916707,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427210,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2c3nc(=O)[nH]c(=O)c-3cc3ccc(Cl)cc32)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420502,,CHEMBL2420502,,0,http://www.openphacts.org/units/Nanomolar,1916706,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427211,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3ccc(O)cc3)c3cc(Cl)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420501,,CHEMBL2420501,,0,http://www.openphacts.org/units/Nanomolar,1916705,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427212,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(C3CCNCC3)c3cc(Cl)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420500,,CHEMBL2420500,,0,http://www.openphacts.org/units/Nanomolar,1916704,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427213,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(C3CCCCC3)c3cc(Cl)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420499,,CHEMBL2420499,,0,http://www.openphacts.org/units/Nanomolar,1916703,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427214,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(C3CC3)c3cc(Cl)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420498,,CHEMBL2420498,,0,http://www.openphacts.org/units/Nanomolar,1916702,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427215,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c2nc(=O)[nH]c(=O)c-2cc2ccc(Cl)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420497,,CHEMBL2420497,,0,http://www.openphacts.org/units/Nanomolar,1916701,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427216,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3ccccc3)c3cccc(Cl)c3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL224548,,CHEMBL224548,,0,http://www.openphacts.org/units/Nanomolar,1916700,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427217,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3ccccc3)c3ccc(Cl)cc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420496,,CHEMBL2420496,,0,http://www.openphacts.org/units/Nanomolar,1916699,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427218,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3ccccc3)c3c(Cl)cccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420495,,CHEMBL2420495,,0,http://www.openphacts.org/units/Nanomolar,1916698,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427219,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)nc2n(-c3ccccc3)c3cc(Cl)ccc3cc-2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420494,,CHEMBL2420494,,0,http://www.openphacts.org/units/Nanomolar,1916697,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427220,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2c3nc(=O)[nH]c(=O)c-3cc3ccc(Cl)cc32)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420493,,CHEMBL2420493,,0,http://www.openphacts.org/units/Nanomolar,1916696,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427221,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(Cc3ccccc3)c3cc(Cl)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420492,,CHEMBL2420492,,0,http://www.openphacts.org/units/Nanomolar,1916695,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427222,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c2nc(=O)[nH]c(=O)c-2cc2ccccc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL228772,,CHEMBL228772,,0,http://www.openphacts.org/units/Nanomolar,1916694,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427223,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3ccccc3)c3ccccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL471342,,CHEMBL471342,,0,http://www.openphacts.org/units/Nanomolar,1916693,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427224,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1nc2n(-c3ccccc3)c3cc(Cl)ccc3cc-2c(=O)[nH]1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL223823,,CHEMBL223823,,0,http://www.openphacts.org/units/Nanomolar,1916692,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427225,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2csc(-c3ccc(C(=O)NS(C)(=O)=O)cc3)c2)cc1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420491,,CHEMBL2420491,,0,http://www.openphacts.org/units/Nanomolar,1916691,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427226,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2csc(-c3cccc(C(=O)NS(C)(=O)=O)c3)c2)cc1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420490,,CHEMBL2420490,,0,http://www.openphacts.org/units/Nanomolar,1916690,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427227,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2csc(C(=O)N3CCCC(C(=O)P(=O)(OC)OC)C3)c2)cc1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420489,,CHEMBL2420489,,0,http://www.openphacts.org/units/Nanomolar,1916689,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427228,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2csc(NC(=O)c3ncn(C)c(=O)c3OCc3ccccc3)c2)cc1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420488,,CHEMBL2420488,,0,http://www.openphacts.org/units/Nanomolar,1916688,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427229,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1CN(C)C2=NC(N)=NC(=O)C2N1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420487,,CHEMBL2420487,,0,http://www.openphacts.org/units/Nanomolar,1916687,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427230,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1N=C(c2ccccc2)C(=O)C2C(=O)N=C(N)N=C21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420486,,CHEMBL2420486,,0,http://www.openphacts.org/units/Nanomolar,1916686,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427231,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1csc(-c2nc3c(=O)nc(N)nc-3n(C)n2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420485,,CHEMBL2420485,,0,http://www.openphacts.org/units/Nanomolar,1916685,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427232,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2cnc3c(n2)c(=O)n(C)c(=O)n3C)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420484,,CHEMBL2420484,,0,http://www.openphacts.org/units/Nanomolar,1916684,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427233,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2cc3c(=O)n(C)c(=O)nc-3n(CC)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420483,,CHEMBL2420483,,0,http://www.openphacts.org/units/Nanomolar,1916683,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427234,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nnc3[nH]c(=O)n(C)c(=O)c3n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420482,,CHEMBL2420482,,0,http://www.openphacts.org/units/Nanomolar,1916682,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427235,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2csc(-c3nc4c(=O)n(C)c(=O)nc-4n(C)n3)c2)cc1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420481,,CHEMBL2420481,,0,http://www.openphacts.org/units/Nanomolar,1916681,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427236,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(-c2cc(-c3ccccc3)cs2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420614,,CHEMBL2420614,,0,http://www.openphacts.org/units/Nanomolar,1916840,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427237,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(-c2cc(Br)cs2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420613,,CHEMBL2420613,,0,http://www.openphacts.org/units/Nanomolar,1916839,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427238,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1csc(-c2nc3c(=O)n(C)c(=O)nc-3n(C)n2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420612,,CHEMBL2420612,,0,http://www.openphacts.org/units/Nanomolar,1916838,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427239,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(-c2cscn2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420611,,CHEMBL2420611,,0,http://www.openphacts.org/units/Nanomolar,1916837,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427240,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2nc3c(=O)n(C)c(=O)nc-3n(C)n2)cc1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2094689,,CHEMBL2094689,,0,http://www.openphacts.org/units/Nanomolar,1916836,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427241,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(-c2ccc3ccccc3c2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420610,,CHEMBL2420610,,0,http://www.openphacts.org/units/Nanomolar,1916835,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427242,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(CCc2ccccc2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420609,,CHEMBL2420609,,0,http://www.openphacts.org/units/Nanomolar,1916834,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427243,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(Cc2ccccc2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL1394266,,CHEMBL1394266,,0,http://www.openphacts.org/units/Nanomolar,1916833,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427244,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(C2CCOCC2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420518,,CHEMBL2420518,,0,http://www.openphacts.org/units/Nanomolar,1916727,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427245,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(C2CCCCC2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420517,,CHEMBL2420517,,0,http://www.openphacts.org/units/Nanomolar,1916726,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427246,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(C2CCCC2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420516,,CHEMBL2420516,,0,http://www.openphacts.org/units/Nanomolar,1916725,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427247,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(C2CC2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420515,,CHEMBL2420515,,0,http://www.openphacts.org/units/Nanomolar,1916724,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427248,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1nc2c(=O)n(C)c(=O)nc-2n(C)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL1325945,,CHEMBL1325945,,0,http://www.openphacts.org/units/Nanomolar,1916723,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427249,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2c(=O)n(C)c(=O)nc-2n(C)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL601757,,CHEMBL601757,,0,http://www.openphacts.org/units/Nanomolar,1916722,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427250,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)n(Cc4ccccc4)c(=O)nc-3n(C)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420514,,CHEMBL2420514,,0,http://www.openphacts.org/units/Nanomolar,1916721,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427251,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)n(-c4ccccc4)c(=O)nc-3n(C)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420513,,CHEMBL2420513,,0,http://www.openphacts.org/units/Nanomolar,1916720,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427252,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)[nH]c(=O)nc-3n(C)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420512,,CHEMBL2420512,,0,http://www.openphacts.org/units/Nanomolar,1916719,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427253,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)n(C)c(=O)nc-3n(Cc3ccccc3)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420511,,CHEMBL2420511,,0,http://www.openphacts.org/units/Nanomolar,1916718,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427254,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)n(C)c(=O)nc-3n(-c3ccccc3)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420510,,CHEMBL2420510,,0,http://www.openphacts.org/units/Nanomolar,1916717,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427255,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)n(C)c(=O)nc-3n(CC3CC3)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420509,,CHEMBL2420509,,0,http://www.openphacts.org/units/Nanomolar,1916716,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427256,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1nc(-c2ccc(CC)cc2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2417582,,CHEMBL2417582,,0,http://www.openphacts.org/units/Nanomolar,1916715,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427257,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)n(C)c(=O)nc-3n(C3CC3)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420508,,CHEMBL2420508,,0,http://www.openphacts.org/units/Nanomolar,1916714,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427258,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)n(C)c(=O)nc-3n(CC)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL1569025,,CHEMBL1569025,,0,http://www.openphacts.org/units/Nanomolar,1916713,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427259,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1nc2c(=O)n(C)c(=O)nc-2n(C)n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL1449180,,CHEMBL1449180,,0,http://www.openphacts.org/units/Nanomolar,1916712,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427260,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2nc3c(=O)n(C)c(=O)nc-3n(C)n2)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420617,,CHEMBL2420617,,0,http://www.openphacts.org/units/Nanomolar,1916850,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427261,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nc3c(=O)n(C)c(=O)nc-3n(C)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL1450796,,CHEMBL1450796,,0,http://www.openphacts.org/units/Nanomolar,1916849,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427262,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(-c2ccc(OC(F)(F)F)cc2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420616,,CHEMBL2420616,,0,http://www.openphacts.org/units/Nanomolar,1916848,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427263,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(-c2ccc(C(F)(F)F)cc2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL1096283,,CHEMBL1096283,,0,http://www.openphacts.org/units/Nanomolar,1916847,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427264,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2nc3c(=O)n(C)c(=O)nc-3n(C)n2)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL2420615,,CHEMBL2420615,,0,http://www.openphacts.org/units/Nanomolar,1916846,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427265,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(-c2ccccc2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL1527391,,CHEMBL1527391,,0,http://www.openphacts.org/units/Nanomolar,1916845,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,13427266,[],CHEMBL2423657,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(-c2ccc(Cl)cc2)nc2c(=O)n(C)c(=O)nc1-2,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2417532,J Med Chem,2013,,CHEMBL1334062,,CHEMBL1334062,,0,http://www.openphacts.org/units/Nanomolar,1916844,>,1,1,>,,IC50,nM,,200000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,200.0,PIM1 kinase
,,15097002,[],CHEMBL3389217,Inhibition of human APE1 after 25 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cccc([N+](=O)[O-])c2[nH]1,,,CHEMBL3351390,J Med Chem,2014,"{'bei': '26.79', 'le': '0.50', 'lle': '3.75', 'sei': '5.74'}",CHEMBL1870764,,CHEMBL1870764,5.52,0,http://www.openphacts.org/units/Nanomolar,2249571,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,15097003,[],CHEMBL3389217,Inhibition of human APE1 after 25 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(Cc1cc(O)c(O)cc1O)C(=O)O,,,CHEMBL3351390,J Med Chem,2014,"{'bei': '32.64', 'le': '0.63', 'lle': '7.20', 'sei': '5.61'}",CHEMBL109037,,CHEMBL109037,6.96,0,http://www.openphacts.org/units/Nanomolar,2249572,=,1,1,=,,IC50,nM,,110.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.11,PIM1 kinase
,,15097004,[],CHEMBL3389217,Inhibition of human APE1 after 25 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12,,,CHEMBL3351390,J Med Chem,2014,"{'bei': '15.57', 'le': '0.30', 'lle': '0.82', 'sei': '16.39'}",CHEMBL279014,LUCANTHONE,CHEMBL279014,5.30,0,http://www.openphacts.org/units/Nanomolar,2249573,=,1,1,=,,IC50,nM,,5000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.0,PIM1 kinase
,,15097005,[],CHEMBL3389217,Inhibition of human APE1 after 25 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,,,,CHEMBL3351390,J Med Chem,2014,"{'bei': '15.98', 'le': None, 'lle': None, 'sei': None}",CHEMBL1524472,,CHEMBL1524472,5.40,0,http://www.openphacts.org/units/Nanomolar,2249574,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.0,PIM1 kinase
,,15097006,[],CHEMBL3389217,Inhibition of human APE1 after 25 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)C1=CC(=C(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)C=CC1=O,,,CHEMBL3351390,J Med Chem,2014,"{'bei': '11.84', 'le': '0.22', 'lle': '2.55', 'sei': '2.95'}",CHEMBL275938,AURINTRICARBOXYLIC ACID,CHEMBL275938,5.00,0,http://www.openphacts.org/units/Nanomolar,2249575,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.0,PIM1 kinase
,,15097007,[],CHEMBL3389217,Inhibition of human APE1 after 25 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,,,CHEMBL3351390,J Med Chem,2014,"{'bei': '20.41', 'le': '0.39', 'lle': '4.80', 'sei': '4.28'}",CHEMBL164,MYRICETIN,CHEMBL164,6.50,0,http://www.openphacts.org/units/Nanomolar,2249576,=,1,1,=,,IC50,nM,,320.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.32,PIM1 kinase
,,15097008,[],CHEMBL3389217,Inhibition of human APE1 after 25 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccc(S(=O)(=O)O)cc4)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O,,,CHEMBL3351390,J Med Chem,2014,"{'bei': '8.53', 'le': '0.18', 'lle': '2.75', 'sei': '2.22'}",CHEMBL1160025,,CHEMBL1160025,6.60,0,http://www.openphacts.org/units/Nanomolar,2249577,=,1,1,=,,IC50,nM,,250.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.25,PIM1 kinase
,,15097009,[],CHEMBL3389218,Inhibition of APE1 (unknown origin) assessed as inhibition of redox activity,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCCCCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O,,,CHEMBL3351390,J Med Chem,2014,"{'bei': '13.21', 'le': '0.25', 'lle': '0.89', 'sei': '5.56'}",CHEMBL578390,APX-3330,CHEMBL578390,5.00,1,http://www.openphacts.org/units/Nanomolar,2249578,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.0,PIM1 kinase
,,18482294,[],CHEMBL4185160,Inhibition of His-tagged human APE1 expressed in Escherichia coli M15 assessed as reduction in cleavage of 26 mer substrate to 13 mer products pre-incubated for 30 mins before substrate addition for 15 mins using 5' end [32P] AP site containing 26 mer oligonucleotide by polyacrylamide gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(C(=O)O)cccc1C(=O)NCc1ccc(Cl)c(Cl)c1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '13.40', 'le': '0.28', 'lle': '1.11', 'sei': '6.27'}",CHEMBL4208817,,CHEMBL4208817,4.75,0,http://www.openphacts.org/units/Nanomolar,3067628,=,1,1,=,,IC50,nM,,18000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,18.0,PIM1 kinase
,,18482295,[],CHEMBL4185160,Inhibition of His-tagged human APE1 expressed in Escherichia coli M15 assessed as reduction in cleavage of 26 mer substrate to 13 mer products pre-incubated for 30 mins before substrate addition for 15 mins using 5' end [32P] AP site containing 26 mer oligonucleotide by polyacrylamide gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(C(=O)O)cccc1C(=O)NCc1cccc(Cl)c1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '15.00', 'le': '0.30', 'lle': '1.82', 'sei': '6.34'}",CHEMBL4212536,,CHEMBL4212536,4.80,0,http://www.openphacts.org/units/Nanomolar,3067627,=,1,1,=,,IC50,nM,,16000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,16.0,PIM1 kinase
,,18482296,[],CHEMBL4185160,Inhibition of His-tagged human APE1 expressed in Escherichia coli M15 assessed as reduction in cleavage of 26 mer substrate to 13 mer products pre-incubated for 30 mins before substrate addition for 15 mins using 5' end [32P] AP site containing 26 mer oligonucleotide by polyacrylamide gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(CNC(=O)c2cccc(C(=O)O)c2OC)cc1OC,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '13.74', 'le': '0.26', 'lle': '2.40', 'sei': '5.04'}",CHEMBL4203257,,CHEMBL4203257,4.75,0,http://www.openphacts.org/units/Nanomolar,3067626,=,1,1,=,,IC50,nM,,18000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,18.0,PIM1 kinase
,,18482297,[],CHEMBL4185160,Inhibition of His-tagged human APE1 expressed in Escherichia coli M15 assessed as reduction in cleavage of 26 mer substrate to 13 mer products pre-incubated for 30 mins before substrate addition for 15 mins using 5' end [32P] AP site containing 26 mer oligonucleotide by polyacrylamide gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,COc1cccc(CNC(=O)c2cccc(C(=O)O)c2OC)c1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '14.97', 'le': '0.28', 'lle': '2.39', 'sei': '5.56'}",CHEMBL4202869,,CHEMBL4202869,4.72,0,http://www.openphacts.org/units/Nanomolar,3067625,=,1,1,=,,IC50,nM,,19000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,19.0,PIM1 kinase
,,18482301,[],CHEMBL4185158,Inhibition of redox activity of full length N-terminal hexa-His SUMO-fused human APE1 using HEX-labeled THF oligonucleotide as substrate preincubated for 30 to 120 mins followed by substrate addition measured after 15 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCCCCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)NOC,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '12.44', 'le': '0.24', 'lle': '1.37', 'sei': '5.58'}",CHEMBL4206043,,CHEMBL4206043,5.07,0,http://www.openphacts.org/units/Nanomolar,3067666,=,1,1,=,,IC50,nM,,8500.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,8.5,PIM1 kinase
,,18482302,[],CHEMBL4185158,Inhibition of redox activity of full length N-terminal hexa-His SUMO-fused human APE1 using HEX-labeled THF oligonucleotide as substrate preincubated for 30 to 120 mins followed by substrate addition measured after 15 mins by fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCCCCC/C(=C\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '13.21', 'le': '0.25', 'lle': '0.89', 'sei': '5.56'}",CHEMBL578390,APX-3330,CHEMBL578390,5.00,1,http://www.openphacts.org/units/Nanomolar,3067665,=,1,1,=,,IC50,nM,,10000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.0,PIM1 kinase
,,18482303,[],CHEMBL4185157,Inhibition of full length human APE1 expressed in Escherichia coli BL21/DE3 assessed as inhibition of incision of depurinated supercoiled pUC18 plasmid DNA after 15 mins,B,,,BAO_0000190,BAO_0000019,assay format,CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '19.91', 'le': '0.39', 'lle': '3.44', 'sei': '13.50'}",CHEMBL22077,HYCANTHONE,CHEMBL22077,7.10,0,http://www.openphacts.org/units/Nanomolar,3067655,=,1,1,=,,IC50,nM,,80.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,nM,UO_0000065,,80.0,PIM1 kinase
,,18482304,[],CHEMBL4185157,Inhibition of full length human APE1 expressed in Escherichia coli BL21/DE3 assessed as inhibition of incision of depurinated supercoiled pUC18 plasmid DNA after 15 mins,B,,,BAO_0000190,BAO_0000019,assay format,CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '15.57', 'le': '0.30', 'lle': '0.82', 'sei': '16.39'}",CHEMBL279014,LUCANTHONE,CHEMBL279014,5.30,1,http://www.openphacts.org/units/Nanomolar,3067654,=,1,1,=,,IC50,nM,,5000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.0,PIM1 kinase
,,18482305,[],CHEMBL4185156,Inhibition of APE1 in human HeLa cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CSc1ncn[nH]1)Nc1cccc2c1C(=O)c1ccccc1C2=O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '14.81', 'le': '0.28', 'lle': '3.09', 'sei': '5.15'}",CHEMBL4217564,,CHEMBL4217564,5.40,0,http://www.openphacts.org/units/Nanomolar,3067653,=,1,1,=,,IC50,nM,,4000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.0,PIM1 kinase
,,18482306,[],CHEMBL4185155,Inhibition of recombinant human APE1 using 5'-F-GCCCCCXGGGGACGTACGATATCCCGCTCC-3' as substrate preincubated for 10 mins followed by substrate addition measured at 5 mins intervals for 30 mins by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc2ccccc2o1)[C@@H](O)c1nc2ccccc2s1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '18.42', 'le': '0.35', 'lle': '1.74', 'sei': '9.00'}",CHEMBL4211692,,CHEMBL4211692,5.70,0,http://www.openphacts.org/units/Nanomolar,3067652,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.0,PIM1 kinase
,,18482307,[],CHEMBL4185155,Inhibition of recombinant human APE1 using 5'-F-GCCCCCXGGGGACGTACGATATCCCGCTCC-3' as substrate preincubated for 10 mins followed by substrate addition measured at 5 mins intervals for 30 mins by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CSc1nc2ccccc2s1)CSc1nc2ccccc2s1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '14.21', 'le': '0.31', 'lle': '0.16', 'sei': '12.89'}",CHEMBL1526448,,CHEMBL1526448,5.52,0,http://www.openphacts.org/units/Nanomolar,3067651,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,18482308,[],CHEMBL4185155,Inhibition of recombinant human APE1 using 5'-F-GCCCCCXGGGGACGTACGATATCCCGCTCC-3' as substrate preincubated for 10 mins followed by substrate addition measured at 5 mins intervals for 30 mins by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(OCC(=O)N1NC(c2ccc3ccccc3c2)=C[C@@H]1c1ccccc1)c1ccc([N+](=O)[O-])s1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '11.38', 'le': '0.22', 'lle': '0.42', 'sei': '5.43'}",CHEMBL4209629,,CHEMBL4209629,5.52,0,http://www.openphacts.org/units/Nanomolar,3067650,=,1,1,=,,IC50,nM,,3000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.0,PIM1 kinase
,,18482309,[],CHEMBL4185154,Inhibition of APE1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)C1=CC(=C(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)C=CC1=O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '17.19', 'le': '0.32', 'lle': '4.81', 'sei': '4.28'}",CHEMBL275938,AURINTRICARBOXYLIC ACID,CHEMBL275938,7.26,0,http://www.openphacts.org/units/Nanomolar,3067642,=,1,1,=,,IC50,nM,,55.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.055,PIM1 kinase
,,18482310,[],CHEMBL4185153,Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccc(S(=O)(=O)[O-])cc4)n3)c(S(=O)(=O)[O-])c2)c2c1C(=O)c1ccccc1C2=O.[Na+].[Na+].[Na+],,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '8.53', 'le': '0.18', 'lle': '2.75', 'sei': '2.22'}",CHEMBL1365553,,CHEMBL1160025,6.60,0,http://www.openphacts.org/units/Nanomolar,3067649,=,1,1,=,,IC50,nM,,250.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.25,PIM1 kinase
,,18482311,[],CHEMBL4185153,Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.Cl.O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '12.82', 'le': '0.24', 'lle': '5.84', 'sei': '3.49'}",CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE,CHEMBL58,5.70,0,http://www.openphacts.org/units/Nanomolar,3067648,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.0,PIM1 kinase
,,18482312,[],CHEMBL4185153,Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '28.53', 'le': '0.59', 'lle': '3.02', 'sei': '16.09'}",CHEMBL399043,THIOLACTOMYCIN,CHEMBL399043,6.00,0,http://www.openphacts.org/units/Nanomolar,3067647,=,1,1,=,,IC50,nM,,1000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.0,PIM1 kinase
,,18482313,[],CHEMBL4185153,Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '22.04', 'le': '0.41', 'lle': '4.25', 'sei': '5.38'}",CHEMBL56393,,CHEMBL56393,6.55,0,http://www.openphacts.org/units/Nanomolar,3067646,=,1,1,=,,IC50,nM,,280.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.28,PIM1 kinase
,,18482314,[],CHEMBL4185153,Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(N=O)c1ccc(O)c(O)c1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '37.47', 'le': '0.72', 'lle': '5.08', 'sei': '8.62'}",CHEMBL1256623,,CHEMBL1256623,6.30,0,http://www.openphacts.org/units/Nanomolar,3067645,=,1,1,=,,IC50,nM,,500.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.5,PIM1 kinase
,,18482315,[],CHEMBL4185153,Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '20.41', 'le': '0.39', 'lle': '4.80', 'sei': '4.28'}",CHEMBL164,MYRICETIN,CHEMBL164,6.50,1,http://www.openphacts.org/units/Nanomolar,3067644,=,1,1,=,,IC50,nM,,320.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.32,PIM1 kinase
,,18482316,[],CHEMBL4185153,Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(Cc1cc(O)c(O)cc1O)C(=O)O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '32.64', 'le': '0.63', 'lle': '7.20', 'sei': '5.61'}",CHEMBL109037,,CHEMBL109037,6.96,1,http://www.openphacts.org/units/Nanomolar,3067643,=,1,1,=,,IC50,nM,,110.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.11,PIM1 kinase
,,18482317,[],CHEMBL4185153,Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)C1=CC(=C(c2ccc(O)c(C(=O)O)c2)c2ccc(O)c(C(=O)O)c2)C=CC1=O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '17.19', 'le': '0.32', 'lle': '4.81', 'sei': '4.28'}",CHEMBL275938,AURINTRICARBOXYLIC ACID,CHEMBL275938,7.26,0,http://www.openphacts.org/units/Nanomolar,3067642,=,1,1,=,,IC50,nM,,55.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.055,PIM1 kinase
,,18482318,[],CHEMBL4185152,Inhibition of recombinant human APE1 using double-stranded DNA as substrate preincubated for 15 mins followed by substrate addition measured at 1 min intervals for 30 mins by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(/N=N/c2c(N)ccc3cc(S(=O)(=O)[O-])cc(O)c23)c(S(=O)(=O)[O-])c1.[Na+].[Na+],,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '11.53', 'le': '0.24', 'lle': '2.43', 'sei': '2.46'}",CHEMBL4205699,,CHEMBL4300020,5.05,0,http://www.openphacts.org/units/Nanomolar,3067641,=,1,1,=,,IC50,nM,,8850.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,8.85,PIM1 kinase
,,18482319,[],CHEMBL4185152,Inhibition of recombinant human APE1 using double-stranded DNA as substrate preincubated for 15 mins followed by substrate addition measured at 1 min intervals for 30 mins by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc2cc(S(=O)(=O)[O-])cc(O)c2c1/N=N/c1ccc([N+](=O)[O-])cc1S(=O)(=O)[O-].[Na+].[Na+],,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '10.91', 'le': '0.23', 'lle': '2.17', 'sei': '2.29'}",CHEMBL4203497,,CHEMBL4299996,5.11,0,http://www.openphacts.org/units/Nanomolar,3067640,=,1,1,=,,IC50,nM,,7760.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,7.76,PIM1 kinase
,,18482320,[],CHEMBL4185152,Inhibition of recombinant human APE1 using double-stranded DNA as substrate preincubated for 15 mins followed by substrate addition measured at 1 min intervals for 30 mins by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(/C=C/c2ccc(N=C=S)c(S(=O)(=O)[O-])c2)c(S(=O)(=O)[O-])c1.[Na+].[Na+],,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '14.53', 'le': '0.31', 'lle': '3.56', 'sei': '4.40'}",CHEMBL4205950,,CHEMBL4300928,6.60,0,http://www.openphacts.org/units/Nanomolar,3067639,=,1,1,=,,IC50,nM,,250.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.25,PIM1 kinase
,,18482322,[],CHEMBL4185150,Inhibition of recombinant His-6 tagged human APE1 expressed in Escherichia coli C41(DE3) using 5'-(F)-CGACTXTTGAATTGACACGCCATGTCGATCAATTCAATAGTCG-(D)-3' as substrate measured every 12 secs by FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,CCn1c2ccccc2c2cc(/C=N/Nc3cc(C)nc4cc5c(cc34)OCO5)ccc21,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '12.75', 'le': '0.23', 'lle': '-0.46', 'sei': '8.88'}",CHEMBL4216250,,CHEMBL4216250,5.39,0,http://www.openphacts.org/units/Nanomolar,3067638,=,1,1,=,,IC50,nM,,4100.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.1,PIM1 kinase
,,18482323,[],CHEMBL4185150,Inhibition of recombinant His-6 tagged human APE1 expressed in Escherichia coli C41(DE3) using 5'-(F)-CGACTXTTGAATTGACACGCCATGTCGATCAATTCAATAGTCG-(D)-3' as substrate measured every 12 secs by FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(N/N=C/c2ccc3c(c2)OCO3)c2cc3c(cc2n1)OCO3,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '15.85', 'le': '0.29', 'lle': '2.09', 'sei': '7.46'}",CHEMBL563444,,CHEMBL563444,5.54,0,http://www.openphacts.org/units/Nanomolar,3067637,=,1,1,=,,IC50,nM,,2900.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.9,PIM1 kinase
,,18482324,[],CHEMBL4185150,Inhibition of recombinant His-6 tagged human APE1 expressed in Escherichia coli C41(DE3) using 5'-(F)-CGACTXTTGAATTGACACGCCATGTCGATCAATTCAATAGTCG-(D)-3' as substrate measured every 12 secs by FRET assay,B,,,BAO_0000190,BAO_0000019,assay format,C/C(=N\Nc1cc(C)nc2cc3c(cc12)OCO3)c1cn(C)n(-c2ccccc2)c1=O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '12.89', 'le': '0.24', 'lle': '1.76', 'sei': '6.48'}",CHEMBL4205877,,CHEMBL4205877,5.36,0,http://www.openphacts.org/units/Nanomolar,3067636,=,1,1,=,,IC50,nM,,4400.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,4.4,PIM1 kinase
,,18482325,[],CHEMBL4185149,Inhibition of human APE1 using a 5'-TAMRA labelled THF abasic site double-stranded oligodeoxynucleotide as substrate in presence of Mg2+ by fluorescence polarization displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(ccc3cc(OC)c(OC)c(O)c32)cc1O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '21.30', 'le': '0.40', 'lle': '2.97', 'sei': '9.39'}",CHEMBL1346456,,CHEMBL1346456,6.40,0,http://www.openphacts.org/units/Nanomolar,3067635,=,1,1,=,,IC50,nM,,400.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.4,PIM1 kinase
,,18482326,[],CHEMBL4185149,Inhibition of human APE1 using a 5'-TAMRA labelled THF abasic site double-stranded oligodeoxynucleotide as substrate in presence of Mg2+ by fluorescence polarization displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)OCC2CCCO2)[nH]c2c1C(=O)CC(c1ccco1)C2,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '15.00', 'le': '0.28', 'lle': '1.99', 'sei': '6.32'}",CHEMBL1541779,,CHEMBL1541779,5.15,0,http://www.openphacts.org/units/Nanomolar,3067634,=,1,1,=,,IC50,nM,,7070.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,7.07,PIM1 kinase
,,18482327,[],CHEMBL4185149,Inhibition of human APE1 using a 5'-TAMRA labelled THF abasic site double-stranded oligodeoxynucleotide as substrate in presence of Mg2+ by fluorescence polarization displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1oc2c(cc1O)oc(=O)c1cc(O)c(O)c(O)c12,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '23.00', 'le': '0.44', 'lle': '5.68', 'sei': '4.53'}",CHEMBL1601846,,CHEMBL1601846,6.40,0,http://www.openphacts.org/units/Nanomolar,3067633,=,1,1,=,,IC50,nM,,400.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.4,PIM1 kinase
,,18482328,[],CHEMBL4185149,Inhibition of human APE1 using a 5'-TAMRA labelled THF abasic site double-stranded oligodeoxynucleotide as substrate in presence of Mg2+ by fluorescence polarization displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)N(Cc2ccco2)C(=O)/C1=C/C=C/c1ccco1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '17.78', 'le': '0.33', 'lle': '3.46', 'sei': '5.99'}",CHEMBL1597042,,CHEMBL1597042,5.55,0,http://www.openphacts.org/units/Nanomolar,3067632,=,1,1,=,,IC50,nM,,2800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.8,PIM1 kinase
,,18482329,[],CHEMBL4185149,Inhibition of human APE1 using a 5'-TAMRA labelled THF abasic site double-stranded oligodeoxynucleotide as substrate in presence of Mg2+ by fluorescence polarization displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1cc(-c2ccc(/C=C3/C(=O)N(c4ccc(C(=O)O)cc4)N=C3C)o2)ccc1Cl,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '10.79', 'le': '0.21', 'lle': '-0.11', 'sei': '4.72'}",CHEMBL1497243,,CHEMBL1497243,5.17,0,http://www.openphacts.org/units/Nanomolar,3067631,=,1,1,=,,IC50,nM,,6800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.8,PIM1 kinase
,,18482330,[],CHEMBL4185148,Inhibition of recombinant human APE1 using a 5'-FAM/3'-Dabsyl labelled double-stranded DNA as substrate after 30 mins by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=[N+]([O-])c1cccc(S(=O)(=O)[N-]c2nc3ccccc3nc2-[n+]2ccc(Cc3ccccc3)cc2)c1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '10.39', 'le': '0.20', 'lle': '0.37', 'sei': '4.27'}",CHEMBL4216803,,CHEMBL4216803,5.17,0,http://www.openphacts.org/units/Nanomolar,3067630,=,1,1,=,,IC50,nM,,6800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,6.8,PIM1 kinase
,,18482331,[],CHEMBL4185148,Inhibition of recombinant human APE1 using a 5'-FAM/3'-Dabsyl labelled double-stranded DNA as substrate after 30 mins by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)CC[C@H]1N[C@@]2(C(=O)Nc3c(Cl)cccc32)[C@H]2C(=O)N(Cc3ccc4c(c3)OCO4)C(=O)[C@@H]12,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '11.54', 'le': '0.22', 'lle': '3.89', 'sei': '4.28'}",CHEMBL4210283,,CHEMBL4210283,5.75,0,http://www.openphacts.org/units/Nanomolar,3067629,=,1,1,=,,IC50,nM,,1800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.8,PIM1 kinase
,,18482332,[],CHEMBL4185147,Inhibition of N-terminal hexa-His tagged human APE1 expressed in Escherichia coli BL21 (Rosetta) using fluorescein-dabcyl-containing oligonucleotide as substrate measured over 5 mins by high-throughput fluorescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cccc(Cl)c1)c1noc2c1CCC2,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '22.06', 'le': '0.44', 'lle': '2.73', 'sei': '10.51'}",CHEMBL2349528,,CHEMBL2349528,5.80,0,http://www.openphacts.org/units/Nanomolar,3067624,=,1,1,=,,IC50,nM,,1600.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.6,PIM1 kinase
,,18482333,[],CHEMBL4185147,Inhibition of N-terminal hexa-His tagged human APE1 expressed in Escherichia coli BL21 (Rosetta) using fluorescein-dabcyl-containing oligonucleotide as substrate measured over 5 mins by high-throughput fluorescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(C)c2c(N)c3cccc(C)c3nc2n1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '23.93', 'le': '0.43', 'lle': '2.39', 'sei': '10.96'}",CHEMBL1453126,,CHEMBL1453126,5.68,0,http://www.openphacts.org/units/Nanomolar,3067623,=,1,1,=,,IC50,nM,,2100.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.1,PIM1 kinase
,,18482334,[],CHEMBL4185147,Inhibition of N-terminal hexa-His tagged human APE1 expressed in Escherichia coli BL21 (Rosetta) using fluorescein-dabcyl-containing oligonucleotide as substrate measured over 5 mins by high-throughput fluorescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(C)n1-c1ccc(OCC(=O)O)cc1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '23.52', 'le': '0.44', 'lle': '3.21', 'sei': '11.21'}",CHEMBL1443537,,CHEMBL1443537,5.77,0,http://www.openphacts.org/units/Nanomolar,3067622,=,1,1,=,,IC50,nM,,1700.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.7,PIM1 kinase
,,18482335,[],CHEMBL4185146,Inhibition of human APE1 measured every 5 mins for 60 mins by FAM fluorophore based fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1=C/C(=C(/c2ccc(O)c(C)c2)c2ccccc2C(=O)O)C=CC1=O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '16.66', 'le': '0.30', 'lle': '1.48', 'sei': '7.73'}",CHEMBL1437054,,CHEMBL1437054,5.77,0,http://www.openphacts.org/units/Nanomolar,3067621,=,1,1,=,,IC50,nM,,1700.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.7,PIM1 kinase
,,18482336,[],CHEMBL4185146,Inhibition of human APE1 measured every 5 mins for 60 mins by FAM fluorophore based fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1c(S(N)(=O)=O)cc(S(N)(=O)=O)cc1S(N)(=O)=O,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '17.72', 'le': '0.42', 'lle': '8.64', 'sei': '2.83'}",CHEMBL1491675,,CHEMBL1491675,5.85,0,http://www.openphacts.org/units/Nanomolar,3067620,=,1,1,=,,IC50,nM,,1400.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.4,PIM1 kinase
,,18482337,[],CHEMBL4185146,Inhibition of human APE1 measured every 5 mins for 60 mins by FAM fluorophore based fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '21.40', 'le': None, 'lle': None, 'sei': None}",CHEMBL1394152,,CHEMBL1394152,7.77,0,http://www.openphacts.org/units/Nanomolar,3067619,=,1,1,=,,IC50,nM,,17.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,nM,UO_0000065,,17.0,PIM1 kinase
,,18482338,[],CHEMBL4185146,Inhibition of human APE1 measured every 5 mins for 60 mins by FAM fluorophore based fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,,Potential transcription error,"Values appear to be an order of magnitude different from previously reported, so units may be incorrect",CHEMBL4184129,Bioorg Med Chem,2017,,CHEMBL1524472,,CHEMBL1524472,,1,http://www.openphacts.org/units/Nanomolar,3067618,=,1,1,=,,IC50,nM,,4.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,nM,UO_0000065,,4.0,PIM1 kinase
,,18482339,[],CHEMBL4185146,Inhibition of human APE1 measured every 5 mins for 60 mins by FAM fluorophore based fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '17.73', 'le': None, 'lle': None, 'sei': None}",CHEMBL1726814,,CHEMBL1726814,6.52,0,http://www.openphacts.org/units/Nanomolar,3067617,=,1,1,=,,IC50,nM,,300.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,nM,UO_0000065,,300.0,PIM1 kinase
,,18482340,[],CHEMBL4185146,Inhibition of human APE1 measured every 5 mins for 60 mins by FAM fluorophore based fluorescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '21.00', 'le': None, 'lle': None, 'sei': None}",CHEMBL2000194,,CHEMBL2000194,6.70,0,http://www.openphacts.org/units/Nanomolar,3067616,=,1,1,=,,IC50,nM,,200.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,nM,UO_0000065,,200.0,PIM1 kinase
,,18482341,[],CHEMBL4185145,Inhibition of APE1 in human HeLa cells assessed as reduction in AP site cleavage 5'-[gamma-32P]CTCGCAAGUGGGTACCGA-3' as substrate after 1 hr,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cc2cccc([N+](=O)[O-])c2[nH]1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '26.75', 'le': '0.50', 'lle': '3.74', 'sei': '5.73'}",CHEMBL1870764,,CHEMBL1870764,5.51,0,http://www.openphacts.org/units/Nanomolar,3067615,=,1,1,=,,IC50,nM,,3060.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,3.06,PIM1 kinase
,,18482342,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1oc(-c2ccccc2F)nc2cc(Cl)ccc12,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '21.02', 'le': '0.42', 'lle': '2.15', 'sei': '13.45'}",CHEMBL1172257,,CHEMBL1172257,5.80,0,http://www.openphacts.org/units/Nanomolar,3067614,=,1,1,=,,IC50,nM,,1600.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.6,PIM1 kinase
,,18482343,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1oc(-c2ccc(Cl)cc2Cl)nc2ccc([N+](=O)[O-])cc12,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '16.90', 'le': '0.35', 'lle': '1.63', 'sei': '6.61'}",CHEMBL4213457,,CHEMBL4213457,5.70,0,http://www.openphacts.org/units/Nanomolar,3067613,=,1,1,=,,IC50,nM,,2000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.0,PIM1 kinase
,,18482344,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(S(=O)(=O)Oc2ccc(-c3ccc(Oc4c(Cl)cccc4[N+](=O)[O-])cc3)cc2)cc1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '10.72', 'le': '0.21', 'lle': '-2.00', 'sei': '6.03'}",CHEMBL4207457,,CHEMBL4207457,5.77,0,http://www.openphacts.org/units/Nanomolar,3067664,=,1,1,=,,IC50,nM,,1700.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.7,PIM1 kinase
,,18482345,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1sc(Nc2cc(Cl)cc(Cl)c2)nc1-c1ccc(-c2ccccc2F)cc1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '14.08', 'le': '0.29', 'lle': '-1.93', 'sei': '24.26'}",CHEMBL4203747,,CHEMBL4203747,6.05,0,http://www.openphacts.org/units/Nanomolar,3067663,=,1,1,=,,IC50,nM,,900.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.9,PIM1 kinase
,,18482346,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1sc(-c2ccc(Cl)cc2)nc1-c1ccc(-c2ccccc2F)cc1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '15.49', 'le': '0.31', 'lle': '-1.36', 'sei': '45.66'}",CHEMBL4212274,,CHEMBL4212274,5.89,0,http://www.openphacts.org/units/Nanomolar,3067662,=,1,1,=,,IC50,nM,,1300.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.3,PIM1 kinase
,,18482347,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(Oc1ccc(-c2ccc(OS(=O)(=O)c3ccc(Cl)c(Cl)c3)cc2)cc1)c1ccc(Cl)c(Cl)c1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '9.51', 'le': '0.22', 'lle': '-1.76', 'sei': '6.62'}",CHEMBL4207384,,CHEMBL4207384,5.75,0,http://www.openphacts.org/units/Nanomolar,3067661,=,1,1,=,,IC50,nM,,1800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.8,PIM1 kinase
,,18482348,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(OC(=O)c2sc3ccccc3c2Cl)c(C(C)(C)C)c1,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '15.21', 'le': '0.31', 'lle': '-1.27', 'sei': '23.18'}",CHEMBL4211672,,CHEMBL4211672,6.10,0,http://www.openphacts.org/units/Nanomolar,3067660,=,1,1,=,,IC50,nM,,800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.8,PIM1 kinase
,,18482349,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,C=C1S/C(=N\c2ccccc2Cl)N(C(=O)c2sc3ccccc3c2Cl)C12CCCCC2,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '12.01', 'le': '0.26', 'lle': '-2.45', 'sei': '17.92'}",CHEMBL4202877,,CHEMBL4202877,5.85,0,http://www.openphacts.org/units/Nanomolar,3067659,=,1,1,=,,IC50,nM,,1400.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.4,PIM1 kinase
,,18482350,[],CHEMBL4185144,Inhibition of nuclease activity of APE1 in human glioblastoma cells assessed as reduction in AP site DNA cleavage,B,,,BAO_0000190,BAO_0000219,cell-based format,Brc1cc(-c2cc(Br)c(Br)c(Br)c2)cc(Br)c1Br,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '10.67', 'le': '0.51', 'lle': '-1.23', 'sei': None}",CHEMBL4217125,,CHEMBL4217125,6.70,0,http://www.openphacts.org/units/Nanomolar,3067658,=,1,1,=,,IC50,nM,,200.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,0.2,PIM1 kinase
,,18482351,[],CHEMBL4185143,Inhibition of human APE1 assessed as reduction in abasic sites DNA cleavage using 6-FAM/TAMRA labelled 17-Tphi as substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2ccc3cc2cc1CNCCNCCNCc1ccc2ccc(cc2c1)CNCCNCCNC3,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '14.18', 'le': '0.26', 'lle': '4.00', 'sei': '10.04'}",CHEMBL4205402,,CHEMBL4205402,7.24,0,http://www.openphacts.org/units/Nanomolar,3067657,=,1,1,=,,IC50,nM,,57.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,nM,UO_0000065,,57.0,PIM1 kinase
,,18482352,[],CHEMBL4185143,Inhibition of human APE1 assessed as reduction in abasic sites DNA cleavage using 6-FAM/TAMRA labelled 17-Tphi as substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2ccc3cc2cc1CNCCOCCNCc1ccc2ccc(cc2c1)CNCCOCCNC3,,,CHEMBL4184129,Bioorg Med Chem,2017,"{'bei': '14.16', 'le': '0.26', 'lle': '3.16', 'sei': '10.90'}",CHEMBL4210534,,CHEMBL4210534,7.26,0,http://www.openphacts.org/units/Nanomolar,3067656,=,1,1,=,,IC50,nM,,55.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,nM,UO_0000065,,55.0,PIM1 kinase
,,19301843,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1/C=C/CC(=O)OCCCC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1c1ccccc1,,,CHEMBL4411319,J Med Chem,2019,,CHEMBL4546113,,CHEMBL4546113,,0,http://www.openphacts.org/units/Nanomolar,3222961,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,19301844,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1/C=C/CC(=O)OCCCCC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1c1ccccc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '8.61', 'le': '0.16', 'lle': '-0.16', 'sei': '4.19'}",CHEMBL4544773,,CHEMBL4544773,4.20,0,http://www.openphacts.org/units/Nanomolar,3222962,=,1,1,=,,IC50,nM,,63500.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,63.5,PIM1 kinase
,,19301845,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)CCCOC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '8.07', 'le': '0.15', 'lle': '0.65', 'sei': '3.57'}",CHEMBL4552083,,CHEMBL4552083,4.97,0,http://www.openphacts.org/units/Nanomolar,3222963,=,1,1,=,,IC50,nM,,10600.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,10.6,PIM1 kinase
,,19301846,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)CCCCOC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.98', 'le': '0.15', 'lle': '0.32', 'sei': '3.61'}",CHEMBL4549101,,CHEMBL4549101,5.03,0,http://www.openphacts.org/units/Nanomolar,3222964,=,1,1,=,,IC50,nM,,9300.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,9.3,PIM1 kinase
,,19301847,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)CCCNC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.36', 'le': '0.14', 'lle': '0.64', 'sei': '3.19'}",CHEMBL4457207,,CHEMBL4457207,4.54,0,http://www.openphacts.org/units/Nanomolar,3222965,=,1,1,=,,IC50,nM,,29200.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,29.2,PIM1 kinase
,,19301848,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)CCCCNC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,,CHEMBL4473699,,CHEMBL4473699,,0,http://www.openphacts.org/units/Nanomolar,3222966,>,1,1,>,,IC50,nM,,50000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,50.0,PIM1 kinase
,,19301849,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)CCNC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.44', 'le': '0.14', 'lle': '0.98', 'sei': '3.15'}",CHEMBL4438346,,CHEMBL4438346,4.48,0,http://www.openphacts.org/units/Nanomolar,3222967,=,1,1,=,,IC50,nM,,33200.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,33.2,PIM1 kinase
,,19301850,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C[C@H](CCc3ccccc3)NC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.91', 'le': '0.15', 'lle': '0.09', 'sei': '3.93'}",CHEMBL4465198,,CHEMBL4465198,5.58,0,http://www.openphacts.org/units/Nanomolar,3222968,=,1,1,=,,IC50,nM,,2600.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.6,PIM1 kinase
,,19301851,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C[C@@H](CCc3ccccc3)NC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.89', 'le': '0.15', 'lle': '0.07', 'sei': '3.92'}",CHEMBL4460339,,CHEMBL4460339,5.57,0,http://www.openphacts.org/units/Nanomolar,3222969,=,1,1,=,,IC50,nM,,2700.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.7,PIM1 kinase
,,19301852,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C[C@@H](c3cccc(C(F)(F)F)c3)NC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '5.74', 'le': '0.11', 'lle': '-1.98', 'sei': '3.01'}",CHEMBL4554677,,CHEMBL4554677,4.28,0,http://www.openphacts.org/units/Nanomolar,3222970,=,1,1,=,,IC50,nM,,52600.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,52.6,PIM1 kinase
,,19301853,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C[C@@H](c3ccc(C(F)(F)F)cc3)NC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.89', 'le': '0.15', 'lle': '-0.37', 'sei': '4.14'}",CHEMBL4473257,,CHEMBL4473257,5.89,0,http://www.openphacts.org/units/Nanomolar,3222971,=,1,1,=,,IC50,nM,,1300.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.3,PIM1 kinase
,,19301854,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc([C@@H]2CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](c3cccn3S(=O)(=O)c3ccc(C)cc3)[C@@H](C)/C=C/CC(=O)N2)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '8.10', 'le': '0.15', 'lle': '0.05', 'sei': '3.94'}",CHEMBL4465479,,CHEMBL4465479,5.60,0,http://www.openphacts.org/units/Nanomolar,3222972,=,1,1,=,,IC50,nM,,2500.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.5,PIM1 kinase
,,19301855,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C[C@@H](c3ccc(F)cc3)NC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.54', 'le': '0.14', 'lle': '-0.14', 'sei': '3.69'}",CHEMBL4455293,,CHEMBL4455293,5.24,0,http://www.openphacts.org/units/Nanomolar,3222973,=,1,1,=,,IC50,nM,,5700.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.7,PIM1 kinase
,,19301856,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C[C@@H](c3ccc(Cl)cc3)NC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '6.90', 'le': '0.13', 'lle': '-0.98', 'sei': '3.46'}",CHEMBL4539845,,CHEMBL4539845,4.92,0,http://www.openphacts.org/units/Nanomolar,3222974,=,1,1,=,,IC50,nM,,12100.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,12.1,PIM1 kinase
,,19301857,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C[C@@H](Cc3ccc(Cl)cc3)NC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.88', 'le': '0.15', 'lle': '-0.05', 'sei': '4.02'}",CHEMBL4581229,,CHEMBL4581229,5.72,0,http://www.openphacts.org/units/Nanomolar,3222975,=,1,1,=,,IC50,nM,,1900.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.9,PIM1 kinase
,,19301858,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1/C=C/CC(=O)N[C@H](c2ccc(C(F)(F)F)cc2)CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1c1ccccc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.59', 'le': '0.14', 'lle': '-1.34', 'sei': '4.44'}",CHEMBL4514209,,CHEMBL4514209,4.58,0,http://www.openphacts.org/units/Nanomolar,3222976,=,1,1,=,,IC50,nM,,26500.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,26.5,PIM1 kinase
,,19301859,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1/C=C/CC(=O)N[C@H](c2ccc(F)cc2)CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1c1ccccc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.71', 'le': '0.14', 'lle': '-0.78', 'sei': '4.13'}",CHEMBL4533818,,CHEMBL4533818,4.26,0,http://www.openphacts.org/units/Nanomolar,3222977,=,1,1,=,,IC50,nM,,55100.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,55.1,PIM1 kinase
,,19301860,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1/C=C/CC(=O)N[C@H](c2ccc(Cl)cc2)CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1c1ccccc1,,,CHEMBL4411319,J Med Chem,2019,,CHEMBL4475832,,CHEMBL4475832,,0,http://www.openphacts.org/units/Nanomolar,3222978,>,1,1,>,,IC50,nM,,100000.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,100.0,PIM1 kinase
,,19301861,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C(Oc3ccccc3)CCOC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.43', 'le': '0.14', 'lle': '-0.11', 'sei': '3.55'}",CHEMBL4566116,,CHEMBL4566116,5.27,0,http://www.openphacts.org/units/Nanomolar,3222979,=,1,1,=,,IC50,nM,,5400.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,5.4,PIM1 kinase
,,19301862,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C(Oc3ccc(C(F)(F)F)cc3)CCOC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '7.21', 'le': '0.14', 'lle': '-0.80', 'sei': '3.77'}",CHEMBL4567730,,CHEMBL4567730,5.60,0,http://www.openphacts.org/units/Nanomolar,3222980,=,1,1,=,,IC50,nM,,2500.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,2.5,PIM1 kinase
,,19301863,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)n2cccc2[C@@H]2NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)C(c3ccccc3)CCOC(=O)C/C=C/[C@@H]2C)cc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '8.55', 'le': '0.16', 'lle': '0.21', 'sei': '4.25'}",CHEMBL4517868,,CHEMBL4517868,5.92,0,http://www.openphacts.org/units/Nanomolar,3222981,=,1,1,=,,IC50,nM,,1200.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.2,PIM1 kinase
,,19301864,[],CHEMBL4413796,Inhibition of full length human APE1 assessed as reduction in endonuclease activity by measuring DNA cleavage of abasic sites using 6-FAM labelled two annealed oligonucleotides as AP site mimic substrate by fluorescence-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1/C=C/CC(=O)OCCC(Oc2ccc3c(c2)OCO3)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1c1ccccc1,,,CHEMBL4411319,J Med Chem,2019,"{'bei': '9.42', 'le': '0.17', 'lle': '0.98', 'sei': '4.49'}",CHEMBL4458126,,CHEMBL4458126,5.75,0,http://www.openphacts.org/units/Nanomolar,3222982,=,1,1,=,,IC50,nM,,1800.0,CHEMBL5619,Homo sapiens,DNA-(apurinic or apyrimidinic site) lyase,9606,,,IC50,uM,UO_0000065,,1.8,PIM1 kinase
,,1989389,[],CHEMBL898066,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1,,,CHEMBL1137531,J Med Chem,2007,"{'bei': '13.91', 'le': '0.25', 'lle': '0.36', 'sei': '6.19'}",CHEMBL398606,,CHEMBL398606,5.76,0,http://www.openphacts.org/units/Nanomolar,663624,=,1,1,=,,IC50,nM,,1720.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.72,PAK4
,,2020277,[],CHEMBL903377,Inhibition of Pim2 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O,,,CHEMBL1139114,Bioorg Med Chem Lett,2007,,CHEMBL391586,,CHEMBL391586,,0,http://www.openphacts.org/units/Nanomolar,671129,>,1,1,>,,IC50,nM,,20000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,20.0,PAK4
,,2136762,[],CHEMBL939217,Inhibition of PIM2 expressed in Escherichia coli by thermal shift assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,,,CHEMBL1145498,Proc Natl Acad Sci U S A,2007,,CHEMBL91829,RUBOXISTAURIN,CHEMBL91829,,0,http://www.openphacts.org/units/Nanomolar,705134,>,1,1,>,,IC50,nM,,20000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,20.0,PAK4
,,2151576,[],CHEMBL931462,Inhibition of Pim2 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1144687,J Nat Prod,2008,"{'bei': '16.19', 'le': '0.29', 'lle': '3.20', 'sei': '10.88'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.55,0,http://www.openphacts.org/units/Nanomolar,706587,=,1,1,=,,IC50,nM,,28.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,28.0,PAK4
,,2151577,[],CHEMBL931462,Inhibition of Pim2 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1O[C@@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O,,,CHEMBL1144687,J Nat Prod,2008,"{'bei': '10.26', 'le': '0.20', 'lle': '4.11', 'sei': '2.42'}",CHEMBL82242,QUERCITRIN,CHEMBL82242,4.60,0,http://www.openphacts.org/units/Nanomolar,706586,=,1,1,=,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,2151578,[],CHEMBL931462,Inhibition of Pim2 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,NCCc1ccc(OC(=O)c2cc(O)c(O)c(O)c2)cc1.O=C(O)C(F)(F)F,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1144687,J Nat Prod,2008,,CHEMBL258248,GALLOYL TYRAMINE,CHEMBL1182651,,0,http://www.openphacts.org/units/Nanomolar,706585,=,1,1,=,,IC50,nM,,161000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,161.0,PAK4
,,2248118,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(/C=C2\SC(O)=NC2=O)cc1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '24.43', 'le': '0.49', 'lle': '2.84', 'sei': '10.79'}",CHEMBL447571,,CHEMBL447571,5.36,0,http://www.openphacts.org/units/Nanomolar,776732,=,1,1,=,,IC50,nM,,4400.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,4.4,PAK4
,,2248119,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(/C=C2\SC(=O)NC2=O)c1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '31.93', 'le': '0.64', 'lle': '4.68', 'sei': '15.16'}",CHEMBL498406,,CHEMBL498406,7.00,0,http://www.openphacts.org/units/Nanomolar,776733,=,1,1,=,,IC50,nM,,100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.1,PAK4
,,2248120,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccc(C(F)(F)F)cc2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '25.97', 'le': '0.54', 'lle': '4.07', 'sei': '15.37'}",CHEMBL447567,,CHEMBL447567,7.10,0,http://www.openphacts.org/units/Nanomolar,776734,=,1,1,=,,IC50,nM,,80.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.08,PAK4
,,2248121,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '25.62', 'le': '0.53', 'lle': '3.97', 'sei': '15.16'}",CHEMBL183906,,CHEMBL183906,7.00,0,http://www.openphacts.org/units/Nanomolar,776827,=,1,1,=,,IC50,nM,,100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.1,PAK4
,,2248122,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1S/C(=C\c2cccc(C(F)(F)F)c2)C(=O)N1Cc1ccc(OC(F)(F)F)cc1,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL497606,,CHEMBL497606,,0,http://www.openphacts.org/units/Nanomolar,776828,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248123,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCOc1c(/C=C2\SC(=O)NC2=O)cccc1C(F)(F)F,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '17.47', 'le': '0.36', 'lle': '2.81', 'sei': '9.01'}",CHEMBL497607,,CHEMBL497607,5.82,0,http://www.openphacts.org/units/Nanomolar,776829,=,1,1,=,,IC50,nM,,1500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.5,PAK4
,,2248124,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1c(/C=C2\SC(=O)NC2=O)cccc1C(F)(F)F,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '12.60', 'le': '0.26', 'lle': '1.33', 'sei': '6.77'}",CHEMBL447741,,CHEMBL447741,4.38,0,http://www.openphacts.org/units/Nanomolar,776830,=,1,1,=,,IC50,nM,,42000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,42.0,PAK4
,,2248125,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(/C=C2\SC(=O)NC2=O)cc1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '27.96', 'le': '0.56', 'lle': '3.95', 'sei': '14.13'}",CHEMBL493742,,CHEMBL493742,6.52,0,http://www.openphacts.org/units/Nanomolar,776831,=,1,1,=,,IC50,nM,,300.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.3,PAK4
,,2248126,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(/C=C2\SC(=O)NC2=O)cc1,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL495827,,CHEMBL495827,,0,http://www.openphacts.org/units/Nanomolar,776832,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248127,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(/C=C2\SC(=O)NC2=O)cc1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '27.73', 'le': '0.56', 'lle': '4.50', 'sei': '11.77'}",CHEMBL85496,,CHEMBL85496,6.52,0,http://www.openphacts.org/units/Nanomolar,776833,=,1,1,=,,IC50,nM,,300.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.3,PAK4
,,2248128,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccc(OC(F)(F)F)cc2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '21.79', 'le': '0.45', 'lle': '3.39', 'sei': '11.37'}",CHEMBL454557,,CHEMBL454557,6.30,0,http://www.openphacts.org/units/Nanomolar,776955,=,1,1,=,,IC50,nM,,500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.5,PAK4
,,2248129,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(/C=C2\SC(=O)NC2=O)c1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '31.45', 'le': '0.63', 'lle': '5.38', 'sei': '13.35'}",CHEMBL496782,,CHEMBL496782,7.40,0,http://www.openphacts.org/units/Nanomolar,776956,=,1,1,=,,IC50,nM,,40.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.04,PAK4
,,2248130,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2cccc(OC(F)(F)F)c2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '20.90', 'le': '0.43', 'lle': '3.14', 'sei': '10.91'}",CHEMBL496783,,CHEMBL496783,6.05,0,http://www.openphacts.org/units/Nanomolar,776957,=,1,1,=,,IC50,nM,,900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.9,PAK4
,,2248131,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(/C=C2\SC(=O)NC2=O)cc1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '17.52', 'le': '0.35', 'lle': '1.96', 'sei': '7.88'}",CHEMBL86257,,CHEMBL86257,4.37,0,http://www.openphacts.org/units/Nanomolar,776958,=,1,1,=,,IC50,nM,,43000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,43.0,PAK4
,,2248132,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2cccc(OC(F)(F)C(F)F)c2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '17.61', 'le': '0.37', 'lle': '2.41', 'sei': '10.21'}",CHEMBL496784,,CHEMBL496784,5.66,0,http://www.openphacts.org/units/Nanomolar,776959,=,1,1,=,,IC50,nM,,2200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.2,PAK4
,,2248133,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '29.24', 'le': '0.58', 'lle': '4.90', 'sei': '13.90'}",CHEMBL84558,,CHEMBL84558,7.70,0,http://www.openphacts.org/units/Nanomolar,776960,=,1,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.02,PAK4
,,2248134,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(/C=C2\SC(=O)NC2=O)cc1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '28.19', 'le': '0.56', 'lle': '4.92', 'sei': '14.17'}",CHEMBL493847,,CHEMBL493847,7.00,0,http://www.openphacts.org/units/Nanomolar,776961,=,1,1,=,,IC50,nM,,100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.1,PAK4
,,2248135,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccc(F)cc2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '25.26', 'le': '0.51', 'lle': '3.49', 'sei': '12.21'}",CHEMBL496786,,CHEMBL496786,5.64,0,http://www.openphacts.org/units/Nanomolar,776962,=,1,1,=,,IC50,nM,,2300.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.3,PAK4
,,2248136,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1S/C(=C\c2ccc(F)cc2)C(=O)N1Cc1ccccc1F,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL496994,,CHEMBL496994,,0,http://www.openphacts.org/units/Nanomolar,777048,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248137,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2cccc(F)c2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '28.66', 'le': '0.58', 'lle': '4.25', 'sei': '13.86'}",CHEMBL448443,,CHEMBL448443,6.40,0,http://www.openphacts.org/units/Nanomolar,777049,=,1,1,=,,IC50,nM,,400.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.4,PAK4
,,2248138,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccc(Cl)cc2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '27.95', 'le': '0.61', 'lle': '4.04', 'sei': '14.51'}",CHEMBL496995,,CHEMBL496995,6.70,0,http://www.openphacts.org/units/Nanomolar,777050,=,1,1,=,,IC50,nM,,200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.2,PAK4
,,2248139,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2cccc(Cl)c2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '30.87', 'le': '0.67', 'lle': '4.74', 'sei': '16.02'}",CHEMBL495398,,CHEMBL495398,7.40,0,http://www.openphacts.org/units/Nanomolar,777051,=,1,1,=,,IC50,nM,,40.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.04,PAK4
,,2248140,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccc(Br)cc2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '24.80', 'le': '0.64', 'lle': '4.28', 'sei': '15.26'}",CHEMBL496996,,CHEMBL496996,7.05,0,http://www.openphacts.org/units/Nanomolar,777052,=,1,1,=,,IC50,nM,,90.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.09,PAK4
,,2248141,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2cccc(Br)c2)S1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '24.64', 'le': '0.64', 'lle': '4.23', 'sei': '15.16'}",CHEMBL496587,,CHEMBL496587,7.00,0,http://www.openphacts.org/units/Nanomolar,777053,=,1,1,=,,IC50,nM,,100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.1,PAK4
,,2248142,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1CSC(=O)N1Cc1ccccc1F,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL506711,,CHEMBL506711,,0,http://www.openphacts.org/units/Nanomolar,777054,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248143,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)N(Cc2ccccc2)/C1=C/c1ccc(Cl)cc1,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL496588,,CHEMBL496588,,0,http://www.openphacts.org/units/Nanomolar,777055,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248144,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(/C=C2\C(=O)NC(=O)N2Cc2ccccc2)cc1,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL498203,,CHEMBL498203,,0,http://www.openphacts.org/units/Nanomolar,777139,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248145,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(/C=C2\C(=O)NC(=O)N2Cc2ccccc2)cc1.Cl,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL526284,,CHEMBL498203,,0,http://www.openphacts.org/units/Nanomolar,777140,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248146,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(/C=C2\C(=O)NC(=O)N2Cc2ccccc2)cc1,,,CHEMBL1139352,J Med Chem,2009,"{'bei': '12.41', 'le': '0.23', 'lle': '0.82', 'sei': '6.82'}",CHEMBL496971,,CHEMBL496971,4.00,0,http://www.openphacts.org/units/Nanomolar,777141,=,1,1,=,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248147,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)N(Cc2ccccc2)/C1=C/c1ccc(Br)cc1,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL522916,,CHEMBL522916,,0,http://www.openphacts.org/units/Nanomolar,777142,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248148,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(/C=C2\C(=O)NC(=O)N2Cc2ccccc2)cc1,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL496972,,CHEMBL496972,,0,http://www.openphacts.org/units/Nanomolar,777143,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2248149,[],CHEMBL957366,Inhibition of human recombinant Pim2 by ATP depletion assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1/C=C1\C(=O)NC(=O)N1Cc1ccccc1,,,CHEMBL1139352,J Med Chem,2009,,CHEMBL496973,,CHEMBL496973,,0,http://www.openphacts.org/units/Nanomolar,777144,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
,,2278977,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.86', 'le': '0.40', 'lle': '5.02', 'sei': '10.64'}",CHEMBL493937,,CHEMBL493937,7.40,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,40.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,40.0,PAK4
,,2278978,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)/C=C/c1cccc(-c2cncc(N3CCCN(C)CC3)n2)c1,,,CHEMBL1153342,J Med Chem,2009,,CHEMBL521831,,CHEMBL521831,,0,http://www.openphacts.org/units/Nanomolar,755500,>,1,1,>,,IC50,nM,,8000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8000.0,PAK4
,,2278979,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(N)=O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '17.55', 'le': '0.32', 'lle': '4.14', 'sei': '7.86'}",CHEMBL493536,,CHEMBL493536,5.92,0,http://www.openphacts.org/units/Nanomolar,755501,=,1,1,=,,IC50,nM,,1200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1200.0,PAK4
,,2278980,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(CCC(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '17.20', 'le': '0.32', 'lle': '3.55', 'sei': '8.42'}",CHEMBL506100,,CHEMBL506100,5.85,0,http://www.openphacts.org/units/Nanomolar,755502,=,1,1,=,,IC50,nM,,1400.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1400.0,PAK4
,,2278981,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C4=NNNN4)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '18.65', 'le': '0.34', 'lle': '5.58', 'sei': '8.42'}",CHEMBL523841,,CHEMBL523841,6.80,0,http://www.openphacts.org/units/Nanomolar,755503,=,1,1,=,,IC50,nM,,160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,160.0,PAK4
,,2279643,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3ccccc3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,,CHEMBL493138,,CHEMBL493138,,0,http://www.openphacts.org/units/Nanomolar,755504,>,1,1,>,,IC50,nM,,8000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8000.0,PAK4
,,2279644,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)/C=C/c1cccc(-c2cncc(N3CCCNCC3)n2)c1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '24.66', 'le': '0.46', 'lle': '5.96', 'sei': '10.21'}",CHEMBL510884,,CHEMBL510884,8.00,0,http://www.openphacts.org/units/Nanomolar,755619,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,,2279645,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)/C=C/c1cccc(-c2cncc(N3CCCCCC3)n2)c1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '16.95', 'le': '0.31', 'lle': '1.86', 'sei': '8.27'}",CHEMBL493754,,CHEMBL493754,5.48,0,http://www.openphacts.org/units/Nanomolar,755620,=,1,1,=,,IC50,nM,,3300.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3300.0,PAK4
,,2279646,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '16.53', 'le': '0.31', 'lle': '3.76', 'sei': '6.99'}",CHEMBL523520,,CHEMBL523520,6.06,0,http://www.openphacts.org/units/Nanomolar,755621,=,1,1,=,,IC50,nM,,880.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,880.0,PAK4
,,2279647,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.04', 'le': '0.39', 'lle': '4.83', 'sei': '9.81'}",CHEMBL492354,,CHEMBL492354,6.82,0,http://www.openphacts.org/units/Nanomolar,755622,=,1,1,=,,IC50,nM,,150.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,150.0,PAK4
,,2279648,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)/C=C/c1cccc(-c2cncc(N3CCNCC3)n2)c1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.58', 'le': '0.40', 'lle': '5.05', 'sei': '8.55'}",CHEMBL522822,,CHEMBL522822,6.70,0,http://www.openphacts.org/units/Nanomolar,755623,=,1,1,=,,IC50,nM,,200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,200.0,PAK4
,,2279649,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)/C=C/c1cccc(-c2cncc(N3CCOCC3)n2)c1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '18.53', 'le': '0.34', 'lle': '3.69', 'sei': '7.64'}",CHEMBL492753,,CHEMBL492753,5.77,0,http://www.openphacts.org/units/Nanomolar,755624,=,1,1,=,,IC50,nM,,1700.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1700.0,PAK4
,,2279650,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '24.11', 'le': '0.45', 'lle': '5.24', 'sei': '6.78'}",CHEMBL455227,,CHEMBL455227,6.85,0,http://www.openphacts.org/units/Nanomolar,755697,=,1,1,=,,IC50,nM,,140.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,140.0,PAK4
,,2279651,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '25.37', 'le': '0.47', 'lle': '5.57', 'sei': '7.48'}",CHEMBL495030,,CHEMBL495030,7.57,0,http://www.openphacts.org/units/Nanomolar,755698,=,1,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,,2279652,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '24.51', 'le': '0.45', 'lle': '5.27', 'sei': '7.57'}",CHEMBL454281,,CHEMBL454281,7.66,0,http://www.openphacts.org/units/Nanomolar,755699,=,1,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.0,PAK4
,,2279653,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.53', 'le': '0.40', 'lle': '4.42', 'sei': '8.97'}",CHEMBL493559,,CHEMBL493559,7.03,0,http://www.openphacts.org/units/Nanomolar,755700,=,1,1,=,,IC50,nM,,94.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,94.0,PAK4
,,2279654,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCN(C)c1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '18.89', 'le': '0.35', 'lle': '3.80', 'sei': '9.25'}",CHEMBL522340,,CHEMBL522340,6.43,0,http://www.openphacts.org/units/Nanomolar,755701,=,1,1,=,,IC50,nM,,370.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,370.0,PAK4
,,2279655,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '18.36', 'le': '0.34', 'lle': '4.20', 'sei': '5.75'}",CHEMBL493560,,CHEMBL493560,5.99,0,http://www.openphacts.org/units/Nanomolar,755702,=,1,1,=,,IC50,nM,,1020.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1020.0,PAK4
,,2279656,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)/C=C/c1cccc(-c2cncc(NCCCO)n2)c1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.74', 'le': '0.40', 'lle': '4.47', 'sei': '6.83'}",CHEMBL494501,,CHEMBL494501,6.51,0,http://www.openphacts.org/units/Nanomolar,755780,=,1,1,=,,IC50,nM,,310.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,310.0,PAK4
,,2279657,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,COCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '20.16', 'le': '0.38', 'lle': '3.63', 'sei': '7.49'}",CHEMBL449471,,CHEMBL449471,6.32,0,http://www.openphacts.org/units/Nanomolar,755781,=,1,1,=,,IC50,nM,,480.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,480.0,PAK4
,,2279658,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)/C=C/c1cccc(-c2cncc(NCC3CCNCC3)n2)c1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '22.46', 'le': '0.42', 'lle': '4.95', 'sei': '8.72'}",CHEMBL455255,,CHEMBL455255,7.60,0,http://www.openphacts.org/units/Nanomolar,755782,=,1,1,=,,IC50,nM,,25.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.0,PAK4
,,2279659,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '22.96', 'le': '0.42', 'lle': '5.35', 'sei': '8.41'}",CHEMBL523534,,CHEMBL523534,7.77,0,http://www.openphacts.org/units/Nanomolar,755783,=,1,1,=,,IC50,nM,,17.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.0,PAK4
,,2279660,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@H](Nc2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '23.41', 'le': '0.43', 'lle': '5.00', 'sei': '7.83'}",CHEMBL494354,,CHEMBL494354,7.92,0,http://www.openphacts.org/units/Nanomolar,755784,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,,2279661,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@@H](Nc2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '22.82', 'le': '0.42', 'lle': '4.80', 'sei': '7.63'}",CHEMBL494355,,CHEMBL494355,7.72,0,http://www.openphacts.org/units/Nanomolar,755785,=,1,1,=,,IC50,nM,,19.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.0,PAK4
,,2279662,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)/C=C/c1cccc(-c2cncc(N[C@H]3CC[C@H](O)CC3)n2)c1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '19.38', 'le': '0.36', 'lle': '3.62', 'sei': '6.90'}",CHEMBL492580,,CHEMBL492580,6.58,0,http://www.openphacts.org/units/Nanomolar,755860,=,1,1,=,,IC50,nM,,265.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,265.0,PAK4
,,2279663,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)/C=C/c1cccc(-c2cnccn2)c1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '25.01', 'le': '0.45', 'lle': '3.42', 'sei': '8.97'}",CHEMBL473468,,CHEMBL473468,5.66,0,http://www.openphacts.org/units/Nanomolar,755861,=,1,1,=,,IC50,nM,,2200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2200.0,PAK4
,,2279664,[],CHEMBL960121,Inhibition of Pim2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cccc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.64', 'le': '0.40', 'lle': '4.31', 'sei': '12.88'}",CHEMBL492581,,CHEMBL492581,7.30,0,http://www.openphacts.org/units/Nanomolar,755862,=,1,1,=,,IC50,nM,,50.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,50.0,PAK4
,,2279671,[],CHEMBL960089,Inhibition of GST-tagged Pim2 by luciferin-luciferase reporter gene-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.86', 'le': '0.40', 'lle': '5.02', 'sei': '10.64'}",CHEMBL493937,,CHEMBL493937,7.40,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,40.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,40.0,PAK4
,,2279681,[],CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '17.48', 'le': '0.32', 'lle': '3.80', 'sei': '11.74'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.15,0,http://www.openphacts.org/units/Nanomolar,755863,=,1,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,,2279682,[],CHEMBL960090,Inhibition of GST-tagged Pim2 after 15 mins by scintillation counting-based competition assay in presence of 1 uM [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '20.25', 'le': '0.37', 'lle': '4.47', 'sei': '9.85'}",CHEMBL493937,,CHEMBL493937,6.85,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,140.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,140.0,PAK4
,,2279683,[],CHEMBL960091,Inhibition of GST-tagged Pim2 after 15 mins by scintillation counting-based competition assay in presence of 10 uM [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '15.95', 'le': '0.29', 'lle': '3.02', 'sei': '7.76'}",CHEMBL493937,,CHEMBL493937,5.40,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,4000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4000.0,PAK4
,,2279684,[],CHEMBL960092,Inhibition of GST-tagged Pim2 after 15 mins by scintillation counting-based competition assay in presence of 100 uM [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,,CHEMBL493937,,CHEMBL493937,,0,http://www.openphacts.org/units/Nanomolar,755426,>,1,1,>,,IC50,nM,,20000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20000.0,PAK4
,,2279685,[],CHEMBL960093,Inhibition of GST-tagged Pim2 preincubated for 30 mins before addition of ATP measured after 30 mins by scintillation counting-reversal assay in presence of 3 uM [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '22.69', 'le': '0.42', 'lle': '5.30', 'sei': '11.04'}",CHEMBL493937,,CHEMBL493937,7.68,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.0,PAK4
,,2279686,[],CHEMBL960094,Inhibition of GST-tagged Pim2 preincubated for 30 mins before addition of ATP measured after 30 mins by scintillation counting-reversal assay in presence of 20 uM [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '17.50', 'le': '0.32', 'lle': '3.54', 'sei': '8.51'}",CHEMBL493937,,CHEMBL493937,5.92,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,1200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1200.0,PAK4
,,2279687,[],CHEMBL960095,Inhibition of GST-tagged Pim2 preincubated for 30 mins before addition of ATP measured after 30 mins by scintillation counting-reversal assay in presence of 50 uM [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '15.95', 'le': '0.29', 'lle': '3.02', 'sei': '7.76'}",CHEMBL493937,,CHEMBL493937,5.40,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,4000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4000.0,PAK4
,,2279715,[],CHEMBL960128,Inhibition of GST-tagged Pim2 after 15 mins by scintillation counting-based competition assay in presence of 5 uM [gamma33P]ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '20.14', 'le': '0.37', 'lle': '4.44', 'sei': '9.80'}",CHEMBL493937,,CHEMBL493937,6.82,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,153.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,153.0,PAK4
,,2279716,[],CHEMBL960130,Inhibition of Pim2 in presence of 100 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '18.08', 'le': '0.33', 'lle': '3.74', 'sei': '8.80'}",CHEMBL493937,,CHEMBL493937,6.12,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,760.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,760.0,PAK4
,,2279758,[],CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '24.51', 'le': '0.45', 'lle': '5.27', 'sei': '7.57'}",CHEMBL454281,,CHEMBL454281,7.66,0,http://www.openphacts.org/units/Nanomolar,755699,=,1,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.0,PAK4
,,2279759,[],CHEMBL960130,Inhibition of Pim2 in presence of 100 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '13.85', 'le': '0.25', 'lle': '2.11', 'sei': '9.30'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,6.46,0,http://www.openphacts.org/units/Nanomolar,755863,=,1,1,=,,IC50,nM,,345.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,345.0,PAK4
,,2279760,[],CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.86', 'le': '0.40', 'lle': '5.02', 'sei': '10.64'}",CHEMBL493937,,CHEMBL493937,7.40,0,http://www.openphacts.org/units/Nanomolar,755426,=,1,1,=,,IC50,nM,,40.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,40.0,PAK4
,,2279761,[],CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cccc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '21.75', 'le': '0.40', 'lle': '4.35', 'sei': '12.95'}",CHEMBL492581,,CHEMBL492581,7.34,0,http://www.openphacts.org/units/Nanomolar,755862,=,1,1,=,,IC50,nM,,46.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,46.0,PAK4
,,2279762,[],CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@H](Nc2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '23.41', 'le': '0.43', 'lle': '5.00', 'sei': '7.83'}",CHEMBL494354,,CHEMBL494354,7.92,0,http://www.openphacts.org/units/Nanomolar,755784,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,,2279763,[],CHEMBL960129,Inhibition of Pim2 in presence of 1 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,COCCCNc1cncc(-c2cccc(/C=C/C(=O)O)c2)n1,,,CHEMBL1153342,J Med Chem,2009,"{'bei': '20.16', 'le': '0.38', 'lle': '3.63', 'sei': '7.49'}",CHEMBL449471,,CHEMBL449471,6.32,0,http://www.openphacts.org/units/Nanomolar,755781,=,1,1,=,,IC50,nM,,480.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,480.0,PAK4
,,2361193,[],CHEMBL970669,Inhibition of PIM2 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,,,CHEMBL1140082,J Med Chem,2008,,CHEMBL505896,,CHEMBL505896,,0,http://www.openphacts.org/units/Nanomolar,747816,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25000.0,PAK4
,,2361238,[],CHEMBL970669,Inhibition of PIM2 kinase,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1,,,CHEMBL1140082,J Med Chem,2008,,CHEMBL447602,,CHEMBL447602,,0,http://www.openphacts.org/units/Nanomolar,748085,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25000.0,PAK4
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",Antagonist,2897329,[],CHEMBL1062793,Inhibition of PIM2 in the presence of 5uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,,,CHEMBL1150976,Biochem J,2007,"{'bei': '22.14', 'le': '0.40', 'lle': '3.67', 'sei': '9.71'}",CHEMBL265470,,CHEMBL1182777,6.96,0,http://www.openphacts.org/units/Nanomolar,845274,=,1,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.11,PAK4
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",Antagonist,2897330,[],CHEMBL1062793,Inhibition of PIM2 in the presence of 5uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br,,,CHEMBL1150976,Biochem J,2007,"{'bei': '13.68', 'le': '0.47', 'lle': '2.34', 'sei': '13.63'}",CHEMBL1794051,,CHEMBL1794051,7.16,0,http://www.openphacts.org/units/Nanomolar,845235,=,1,1,=,,IC50,nM,,70.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.07,PAK4
,,2924630,[],CHEMBL1051395,Inhibition of Pim-2,B,,,BAO_0000190,BAO_0000357,single protein format,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,,,CHEMBL1154186,J Med Chem,2009,"{'bei': '26.86', 'le': '0.48', 'lle': '2.68', 'sei': '12.93'}",CHEMBL583972,,CHEMBL583972,6.29,0,http://www.openphacts.org/units/Nanomolar,850149,=,1,1,=,,IC50,nM,,510.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.51,PAK4
,,3084447,[],CHEMBL1073310,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,,,CHEMBL1153138,Bioorg Med Chem Lett,2010,,CHEMBL590109,,CHEMBL590109,,0,http://www.openphacts.org/units/Nanomolar,871256,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,3117946,[],CHEMBL1072222,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1,,,CHEMBL1157561,J Med Chem,2010,,CHEMBL599224,,CHEMBL599224,,0,http://www.openphacts.org/units/Nanomolar,887311,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,3117999,[],CHEMBL1072222,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2,,,CHEMBL1157561,J Med Chem,2010,,CHEMBL599428,,CHEMBL599428,,0,http://www.openphacts.org/units/Nanomolar,887313,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,3118052,[],CHEMBL1072222,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2,,,CHEMBL1157561,J Med Chem,2010,,CHEMBL597754,,CHEMBL597754,,0,http://www.openphacts.org/units/Nanomolar,887500,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,3130769,[],CHEMBL1065740,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC,,,CHEMBL1157712,J Med Chem,2010,,CHEMBL604087,,CHEMBL604087,,0,http://www.openphacts.org/units/Nanomolar,882696,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,3240827,[],CHEMBL1109680,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1,,,CHEMBL1156213,Bioorg Med Chem Lett,2010,,CHEMBL1090360,,CHEMBL1090360,,0,http://www.openphacts.org/units/Nanomolar,904836,>,1,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.0,PAK4
,,3435280,[],CHEMBL1248424,Inhibition of human GST fused Pim2 expressed in Escherichia coli after 30 mins,B,,,BAO_0000190,BAO_0000019,assay format,O=Cc1c[nH]c2c1ccc1c2[nH]c2cccc(Br)c21,,,CHEMBL1240519,Bioorg Med Chem,2010,"{'bei': '21.98', 'le': '0.49', 'lle': '2.50', 'sei': '14.15'}",CHEMBL1240961,,CHEMBL1240961,6.88,0,http://www.openphacts.org/units/Nanomolar,951508,=,1,1,=,,IC50,nM,,131.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.131,PAK4
,,3435281,[],CHEMBL1248424,Inhibition of human GST fused Pim2 expressed in Escherichia coli after 30 mins,B,,,BAO_0000190,BAO_0000019,assay format,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,,,CHEMBL1240519,Bioorg Med Chem,2010,"{'bei': '26.86', 'le': '0.48', 'lle': '2.68', 'sei': '12.93'}",CHEMBL583972,,CHEMBL583972,6.29,1,http://www.openphacts.org/units/Nanomolar,951432,=,1,1,=,,IC50,nM,,510.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.51,PAK4
,,6198143,[],CHEMBL1776305,Inhibition of PIM2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1,,,CHEMBL1773059,Bioorg Med Chem Lett,2011,,CHEMBL1738758,ONVANSERTIB,CHEMBL1738758,,0,http://www.openphacts.org/units/Nanomolar,1422263,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,6227667,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(C(F)(F)F)ccc2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '21.16', 'le': '0.42', 'lle': '1.72', 'sei': '9.65'}",CHEMBL1782505,,CHEMBL1782505,4.87,0,http://www.openphacts.org/units/Nanomolar,1427016,=,1,1,=,,IC50,nM,,13500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,13.5,PAK4
,,6227668,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(-c3cccnc3)ccc2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '21.52', 'le': '0.39', 'lle': '1.96', 'sei': '8.13'}",CHEMBL1204914,,CHEMBL1204914,5.15,0,http://www.openphacts.org/units/Nanomolar,1427018,=,1,1,=,,IC50,nM,,7100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,7.1,PAK4
,,6227669,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(-c3cnccn3)ccc2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '20.50', 'le': '0.37', 'lle': '2.33', 'sei': '6.46'}",CHEMBL1782507,,CHEMBL1782507,4.92,0,http://www.openphacts.org/units/Nanomolar,1427019,=,1,1,=,,IC50,nM,,11900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,11.9,PAK4
,,6227670,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc3oc(C(=O)O)cc3c2)cn1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '22.86', 'le': '0.42', 'lle': '3.01', 'sei': '8.11'}",CHEMBL1782508,,CHEMBL1782508,5.54,0,http://www.openphacts.org/units/Nanomolar,1427020,=,1,1,=,,IC50,nM,,2900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.9,PAK4
,,6227671,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(-c3cncc(NCC4CCNCC4)n3)ccc2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '19.29', 'le': '0.36', 'lle': '3.80', 'sei': '6.78'}",CHEMBL1782509,,CHEMBL1782509,6.80,0,http://www.openphacts.org/units/Nanomolar,1427021,=,1,1,=,,IC50,nM,,160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.16,PAK4
,,6227672,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(-c3cnn(C4CCNCC4)c3)ccc2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '16.82', 'le': '0.31', 'lle': '2.32', 'sei': '6.52'}",CHEMBL1782510,,CHEMBL1782510,5.24,0,http://www.openphacts.org/units/Nanomolar,1427022,=,1,1,=,,IC50,nM,,5800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,5.8,PAK4
,,6227673,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCCNc1ccnc(-c2ccc3oc(C(=O)O)cc3c2)n1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '18.14', 'le': '0.34', 'lle': '3.18', 'sei': '5.18'}",CHEMBL1782511,,CHEMBL1782511,5.92,0,http://www.openphacts.org/units/Nanomolar,1427023,=,1,1,=,,IC50,nM,,1200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.2,PAK4
,,6227674,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCCNc1nccc(-c2ccc3oc(C(=O)O)cc3c2)n1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '19.09', 'le': '0.35', 'lle': '3.49', 'sei': '5.45'}",CHEMBL1782512,,CHEMBL1782512,6.23,0,http://www.openphacts.org/units/Nanomolar,1427024,=,1,1,=,,IC50,nM,,590.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.59,PAK4
,,6227675,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@H](Nc2cncc(-c3ccc4oc(C(=O)O)cc4c3)n2)CC1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '20.62', 'le': '0.38', 'lle': '4.00', 'sei': '6.36'}",CHEMBL1782513,,CHEMBL1782513,7.27,0,http://www.openphacts.org/units/Nanomolar,1427025,=,1,1,=,,IC50,nM,,54.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.054,PAK4
,,6227676,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@@H](Nc2cncc(-c3ccc4oc(C(=O)O)cc4c3)n2)CC1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '19.75', 'le': '0.37', 'lle': '3.69', 'sei': '6.09'}",CHEMBL1782514,,CHEMBL1782514,6.96,0,http://www.openphacts.org/units/Nanomolar,1427026,=,1,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.11,PAK4
,,6227677,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(-c3cncc(NC4CCNCC4)n3)ccc2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '20.17', 'le': '0.37', 'lle': '4.07', 'sei': '6.80'}",CHEMBL1782515,,CHEMBL1782515,6.82,0,http://www.openphacts.org/units/Nanomolar,1427027,=,1,1,=,,IC50,nM,,150.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.15,PAK4
,,6227678,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@H]1CC[C@H](Nc2cncc(-c3ccc4oc(C(=O)O)cc4c3)n2)CC1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '20.95', 'le': '0.39', 'lle': '4.16', 'sei': '6.72'}",CHEMBL1782516,,CHEMBL1782516,7.68,0,http://www.openphacts.org/units/Nanomolar,1427028,=,1,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.021,PAK4
,,6227679,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(-c3cncc(NC4CNC4)n3)ccc2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '22.56', 'le': '0.42', 'lle': '5.03', 'sei': '6.98'}",CHEMBL1782517,,CHEMBL1782517,7.00,0,http://www.openphacts.org/units/Nanomolar,1427029,=,1,1,=,,IC50,nM,,100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.1,PAK4
,,6227680,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(OCC3CCNCC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '18.64', 'le': '0.43', 'lle': '3.33', 'sei': '9.21'}",CHEMBL1782518,,CHEMBL1782518,6.60,0,http://www.openphacts.org/units/Nanomolar,1427030,=,1,1,=,,IC50,nM,,250.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.25,PAK4
,,6227681,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(OCc3ccncc3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '14.08', 'le': '0.32', 'lle': '1.03', 'sei': '6.76'}",CHEMBL1782519,,CHEMBL1782519,4.90,0,http://www.openphacts.org/units/Nanomolar,1427031,=,1,1,=,,IC50,nM,,12500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,12.5,PAK4
,,6227682,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(OCC3CCCNC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '18.30', 'le': '0.42', 'lle': '3.21', 'sei': '9.04'}",CHEMBL1782520,,CHEMBL1782520,6.48,0,http://www.openphacts.org/units/Nanomolar,1427032,=,1,1,=,,IC50,nM,,330.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.33,PAK4
,,6227683,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(NCC3CCNCC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '19.03', 'le': '0.44', 'lle': '3.41', 'sei': '9.02'}",CHEMBL1782521,,CHEMBL1782521,6.72,0,http://www.openphacts.org/units/Nanomolar,1427033,=,1,1,=,,IC50,nM,,190.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.19,PAK4
,,6227684,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(OCCC3CCNCC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '17.53', 'le': '0.40', 'lle': '2.80', 'sei': '9.00'}",CHEMBL1782522,,CHEMBL1782522,6.46,0,http://www.openphacts.org/units/Nanomolar,1427034,=,1,1,=,,IC50,nM,,350.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.35,PAK4
,,6227685,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(OCCc3ccncc3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '12.91', 'le': '0.29', 'lle': '0.77', 'sei': '6.44'}",CHEMBL1782523,,CHEMBL1782523,4.68,0,http://www.openphacts.org/units/Nanomolar,1427035,=,1,1,=,,IC50,nM,,21100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,21.1,PAK4
,,6227686,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(NCCC3CCNCC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '17.07', 'le': '0.39', 'lle': '2.57', 'sei': '8.41'}",CHEMBL1782524,,CHEMBL1782524,6.27,0,http://www.openphacts.org/units/Nanomolar,1427036,=,1,1,=,,IC50,nM,,540.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.54,PAK4
,,6227687,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(NC(=O)C3CCNCC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '17.93', 'le': '0.41', 'lle': '3.76', 'sei': '7.19'}",CHEMBL1782525,,CHEMBL1782525,6.58,0,http://www.openphacts.org/units/Nanomolar,1427037,=,1,1,=,,IC50,nM,,260.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.26,PAK4
,,6227688,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CCNCC1)Nc1cc(Br)cc2cc(C(=O)O)oc12,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '16.97', 'le': '0.38', 'lle': '3.25', 'sei': '7.06'}",CHEMBL1782526,,CHEMBL1782526,6.47,0,http://www.openphacts.org/units/Nanomolar,1427038,=,1,1,=,,IC50,nM,,340.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.34,PAK4
,,6227689,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(OCC(=O)N3CCNCC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '15.36', 'le': '0.35', 'lle': '4.19', 'sei': '6.40'}",CHEMBL1782527,,CHEMBL1782527,5.89,0,http://www.openphacts.org/units/Nanomolar,1427039,=,1,1,=,,IC50,nM,,1300.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.3,PAK4
,,6227690,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(C(=O)NC3CCNCC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '14.04', 'le': '0.32', 'lle': '2.77', 'sei': '5.63'}",CHEMBL1782528,,CHEMBL1782528,5.16,0,http://www.openphacts.org/units/Nanomolar,1427040,=,1,1,=,,IC50,nM,,7000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,7.0,PAK4
,,6227691,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(C(=O)NCC3CCNCC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '15.44', 'le': '0.35', 'lle': '3.27', 'sei': '6.43'}",CHEMBL1782529,,CHEMBL1782529,5.89,0,http://www.openphacts.org/units/Nanomolar,1427041,=,1,1,=,,IC50,nM,,1300.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.3,PAK4
,,6227692,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@@H](Nc2cc(Br)cc3cc(C(=O)O)oc23)CC1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '23.78', 'le': '0.55', 'lle': '4.82', 'sei': '9.49'}",CHEMBL1782530,,CHEMBL1782530,8.40,0,http://www.openphacts.org/units/Nanomolar,1427042,=,1,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.004,PAK4
,,6227693,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@H](Nc2cc(Br)cc3cc(C(=O)O)oc23)CC1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '20.33', 'le': '0.47', 'lle': '3.60', 'sei': '8.11'}",CHEMBL1782531,,CHEMBL1782531,7.18,0,http://www.openphacts.org/units/Nanomolar,1427043,=,1,1,=,,IC50,nM,,66.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.066,PAK4
,,6227694,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(N[C@H]3CC[C@@H](O)CC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '14.59', 'le': '0.34', 'lle': '1.56', 'sei': '6.25'}",CHEMBL1782532,,CHEMBL1782532,5.17,0,http://www.openphacts.org/units/Nanomolar,1427044,=,1,1,=,,IC50,nM,,6800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,6.8,PAK4
,,6227695,[],CHEMBL1786238,Inhibition of human Pim2 using 5-FAM-RSRHSSYPAGT-CONH2 as substrate after 90 mins by off-chip mobility shift method,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cc2cc(Br)cc(N[C@H]3CC[C@H](O)CC3)c2o1,,,CHEMBL1781944,Bioorg Med Chem Lett,2011,"{'bei': '14.72', 'le': '0.34', 'lle': '1.60', 'sei': '6.31'}",CHEMBL1782533,,CHEMBL1782533,5.21,0,http://www.openphacts.org/units/Nanomolar,1427045,=,1,1,=,,IC50,nM,,6100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,6.1,PAK4
,,6386327,[],CHEMBL1839914,Inhibition of recombinant PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O,,,CHEMBL1833940,J Med Chem,2011,,CHEMBL1834657,INFIGRATINIB PHOSPHATE,CHEMBL1852688,,0,http://www.openphacts.org/units/Nanomolar,1460724,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,7847020,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cc1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '19.95', 'le': '0.36', 'lle': '4.00', 'sei': '9.61'}",CHEMBL1910893,,CHEMBL1910893,7.41,0,http://www.openphacts.org/units/Nanomolar,1543217,=,1,1,=,,IC50,nM,,39.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.039,PAK4
,,7847021,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)c[nH]c3n2)cc1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '17.68', 'le': '0.32', 'lle': '2.54', 'sei': '10.20'}",CHEMBL1910892,,CHEMBL1910892,6.55,0,http://www.openphacts.org/units/Nanomolar,1543216,=,1,1,=,,IC50,nM,,283.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.283,PAK4
,,7847022,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)c[nH]c3c2)cc1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '19.97', 'le': '0.36', 'lle': '2.76', 'sei': '14.38'}",CHEMBL1910894,,CHEMBL1910894,7.38,0,http://www.openphacts.org/units/Nanomolar,1543218,=,1,1,=,,IC50,nM,,42.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.042,PAK4
,,7847023,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cc1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '14.47', 'le': '0.26', 'lle': '1.44', 'sei': '9.05'}",CHEMBL1910895,,CHEMBL1910895,5.14,0,http://www.openphacts.org/units/Nanomolar,1543219,=,1,1,=,,IC50,nM,,7200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,7.2,PAK4
,,7847024,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cc1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,,CHEMBL1910896,,CHEMBL1910896,,0,http://www.openphacts.org/units/Nanomolar,1543220,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,7847025,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)ccn1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,,CHEMBL1910897,,CHEMBL1910897,,0,http://www.openphacts.org/units/Nanomolar,1543221,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,7847026,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cn1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,,CHEMBL1910898,,CHEMBL1910898,,0,http://www.openphacts.org/units/Nanomolar,1543222,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,7847027,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)ccn1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '12.65', 'le': '0.23', 'lle': '2.02', 'sei': '4.91'}",CHEMBL1910899,,CHEMBL1910899,4.70,0,http://www.openphacts.org/units/Nanomolar,1543223,=,1,1,=,,IC50,nM,,20000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,20.0,PAK4
,,7847028,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)cc1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,,CHEMBL1910900,,CHEMBL1910900,,0,http://www.openphacts.org/units/Nanomolar,1543224,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,7847029,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3n2)c2cc[nH]c2c1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '15.68', 'le': '0.28', 'lle': '2.01', 'sei': '8.52'}",CHEMBL1910901,,CHEMBL1910901,6.19,0,http://www.openphacts.org/units/Nanomolar,1543225,=,1,1,=,,IC50,nM,,650.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.65,PAK4
,,7847030,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ncc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)cn1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,,CHEMBL1909654,,CHEMBL1909654,,0,http://www.openphacts.org/units/Nanomolar,1543226,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,7847031,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cncc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)c1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '13.61', 'le': '0.24', 'lle': '0.51', 'sei': '10.98'}",CHEMBL1910902,,CHEMBL1910902,4.82,0,http://www.openphacts.org/units/Nanomolar,1543227,=,1,1,=,,IC50,nM,,15000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,15.0,PAK4
,,7847032,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)ccn1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,,CHEMBL1910903,,CHEMBL1910903,,0,http://www.openphacts.org/units/Nanomolar,1543228,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,7847033,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)nc1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,,CHEMBL1910904,,CHEMBL1910904,,0,http://www.openphacts.org/units/Nanomolar,1543229,>,1,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,7847034,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cnc(-c2ccc3[nH]cc(-c4ccc(N5CCNCC5)cc4)c3c2)cn1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '13.69', 'le': '0.25', 'lle': '1.17', 'sei': '8.56'}",CHEMBL1910905,,CHEMBL1910905,4.87,0,http://www.openphacts.org/units/Nanomolar,1543230,=,1,1,=,,IC50,nM,,13600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,13.6,PAK4
,,7847035,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c[nH]c3ccc(-c4cnccn4)cc23)c(F)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '17.36', 'le': '0.31', 'lle': '1.89', 'sei': '6.59'}",CHEMBL1910906,,CHEMBL1910906,5.30,0,http://www.openphacts.org/units/Nanomolar,1543231,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,5.0,PAK4
,,7847036,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(O[C@H]5CC[C@H](N)CC5)n4)cc23)c(F)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '16.92', 'le': '0.31', 'lle': '3.02', 'sei': '6.12'}",CHEMBL1910907,,CHEMBL1910907,7.08,0,http://www.openphacts.org/units/Nanomolar,1543232,=,1,1,=,,IC50,nM,,83.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.083,PAK4
,,7847037,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(N5CCNCC5)n4)cc23)c(F)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '18.53', 'le': '0.34', 'lle': '4.39', 'sei': '7.53'}",CHEMBL1910908,,CHEMBL1910908,7.21,0,http://www.openphacts.org/units/Nanomolar,1543233,=,1,1,=,,IC50,nM,,61.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.061,PAK4
,,7847038,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(N5CCCC(N)C5)n4)cc23)c(F)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '17.58', 'le': '0.32', 'lle': '3.75', 'sei': '6.46'}",CHEMBL1910909,,CHEMBL1910909,7.09,0,http://www.openphacts.org/units/Nanomolar,1543234,=,1,1,=,,IC50,nM,,81.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.081,PAK4
,,7847039,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](N)COc1cncc(-c2ccc3[nH]cc(-c4ccc(N)nc4F)c3c2)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '19.16', 'le': '0.35', 'lle': '4.12', 'sei': '6.27'}",CHEMBL1910910,,CHEMBL1910910,7.25,0,http://www.openphacts.org/units/Nanomolar,1543235,=,1,1,=,,IC50,nM,,56.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.056,PAK4
,,7847040,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](N)COc1cncc(-c2ccc3[nH]cc(-c4ccc(N)nc4F)c3c2)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '19.33', 'le': '0.36', 'lle': '4.07', 'sei': '6.55'}",CHEMBL1910911,,CHEMBL1910911,7.58,0,http://www.openphacts.org/units/Nanomolar,1543236,=,1,1,=,,IC50,nM,,26.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.026,PAK4
,,7847041,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](N)COc1cncc(-c2ccc3[nH]cc(-c4ccc(N)nc4F)c3c2)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '17.57', 'le': '0.33', 'lle': '3.37', 'sei': '6.17'}",CHEMBL1910912,,CHEMBL1910912,7.14,0,http://www.openphacts.org/units/Nanomolar,1543237,=,1,1,=,,IC50,nM,,72.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.072,PAK4
,,7847042,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@H](N)COc1cncc(-c2ccc3[nH]cc(-c4ccc(N)nc4F)c3c2)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '16.44', 'le': '0.30', 'lle': '2.75', 'sei': '5.97'}",CHEMBL1910913,,CHEMBL1910913,6.91,0,http://www.openphacts.org/units/Nanomolar,1543238,=,1,1,=,,IC50,nM,,122.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.122,PAK4
,,7847043,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(OC[C@@H](N)c5ccccc5)n4)cc23)c(F)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '18.16', 'le': '0.33', 'lle': '3.51', 'sei': '6.91'}",CHEMBL1910914,,CHEMBL1910914,8.00,0,http://www.openphacts.org/units/Nanomolar,1543239,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,7847044,[],CHEMBL1912526,Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c[nH]c3ccc(-c4cncc(OC[C@H](N)c5ccccc5)n4)cc23)c(F)n1,,,CHEMBL1909629,Bioorg Med Chem Lett,2011,"{'bei': '17.48', 'le': '0.32', 'lle': '3.21', 'sei': '6.65'}",CHEMBL1910915,,CHEMBL1910915,7.70,0,http://www.openphacts.org/units/Nanomolar,1543240,=,1,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.02,PAK4
,,7922569,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '19.24', 'le': '0.37', 'lle': '1.85', 'sei': '8.96'}",CHEMBL1230165,SILMITASERTIB,CHEMBL1230165,6.73,0,http://www.openphacts.org/units/Nanomolar,1557601,=,1,1,=,,IC50,nM,,186.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.186,PAK4
,,7922570,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,,CHEMBL1649759,,CHEMBL1649759,,0,http://www.openphacts.org/units/Nanomolar,1557602,>,1,1,>,,IC50,nM,,2500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.5,PAK4
,,7922571,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '16.92', 'le': '0.32', 'lle': '1.62', 'sei': '7.30'}",CHEMBL1649761,,CHEMBL1649761,5.90,0,http://www.openphacts.org/units/Nanomolar,1557603,=,1,1,=,,IC50,nM,,1250.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.25,PAK4
,,7922572,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Clc1cccc(Nc2nc3ccccc3c3cnccc23)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,,CHEMBL1649762,,CHEMBL1649762,,0,http://www.openphacts.org/units/Nanomolar,1557604,>,1,1,>,,IC50,nM,,2500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.5,PAK4
,,7922573,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1ccc2nc(Nc3cccc(Cl)c3)c3ccncc3c2c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '18.67', 'le': '0.36', 'lle': '1.65', 'sei': '8.70'}",CHEMBL1649586,,CHEMBL1649586,6.53,0,http://www.openphacts.org/units/Nanomolar,1557605,=,1,1,=,,IC50,nM,,294.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.294,PAK4
,,7922574,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc2nc(Nc3cccc(Cl)c3)c3ccncc3c2c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,,CHEMBL1915419,,CHEMBL1915419,,0,http://www.openphacts.org/units/Nanomolar,1557606,>,1,1,>,,IC50,nM,,2500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.5,PAK4
,,7922575,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '16.63', 'le': '0.32', 'lle': '1.08', 'sei': '9.43'}",CHEMBL1915420,,CHEMBL1915420,6.05,0,http://www.openphacts.org/units/Nanomolar,1557607,=,1,1,=,,IC50,nM,,894.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.894,PAK4
,,7922576,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.09', 'le': '0.38', 'lle': '2.15', 'sei': '9.36'}",CHEMBL1649765,,CHEMBL1649765,7.03,0,http://www.openphacts.org/units/Nanomolar,1557608,=,1,1,=,,IC50,nM,,94.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.094,PAK4
,,7922577,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.84', 'le': '0.40', 'lle': '2.99', 'sei': '8.98'}",CHEMBL1915421,,CHEMBL1915421,7.27,0,http://www.openphacts.org/units/Nanomolar,1557609,=,1,1,=,,IC50,nM,,54.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.054,PAK4
,,7922578,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '21.35', 'le': '0.41', 'lle': '3.20', 'sei': '11.57'}",CHEMBL1915422,,CHEMBL1915422,7.75,0,http://www.openphacts.org/units/Nanomolar,1557610,=,1,1,=,,IC50,nM,,18.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.018,PAK4
,,7922579,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,,CHEMBL1915423,,CHEMBL1915423,,0,http://www.openphacts.org/units/Nanomolar,1557611,>,1,1,>,,IC50,nM,,2500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.5,PAK4
,,7922580,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CC1)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '18.34', 'le': '0.35', 'lle': '2.06', 'sei': '10.66'}",CHEMBL1915424,,CHEMBL1915424,7.13,0,http://www.openphacts.org/units/Nanomolar,1557612,=,1,1,=,,IC50,nM,,74.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.074,PAK4
,,7922581,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COCCNC(=O)c1cccc2c1nc(Nc1cccc(Cl)c1)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '16.72', 'le': '0.32', 'lle': '2.24', 'sei': '8.93'}",CHEMBL1915425,,CHEMBL1915425,6.80,0,http://www.openphacts.org/units/Nanomolar,1557613,=,1,1,=,,IC50,nM,,158.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.158,PAK4
,,7922582,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Clc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.77', 'le': '0.39', 'lle': '2.77', 'sei': '9.76'}",CHEMBL1915426,,CHEMBL1915426,7.75,0,http://www.openphacts.org/units/Nanomolar,1557614,=,1,1,=,,IC50,nM,,18.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.018,PAK4
,,7922583,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Clc1cccc(Nc2nc3c(-c4nnco4)cccc3c3cnccc23)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '18.54', 'le': '0.35', 'lle': '1.70', 'sei': '9.03'}",CHEMBL1915427,,CHEMBL1915427,6.93,0,http://www.openphacts.org/units/Nanomolar,1557615,=,1,1,=,,IC50,nM,,117.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.117,PAK4
,,7922584,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2nnc[nH]2)c2nc(NC3CC3)c3ccncc3c2c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '26.78', 'le': '0.48', 'lle': '4.96', 'sei': '10.20'}",CHEMBL1915428,,CHEMBL1915428,8.10,0,http://www.openphacts.org/units/Nanomolar,1557616,=,1,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.008,PAK4
,,7922585,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2nnc[nH]2)c2nc(NC3CCC3)c3ccncc3c2c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '24.34', 'le': '0.44', 'lle': '4.17', 'sei': '9.70'}",CHEMBL1915429,,CHEMBL1915429,7.70,0,http://www.openphacts.org/units/Nanomolar,1557617,=,1,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.02,PAK4
,,7922586,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2nnc[nH]2)c2nc(NC3CCCC3)c3ccncc3c2c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '22.96', 'le': '0.41', 'lle': '3.67', 'sei': '9.56'}",CHEMBL1915430,,CHEMBL1915430,7.58,0,http://www.openphacts.org/units/Nanomolar,1557618,=,1,1,=,,IC50,nM,,26.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.026,PAK4
,,7922587,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,OCCNc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.70', 'le': '0.43', 'lle': '5.29', 'sei': '7.29'}",CHEMBL1915431,,CHEMBL1915431,7.26,0,http://www.openphacts.org/units/Nanomolar,1557619,=,1,1,=,,IC50,nM,,55.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.055,PAK4
,,7922588,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2nnc[nH]2)c2nc(N3CCCC3)c3ccncc3c2c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '21.37', 'le': '0.38', 'lle': '3.59', 'sei': '9.58'}",CHEMBL1915432,,CHEMBL1915432,6.76,0,http://www.openphacts.org/units/Nanomolar,1557620,=,1,1,=,,IC50,nM,,174.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.174,PAK4
,,7922589,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)cc1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.64', 'le': '0.42', 'lle': '3.69', 'sei': '10.08'}",CHEMBL1915433,,CHEMBL1915433,8.00,0,http://www.openphacts.org/units/Nanomolar,1557621,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,7922590,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.59', 'le': '0.37', 'lle': '3.27', 'sei': '8.56'}",CHEMBL1915434,,CHEMBL1915434,7.58,0,http://www.openphacts.org/units/Nanomolar,1557622,=,1,1,=,,IC50,nM,,26.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.026,PAK4
,,7922591,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '19.10', 'le': '0.34', 'lle': '2.72', 'sei': '7.94'}",CHEMBL1915435,,CHEMBL1915435,7.04,0,http://www.openphacts.org/units/Nanomolar,1557623,=,1,1,=,,IC50,nM,,92.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.092,PAK4
,,7922592,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,C#Cc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '22.08', 'le': '0.39', 'lle': '3.71', 'sei': '10.08'}",CHEMBL1915436,,CHEMBL1915436,8.00,0,http://www.openphacts.org/units/Nanomolar,1557624,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,7922593,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)cc1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.59', 'le': '0.39', 'lle': '2.71', 'sei': '9.67'}",CHEMBL1915437,,CHEMBL1915437,7.68,0,http://www.openphacts.org/units/Nanomolar,1557625,=,1,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.021,PAK4
,,7922594,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '22.05', 'le': '0.42', 'lle': '3.25', 'sei': '10.36'}",CHEMBL1915438,,CHEMBL1915438,8.22,0,http://www.openphacts.org/units/Nanomolar,1557626,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,7922595,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1ccccc1Cl)c1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.22', 'le': '0.38', 'lle': '2.83', 'sei': '11.08'}",CHEMBL1915439,,CHEMBL1915439,7.82,0,http://www.openphacts.org/units/Nanomolar,1557627,=,1,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.015,PAK4
,,7922596,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.29', 'le': '0.37', 'lle': '2.78', 'sei': '9.11'}",CHEMBL1915440,,CHEMBL1915440,7.23,0,http://www.openphacts.org/units/Nanomolar,1557628,=,1,1,=,,IC50,nM,,59.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.059,PAK4
,,7922597,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)cc1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '21.88', 'le': '0.39', 'lle': '3.35', 'sei': '9.82'}",CHEMBL1915441,,CHEMBL1915441,7.80,0,http://www.openphacts.org/units/Nanomolar,1557629,=,1,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.016,PAK4
,,7922598,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.92', 'le': '0.43', 'lle': '4.07', 'sei': '10.74'}",CHEMBL1915442,,CHEMBL1915442,8.52,0,http://www.openphacts.org/units/Nanomolar,1557630,=,1,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.003,PAK4
,,7922599,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.33', 'le': '0.42', 'lle': '3.60', 'sei': '10.36'}",CHEMBL1915443,,CHEMBL1915443,8.22,0,http://www.openphacts.org/units/Nanomolar,1557631,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,7922600,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '19.21', 'le': '0.37', 'lle': '2.41', 'sei': '9.46'}",CHEMBL1915444,,CHEMBL1915444,7.51,0,http://www.openphacts.org/units/Nanomolar,1557632,=,1,1,=,,IC50,nM,,31.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.031,PAK4
,,7922601,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '22.37', 'le': '0.42', 'lle': '4.03', 'sei': '8.73'}",CHEMBL1915445,,CHEMBL1915445,8.70,0,http://www.openphacts.org/units/Nanomolar,1557633,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.002,PAK4
,,7922602,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '16.31', 'le': '0.32', 'lle': '2.99', 'sei': '6.48'}",CHEMBL1915446,,CHEMBL1915446,7.36,0,http://www.openphacts.org/units/Nanomolar,1557634,=,1,1,=,,IC50,nM,,44.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.044,PAK4
,,7922603,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '15.21', 'le': '0.30', 'lle': '1.09', 'sei': '7.84'}",CHEMBL1915447,,CHEMBL1915447,6.95,0,http://www.openphacts.org/units/Nanomolar,1557635,=,1,1,=,,IC50,nM,,113.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.113,PAK4
,,7922604,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Clc1cc(OCCN2CCOCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '16.25', 'le': '0.31', 'lle': '3.47', 'sei': '8.07'}",CHEMBL1915448,,CHEMBL1915448,8.15,0,http://www.openphacts.org/units/Nanomolar,1557636,=,1,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.007,PAK4
,,7922605,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3nc4c(-c5nnc[nH]5)cccc4c4cnccc34)c(Cl)c2)CC1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '16.82', 'le': '0.32', 'lle': '3.20', 'sei': '9.23'}",CHEMBL1915449,,CHEMBL1915449,7.92,0,http://www.openphacts.org/units/Nanomolar,1557637,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.012,PAK4
,,7922606,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c1Cl,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '22.34', 'le': '0.42', 'lle': '4.03', 'sei': '10.16'}",CHEMBL1915633,,CHEMBL1915633,9.00,0,http://www.openphacts.org/units/Nanomolar,1557876,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.001,PAK4
,,7922607,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '21.86', 'le': '0.39', 'lle': '3.34', 'sei': '10.20'}",CHEMBL1915634,,CHEMBL1915634,8.10,0,http://www.openphacts.org/units/Nanomolar,1557877,=,1,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.008,PAK4
,,7922608,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)cc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '21.86', 'le': '0.39', 'lle': '3.34', 'sei': '10.20'}",CHEMBL1915635,,CHEMBL1915635,8.10,0,http://www.openphacts.org/units/Nanomolar,1557878,=,1,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.008,PAK4
,,7922609,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '24.04', 'le': '0.44', 'lle': '4.41', 'sei': '11.34'}",CHEMBL1915636,,CHEMBL1915636,9.00,0,http://www.openphacts.org/units/Nanomolar,1557879,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.001,PAK4
,,7922610,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(F)c1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.50', 'le': '0.37', 'lle': '3.46', 'sei': '8.94'}",CHEMBL1915637,,CHEMBL1915637,7.92,0,http://www.openphacts.org/units/Nanomolar,1557880,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.012,PAK4
,,7922611,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '21.96', 'le': '0.40', 'lle': '3.63', 'sei': '10.36'}",CHEMBL1915638,,CHEMBL1915638,8.22,0,http://www.openphacts.org/units/Nanomolar,1557881,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,7922612,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Cl)cc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.47', 'le': '0.39', 'lle': '2.90', 'sei': '10.08'}",CHEMBL1915639,,CHEMBL1915639,8.00,0,http://www.openphacts.org/units/Nanomolar,1557882,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,7922613,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '18.59', 'le': '0.34', 'lle': '3.52', 'sei': '8.18'}",CHEMBL1915640,,CHEMBL1915640,8.00,0,http://www.openphacts.org/units/Nanomolar,1557883,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,7922614,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OCCN2CCCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '16.87', 'le': '0.31', 'lle': '2.99', 'sei': '8.62'}",CHEMBL1915641,,CHEMBL1915641,7.92,0,http://www.openphacts.org/units/Nanomolar,1557884,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.012,PAK4
,,7922615,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '17.36', 'le': '0.32', 'lle': '3.31', 'sei': '8.38'}",CHEMBL1915642,,CHEMBL1915642,7.70,0,http://www.openphacts.org/units/Nanomolar,1557885,=,1,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.02,PAK4
,,7922616,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.21', 'le': '0.44', 'lle': '3.82', 'sei': '10.01'}",CHEMBL1915643,,CHEMBL1915643,8.10,0,http://www.openphacts.org/units/Nanomolar,1557886,=,1,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.008,PAK4
,,7922617,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '24.81', 'le': '0.47', 'lle': '4.46', 'sei': '13.45'}",CHEMBL1915644,,CHEMBL1915644,9.00,0,http://www.openphacts.org/units/Nanomolar,1557887,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.001,PAK4
,,7922618,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc2c1nc(Nc1cccc(OC)c1Cl)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '21.13', 'le': '0.40', 'lle': '3.75', 'sei': '10.90'}",CHEMBL1915645,,CHEMBL1915645,8.30,0,http://www.openphacts.org/units/Nanomolar,1557888,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,7922619,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.08', 'le': '0.44', 'lle': '3.77', 'sei': '13.00'}",CHEMBL1915646,,CHEMBL1915646,8.70,0,http://www.openphacts.org/units/Nanomolar,1557889,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.002,PAK4
,,7922620,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '22.26', 'le': '0.42', 'lle': '3.38', 'sei': '13.00'}",CHEMBL1915647,,CHEMBL1915647,8.70,0,http://www.openphacts.org/units/Nanomolar,1557890,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.002,PAK4
,,7922621,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.50', 'le': '0.39', 'lle': '2.73', 'sei': '12.41'}",CHEMBL1915648,,CHEMBL1915648,8.30,0,http://www.openphacts.org/units/Nanomolar,1557891,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,7922622,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2c1nc(Nc1ccccc1F)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '24.07', 'le': '0.44', 'lle': '4.24', 'sei': '9.89'}",CHEMBL1915649,,CHEMBL1915649,8.00,0,http://www.openphacts.org/units/Nanomolar,1557892,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,7922623,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc2c1nc(Nc1ccccc1F)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '24.25', 'le': '0.44', 'lle': '4.37', 'sei': '12.55'}",CHEMBL1915650,,CHEMBL1915650,8.40,0,http://www.openphacts.org/units/Nanomolar,1557893,=,1,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.004,PAK4
,,7922624,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2c1nc(Nc1c(F)cccc1F)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.97', 'le': '0.44', 'lle': '4.50', 'sei': '10.38'}",CHEMBL1915651,,CHEMBL1915651,8.40,0,http://www.openphacts.org/units/Nanomolar,1557894,=,1,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.004,PAK4
,,7922625,[],CHEMBL1919014,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay in the presence of 5 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc2c1nc(Nc1c(F)cccc1F)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.87', 'le': '0.44', 'lle': '4.54', 'sei': '13.00'}",CHEMBL1914471,,CHEMBL1914471,8.70,0,http://www.openphacts.org/units/Nanomolar,1557895,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.002,PAK4
,,7922752,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)cc1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.12', 'le': '0.41', 'lle': '3.51', 'sei': '9.86'}",CHEMBL1915433,,CHEMBL1915433,7.82,0,http://www.openphacts.org/units/Nanomolar,1557621,=,1,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.015,PAK4
,,7922753,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '22.05', 'le': '0.42', 'lle': '3.25', 'sei': '10.36'}",CHEMBL1915438,,CHEMBL1915438,8.22,0,http://www.openphacts.org/units/Nanomolar,1557626,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,7922754,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.29', 'le': '0.42', 'lle': '3.85', 'sei': '10.46'}",CHEMBL1915442,,CHEMBL1915442,8.30,0,http://www.openphacts.org/units/Nanomolar,1557630,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,7922755,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(Cl)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '23.15', 'le': '0.44', 'lle': '4.33', 'sei': '9.04'}",CHEMBL1915445,,CHEMBL1915445,9.00,0,http://www.openphacts.org/units/Nanomolar,1557633,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.001,PAK4
,,7922756,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Clc1cc(OCCN2CCOCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '15.65', 'le': '0.30', 'lle': '3.17', 'sei': '7.77'}",CHEMBL1915448,,CHEMBL1915448,7.85,0,http://www.openphacts.org/units/Nanomolar,1557636,=,1,1,=,,IC50,nM,,14.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.014,PAK4
,,7922757,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.90', 'le': '0.38', 'lle': '3.23', 'sei': '9.86'}",CHEMBL1915638,,CHEMBL1915638,7.82,0,http://www.openphacts.org/units/Nanomolar,1557881,=,1,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.015,PAK4
,,7922758,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Cl)cc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '20.27', 'le': '0.39', 'lle': '2.82', 'sei': '9.98'}",CHEMBL1915639,,CHEMBL1915639,7.92,0,http://www.openphacts.org/units/Nanomolar,1557882,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.012,PAK4
,,7922759,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cnccc23)c(F)c1,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '17.48', 'le': '0.32', 'lle': '3.04', 'sei': '7.69'}",CHEMBL1915640,,CHEMBL1915640,7.52,0,http://www.openphacts.org/units/Nanomolar,1557883,=,1,1,=,,IC50,nM,,30.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.03,PAK4
,,7922760,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OCCN2CCCC2)ccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '16.09', 'le': '0.29', 'lle': '2.62', 'sei': '8.22'}",CHEMBL1915641,,CHEMBL1915641,7.55,0,http://www.openphacts.org/units/Nanomolar,1557884,=,1,1,=,,IC50,nM,,28.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.028,PAK4
,,7922761,[],CHEMBL1919424,Inhibition of PIM2 by millipore assay in the presence of 15 uM [ATP],B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccncc12,,,CHEMBL1914433,Bioorg Med Chem Lett,2011,"{'bei': '22.88', 'le': '0.44', 'lle': '3.76', 'sei': '12.41'}",CHEMBL1915644,,CHEMBL1915644,8.30,0,http://www.openphacts.org/units/Nanomolar,1557887,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,7961107,[],CHEMBL1931535,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O,,,CHEMBL1926590,Bioorg Med Chem Lett,2011,,CHEMBL1929238,,CHEMBL1929238,,0,http://www.openphacts.org/units/Nanomolar,1566418,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,7961108,[],CHEMBL1931535,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,,,CHEMBL1926590,Bioorg Med Chem Lett,2011,,CHEMBL103667,DORAMAPIMOD,CHEMBL103667,,0,http://www.openphacts.org/units/Nanomolar,1566420,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,7987127,[],CHEMBL1936080,Inhibition of Pim-2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21,,,CHEMBL1933021,Bioorg Med Chem Lett,2012,,CHEMBL1933538,,CHEMBL1933538,,0,http://www.openphacts.org/units/Nanomolar,1567359,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,7987149,[],CHEMBL1936080,Inhibition of Pim-2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21,,,CHEMBL1933021,Bioorg Med Chem Lett,2012,,CHEMBL1933550,,CHEMBL1933550,,0,http://www.openphacts.org/units/Nanomolar,1567372,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,7987171,[],CHEMBL1936080,Inhibition of Pim-2,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1,,,CHEMBL1933021,Bioorg Med Chem Lett,2012,,CHEMBL1933551,,CHEMBL1933551,,0,http://www.openphacts.org/units/Nanomolar,1567373,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,7987203,[],CHEMBL1936080,Inhibition of Pim-2,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1,,,CHEMBL1933021,Bioorg Med Chem Lett,2012,,CHEMBL1933552,,CHEMBL1933552,,0,http://www.openphacts.org/units/Nanomolar,1567374,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,8013089,[],CHEMBL1948023,Inhibition of PIM2 using ATP as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O,,,CHEMBL1944596,J Med Chem,2012,"{'bei': '18.22', 'le': '0.38', 'lle': '3.66', 'sei': '9.48'}",CHEMBL1945559,,CHEMBL1945559,6.62,0,http://www.openphacts.org/units/Nanomolar,1574680,=,1,1,=,,IC50,nM,,240.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.24,PAK4
,,8037874,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)Oc1cccc(-n2nnc3ccc(NCC4CCNCC4)nc32)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '16.92', 'le': '0.32', 'lle': '3.51', 'sei': '8.63'}",CHEMBL1952113,,CHEMBL1952113,6.64,0,http://www.openphacts.org/units/Nanomolar,1579706,=,1,1,=,,IC50,nM,,230.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,230.0,PAK4
,,8037875,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)Oc1cccc(-n2nnc3ccc(NC4CCNCC4)nc32)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '16.37', 'le': '0.31', 'lle': '3.31', 'sei': '8.06'}",CHEMBL1952121,,CHEMBL1952121,6.19,0,http://www.openphacts.org/units/Nanomolar,1579714,=,1,1,=,,IC50,nM,,640.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,640.0,PAK4
,,8037876,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)Oc1cccc(-n2nnc3ccc(NC4CC5(CCNCC5)C4)nc32)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '15.92', 'le': '0.30', 'lle': '3.00', 'sei': '8.66'}",CHEMBL1952125,,CHEMBL1952125,6.66,0,http://www.openphacts.org/units/Nanomolar,1579718,=,1,1,=,,IC50,nM,,218.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,218.0,PAK4
,,8037877,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)Oc1cccc(-n2nnc3ccc(NCC4CC5(CCNCC5)C4)nc32)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '14.78', 'le': '0.28', 'lle': '2.48', 'sei': '8.32'}",CHEMBL1952126,,CHEMBL1952126,6.39,0,http://www.openphacts.org/units/Nanomolar,1579719,=,1,1,=,,IC50,nM,,404.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,404.0,PAK4
,,8037878,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,O[C@H]1CC[C@H](Nc2ccc3nnn(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '18.20', 'le': '0.35', 'lle': '3.73', 'sei': '8.42'}",CHEMBL1952132,,CHEMBL1952132,7.16,0,http://www.openphacts.org/units/Nanomolar,1579725,=,1,1,=,,IC50,nM,,69.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,69.0,PAK4
,,8037879,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,O[C@H]1CC[C@@H](Nc2ccc3nnn(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '17.33', 'le': '0.33', 'lle': '3.39', 'sei': '8.01'}",CHEMBL1952133,,CHEMBL1952133,6.82,0,http://www.openphacts.org/units/Nanomolar,1579726,=,1,1,=,,IC50,nM,,152.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,152.0,PAK4
,,8037880,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1cccc(-n2nnc3ccc(NCC4CCNCC4)nc32)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,,CHEMBL1952134,,CHEMBL1952134,,0,http://www.openphacts.org/units/Nanomolar,1579727,>,1,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,,8037881,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)c1cccc(-n2nnc3ccc(NCC4CC5(CCNCC5)C4)nc32)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '14.57', 'le': '0.28', 'lle': '2.04', 'sei': '8.97'}",CHEMBL1952136,,CHEMBL1952136,6.07,0,http://www.openphacts.org/units/Nanomolar,1579729,=,1,1,=,,IC50,nM,,853.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,853.0,PAK4
,,8037882,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)c1cccc(-n2nnc3ccc(NC4CC5(CCNCC5)C4)nc32)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '16.02', 'le': '0.30', 'lle': '2.67', 'sei': '9.53'}",CHEMBL1952137,,CHEMBL1952137,6.45,0,http://www.openphacts.org/units/Nanomolar,1579730,=,1,1,=,,IC50,nM,,358.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,358.0,PAK4
,,8037883,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1.O=S(=O)(O)O,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '15.88', 'le': '0.30', 'lle': '2.39', 'sei': '11.78'}",CHEMBL1952141,,CHEMBL1952329,6.44,0,http://www.openphacts.org/units/Nanomolar,1579734,=,1,1,=,,IC50,nM,,363.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,363.0,PAK4
,,8037884,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(OC(F)(F)F)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '17.84', 'le': '0.34', 'lle': '4.41', 'sei': '8.75'}",CHEMBL1952142,,CHEMBL1952142,7.54,0,http://www.openphacts.org/units/Nanomolar,1579735,=,1,1,=,,IC50,nM,,29.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.0,PAK4
,,8037885,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(N(C)C)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '16.05', 'le': '0.30', 'lle': '3.82', 'sei': '7.64'}",CHEMBL1952143,,CHEMBL1952143,6.12,0,http://www.openphacts.org/units/Nanomolar,1579736,=,1,1,=,,IC50,nM,,752.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,752.0,PAK4
,,8037886,[],CHEMBL1954567,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)Oc1cccc(-n2nnc3cc(Cl)c(NCC4CCNCC4)nc32)c1,,,CHEMBL1949661,Bioorg Med Chem Lett,2012,"{'bei': '14.06', 'le': '0.28', 'lle': '2.22', 'sei': '7.80'}",CHEMBL1952144,,CHEMBL1952144,6.00,0,http://www.openphacts.org/units/Nanomolar,1579737,=,1,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,,8044225,[],CHEMBL1955504,Inhibition of human recombinant PIM2 expressed in Escherichia coli using RSRHSSYPAGT as substrate after 30 mins,B,,,BAO_0000190,BAO_0000019,assay format,O=Cc1cn2c3c1ccc1c4ccccc4n(c13)CCCC2,,,CHEMBL1949527,Eur J Med Chem,2012,"{'bei': '22.39', 'le': '0.40', 'lle': '2.10', 'sei': '23.97'}",CHEMBL1950228,,CHEMBL1950228,6.46,0,http://www.openphacts.org/units/Nanomolar,1577444,=,1,1,=,,IC50,nM,,350.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.35,PAK4
,,10849723,[],CHEMBL2019682,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12,,,CHEMBL2016462,ACS Med Chem Lett,2011,,CHEMBL2017214,,CHEMBL2017214,,0,http://www.openphacts.org/units/Nanomolar,1634757,>,1,1,>,,IC50,nM,,40000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,40.0,PAK4
,,10859905,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.78', 'le': '0.43', 'lle': '2.84', 'sei': '11.77'}",CHEMBL2017322,,CHEMBL2017322,7.82,0,http://www.openphacts.org/units/Nanomolar,1634878,=,1,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.015,PAK4
,,10859906,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2sccc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '23.02', 'le': '0.46', 'lle': '3.07', 'sei': '13.08'}",CHEMBL2017323,,CHEMBL2017323,8.70,0,http://www.openphacts.org/units/Nanomolar,1634879,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.002,PAK4
,,10859907,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2sccc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '24.07', 'le': '0.46', 'lle': '3.58', 'sei': '13.08'}",CHEMBL2017324,,CHEMBL2017324,8.70,0,http://www.openphacts.org/units/Nanomolar,1634880,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.002,PAK4
,,10859908,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3cscc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.62', 'le': '0.42', 'lle': '2.79', 'sei': '11.69'}",CHEMBL2017325,,CHEMBL2017325,7.77,0,http://www.openphacts.org/units/Nanomolar,1634881,=,1,1,=,,IC50,nM,,17.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.017,PAK4
,,10859909,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cscc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '21.43', 'le': '0.43', 'lle': '2.47', 'sei': '12.18'}",CHEMBL2017326,,CHEMBL2017326,8.10,0,http://www.openphacts.org/units/Nanomolar,1634882,=,1,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.008,PAK4
,,10859910,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3ccsc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.87', 'le': '0.43', 'lle': '2.87', 'sei': '11.81'}",CHEMBL2017327,,CHEMBL2017327,7.85,0,http://www.openphacts.org/units/Nanomolar,1634883,=,1,1,=,,IC50,nM,,14.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.014,PAK4
,,10859911,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2ccsc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '21.76', 'le': '0.43', 'lle': '2.59', 'sei': '12.37'}",CHEMBL2017328,,CHEMBL2017328,8.22,0,http://www.openphacts.org/units/Nanomolar,1634884,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,10859912,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2scnc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '21.24', 'le': '0.42', 'lle': '3.02', 'sei': '10.14'}",CHEMBL2017329,,CHEMBL2017329,8.05,0,http://www.openphacts.org/units/Nanomolar,1634885,=,1,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.009,PAK4
,,10859913,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3n3cccc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '23.05', 'le': '0.41', 'lle': '3.50', 'sei': '10.61'}",CHEMBL2017330,,CHEMBL2017330,7.52,0,http://www.openphacts.org/units/Nanomolar,1634886,=,1,1,=,,IC50,nM,,30.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.03,PAK4
,,10859914,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2n2cccc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.47', 'le': '0.39', 'lle': '2.72', 'sei': '10.42'}",CHEMBL2017331,,CHEMBL2017331,7.39,0,http://www.openphacts.org/units/Nanomolar,1634887,=,1,1,=,,IC50,nM,,41.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.041,PAK4
,,10859915,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2n2cccc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.36', 'le': '0.40', 'lle': '3.54', 'sei': '10.86'}",CHEMBL2017332,,CHEMBL2017332,7.70,0,http://www.openphacts.org/units/Nanomolar,1634888,=,1,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.02,PAK4
,,10859916,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2n2cncc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '21.33', 'le': '0.39', 'lle': '3.82', 'sei': '8.79'}",CHEMBL2017333,,CHEMBL2017333,7.37,0,http://www.openphacts.org/units/Nanomolar,1634889,=,1,1,=,,IC50,nM,,43.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.043,PAK4
,,10859917,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2nnc[nH]2)c2nc(NC3CC3)c3ccsc3c2c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '24.73', 'le': '0.47', 'lle': '3.79', 'sei': '11.43'}",CHEMBL2017334,,CHEMBL2017334,7.60,0,http://www.openphacts.org/units/Nanomolar,1634890,=,1,1,=,,IC50,nM,,25.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.025,PAK4
,,10859918,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2nnc[nH]2)c2nc(N3CCOCC3)c3ccsc3c2c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '23.71', 'le': '0.46', 'lle': '4.93', 'sei': '11.95'}",CHEMBL2017335,,CHEMBL2017335,8.00,0,http://www.openphacts.org/units/Nanomolar,1634891,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,10859919,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CNc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.38', 'le': '0.38', 'lle': '2.43', 'sei': '10.96'}",CHEMBL2017336,,CHEMBL2017336,7.28,0,http://www.openphacts.org/units/Nanomolar,1634892,=,1,1,=,,IC50,nM,,52.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.052,PAK4
,,10859920,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cncc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.23', 'le': '0.42', 'lle': '3.29', 'sei': '9.65'}",CHEMBL2017337,,CHEMBL2017337,7.66,0,http://www.openphacts.org/units/Nanomolar,1634893,=,1,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.022,PAK4
,,10859921,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2nnc[nH]2)c2nc(Nc3ccncc3)c3ccsc3c2c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.81', 'le': '0.39', 'lle': '2.80', 'sei': '9.03'}",CHEMBL2017338,,CHEMBL2017338,7.17,0,http://www.openphacts.org/units/Nanomolar,1634894,=,1,1,=,,IC50,nM,,68.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.068,PAK4
,,10859922,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '21.76', 'le': '0.43', 'lle': '2.59', 'sei': '12.37'}",CHEMBL2017339,,CHEMBL2017339,8.22,0,http://www.openphacts.org/units/Nanomolar,1634895,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,10859923,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '18.70', 'le': '0.37', 'lle': '1.44', 'sei': '10.63'}",CHEMBL2017340,,CHEMBL2017340,7.07,0,http://www.openphacts.org/units/Nanomolar,1634896,=,1,1,=,,IC50,nM,,86.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.086,PAK4
,,10859924,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c(Cl)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '21.32', 'le': '0.42', 'lle': '3.06', 'sei': '9.68'}",CHEMBL2017341,,CHEMBL2017341,8.40,0,http://www.openphacts.org/units/Nanomolar,1634897,=,1,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.004,PAK4
,,10859925,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c(Cl)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.33', 'le': '0.41', 'lle': '2.28', 'sei': '12.10'}",CHEMBL2017342,,CHEMBL2017342,8.05,0,http://www.openphacts.org/units/Nanomolar,1634898,=,1,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.009,PAK4
,,10859926,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1Cl,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '18.82', 'le': '0.37', 'lle': '2.04', 'sei': '10.14'}",CHEMBL2017343,,CHEMBL2017343,7.68,0,http://www.openphacts.org/units/Nanomolar,1634899,=,1,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.021,PAK4
,,10859927,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)Oc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c(Cl)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '15.41', 'le': '0.31', 'lle': '0.59', 'sei': '9.40'}",CHEMBL2017345,,CHEMBL2017345,7.12,0,http://www.openphacts.org/units/Nanomolar,1634901,=,1,1,=,,IC50,nM,,76.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.076,PAK4
,,10859928,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.97', 'le': '0.44', 'lle': '3.18', 'sei': '12.48'}",CHEMBL2017346,,CHEMBL2017346,8.30,0,http://www.openphacts.org/units/Nanomolar,1634902,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,10859929,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.56', 'le': '0.43', 'lle': '3.03', 'sei': '12.26'}",CHEMBL2017347,,CHEMBL2017347,8.15,0,http://www.openphacts.org/units/Nanomolar,1634903,=,1,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.007,PAK4
,,10859930,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c(F)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.93', 'le': '0.44', 'lle': '3.44', 'sei': '13.08'}",CHEMBL2017348,,CHEMBL2017348,8.70,0,http://www.openphacts.org/units/Nanomolar,1634904,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.002,PAK4
,,10859931,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1F,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.62', 'le': '0.40', 'lle': '2.56', 'sei': '11.77'}",CHEMBL2017349,,CHEMBL2017349,7.82,0,http://www.openphacts.org/units/Nanomolar,1634905,=,1,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.015,PAK4
,,10859932,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(F)cc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.08', 'le': '0.39', 'lle': '2.36', 'sei': '11.46'}",CHEMBL2017344,,CHEMBL2017344,7.62,0,http://www.openphacts.org/units/Nanomolar,1634900,=,1,1,=,,IC50,nM,,24.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.024,PAK4
,,10859933,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2sccc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '19.57', 'le': '0.37', 'lle': '2.32', 'sei': '9.65'}",CHEMBL2017350,,CHEMBL2017350,7.31,0,http://www.openphacts.org/units/Nanomolar,1634906,=,1,1,=,,IC50,nM,,49.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.049,PAK4
,,10859934,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.23', 'le': '0.38', 'lle': '2.56', 'sei': '9.97'}",CHEMBL2017351,,CHEMBL2017351,7.55,0,http://www.openphacts.org/units/Nanomolar,1634907,=,1,1,=,,IC50,nM,,28.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.028,PAK4
,,10859935,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.02', 'le': '0.42', 'lle': '3.23', 'sei': '10.86'}",CHEMBL2017352,,CHEMBL2017352,8.22,0,http://www.openphacts.org/units/Nanomolar,1634908,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,10859936,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '17.35', 'le': '0.33', 'lle': '2.55', 'sei': '9.46'}",CHEMBL2017353,,CHEMBL2017353,7.47,0,http://www.openphacts.org/units/Nanomolar,1634909,=,1,1,=,,IC50,nM,,34.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.034,PAK4
,,10859937,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)c1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '17.70', 'le': '0.34', 'lle': '1.28', 'sei': '10.96'}",CHEMBL2017354,,CHEMBL2017354,7.28,0,http://www.openphacts.org/units/Nanomolar,1634910,=,1,1,=,,IC50,nM,,52.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.052,PAK4
,,10859938,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '21.50', 'le': '0.40', 'lle': '3.07', 'sei': '8.77'}",CHEMBL2017355,,CHEMBL2017355,7.92,0,http://www.openphacts.org/units/Nanomolar,1634911,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.012,PAK4
,,10859939,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#Cc1cccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)c1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.59', 'le': '0.42', 'lle': '3.34', 'sei': '12.48'}",CHEMBL2017356,,CHEMBL2017356,8.30,0,http://www.openphacts.org/units/Nanomolar,1634912,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,10859940,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(Nc2nc3c(-c4nnc[nH]4)cccc3c3sccc23)cc1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.11', 'le': '0.38', 'lle': '3.69', 'sei': '7.09'}",CHEMBL2017357,,CHEMBL2017357,7.77,0,http://www.openphacts.org/units/Nanomolar,1634913,=,1,1,=,,IC50,nM,,17.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.017,PAK4
,,10859941,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccsc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '19.49', 'le': '0.39', 'lle': '1.38', 'sei': '11.12'}",CHEMBL2017358,,CHEMBL2017358,6.92,0,http://www.openphacts.org/units/Nanomolar,1634914,=,1,1,=,,IC50,nM,,121.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.121,PAK4
,,10859942,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccsc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '22.39', 'le': '0.45', 'lle': '2.97', 'sei': '11.65'}",CHEMBL2017359,,CHEMBL2017359,7.92,0,http://www.openphacts.org/units/Nanomolar,1634915,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.012,PAK4
,,10859943,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc2c1nc(Nc1ccccc1Cl)c1ccsc12,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '20.53', 'le': '0.41', 'lle': '2.34', 'sei': '13.98'}",CHEMBL2017360,,CHEMBL2017360,7.55,0,http://www.openphacts.org/units/Nanomolar,1634916,=,1,1,=,,IC50,nM,,28.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.028,PAK4
,,10860649,[],CHEMBL2020772,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate and 5 uM ATP by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(Nc3ccccc3F)nc3c(-c4nnc[nH]4)cccc3c2s1,,,CHEMBL2016532,Bioorg Med Chem Lett,2012,"{'bei': '21.90', 'le': '0.42', 'lle': '2.79', 'sei': '12.37'}",CHEMBL2017361,,CHEMBL2017361,8.22,0,http://www.openphacts.org/units/Nanomolar,1634917,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,10889040,[],CHEMBL2032475,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1,,,CHEMBL2029218,J Med Chem,2012,"{'bei': '8.53', 'le': '0.16', 'lle': '-0.11', 'sei': '3.82'}",CHEMBL460472,,CHEMBL460472,4.60,0,http://www.openphacts.org/units/Nanomolar,1644201,=,1,1,=,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,10889067,[],CHEMBL2032475,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC,,,CHEMBL2029218,J Med Chem,2012,"{'bei': '8.71', 'le': '0.16', 'lle': '-0.63', 'sei': '4.76'}",CHEMBL2031893,,CHEMBL2031893,4.60,0,http://www.openphacts.org/units/Nanomolar,1644002,=,1,1,=,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,25.0,PAK4
,,10900570,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.26', 'le': '0.38', 'lle': '1.36', 'sei': '10.37'}",CHEMBL2035603,,CHEMBL2035603,6.11,0,http://www.openphacts.org/units/Nanomolar,1645401,=,1,1,=,,IC50,nM,,781.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,781.0,PAK4
,,10900571,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccccc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.87', 'le': '0.34', 'lle': '1.31', 'sei': '9.00'}",CHEMBL2035597,,CHEMBL2035597,5.30,0,http://www.openphacts.org/units/Nanomolar,1645394,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900572,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(Cl)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '18.32', 'le': '0.38', 'lle': '1.43', 'sei': '10.30'}",CHEMBL2035598,,CHEMBL2035598,6.07,0,http://www.openphacts.org/units/Nanomolar,1645395,=,1,1,=,,IC50,nM,,858.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,858.0,PAK4
,,10900573,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.39', 'le': '0.34', 'lle': '1.11', 'sei': '9.18'}",CHEMBL2035604,,CHEMBL2035604,5.41,0,http://www.openphacts.org/units/Nanomolar,1645402,=,1,1,=,,IC50,nM,,3934.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3934.0,PAK4
,,10900574,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.87', 'le': '0.35', 'lle': '1.84', 'sei': '8.57'}",CHEMBL2035605,,CHEMBL2035605,5.84,0,http://www.openphacts.org/units/Nanomolar,1645403,=,1,1,=,,IC50,nM,,1451.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1451.0,PAK4
,,10900575,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(O)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.35', 'le': '0.34', 'lle': '1.73', 'sei': '6.86'}",CHEMBL2035606,,CHEMBL2035606,5.42,0,http://www.openphacts.org/units/Nanomolar,1645404,=,1,1,=,,IC50,nM,,3755.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3755.0,PAK4
,,10900576,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,N#Cc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.99', 'le': '0.32', 'lle': '1.60', 'sei': '6.61'}",CHEMBL2035607,,CHEMBL2035607,5.46,0,http://www.openphacts.org/units/Nanomolar,1645405,=,1,1,=,,IC50,nM,,3429.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3429.0,PAK4
,,10900577,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(-c3ccccc3)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '14.22', 'le': '0.27', 'lle': '-0.36', 'sei': '9.00'}",CHEMBL2035608,,CHEMBL2035608,5.30,0,http://www.openphacts.org/units/Nanomolar,1645406,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900578,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(OC(F)(F)F)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '13.92', 'le': '0.28', 'lle': '0.41', 'sei': '7.78'}",CHEMBL2035609,,CHEMBL2035609,5.30,0,http://www.openphacts.org/units/Nanomolar,1645407,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900579,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1ccc(C(F)(F)F)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '15.44', 'le': '0.31', 'lle': '0.62', 'sei': '9.56'}",CHEMBL2035610,,CHEMBL2035610,5.63,0,http://www.openphacts.org/units/Nanomolar,1645408,=,1,1,=,,IC50,nM,,2330.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2330.0,PAK4
,,10900580,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,Nc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.01', 'le': '0.33', 'lle': '1.73', 'sei': '6.24'}",CHEMBL2035611,,CHEMBL2035611,5.30,0,http://www.openphacts.org/units/Nanomolar,1645409,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900581,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CNc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.27', 'le': '0.31', 'lle': '1.27', 'sei': '7.47'}",CHEMBL2035612,,CHEMBL2035612,5.30,0,http://www.openphacts.org/units/Nanomolar,1645410,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900582,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)Nc1ccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c2c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '14.98', 'le': '0.29', 'lle': '1.35', 'sei': '6.02'}",CHEMBL2035613,,CHEMBL2035613,5.30,0,http://www.openphacts.org/units/Nanomolar,1645411,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900583,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccccc2Cl)nc2c1oc1cc(O)ccc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.98', 'le': '0.35', 'lle': '1.92', 'sei': '7.11'}",CHEMBL2035614,,CHEMBL2035614,5.62,0,http://www.openphacts.org/units/Nanomolar,1645412,=,1,1,=,,IC50,nM,,2377.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2377.0,PAK4
,,10900584,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2c(c1)oc1c(=O)[nH]c(-c3ccccc3Cl)nc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.22', 'le': '0.31', 'lle': '1.30', 'sei': '7.78'}",CHEMBL2035615,,CHEMBL2035615,5.30,0,http://www.openphacts.org/units/Nanomolar,1645413,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900585,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1cccc2oc3c(=O)[nH]c(-c4ccccc4Cl)nc3c12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.22', 'le': '0.31', 'lle': '1.30', 'sei': '7.78'}",CHEMBL2035616,,CHEMBL2035616,5.30,0,http://www.openphacts.org/units/Nanomolar,1645414,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900586,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2c(F)cccc2Cl)nc2c1oc1ccc(C3CC3)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '15.44', 'le': '0.30', 'lle': '0.47', 'sei': '9.30'}",CHEMBL2035617,,CHEMBL2035617,5.48,0,http://www.openphacts.org/units/Nanomolar,1645415,=,1,1,=,,IC50,nM,,3330.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3330.0,PAK4
,,10900587,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccccc1-c1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,,CHEMBL2035618,,CHEMBL2035618,,0,http://www.openphacts.org/units/Nanomolar,1645416,>,1,1,>,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900588,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(C)c1ccccc1-c1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '13.83', 'le': '0.30', 'lle': '0.08', 'sei': '9.00'}",CHEMBL2035619,,CHEMBL2035619,5.30,0,http://www.openphacts.org/units/Nanomolar,1645417,=,1,1,=,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,,10900589,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccc(F)cc2Cl)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '15.42', 'le': '0.36', 'lle': '1.18', 'sei': '10.31'}",CHEMBL2035620,,CHEMBL2035620,6.07,0,http://www.openphacts.org/units/Nanomolar,1645418,=,1,1,=,,IC50,nM,,850.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,850.0,PAK4
,,10900590,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2cc(F)ccc2Cl)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '15.71', 'le': '0.37', 'lle': '1.30', 'sei': '10.50'}",CHEMBL2035621,,CHEMBL2035621,6.18,0,http://www.openphacts.org/units/Nanomolar,1645419,=,1,1,=,,IC50,nM,,653.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,653.0,PAK4
,,10900591,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2c(F)cccc2Cl)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '15.17', 'le': '0.35', 'lle': '1.08', 'sei': '10.14'}",CHEMBL2035622,,CHEMBL2035622,5.97,0,http://www.openphacts.org/units/Nanomolar,1645420,=,1,1,=,,IC50,nM,,1068.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1068.0,PAK4
,,10900592,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2cccc(Cl)c2Cl)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '15.18', 'le': '0.37', 'lle': '0.81', 'sei': '10.57'}",CHEMBL2035623,,CHEMBL2035623,6.22,0,http://www.openphacts.org/units/Nanomolar,1645421,=,1,1,=,,IC50,nM,,598.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,598.0,PAK4
,,10900593,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccc(Cl)cc2Cl)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '15.93', 'le': '0.39', 'lle': '1.12', 'sei': '11.09'}",CHEMBL2035624,,CHEMBL2035624,6.53,0,http://www.openphacts.org/units/Nanomolar,1645422,=,1,1,=,,IC50,nM,,293.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,293.0,PAK4
,,10900594,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1cccc(-c2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)c1Cl,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '14.20', 'le': '0.33', 'lle': '1.00', 'sei': '8.45'}",CHEMBL2035625,,CHEMBL2035625,5.76,0,http://www.openphacts.org/units/Nanomolar,1645423,=,1,1,=,,IC50,nM,,1741.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1741.0,PAK4
,,10900595,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,NCc1ccc(-c2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)c(Cl)c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.45', 'le': '0.40', 'lle': '2.85', 'sei': '8.32'}",CHEMBL2035626,,CHEMBL2035626,7.06,0,http://www.openphacts.org/units/Nanomolar,1645424,=,1,1,=,,IC50,nM,,87.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,87.0,PAK4
,,10900596,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(NCCN1CCCCC1)c1ccc(-c2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)c(Cl)c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '12.97', 'le': '0.28', 'lle': '1.90', 'sei': '7.53'}",CHEMBL2035627,,CHEMBL2035627,6.87,0,http://www.openphacts.org/units/Nanomolar,1645425,=,1,1,=,,IC50,nM,,134.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,134.0,PAK4
,,10900597,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccc(CNC3CCNCC3)cc2Cl)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '15.45', 'le': '0.34', 'lle': '2.95', 'sei': '9.09'}",CHEMBL2035628,,CHEMBL2035628,7.54,0,http://www.openphacts.org/units/Nanomolar,1645426,=,1,1,=,,IC50,nM,,29.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.0,PAK4
,,10900598,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=C(CCN1CCCCC1)Nc1ccc(-c2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)c(Cl)c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '13.53', 'le': '0.30', 'lle': '1.60', 'sei': '7.86'}",CHEMBL2035629,,CHEMBL2035629,7.17,0,http://www.openphacts.org/units/Nanomolar,1645427,=,1,1,=,,IC50,nM,,68.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,68.0,PAK4
,,10900599,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(-c2ccc(NCC3CCNCC3)cc2)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.63', 'le': '0.35', 'lle': '3.03', 'sei': '9.09'}",CHEMBL2035630,,CHEMBL2035630,7.54,0,http://www.openphacts.org/units/Nanomolar,1645428,=,1,1,=,,IC50,nM,,29.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.0,PAK4
,,10900600,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(CN2CCCCC2)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.94', 'le': '0.38', 'lle': '2.72', 'sei': '9.88'}",CHEMBL2035631,,CHEMBL2035631,6.14,0,http://www.openphacts.org/units/Nanomolar,1645429,=,1,1,=,,IC50,nM,,730.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,730.0,PAK4
,,10900601,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(CN2CCCC2)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '19.28', 'le': '0.44', 'lle': '3.68', 'sei': '10.80'}",CHEMBL2030389,,CHEMBL2030389,6.71,0,http://www.openphacts.org/units/Nanomolar,1645430,=,1,1,=,,IC50,nM,,194.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,194.0,PAK4
,,10900602,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(CN2CCC2)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '21.45', 'le': '0.49', 'lle': '4.53', 'sei': '11.54'}",CHEMBL2035632,,CHEMBL2035632,7.17,0,http://www.openphacts.org/units/Nanomolar,1645431,=,1,1,=,,IC50,nM,,68.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,68.0,PAK4
,,10900603,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1CCN(Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)CC1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.78', 'le': '0.40', 'lle': '4.53', 'sei': '10.26'}",CHEMBL2035633,,CHEMBL2035633,6.71,0,http://www.openphacts.org/units/Nanomolar,1645432,=,1,1,=,,IC50,nM,,197.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,197.0,PAK4
,,10900604,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(c1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1)N1CCN(C)CC1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.10', 'le': '0.36', 'lle': '3.56', 'sei': '9.64'}",CHEMBL2035634,,CHEMBL2035634,6.30,0,http://www.openphacts.org/units/Nanomolar,1645433,=,1,1,=,,IC50,nM,,503.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,503.0,PAK4
,,10900605,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1C[C@@H]2C[C@H]1CN2Cc1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.88', 'le': '0.40', 'lle': '4.64', 'sei': '10.64'}",CHEMBL2035635,,CHEMBL2035635,6.96,0,http://www.openphacts.org/units/Nanomolar,1645434,=,1,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,110.0,PAK4
,,10900606,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1C[C@@H]2CC[C@H]1CN2Cc1nc2c(oc3ccc(Br)cc32)c(=O)[nH]1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.84', 'le': '0.37', 'lle': '4.08', 'sei': '10.39'}",CHEMBL2035636,,CHEMBL2035636,6.79,0,http://www.openphacts.org/units/Nanomolar,1645435,=,1,1,=,,IC50,nM,,162.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,162.0,PAK4
,,10900607,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,N[C@H]1CCN(Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)C1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '20.13', 'le': '0.45', 'lle': '5.35', 'sei': '8.29'}",CHEMBL2030387,,CHEMBL2030387,7.31,0,http://www.openphacts.org/units/Nanomolar,1645436,=,1,1,=,,IC50,nM,,49.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,49.0,PAK4
,,10900608,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,N[C@@H]1CCN(Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)C1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '19.66', 'le': '0.44', 'lle': '5.18', 'sei': '8.10'}",CHEMBL2030388,,CHEMBL2030388,7.14,0,http://www.openphacts.org/units/Nanomolar,1645437,=,1,1,=,,IC50,nM,,72.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,72.0,PAK4
,,10900609,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1CCCC(Cc2nc3c(oc4ccc(Br)cc43)c(=O)[nH]2)C1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.67', 'le': '0.37', 'lle': '2.95', 'sei': '10.10'}",CHEMBL2035637,,CHEMBL2035637,6.27,0,http://www.openphacts.org/units/Nanomolar,1645438,=,1,1,=,,IC50,nM,,534.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,534.0,PAK4
,,10900610,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(CN2CC[C@H](O)C2)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '18.99', 'le': '0.43', 'lle': '4.92', 'sei': '8.40'}",CHEMBL2030376,,CHEMBL2030376,6.92,0,http://www.openphacts.org/units/Nanomolar,1645439,=,1,1,=,,IC50,nM,,121.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,121.0,PAK4
,,10900611,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(CN2CC[C@@H](O)C2)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '19.68', 'le': '0.44', 'lle': '5.17', 'sei': '8.70'}",CHEMBL2030386,,CHEMBL2030386,7.17,0,http://www.openphacts.org/units/Nanomolar,1645440,=,1,1,=,,IC50,nM,,68.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,68.0,PAK4
,,10900612,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(CN2CC(O)C2)nc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '19.56', 'le': '0.45', 'lle': '5.24', 'sei': '8.31'}",CHEMBL2035638,,CHEMBL2035638,6.85,0,http://www.openphacts.org/units/Nanomolar,1645441,=,1,1,=,,IC50,nM,,142.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,142.0,PAK4
,,10900613,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1CCN(Cc2nc3c(oc4ccc(Cl)cc43)c(=O)[nH]2)CC1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '18.99', 'le': '0.38', 'lle': '4.25', 'sei': '9.67'}",CHEMBL2035639,,CHEMBL2035639,6.32,0,http://www.openphacts.org/units/Nanomolar,1645442,=,1,1,=,,IC50,nM,,480.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,480.0,PAK4
,,10900614,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1CCN(Cc2nc3c(oc4ccc(I)cc43)c(=O)[nH]2)CC1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '16.16', 'le': '0.41', 'lle': '4.83', 'sei': '10.48'}",CHEMBL2035640,,CHEMBL2035640,6.85,0,http://www.openphacts.org/units/Nanomolar,1645443,=,1,1,=,,IC50,nM,,140.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,140.0,PAK4
,,10900615,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CN1CCN(Cc2nc3c(oc4ccc(C5CC5)cc43)c(=O)[nH]2)CC1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '17.95', 'le': '0.33', 'lle': '3.79', 'sei': '9.29'}",CHEMBL2035641,,CHEMBL2035641,6.08,0,http://www.openphacts.org/units/Nanomolar,1645444,=,1,1,=,,IC50,nM,,840.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,840.0,PAK4
,,10900616,[],CHEMBL2038009,Inhibition of N-terminal His-tagged human PIM2 expressed in Escherichia coli using AKRRRLSA as substrate after 1 to 2 hrs by luciferasse-luciferin-coupled chemiluminescence assay,B,,,BAO_0000190,BAO_0000019,assay format,CC(=O)c1ccc2oc3c(=O)[nH]c(CN4CCN(C)CC4)nc3c2c1,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '18.24', 'le': '0.34', 'lle': '4.59', 'sei': '7.53'}",CHEMBL2035642,,CHEMBL2035642,6.21,0,http://www.openphacts.org/units/Nanomolar,1645445,=,1,1,=,,IC50,nM,,620.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,620.0,PAK4
,,10901708,[],CHEMBL2038187,Inhibition of PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]cnc2c1oc1ccc(Br)cc12,,,CHEMBL2034948,Bioorg Med Chem Lett,2012,"{'bei': '20.86', 'le': '0.50', 'lle': '3.10', 'sei': '9.39'}",CHEMBL2030375,,CHEMBL2030375,5.53,0,http://www.openphacts.org/units/Nanomolar,1645399,=,1,1,=,,IC50,nM,,2963.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2963.0,PAK4
,,10905789,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc(-c2cccc(C(=O)NCCN3CCCC3)c2)o1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '15.60', 'le': '0.30', 'lle': '2.29', 'sei': '9.66'}",CHEMBL2037195,,CHEMBL2037195,7.21,0,http://www.openphacts.org/units/Nanomolar,1647502,=,1,1,=,,IC50,nM,,62.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.062,PAK4
,,10905790,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.O=C1Nc2ccc(F)cc2/C1=C\c1ccc(-c2cccc(C(=O)NCCN3CCCC3)c2)o1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '15.48', 'le': '0.29', 'lle': '2.50', 'sei': '9.25'}",CHEMBL2037196,,CHEMBL2079260,6.90,0,http://www.openphacts.org/units/Nanomolar,1647503,=,1,1,=,,IC50,nM,,127.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.127,PAK4
,,10905791,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2c(Cl)cccc2/C1=C\c1ccc(-c2cccc(C(=O)NCCN3CCCC3)c2)o1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '13.75', 'le': '0.26', 'lle': '1.43', 'sei': '8.52'}",CHEMBL2037197,,CHEMBL2037197,6.35,0,http://www.openphacts.org/units/Nanomolar,1647504,=,1,1,=,,IC50,nM,,445.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.445,PAK4
,,10905792,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccc(F)cc2/C1=C\c1ccc(-c2cccc(C(=O)NC3CC3)c2)o1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '17.93', 'le': '0.33', 'lle': '2.49', 'sei': '9.76'}",CHEMBL2037198,,CHEMBL2037198,6.96,0,http://www.openphacts.org/units/Nanomolar,1647505,=,1,1,=,,IC50,nM,,109.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.109,PAK4
,,10905793,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc(-c2cccc(C(=O)NCCCO)c2)o1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '17.55', 'le': '0.34', 'lle': '3.22', 'sei': '8.10'}",CHEMBL2037199,,CHEMBL2037199,7.42,0,http://www.openphacts.org/units/Nanomolar,1647506,=,1,1,=,,IC50,nM,,38.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.038,PAK4
,,10905794,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(C(=O)c2cccc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '16.46', 'le': '0.31', 'lle': '2.73', 'sei': '11.56'}",CHEMBL2037200,,CHEMBL2037200,7.60,0,http://www.openphacts.org/units/Nanomolar,1647507,=,1,1,=,,IC50,nM,,25.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.025,PAK4
,,10905795,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc(-c2cccc(C(=O)N3CCCNCC3)c2)o1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '17.10', 'le': '0.33', 'lle': '3.13', 'sei': '10.27'}",CHEMBL2037201,,CHEMBL2037201,7.66,0,http://www.openphacts.org/units/Nanomolar,1647508,=,1,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.022,PAK4
,,10905796,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(C(=O)c2cncc(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)n2)CC1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '14.33', 'le': '0.28', 'lle': '2.99', 'sei': '7.26'}",CHEMBL2037202,,CHEMBL2037202,6.65,0,http://www.openphacts.org/units/Nanomolar,1647509,=,1,1,=,,IC50,nM,,225.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.225,PAK4
,,10905797,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(C(=O)c2ccc(Cl)c(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '13.42', 'le': '0.27', 'lle': '1.14', 'sei': '10.13'}",CHEMBL2037203,,CHEMBL2037203,6.66,0,http://www.openphacts.org/units/Nanomolar,1647510,=,1,1,=,,IC50,nM,,217.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.217,PAK4
,,10905798,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(C(=O)c2ccc(F)c(-c3ccc(/C=C4/C(=O)Nc5ccc(Cl)cc54)o3)c2)CC1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '17.30', 'le': '0.33', 'lle': '3.29', 'sei': '12.62'}",CHEMBL2037204,,CHEMBL2037204,8.30,0,http://www.openphacts.org/units/Nanomolar,1647511,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,10905799,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=C1C(=O)Nc2ccc(Cl)cc21)c1ccc(-c2cccc(C(=O)N3CCCN(C)CC3)c2)o1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '15.59', 'le': '0.30', 'lle': '2.16', 'sei': '11.28'}",CHEMBL2037205,,CHEMBL2037205,7.42,0,http://www.openphacts.org/units/Nanomolar,1647512,=,1,1,=,,IC50,nM,,38.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.038,PAK4
,,10905800,[],CHEMBL2038829,Inhibition of human recombinant Pim2 using RSRHSSYPAGT as substrate by radiometric assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(=C1C(=O)Nc2ccc(Cl)cc21)c1ccc(-c2cccc(C(=O)N3CCCN(C)CC3)c2)o1,,,CHEMBL2034977,ACS Med Chem Lett,2012,"{'bei': '14.46', 'le': '0.28', 'lle': '1.44', 'sei': '10.77'}",CHEMBL2037206,,CHEMBL2037206,7.09,0,http://www.openphacts.org/units/Nanomolar,1647513,=,1,1,=,,IC50,nM,,82.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.082,PAK4
,,10936850,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cc(/C=C2\SC(=O)NC2=O)ccc1O,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '25.62', 'le': '0.52', 'lle': '4.69', 'sei': '8.99'}",CHEMBL2047864,,CHEMBL2047864,6.80,0,http://www.openphacts.org/units/Nanomolar,1654369,=,1,1,=,,IC50,nM,,160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.16,PAK4
,,10936851,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(/C=C2\SC(=O)NC2=O)cc1OC,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '21.12', 'le': '0.43', 'lle': '3.57', 'sei': '8.67'}",CHEMBL255421,,CHEMBL255421,5.60,0,http://www.openphacts.org/units/Nanomolar,1654370,=,1,1,=,,IC50,nM,,2500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.5,PAK4
,,10936852,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccccc2)S1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '25.96', 'le': '0.52', 'lle': '3.32', 'sei': '11.54'}",CHEMBL85105,,CHEMBL85105,5.33,0,http://www.openphacts.org/units/Nanomolar,1654371,=,1,1,=,,IC50,nM,,4700.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,4.7,PAK4
,,10936853,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C1CCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '19.85', 'le': '0.39', 'lle': '4.15', 'sei': '11.97'}",CHEMBL2048859,,CHEMBL2048859,6.30,0,http://www.openphacts.org/units/Nanomolar,1654372,=,1,1,=,,IC50,nM,,500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.5,PAK4
,,10936854,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)N[C@H]1CCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '12.39', 'le': '0.24', 'lle': '1.71', 'sei': '5.50'}",CHEMBL2048860,,CHEMBL2048860,4.82,0,http://www.openphacts.org/units/Nanomolar,1654373,=,1,1,=,,IC50,nM,,15000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,15.0,PAK4
,,10936855,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2ccccc2N2CCNCC2)S1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '23.31', 'le': '0.46', 'lle': '5.32', 'sei': '10.98'}",CHEMBL2048861,,CHEMBL2048861,6.75,0,http://www.openphacts.org/units/Nanomolar,1654374,=,1,1,=,,IC50,nM,,180.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.18,PAK4
,,10936856,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '22.82', 'le': '0.45', 'lle': '5.05', 'sei': '8.75'}",CHEMBL2048862,,CHEMBL2048862,6.60,0,http://www.openphacts.org/units/Nanomolar,1654375,=,1,1,=,,IC50,nM,,250.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.25,PAK4
,,10936857,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCN(c2c(Cl)cccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '23.48', 'le': '0.49', 'lle': '5.40', 'sei': '10.08'}",CHEMBL2048863,,CHEMBL2048863,7.60,0,http://www.openphacts.org/units/Nanomolar,1654376,=,1,1,=,,IC50,nM,,25.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.025,PAK4
,,10936858,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCN(c2cc(Cl)ccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '21.93', 'le': '0.46', 'lle': '4.90', 'sei': '9.42'}",CHEMBL2046468,,CHEMBL2046468,7.10,0,http://www.openphacts.org/units/Nanomolar,1654377,=,1,1,=,,IC50,nM,,79.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.079,PAK4
,,10936859,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NC(=O)/C(=C/c2cccc(Cl)c2N2CCNCC2)S1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '21.88', 'le': '0.46', 'lle': '5.02', 'sei': '11.53'}",CHEMBL2048864,,CHEMBL2048864,7.09,0,http://www.openphacts.org/units/Nanomolar,1654378,=,1,1,=,,IC50,nM,,82.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.082,PAK4
,,10936860,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '25.89', 'le': '0.51', 'lle': '5.91', 'sei': '10.41'}",CHEMBL2048865,,CHEMBL2048865,7.85,0,http://www.openphacts.org/units/Nanomolar,1654379,=,1,1,=,,IC50,nM,,14.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.014,PAK4
,,10936861,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(Cl)cccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '24.57', 'le': '0.52', 'lle': '5.71', 'sei': '11.00'}",CHEMBL2048866,,CHEMBL2048866,8.30,0,http://www.openphacts.org/units/Nanomolar,1654380,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,10936862,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(Br)cccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,,CHEMBL2048867,,CHEMBL2048867,,0,http://www.openphacts.org/units/Nanomolar,1654381,<,1,1,<,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.003,PAK4
,,10936863,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '24.90', 'le': '0.49', 'lle': '6.35', 'sei': '9.81'}",CHEMBL2048868,,CHEMBL2048868,8.30,0,http://www.openphacts.org/units/Nanomolar,1654382,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,10936864,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,,CHEMBL2048869,,CHEMBL2048869,,0,http://www.openphacts.org/units/Nanomolar,1654383,<,1,1,<,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.004,PAK4
,,10936865,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,,CHEMBL2048870,,CHEMBL2048870,,0,http://www.openphacts.org/units/Nanomolar,1654384,<,1,1,<,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.004,PAK4
,,10936866,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,,CHEMBL2048871,,CHEMBL2048871,,0,http://www.openphacts.org/units/Nanomolar,1654385,<,1,1,<,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.003,PAK4
,,10936867,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '21.87', 'le': '0.42', 'lle': '4.69', 'sei': '11.00'}",CHEMBL2048872,,CHEMBL2048872,8.30,0,http://www.openphacts.org/units/Nanomolar,1654386,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.005,PAK4
,,10936868,[],CHEMBL2049740,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccncc2)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '20.29', 'le': '0.39', 'lle': '4.72', 'sei': '8.74'}",CHEMBL2048873,,CHEMBL2048873,7.72,0,http://www.openphacts.org/units/Nanomolar,1654387,=,1,1,=,,IC50,nM,,19.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.019,PAK4
,,10936897,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2ccccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '19.52', 'le': '0.39', 'lle': '3.98', 'sei': '7.85'}",CHEMBL2048865,,CHEMBL2048865,5.92,0,http://www.openphacts.org/units/Nanomolar,1654379,=,1,1,=,,IC50,nM,,1200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.2,PAK4
,,10936898,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(Cl)cccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '19.27', 'le': '0.40', 'lle': '3.92', 'sei': '8.63'}",CHEMBL2048866,,CHEMBL2048866,6.51,0,http://www.openphacts.org/units/Nanomolar,1654380,=,1,1,=,,IC50,nM,,310.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.31,PAK4
,,10936899,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(Br)cccc2/C=C2\SC(=O)NC2=O)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '17.85', 'le': '0.42', 'lle': '4.12', 'sei': '9.05'}",CHEMBL2048867,,CHEMBL2048867,6.82,0,http://www.openphacts.org/units/Nanomolar,1654381,=,1,1,=,,IC50,nM,,150.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.15,PAK4
,,10936900,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '19.48', 'le': '0.39', 'lle': '4.54', 'sei': '7.67'}",CHEMBL2048868,,CHEMBL2048868,6.50,0,http://www.openphacts.org/units/Nanomolar,1654382,=,1,1,=,,IC50,nM,,320.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.32,PAK4
,,10936901,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '19.56', 'le': '0.39', 'lle': '4.46', 'sei': '8.03'}",CHEMBL2048869,,CHEMBL2048869,6.80,0,http://www.openphacts.org/units/Nanomolar,1654383,=,1,1,=,,IC50,nM,,160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.16,PAK4
,,10936902,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '18.25', 'le': '0.36', 'lle': '3.88', 'sei': '8.10'}",CHEMBL2048870,,CHEMBL2048870,6.85,0,http://www.openphacts.org/units/Nanomolar,1654384,=,1,1,=,,IC50,nM,,140.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.14,PAK4
,,10936903,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '20.20', 'le': '0.40', 'lle': '4.57', 'sei': '8.62'}",CHEMBL2048871,,CHEMBL2048871,7.30,0,http://www.openphacts.org/units/Nanomolar,1654385,=,1,1,=,,IC50,nM,,50.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.05,PAK4
,,10936904,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '17.98', 'le': '0.35', 'lle': '3.21', 'sei': '9.05'}",CHEMBL2048872,,CHEMBL2048872,6.82,0,http://www.openphacts.org/units/Nanomolar,1654386,=,1,1,=,,IC50,nM,,150.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.15,PAK4
,,10936905,[],CHEMBL2049743,Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATP,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccncc2)C1,,,CHEMBL2046384,Bioorg Med Chem Lett,2012,"{'bei': '16.19', 'le': '0.31', 'lle': '3.16', 'sei': '6.98'}",CHEMBL2048873,,CHEMBL2048873,6.16,0,http://www.openphacts.org/units/Nanomolar,1654387,=,1,1,=,,IC50,nM,,690.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.69,PAK4
,,10980313,[],CHEMBL2065157,Inhibition of PIM2 by FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12,,,CHEMBL2062359,Bioorg Med Chem Lett,2012,,CHEMBL2063926,,CHEMBL2063926,,0,http://www.openphacts.org/units/Nanomolar,1659922,<,1,1,<,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,11007116,[],CHEMBL2090488,Inhibition of human Pim2 using RSRHSSYPAGT as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,,,CHEMBL2086229,Eur J Med Chem,2012,"{'bei': '26.86', 'le': '0.48', 'lle': '2.68', 'sei': '12.93'}",CHEMBL583972,,CHEMBL583972,6.29,1,http://www.openphacts.org/units/Nanomolar,1676291,=,1,1,=,,IC50,nM,,510.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.51,PAK4
,,12037034,[],CHEMBL2149336,Inhibition of PIM2 by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ccccc13)C2=O,,,CHEMBL2146430,J Med Chem,2012,"{'bei': '15.20', 'le': '0.28', 'lle': '3.35', 'sei': '7.47'}",CHEMBL2147845,,CHEMBL2147845,5.94,0,http://www.openphacts.org/units/Nanomolar,1728885,=,1,1,=,,IC50,nM,,1160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1160.0,PAK4
,,12139743,[],CHEMBL2184777,Competitive inhibition of PIM2 in presence of ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,,,CHEMBL2176972,J Med Chem,2012,"{'bei': '15.88', 'le': '0.30', 'lle': '2.39', 'sei': '11.78'}",CHEMBL1952329,SGI-1776,CHEMBL1952329,6.44,0,http://www.openphacts.org/units/Nanomolar,1749965,=,1,1,=,,IC50,nM,,363.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.363,PAK4
,,12139744,[],CHEMBL2184777,Competitive inhibition of PIM2 in presence of ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1,,,CHEMBL2176972,J Med Chem,2012,"{'bei': '21.86', 'le': '0.40', 'lle': '5.02', 'sei': '10.64'}",CHEMBL493937,,CHEMBL493937,7.40,1,http://www.openphacts.org/units/Nanomolar,1749964,=,1,1,=,,IC50,nM,,40.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.04,PAK4
,,12150581,[],CHEMBL2188517,Inhibition of human recombinant PIM2 by radiometric kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1,,,CHEMBL2177100,J Med Chem,2012,,CHEMBL2178352,,CHEMBL2178352,,0,http://www.openphacts.org/units/Nanomolar,1751227,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,12629493,[],CHEMBL2319122,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,,,CHEMBL2311468,Bioorg Med Chem Lett,2013,,CHEMBL2312304,,CHEMBL2312304,,0,http://www.openphacts.org/units/Nanomolar,1841874,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,12629494,[],CHEMBL2319122,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,,,CHEMBL2311468,Bioorg Med Chem Lett,2013,,CHEMBL2312303,,CHEMBL2312303,,0,http://www.openphacts.org/units/Nanomolar,1841873,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,12629495,[],CHEMBL2319122,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1,,,CHEMBL2311468,Bioorg Med Chem Lett,2013,,CHEMBL2312301,,CHEMBL2312301,,0,http://www.openphacts.org/units/Nanomolar,1841871,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,12629496,[],CHEMBL2319122,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC,,,CHEMBL2311468,Bioorg Med Chem Lett,2013,"{'bei': '9.50', 'le': '0.18', 'lle': '1.60', 'sei': '4.12'}",CHEMBL2312290,,CHEMBL2312290,4.85,0,http://www.openphacts.org/units/Nanomolar,1841860,=,1,1,=,,IC50,nM,,14110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,14.11,PAK4
,,13506633,[],CHEMBL2443982,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1,,,CHEMBL2439976,Bioorg Med Chem,2013,,CHEMBL2443026,,CHEMBL2443026,,0,http://www.openphacts.org/units/Nanomolar,1929780,>,1,1,>,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,,13506634,[],CHEMBL2443982,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1,,,CHEMBL2439976,Bioorg Med Chem,2013,,CHEMBL2443139,,CHEMBL2443139,,0,http://www.openphacts.org/units/Nanomolar,1929917,>,1,1,>,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,,13506635,[],CHEMBL2443982,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1,,,CHEMBL2439976,Bioorg Med Chem,2013,,CHEMBL2443138,,CHEMBL2443138,,0,http://www.openphacts.org/units/Nanomolar,1929916,>,1,1,>,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,,13506636,[],CHEMBL2443982,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1,,,CHEMBL2439976,Bioorg Med Chem,2013,,CHEMBL2443044,,CHEMBL2443044,,0,http://www.openphacts.org/units/Nanomolar,1929798,>,1,1,>,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,,13515609,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1ccn2ncc(-c3cccc(-c4ccco4)c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '22.08', 'le': '0.40', 'lle': '4.02', 'sei': '8.66'}",CHEMBL2442290,,CHEMBL2442290,7.05,0,http://www.openphacts.org/units/Nanomolar,1928876,=,1,1,=,,IC50,nM,,89.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,89.0,PAK4
,,13515612,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCCC1CNc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '14.44', 'le': '0.26', 'lle': '0.92', 'sei': '11.80'}",CHEMBL2442301,,CHEMBL2442301,5.37,0,http://www.openphacts.org/units/Nanomolar,1928887,=,1,1,=,,IC50,nM,,4308.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4308.0,PAK4
,,13515613,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCCNc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '17.76', 'le': '0.32', 'lle': '2.33', 'sei': '8.26'}",CHEMBL2442299,,CHEMBL2442299,5.64,0,http://www.openphacts.org/units/Nanomolar,1928885,=,1,1,=,,IC50,nM,,2302.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2302.0,PAK4
,,13515614,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2cc(-c3cnn4ccc(NC5CNC5)nc34)ccc2c1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '19.37', 'le': '0.35', 'lle': '3.18', 'sei': '11.26'}",CHEMBL2442297,,CHEMBL2442297,6.11,0,http://www.openphacts.org/units/Nanomolar,1928883,=,1,1,=,,IC50,nM,,781.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,781.0,PAK4
,,13515615,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '23.27', 'le': '0.42', 'lle': '4.14', 'sei': '10.35'}",CHEMBL2442296,,CHEMBL2442296,7.06,0,http://www.openphacts.org/units/Nanomolar,1928882,=,1,1,=,,IC50,nM,,87.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,87.0,PAK4
,,13515616,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2cc(-c3cnn4ccc(N5CCNCC5)nc34)ccc2c1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '17.71', 'le': '0.32', 'lle': '2.88', 'sei': '12.84'}",CHEMBL2442295,,CHEMBL2442295,5.83,0,http://www.openphacts.org/units/Nanomolar,1928881,=,1,1,=,,IC50,nM,,1462.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1462.0,PAK4
,,13515617,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCC[C@H]1Nc1ccn2ncc(-c3ccc4ccccc4c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '19.03', 'le': '0.34', 'lle': '2.57', 'sei': '9.97'}",CHEMBL2442317,,CHEMBL2442317,6.80,0,http://www.openphacts.org/units/Nanomolar,1928903,=,1,1,=,,IC50,nM,,157.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,157.0,PAK4
,,13515618,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@H](Nc2ccn3ncc(-c4ccc5ccccc5c4)c3n2)CC1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '18.80', 'le': '0.34', 'lle': '2.49', 'sei': '9.85'}",CHEMBL2442316,,CHEMBL2442316,6.72,0,http://www.openphacts.org/units/Nanomolar,1928902,=,1,1,=,,IC50,nM,,190.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,190.0,PAK4
,,13515647,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1ccn2ncc(-c3cccc(OCc4ccccc4)c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '16.84', 'le': '0.31', 'lle': '2.70', 'sei': '7.81'}",CHEMBL2442293,,CHEMBL2442293,6.05,0,http://www.openphacts.org/units/Nanomolar,1928879,=,1,1,=,,IC50,nM,,886.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,886.0,PAK4
,,13515648,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(-c2cccc(-c3cnn4ccc(NCCN)nc34)c2)o1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '24.26', 'le': '0.44', 'lle': '6.01', 'sei': '7.59'}",CHEMBL2442291,,CHEMBL2442291,8.14,0,http://www.openphacts.org/units/Nanomolar,1928877,=,1,1,=,,IC50,nM,,7.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.3,PAK4
,,13515649,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1ccn2ncc(-c3cccc(-c4ccccc4)c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '20.84', 'le': '0.37', 'lle': '3.43', 'sei': '10.06'}",CHEMBL2442307,,CHEMBL2442307,6.86,0,http://www.openphacts.org/units/Nanomolar,1928893,=,1,1,=,,IC50,nM,,137.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,137.0,PAK4
,,13515650,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1ccn2ncc(-c3ccc4cn[nH]c4c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '25.98', 'le': '0.47', 'lle': '5.98', 'sei': '7.86'}",CHEMBL2442305,,CHEMBL2442305,7.62,0,http://www.openphacts.org/units/Nanomolar,1928891,=,1,1,=,,IC50,nM,,24.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.0,PAK4
,,13515651,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1ccn2ncc(-c3ccc4[nH]c(=O)[nH]c4c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '24.96', 'le': '0.46', 'lle': '6.78', 'sei': '6.61'}",CHEMBL2442304,,CHEMBL2442304,7.72,0,http://www.openphacts.org/units/Nanomolar,1928890,=,1,1,=,,IC50,nM,,19.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.0,PAK4
,,13515652,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1ccn2ncc(-c3ccc4scnc4c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '21.50', 'le': '0.41', 'lle': '4.29', 'sei': '8.23'}",CHEMBL2442303,,CHEMBL2442303,6.67,0,http://www.openphacts.org/units/Nanomolar,1928889,=,1,1,=,,IC50,nM,,212.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,212.0,PAK4
,,13515653,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1ccn2ncc(-c3ccc4sccc4c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '22.44', 'le': '0.43', 'lle': '3.96', 'sei': '10.17'}",CHEMBL2442302,,CHEMBL2442302,6.94,0,http://www.openphacts.org/units/Nanomolar,1928888,=,1,1,=,,IC50,nM,,114.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,114.0,PAK4
,,13515680,[],CHEMBL2446212,Inhibition of Pim2 (unknown origin) using STK1 as substrate preincubated for 30 mins followed by substrate and ATP addition after 60 mins by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1ccn2ncc(-c3cn[nH]c3)c2n1,,,CHEMBL2440090,Bioorg Med Chem Lett,2013,"{'bei': '24.81', 'le': '0.46', 'lle': '5.64', 'sei': '9.08'}",CHEMBL2442287,,CHEMBL2442287,6.73,0,http://www.openphacts.org/units/Nanomolar,1928873,=,1,1,=,,IC50,nM,,185.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,185.0,PAK4
,,14593762,[],CHEMBL3241181,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1,,,CHEMBL3232836,Bioorg Med Chem Lett,2014,,CHEMBL3133821,,CHEMBL3133821,,0,http://www.openphacts.org/units/Nanomolar,2087586,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,14668845,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '18.45', 'le': '0.33', 'lle': '3.07', 'sei': '5.98'}",CHEMBL3264252,,CHEMBL3264252,6.13,0,http://www.openphacts.org/units/Nanomolar,2103410,=,1,1,=,,IC50,nM,,740.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,740.0,PAK4
,,14668846,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '17.10', 'le': '0.31', 'lle': '3.82', 'sei': '6.07'}",CHEMBL3264253,,CHEMBL3264253,6.42,0,http://www.openphacts.org/units/Nanomolar,2103411,=,1,1,=,,IC50,nM,,380.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,380.0,PAK4
,,14668847,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '15.44', 'le': '0.28', 'lle': '2.85', 'sei': '5.89'}",CHEMBL3264254,,CHEMBL3264254,6.23,0,http://www.openphacts.org/units/Nanomolar,2103412,=,1,1,=,,IC50,nM,,590.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,590.0,PAK4
,,14668848,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '16.09', 'le': '0.30', 'lle': '3.28', 'sei': '5.92'}",CHEMBL3264255,,CHEMBL3264255,6.27,0,http://www.openphacts.org/units/Nanomolar,2103413,=,1,1,=,,IC50,nM,,540.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,540.0,PAK4
,,14668849,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCCOc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '14.80', 'le': '0.27', 'lle': '2.41', 'sei': '5.84'}",CHEMBL3264256,,CHEMBL3264256,6.18,0,http://www.openphacts.org/units/Nanomolar,2103414,=,1,1,=,,IC50,nM,,660.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,660.0,PAK4
,,14668850,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '18.58', 'le': '0.34', 'lle': '4.32', 'sei': '6.41'}",CHEMBL3264257,,CHEMBL3264257,6.96,0,http://www.openphacts.org/units/Nanomolar,2103415,=,1,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,110.0,PAK4
,,14668851,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '16.17', 'le': '0.30', 'lle': '3.09', 'sei': '5.99'}",CHEMBL3264258,,CHEMBL3264258,6.51,0,http://www.openphacts.org/units/Nanomolar,2103416,=,1,1,=,,IC50,nM,,310.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,310.0,PAK4
,,14668852,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '15.96', 'le': '0.29', 'lle': '3.17', 'sei': '5.71'}",CHEMBL3264259,,CHEMBL3264259,6.20,0,http://www.openphacts.org/units/Nanomolar,2103417,=,1,1,=,,IC50,nM,,630.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,630.0,PAK4
,,14668853,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '14.49', 'le': '0.27', 'lle': '2.23', 'sei': '5.56'}",CHEMBL3264260,,CHEMBL3264260,6.04,0,http://www.openphacts.org/units/Nanomolar,2103418,=,1,1,=,,IC50,nM,,920.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,920.0,PAK4
,,14668854,[],CHEMBL3269287,Inhibition of PIM2 kinase (unknown origin) using 5-FAM-labeled BAD peptide as substrate after 90 mins by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN(C)c1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL3259764,Bioorg Med Chem Lett,2014,"{'bei': '17.36', 'le': '0.32', 'lle': '4.08', 'sei': '6.75'}",CHEMBL3264261,,CHEMBL3264261,6.75,0,http://www.openphacts.org/units/Nanomolar,2103419,=,1,1,=,,IC50,nM,,180.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,180.0,PAK4
,,14751851,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)cn21)NCc1cccc(F)c1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '12.22', 'le': '0.23', 'lle': '1.14', 'sei': '8.62'}",CHEMBL3298564,,CHEMBL3298564,5.44,0,http://www.openphacts.org/units/Nanomolar,2120709,=,1,1,=,,IC50,nM,,3620.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,3.62,PAK4
,,14751852,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)cn21)NCC1CCOCC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '12.64', 'le': '0.24', 'lle': '2.11', 'sei': '7.61'}",CHEMBL3298817,,CHEMBL3298817,5.50,0,http://www.openphacts.org/units/Nanomolar,2121046,=,1,1,=,,IC50,nM,,3130.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,3.13,PAK4
,,14751853,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)cn21)NCC1CCCCC1,,,CHEMBL3297733,Bioorg Med Chem,2013,,CHEMBL3298818,,CHEMBL3298818,,0,http://www.openphacts.org/units/Nanomolar,2121047,>,1,1,>,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,5.0,PAK4
,,14751854,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3ccccc3F)cn21)NCC1CCCCC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '14.36', 'le': '0.27', 'lle': '1.84', 'sei': '8.72'}",CHEMBL3298819,,CHEMBL3298819,5.51,0,http://www.openphacts.org/units/Nanomolar,2121048,=,1,1,=,,IC50,nM,,3120.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,3.12,PAK4
,,14751855,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3cccc(F)c3)cn21)NCC1CCCCC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '14.63', 'le': '0.27', 'lle': '1.94', 'sei': '8.88'}",CHEMBL3298820,,CHEMBL3298820,5.61,0,http://www.openphacts.org/units/Nanomolar,2121049,=,1,1,=,,IC50,nM,,2460.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.46,PAK4
,,14751856,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3ccc(F)c(F)c3)cn21)NCC1CCCCC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '13.33', 'le': '0.25', 'lle': '1.55', 'sei': '8.47'}",CHEMBL3298821,,CHEMBL3298821,5.35,0,http://www.openphacts.org/units/Nanomolar,2121050,=,1,1,=,,IC50,nM,,4470.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,4.47,PAK4
,,14751857,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3ccnc(Cl)n3)cn21)NCC1CCCCC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '14.63', 'le': '0.29', 'lle': '2.91', 'sei': '6.61'}",CHEMBL3298822,,CHEMBL3298822,5.88,0,http://www.openphacts.org/units/Nanomolar,2121051,=,1,1,=,,IC50,nM,,1315.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.315,PAK4
,,14751858,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3cn[nH]c3)cn21)NCc1cccc(F)c1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '16.80', 'le': '0.31', 'lle': '4.16', 'sei': '6.72'}",CHEMBL3298823,,CHEMBL3298823,6.17,0,http://www.openphacts.org/units/Nanomolar,2121052,=,1,1,=,,IC50,nM,,675.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.675,PAK4
,,14751859,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3ccc(F)c(F)c3)cn21)NCc1ccco1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '14.67', 'le': '0.28', 'lle': '2.63', 'sei': '7.41'}",CHEMBL3298824,,CHEMBL3298824,5.65,0,http://www.openphacts.org/units/Nanomolar,2121053,=,1,1,=,,IC50,nM,,2222.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.222,PAK4
,,14751860,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3cccc(Cl)c3)cn21)NCc1ccco1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '15.65', 'le': '0.30', 'lle': '2.62', 'sei': '7.88'}",CHEMBL3298886,,CHEMBL3298886,6.01,0,http://www.openphacts.org/units/Nanomolar,2121157,=,1,1,=,,IC50,nM,,980.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.98,PAK4
,,14751861,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CC1CNC(=O)c2cc(-c3cc(Cl)ccc3F)cn21)NCc1ccco1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '13.98', 'le': '0.27', 'lle': '2.09', 'sei': '7.37'}",CHEMBL3298887,,CHEMBL3298887,5.62,0,http://www.openphacts.org/units/Nanomolar,2121158,=,1,1,=,,IC50,nM,,2406.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.406,PAK4
,,14751862,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cl)cc1-c1cc2n(c1)C(CC(=O)NCc1ccco1)CNC2=O,,,CHEMBL3297733,Bioorg Med Chem,2013,,CHEMBL3298888,,CHEMBL3298888,,0,http://www.openphacts.org/units/Nanomolar,2121159,>,1,1,>,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,5.0,PAK4
,,14751863,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@@H](NC(=O)C[C@H]1CNC(=O)c2cc(-c3ccnc(F)c3)cn21)c1ccccc1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '17.21', 'le': '0.32', 'lle': '4.83', 'sei': '6.87'}",CHEMBL3298889,,CHEMBL3298889,7.01,0,http://www.openphacts.org/units/Nanomolar,2121160,=,1,1,=,,IC50,nM,,97.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.097,PAK4
,,14751864,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@@H](NC(=O)C[C@@H]1CNC(=O)c2cc(-c3ccnc(F)c3)cn21)c1ccccc1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '15.46', 'le': '0.29', 'lle': '4.12', 'sei': '6.17'}",CHEMBL3298890,,CHEMBL3298890,6.30,0,http://www.openphacts.org/units/Nanomolar,2121161,=,1,1,=,,IC50,nM,,502.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.502,PAK4
,,14751865,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@@H](NC(=O)C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)c1ccccc1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '16.57', 'le': '0.31', 'lle': '3.95', 'sei': '7.55'}",CHEMBL3298891,,CHEMBL3298891,6.74,0,http://www.openphacts.org/units/Nanomolar,2121162,=,1,1,=,,IC50,nM,,184.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.184,PAK4
,,14751866,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)N[C@H](CO)C1CCCCC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '15.96', 'le': '0.30', 'lle': '3.57', 'sei': '7.92'}",CHEMBL3298892,,CHEMBL3298892,6.60,0,http://www.openphacts.org/units/Nanomolar,2121163,=,1,1,=,,IC50,nM,,252.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.252,PAK4
,,14751867,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)N[C@H](CO)c1ccccc1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '15.43', 'le': '0.29', 'lle': '3.47', 'sei': '7.54'}",CHEMBL3298893,,CHEMBL3298893,6.29,0,http://www.openphacts.org/units/Nanomolar,2121164,=,1,1,=,,IC50,nM,,516.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.516,PAK4
,,14751868,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)N[C@H](CO)Cc1ccccc1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '14.63', 'le': '0.27', 'lle': '3.47', 'sei': '7.40'}",CHEMBL3297758,,CHEMBL3297758,6.17,0,http://www.openphacts.org/units/Nanomolar,2119746,=,1,1,=,,IC50,nM,,684.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.684,PAK4
,,14751869,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,NC[C@@H](NC(=O)C[C@H]1CNC(=O)c2cc(-c3cccc(F)c3)cn21)C1CCCCC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '15.90', 'le': '0.30', 'lle': '3.57', 'sei': '7.36'}",CHEMBL3297759,,CHEMBL3297759,6.56,0,http://www.openphacts.org/units/Nanomolar,2119747,=,1,1,=,,IC50,nM,,275.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.275,PAK4
,,14751870,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(F)c4)cn32)[C@@H](c2ccccc2)C1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '13.48', 'le': '0.25', 'lle': '2.54', 'sei': '10.45'}",CHEMBL3297760,,CHEMBL3297760,6.02,0,http://www.openphacts.org/units/Nanomolar,2119748,=,1,1,=,,IC50,nM,,956.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.956,PAK4
,,14751871,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(F)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '13.77', 'le': '0.26', 'lle': '3.54', 'sei': '9.80'}",CHEMBL3297761,,CHEMBL3297761,6.82,0,http://www.openphacts.org/units/Nanomolar,2119749,=,1,1,=,,IC50,nM,,150.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.15,PAK4
,,14751872,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '13.94', 'le': '0.27', 'lle': '3.34', 'sei': '10.25'}",CHEMBL3297762,,CHEMBL3297762,7.14,0,http://www.openphacts.org/units/Nanomolar,2119750,=,1,1,=,,IC50,nM,,73.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.073,PAK4
,,14751873,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4ccc(F)c(F)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '12.85', 'le': '0.24', 'lle': '3.18', 'sei': '9.48'}",CHEMBL3297763,,CHEMBL3297763,6.60,0,http://www.openphacts.org/units/Nanomolar,2119751,=,1,1,=,,IC50,nM,,250.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.25,PAK4
,,14751874,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cc(Cl)ccc4F)cn32)C2CCCCC2)CC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '12.98', 'le': '0.25', 'lle': '2.95', 'sei': '9.88'}",CHEMBL3297764,,CHEMBL3297764,6.88,0,http://www.openphacts.org/units/Nanomolar,2119752,=,1,1,=,,IC50,nM,,132.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.132,PAK4
,,14751875,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4ccnc(F)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '14.14', 'le': '0.27', 'lle': '4.34', 'sei': '8.51'}",CHEMBL3297765,,CHEMBL3297765,7.02,0,http://www.openphacts.org/units/Nanomolar,2119753,=,1,1,=,,IC50,nM,,95.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.095,PAK4
,,14751876,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C(C)(C)C)CC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '13.54', 'le': '0.26', 'lle': '3.32', 'sei': '9.46'}",CHEMBL3297767,,CHEMBL3297767,6.58,0,http://www.openphacts.org/units/Nanomolar,2119755,=,1,1,=,,IC50,nM,,262.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.262,PAK4
,,14751877,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CN1CCN(C)CC1)NC(=O)C[C@H]1CNC(=O)c2cc(-c3cccc(Cl)c3)cn21,,,CHEMBL3297733,Bioorg Med Chem,2013,,CHEMBL3297768,,CHEMBL3297768,,0,http://www.openphacts.org/units/Nanomolar,2119756,>,1,1,>,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,5.0,PAK4
,,14751913,[],CHEMBL3300844,Inhibition of human PIM2 using ARK-RERTYSFGHHA as substrate incubated for 60 mins prior to substrate addition by topcount scintillation counting analysis in presence of [P33gamma]-ATP,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3297733,Bioorg Med Chem,2013,"{'bei': '13.78', 'le': '0.27', 'lle': '2.87', 'sei': '10.69'}",CHEMBL3297766,,CHEMBL3297766,7.44,0,http://www.openphacts.org/units/Nanomolar,2119754,=,1,1,=,,IC50,nM,,36.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.036,PAK4
,,14976415,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cnccc1O[C@H]1CCNC1)c1csc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '19.52', 'le': '0.38', 'lle': '4.37', 'sei': '10.32'}",CHEMBL3354511,,CHEMBL3354511,7.85,0,http://www.openphacts.org/units/Nanomolar,2246161,=,1,1,=,,IC50,nM,,14.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.0,PAK4
,,14976416,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cnccc1O[C@@H]1CCNC1)c1csc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '16.01', 'le': '0.31', 'lle': '2.96', 'sei': '8.46'}",CHEMBL3354512,,CHEMBL3354512,6.44,0,http://www.openphacts.org/units/Nanomolar,2246162,=,1,1,=,,IC50,nM,,360.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,360.0,PAK4
,,14976417,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cnccc1OC1CCNCC1)c1csc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '18.60', 'le': '0.36', 'lle': '3.87', 'sei': '10.17'}",CHEMBL3354513,,CHEMBL3354513,7.75,0,http://www.openphacts.org/units/Nanomolar,2246163,=,1,1,=,,IC50,nM,,18.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,18.0,PAK4
,,14976418,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cnccc1OC1CCCCC1)c1csc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '15.89', 'le': '0.31', 'lle': '1.15', 'sei': '10.30'}",CHEMBL3354514,,CHEMBL3354514,6.60,0,http://www.openphacts.org/units/Nanomolar,2246164,=,1,1,=,,IC50,nM,,250.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,250.0,PAK4
,,14976419,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cnccc1OC1CCOCC1)c1csc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '15.33', 'le': '0.30', 'lle': '2.11', 'sei': '8.72'}",CHEMBL3354515,,CHEMBL3354515,6.40,0,http://www.openphacts.org/units/Nanomolar,2246165,=,1,1,=,,IC50,nM,,400.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,400.0,PAK4
,,14976420,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cnccc1OCC1CCOCC1)c1csc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '16.81', 'le': '0.33', 'lle': '2.71', 'sei': '9.89'}",CHEMBL3354516,,CHEMBL3354516,7.25,0,http://www.openphacts.org/units/Nanomolar,2246166,=,1,1,=,,IC50,nM,,56.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,56.0,PAK4
,,14976421,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cnccc1O[C@H]1CC[C@H](O)CC1)c1csc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '17.25', 'le': '0.34', 'lle': '3.02', 'sei': '8.83'}",CHEMBL3354517,,CHEMBL3354517,7.44,0,http://www.openphacts.org/units/Nanomolar,2246167,=,1,1,=,,IC50,nM,,36.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,36.0,PAK4
,,14976422,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1O[C@H]1CCNC1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '21.56', 'le': '0.42', 'lle': '5.94', 'sei': '8.81'}",CHEMBL3354518,,CHEMBL3354518,9.00,0,http://www.openphacts.org/units/Nanomolar,2246168,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,,14976423,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1-c1cccc(CNc2cnccc2OC2CCNCC2)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '14.38', 'le': '0.27', 'lle': '1.41', 'sei': '9.22'}",CHEMBL3354519,,CHEMBL3354519,5.44,0,http://www.openphacts.org/units/Nanomolar,2246169,=,1,1,=,,IC50,nM,,3600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3600.0,PAK4
,,14976424,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1cccc(CNc2cnccc2OC2CCNCC2)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '13.56', 'le': '0.25', 'lle': '1.22', 'sei': '9.10'}",CHEMBL3354520,,CHEMBL3354520,5.38,0,http://www.openphacts.org/units/Nanomolar,2246170,=,1,1,=,,IC50,nM,,4200.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4200.0,PAK4
,,14976425,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cnccc1OC1CCNCC1)c1cccc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '16.63', 'le': '0.31', 'lle': '3.02', 'sei': '8.96'}",CHEMBL3354521,,CHEMBL3354521,6.82,0,http://www.openphacts.org/units/Nanomolar,2246171,=,1,1,=,,IC50,nM,,150.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,150.0,PAK4
,,14976426,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1nc2c(Nc3cnccc3O[C@H]3CCNC3)cccc2s1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '15.89', 'le': '0.31', 'lle': '1.62', 'sei': '11.42'}",CHEMBL3354522,,CHEMBL3354522,6.75,0,http://www.openphacts.org/units/Nanomolar,2246172,=,1,1,=,,IC50,nM,,180.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,180.0,PAK4
,,14976427,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1nc(-c2ccc3nccc(N4CCNCC4)c3c2)cs1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '16.45', 'le': '0.32', 'lle': '2.01', 'sei': '16.37'}",CHEMBL3354523,,CHEMBL3354523,6.72,0,http://www.openphacts.org/units/Nanomolar,2246173,=,1,1,=,,IC50,nM,,190.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,190.0,PAK4
,,14976428,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(-c2csc(-c3c(F)cccc3F)n2)cc1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,,CHEMBL3354524,,CHEMBL3354524,,0,http://www.openphacts.org/units/Nanomolar,2246174,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,,14976429,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1cccnc1)c1csc(-c2c(F)cccc2F)n1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,,CHEMBL3354525,,CHEMBL3354525,,0,http://www.openphacts.org/units/Nanomolar,2246175,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,,14976430,[],CHEMBL3376647,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(-c2c[nH]c3ncnc(NCCO)c23)cc1,,,CHEMBL3352230,Bioorg Med Chem Lett,2015,"{'bei': '19.24', 'le': '0.36', 'lle': '4.59', 'sei': '4.89'}",CHEMBL3354526,,CHEMBL3354526,5.72,0,http://www.openphacts.org/units/Nanomolar,2246176,=,1,1,=,,IC50,nM,,1900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1900.0,PAK4
,,14981006,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '16.79', 'le': '0.33', 'lle': '1.57', 'sei': '11.65'}",CHEMBL3355988,,CHEMBL3355988,5.99,0,http://www.openphacts.org/units/Nanomolar,2252453,=,1,1,=,,IC50,nM,,1020.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1020.0,PAK4
,,14981007,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '17.26', 'le': '0.34', 'lle': '1.85', 'sei': '10.64'}",CHEMBL3355987,,CHEMBL3355987,6.64,0,http://www.openphacts.org/units/Nanomolar,2252452,=,1,1,=,,IC50,nM,,228.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,228.0,PAK4
,,14981008,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(O)CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '16.53', 'le': '0.32', 'lle': '1.74', 'sei': '9.45'}",CHEMBL3355560,,CHEMBL3355560,5.90,0,http://www.openphacts.org/units/Nanomolar,2250298,=,1,1,=,,IC50,nM,,1260.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1260.0,PAK4
,,14981009,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '18.36', 'le': '0.36', 'lle': '2.53', 'sei': '10.08'}",CHEMBL3355559,,CHEMBL3355559,6.30,0,http://www.openphacts.org/units/Nanomolar,2250297,=,1,1,=,,IC50,nM,,506.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,506.0,PAK4
,,14981010,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccn3ncc(-c4cccc(Cl)c4)c3n2)C1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '17.38', 'le': '0.34', 'lle': '2.72', 'sei': '9.58'}",CHEMBL3355558,,CHEMBL3355558,5.70,0,http://www.openphacts.org/units/Nanomolar,2250296,=,1,1,=,,IC50,nM,,2005.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2005.0,PAK4
,,14981011,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '17.95', 'le': '0.35', 'lle': '2.41', 'sei': '8.99'}",CHEMBL3355557,,CHEMBL3355557,6.13,0,http://www.openphacts.org/units/Nanomolar,2250295,=,1,1,=,,IC50,nM,,732.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,732.0,PAK4
,,14981012,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S1(=O)CCC(CNc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '12.30', 'le': '0.25', 'lle': '1.57', 'sei': '6.84'}",CHEMBL3355555,,CHEMBL3355555,5.22,0,http://www.openphacts.org/units/Nanomolar,2250293,=,1,1,=,,IC50,nM,,6020.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6020.0,PAK4
,,14981014,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)c1cccc(-c2cnn3ccc(NCC4CCOCC4)nc23)c1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '15.16', 'le': '0.29', 'lle': '1.46', 'sei': '11.09'}",CHEMBL3355554,,CHEMBL3355554,5.71,0,http://www.openphacts.org/units/Nanomolar,2250292,=,1,1,=,,IC50,nM,,1970.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1970.0,PAK4
,,14981015,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '13.66', 'le': '0.26', 'lle': '0.55', 'sei': '10.36'}",CHEMBL3355553,,CHEMBL3355553,5.33,0,http://www.openphacts.org/units/Nanomolar,2250291,=,1,1,=,,IC50,nM,,4660.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4660.0,PAK4
,,14981016,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '15.01', 'le': '0.29', 'lle': '1.12', 'sei': '10.06'}",CHEMBL3355552,,CHEMBL3355552,6.28,0,http://www.openphacts.org/units/Nanomolar,2250290,=,1,1,=,,IC50,nM,,525.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,525.0,PAK4
,,14981017,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(O)CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '15.87', 'le': '0.30', 'lle': '1.67', 'sei': '9.92'}",CHEMBL3355551,,CHEMBL3355551,6.19,0,http://www.openphacts.org/units/Nanomolar,2250289,=,1,1,=,,IC50,nM,,639.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,639.0,PAK4
,,14981018,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(C(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '17.40', 'le': '0.33', 'lle': '2.42', 'sei': '10.49'}",CHEMBL3355550,,CHEMBL3355550,6.55,0,http://www.openphacts.org/units/Nanomolar,2250288,=,1,1,=,,IC50,nM,,282.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,282.0,PAK4
,,14981019,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S1(=O)CCC(CNc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '11.55', 'le': '0.23', 'lle': '1.56', 'sei': '5.94'}",CHEMBL3355549,,CHEMBL3355549,5.09,0,http://www.openphacts.org/units/Nanomolar,2250287,=,1,1,=,,IC50,nM,,8160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8160.0,PAK4
,,14981020,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)Oc1cccc(-c2cnn3ccc(NCC4CCOCC4)nc23)c1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '13.83', 'le': '0.26', 'lle': '1.30', 'sei': '8.95'}",CHEMBL3355548,,CHEMBL3355548,5.43,0,http://www.openphacts.org/units/Nanomolar,2250286,=,1,1,=,,IC50,nM,,3730.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3730.0,PAK4
,,14981021,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '13.39', 'le': '0.26', 'lle': '0.78', 'sei': '8.97'}",CHEMBL3355547,,CHEMBL3355547,5.44,0,http://www.openphacts.org/units/Nanomolar,2250285,=,1,1,=,,IC50,nM,,3620.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3620.0,PAK4
,,14981022,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '12.40', 'le': '0.24', 'lle': '0.35', 'sei': '7.52'}",CHEMBL3355546,,CHEMBL3355546,5.39,0,http://www.openphacts.org/units/Nanomolar,2250284,=,1,1,=,,IC50,nM,,4090.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4090.0,PAK4
,,14981023,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(O)CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '14.00', 'le': '0.27', 'lle': '1.29', 'sei': '7.94'}",CHEMBL3355545,,CHEMBL3355545,5.69,0,http://www.openphacts.org/units/Nanomolar,2250283,=,1,1,=,,IC50,nM,,2040.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2040.0,PAK4
,,14981024,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,O[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '16.74', 'le': '0.32', 'lle': '2.56', 'sei': '9.17'}",CHEMBL3355544,,CHEMBL3355544,6.57,0,http://www.openphacts.org/units/Nanomolar,2250282,=,1,1,=,,IC50,nM,,269.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,269.0,PAK4
,,14981025,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)C1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '15.91', 'le': '0.30', 'lle': '2.79', 'sei': '8.74'}",CHEMBL3355543,,CHEMBL3355543,6.01,0,http://www.openphacts.org/units/Nanomolar,2250281,=,1,1,=,,IC50,nM,,987.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,987.0,PAK4
,,14981026,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CC[C@H](Nc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '17.88', 'le': '0.34', 'lle': '3.02', 'sei': '9.04'}",CHEMBL3355542,,CHEMBL3355542,7.00,0,http://www.openphacts.org/units/Nanomolar,2250280,=,1,1,=,,IC50,nM,,100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,100.0,PAK4
,,14981027,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2ccn3ncc(-c4cccc(OC(F)(F)F)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '14.37', 'le': '0.27', 'lle': '1.78', 'sei': '10.65'}",CHEMBL3355541,,CHEMBL3355541,5.83,0,http://www.openphacts.org/units/Nanomolar,2250279,=,1,1,=,,IC50,nM,,1491.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1491.0,PAK4
,,14981054,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,Clc1cccc(-c2cnn3ccc(NCC4CCOCC4)nc23)c1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '16.87', 'le': '0.33', 'lle': '1.90', 'sei': '11.24'}",CHEMBL3355989,,CHEMBL3355989,5.79,0,http://www.openphacts.org/units/Nanomolar,2252454,=,1,1,=,,IC50,nM,,1640.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1640.0,PAK4
,,14981055,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S1(=O)CCC(CNc2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '14.54', 'le': '0.30', 'lle': '2.39', 'sei': '7.44'}",CHEMBL3355990,,CHEMBL3355990,5.68,0,http://www.openphacts.org/units/Nanomolar,2252455,=,1,1,=,,IC50,nM,,2070.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2070.0,PAK4
,,14981056,[],CHEMBL3375413,Inhibition of Pim2 (unknown origin) using luciferase-luciferin based ATP detection reagent by Kinase-Glo assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1CCN(c2ccn3ncc(-c4cccc(Cl)c4)c3n2)CC1,,,CHEMBL3351833,ACS Med Chem Lett,2015,"{'bei': '19.12', 'le': '0.37', 'lle': '3.03', 'sei': '12.37'}",CHEMBL3355991,,CHEMBL3355991,6.25,0,http://www.openphacts.org/units/Nanomolar,2252456,=,1,1,=,,IC50,nM,,564.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,564.0,PAK4
,,15143572,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccnc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.74', 'le': '0.36', 'lle': '4.48', 'sei': '9.28'}",CHEMBL3393710,,CHEMBL3393710,8.22,0,http://www.openphacts.org/units/Nanomolar,2277258,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,,15143573,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)cc1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '21.05', 'le': '0.38', 'lle': '4.16', 'sei': '11.05'}",CHEMBL3393709,,CHEMBL3393709,8.37,0,http://www.openphacts.org/units/Nanomolar,2277257,=,1,1,=,,IC50,nM,,4.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.3,PAK4
,,15143574,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '21.39', 'le': '0.39', 'lle': '4.54', 'sei': '11.74'}",CHEMBL3393708,,CHEMBL3393708,8.89,0,http://www.openphacts.org/units/Nanomolar,2277256,=,1,1,=,,IC50,nM,,1.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.3,PAK4
,,15143575,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(O[C@@H]4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '15.43', 'le': '0.29', 'lle': '2.20', 'sei': '8.84'}",CHEMBL3393707,,CHEMBL3393707,6.69,0,http://www.openphacts.org/units/Nanomolar,2277255,=,1,1,=,,IC50,nM,,204.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,204.0,PAK4
,,15143576,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '20.67', 'le': '0.38', 'lle': '4.47', 'sei': '11.83'}",CHEMBL3393706,,CHEMBL3393706,8.96,0,http://www.openphacts.org/units/Nanomolar,2277254,=,1,1,=,,IC50,nM,,1.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.1,PAK4
,,15143577,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCNCC1Oc1cncc(-c2n[nH]c3ccc(-c4c(F)cccc4F)cc23)n1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '17.90', 'le': '0.33', 'lle': '3.07', 'sei': '10.30'}",CHEMBL3393705,,CHEMBL3393705,7.80,0,http://www.openphacts.org/units/Nanomolar,2277253,=,1,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.0,PAK4
,,15143578,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.66', 'le': '0.36', 'lle': '4.03', 'sei': '11.26'}",CHEMBL3393704,,CHEMBL3393704,8.52,0,http://www.openphacts.org/units/Nanomolar,2277252,=,1,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,,15143579,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,C=C1CCNCC1Oc1cncc(-c2n[nH]c3ccc(-c4c(F)cccc4F)cc23)n1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.07', 'le': '0.35', 'lle': '3.74', 'sei': '10.57'}",CHEMBL3393703,,CHEMBL3393703,8.00,0,http://www.openphacts.org/units/Nanomolar,2277251,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,,15143580,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CCCNC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.13', 'le': '0.35', 'lle': '3.70', 'sei': '10.30'}",CHEMBL3393702,,CHEMBL3393702,7.80,0,http://www.openphacts.org/units/Nanomolar,2277250,=,1,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.0,PAK4
,,15143581,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(OC4CCNCC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '18.36', 'le': '0.34', 'lle': '3.38', 'sei': '9.88'}",CHEMBL3393701,,CHEMBL3393701,7.48,0,http://www.openphacts.org/units/Nanomolar,2277249,=,1,1,=,,IC50,nM,,33.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,33.0,PAK4
,,15143582,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(NC4CNC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.19', 'le': '0.35', 'lle': '3.91', 'sei': '9.25'}",CHEMBL3393700,,CHEMBL3393700,7.26,0,http://www.openphacts.org/units/Nanomolar,2277248,=,1,1,=,,IC50,nM,,55.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,55.0,PAK4
,,15143583,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(NC4CCNC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.74', 'le': '0.36', 'lle': '4.00', 'sei': '9.86'}",CHEMBL3393699,,CHEMBL3393699,7.75,0,http://www.openphacts.org/units/Nanomolar,2277247,=,1,1,=,,IC50,nM,,18.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,18.0,PAK4
,,15143584,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(NC4CCCNC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.25', 'le': '0.36', 'lle': '3.69', 'sei': '9.96'}",CHEMBL3393698,,CHEMBL3393698,7.82,0,http://www.openphacts.org/units/Nanomolar,2277246,=,1,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.0,PAK4
,,15143585,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(NC4CCNCC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '20.23', 'le': '0.37', 'lle': '4.09', 'sei': '10.47'}",CHEMBL3393697,,CHEMBL3393697,8.22,0,http://www.openphacts.org/units/Nanomolar,2277245,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,,15143586,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,OC1CCN(c2cncc(-c3n[nH]c4ccc(-c5c(F)cccc5F)cc34)n2)CC1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '15.81', 'le': '0.29', 'lle': '2.51', 'sei': '8.27'}",CHEMBL3393696,,CHEMBL3393696,6.44,0,http://www.openphacts.org/units/Nanomolar,2277244,=,1,1,=,,IC50,nM,,362.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,362.0,PAK4
,,15143587,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(N4CCNCC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.21', 'le': '0.35', 'lle': '4.17', 'sei': '10.81'}",CHEMBL3393695,,CHEMBL3393695,7.54,0,http://www.openphacts.org/units/Nanomolar,2277243,=,1,1,=,,IC50,nM,,29.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.0,PAK4
,,15143588,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(N4CCCNCC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '17.79', 'le': '0.33', 'lle': '3.47', 'sei': '10.37'}",CHEMBL3393694,,CHEMBL3393694,7.23,0,http://www.openphacts.org/units/Nanomolar,2277242,=,1,1,=,,IC50,nM,,59.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,59.0,PAK4
,,15143589,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(c2cncc(-c3n[nH]c4ccc(-c5c(F)cccc5F)cc34)n2)C1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '18.22', 'le': '0.34', 'lle': '3.65', 'sei': '8.54'}",CHEMBL3393693,,CHEMBL3393693,7.15,0,http://www.openphacts.org/units/Nanomolar,2277241,=,1,1,=,,IC50,nM,,71.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,71.0,PAK4
,,15143590,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(c2cncc(-c3n[nH]c4ccc(-c5c(F)cccc5F)cc34)n2)CC1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.80', 'le': '0.37', 'lle': '4.16', 'sei': '9.61'}",CHEMBL3393692,,CHEMBL3393692,8.05,0,http://www.openphacts.org/units/Nanomolar,2277240,=,1,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,,15143622,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccncc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.93', 'le': '0.37', 'lle': '4.56', 'sei': '9.37'}",CHEMBL3393711,,CHEMBL3393711,8.30,0,http://www.openphacts.org/units/Nanomolar,2277259,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,,15143623,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cnccc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '19.74', 'le': '0.36', 'lle': '4.48', 'sei': '9.28'}",CHEMBL3393712,,CHEMBL3393712,8.22,0,http://www.openphacts.org/units/Nanomolar,2277260,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,,15143624,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ncccc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '20.17', 'le': '0.37', 'lle': '4.66', 'sei': '9.48'}",CHEMBL3393713,,CHEMBL3393713,8.40,0,http://www.openphacts.org/units/Nanomolar,2277261,=,1,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,,15143625,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cncc1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '18.03', 'le': '0.33', 'lle': '4.30', 'sei': '7.74'}",CHEMBL3393714,,CHEMBL3393714,7.24,0,http://www.openphacts.org/units/Nanomolar,2277262,=,1,1,=,,IC50,nM,,58.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,58.0,PAK4
,,15143626,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,c1csc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)n1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '20.02', 'le': '0.38', 'lle': '4.44', 'sei': '9.14'}",CHEMBL3393715,,CHEMBL3393715,8.10,0,http://www.openphacts.org/units/Nanomolar,2277263,=,1,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,,15143627,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '21.83', 'le': '0.40', 'lle': '5.47', 'sei': '9.24'}",CHEMBL3393716,,CHEMBL3393716,9.40,0,http://www.openphacts.org/units/Nanomolar,2277264,=,1,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,,15143628,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '21.22', 'le': '0.39', 'lle': '5.10', 'sei': '9.54'}",CHEMBL3393717,,CHEMBL3393717,9.15,0,http://www.openphacts.org/units/Nanomolar,2277265,=,1,1,=,,IC50,nM,,0.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.7,PAK4
,,15143629,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '20.11', 'le': '0.37', 'lle': '5.77', 'sei': '7.76'}",CHEMBL3393718,,CHEMBL3393718,9.22,0,http://www.openphacts.org/units/Nanomolar,2277266,=,1,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,,15143630,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '17.88', 'le': '0.34', 'lle': '5.07', 'sei': '8.03'}",CHEMBL3393719,,CHEMBL3393719,8.82,0,http://www.openphacts.org/units/Nanomolar,2277267,=,1,1,=,,IC50,nM,,1.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.5,PAK4
,,15143631,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(-c4cncc(O[C@H]5CNCCC56CC6)n4)c3c2)c(F)c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '18.13', 'le': '0.35', 'lle': '5.50', 'sei': '7.57'}",CHEMBL3393720,,CHEMBL3393720,9.22,0,http://www.openphacts.org/units/Nanomolar,2277268,=,1,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,,15143632,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(N4CCCCC4)n3)c2c1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '14.11', 'le': '0.26', 'lle': '0.56', 'sei': '9.57'}",CHEMBL3393721,,CHEMBL3393721,5.52,0,http://www.openphacts.org/units/Nanomolar,2277269,=,1,1,=,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,,15143633,[],CHEMBL3396420,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as phosphorylation of biotinylated-BAD peptide at Serine 112 residue,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCN(c2cncc(-c3n[nH]c4ccc(-c5c(F)cccc5F)cc34)n2)C1,,,CHEMBL3392976,Bioorg Med Chem Lett,2015,"{'bei': '17.60', 'le': '0.33', 'lle': '3.26', 'sei': '8.55'}",CHEMBL3393722,,CHEMBL3393722,7.16,0,http://www.openphacts.org/units/Nanomolar,2277270,=,1,1,=,,IC50,nM,,70.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,70.0,PAK4
,,15146735,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ccc3[nH]nc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '21.86', 'le': '0.41', 'lle': '3.03', 'sei': '9.33'}",CHEMBL3394059,,CHEMBL3394059,7.51,0,http://www.openphacts.org/units/Nanomolar,2277667,=,1,1,=,,IC50,nM,,31.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.031,PAK4
,,15146736,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '16.26', 'le': '0.30', 'lle': '0.48', 'sei': '8.24'}",CHEMBL3394060,,CHEMBL3394060,5.57,0,http://www.openphacts.org/units/Nanomolar,2277668,=,1,1,=,,IC50,nM,,2710.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.71,PAK4
,,15146737,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '17.46', 'le': '0.33', 'lle': '1.52', 'sei': '7.45'}",CHEMBL3394061,,CHEMBL3394061,6.00,0,http://www.openphacts.org/units/Nanomolar,2277669,=,1,1,=,,IC50,nM,,1010.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.01,PAK4
,,15146738,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '16.19', 'le': '0.30', 'lle': '0.85', 'sei': '8.70'}",CHEMBL3394062,,CHEMBL3394062,5.79,0,http://www.openphacts.org/units/Nanomolar,2277670,=,1,1,=,,IC50,nM,,1630.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.63,PAK4
,,15146739,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,,CHEMBL3394063,,CHEMBL3394063,,0,http://www.openphacts.org/units/Nanomolar,2277671,>,1,1,>,,IC50,nM,,22000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,22.0,PAK4
,,15146740,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4c(F)cccc4F)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '19.67', 'le': '0.38', 'lle': '2.25', 'sei': '9.56'}",CHEMBL3394064,,CHEMBL3394064,6.46,0,http://www.openphacts.org/units/Nanomolar,2277672,=,1,1,=,,IC50,nM,,348.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.348,PAK4
,,15146741,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '19.49', 'le': '0.37', 'lle': '3.10', 'sei': '5.64'}",CHEMBL3394065,,CHEMBL3394065,6.01,0,http://www.openphacts.org/units/Nanomolar,2277673,=,1,1,=,,IC50,nM,,977.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.977,PAK4
,,15146742,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '19.27', 'le': '0.37', 'lle': '3.05', 'sei': '8.34'}",CHEMBL3394066,,CHEMBL3394066,6.98,0,http://www.openphacts.org/units/Nanomolar,2277674,=,1,1,=,,IC50,nM,,104.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.104,PAK4
,,15146748,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '19.10', 'le': '0.37', 'lle': '4.06', 'sei': '7.78'}",CHEMBL3394067,,CHEMBL3394067,7.23,0,http://www.openphacts.org/units/Nanomolar,2277675,=,1,1,=,,IC50,nM,,59.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.059,PAK4
,,15146749,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '21.21', 'le': '0.41', 'lle': '3.28', 'sei': '8.03'}",CHEMBL3394068,,CHEMBL3394068,7.43,0,http://www.openphacts.org/units/Nanomolar,2277676,=,1,1,=,,IC50,nM,,37.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.037,PAK4
,,15146750,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '20.39', 'le': '0.39', 'lle': '2.99', 'sei': '8.30'}",CHEMBL3394069,,CHEMBL3394069,7.68,0,http://www.openphacts.org/units/Nanomolar,2277677,=,1,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.021,PAK4
,,15146751,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '17.01', 'le': '0.32', 'lle': '1.56', 'sei': '7.18'}",CHEMBL3394070,,CHEMBL3394070,6.64,0,http://www.openphacts.org/units/Nanomolar,2277678,=,1,1,=,,IC50,nM,,227.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.227,PAK4
,,15146752,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '21.71', 'le': '0.42', 'lle': '4.41', 'sei': '5.63'}",CHEMBL3394071,,CHEMBL3394071,6.72,0,http://www.openphacts.org/units/Nanomolar,2277679,=,1,1,=,,IC50,nM,,192.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.192,PAK4
,,15146753,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '20.30', 'le': '0.39', 'lle': '4.05', 'sei': '7.64'}",CHEMBL3394072,,CHEMBL3394072,7.38,0,http://www.openphacts.org/units/Nanomolar,2277680,=,1,1,=,,IC50,nM,,42.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.042,PAK4
,,15146754,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '20.87', 'le': '0.40', 'lle': '5.36', 'sei': '7.48'}",CHEMBL3394073,,CHEMBL3394073,7.92,0,http://www.openphacts.org/units/Nanomolar,2277681,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.012,PAK4
,,15146755,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '22.76', 'le': '0.44', 'lle': '4.45', 'sei': '7.59'}",CHEMBL3394074,,CHEMBL3394074,8.00,0,http://www.openphacts.org/units/Nanomolar,2277682,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,15146756,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '21.78', 'le': '0.42', 'lle': '4.14', 'sei': '7.80'}",CHEMBL3394164,,CHEMBL3394164,8.22,0,http://www.openphacts.org/units/Nanomolar,2277776,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,15146757,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '19.78', 'le': '0.38', 'lle': '3.27', 'sei': '7.35'}",CHEMBL3394165,,CHEMBL3394165,7.75,0,http://www.openphacts.org/units/Nanomolar,2277777,=,1,1,=,,IC50,nM,,18.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.018,PAK4
,,15146758,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '22.70', 'le': '0.44', 'lle': '3.93', 'sei': '8.54'}",CHEMBL3394166,,CHEMBL3394166,7.66,0,http://www.openphacts.org/units/Nanomolar,2277778,=,1,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.022,PAK4
,,15146759,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '22.76', 'le': '0.44', 'lle': '3.88', 'sei': '8.92'}",CHEMBL3394167,,CHEMBL3394167,8.00,0,http://www.openphacts.org/units/Nanomolar,2277779,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,15146760,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '19.57', 'le': '0.37', 'lle': '2.74', 'sei': '8.23'}",CHEMBL3394168,,CHEMBL3394168,7.39,0,http://www.openphacts.org/units/Nanomolar,2277780,=,1,1,=,,IC50,nM,,41.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.041,PAK4
,,15146761,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '17.73', 'le': '0.34', 'lle': '1.90', 'sei': '7.74'}",CHEMBL3394169,,CHEMBL3394169,6.94,0,http://www.openphacts.org/units/Nanomolar,2277781,=,1,1,=,,IC50,nM,,114.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.114,PAK4
,,15146762,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '22.32', 'le': '0.43', 'lle': '4.43', 'sei': '7.36'}",CHEMBL3394170,,CHEMBL3394170,7.55,0,http://www.openphacts.org/units/Nanomolar,2277782,=,1,1,=,,IC50,nM,,28.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.028,PAK4
,,15146763,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '22.05', 'le': '0.42', 'lle': '4.26', 'sei': '7.57'}",CHEMBL3394171,,CHEMBL3394171,7.77,0,http://www.openphacts.org/units/Nanomolar,2277783,=,1,1,=,,IC50,nM,,17.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.017,PAK4
,,15146764,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(OC5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '20.09', 'le': '0.38', 'lle': '3.55', 'sei': '7.41'}",CHEMBL3394172,,CHEMBL3394172,7.60,0,http://www.openphacts.org/units/Nanomolar,2277784,=,1,1,=,,IC50,nM,,25.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.025,PAK4
,,15146765,[],CHEMBL3395659,Inhibition of full length recombinant PIM2 (unknown origin) using biotinylated-BAD peptide as substrate assessed as phosphorylation at serine 112 after 90 mins by HTRF method,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cnc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cn1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '16.71', 'le': '0.32', 'lle': '2.38', 'sei': '5.74'}",CHEMBL3394173,,CHEMBL3394173,5.89,0,http://www.openphacts.org/units/Nanomolar,2277785,=,1,1,=,,IC50,nM,,1290.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.29,PAK4
,,15146814,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,,CHEMBL3394061,,CHEMBL3394061,,0,http://www.openphacts.org/units/Nanomolar,2277669,>,1,1,>,,IC50,nM,,31600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,31.6,PAK4
,,15146817,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,,CHEMBL3394066,,CHEMBL3394066,,0,http://www.openphacts.org/units/Nanomolar,2277674,>,1,1,>,,IC50,nM,,31600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,31.6,PAK4
,,15146818,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '13.53', 'le': '0.26', 'lle': '1.95', 'sei': '5.51'}",CHEMBL3394067,,CHEMBL3394067,5.12,0,http://www.openphacts.org/units/Nanomolar,2277675,=,1,1,=,,IC50,nM,,7570.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,7.57,PAK4
,,15146819,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '16.15', 'le': '0.31', 'lle': '1.51', 'sei': '6.12'}",CHEMBL3394068,,CHEMBL3394068,5.66,0,http://www.openphacts.org/units/Nanomolar,2277676,=,1,1,=,,IC50,nM,,2190.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.19,PAK4
,,15146820,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '14.64', 'le': '0.28', 'lle': '0.82', 'sei': '5.96'}",CHEMBL3394069,,CHEMBL3394069,5.51,0,http://www.openphacts.org/units/Nanomolar,2277677,=,1,1,=,,IC50,nM,,3090.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,3.09,PAK4
,,15146823,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '13.53', 'le': '0.26', 'lle': '1.59', 'sei': '5.09'}",CHEMBL3394072,,CHEMBL3394072,4.92,0,http://www.openphacts.org/units/Nanomolar,2277680,=,1,1,=,,IC50,nM,,12100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,12.1,PAK4
,,15146824,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '15.08', 'le': '0.29', 'lle': '3.16', 'sei': '5.41'}",CHEMBL3394073,,CHEMBL3394073,5.72,0,http://www.openphacts.org/units/Nanomolar,2277681,=,1,1,=,,IC50,nM,,1900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.9,PAK4
,,15146825,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '17.14', 'le': '0.33', 'lle': '2.47', 'sei': '5.72'}",CHEMBL3394074,,CHEMBL3394074,6.03,0,http://www.openphacts.org/units/Nanomolar,2277682,=,1,1,=,,IC50,nM,,945.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.945,PAK4
,,15146826,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '15.67', 'le': '0.30', 'lle': '1.83', 'sei': '5.61'}",CHEMBL3394164,,CHEMBL3394164,5.91,0,http://www.openphacts.org/units/Nanomolar,2277776,=,1,1,=,,IC50,nM,,1220.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.22,PAK4
,,15146827,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '14.27', 'le': '0.27', 'lle': '1.12', 'sei': '5.30'}",CHEMBL3394165,,CHEMBL3394165,5.58,0,http://www.openphacts.org/units/Nanomolar,2277777,=,1,1,=,,IC50,nM,,2600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.6,PAK4
,,15146828,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '16.09', 'le': '0.31', 'lle': '1.70', 'sei': '6.05'}",CHEMBL3394166,,CHEMBL3394166,5.43,0,http://www.openphacts.org/units/Nanomolar,2277778,=,1,1,=,,IC50,nM,,3730.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,3.73,PAK4
,,15146829,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '16.09', 'le': '0.31', 'lle': '1.53', 'sei': '6.30'}",CHEMBL3394167,,CHEMBL3394167,5.65,0,http://www.openphacts.org/units/Nanomolar,2277779,=,1,1,=,,IC50,nM,,2220.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.22,PAK4
,,15146830,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '13.67', 'le': '0.26', 'lle': '0.51', 'sei': '5.75'}",CHEMBL3394168,,CHEMBL3394168,5.16,0,http://www.openphacts.org/units/Nanomolar,2277780,=,1,1,=,,IC50,nM,,6900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,6.9,PAK4
,,15146831,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,,CHEMBL3394169,,CHEMBL3394169,,0,http://www.openphacts.org/units/Nanomolar,2277781,>,1,1,>,,IC50,nM,,31600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,31.6,PAK4
,,15146832,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '16.43', 'le': '0.32', 'lle': '2.44', 'sei': '5.42'}",CHEMBL3394170,,CHEMBL3394170,5.56,0,http://www.openphacts.org/units/Nanomolar,2277782,=,1,1,=,,IC50,nM,,2750.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.75,PAK4
,,15146833,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '16.04', 'le': '0.31', 'lle': '2.14', 'sei': '5.51'}",CHEMBL3394171,,CHEMBL3394171,5.65,0,http://www.openphacts.org/units/Nanomolar,2277783,=,1,1,=,,IC50,nM,,2220.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.22,PAK4
,,15146834,[],CHEMBL3395662,Inhibition of PIM2 in human U2OS cells assessed as phosphorylation of BAD,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(OC5CCCC5)n4)c3c2)s1,,,CHEMBL3393014,Bioorg Med Chem Lett,2015,"{'bei': '13.70', 'le': '0.26', 'lle': '1.13', 'sei': '5.05'}",CHEMBL3394172,,CHEMBL3394172,5.18,0,http://www.openphacts.org/units/Nanomolar,2277784,=,1,1,=,,IC50,nM,,6540.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,6.54,PAK4
,,15685912,[],CHEMBL3606455,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2,,,CHEMBL3603755,J Med Chem,2015,,CHEMBL3606021,,CHEMBL3606021,,0,http://www.openphacts.org/units/Nanomolar,2496286,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,288346,16258330,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2ccc3c(C(N)=O)c(C)n(CCO)c3c2n1,,,CHEMBL3639053,,2015,"{'bei': '20.19', 'le': '0.40', 'lle': '4.68', 'sei': '6.80'}",CHEMBL3703180,,CHEMBL3703180,6.39,0,http://www.openphacts.org/units/Nanomolar,2580586,=,37,1,=,,IC50,nM,,408.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,408.0,PAK4
,292088,16258361,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1NS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '9.65', 'le': '0.19', 'lle': '1.58', 'sei': '4.05'}",CHEMBL3687437,,CHEMBL3687437,5.15,0,http://www.openphacts.org/units/Nanomolar,2563784,=,37,1,=,,IC50,nM,,7100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7100.0,PAK4
,225942,16258944,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](O)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.05', 'le': '0.36', 'lle': '5.37', 'sei': '7.42'}",CHEMBL3652015,,CHEMBL3652015,9.00,0,http://www.openphacts.org/units/Nanomolar,2525896,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,292159,16258991,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C(C)(C)O)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.79', 'le': '0.32', 'lle': '3.98', 'sei': '8.04'}",CHEMBL3687507,,CHEMBL3687507,8.88,0,http://www.openphacts.org/units/Nanomolar,2563855,=,37,1,=,,IC50,nM,,1.33,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.33,PAK4
,225865,16259109,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)ccc2F)c1F,,,CHEMBL3638421,,2013,"{'bei': '18.49', 'le': '0.35', 'lle': '4.38', 'sei': '8.60'}",CHEMBL3651940,,CHEMBL3651940,8.70,0,http://www.openphacts.org/units/Nanomolar,2525819,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,225941,16259190,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccncc3)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.33', 'le': '0.34', 'lle': '5.67', 'sei': '6.60'}",CHEMBL3652014,,CHEMBL3652014,7.75,0,http://www.openphacts.org/units/Nanomolar,2525895,=,37,1,=,,IC50,nM,,18.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,18.0,PAK4
,225837,16259327,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(C3CCCCC3)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.94', 'le': '0.38', 'lle': '5.46', 'sei': '8.17'}",CHEMBL3651912,,CHEMBL3651912,8.52,0,http://www.openphacts.org/units/Nanomolar,2525791,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292131,16259422,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '18.86', 'le': '0.37', 'lle': '4.76', 'sei': '7.69'}",CHEMBL3687479,,CHEMBL3687479,8.93,0,http://www.openphacts.org/units/Nanomolar,2563827,=,37,1,=,,IC50,nM,,1.17,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.17,PAK4
,292191,16259476,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '13.50', 'le': '0.27', 'lle': '4.49', 'sei': '6.02'}",CHEMBL3691914,,CHEMBL3691914,8.60,0,http://www.openphacts.org/units/Nanomolar,2568457,=,37,1,=,,IC50,nM,,2.54,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.54,PAK4
,292180,16259718,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '13.57', 'le': '0.27', 'lle': '3.95', 'sei': '6.02'}",CHEMBL3687528,,CHEMBL3687528,8.04,0,http://www.openphacts.org/units/Nanomolar,2563877,=,37,1,=,,IC50,nM,,9.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.07,PAK4
,292184,16260001,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1Oc1ccccn1,,,CHEMBL3639088,,2015,"{'bei': '16.52', 'le': '0.31', 'lle': '3.32', 'sei': '8.56'}",CHEMBL3687532,,CHEMBL3687532,8.81,0,http://www.openphacts.org/units/Nanomolar,2563881,=,37,1,=,,IC50,nM,,1.53,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.53,PAK4
,292204,16260243,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '17.02', 'le': '0.32', 'lle': '3.84', 'sei': '8.57'}",CHEMBL3691927,,CHEMBL3691927,8.52,0,http://www.openphacts.org/units/Nanomolar,2568470,=,37,1,=,,IC50,nM,,3.02,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.02,PAK4
,225950,16260750,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)ccc(F)c3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.59', 'le': '0.35', 'lle': '3.34', 'sei': '10.54'}",CHEMBL3652023,,CHEMBL3652023,8.52,0,http://www.openphacts.org/units/Nanomolar,2525904,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,225957,16261006,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(F)c(-c2ccncc2F)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,,,CHEMBL3638421,,2013,"{'bei': '17.95', 'le': '0.34', 'lle': '3.98', 'sei': '6.36'}",CHEMBL3652028,,CHEMBL3652028,7.62,0,http://www.openphacts.org/units/Nanomolar,2525911,=,37,1,=,,IC50,nM,,24.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.0,PAK4
,225884,16261325,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '20.17', 'le': '0.38', 'lle': '3.61', 'sei': '10.54'}",CHEMBL3651959,,CHEMBL3651959,8.52,0,http://www.openphacts.org/units/Nanomolar,2525838,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,225859,16261362,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.15', 'le': '0.36', 'lle': '3.79', 'sei': '8.30'}",CHEMBL3651934,,CHEMBL3651934,8.40,0,http://www.openphacts.org/units/Nanomolar,2525813,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,292163,16261486,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC(C)C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.12', 'le': '0.31', 'lle': '3.06', 'sei': '8.58'}",CHEMBL3687511,,CHEMBL3687511,8.52,0,http://www.openphacts.org/units/Nanomolar,2563859,=,37,1,=,,IC50,nM,,3.01,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.01,PAK4
,292120,16261690,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(C)[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.26', 'le': '0.31', 'lle': '4.85', 'sei': '7.76'}",CHEMBL3687468,,CHEMBL3687468,8.82,0,http://www.openphacts.org/units/Nanomolar,2563816,=,37,1,=,,IC50,nM,,1.51,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.51,PAK4
,225885,16261793,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCOc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)ccc2F)c1,,,CHEMBL3638421,,2013,"{'bei': '14.75', 'le': '0.28', 'lle': '2.70', 'sei': '6.45'}",CHEMBL3651960,,CHEMBL3651960,7.12,0,http://www.openphacts.org/units/Nanomolar,2525839,=,37,1,=,,IC50,nM,,76.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,76.0,PAK4
,292073,16261997,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)C1=O,,,CHEMBL3639088,,2015,"{'bei': '16.45', 'le': '0.31', 'lle': '3.26', 'sei': '7.63'}",CHEMBL3687424,,CHEMBL3687424,7.48,0,http://www.openphacts.org/units/Nanomolar,2563770,=,37,1,=,,IC50,nM,,33.31,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,33.31,PAK4
,292182,16262258,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '13.30', 'le': '0.26', 'lle': '4.16', 'sei': '5.69'}",CHEMBL3687530,,CHEMBL3687530,8.23,0,http://www.openphacts.org/units/Nanomolar,2563879,=,37,1,=,,IC50,nM,,5.93,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.93,PAK4
,225953,16262365,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.61', 'le': '0.33', 'lle': '4.70', 'sei': '6.53'}",CHEMBL3652025,,CHEMBL3652025,8.30,0,http://www.openphacts.org/units/Nanomolar,2525907,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,292249,16262424,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(C(C)(C)O)nn1,,,CHEMBL3639088,,2015,"{'bei': '14.64', 'le': '0.28', 'lle': '3.57', 'sei': '6.28'}",CHEMBL3691972,,CHEMBL3691972,8.28,0,http://www.openphacts.org/units/Nanomolar,2568515,=,37,1,=,,IC50,nM,,5.27,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.27,PAK4
,292151,16262504,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCO[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '11.70', 'le': '0.22', 'lle': '0.46', 'sei': '6.47'}",CHEMBL3687499,,CHEMBL3687499,5.83,0,http://www.openphacts.org/units/Nanomolar,2563847,=,37,1,=,,IC50,nM,,1471.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1471.24,PAK4
,225867,16262627,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(O)ccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.84', 'le': '0.37', 'lle': '4.09', 'sei': '8.60'}",CHEMBL3651942,,CHEMBL3651942,8.70,0,http://www.openphacts.org/units/Nanomolar,2525821,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,292185,16262809,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.42', 'le': '0.29', 'lle': '3.70', 'sei': '7.73'}",CHEMBL3687533,,CHEMBL3687533,8.39,0,http://www.openphacts.org/units/Nanomolar,2563882,=,37,1,=,,IC50,nM,,4.03,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.03,PAK4
,225925,16263351,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@@H](N)C1,,,CHEMBL3638421,,2013,"{'bei': '17.94', 'le': '0.34', 'lle': '4.68', 'sei': '6.20'}",CHEMBL3651998,,CHEMBL3651998,7.89,0,http://www.openphacts.org/units/Nanomolar,2525879,=,37,1,=,,IC50,nM,,13.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.0,PAK4
,292086,16263472,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '11.19', 'le': '0.21', 'lle': '1.41', 'sei': '5.06'}",CHEMBL3687435,,CHEMBL3687435,5.57,0,http://www.openphacts.org/units/Nanomolar,2563782,=,37,1,=,,IC50,nM,,2700.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2700.0,PAK4
,225947,16264184,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(C(F)(F)F)ccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '14.15', 'le': '0.27', 'lle': '2.28', 'sei': '7.09'}",CHEMBL3652020,,CHEMBL3652020,7.17,0,http://www.openphacts.org/units/Nanomolar,2525901,=,37,1,=,,IC50,nM,,68.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,68.0,PAK4
,292127,16264461,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N(C)[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '10.83', 'le': '0.20', 'lle': '2.11', 'sei': '5.32'}",CHEMBL3687475,,CHEMBL3687475,5.55,0,http://www.openphacts.org/units/Nanomolar,2563823,=,37,1,=,,IC50,nM,,2800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2800.0,PAK4
,292076,16264545,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCc1cn([C@@H]2[C@H](N)CN(c3ccncc3NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)C[C@@H]2C)nn1,,,CHEMBL3639088,,2015,"{'bei': '15.86', 'le': '0.30', 'lle': '5.18', 'sei': '7.06'}",CHEMBL3687427,,CHEMBL3687427,8.76,0,http://www.openphacts.org/units/Nanomolar,2563773,=,37,1,=,,IC50,nM,,1.72,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.72,PAK4
,225841,16264598,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3CCC[C@H](N)C3)ccc2F)c1F,,,CHEMBL3638421,,2013,"{'bei': '18.51', 'le': '0.35', 'lle': '3.04', 'sei': '10.08'}",CHEMBL3651916,,CHEMBL3651916,8.15,0,http://www.openphacts.org/units/Nanomolar,2525795,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,225850,16264721,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3C[C@H](N)C[C@H](N)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '19.20', 'le': '0.36', 'lle': '4.50', 'sei': '7.85'}",CHEMBL3651925,,CHEMBL3651925,8.40,0,http://www.openphacts.org/units/Nanomolar,2525804,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,225858,16264736,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3ccc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.39', 'le': '0.36', 'lle': '3.68', 'sei': '8.06'}",CHEMBL3651933,,CHEMBL3651933,8.15,0,http://www.openphacts.org/units/Nanomolar,2525812,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,225847,16265661,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.79', 'le': '0.37', 'lle': '5.88', 'sei': '8.33'}",CHEMBL3651922,,CHEMBL3651922,8.70,0,http://www.openphacts.org/units/Nanomolar,2525801,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,225835,16265786,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(F)cc(F)c3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '16.65', 'le': '0.32', 'lle': '2.46', 'sei': '9.14'}",CHEMBL3651910,,CHEMBL3651910,7.40,0,http://www.openphacts.org/units/Nanomolar,2525789,=,37,1,=,,IC50,nM,,40.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,40.0,PAK4
,292262,16266156,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '12.39', 'le': '0.24', 'lle': '2.28', 'sei': '5.94'}",CHEMBL3691984,,CHEMBL3691984,7.63,0,http://www.openphacts.org/units/Nanomolar,2568528,=,37,1,=,,IC50,nM,,23.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,23.47,PAK4
,292137,16266644,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '18.01', 'le': '0.34', 'lle': '3.80', 'sei': '9.40'}",CHEMBL3687485,,CHEMBL3687485,8.47,0,http://www.openphacts.org/units/Nanomolar,2563833,=,37,1,=,,IC50,nM,,3.37,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.37,PAK4
,292142,16266651,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.19', 'le': '0.33', 'lle': '5.46', 'sei': '7.42'}",CHEMBL3687490,,CHEMBL3687490,9.09,0,http://www.openphacts.org/units/Nanomolar,2563838,=,37,1,=,,IC50,nM,,0.82,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.82,PAK4
,225852,16266857,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '18.02', 'le': '0.34', 'lle': '3.97', 'sei': '8.06'}",CHEMBL3651927,,CHEMBL3651927,8.15,0,http://www.openphacts.org/units/Nanomolar,2525806,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,225938,16266924,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](O)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.97', 'le': '0.34', 'lle': '4.17', 'sei': '8.62'}",CHEMBL3652011,,CHEMBL3652011,8.22,0,http://www.openphacts.org/units/Nanomolar,2525892,=,37,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,292217,16267219,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '17.82', 'le': '0.35', 'lle': '6.18', 'sei': '6.47'}",CHEMBL3691940,,CHEMBL3691940,9.11,0,http://www.openphacts.org/units/Nanomolar,2568483,=,37,1,=,,IC50,nM,,0.77,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.77,PAK4
,292176,16267232,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '16.50', 'le': '0.34', 'lle': '5.04', 'sei': '6.10'}",CHEMBL3687525,,CHEMBL3687525,8.61,0,http://www.openphacts.org/units/Nanomolar,2563873,=,37,1,=,,IC50,nM,,2.48,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.48,PAK4
,276606,16267255,[],CHEMBL3707966,"Kinase Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates are trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors.At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP is captured by an excess of the ion exchange dowex resin; the resin then settles down to the bottom of the reaction plate by gravity.Supernatant is subsequently withdrawn and transferred into a counting plate, then evaluated by (3-counting.Reagents/Assay ConditionsDowex Resin Preparation500 g of wet resin (SIGMA, custom prepared resin DOWEX 1x8 200-400 mesh, 2.5 Kg) are weighed out and diluted to 2 L in 150 mM sodium formate, pH 3.00.The resin is allowed to settle down (some hours) and then the supernatant is discarded.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(=O)N[C@H](CN)c3ccccc3)nn1C)CCC2,,,CHEMBL3638988,,2014,"{'bei': '8.70', 'le': '0.16', 'lle': '2.05', 'sei': '3.56'}",CHEMBL3666778,,CHEMBL3666778,5.42,0,http://www.openphacts.org/units/Nanomolar,2541892,=,37,1,=,,IC50,nM,,3761.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3761.0,PAK4
,225908,16267661,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)CC[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.57', 'le': '0.33', 'lle': '3.83', 'sei': '7.37'}",CHEMBL3651983,,CHEMBL3651983,7.46,0,http://www.openphacts.org/units/Nanomolar,2525862,=,37,1,=,,IC50,nM,,35.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.0,PAK4
,292248,16267716,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C=C(C)c1cn([C@@H]2[C@H](N)C[C@H](c3ccncc3NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)C[C@@H]2C)nn1,,,CHEMBL3639088,,2015,"{'bei': '15.62', 'le': '0.29', 'lle': '3.03', 'sei': '7.66'}",CHEMBL3691971,,CHEMBL3691971,8.55,0,http://www.openphacts.org/units/Nanomolar,2568514,=,37,1,=,,IC50,nM,,2.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.79,PAK4
,288347,16267907,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2ccc3c(C(N)=O)c(C)n(C(C)C)c3c2n1,,,CHEMBL3639053,,2015,"{'bei': '25.19', 'le': '0.49', 'lle': '4.63', 'sei': '10.73'}",CHEMBL3703181,,CHEMBL3703181,7.92,0,http://www.openphacts.org/units/Nanomolar,2580587,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,225940,16268083,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccncc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.07', 'le': '0.36', 'lle': '6.19', 'sei': '7.16'}",CHEMBL3652013,,CHEMBL3652013,8.40,0,http://www.openphacts.org/units/Nanomolar,2525894,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,292091,16268115,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1N=[N+]=[N-],,,CHEMBL3639088,,2015,"{'bei': '16.67', 'le': '0.31', 'lle': '2.70', 'sei': '6.19'}",CHEMBL3687440,,CHEMBL3687440,8.03,0,http://www.openphacts.org/units/Nanomolar,2563787,=,37,1,=,,IC50,nM,,9.44,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.44,PAK4
,292092,16268689,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.35', 'le': '0.27', 'lle': '2.98', 'sei': '6.49'}",CHEMBL3687441,,CHEMBL3687441,7.14,0,http://www.openphacts.org/units/Nanomolar,2563788,=,37,1,=,,IC50,nM,,72.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,72.8,PAK4
,225843,16268792,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@H](O)[C@@H](C)C3)ccc2F)c1F,,,CHEMBL3638421,,2013,"{'bei': '18.45', 'le': '0.35', 'lle': '5.43', 'sei': '8.33'}",CHEMBL3651918,,CHEMBL3651918,8.70,0,http://www.openphacts.org/units/Nanomolar,2525797,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,213994,16268925,[],CHEMBL3707524,"Inhibition Assay: Inhibition assay using PIM-1, PIM-2 and PIM-3.",B,,,BAO_0000190,BAO_0000357,single protein format,O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12,,,CHEMBL3639232,,2013,"{'bei': '26.86', 'le': '0.48', 'lle': '2.68', 'sei': '12.93'}",CHEMBL583972,,CHEMBL583972,6.29,1,http://www.openphacts.org/units/Nanomolar,2525136,=,37,1,=,,IC50,nM,,510.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,510.0,PAK4
,225927,16269222,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(C2CCCCC2)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,,,CHEMBL3638421,,2013,"{'bei': '19.46', 'le': '0.36', 'lle': '3.32', 'sei': '7.16'}",CHEMBL3652000,,CHEMBL3652000,7.66,0,http://www.openphacts.org/units/Nanomolar,2525881,=,37,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.0,PAK4
,292129,16269945,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1C#N,,,CHEMBL3639088,,2015,"{'bei': '15.32', 'le': '0.29', 'lle': '2.34', 'sei': '6.81'}",CHEMBL3687477,,CHEMBL3687477,7.13,0,http://www.openphacts.org/units/Nanomolar,2563825,=,37,1,=,,IC50,nM,,73.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,73.6,PAK4
,225935,16270852,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C[C@@H](O)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.35', 'le': '0.36', 'lle': '5.67', 'sei': '8.65'}",CHEMBL3652008,,CHEMBL3652008,8.52,0,http://www.openphacts.org/units/Nanomolar,2525889,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,225830,16270943,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.08', 'le': '0.36', 'lle': '3.74', 'sei': '8.01'}",CHEMBL3651905,,CHEMBL3651905,8.10,0,http://www.openphacts.org/units/Nanomolar,2525784,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,292089,16271747,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1NS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '13.83', 'le': '0.27', 'lle': '3.81', 'sei': '5.81'}",CHEMBL3687438,,CHEMBL3687438,7.38,0,http://www.openphacts.org/units/Nanomolar,2563785,=,37,1,=,,IC50,nM,,41.98,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,41.98,PAK4
,292213,16271782,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccccc1=O,,,CHEMBL3639088,,2015,"{'bei': '9.69', 'le': '0.18', 'lle': '0.11', 'sei': '5.02'}",CHEMBL3691936,,CHEMBL3691936,5.17,0,http://www.openphacts.org/units/Nanomolar,2568479,=,37,1,=,,IC50,nM,,6800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6800.0,PAK4
,292087,16272040,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.28', 'le': '0.29', 'lle': '3.44', 'sei': '6.91'}",CHEMBL3687436,,CHEMBL3687436,7.60,0,http://www.openphacts.org/units/Nanomolar,2563783,=,37,1,=,,IC50,nM,,25.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.04,PAK4
,225827,16272048,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2cccc(-c3ccc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.49', 'le': '0.36', 'lle': '3.69', 'sei': '7.83'}",CHEMBL3651902,,CHEMBL3651902,7.92,0,http://www.openphacts.org/units/Nanomolar,2525781,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,292069,16272676,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@@H]2[C@H](N)CN(c3ccncc3NC(=O)c3ccc(F)c(-c4c(F)cccc4F)n3)C[C@@H]2C)nn1,,,CHEMBL3639088,,2015,"{'bei': '16.95', 'le': '0.32', 'lle': '5.12', 'sei': '7.71'}",CHEMBL3687420,,CHEMBL3687420,8.86,0,http://www.openphacts.org/units/Nanomolar,2563766,=,37,1,=,,IC50,nM,,1.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.39,PAK4
,292132,16272710,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ncc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.01', 'le': '0.32', 'lle': '4.46', 'sei': '6.18'}",CHEMBL3687480,,CHEMBL3687480,7.97,0,http://www.openphacts.org/units/Nanomolar,2563828,=,37,1,=,,IC50,nM,,10.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.7,PAK4
,225826,16272780,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(O)ccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '16.94', 'le': '0.32', 'lle': '4.12', 'sei': '6.34'}",CHEMBL3651901,,CHEMBL3651901,7.70,0,http://www.openphacts.org/units/Nanomolar,2525780,=,37,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.0,PAK4
,292168,16273999,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](NC(=O)OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '12.96', 'le': '0.25', 'lle': '3.21', 'sei': '5.53'}",CHEMBL3687516,,CHEMBL3687516,7.61,0,http://www.openphacts.org/units/Nanomolar,2563864,=,37,1,=,,IC50,nM,,24.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.4,PAK4
,292126,16274091,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '17.56', 'le': '0.34', 'lle': '4.54', 'sei': '6.43'}",CHEMBL3687474,,CHEMBL3687474,9.00,0,http://www.openphacts.org/units/Nanomolar,2563822,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,225946,16274186,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)ccc(O)c3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.72', 'le': '0.37', 'lle': '4.25', 'sei': '8.90'}",CHEMBL3652019,,CHEMBL3652019,9.00,0,http://www.openphacts.org/units/Nanomolar,2525900,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,225831,16274247,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '17.50', 'le': '0.33', 'lle': '2.92', 'sei': '7.83'}",CHEMBL3651906,,CHEMBL3651906,7.92,0,http://www.openphacts.org/units/Nanomolar,2525785,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,292232,16274379,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '13.15', 'le': '0.25', 'lle': '2.95', 'sei': '6.14'}",CHEMBL3691955,,CHEMBL3691955,7.99,0,http://www.openphacts.org/units/Nanomolar,2568498,=,37,1,=,,IC50,nM,,10.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.18,PAK4
,225882,16274431,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(F)ccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.67', 'le': '0.35', 'lle': '3.18', 'sei': '10.16'}",CHEMBL3651957,,CHEMBL3651957,8.22,0,http://www.openphacts.org/units/Nanomolar,2525836,=,37,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,292224,16274656,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4COC4)cc3F)n2)C[C@@H](N)[C@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '15.45', 'le': '0.29', 'lle': '3.67', 'sei': '7.10'}",CHEMBL3691947,,CHEMBL3691947,8.74,0,http://www.openphacts.org/units/Nanomolar,2568490,=,37,1,=,,IC50,nM,,1.83,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.83,PAK4
,292219,16274668,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.55', 'le': '0.30', 'lle': '5.40', 'sei': '6.37'}",CHEMBL3691942,,CHEMBL3691942,9.09,0,http://www.openphacts.org/units/Nanomolar,2568485,=,37,1,=,,IC50,nM,,0.81,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.81,PAK4
,292110,16274842,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1n1cncn1,,,CHEMBL3639088,,2015,"{'bei': '12.55', 'le': '0.24', 'lle': '1.88', 'sei': '5.71'}",CHEMBL3687458,,CHEMBL3687458,6.37,0,http://www.openphacts.org/units/Nanomolar,2563806,=,37,1,=,,IC50,nM,,426.76,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,426.76,PAK4
,292253,16274861,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.54', 'le': '0.29', 'lle': '3.85', 'sei': '6.91'}",CHEMBL3691976,,CHEMBL3691976,8.36,0,http://www.openphacts.org/units/Nanomolar,2568519,=,37,1,=,,IC50,nM,,4.42,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.42,PAK4
,292150,16274934,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.80', 'le': '0.34', 'lle': '3.57', 'sei': '9.57'}",CHEMBL3687498,,CHEMBL3687498,8.62,0,http://www.openphacts.org/units/Nanomolar,2563846,=,37,1,=,,IC50,nM,,2.37,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.37,PAK4
,292174,16275219,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '14.82', 'le': '0.29', 'lle': '4.05', 'sei': '6.54'}",CHEMBL3687522,,CHEMBL3687522,8.13,0,http://www.openphacts.org/units/Nanomolar,2563870,=,37,1,=,,IC50,nM,,7.37,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.37,PAK4
,225874,16275692,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c([C@H]3CC[C@@H](O)CC3)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '16.55', 'le': '0.31', 'lle': '2.96', 'sei': '6.75'}",CHEMBL3651949,,CHEMBL3651949,6.83,0,http://www.openphacts.org/units/Nanomolar,2525828,=,37,1,=,,IC50,nM,,149.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,149.0,PAK4
,292215,16275959,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '17.59', 'le': '0.34', 'lle': '4.99', 'sei': '6.53'}",CHEMBL3691938,,CHEMBL3691938,8.98,0,http://www.openphacts.org/units/Nanomolar,2568481,=,37,1,=,,IC50,nM,,1.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.04,PAK4
,225896,16276736,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.47', 'le': '0.35', 'lle': '4.22', 'sei': '8.01'}",CHEMBL3651971,,CHEMBL3651971,8.10,0,http://www.openphacts.org/units/Nanomolar,2525850,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,292200,16276891,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H](N)[C@@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '14.08', 'le': '0.28', 'lle': '4.45', 'sei': '6.16'}",CHEMBL3691923,,CHEMBL3691923,8.91,0,http://www.openphacts.org/units/Nanomolar,2568466,=,37,1,=,,IC50,nM,,1.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.24,PAK4
,225916,16277631,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.30', 'le': '0.34', 'lle': '4.84', 'sei': '6.53'}",CHEMBL3651990,,CHEMBL3651990,8.30,0,http://www.openphacts.org/units/Nanomolar,2525870,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,225869,16277813,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2cccc(-c3cc(F)cc(F)c3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '16.69', 'le': '0.31', 'lle': '2.32', 'sei': '8.80'}",CHEMBL3651944,,CHEMBL3651944,7.12,0,http://www.openphacts.org/units/Nanomolar,2525823,=,37,1,=,,IC50,nM,,76.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,76.0,PAK4
,225960,16277883,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1F,,,CHEMBL3638421,,2013,"{'bei': '18.11', 'le': '0.34', 'lle': '3.31', 'sei': '10.26'}",CHEMBL3652031,,CHEMBL3652031,8.30,0,http://www.openphacts.org/units/Nanomolar,2525914,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,292179,16278380,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '13.44', 'le': '0.26', 'lle': '4.83', 'sei': '5.79'}",CHEMBL3687527,,CHEMBL3687527,8.91,0,http://www.openphacts.org/units/Nanomolar,2563876,=,37,1,=,,IC50,nM,,1.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.24,PAK4
,292170,16278452,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '14.66', 'le': '0.29', 'lle': '4.19', 'sei': '6.38'}",CHEMBL3687518,,CHEMBL3687518,8.63,0,http://www.openphacts.org/units/Nanomolar,2563866,=,37,1,=,,IC50,nM,,2.34,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.34,PAK4
,292225,16278817,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4COC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '11.63', 'le': '0.22', 'lle': '3.03', 'sei': '5.29'}",CHEMBL3691948,,CHEMBL3691948,6.57,0,http://www.openphacts.org/units/Nanomolar,2568491,=,37,1,=,,IC50,nM,,270.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,270.24,PAK4
,225836,16279509,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '16.22', 'le': '0.30', 'lle': '3.13', 'sei': '7.48'}",CHEMBL3651911,,CHEMBL3651911,7.57,0,http://www.openphacts.org/units/Nanomolar,2525790,=,37,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,292144,16279795,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '19.44', 'le': '0.38', 'lle': '5.04', 'sei': '7.93'}",CHEMBL3687492,,CHEMBL3687492,9.21,0,http://www.openphacts.org/units/Nanomolar,2563840,=,37,1,=,,IC50,nM,,0.62,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.62,PAK4
,225924,16280048,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.82', 'le': '0.34', 'lle': '5.70', 'sei': '6.21'}",CHEMBL3651997,,CHEMBL3651997,8.10,0,http://www.openphacts.org/units/Nanomolar,2525878,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,292256,16280085,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '12.90', 'le': '0.24', 'lle': '2.40', 'sei': '6.51'}",CHEMBL3691979,,CHEMBL3691979,7.86,0,http://www.openphacts.org/units/Nanomolar,2568522,=,37,1,=,,IC50,nM,,13.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.74,PAK4
,225892,16280252,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](N)C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2F)C1,,,CHEMBL3638421,,2013,"{'bei': '12.96', 'le': '0.24', 'lle': '0.67', 'sei': '7.06'}",CHEMBL3651967,,CHEMBL3651967,5.71,0,http://www.openphacts.org/units/Nanomolar,2525846,=,37,1,=,,IC50,nM,,1947.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1947.0,PAK4
,292220,16280513,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.58', 'le': '0.28', 'lle': '5.08', 'sei': '6.36'}",CHEMBL3691943,,CHEMBL3691943,8.96,0,http://www.openphacts.org/units/Nanomolar,2568486,=,37,1,=,,IC50,nM,,1.09,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.09,PAK4
,288351,16280767,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2ccc3c(C(N)=O)cn(C4CCNCC4)c3c2n1,,,CHEMBL3639053,,2015,"{'bei': '22.37', 'le': '0.43', 'lle': '5.31', 'sei': '8.90'}",CHEMBL3703185,,CHEMBL3703185,7.64,0,http://www.openphacts.org/units/Nanomolar,2580591,=,37,1,=,,IC50,nM,,23.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,23.0,PAK4
,292065,16280811,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '13.90', 'le': '0.26', 'lle': '2.52', 'sei': '6.64'}",CHEMBL3687416,,CHEMBL3687416,7.31,0,http://www.openphacts.org/units/Nanomolar,2563762,=,37,1,=,,IC50,nM,,49.42,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,49.42,PAK4
,292251,16282328,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OCC(=O)O,,,CHEMBL3639088,,2015,"{'bei': '14.24', 'le': '0.27', 'lle': '3.21', 'sei': '5.75'}",CHEMBL3691974,,CHEMBL3691974,7.33,0,http://www.openphacts.org/units/Nanomolar,2568517,=,37,1,=,,IC50,nM,,47.26,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,47.26,PAK4
,292152,16282385,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCO[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '11.81', 'le': '0.22', 'lle': '0.66', 'sei': '6.35'}",CHEMBL3687500,,CHEMBL3687500,5.72,0,http://www.openphacts.org/units/Nanomolar,2563848,=,37,1,=,,IC50,nM,,1900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1900.0,PAK4
,288340,16283188,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c2c(c(C(N)=O)c1-c1ccccc1)CCc1cnc(N)nc1-2,,,CHEMBL3639053,,2015,,CHEMBL3703174,,CHEMBL3703174,,0,http://www.openphacts.org/units/Nanomolar,2580580,>,37,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,292064,16283347,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.26', 'le': '0.27', 'lle': '3.73', 'sei': '6.31'}",CHEMBL3687415,,CHEMBL3687415,7.52,0,http://www.openphacts.org/units/Nanomolar,2563761,=,37,1,=,,IC50,nM,,30.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.07,PAK4
,292164,16284451,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.88', 'le': '0.34', 'lle': '3.68', 'sei': '9.61'}",CHEMBL3687512,,CHEMBL3687512,8.66,0,http://www.openphacts.org/units/Nanomolar,2563860,=,37,1,=,,IC50,nM,,2.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.18,PAK4
,292116,16284501,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1C#N,,,CHEMBL3639088,,2015,"{'bei': '17.74', 'le': '0.34', 'lle': '5.09', 'sei': '6.22'}",CHEMBL3687464,,CHEMBL3687464,8.33,0,http://www.openphacts.org/units/Nanomolar,2563812,=,37,1,=,,IC50,nM,,4.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.68,PAK4
,225917,16285216,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.67', 'le': '0.37', 'lle': '6.04', 'sei': '8.62'}",CHEMBL3105022,,CHEMBL3105022,9.00,0,http://www.openphacts.org/units/Nanomolar,2525871,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,292238,16285301,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.19', 'le': '0.27', 'lle': '5.40', 'sei': '5.74'}",CHEMBL3691961,,CHEMBL3691961,8.72,0,http://www.openphacts.org/units/Nanomolar,2568504,=,37,1,=,,IC50,nM,,1.89,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.89,PAK4
,225931,16285427,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(F)c(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@H]1C[C@@H](N)C[C@@H](C(F)(F)F)C1,,,CHEMBL3638421,,2013,"{'bei': '17.67', 'le': '0.34', 'lle': '3.83', 'sei': '8.42'}",CHEMBL3652004,,CHEMBL3652004,9.00,0,http://www.openphacts.org/units/Nanomolar,2525885,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,225868,16285498,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)ccc2F)c1F,,,CHEMBL3638421,,2013,"{'bei': '17.26', 'le': '0.33', 'lle': '4.38', 'sei': '7.61'}",CHEMBL3651943,,CHEMBL3651943,8.40,0,http://www.openphacts.org/units/Nanomolar,2525822,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,292167,16286492,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](NC(=O)OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '14.32', 'le': '0.27', 'lle': '5.08', 'sei': '5.98'}",CHEMBL3687515,,CHEMBL3687515,8.43,0,http://www.openphacts.org/units/Nanomolar,2563863,=,37,1,=,,IC50,nM,,3.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.74,PAK4
,292195,16286829,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.70', 'le': '0.33', 'lle': '3.07', 'sei': '8.49'}",CHEMBL3691918,,CHEMBL3691918,7.66,0,http://www.openphacts.org/units/Nanomolar,2568461,=,37,1,=,,IC50,nM,,22.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.07,PAK4
,225862,16287027,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '17.26', 'le': '0.32', 'lle': '3.63', 'sei': '7.48'}",CHEMBL3651937,,CHEMBL3651937,7.57,0,http://www.openphacts.org/units/Nanomolar,2525816,=,37,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,225861,16287148,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)ccc2F)c1F,,,CHEMBL3638421,,2013,"{'bei': '18.11', 'le': '0.34', 'lle': '4.20', 'sei': '8.43'}",CHEMBL3651936,,CHEMBL3651936,8.52,0,http://www.openphacts.org/units/Nanomolar,2525815,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,225878,16287550,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.88', 'le': '0.37', 'lle': '3.49', 'sei': '10.38'}",CHEMBL3651953,,CHEMBL3651953,8.40,0,http://www.openphacts.org/units/Nanomolar,2525832,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,292247,16287908,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(C2CC2)nn1,,,CHEMBL3639088,,2015,"{'bei': '15.33', 'le': '0.29', 'lle': '3.03', 'sei': '7.52'}",CHEMBL3691970,,CHEMBL3691970,8.39,0,http://www.openphacts.org/units/Nanomolar,2568513,=,37,1,=,,IC50,nM,,4.05,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.05,PAK4
,225873,16287930,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.44', 'le': '0.36', 'lle': '4.64', 'sei': '8.43'}",CHEMBL3651948,,CHEMBL3651948,8.52,0,http://www.openphacts.org/units/Nanomolar,2525827,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292252,16289076,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '13.92', 'le': '0.26', 'lle': '3.18', 'sei': '5.89'}",CHEMBL3691975,,CHEMBL3691975,7.57,0,http://www.openphacts.org/units/Nanomolar,2568518,=,37,1,=,,IC50,nM,,27.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.18,PAK4
,225871,16289839,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.67', 'le': '0.35', 'lle': '4.51', 'sei': '8.43'}",CHEMBL3651946,,CHEMBL3651946,8.52,0,http://www.openphacts.org/units/Nanomolar,2525825,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292221,16290014,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '14.33', 'le': '0.27', 'lle': '5.29', 'sei': '6.04'}",CHEMBL3691944,,CHEMBL3691944,8.72,0,http://www.openphacts.org/units/Nanomolar,2568487,=,37,1,=,,IC50,nM,,1.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.9,PAK4
,225894,16290226,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)ccc2F)c1,,,CHEMBL3638421,,2013,"{'bei': '17.89', 'le': '0.34', 'lle': '3.92', 'sei': '8.01'}",CHEMBL3651969,,CHEMBL3651969,8.10,0,http://www.openphacts.org/units/Nanomolar,2525848,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,225929,16290502,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)C[C@@H](C(F)(F)F)C3)n2)c1,,,CHEMBL3638421,,2013,"{'bei': '17.26', 'le': '0.33', 'lle': '2.53', 'sei': '10.08'}",CHEMBL3652002,,CHEMBL3652002,8.15,0,http://www.openphacts.org/units/Nanomolar,2525883,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,288343,16290520,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)c(C)n1C)CC2,,,CHEMBL3639053,,2015,,CHEMBL3703177,,CHEMBL3703177,,0,http://www.openphacts.org/units/Nanomolar,2580583,>,37,1,>,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,292077,16291053,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1S(=O)(=O)CCO,,,CHEMBL3639088,,2015,"{'bei': '15.40', 'le': '0.30', 'lle': '5.02', 'sei': '6.25'}",CHEMBL3639862,,CHEMBL3639862,8.45,0,http://www.openphacts.org/units/Nanomolar,2563774,=,37,1,=,,IC50,nM,,3.56,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.56,PAK4
,292139,16291169,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '15.72', 'le': '0.31', 'lle': '4.76', 'sei': '7.11'}",CHEMBL3687487,,CHEMBL3687487,8.84,0,http://www.openphacts.org/units/Nanomolar,2563835,=,37,1,=,,IC50,nM,,1.44,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.44,PAK4
,292162,16291245,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '16.05', 'le': '0.30', 'lle': '3.27', 'sei': '8.54'}",CHEMBL3687510,,CHEMBL3687510,8.48,0,http://www.openphacts.org/units/Nanomolar,2563858,=,37,1,=,,IC50,nM,,3.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.3,PAK4
,292122,16291426,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(C)[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.91', 'le': '0.28', 'lle': '3.15', 'sei': '7.12'}",CHEMBL3687470,,CHEMBL3687470,7.87,0,http://www.openphacts.org/units/Nanomolar,2563818,=,37,1,=,,IC50,nM,,13.56,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.56,PAK4
,225951,16292026,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.30', 'le': '0.33', 'lle': '4.55', 'sei': '6.41'}",CHEMBL3652024,,CHEMBL3652024,8.15,0,http://www.openphacts.org/units/Nanomolar,2525905,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,292229,16292552,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '14.23', 'le': '0.27', 'lle': '3.76', 'sei': '6.36'}",CHEMBL3691952,,CHEMBL3691952,8.28,0,http://www.openphacts.org/units/Nanomolar,2568495,=,37,1,=,,IC50,nM,,5.31,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.31,PAK4
,292205,16292714,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '14.73', 'le': '0.29', 'lle': '4.64', 'sei': '6.54'}",CHEMBL3691928,,CHEMBL3691928,8.73,0,http://www.openphacts.org/units/Nanomolar,2568471,=,37,1,=,,IC50,nM,,1.86,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.86,PAK4
,292148,16292963,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '13.74', 'le': '0.26', 'lle': '2.05', 'sei': '6.15'}",CHEMBL3687496,,CHEMBL3687496,7.00,0,http://www.openphacts.org/units/Nanomolar,2563844,=,37,1,=,,IC50,nM,,99.56,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,99.56,PAK4
,292201,16293013,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H](N)[C@@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '12.93', 'le': '0.25', 'lle': '3.93', 'sei': '6.00'}",CHEMBL3691924,,CHEMBL3691924,8.57,0,http://www.openphacts.org/units/Nanomolar,2568467,=,37,1,=,,IC50,nM,,2.69,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.69,PAK4
,225824,16293377,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.05', 'le': '0.36', 'lle': '6.46', 'sei': '6.90'}",CHEMBL3105021,,CHEMBL3105021,9.00,0,http://www.openphacts.org/units/Nanomolar,2525778,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,292096,16293526,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '14.13', 'le': '0.28', 'lle': '3.26', 'sei': '6.37'}",CHEMBL3687444,,CHEMBL3687444,7.33,0,http://www.openphacts.org/units/Nanomolar,2563792,=,37,1,=,,IC50,nM,,47.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,47.24,PAK4
,292112,16293609,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.94', 'le': '0.33', 'lle': '3.18', 'sei': '8.62'}",CHEMBL3687460,,CHEMBL3687460,7.77,0,http://www.openphacts.org/units/Nanomolar,2563808,=,37,1,=,,IC50,nM,,17.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.07,PAK4
,225822,16294017,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](O)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '17.54', 'le': '0.33', 'lle': '2.66', 'sei': '10.31'}",CHEMBL3651898,,CHEMBL3651898,7.75,0,http://www.openphacts.org/units/Nanomolar,2525776,=,37,1,=,,IC50,nM,,18.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,18.0,PAK4
,292095,16294036,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CS[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '18.84', 'le': '0.37', 'lle': '3.78', 'sei': '11.33'}",CHEMBL3687443,,CHEMBL3687443,9.17,0,http://www.openphacts.org/units/Nanomolar,2563791,=,37,1,=,,IC50,nM,,0.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.68,PAK4
,292085,16294499,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '11.40', 'le': '0.22', 'lle': '1.47', 'sei': '4.91'}",CHEMBL3687434,,CHEMBL3687434,5.85,0,http://www.openphacts.org/units/Nanomolar,2563781,=,37,1,=,,IC50,nM,,1400.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1400.0,PAK4
,225877,16295522,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c([C@H]3CC[C@H](O)CC3)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '17.19', 'le': '0.32', 'lle': '3.22', 'sei': '7.01'}",CHEMBL3651952,,CHEMBL3651952,7.09,0,http://www.openphacts.org/units/Nanomolar,2525831,=,37,1,=,,IC50,nM,,81.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,81.0,PAK4
,225879,16295864,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)n2)c1,,,CHEMBL3638421,,2013,"{'bei': '19.35', 'le': '0.36', 'lle': '3.03', 'sei': '10.01'}",CHEMBL3651954,,CHEMBL3651954,8.10,0,http://www.openphacts.org/units/Nanomolar,2525833,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,225936,16295935,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C[C@@H](O)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.75', 'le': '0.37', 'lle': '5.85', 'sei': '8.82'}",CHEMBL3652009,,CHEMBL3652009,8.70,0,http://www.openphacts.org/units/Nanomolar,2525890,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,288338,16296104,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(C(N)=O)c2c1-c1nc(N)ncc1CC2,,,CHEMBL3639053,,2015,,CHEMBL3703172,,CHEMBL3703172,,0,http://www.openphacts.org/units/Nanomolar,2580578,>,37,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,292136,16296783,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](C)[C@@H](OCCS(C)(=O)=O)[C@@H](N)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '9.72', 'le': '0.19', 'lle': '1.22', 'sei': '4.51'}",CHEMBL3687484,,CHEMBL3687484,5.61,0,http://www.openphacts.org/units/Nanomolar,2563832,=,37,1,=,,IC50,nM,,2483.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2483.1,PAK4
,225846,16297205,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3ccccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.79', 'le': '0.37', 'lle': '5.88', 'sei': '8.33'}",CHEMBL3651921,,CHEMBL3651921,8.70,0,http://www.openphacts.org/units/Nanomolar,2525800,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,292108,16297708,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(C)[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '14.45', 'le': '0.28', 'lle': '3.44', 'sei': '5.62'}",CHEMBL3687456,,CHEMBL3687456,7.67,0,http://www.openphacts.org/units/Nanomolar,2563804,=,37,1,=,,IC50,nM,,21.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.39,PAK4
,292194,16297835,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '13.70', 'le': '0.28', 'lle': '3.53', 'sei': '6.07'}",CHEMBL3691917,,CHEMBL3691917,7.54,0,http://www.openphacts.org/units/Nanomolar,2568460,=,37,1,=,,IC50,nM,,28.66,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,28.66,PAK4
,225880,16297855,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)ccc2F)c1,,,CHEMBL3638421,,2013,"{'bei': '19.53', 'le': '0.36', 'lle': '3.31', 'sei': '10.54'}",CHEMBL3651955,,CHEMBL3651955,8.52,0,http://www.openphacts.org/units/Nanomolar,2525834,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292203,16297955,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC(C)C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.22', 'le': '0.33', 'lle': '3.64', 'sei': '9.16'}",CHEMBL3691926,,CHEMBL3691926,9.10,0,http://www.openphacts.org/units/Nanomolar,2568469,=,37,1,=,,IC50,nM,,0.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.79,PAK4
,292183,16298425,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.80', 'le': '0.31', 'lle': '4.03', 'sei': '7.31'}",CHEMBL3687531,,CHEMBL3687531,8.41,0,http://www.openphacts.org/units/Nanomolar,2563880,=,37,1,=,,IC50,nM,,3.85,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.85,PAK4
,225888,16298475,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCOc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)c(N)cc2F)c1,,,CHEMBL3638421,,2013,"{'bei': '16.39', 'le': '0.31', 'lle': '4.15', 'sei': '5.98'}",CHEMBL3651963,,CHEMBL3651963,8.15,0,http://www.openphacts.org/units/Nanomolar,2525842,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,292106,16299517,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1OCCC(=O)O,,,CHEMBL3639088,,2015,"{'bei': '12.37', 'le': '0.24', 'lle': '2.03', 'sei': '5.13'}",CHEMBL3687454,,CHEMBL3687454,6.54,0,http://www.openphacts.org/units/Nanomolar,2563802,=,37,1,=,,IC50,nM,,289.11,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,289.11,PAK4
,292208,16299812,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.48', 'le': '0.29', 'lle': '4.55', 'sei': '7.07'}",CHEMBL3691931,,CHEMBL3691931,8.77,0,http://www.openphacts.org/units/Nanomolar,2568474,=,37,1,=,,IC50,nM,,1.69,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.69,PAK4
,292214,16300226,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '14.93', 'le': '0.28', 'lle': '3.20', 'sei': '7.41'}",CHEMBL3691937,,CHEMBL3691937,9.13,0,http://www.openphacts.org/units/Nanomolar,2568480,=,37,1,=,,IC50,nM,,0.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.74,PAK4
,292226,16300279,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCC#N)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '16.58', 'le': '0.31', 'lle': '3.99', 'sei': '7.27'}",CHEMBL3691949,,CHEMBL3691949,8.95,0,http://www.openphacts.org/units/Nanomolar,2568492,=,37,1,=,,IC50,nM,,1.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.13,PAK4
,292263,16301028,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](NC(=O)OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '13.63', 'le': '0.26', 'lle': '2.87', 'sei': '6.07'}",CHEMBL3691985,,CHEMBL3691985,7.79,0,http://www.openphacts.org/units/Nanomolar,2568529,=,37,1,=,,IC50,nM,,16.14,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.14,PAK4
,225856,16301054,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3cc(O)ccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.55', 'le': '0.36', 'lle': '3.75', 'sei': '8.13'}",CHEMBL3651931,,CHEMBL3651931,8.22,0,http://www.openphacts.org/units/Nanomolar,2525810,=,37,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,225838,16301092,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '16.90', 'le': '0.32', 'lle': '3.45', 'sei': '7.80'}",CHEMBL3651913,,CHEMBL3651913,7.89,0,http://www.openphacts.org/units/Nanomolar,2525792,=,37,1,=,,IC50,nM,,13.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.0,PAK4
,292210,16301227,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC(C)C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.09', 'le': '0.27', 'lle': '2.88', 'sei': '6.27'}",CHEMBL3691933,,CHEMBL3691933,8.05,0,http://www.openphacts.org/units/Nanomolar,2568476,=,37,1,=,,IC50,nM,,8.88,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.88,PAK4
,292235,16301901,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.35', 'le': '0.33', 'lle': '6.29', 'sei': '6.19'}",CHEMBL3691958,,CHEMBL3691958,9.19,0,http://www.openphacts.org/units/Nanomolar,2568501,=,37,1,=,,IC50,nM,,0.65,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.65,PAK4
,292094,16301978,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1[S@+](C)[O-],,,CHEMBL3639088,,2015,"{'bei': '13.88', 'le': '0.27', 'lle': '2.57', 'sei': '6.71'}",CHEMBL3687442,,CHEMBL3687442,6.97,0,http://www.openphacts.org/units/Nanomolar,2563790,=,37,1,=,,IC50,nM,,106.11,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,106.11,PAK4
,225956,16302238,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '15.46', 'le': '0.29', 'lle': '3.05', 'sei': '6.98'}",CHEMBL3652027,,CHEMBL3652027,7.06,0,http://www.openphacts.org/units/Nanomolar,2525910,=,37,1,=,,IC50,nM,,88.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,88.0,PAK4
,288350,16302476,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2ccc3c(C(N)=O)cn([C@H]4CC[C@@H](N)CC4)c3c2n1,,,CHEMBL3639053,,2015,"{'bei': '25.32', 'le': '0.49', 'lle': '6.15', 'sei': '9.02'}",CHEMBL3703184,,CHEMBL3703184,9.00,0,http://www.openphacts.org/units/Nanomolar,2580590,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,292177,16302565,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '14.29', 'le': '0.28', 'lle': '3.64', 'sei': '6.63'}",CHEMBL3687526,,CHEMBL3687526,8.24,0,http://www.openphacts.org/units/Nanomolar,2563874,=,37,1,=,,IC50,nM,,5.78,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.78,PAK4
,225851,16302966,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](O)[C@@H](C)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '17.50', 'le': '0.33', 'lle': '3.74', 'sei': '7.83'}",CHEMBL3651926,,CHEMBL3651926,7.92,0,http://www.openphacts.org/units/Nanomolar,2525805,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,292240,16303355,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '13.98', 'le': '0.26', 'lle': '4.02', 'sei': '6.02'}",CHEMBL3691963,,CHEMBL3691963,8.50,0,http://www.openphacts.org/units/Nanomolar,2568506,=,37,1,=,,IC50,nM,,3.19,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.19,PAK4
,292146,16303404,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](C)[C@@H](OCCC#N)[C@@H](N)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '13.74', 'le': '0.26', 'lle': '1.93', 'sei': '6.31'}",CHEMBL3687494,,CHEMBL3687494,7.19,0,http://www.openphacts.org/units/Nanomolar,2563842,=,37,1,=,,IC50,nM,,64.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,64.13,PAK4
,225864,16303652,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3cc(O)ccc3F)ccc2F)C1,,,CHEMBL3638421,,2013,"{'bei': '18.75', 'le': '0.35', 'lle': '3.61', 'sei': '8.13'}",CHEMBL3651939,,CHEMBL3651939,8.22,0,http://www.openphacts.org/units/Nanomolar,2525818,=,37,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,292123,16304050,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(C)[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.97', 'le': '0.32', 'lle': '5.31', 'sei': '7.89'}",CHEMBL3687471,,CHEMBL3687471,8.97,0,http://www.openphacts.org/units/Nanomolar,2563819,=,37,1,=,,IC50,nM,,1.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.07,PAK4
,288344,16304208,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2c(n1)-c1c(c(C(N)=O)cn1C(C)C)CC2,,,CHEMBL3639053,,2015,"{'bei': '25.20', 'le': '0.50', 'lle': '5.17', 'sei': '10.32'}",CHEMBL3703178,,CHEMBL3703178,7.62,0,http://www.openphacts.org/units/Nanomolar,2580584,=,37,1,=,,IC50,nM,,24.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.0,PAK4
,225887,16304719,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(F)c(-c2ccccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,,,CHEMBL3638421,,2013,"{'bei': '19.11', 'le': '0.36', 'lle': '5.19', 'sei': '6.60'}",CHEMBL3651962,,CHEMBL3651962,8.40,0,http://www.openphacts.org/units/Nanomolar,2525841,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,292140,16304969,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '10.59', 'le': '0.21', 'lle': '1.88', 'sei': '4.79'}",CHEMBL3687488,,CHEMBL3687488,5.96,0,http://www.openphacts.org/units/Nanomolar,2563836,=,37,1,=,,IC50,nM,,1100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1100.0,PAK4
,225840,16305039,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CCC[C@H](N)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '16.65', 'le': '0.31', 'lle': '2.05', 'sei': '8.98'}",CHEMBL3651915,,CHEMBL3651915,7.27,0,http://www.openphacts.org/units/Nanomolar,2525794,=,37,1,=,,IC50,nM,,54.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,54.0,PAK4
,292193,16305254,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3C3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.20', 'le': '0.29', 'lle': '4.33', 'sei': '6.80'}",CHEMBL3691916,,CHEMBL3691916,8.84,0,http://www.openphacts.org/units/Nanomolar,2568459,=,37,1,=,,IC50,nM,,1.45,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.45,PAK4
,225881,16305306,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cccc(F)c3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.85', 'le': '0.35', 'lle': '3.26', 'sei': '10.26'}",CHEMBL3651956,,CHEMBL3651956,8.30,0,http://www.openphacts.org/units/Nanomolar,2525835,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,225920,16305547,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.47', 'le': '0.37', 'lle': '3.50', 'sei': '10.26'}",CHEMBL3651993,,CHEMBL3651993,8.30,0,http://www.openphacts.org/units/Nanomolar,2525874,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,225901,16305682,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2F)C1,,,CHEMBL3638421,,2013,"{'bei': '17.25', 'le': '0.32', 'lle': '2.56', 'sei': '9.09'}",CHEMBL3651976,,CHEMBL3651976,7.36,0,http://www.openphacts.org/units/Nanomolar,2525855,=,37,1,=,,IC50,nM,,44.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,44.0,PAK4
,292260,16306114,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '13.87', 'le': '0.27', 'lle': '4.25', 'sei': '6.49'}",CHEMBL3691982,,CHEMBL3691982,8.55,0,http://www.openphacts.org/units/Nanomolar,2568526,=,37,1,=,,IC50,nM,,2.81,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.81,PAK4
,225848,16306337,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)ccc2F)c1F,,,CHEMBL3638421,,2013,"{'bei': '18.75', 'le': '0.35', 'lle': '3.17', 'sei': '10.54'}",CHEMBL3651923,,CHEMBL3651923,8.52,0,http://www.openphacts.org/units/Nanomolar,2525802,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,225893,16306482,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](N)C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '14.26', 'le': '0.27', 'lle': '1.24', 'sei': '7.77'}",CHEMBL3651968,,CHEMBL3651968,6.28,0,http://www.openphacts.org/units/Nanomolar,2525847,=,37,1,=,,IC50,nM,,522.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,522.0,PAK4
,292115,16306618,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(C)[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.48', 'le': '0.27', 'lle': '2.81', 'sei': '7.10'}",CHEMBL3687463,,CHEMBL3687463,7.84,0,http://www.openphacts.org/units/Nanomolar,2563811,=,37,1,=,,IC50,nM,,14.32,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.32,PAK4
,292241,16306624,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.40', 'le': '0.29', 'lle': '3.44', 'sei': '6.82'}",CHEMBL3691964,,CHEMBL3691964,8.13,0,http://www.openphacts.org/units/Nanomolar,2568507,=,37,1,=,,IC50,nM,,7.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.47,PAK4
,292242,16306631,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '16.64', 'le': '0.31', 'lle': '3.88', 'sei': '7.78'}",CHEMBL3691965,,CHEMBL3691965,8.68,0,http://www.openphacts.org/units/Nanomolar,2568508,=,37,1,=,,IC50,nM,,2.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.1,PAK4
,225914,16306853,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1C1=C[C@@H](N)[C@@H](O)CC1,,,CHEMBL3638421,,2013,"{'bei': '18.51', 'le': '0.35', 'lle': '4.98', 'sei': '6.37'}",CHEMBL3651988,,CHEMBL3651988,8.10,0,http://www.openphacts.org/units/Nanomolar,2525868,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,225853,16307000,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.98', 'le': '0.36', 'lle': '3.90', 'sei': '8.30'}",CHEMBL3651928,,CHEMBL3651928,8.40,0,http://www.openphacts.org/units/Nanomolar,2525807,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,292237,16307178,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '17.44', 'le': '0.33', 'lle': '5.04', 'sei': '6.62'}",CHEMBL3691960,,CHEMBL3691960,9.11,0,http://www.openphacts.org/units/Nanomolar,2568503,=,37,1,=,,IC50,nM,,0.77,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.77,PAK4
,292257,16307755,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)n2)c1,,,CHEMBL3639088,,2015,"{'bei': '15.02', 'le': '0.28', 'lle': '4.66', 'sei': '5.15'}",CHEMBL3691980,,CHEMBL3691980,8.59,0,http://www.openphacts.org/units/Nanomolar,2568523,=,37,1,=,,IC50,nM,,2.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.6,PAK4
,292102,16308429,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '14.79', 'le': '0.29', 'lle': '3.91', 'sei': '6.36'}",CHEMBL3687450,,CHEMBL3687450,7.91,0,http://www.openphacts.org/units/Nanomolar,2563798,=,37,1,=,,IC50,nM,,12.41,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.41,PAK4
,292212,16308598,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '14.23', 'le': '0.27', 'lle': '4.29', 'sei': '7.00'}",CHEMBL3691935,,CHEMBL3691935,8.69,0,http://www.openphacts.org/units/Nanomolar,2568478,=,37,1,=,,IC50,nM,,2.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.04,PAK4
,198714,16308674,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cccc(CC)c1NC(=O)c1cn(C)c2c1CCCc1cnc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc1-2,,,CHEMBL3639053,,2015,,CHEMBL3703188,,CHEMBL3703188,,0,http://www.openphacts.org/units/Nanomolar,2580594,>,37,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,292113,16309242,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccnc(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.79', 'le': '0.30', 'lle': '3.24', 'sei': '6.95'}",CHEMBL3687461,,CHEMBL3687461,7.16,0,http://www.openphacts.org/units/Nanomolar,2563809,=,37,1,=,,IC50,nM,,69.11,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,69.11,PAK4
,292149,16309533,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1N=[N+]=[N-],,,CHEMBL3639088,,2015,"{'bei': '18.93', 'le': '0.36', 'lle': '4.85', 'sei': '6.87'}",CHEMBL3687497,,CHEMBL3687497,9.13,0,http://www.openphacts.org/units/Nanomolar,2563845,=,37,1,=,,IC50,nM,,0.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.74,PAK4
,225934,16309984,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '15.41', 'le': '0.29', 'lle': '4.09', 'sei': '6.76'}",CHEMBL3652007,,CHEMBL3652007,7.05,0,http://www.openphacts.org/units/Nanomolar,2525888,=,37,1,=,,IC50,nM,,89.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,89.0,PAK4
,225839,16310121,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '15.93', 'le': '0.30', 'lle': '3.02', 'sei': '7.13'}",CHEMBL3651914,,CHEMBL3651914,7.21,0,http://www.openphacts.org/units/Nanomolar,2525793,=,37,1,=,,IC50,nM,,62.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,62.0,PAK4
,292081,16310155,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1NS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '16.06', 'le': '0.32', 'lle': '6.08', 'sei': '6.59'}",CHEMBL3687431,,CHEMBL3687431,8.59,0,http://www.openphacts.org/units/Nanomolar,2563778,=,37,1,=,,IC50,nM,,2.59,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.59,PAK4
,225898,16310600,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(F)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '17.90', 'le': '0.34', 'lle': '2.85', 'sei': '9.75'}",CHEMBL3651973,,CHEMBL3651973,7.89,0,http://www.openphacts.org/units/Nanomolar,2525852,=,37,1,=,,IC50,nM,,13.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.0,PAK4
,292259,16311032,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2nc(-c3cc(C(=O)NC(C)C)ccc3F)ccc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.97', 'le': '0.28', 'lle': '5.90', 'sei': '4.88'}",CHEMBL3639908,,CHEMBL3639908,8.66,0,http://www.openphacts.org/units/Nanomolar,2568525,=,37,1,=,,IC50,nM,,2.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.18,PAK4
,292227,16311079,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '17.92', 'le': '0.34', 'lle': '4.86', 'sei': '6.72'}",CHEMBL3691950,,CHEMBL3691950,9.40,0,http://www.openphacts.org/units/Nanomolar,2568493,=,37,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,292173,16311484,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCC#N)[C@@H](C)C3)n2)c1,,,CHEMBL3639088,,2015,"{'bei': '15.92', 'le': '0.30', 'lle': '4.73', 'sei': '5.40'}",CHEMBL3687521,,CHEMBL3687521,9.13,0,http://www.openphacts.org/units/Nanomolar,2563869,=,37,1,=,,IC50,nM,,0.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.74,PAK4
,292254,16311501,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '16.24', 'le': '0.31', 'lle': '5.31', 'sei': '7.05'}",CHEMBL3691977,,CHEMBL3691977,8.75,0,http://www.openphacts.org/units/Nanomolar,2568520,=,37,1,=,,IC50,nM,,1.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.79,PAK4
,225857,16311664,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.44', 'le': '0.36', 'lle': '3.91', 'sei': '8.43'}",CHEMBL3651932,,CHEMBL3651932,8.52,0,http://www.openphacts.org/units/Nanomolar,2525811,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292261,16311780,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3cc(C(=O)NC(C)C)ccc3F)ccc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.34', 'le': '0.27', 'lle': '4.46', 'sei': '4.75'}",CHEMBL3691983,,CHEMBL3691983,8.29,0,http://www.openphacts.org/units/Nanomolar,2568527,=,37,1,=,,IC50,nM,,5.19,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.19,PAK4
,292063,16311849,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '16.94', 'le': '0.32', 'lle': '4.11', 'sei': '7.70'}",CHEMBL3687414,,CHEMBL3687414,8.60,0,http://www.openphacts.org/units/Nanomolar,2563760,=,37,1,=,,IC50,nM,,2.53,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.53,PAK4
,292118,16312000,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cncn1,,,CHEMBL3639088,,2015,"{'bei': '17.35', 'le': '0.33', 'lle': '5.39', 'sei': '7.68'}",CHEMBL3687466,,CHEMBL3687466,8.82,0,http://www.openphacts.org/units/Nanomolar,2563814,=,37,1,=,,IC50,nM,,1.51,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.51,PAK4
,225870,16312047,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.75', 'le': '0.35', 'lle': '3.09', 'sei': '10.54'}",CHEMBL3651945,,CHEMBL3651945,8.52,0,http://www.openphacts.org/units/Nanomolar,2525824,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,225921,16312065,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(F)c(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,,,CHEMBL3638421,,2013,"{'bei': '20.39', 'le': '0.38', 'lle': '4.62', 'sei': '8.42'}",CHEMBL3651994,,CHEMBL3651994,9.00,0,http://www.openphacts.org/units/Nanomolar,2525875,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,292117,16312475,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](C#N)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '16.55', 'le': '0.31', 'lle': '3.91', 'sei': '7.37'}",CHEMBL3687465,,CHEMBL3687465,7.95,0,http://www.openphacts.org/units/Nanomolar,2563813,=,37,1,=,,IC50,nM,,11.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.18,PAK4
,292243,16312521,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4COC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '13.04', 'le': '0.25', 'lle': '2.94', 'sei': '5.78'}",CHEMBL3691966,,CHEMBL3691966,7.43,0,http://www.openphacts.org/units/Nanomolar,2568509,=,37,1,=,,IC50,nM,,37.43,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,37.43,PAK4
,292075,16312598,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C1\[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.20', 'le': '0.32', 'lle': '3.66', 'sei': '8.11'}",CHEMBL3687426,,CHEMBL3687426,8.32,0,http://www.openphacts.org/units/Nanomolar,2563772,=,37,1,=,,IC50,nM,,4.82,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.82,PAK4
,292250,16312682,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1OCC(=O)O,,,CHEMBL3639088,,2015,"{'bei': '10.41', 'le': '0.20', 'lle': '1.24', 'sei': '4.20'}",CHEMBL3691973,,CHEMBL3691973,5.36,0,http://www.openphacts.org/units/Nanomolar,2568516,=,37,1,=,,IC50,nM,,4400.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4400.0,PAK4
,288353,16313034,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2ccc3c(C(N)=O)cn(CC(C)(C)CN)c3c2n1,,,CHEMBL3639053,,2015,"{'bei': '21.74', 'le': '0.42', 'lle': '5.08', 'sei': '7.48'}",CHEMBL3703187,,CHEMBL3703187,7.47,0,http://www.openphacts.org/units/Nanomolar,2580593,=,37,1,=,,IC50,nM,,34.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.0,PAK4
,225875,16313491,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c([C@H]3CC[C@@H](O)CC3)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '17.78', 'le': '0.33', 'lle': '3.47', 'sei': '7.50'}",CHEMBL3651950,,CHEMBL3651950,7.58,0,http://www.openphacts.org/units/Nanomolar,2525829,=,37,1,=,,IC50,nM,,26.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,26.0,PAK4
,225952,16313505,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(F)c(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,,,CHEMBL3638421,,2013,"{'bei': '17.83', 'le': '0.34', 'lle': '4.80', 'sei': '6.41'}",CHEMBL3651961,,CHEMBL3651961,8.15,0,http://www.openphacts.org/units/Nanomolar,2525906,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,292082,16313696,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCS(=O)(=O)[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.53', 'le': '0.29', 'lle': '4.10', 'sei': '6.58'}",CHEMBL3687432,,CHEMBL3687432,8.18,0,http://www.openphacts.org/units/Nanomolar,2563779,=,37,1,=,,IC50,nM,,6.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.68,PAK4
,225854,16313851,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(O)ccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.96', 'le': '0.35', 'lle': '3.69', 'sei': '7.96'}",CHEMBL3651929,,CHEMBL3651929,8.05,0,http://www.openphacts.org/units/Nanomolar,2525808,=,37,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,292178,16314528,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.45', 'le': '0.29', 'lle': '4.15', 'sei': '7.37'}",CHEMBL3639863,,CHEMBL3639863,8.81,0,http://www.openphacts.org/units/Nanomolar,2563875,=,37,1,=,,IC50,nM,,1.53,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.53,PAK4
,225930,16315048,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)C[C@@H](C(F)(F)F)C3)n2)c(F)c1,,,CHEMBL3638421,,2013,"{'bei': '17.18', 'le': '0.33', 'lle': '3.24', 'sei': '9.65'}",CHEMBL3652003,,CHEMBL3652003,8.70,0,http://www.openphacts.org/units/Nanomolar,2525884,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,225944,16315137,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)CC(C)(C)C3)ccc2F)c(F)c1,,,CHEMBL3638421,,2013,"{'bei': '17.33', 'le': '0.33', 'lle': '2.96', 'sei': '9.32'}",CHEMBL3652017,,CHEMBL3652017,8.40,0,http://www.openphacts.org/units/Nanomolar,2525898,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,225911,16315413,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(C3CCCCC3)ccc2N)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.89', 'le': '0.35', 'lle': '4.44', 'sei': '6.29'}",CHEMBL3639508,,CHEMBL3639508,8.00,0,http://www.openphacts.org/units/Nanomolar,2525865,=,37,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,292228,16315424,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.08', 'le': '0.27', 'lle': '3.47', 'sei': '5.89'}",CHEMBL3691951,,CHEMBL3691951,8.22,0,http://www.openphacts.org/units/Nanomolar,2568494,=,37,1,=,,IC50,nM,,6.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.07,PAK4
,225932,16315887,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(C3CCCCC3)n2)C[C@H](C(F)(F)F)C1,,,CHEMBL3638421,,2013,"{'bei': '17.87', 'le': '0.34', 'lle': '2.61', 'sei': '10.26'}",CHEMBL3652005,,CHEMBL3652005,8.30,0,http://www.openphacts.org/units/Nanomolar,2525886,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,292067,16315894,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '17.52', 'le': '0.33', 'lle': '5.48', 'sei': '7.75'}",CHEMBL3687418,,CHEMBL3687418,8.91,0,http://www.openphacts.org/units/Nanomolar,2563764,=,37,1,=,,IC50,nM,,1.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.24,PAK4
,225889,16316328,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCOc1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)n2)c1,,,CHEMBL3638421,,2013,"{'bei': '16.88', 'le': '0.32', 'lle': '4.24', 'sei': '5.94'}",CHEMBL3651964,,CHEMBL3651964,8.10,0,http://www.openphacts.org/units/Nanomolar,2525843,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,292134,16316707,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.55', 'le': '0.34', 'lle': '6.25', 'sei': '6.12'}",CHEMBL3687482,,CHEMBL3687482,9.08,0,http://www.openphacts.org/units/Nanomolar,2563830,=,37,1,=,,IC50,nM,,0.83,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.83,PAK4
,225863,16317218,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cc(O)cc3F)ccc2F)C1,,,CHEMBL3638421,,2013,"{'bei': '19.06', 'le': '0.36', 'lle': '3.95', 'sei': '8.60'}",CHEMBL3651938,,CHEMBL3651938,8.70,0,http://www.openphacts.org/units/Nanomolar,2525817,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,292199,16317715,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.49', 'le': '0.31', 'lle': '3.87', 'sei': '8.08'}",CHEMBL3691922,,CHEMBL3691922,8.91,0,http://www.openphacts.org/units/Nanomolar,2568465,=,37,1,=,,IC50,nM,,1.22,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.22,PAK4
,292207,16317783,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '16.15', 'le': '0.32', 'lle': '5.66', 'sei': '6.21'}",CHEMBL3691930,,CHEMBL3691930,9.33,0,http://www.openphacts.org/units/Nanomolar,2568473,=,37,1,=,,IC50,nM,,0.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.47,PAK4
,225842,16318326,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '17.50', 'le': '0.33', 'lle': '2.42', 'sei': '9.75'}",CHEMBL3651917,,CHEMBL3651917,7.89,0,http://www.openphacts.org/units/Nanomolar,2525796,=,37,1,=,,IC50,nM,,13.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.0,PAK4
,292130,16318460,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1C#N,,,CHEMBL3639088,,2015,"{'bei': '17.02', 'le': '0.32', 'lle': '3.13', 'sei': '7.57'}",CHEMBL3687478,,CHEMBL3687478,7.92,0,http://www.openphacts.org/units/Nanomolar,2563826,=,37,1,=,,IC50,nM,,11.96,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.96,PAK4
,292246,16318570,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(C#N)nn1,,,CHEMBL3639088,,2015,"{'bei': '14.79', 'le': '0.28', 'lle': '3.52', 'sei': '5.82'}",CHEMBL3691969,,CHEMBL3691969,7.88,0,http://www.openphacts.org/units/Nanomolar,2568512,=,37,1,=,,IC50,nM,,13.33,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.33,PAK4
,225954,16318833,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C1,,,CHEMBL3638421,,2013,"{'bei': '18.44', 'le': '0.35', 'lle': '3.77', 'sei': '7.85'}",CHEMBL3651947,,CHEMBL3651947,8.40,0,http://www.openphacts.org/units/Nanomolar,2525908,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,292124,16319778,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.62', 'le': '0.33', 'lle': '3.56', 'sei': '9.47'}",CHEMBL3687472,,CHEMBL3687472,8.54,0,http://www.openphacts.org/units/Nanomolar,2563820,=,37,1,=,,IC50,nM,,2.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.9,PAK4
,225832,16319872,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)CC(C)(C)C3)ccc2F)c1F,,,CHEMBL3638421,,2013,"{'bei': '17.72', 'le': '0.33', 'lle': '2.56', 'sei': '10.26'}",CHEMBL3651907,,CHEMBL3651907,8.30,0,http://www.openphacts.org/units/Nanomolar,2525786,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,292111,16320522,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cncn1,,,CHEMBL3639088,,2015,"{'bei': '17.58', 'le': '0.33', 'lle': '4.43', 'sei': '7.99'}",CHEMBL3687459,,CHEMBL3687459,8.92,0,http://www.openphacts.org/units/Nanomolar,2563807,=,37,1,=,,IC50,nM,,1.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.2,PAK4
,292158,16320583,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.05', 'le': '0.29', 'lle': '2.98', 'sei': '8.67'}",CHEMBL3687506,,CHEMBL3687506,8.62,0,http://www.openphacts.org/units/Nanomolar,2563854,=,37,1,=,,IC50,nM,,2.42,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.42,PAK4
,288352,16320725,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2ccc3c(C(N)=O)c[nH]c3c2n1,,,CHEMBL3639053,,2015,"{'bei': '28.40', 'le': '0.56', 'lle': '5.41', 'sei': '8.67'}",CHEMBL3703186,,CHEMBL3703186,7.34,0,http://www.openphacts.org/units/Nanomolar,2580592,=,37,1,=,,IC50,nM,,46.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,46.0,PAK4
,292187,16321099,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3cc(C(=O)NC(C)C)ccc3F)ccc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.07', 'le': '0.30', 'lle': '4.48', 'sei': '5.92'}",CHEMBL3687535,,CHEMBL3687535,8.59,0,http://www.openphacts.org/units/Nanomolar,2563884,=,37,1,=,,IC50,nM,,2.56,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.56,PAK4
,292239,16321753,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '12.75', 'le': '0.24', 'lle': '3.45', 'sei': '5.26'}",CHEMBL3691962,,CHEMBL3691962,7.83,0,http://www.openphacts.org/units/Nanomolar,2568505,=,37,1,=,,IC50,nM,,14.94,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.94,PAK4
,292244,16321791,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '13.96', 'le': '0.26', 'lle': '3.00', 'sei': '6.43'}",CHEMBL3691967,,CHEMBL3691967,8.51,0,http://www.openphacts.org/units/Nanomolar,2568510,=,37,1,=,,IC50,nM,,3.08,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.08,PAK4
,292066,16322371,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(-c2ccsc2)nn1,,,CHEMBL3639088,,2015,"{'bei': '14.17', 'le': '0.27', 'lle': '3.21', 'sei': '7.29'}",CHEMBL3687417,,CHEMBL3687417,8.37,0,http://www.openphacts.org/units/Nanomolar,2563763,=,37,1,=,,IC50,nM,,4.28,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.28,PAK4
,292161,16322472,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.17', 'le': '0.31', 'lle': '3.41', 'sei': '9.02'}",CHEMBL3687509,,CHEMBL3687509,8.97,0,http://www.openphacts.org/units/Nanomolar,2563857,=,37,1,=,,IC50,nM,,1.08,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.08,PAK4
,225909,16323197,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)CC[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.99', 'le': '0.34', 'lle': '4.19', 'sei': '7.87'}",CHEMBL3651984,,CHEMBL3651984,7.96,0,http://www.openphacts.org/units/Nanomolar,2525863,=,37,1,=,,IC50,nM,,11.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.0,PAK4
,225919,16323210,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.30', 'le': '0.34', 'lle': '4.84', 'sei': '6.53'}",CHEMBL3651992,,CHEMBL3651992,8.30,0,http://www.openphacts.org/units/Nanomolar,2525873,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,292223,16323260,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4COC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.38', 'le': '0.29', 'lle': '5.33', 'sei': '6.66'}",CHEMBL3691946,,CHEMBL3691946,8.78,0,http://www.openphacts.org/units/Nanomolar,2568489,=,37,1,=,,IC50,nM,,1.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.68,PAK4
,292125,16323601,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@H](N)[C@@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '12.56', 'le': '0.24', 'lle': '1.98', 'sei': '4.60'}",CHEMBL3687473,,CHEMBL3687473,6.44,0,http://www.openphacts.org/units/Nanomolar,2563821,=,37,1,=,,IC50,nM,,364.41,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,364.41,PAK4
,292084,16323744,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.30', 'le': '0.29', 'lle': '3.48', 'sei': '6.59'}",CHEMBL3687423,,CHEMBL3687423,7.86,0,http://www.openphacts.org/units/Nanomolar,2563769,=,37,1,=,,IC50,nM,,13.88,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.88,PAK4
,225872,16323946,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C1,,,CHEMBL3638421,,2013,"{'bei': '19.10', 'le': '0.36', 'lle': '4.07', 'sei': '8.14'}",CHEMBL3651947,,CHEMBL3651947,8.70,0,http://www.openphacts.org/units/Nanomolar,2525826,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,288349,16324081,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2c(n1)-c1c(c(C(N)=O)cn1[C@H]1CC[C@@H](N)CC1)CC2,,,CHEMBL3639053,,2015,"{'bei': '22.81', 'le': '0.45', 'lle': '5.84', 'sei': '8.17'}",CHEMBL3703183,,CHEMBL3703183,8.15,0,http://www.openphacts.org/units/Nanomolar,2580589,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,292078,16325141,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@H]1NS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '8.74', 'le': '0.17', 'lle': '1.09', 'sei': '3.67'}",CHEMBL3687428,,CHEMBL3687428,4.66,0,http://www.openphacts.org/units/Nanomolar,2563775,=,37,1,=,,IC50,nM,,21700.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21700.0,PAK4
,225913,16325203,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1C1=CC(N)C(O)CC1,,,CHEMBL3638421,,2013,"{'bei': '18.39', 'le': '0.34', 'lle': '4.93', 'sei': '6.33'}",CHEMBL3651987,,CHEMBL3651987,8.05,0,http://www.openphacts.org/units/Nanomolar,2525867,=,37,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,225949,16326028,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.72', 'le': '0.37', 'lle': '4.25', 'sei': '8.90'}",CHEMBL3652022,,CHEMBL3652022,9.00,0,http://www.openphacts.org/units/Nanomolar,2525903,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,292098,16326044,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1[S+](C)[O-],,,CHEMBL3639088,,2015,"{'bei': '14.99', 'le': '0.29', 'lle': '3.13', 'sei': '7.24'}",CHEMBL3687446,,CHEMBL3687446,7.53,0,http://www.openphacts.org/units/Nanomolar,2563794,=,37,1,=,,IC50,nM,,29.43,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.43,PAK4
,225860,16326127,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3ccc(O)cc3F)ccc2F)C1,,,CHEMBL3638421,,2013,"{'bei': '17.23', 'le': '0.32', 'lle': '2.94', 'sei': '7.47'}",CHEMBL3651935,,CHEMBL3651935,7.55,0,http://www.openphacts.org/units/Nanomolar,2525814,=,37,1,=,,IC50,nM,,28.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,28.0,PAK4
,292234,16326575,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.74', 'le': '0.30', 'lle': '5.24', 'sei': '6.51'}",CHEMBL3691957,,CHEMBL3691957,8.57,0,http://www.openphacts.org/units/Nanomolar,2568500,=,37,1,=,,IC50,nM,,2.67,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.67,PAK4
,292264,16326924,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](NC(=O)OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.33', 'le': '0.29', 'lle': '4.92', 'sei': '6.66'}",CHEMBL3691986,,CHEMBL3691986,8.78,0,http://www.openphacts.org/units/Nanomolar,2568530,=,37,1,=,,IC50,nM,,1.67,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.67,PAK4
,292138,16326997,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '11.01', 'le': '0.21', 'lle': '0.51', 'sei': '5.75'}",CHEMBL3687486,,CHEMBL3687486,5.18,0,http://www.openphacts.org/units/Nanomolar,2563834,=,37,1,=,,IC50,nM,,6600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6600.0,PAK4
,292097,16327177,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CS[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.65', 'le': '0.33', 'lle': '2.71', 'sei': '10.01'}",CHEMBL3687445,,CHEMBL3687445,8.10,0,http://www.openphacts.org/units/Nanomolar,2563793,=,37,1,=,,IC50,nM,,7.94,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.94,PAK4
,292175,16327188,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1Oc1ccccn1,,,CHEMBL3639088,,2015,"{'bei': '12.97', 'le': '0.24', 'lle': '1.42', 'sei': '6.72'}",CHEMBL3687523,,CHEMBL3687523,6.92,0,http://www.openphacts.org/units/Nanomolar,2563871,=,37,1,=,,IC50,nM,,120.03,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,120.03,PAK4
,292218,16327585,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.74', 'le': '0.30', 'lle': '4.95', 'sei': '7.19'}",CHEMBL3691941,,CHEMBL3691941,8.92,0,http://www.openphacts.org/units/Nanomolar,2568484,=,37,1,=,,IC50,nM,,1.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.2,PAK4
,288339,16327754,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1c(-c2ccccc2)[nH]c2c1ccc1cnc(N)nc12,,,CHEMBL3639053,,2015,,CHEMBL3703173,,CHEMBL3703173,,0,http://www.openphacts.org/units/Nanomolar,2580579,>,37,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,225883,16327758,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2cccc(-c3ccccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '20.16', 'le': '0.37', 'lle': '3.38', 'sei': '10.08'}",CHEMBL3651958,,CHEMBL3651958,8.15,0,http://www.openphacts.org/units/Nanomolar,2525837,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,292245,16328187,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '14.99', 'le': '0.28', 'lle': '3.37', 'sei': '6.48'}",CHEMBL3691968,,CHEMBL3691968,8.69,0,http://www.openphacts.org/units/Nanomolar,2568511,=,37,1,=,,IC50,nM,,2.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.04,PAK4
,225904,16328350,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2cccc(-c3ccccc3F)n2)CC[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.01', 'le': '0.33', 'lle': '3.83', 'sei': '7.24'}",CHEMBL3651979,,CHEMBL3651979,7.32,0,http://www.openphacts.org/units/Nanomolar,2525858,=,37,1,=,,IC50,nM,,48.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,48.0,PAK4
,292171,16328621,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](S(C)(=O)=O)[C@@H](C)C3)n2)c1,,,CHEMBL3639088,,2015,"{'bei': '15.09', 'le': '0.29', 'lle': '5.28', 'sei': '5.17'}",CHEMBL3687519,,CHEMBL3687519,8.79,0,http://www.openphacts.org/units/Nanomolar,2563867,=,37,1,=,,IC50,nM,,1.61,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.61,PAK4
,292145,16328846,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCC#N)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '17.57', 'le': '0.33', 'lle': '3.94', 'sei': '8.08'}",CHEMBL3687493,,CHEMBL3687493,9.20,0,http://www.openphacts.org/units/Nanomolar,2563841,=,37,1,=,,IC50,nM,,0.63,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.63,PAK4
,276605,16329051,[],CHEMBL3707966,"Kinase Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates are trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors.At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP is captured by an excess of the ion exchange dowex resin; the resin then settles down to the bottom of the reaction plate by gravity.Supernatant is subsequently withdrawn and transferred into a counting plate, then evaluated by (3-counting.Reagents/Assay ConditionsDowex Resin Preparation500 g of wet resin (SIGMA, custom prepared resin DOWEX 1x8 200-400 mesh, 2.5 Kg) are weighed out and diluted to 2 L in 150 mM sodium formate, pH 3.00.The resin is allowed to settle down (some hours) and then the supernatant is discarded.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CCC2,,,CHEMBL3638988,,2014,"{'bei': '11.30', 'le': '0.21', 'lle': '3.26', 'sei': '4.57'}",CHEMBL3666767,,CHEMBL3666767,5.23,0,http://www.openphacts.org/units/Nanomolar,2541881,=,37,1,=,,IC50,nM,,5913.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5913.0,PAK4
,292181,16329431,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '13.49', 'le': '0.27', 'lle': '2.84', 'sei': '5.94'}",CHEMBL3687529,,CHEMBL3687529,6.83,0,http://www.openphacts.org/units/Nanomolar,2563878,=,37,1,=,,IC50,nM,,146.59,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,146.59,PAK4
,292233,16329615,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '15.19', 'le': '0.29', 'lle': '3.91', 'sei': '6.65'}",CHEMBL3691956,,CHEMBL3691956,8.77,0,http://www.openphacts.org/units/Nanomolar,2568499,=,37,1,=,,IC50,nM,,1.69,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.69,PAK4
,225906,16329783,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.67', 'le': '0.35', 'lle': '4.51', 'sei': '8.43'}",CHEMBL3651981,,CHEMBL3651981,8.52,0,http://www.openphacts.org/units/Nanomolar,2525860,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292147,16329978,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OCCC#N,,,CHEMBL3639088,,2015,"{'bei': '17.56', 'le': '0.33', 'lle': '4.00', 'sei': '7.85'}",CHEMBL3687495,,CHEMBL3687495,8.95,0,http://www.openphacts.org/units/Nanomolar,2563843,=,37,1,=,,IC50,nM,,1.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.13,PAK4
,225912,16330186,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(C3CCCCC3)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.29', 'le': '0.36', 'lle': '2.77', 'sei': '9.79'}",CHEMBL3651986,,CHEMBL3651986,7.92,0,http://www.openphacts.org/units/Nanomolar,2525866,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,292192,16330843,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '17.31', 'le': '0.34', 'lle': '5.24', 'sei': '7.48'}",CHEMBL3691915,,CHEMBL3691915,8.59,0,http://www.openphacts.org/units/Nanomolar,2568458,=,37,1,=,,IC50,nM,,2.55,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.55,PAK4
,225922,16331100,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)O[C@H]1CC[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@H]1N,,,CHEMBL3638421,,2013,"{'bei': '16.94', 'le': '0.32', 'lle': '4.37', 'sei': '6.12'}",CHEMBL3651995,,CHEMBL3651995,8.15,0,http://www.openphacts.org/units/Nanomolar,2525876,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,292172,16331427,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '12.86', 'le': '0.25', 'lle': '2.94', 'sei': '6.42'}",CHEMBL3687520,,CHEMBL3687520,7.98,0,http://www.openphacts.org/units/Nanomolar,2563868,=,37,1,=,,IC50,nM,,10.38,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.38,PAK4
,292068,16331485,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)/C1=N\O,,,CHEMBL3639088,,2015,"{'bei': '17.40', 'le': '0.33', 'lle': '3.69', 'sei': '7.20'}",CHEMBL3687419,,CHEMBL3687419,8.17,0,http://www.openphacts.org/units/Nanomolar,2563765,=,37,1,=,,IC50,nM,,6.81,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.81,PAK4
,225828,16331601,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2cccc(-c3cc(O)ccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.92', 'le': '0.37', 'lle': '3.87', 'sei': '8.01'}",CHEMBL3651903,,CHEMBL3651903,8.10,0,http://www.openphacts.org/units/Nanomolar,2525782,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,292093,16332125,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1[S@@+](C)[O-],,,CHEMBL3639088,,2015,"{'bei': '15.88', 'le': '0.31', 'lle': '3.58', 'sei': '7.68'}",CHEMBL3984944,,CHEMBL3984944,7.98,0,http://www.openphacts.org/units/Nanomolar,2563789,=,37,1,=,,IC50,nM,,10.45,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.45,PAK4
,292156,16332135,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4CCS(=O)(=O)CC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.32', 'le': '0.28', 'lle': '3.67', 'sei': '6.94'}",CHEMBL3687504,,CHEMBL3687504,8.63,0,http://www.openphacts.org/units/Nanomolar,2563852,=,37,1,=,,IC50,nM,,2.35,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.35,PAK4
,225945,16332172,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)ccc(O)c3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.66', 'le': '0.37', 'lle': '4.20', 'sei': '8.60'}",CHEMBL3652018,,CHEMBL3652018,8.70,0,http://www.openphacts.org/units/Nanomolar,2525899,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,292135,16332319,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.37', 'le': '0.30', 'lle': '4.47', 'sei': '7.13'}",CHEMBL3687483,,CHEMBL3687483,8.86,0,http://www.openphacts.org/units/Nanomolar,2563831,=,37,1,=,,IC50,nM,,1.37,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.37,PAK4
,225845,16332689,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2F)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.02', 'le': '0.36', 'lle': '5.74', 'sei': '8.33'}",CHEMBL3651920,,CHEMBL3651920,8.70,0,http://www.openphacts.org/units/Nanomolar,2525799,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,225939,16333323,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3cccnc3)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.84', 'le': '0.33', 'lle': '5.47', 'sei': '6.43'}",CHEMBL3652012,,CHEMBL3652012,7.54,0,http://www.openphacts.org/units/Nanomolar,2525893,=,37,1,=,,IC50,nM,,29.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.0,PAK4
,292230,16333372,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '14.49', 'le': '0.28', 'lle': '2.77', 'sei': '6.44'}",CHEMBL3691953,,CHEMBL3691953,7.18,0,http://www.openphacts.org/units/Nanomolar,2568496,=,37,1,=,,IC50,nM,,65.66,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,65.66,PAK4
,292186,16333419,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '14.09', 'le': '0.28', 'lle': '4.13', 'sei': '6.55'}",CHEMBL3687534,,CHEMBL3687534,8.75,0,http://www.openphacts.org/units/Nanomolar,2563883,=,37,1,=,,IC50,nM,,1.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.79,PAK4
,225902,16333584,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cc(F)ccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '17.83', 'le': '0.33', 'lle': '2.80', 'sei': '9.40'}",CHEMBL3651977,,CHEMBL3651977,7.60,0,http://www.openphacts.org/units/Nanomolar,2525856,=,37,1,=,,IC50,nM,,25.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.0,PAK4
,292079,16333811,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1NS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '12.01', 'le': '0.24', 'lle': '2.84', 'sei': '5.04'}",CHEMBL3687429,,CHEMBL3687429,6.41,0,http://www.openphacts.org/units/Nanomolar,2563776,=,37,1,=,,IC50,nM,,388.52,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,388.52,PAK4
,292121,16333924,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(C)[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '11.49', 'le': '0.22', 'lle': '1.34', 'sei': '5.49'}",CHEMBL3687469,,CHEMBL3687469,6.06,0,http://www.openphacts.org/units/Nanomolar,2563817,=,37,1,=,,IC50,nM,,866.28,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,866.28,PAK4
,225910,16334367,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(C3CCCCC3)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.00', 'le': '0.34', 'lle': '3.56', 'sei': '7.59'}",CHEMBL3651985,,CHEMBL3651985,7.68,0,http://www.openphacts.org/units/Nanomolar,2525864,=,37,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.0,PAK4
,292258,16334556,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)n2)c1,,,CHEMBL3639088,,2015,"{'bei': '14.47', 'le': '0.27', 'lle': '5.42', 'sei': '4.88'}",CHEMBL3691981,,CHEMBL3691981,8.29,0,http://www.openphacts.org/units/Nanomolar,2568524,=,37,1,=,,IC50,nM,,5.15,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.15,PAK4
,225948,16334896,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cccc(C(F)(F)F)c3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '13.59', 'le': '0.26', 'lle': '1.99', 'sei': '6.81'}",CHEMBL3652021,,CHEMBL3652021,6.88,0,http://www.openphacts.org/units/Nanomolar,2525902,=,37,1,=,,IC50,nM,,131.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,131.0,PAK4
,292105,16334977,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)C12OCCO2,,,CHEMBL3639088,,2015,"{'bei': '13.01', 'le': '0.25', 'lle': '2.08', 'sei': '6.53'}",CHEMBL3687453,,CHEMBL3687453,6.49,0,http://www.openphacts.org/units/Nanomolar,2563801,=,37,1,=,,IC50,nM,,327.41,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,327.41,PAK4
,225955,16335451,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.08', 'le': '0.32', 'lle': '3.79', 'sei': '7.71'}",CHEMBL3652026,,CHEMBL3652026,7.80,0,http://www.openphacts.org/units/Nanomolar,2525909,=,37,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.0,PAK4
,225895,16335788,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](O)[C@@H](C)C3)n2)c1,,,CHEMBL3638421,,2013,"{'bei': '17.88', 'le': '0.33', 'lle': '3.72', 'sei': '7.68'}",CHEMBL3651970,,CHEMBL3651970,7.77,0,http://www.openphacts.org/units/Nanomolar,2525849,=,37,1,=,,IC50,nM,,17.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.0,PAK4
,288342,16335826,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cccc(CC)c1NC(=O)c1c2c(n(C)c1C)-c1nc(Nc3ccc(N4CCC(N5CCCC5)CC4)cc3OC)ncc1CC2,,,CHEMBL3639053,,2015,,CHEMBL3703176,,CHEMBL3703176,,0,http://www.openphacts.org/units/Nanomolar,2580582,>,37,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,225915,16336158,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.79', 'le': '0.35', 'lle': '5.06', 'sei': '6.70'}",CHEMBL3651989,,CHEMBL3651989,8.52,0,http://www.openphacts.org/units/Nanomolar,2525869,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292169,16336213,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '13.12', 'le': '0.26', 'lle': '3.48', 'sei': '6.08'}",CHEMBL3687517,,CHEMBL3687517,8.11,0,http://www.openphacts.org/units/Nanomolar,2563865,=,37,1,=,,IC50,nM,,7.69,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.69,PAK4
,276607,16336851,[],CHEMBL3707966,"Kinase Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates are trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors.At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP is captured by an excess of the ion exchange dowex resin; the resin then settles down to the bottom of the reaction plate by gravity.Supernatant is subsequently withdrawn and transferred into a counting plate, then evaluated by (3-counting.Reagents/Assay ConditionsDowex Resin Preparation500 g of wet resin (SIGMA, custom prepared resin DOWEX 1x8 200-400 mesh, 2.5 Kg) are weighed out and diluted to 2 L in 150 mM sodium formate, pH 3.00.The resin is allowed to settle down (some hours) and then the supernatant is discarded.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CCC4)cc2)CC1,,,CHEMBL3638988,,2014,"{'bei': '12.59', 'le': '0.23', 'lle': '3.48', 'sei': '5.17'}",CHEMBL3666763,,CHEMBL3666763,5.44,0,http://www.openphacts.org/units/Nanomolar,2541877,=,37,1,=,,IC50,nM,,3599.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3599.0,PAK4
,292083,16336927,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.28', 'le': '0.31', 'lle': '5.02', 'sei': '7.17'}",CHEMBL3687433,,CHEMBL3687433,8.12,0,http://www.openphacts.org/units/Nanomolar,2563780,=,37,1,=,,IC50,nM,,7.66,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.66,PAK4
,225926,16337133,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CC(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)=CC(O)C1,,,CHEMBL3638421,,2013,"{'bei': '18.84', 'le': '0.35', 'lle': '3.79', 'sei': '8.13'}",CHEMBL3651999,,CHEMBL3651999,8.22,0,http://www.openphacts.org/units/Nanomolar,2525880,=,37,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,225897,16337585,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.44', 'le': '0.36', 'lle': '4.64', 'sei': '8.43'}",CHEMBL3651972,,CHEMBL3651972,8.52,0,http://www.openphacts.org/units/Nanomolar,2525851,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292157,16337705,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C(C)C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.29', 'le': '0.33', 'lle': '3.07', 'sei': '9.83'}",CHEMBL3687505,,CHEMBL3687505,8.86,0,http://www.openphacts.org/units/Nanomolar,2563853,=,37,1,=,,IC50,nM,,1.38,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.38,PAK4
,292198,16337860,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.75', 'le': '0.30', 'lle': '3.76', 'sei': '8.28'}",CHEMBL3691921,,CHEMBL3691921,8.99,0,http://www.openphacts.org/units/Nanomolar,2568464,=,37,1,=,,IC50,nM,,1.03,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.03,PAK4
,292209,16337944,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC(C)C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.90', 'le': '0.30', 'lle': '4.99', 'sei': '6.91'}",CHEMBL3691932,,CHEMBL3691932,9.10,0,http://www.openphacts.org/units/Nanomolar,2568475,=,37,1,=,,IC50,nM,,0.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.79,PAK4
,292143,16338056,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.59', 'le': '0.33', 'lle': '5.73', 'sei': '7.39'}",CHEMBL3687491,,CHEMBL3687491,9.05,0,http://www.openphacts.org/units/Nanomolar,2563839,=,37,1,=,,IC50,nM,,0.89,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.89,PAK4
,292206,16338492,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '18.63', 'le': '0.35', 'lle': '4.80', 'sei': '7.79'}",CHEMBL3691929,,CHEMBL3691929,9.05,0,http://www.openphacts.org/units/Nanomolar,2568472,=,37,1,=,,IC50,nM,,0.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.9,PAK4
,292190,16338639,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '12.95', 'le': '0.26', 'lle': '3.55', 'sei': '6.45'}",CHEMBL3691913,,CHEMBL3691913,8.61,0,http://www.openphacts.org/units/Nanomolar,2568456,=,37,1,=,,IC50,nM,,2.46,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.46,PAK4
,225834,16338685,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@H](O)[C@@H](C)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '18.52', 'le': '0.35', 'lle': '5.27', 'sei': '8.05'}",CHEMBL3651909,,CHEMBL3651909,8.40,0,http://www.openphacts.org/units/Nanomolar,2525788,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,292099,16338804,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '16.44', 'le': '0.32', 'lle': '4.45', 'sei': '7.41'}",CHEMBL3687447,,CHEMBL3687447,8.52,0,http://www.openphacts.org/units/Nanomolar,2563795,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,292103,16338975,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1OS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '14.39', 'le': '0.28', 'lle': '3.69', 'sei': '6.19'}",CHEMBL3687451,,CHEMBL3687451,7.69,0,http://www.openphacts.org/units/Nanomolar,2563799,=,37,1,=,,IC50,nM,,20.32,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.32,PAK4
,225855,16339435,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2nc(-c3cc(O)ccc3F)ccc2F)C1,,,CHEMBL3638421,,2013,"{'bei': '16.90', 'le': '0.32', 'lle': '2.81', 'sei': '7.09'}",CHEMBL3651930,,CHEMBL3651930,7.17,0,http://www.openphacts.org/units/Nanomolar,2525809,=,37,1,=,,IC50,nM,,67.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,67.0,PAK4
,225876,16340250,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c([C@H]3CC[C@H](O)CC3)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.66', 'le': '0.35', 'lle': '3.84', 'sei': '7.87'}",CHEMBL3651951,,CHEMBL3651951,7.96,0,http://www.openphacts.org/units/Nanomolar,2525830,=,37,1,=,,IC50,nM,,11.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.0,PAK4
,292074,16340254,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO/N=C1/[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.12', 'le': '0.30', 'lle': '3.13', 'sei': '7.60'}",CHEMBL3687425,,CHEMBL3687425,7.79,0,http://www.openphacts.org/units/Nanomolar,2563771,=,37,1,=,,IC50,nM,,16.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.07,PAK4
,292222,16340375,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)c(-c2nc(C(=O)Nc3cnccc3N3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '17.34', 'le': '0.33', 'lle': '5.32', 'sei': '7.89'}",CHEMBL3691945,,CHEMBL3691945,9.06,0,http://www.openphacts.org/units/Nanomolar,2568488,=,37,1,=,,IC50,nM,,0.87,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.87,PAK4
,225900,16340484,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3cccc(F)c3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.05', 'le': '0.34', 'lle': '2.90', 'sei': '9.52'}",CHEMBL3651975,,CHEMBL3651975,7.70,0,http://www.openphacts.org/units/Nanomolar,2525854,=,37,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.0,PAK4
,225866,16340662,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)ccc2F)c1,,,CHEMBL3638421,,2013,"{'bei': '19.22', 'le': '0.36', 'lle': '3.79', 'sei': '9.65'}",CHEMBL3651941,,CHEMBL3651941,8.70,0,http://www.openphacts.org/units/Nanomolar,2525820,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,292101,16340735,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1OP(C)(C)=O,,,CHEMBL3639088,,2015,"{'bei': '14.10', 'le': '0.28', 'lle': '1.93', 'sei': '7.01'}",CHEMBL3687449,,CHEMBL3687449,7.51,0,http://www.openphacts.org/units/Nanomolar,2563797,=,37,1,=,,IC50,nM,,30.92,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.92,PAK4
,288345,16341122,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2c(n1)-c1c(c(C(N)=O)cn1CCO)CC2,,,CHEMBL3639053,,2015,"{'bei': '20.59', 'le': '0.41', 'lle': '5.41', 'sei': '6.67'}",CHEMBL3703179,,CHEMBL3703179,6.27,0,http://www.openphacts.org/units/Nanomolar,2580585,=,37,1,=,,IC50,nM,,540.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,540.0,PAK4
,292114,16341906,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(C)[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '11.34', 'le': '0.21', 'lle': '1.11', 'sei': '5.56'}",CHEMBL3687462,,CHEMBL3687462,6.14,0,http://www.openphacts.org/units/Nanomolar,2563810,=,37,1,=,,IC50,nM,,726.23,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,726.23,PAK4
,292070,16342272,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.57', 'le': '0.28', 'lle': '2.92', 'sei': '6.45'}",CHEMBL3687421,,CHEMBL3687421,7.69,0,http://www.openphacts.org/units/Nanomolar,2563767,=,37,1,=,,IC50,nM,,20.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.5,PAK4
,225833,16342463,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)CC(C)(C)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '17.76', 'le': '0.33', 'lle': '2.40', 'sei': '9.89'}",CHEMBL3651908,,CHEMBL3651908,8.00,0,http://www.openphacts.org/units/Nanomolar,2525787,=,37,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,292109,16342496,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(C)[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '9.05', 'le': '0.18', 'lle': '0.57', 'sei': '3.52'}",CHEMBL3687457,,CHEMBL3687457,4.80,0,http://www.openphacts.org/units/Nanomolar,2563805,=,37,1,=,,IC50,nM,,15800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15800.0,PAK4
,292197,16342708,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '16.71', 'le': '0.32', 'lle': '3.62', 'sei': '8.89'}",CHEMBL3691920,,CHEMBL3691920,8.83,0,http://www.openphacts.org/units/Nanomolar,2568463,=,37,1,=,,IC50,nM,,1.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.47,PAK4
,292188,16342714,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(F)CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '15.20', 'le': '0.29', 'lle': '3.06', 'sei': '8.76'}",CHEMBL3687536,,CHEMBL3687536,8.70,0,http://www.openphacts.org/units/Nanomolar,2563885,=,37,1,=,,IC50,nM,,1.98,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.98,PAK4
,292155,16342899,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OC)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.49', 'le': '0.30', 'lle': '3.74', 'sei': '7.77'}",CHEMBL3687503,,CHEMBL3687503,8.43,0,http://www.openphacts.org/units/Nanomolar,2563851,=,37,1,=,,IC50,nM,,3.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.68,PAK4
,225918,16343939,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2N)C[C@@H](N)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '17.64', 'le': '0.33', 'lle': '4.54', 'sei': '6.29'}",CHEMBL3651991,,CHEMBL3651991,8.00,0,http://www.openphacts.org/units/Nanomolar,2525872,=,37,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,288348,16343960,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ncc2c(n1)-c1c(c(C(N)=O)cn1C1CCNCC1)CC2,,,CHEMBL3639053,,2015,"{'bei': '19.79', 'le': '0.39', 'lle': '5.01', 'sei': '7.92'}",CHEMBL3703182,,CHEMBL3703182,6.80,0,http://www.openphacts.org/units/Nanomolar,2580588,=,37,1,=,,IC50,nM,,159.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,159.0,PAK4
,292104,16343997,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)C12OCCO2,,,CHEMBL3639088,,2015,"{'bei': '17.47', 'le': '0.33', 'lle': '4.31', 'sei': '8.76'}",CHEMBL3687452,,CHEMBL3687452,8.71,0,http://www.openphacts.org/units/Nanomolar,2563800,=,37,1,=,,IC50,nM,,1.96,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.96,PAK4
,225903,16344319,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3ccc(F)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '16.64', 'le': '0.31', 'lle': '2.30', 'sei': '8.77'}",CHEMBL3651978,,CHEMBL3651978,7.10,0,http://www.openphacts.org/units/Nanomolar,2525857,=,37,1,=,,IC50,nM,,80.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,80.0,PAK4
,225943,16344352,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '18.49', 'le': '0.35', 'lle': '3.56', 'sei': '8.60'}",CHEMBL3652016,,CHEMBL3652016,8.70,0,http://www.openphacts.org/units/Nanomolar,2525897,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,292196,16344615,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H](N)[C@H]1OCCS(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '16.10', 'le': '0.33', 'lle': '5.52', 'sei': '6.06'}",CHEMBL3691919,,CHEMBL3691919,9.11,0,http://www.openphacts.org/units/Nanomolar,2568462,=,37,1,=,,IC50,nM,,0.78,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.78,PAK4
,292100,16344947,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1OP(C)(C)=O,,,CHEMBL3639088,,2015,"{'bei': '13.79', 'le': '0.27', 'lle': '1.76', 'sei': '6.85'}",CHEMBL3687448,,CHEMBL3687448,7.34,0,http://www.openphacts.org/units/Nanomolar,2563796,=,37,1,=,,IC50,nM,,45.51,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,45.51,PAK4
,292107,16345239,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@H]1OCCC(=O)O,,,CHEMBL3639088,,2015,,CHEMBL3687455,,CHEMBL3687455,,0,http://www.openphacts.org/units/Nanomolar,2563803,>,37,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25000.0,PAK4
,225923,16345369,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,,,CHEMBL3638421,,2013,"{'bei': '19.11', 'le': '0.36', 'lle': '5.19', 'sei': '6.60'}",CHEMBL3651996,,CHEMBL3651996,8.40,0,http://www.openphacts.org/units/Nanomolar,2525877,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,225905,16345518,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCOc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CC[C@H](O)[C@H](N)C3)n2)c1,,,CHEMBL3638421,,2013,"{'bei': '14.61', 'le': '0.27', 'lle': '2.51', 'sei': '6.15'}",CHEMBL3651980,,CHEMBL3651980,6.79,0,http://www.openphacts.org/units/Nanomolar,2525859,=,37,1,=,,IC50,nM,,163.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,163.0,PAK4
,292160,16346018,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C4(O)CCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.21', 'le': '0.31', 'lle': '3.72', 'sei': '7.94'}",CHEMBL3687508,,CHEMBL3687508,8.76,0,http://www.openphacts.org/units/Nanomolar,2563856,=,37,1,=,,IC50,nM,,1.72,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.72,PAK4
,292211,16346125,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1n1ccccc1=O,,,CHEMBL3639088,,2015,,CHEMBL3691934,,CHEMBL3691934,,0,http://www.openphacts.org/units/Nanomolar,2568477,>,37,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25000.0,PAK4
,225937,16347063,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](O)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.63', 'le': '0.37', 'lle': '6.01', 'sei': '9.13'}",CHEMBL3652010,,CHEMBL3652010,9.00,0,http://www.openphacts.org/units/Nanomolar,2525891,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,225823,16347278,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.01', 'le': '0.36', 'lle': '6.34', 'sei': '7.22'}",CHEMBL3651899,,CHEMBL3651899,9.00,0,http://www.openphacts.org/units/Nanomolar,2525777,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,288341,16347939,[],CHEMBL3707582,"Kinase Inhibition Assay: The buffer for PIM-2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSAFull-length human PIM-2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 microMATP=4 microM33P-Î³-ATP=1 nM.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccccc2)c(C(N)=O)c2ccc3cnc(N)nc3c21,,,CHEMBL3639053,,2015,,CHEMBL3703175,,CHEMBL3703175,,0,http://www.openphacts.org/units/Nanomolar,2580581,>,37,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,292236,16348756,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '16.40', 'le': '0.31', 'lle': '4.71', 'sei': '5.97'}",CHEMBL3691959,,CHEMBL3691959,8.67,0,http://www.openphacts.org/units/Nanomolar,2568502,=,37,1,=,,IC50,nM,,2.15,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.15,PAK4
,292255,16348832,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2N)C[C@@H](N)[C@H]1n1ccnn1,,,CHEMBL3639088,,2015,"{'bei': '16.83', 'le': '0.32', 'lle': '5.80', 'sei': '6.26'}",CHEMBL3691978,,CHEMBL3691978,8.81,0,http://www.openphacts.org/units/Nanomolar,2568521,=,37,1,=,,IC50,nM,,1.54,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.54,PAK4
,292231,16348962,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(OC4CCOCC4)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '12.81', 'le': '0.24', 'lle': '2.92', 'sei': '5.71'}",CHEMBL3691954,,CHEMBL3691954,7.86,0,http://www.openphacts.org/units/Nanomolar,2568497,=,37,1,=,,IC50,nM,,13.84,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.84,PAK4
,292216,16349642,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOCc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](n4ccnn4)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '15.31', 'le': '0.29', 'lle': '3.64', 'sei': '7.16'}",CHEMBL3691939,,CHEMBL3691939,8.66,0,http://www.openphacts.org/units/Nanomolar,2568482,=,37,1,=,,IC50,nM,,2.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.2,PAK4
,292154,16350303,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.70', 'le': '0.33', 'lle': '3.66', 'sei': '9.24'}",CHEMBL3687502,,CHEMBL3687502,8.33,0,http://www.openphacts.org/units/Nanomolar,2563850,=,37,1,=,,IC50,nM,,4.71,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.71,PAK4
,225958,16352147,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CC(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)=CC(O)C1,,,CHEMBL3638421,,2013,"{'bei': '17.52', 'le': '0.33', 'lle': '2.71', 'sei': '10.25'}",CHEMBL3652029,,CHEMBL3652029,7.70,0,http://www.openphacts.org/units/Nanomolar,2525912,=,37,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.0,PAK4
,292119,16352340,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1C#N,,,CHEMBL3639088,,2015,"{'bei': '17.56', 'le': '0.33', 'lle': '4.45', 'sei': '7.59'}",CHEMBL3687467,,CHEMBL3687467,8.19,0,http://www.openphacts.org/units/Nanomolar,2563815,=,37,1,=,,IC50,nM,,6.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.47,PAK4
,292153,16352376,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.34', 'le': '0.33', 'lle': '3.28', 'sei': '9.59'}",CHEMBL3687501,,CHEMBL3687501,8.65,0,http://www.openphacts.org/units/Nanomolar,2563849,=,37,1,=,,IC50,nM,,2.26,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.26,PAK4
,225886,16352531,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(F)c(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,,,CHEMBL3638421,,2013,"{'bei': '18.36', 'le': '0.35', 'lle': '5.05', 'sei': '6.60'}",CHEMBL3651961,,CHEMBL3651961,8.40,0,http://www.openphacts.org/units/Nanomolar,2525840,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,225933,16352972,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@H]1C[C@@H](N)C[C@@H](C(F)(F)F)C1,,,CHEMBL3638421,,2013,"{'bei': '18.31', 'le': '0.35', 'lle': '3.97', 'sei': '8.42'}",CHEMBL3652006,,CHEMBL3652006,9.00,0,http://www.openphacts.org/units/Nanomolar,2525887,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,292072,16352994,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '14.54', 'le': '0.28', 'lle': '3.09', 'sei': '6.26'}",CHEMBL3687423,,CHEMBL3687423,7.47,0,http://www.openphacts.org/units/Nanomolar,2563769,=,37,1,=,,IC50,nM,,34.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.07,PAK4
,225928,16353191,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1C1=CC(N)CCC1,,,CHEMBL3638421,,2013,"{'bei': '19.35', 'le': '0.36', 'lle': '4.00', 'sei': '7.63'}",CHEMBL3652001,,CHEMBL3652001,8.15,0,http://www.openphacts.org/units/Nanomolar,2525882,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,292128,16353413,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1n1cc(CO)nn1,,,CHEMBL3639088,,2015,"{'bei': '16.58', 'le': '0.31', 'lle': '6.01', 'sei': '6.61'}",CHEMBL3687476,,CHEMBL3687476,8.93,0,http://www.openphacts.org/units/Nanomolar,2563824,=,37,1,=,,IC50,nM,,1.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.18,PAK4
,225825,16353436,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(O)cc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.04', 'le': '0.34', 'lle': '4.80', 'sei': '7.02'}",CHEMBL3651900,,CHEMBL3651900,8.52,0,http://www.openphacts.org/units/Nanomolar,2525779,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,225829,16354093,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cc(O)cc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.79', 'le': '0.37', 'lle': '4.04', 'sei': '8.30'}",CHEMBL3651904,,CHEMBL3651904,8.40,0,http://www.openphacts.org/units/Nanomolar,2525783,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,225907,16354155,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '15.13', 'le': '0.29', 'lle': '2.90', 'sei': '6.83'}",CHEMBL3651982,,CHEMBL3651982,6.91,0,http://www.openphacts.org/units/Nanomolar,2525861,=,37,1,=,,IC50,nM,,124.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,124.0,PAK4
,225891,16354441,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638421,,2013,"{'bei': '19.75', 'le': '0.37', 'lle': '3.66', 'sei': '10.75'}",CHEMBL3651966,LGH-447,CHEMBL3651966,8.70,0,http://www.openphacts.org/units/Nanomolar,2525845,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,292071,16354496,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)OC(=O)N[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '13.34', 'le': '0.25', 'lle': '2.07', 'sei': '6.06'}",CHEMBL3687422,,CHEMBL3687422,7.23,0,http://www.openphacts.org/units/Nanomolar,2563768,=,37,1,=,,IC50,nM,,59.37,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,59.37,PAK4
,225899,16354599,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2cccc(-c3c(F)cccc3F)n2)CC[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '18.43', 'le': '0.34', 'lle': '4.19', 'sei': '7.74'}",CHEMBL3651974,,CHEMBL3651974,7.82,0,http://www.openphacts.org/units/Nanomolar,2525853,=,37,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.0,PAK4
,292090,16354706,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@H](N)[C@@H]1N=[N+]=[N-],,,CHEMBL3639088,,2015,"{'bei': '13.76', 'le': '0.26', 'lle': '1.29', 'sei': '5.11'}",CHEMBL3687439,,CHEMBL3687439,6.62,0,http://www.openphacts.org/units/Nanomolar,2563786,=,37,1,=,,IC50,nM,,237.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,237.5,PAK4
,292080,16354896,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1N,,,CHEMBL3639088,,2015,"{'bei': '19.86', 'le': '0.38', 'lle': '6.15', 'sei': '8.23'}",CHEMBL3687430,,CHEMBL3687430,9.07,0,http://www.openphacts.org/units/Nanomolar,2563777,=,37,1,=,,IC50,nM,,0.86,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.86,PAK4
,225890,16355115,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ccc2F)C1,,,CHEMBL3638421,,2013,"{'bei': '18.51', 'le': '0.35', 'lle': '3.11', 'sei': '10.08'}",CHEMBL3651965,,CHEMBL3651965,8.15,0,http://www.openphacts.org/units/Nanomolar,2525844,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,292141,16355758,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)ncc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '18.33', 'le': '0.35', 'lle': '5.08', 'sei': '6.66'}",CHEMBL3687489,,CHEMBL3687489,8.59,0,http://www.openphacts.org/units/Nanomolar,2563837,=,37,1,=,,IC50,nM,,2.57,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.57,PAK4
,225849,16355864,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c(-c2cccc(C(=O)Nc3cnccc3[C@@H]3CCC[C@H](N)C3)n2)c1F,,,CHEMBL3638421,,2013,"{'bei': '18.84', 'le': '0.35', 'lle': '2.99', 'sei': '9.84'}",CHEMBL3651924,,CHEMBL3651924,7.96,0,http://www.openphacts.org/units/Nanomolar,2525803,=,37,1,=,,IC50,nM,,11.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.0,PAK4
,292166,16356103,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2ccnc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1S(C)(=O)=O,,,CHEMBL3639088,,2015,"{'bei': '13.70', 'le': '0.27', 'lle': '3.55', 'sei': '5.37'}",CHEMBL3687514,,CHEMBL3687514,6.87,0,http://www.openphacts.org/units/Nanomolar,2563862,=,37,1,=,,IC50,nM,,135.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,135.2,PAK4
,292133,16356581,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CCO[C@@H]1[C@H](N)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C[C@@H]1C,,,CHEMBL3639088,,2015,"{'bei': '17.99', 'le': '0.35', 'lle': '4.21', 'sei': '7.55'}",CHEMBL3687481,,CHEMBL3687481,8.77,0,http://www.openphacts.org/units/Nanomolar,2563829,=,37,1,=,,IC50,nM,,1.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.7,PAK4
,292189,16356672,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1ccc(F)c(-c2ccc(N)c(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)n2)c1,,,CHEMBL3639088,,2015,"{'bei': '14.23', 'le': '0.28', 'lle': '5.39', 'sei': '4.97'}",CHEMBL3687537,,CHEMBL3687537,8.92,0,http://www.openphacts.org/units/Nanomolar,2563886,=,37,1,=,,IC50,nM,,1.21,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.21,PAK4
,225959,16356749,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C[C@@H](O)[C@H]1O,,,CHEMBL3638421,,2013,"{'bei': '16.06', 'le': '0.30', 'lle': '3.30', 'sei': '7.71'}",CHEMBL3652030,,CHEMBL3652030,7.35,0,http://www.openphacts.org/units/Nanomolar,2525913,=,37,1,=,,IC50,nM,,45.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,45.0,PAK4
,225844,16356869,[],CHEMBL3707781,"ATP Depletion Assay: The activity of PIM1, PIM2, and PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2cccc(-c3ccccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638421,,2013,"{'bei': '19.69', 'le': '0.37', 'lle': '5.62', 'sei': '7.95'}",CHEMBL3651919,,CHEMBL3651919,8.30,0,http://www.openphacts.org/units/Nanomolar,2525798,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,292202,16356932,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc(F)c(-c2nc(C(=O)Nc3cnccc3[C@H]3C[C@@H](N)[C@@H](OCCS(C)(=O)=O)[C@@H](C)C3)ccc2F)c(F)c1,,,CHEMBL3639088,,2015,"{'bei': '14.39', 'le': '0.28', 'lle': '4.06', 'sei': '6.69'}",CHEMBL3691925,,CHEMBL3691925,8.93,0,http://www.openphacts.org/units/Nanomolar,2568468,=,37,1,=,,IC50,nM,,1.17,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.17,PAK4
,292165,16356969,[],CHEMBL3707802,"AlphaScreen Assay: Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1[C@H](C)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cc(C)cc3F)n2)C[C@@H]1N,,,CHEMBL3639088,,2015,"{'bei': '14.21', 'le': '0.27', 'lle': '1.90', 'sei': '7.64'}",CHEMBL3687513,,CHEMBL3687513,6.88,0,http://www.openphacts.org/units/Nanomolar,2563861,=,37,1,=,,IC50,nM,,130.33,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,130.33,PAK4
,,16379544,[],CHEMBL3738379,Inhibition of PIM2 (unknown origin) by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ccccc13)C2=O,,,CHEMBL3734671,Bioorg Med Chem Lett,2015,,CHEMBL2147845,,CHEMBL2147845,,0,http://www.openphacts.org/units/Nanomolar,2735294,>,1,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.0,PAK4
,,16413491,[],CHEMBL3742689,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1,,,CHEMBL3739276,J Med Chem,2015,,CHEMBL3741589,,CHEMBL3741589,,0,http://www.openphacts.org/units/Nanomolar,2738383,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,16431956,[],CHEMBL3748049,Inhibition of human PIM2 using [RSRHSSYPAGT] as substrate,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,,,CHEMBL3745707,Bioorg Med Chem,2016,,CHEMBL3745885,,CHEMBL3745885,,0,http://www.openphacts.org/units/Nanomolar,2741358,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,16566186,[],CHEMBL3803176,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2cccc3nc(-c4nc(-c5cc(C(=O)N(C)C)ccn5)cnc4N)n(C)c23)CCN1,,,CHEMBL3797138,J Med Chem,2016,"{'bei': '13.01', 'le': '0.24', 'lle': '3.97', 'sei': '5.20'}",CHEMBL3800585,,CHEMBL3800585,6.14,0,http://www.openphacts.org/units/Nanomolar,2776194,=,1,1,=,,IC50,nM,,730.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.73,PAK4
,,16596770,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1NC/C=C/C[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.93', 'le': '0.49', 'lle': '6.17', 'sei': '11.25'}",CHEMBL3809463,,CHEMBL3809463,9.30,0,http://www.openphacts.org/units/Nanomolar,2779969,=,1,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,,16596771,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1NC/C=C/C[C@@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.06', 'le': '0.47', 'lle': '5.87', 'sei': '10.88'}",CHEMBL3809044,,CHEMBL3809044,9.00,0,http://www.openphacts.org/units/Nanomolar,2780095,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,,16596772,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1NC/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '29.40', 'le': '0.53', 'lle': '7.02', 'sei': '12.28'}",CHEMBL3810121,,CHEMBL3810121,10.15,0,http://www.openphacts.org/units/Nanomolar,2780096,=,1,1,=,,IC50,nM,,0.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.07,PAK4
,,16596773,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1NC/C=C\C[C@@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.06', 'le': '0.47', 'lle': '5.87', 'sei': '10.88'}",CHEMBL3808445,,CHEMBL3808445,9.00,0,http://www.openphacts.org/units/Nanomolar,2780097,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,,16596774,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1NCCCC[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '29.65', 'le': '0.54', 'lle': '6.94', 'sei': '12.46'}",CHEMBL3808669,,CHEMBL3808669,10.30,0,http://www.openphacts.org/units/Nanomolar,2780098,=,1,1,=,,IC50,nM,,0.05,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.05,PAK4
,,16596775,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1NCCCC[C@@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '27.92', 'le': '0.51', 'lle': '6.34', 'sei': '11.73'}",CHEMBL3808942,,CHEMBL3808942,9.70,0,http://www.openphacts.org/units/Nanomolar,2780099,=,1,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,,16596776,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1N[C@H](C)/C=C/C[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '28.66', 'le': '0.52', 'lle': '6.78', 'sei': '12.46'}",CHEMBL3808887,,CHEMBL3808887,10.30,0,http://www.openphacts.org/units/Nanomolar,2780100,=,1,1,=,,IC50,nM,,0.05,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.05,PAK4
,,16596777,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1N[C@@H](C)/C=C/C[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.49', 'le': '0.48', 'lle': '6.00', 'sei': '11.51'}",CHEMBL3809986,,CHEMBL3809986,9.52,0,http://www.openphacts.org/units/Nanomolar,2780101,=,1,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,,16596778,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,C/C1=C\C[C@H]2CNC(=O)c3cc([nH]c32)-c2cccc3nc(C)c(nc23)NC1,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '28.09', 'le': '0.51', 'lle': '6.58', 'sei': '12.21'}",CHEMBL3808662,,CHEMBL3808662,10.10,0,http://www.openphacts.org/units/Nanomolar,2780102,=,1,1,=,,IC50,nM,,0.08,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.08,PAK4
,,16596779,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1N[C@H](C)/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '25.88', 'le': '0.47', 'lle': '5.78', 'sei': '11.25'}",CHEMBL3809691,,CHEMBL3809691,9.30,0,http://www.openphacts.org/units/Nanomolar,2780103,=,1,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,,16596780,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,C/C1=C/C[C@H]2CNC(=O)c3cc([nH]c32)-c2cccc3nc(C)c(nc23)NC1,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.98', 'le': '0.49', 'lle': '6.18', 'sei': '11.73'}",CHEMBL3809940,,CHEMBL3809940,9.70,0,http://www.openphacts.org/units/Nanomolar,2780104,=,1,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,,16596781,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1N[C@H](C)CCC[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.83', 'le': '0.49', 'lle': '5.96', 'sei': '11.73'}",CHEMBL3810095,,CHEMBL3810095,9.70,0,http://www.openphacts.org/units/Nanomolar,2780105,=,1,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,,16596782,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1N[C@@H](C)CCC[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.00', 'le': '0.48', 'lle': '5.66', 'sei': '11.36'}",CHEMBL3809127,,CHEMBL3809127,9.40,0,http://www.openphacts.org/units/Nanomolar,2780106,=,1,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,,16596783,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1NC[C@@H](C)CC[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.35', 'le': '0.48', 'lle': '5.92', 'sei': '11.51'}",CHEMBL3809565,,CHEMBL3809565,9.52,0,http://www.openphacts.org/units/Nanomolar,2780107,=,1,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,,16596784,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc3c2nc1NC[C@H](C)CC[C@H]1CNC(=O)c2cc-3[nH]c21,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '26.00', 'le': '0.48', 'lle': '5.80', 'sei': '11.36'}",CHEMBL3809377,,CHEMBL3809377,9.40,0,http://www.openphacts.org/units/Nanomolar,2780108,=,1,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,,16596785,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccccc1,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '23.55', 'le': '0.42', 'lle': '4.74', 'sei': '10.52'}",CHEMBL3810085,,CHEMBL3810085,8.70,0,http://www.openphacts.org/units/Nanomolar,2780137,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,,16596786,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CCCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '25.94', 'le': '0.48', 'lle': '5.66', 'sei': '10.52'}",CHEMBL3808459,,CHEMBL3808459,8.70,0,http://www.openphacts.org/units/Nanomolar,2780138,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,,16596787,[],CHEMBL3812018,Inhibition of human full-length Pim2 expressed in Escherichia coli assessed as phosphorylation of biotinylated BAD peptide at Ser 112 preincubated for 30 mins followed by substrate addition measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000019,assay format,CCCCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3808325,ACS Med Chem Lett,2016,"{'bei': '24.89', 'le': '0.46', 'lle': '5.27', 'sei': '10.52'}",CHEMBL3809623,,CHEMBL3809623,8.70,0,http://www.openphacts.org/units/Nanomolar,2780139,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,,16615520,[],CHEMBL3815561,Inhibition of human full length GST-tagged Pim-2 expressed in Escherichia coli using RSRHSSYPAGT as substrate measured for 30 mins by [gamma-33P]ATP-based kinase assay,B,,,BAO_0000190,BAO_0000019,assay format,c1ccc2c(c1)[nH]c1c3[nH]c4ccccc4c3c3[nH]ncc3c21,,,CHEMBL3813662,Bioorg Med Chem,2016,"{'bei': '21.02', 'le': '0.37', 'lle': '1.40', 'sei': '10.34'}",CHEMBL3814423,,CHEMBL3814423,6.23,0,http://www.openphacts.org/units/Nanomolar,2782057,=,1,1,=,,IC50,nM,,590.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.59,PAK4
,,16776932,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ncncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '16.47', 'le': '0.31', 'lle': '3.82', 'sei': '7.15'}",CHEMBL3941443,,CHEMBL3941443,6.96,1,http://www.openphacts.org/units/Nanomolar,2804782,=,1,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,110.0,PAK4
,,16776933,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2cnccc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,,CHEMBL3904472,,CHEMBL3904472,,1,http://www.openphacts.org/units/Nanomolar,2804781,>,1,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,,16776934,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '22.07', 'le': '0.41', 'lle': '5.56', 'sei': '11.02'}",CHEMBL3919646,,CHEMBL3919646,9.30,1,http://www.openphacts.org/units/Nanomolar,2804780,=,1,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,,16776935,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccccc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '19.47', 'le': '0.36', 'lle': '3.84', 'sei': '11.45'}",CHEMBL3921064,,CHEMBL3921064,8.19,1,http://www.openphacts.org/units/Nanomolar,2804779,=,1,1,=,,IC50,nM,,6.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.5,PAK4
,,16776973,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2sncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '15.98', 'le': '0.31', 'lle': '3.03', 'sei': '8.09'}",CHEMBL3935874,,CHEMBL3935874,6.83,0,http://www.openphacts.org/units/Nanomolar,2804783,=,1,1,=,,IC50,nM,,148.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,148.0,PAK4
,,16776974,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(Cl)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '20.37', 'le': '0.40', 'lle': '4.55', 'sei': '8.30'}",CHEMBL3950192,,CHEMBL3950192,7.00,1,http://www.openphacts.org/units/Nanomolar,2804784,=,1,1,=,,IC50,nM,,99.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,99.0,PAK4
,,16776975,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '21.80', 'le': '0.40', 'lle': '5.20', 'sei': '10.43'}",CHEMBL3922469,,CHEMBL3922469,8.80,0,http://www.openphacts.org/units/Nanomolar,2804785,=,1,1,=,,IC50,nM,,1.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.6,PAK4
,,16776976,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4Cl)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '20.17', 'le': '0.39', 'lle': '4.35', 'sei': '10.04'}",CHEMBL3924352,,CHEMBL3924352,8.47,0,http://www.openphacts.org/units/Nanomolar,2804786,=,1,1,=,,IC50,nM,,3.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.4,PAK4
,,16776977,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccc(F)cc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '20.19', 'le': '0.37', 'lle': '4.77', 'sei': '10.08'}",CHEMBL3931386,,CHEMBL3931386,8.51,0,http://www.openphacts.org/units/Nanomolar,2804787,=,1,1,=,,IC50,nM,,3.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.1,PAK4
,,16776978,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccc(Cl)cc4Cl)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '17.52', 'le': '0.35', 'lle': '3.19', 'sei': '9.43'}",CHEMBL3970651,,CHEMBL3970651,7.96,1,http://www.openphacts.org/units/Nanomolar,2804788,=,1,1,=,,IC50,nM,,11.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.0,PAK4
,,16776979,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccn4)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '21.20', 'le': '0.39', 'lle': '5.33', 'sei': '8.42'}",CHEMBL3937423,,CHEMBL3937423,8.19,1,http://www.openphacts.org/units/Nanomolar,2804789,=,1,1,=,,IC50,nM,,6.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.4,PAK4
,,16776980,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '22.15', 'le': '0.41', 'lle': '5.96', 'sei': '9.21'}",CHEMBL3914287,,CHEMBL3914287,8.96,1,http://www.openphacts.org/units/Nanomolar,2804790,=,1,1,=,,IC50,nM,,1.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.1,PAK4
,,16776981,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4cccnc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '19.58', 'le': '0.36', 'lle': '4.92', 'sei': '8.14'}",CHEMBL3905239,,CHEMBL3905239,7.92,1,http://www.openphacts.org/units/Nanomolar,2804791,=,1,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,,16776982,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4Cl)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '20.40', 'le': '0.39', 'lle': '5.08', 'sei': '8.83'}",CHEMBL3920733,,CHEMBL3920733,8.59,1,http://www.openphacts.org/units/Nanomolar,2804792,=,1,1,=,,IC50,nM,,2.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.6,PAK4
,,16776983,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '21.75', 'le': '0.42', 'lle': '5.62', 'sei': '8.78'}",CHEMBL3910008,,CHEMBL3910008,8.54,0,http://www.openphacts.org/units/Nanomolar,2804793,=,1,1,=,,IC50,nM,,2.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.9,PAK4
,,16776984,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '17.69', 'le': '0.33', 'lle': '3.72', 'sei': '8.84'}",CHEMBL3911258,,CHEMBL3911258,7.46,1,http://www.openphacts.org/units/Nanomolar,2804794,=,1,1,=,,IC50,nM,,35.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.0,PAK4
,,16776985,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,O[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '17.81', 'le': '0.33', 'lle': '3.75', 'sei': '9.57'}",CHEMBL3920197,,CHEMBL3920197,7.52,1,http://www.openphacts.org/units/Nanomolar,2804796,=,1,1,=,,IC50,nM,,30.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.0,PAK4
,,16776986,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '18.00', 'le': '0.33', 'lle': '2.77', 'sei': '9.33'}",CHEMBL3948849,,CHEMBL3948849,7.57,1,http://www.openphacts.org/units/Nanomolar,2804797,=,1,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,,16776987,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '17.24', 'le': '0.32', 'lle': '3.51', 'sei': '10.67'}",CHEMBL3912242,,CHEMBL3912242,7.51,1,http://www.openphacts.org/units/Nanomolar,2804798,=,1,1,=,,IC50,nM,,31.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,31.0,PAK4
,,16776988,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,,CHEMBL3928490,,CHEMBL3928490,,1,http://www.openphacts.org/units/Nanomolar,2804799,>,1,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,,16776989,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '18.99', 'le': '0.35', 'lle': '4.14', 'sei': '9.80'}",CHEMBL3956489,,CHEMBL3956489,8.27,0,http://www.openphacts.org/units/Nanomolar,2804800,=,1,1,=,,IC50,nM,,5.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.4,PAK4
,,16776990,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '21.90', 'le': '0.41', 'lle': '5.41', 'sei': '11.30'}",CHEMBL3905194,,CHEMBL3905194,9.54,1,http://www.openphacts.org/units/Nanomolar,2804801,=,1,1,=,,IC50,nM,,0.29,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.29,PAK4
,,16776991,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(N)CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '19.88', 'le': '0.37', 'lle': '4.53', 'sei': '10.26'}",CHEMBL3974415,,CHEMBL3974415,8.66,0,http://www.openphacts.org/units/Nanomolar,2804802,=,1,1,=,,IC50,nM,,2.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.2,PAK4
,,16776992,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1N,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '22.38', 'le': '0.42', 'lle': '5.75', 'sei': '11.55'}",CHEMBL3896244,,CHEMBL3896244,9.74,0,http://www.openphacts.org/units/Nanomolar,2804803,=,1,1,=,,IC50,nM,,0.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.18,PAK4
,,16776993,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1N,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '20.20', 'le': '0.38', 'lle': '4.81', 'sei': '10.43'}",CHEMBL3902228,,CHEMBL3902228,8.80,0,http://www.openphacts.org/units/Nanomolar,2804804,=,1,1,=,,IC50,nM,,1.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.6,PAK4
,,16776994,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CC[C@H]1F,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '16.63', 'le': '0.31', 'lle': '3.62', 'sei': '8.66'}",CHEMBL3973432,,CHEMBL3973432,7.31,1,http://www.openphacts.org/units/Nanomolar,2804805,=,1,1,=,,IC50,nM,,49.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,49.0,PAK4
,,16776995,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '23.02', 'le': '0.43', 'lle': '6.04', 'sei': '11.88'}",CHEMBL3942186,,CHEMBL3942186,10.03,0,http://www.openphacts.org/units/Nanomolar,2804806,=,1,1,=,,IC50,nM,,0.094,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.094,PAK4
,,16776996,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](F)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '19.33', 'le': '0.36', 'lle': '4.80', 'sei': '10.07'}",CHEMBL3913112,,CHEMBL3913112,8.49,1,http://www.openphacts.org/units/Nanomolar,2804807,=,1,1,=,,IC50,nM,,3.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.2,PAK4
,,16776997,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '20.90', 'le': '0.39', 'lle': '5.11', 'sei': '10.79'}",CHEMBL3897323,,CHEMBL3897323,9.10,1,http://www.openphacts.org/units/Nanomolar,2804808,=,1,1,=,,IC50,nM,,0.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.79,PAK4
,,16776998,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '21.83', 'le': '0.41', 'lle': '5.38', 'sei': '11.27'}",CHEMBL3965757,,CHEMBL3965757,9.51,1,http://www.openphacts.org/units/Nanomolar,2804809,=,1,1,=,,IC50,nM,,0.31,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.31,PAK4
,,16776999,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '20.67', 'le': '0.38', 'lle': '4.87', 'sei': '10.67'}",CHEMBL3900646,,CHEMBL3900646,9.00,0,http://www.openphacts.org/units/Nanomolar,2804810,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,,16777000,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H](N)[C@H]1O,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '22.20', 'le': '0.42', 'lle': '8.40', 'sei': '7.69'}",CHEMBL3950251,,CHEMBL3950251,10.05,0,http://www.openphacts.org/units/Nanomolar,2804811,=,1,1,=,,IC50,nM,,0.09,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.09,PAK4
,,16777001,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '22.38', 'le': '0.41', 'lle': '6.13', 'sei': '9.63'}",CHEMBL3913540,,CHEMBL3913540,9.37,0,http://www.openphacts.org/units/Nanomolar,2804812,=,1,1,=,,IC50,nM,,0.43,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.43,PAK4
,,16777002,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '21.23', 'le': '0.39', 'lle': '5.50', 'sei': '9.14'}",CHEMBL3963283,,CHEMBL3963283,8.89,0,http://www.openphacts.org/units/Nanomolar,2804813,=,1,1,=,,IC50,nM,,1.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.3,PAK4
,,16777003,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C[C@H](N)[C@H]1O,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '20.41', 'le': '0.38', 'lle': '7.99', 'sei': '6.19'}",CHEMBL3904539,,CHEMBL3904539,8.89,0,http://www.openphacts.org/units/Nanomolar,2804814,=,1,1,=,,IC50,nM,,1.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.3,PAK4
,,16777004,[],CHEMBL3864806,Inhibition of recombinant Pim2 (unknown origin) by electrochemiluminescence assay,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccnc(NC(=O)c3c[nH]c4ccc(-c5ccccc5F)nc34)c2)C1,,,CHEMBL3864151,Bioorg Med Chem Lett,2016,"{'bei': '15.11', 'le': '0.28', 'lle': '2.56', 'sei': '6.51'}",CHEMBL3932537,,CHEMBL3932537,6.50,0,http://www.openphacts.org/units/Nanomolar,2804815,=,1,1,=,,IC50,nM,,314.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,314.0,PAK4
,191660,17601958,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OC2CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '18.08', 'le': '0.33', 'lle': '3.16', 'sei': '9.70'}",CHEMBL3660014,,CHEMBL3660014,6.24,0,http://www.openphacts.org/units/Nanomolar,2534558,=,37,1,=,,IC50,nM,,570.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,570.0,PAK4
,191662,17601960,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '24.64', 'le': '0.45', 'lle': '5.88', 'sei': '14.46'}",CHEMBL3664634,,CHEMBL3664634,9.30,0,http://www.openphacts.org/units/Nanomolar,2539586,=,37,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,222542,17611137,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(NC2CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '17.29', 'le': '0.31', 'lle': '2.85', 'sei': '8.87'}",CHEMBL3660006,,CHEMBL3660006,5.96,0,http://www.openphacts.org/units/Nanomolar,2534550,=,37,1,=,,IC50,nM,,1107.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1107.0,PAK4
,222543,17611138,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CC(Nc2cccc3ccc(-c4nnc5ccccn45)nc23)CC(C)(C)N1,,,CHEMBL3639321,,2013,"{'bei': '12.48', 'le': '0.23', 'lle': '0.33', 'sei': '7.45'}",CHEMBL3660007,,CHEMBL3660007,5.00,0,http://www.openphacts.org/units/Nanomolar,2534551,=,37,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,222544,17611139,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,OC1CCC(Nc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '16.95', 'le': '0.31', 'lle': '2.43', 'sei': '8.09'}",CHEMBL3660008,,CHEMBL3660008,6.09,0,http://www.openphacts.org/units/Nanomolar,2534552,=,37,1,=,,IC50,nM,,807.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,807.0,PAK4
,222545,17611140,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(N[C@H]2CCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '15.80', 'le': '0.29', 'lle': '2.50', 'sei': '7.77'}",CHEMBL3660009,,CHEMBL3660009,5.22,0,http://www.openphacts.org/units/Nanomolar,2534553,=,37,1,=,,IC50,nM,,6025.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6025.0,PAK4
,222546,17611141,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(N[C@@H]2CCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '17.23', 'le': '0.31', 'lle': '2.97', 'sei': '8.48'}",CHEMBL3660010,,CHEMBL3660010,5.69,0,http://www.openphacts.org/units/Nanomolar,2534554,=,37,1,=,,IC50,nM,,2021.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2021.0,PAK4
,222547,17611142,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)OC(=O)NCCCNc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '11.95', 'le': '0.22', 'lle': '0.73', 'sei': '5.35'}",CHEMBL3660011,,CHEMBL3660011,5.00,0,http://www.openphacts.org/units/Nanomolar,2534555,=,37,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,222548,17611143,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCCNc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '18.79', 'le': '0.34', 'lle': '3.27', 'sei': '7.37'}",CHEMBL3660012,,CHEMBL3660012,5.98,0,http://www.openphacts.org/units/Nanomolar,2534556,=,37,1,=,,IC50,nM,,1045.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1045.0,PAK4
,222549,17611144,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCN(CCCN)c1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '13.52', 'le': '0.25', 'lle': '1.10', 'sei': '7.26'}",CHEMBL3660013,,CHEMBL3660013,5.25,0,http://www.openphacts.org/units/Nanomolar,2534557,=,37,1,=,,IC50,nM,,5573.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5573.0,PAK4
,222550,17611145,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCCOc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '19.69', 'le': '0.36', 'lle': '3.62', 'sei': '8.03'}",CHEMBL3660015,,CHEMBL3660015,6.29,0,http://www.openphacts.org/units/Nanomolar,2534559,=,37,1,=,,IC50,nM,,514.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,514.0,PAK4
,222551,17611146,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(O[C@@H]2CCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.92', 'le': '0.31', 'lle': '2.92', 'sei': '8.72'}",CHEMBL3660016,,CHEMBL3660016,5.61,0,http://www.openphacts.org/units/Nanomolar,2534560,=,37,1,=,,IC50,nM,,2470.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2470.0,PAK4
,222552,17611147,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(O[C@H]2CCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.02', 'le': '0.29', 'lle': '2.62', 'sei': '8.25'}",CHEMBL3660017,,CHEMBL3660017,5.31,0,http://www.openphacts.org/units/Nanomolar,2534561,=,37,1,=,,IC50,nM,,4910.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4910.0,PAK4
,222553,17611148,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)[C@@H]1C[C@@H](Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,,,CHEMBL3639321,,2013,"{'bei': '16.67', 'le': '0.31', 'lle': '4.10', 'sei': '7.42'}",CHEMBL3660018,,CHEMBL3660018,6.72,0,http://www.openphacts.org/units/Nanomolar,2534562,=,37,1,=,,IC50,nM,,189.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,189.0,PAK4
,222554,17611149,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OCC2CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '17.39', 'le': '0.32', 'lle': '2.93', 'sei': '9.71'}",CHEMBL3660019,,CHEMBL3660019,6.25,0,http://www.openphacts.org/units/Nanomolar,2534563,=,37,1,=,,IC50,nM,,562.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,562.0,PAK4
,222555,17611150,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OCCC2CCCCN2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '14.39', 'le': '0.26', 'lle': '1.51', 'sei': '8.35'}",CHEMBL3660020,,CHEMBL3660020,5.38,0,http://www.openphacts.org/units/Nanomolar,2534564,=,37,1,=,,IC50,nM,,4219.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4219.0,PAK4
,222556,17611151,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OCC2CCCNC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '18.84', 'le': '0.34', 'lle': '3.45', 'sei': '10.53'}",CHEMBL3660021,,CHEMBL3660021,6.77,0,http://www.openphacts.org/units/Nanomolar,2534565,=,37,1,=,,IC50,nM,,169.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,169.0,PAK4
,222557,17611152,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '19.12', 'le': '0.35', 'lle': '3.28', 'sei': '8.77'}",CHEMBL3660022,,CHEMBL3660022,6.87,0,http://www.openphacts.org/units/Nanomolar,2534566,=,37,1,=,,IC50,nM,,134.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,134.0,PAK4
,222558,17611153,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '21.04', 'le': '0.38', 'lle': '4.00', 'sei': '9.33'}",CHEMBL3660023,,CHEMBL3660023,7.31,0,http://www.openphacts.org/units/Nanomolar,2534567,=,37,1,=,,IC50,nM,,49.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,49.0,PAK4
,222559,17611154,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CO)COc1cccc2ccc(-c3nnc4cc(CN)ccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '20.58', 'le': '0.38', 'lle': '4.97', 'sei': '7.88'}",CHEMBL3660024,,CHEMBL3660024,7.77,0,http://www.openphacts.org/units/Nanomolar,2534568,=,37,1,=,,IC50,nM,,17.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.0,PAK4
,222560,17611155,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1cccc2ccc(-c3nnc4cc(CN)ccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '20.99', 'le': '0.38', 'lle': '3.85', 'sei': '9.31'}",CHEMBL3660025,,CHEMBL3660025,7.29,0,http://www.openphacts.org/units/Nanomolar,2534569,=,37,1,=,,IC50,nM,,51.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,51.0,PAK4
,222561,17611156,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC(C)(C)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '15.63', 'le': '0.29', 'lle': '1.96', 'sei': '10.56'}",CHEMBL3660026,,CHEMBL3660026,5.87,0,http://www.openphacts.org/units/Nanomolar,2534570,=,37,1,=,,IC50,nM,,1354.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1354.0,PAK4
,222562,17611157,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,OCC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '18.19', 'le': '0.33', 'lle': '3.20', 'sei': '8.69'}",CHEMBL3660027,,CHEMBL3660027,6.30,0,http://www.openphacts.org/units/Nanomolar,2534571,=,37,1,=,,IC50,nM,,501.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,501.0,PAK4
,222563,17611158,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '20.58', 'le': '0.37', 'lle': '2.47', 'sei': '13.08'}",CHEMBL3660028,,CHEMBL3660028,6.84,0,http://www.openphacts.org/units/Nanomolar,2534572,=,37,1,=,,IC50,nM,,144.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,144.0,PAK4
,222564,17611159,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CO)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '20.42', 'le': '0.37', 'lle': '3.77', 'sei': '9.81'}",CHEMBL3660029,,CHEMBL3660029,7.11,0,http://www.openphacts.org/units/Nanomolar,2534573,=,37,1,=,,IC50,nM,,77.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,77.0,PAK4
,222565,17611160,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,F[C@H]1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '16.96', 'le': '0.31', 'lle': '3.14', 'sei': '9.58'}",CHEMBL3660030,,CHEMBL3660030,6.16,0,http://www.openphacts.org/units/Nanomolar,2534574,=,37,1,=,,IC50,nM,,686.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,686.0,PAK4
,222566,17611161,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,F[C@@H]1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '18.89', 'le': '0.35', 'lle': '3.84', 'sei': '10.67'}",CHEMBL3660031,,CHEMBL3660031,6.86,0,http://www.openphacts.org/units/Nanomolar,2534575,=,37,1,=,,IC50,nM,,137.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,137.0,PAK4
,222567,17611162,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNCC(C)(C)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '17.29', 'le': '0.32', 'lle': '2.53', 'sei': '10.09'}",CHEMBL3660032,,CHEMBL3660032,6.49,0,http://www.openphacts.org/units/Nanomolar,2534576,=,37,1,=,,IC50,nM,,323.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,323.0,PAK4
,222568,17611163,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CNCC(C)(C)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '18.94', 'le': '0.35', 'lle': '3.27', 'sei': '10.64'}",CHEMBL3660033,,CHEMBL3660033,6.84,0,http://www.openphacts.org/units/Nanomolar,2534577,=,37,1,=,,IC50,nM,,143.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,143.0,PAK4
,222569,17611164,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OC2CC3CCC(C2)N3)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.78', 'le': '0.30', 'lle': '2.62', 'sei': '9.69'}",CHEMBL3660034,,CHEMBL3660034,6.23,0,http://www.openphacts.org/units/Nanomolar,2534578,=,37,1,=,,IC50,nM,,585.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,585.0,PAK4
,222570,17611165,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(Oc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@@H](CC)CN,,,CHEMBL3639321,,2013,"{'bei': '17.30', 'le': '0.32', 'lle': '2.41', 'sei': '8.30'}",CHEMBL3660035,,CHEMBL3660035,6.50,0,http://www.openphacts.org/units/Nanomolar,2534579,=,37,1,=,,IC50,nM,,318.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,318.0,PAK4
,222571,17611166,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(Oc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@H](CC)CN,,,CHEMBL3639321,,2013,"{'bei': '17.00', 'le': '0.31', 'lle': '2.29', 'sei': '8.15'}",CHEMBL3660036,,CHEMBL3660036,6.38,0,http://www.openphacts.org/units/Nanomolar,2534580,=,37,1,=,,IC50,nM,,413.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,413.0,PAK4
,222572,17611167,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](CN)C(C)Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '17.70', 'le': '0.32', 'lle': '2.70', 'sei': '8.17'}",CHEMBL3660037,,CHEMBL3660037,6.40,0,http://www.openphacts.org/units/Nanomolar,2534581,=,37,1,=,,IC50,nM,,399.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,399.0,PAK4
,222573,17611168,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](CN)C(C)Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '18.13', 'le': '0.33', 'lle': '2.85', 'sei': '8.37'}",CHEMBL3660038,,CHEMBL3660038,6.55,0,http://www.openphacts.org/units/Nanomolar,2534582,=,37,1,=,,IC50,nM,,279.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,279.0,PAK4
,222574,17611169,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(Oc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@@H](CC)CN,,,CHEMBL3639321,,2013,"{'bei': '15.07', 'le': '0.28', 'lle': '1.39', 'sei': '7.50'}",CHEMBL3660039,,CHEMBL3660039,5.87,0,http://www.openphacts.org/units/Nanomolar,2534583,=,37,1,=,,IC50,nM,,1346.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1346.0,PAK4
,222575,17611170,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(Oc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@H](CC)CN,,,CHEMBL3639321,,2013,"{'bei': '15.06', 'le': '0.28', 'lle': '1.39', 'sei': '7.49'}",CHEMBL3660040,,CHEMBL3660040,5.87,0,http://www.openphacts.org/units/Nanomolar,2534584,=,37,1,=,,IC50,nM,,1359.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1359.0,PAK4
,222576,17611171,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)COc1cc(F)cc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '20.76', 'le': '0.38', 'lle': '4.14', 'sei': '9.68'}",CHEMBL3660041,,CHEMBL3660041,7.58,0,http://www.openphacts.org/units/Nanomolar,2534585,=,37,1,=,,IC50,nM,,26.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,26.0,PAK4
,222577,17611172,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)N1CCC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '15.17', 'le': '0.28', 'lle': '3.02', 'sei': '5.98'}",CHEMBL3660042,,CHEMBL3660042,5.89,0,http://www.openphacts.org/units/Nanomolar,2534586,=,37,1,=,,IC50,nM,,1277.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1277.0,PAK4
,222578,17611173,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC(F)(F)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '18.97', 'le': '0.35', 'lle': '3.82', 'sei': '8.60'}",CHEMBL3660043,,CHEMBL3660043,6.74,0,http://www.openphacts.org/units/Nanomolar,2534587,=,37,1,=,,IC50,nM,,182.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,182.0,PAK4
,222579,17611174,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '21.30', 'le': '0.39', 'lle': '4.07', 'sei': '9.78'}",CHEMBL3660022,,CHEMBL3660022,7.66,0,http://www.openphacts.org/units/Nanomolar,2534588,=,37,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.0,PAK4
,222580,17611175,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)COc1ccc(F)c2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '13.68', 'le': '0.25', 'lle': '1.55', 'sei': '6.38'}",CHEMBL3660045,,CHEMBL3660045,5.00,0,http://www.openphacts.org/units/Nanomolar,2534589,=,37,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,222581,17611176,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cncc(COc2cccc3ccc(-c4nnc5ccccn45)nc23)c1,,,CHEMBL3639321,,2013,"{'bei': '14.51', 'le': '0.26', 'lle': '1.21', 'sei': '7.86'}",CHEMBL3660046,,CHEMBL3660046,5.13,0,http://www.openphacts.org/units/Nanomolar,2534590,=,37,1,=,,IC50,nM,,7473.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7473.0,PAK4
,222582,17611177,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OCc2ccncc2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.30', 'le': '0.29', 'lle': '1.84', 'sei': '8.84'}",CHEMBL3660047,,CHEMBL3660047,5.76,0,http://www.openphacts.org/units/Nanomolar,2534591,=,37,1,=,,IC50,nM,,1734.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1734.0,PAK4
,222583,17611178,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '18.59', 'le': '0.34', 'lle': '3.61', 'sei': '10.91'}",CHEMBL3660048,,CHEMBL3660048,7.02,0,http://www.openphacts.org/units/Nanomolar,2534592,=,37,1,=,,IC50,nM,,96.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,96.0,PAK4
,222584,17611179,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '15.71', 'le': '0.29', 'lle': '2.52', 'sei': '9.22'}",CHEMBL3660048,,CHEMBL3660048,5.93,0,http://www.openphacts.org/units/Nanomolar,2534592,=,37,1,=,,IC50,nM,,1174.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1174.0,PAK4
,222585,17611180,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '18.10', 'le': '0.33', 'lle': '3.42', 'sei': '10.62'}",CHEMBL3660048,,CHEMBL3660048,6.83,0,http://www.openphacts.org/units/Nanomolar,2534592,=,37,1,=,,IC50,nM,,147.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,147.0,PAK4
,222586,17611181,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '18.55', 'le': '0.34', 'lle': '3.59', 'sei': '10.88'}",CHEMBL3660048,,CHEMBL3660048,7.00,0,http://www.openphacts.org/units/Nanomolar,2534592,=,37,1,=,,IC50,nM,,100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,100.0,PAK4
,222587,17611182,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '17.32', 'le': '0.32', 'lle': '3.13', 'sei': '10.16'}",CHEMBL3660048,,CHEMBL3660048,6.54,0,http://www.openphacts.org/units/Nanomolar,2534592,=,37,1,=,,IC50,nM,,290.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,290.0,PAK4
,222588,17611183,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CNCCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '16.93', 'le': '0.31', 'lle': '2.98', 'sei': '9.93'}",CHEMBL3660049,,CHEMBL3660049,6.39,0,http://www.openphacts.org/units/Nanomolar,2534593,=,37,1,=,,IC50,nM,,406.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,406.0,PAK4
,222589,17611184,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OC2CCCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '19.36', 'le': '0.35', 'lle': '3.49', 'sei': '10.82'}",CHEMBL3660050,,CHEMBL3660050,6.96,0,http://www.openphacts.org/units/Nanomolar,2534594,=,37,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,110.0,PAK4
,222590,17611185,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)[C@@H]1CC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,,,CHEMBL3639321,,2013,"{'bei': '12.01', 'le': '0.22', 'lle': '2.47', 'sei': '5.91'}",CHEMBL3660051,,CHEMBL3660051,5.00,0,http://www.openphacts.org/units/Nanomolar,2534595,=,37,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,222591,17611186,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CON(C)C(=O)[C@@H]1CC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,,,CHEMBL3639321,,2013,"{'bei': '11.56', 'le': '0.21', 'lle': '2.54', 'sei': '5.33'}",CHEMBL3660052,,CHEMBL3660052,5.00,0,http://www.openphacts.org/units/Nanomolar,2534596,=,37,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,222592,17611187,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@@H]1CC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,,,CHEMBL3639321,,2013,"{'bei': '16.97', 'le': '0.31', 'lle': '3.93', 'sei': '7.53'}",CHEMBL3660053,,CHEMBL3660053,6.37,0,http://www.openphacts.org/units/Nanomolar,2534597,=,37,1,=,,IC50,nM,,427.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,427.0,PAK4
,222593,17611188,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@@H]1CC(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN1,,,CHEMBL3639321,,2013,"{'bei': '16.22', 'le': '0.30', 'lle': '3.23', 'sei': '8.58'}",CHEMBL3660054,,CHEMBL3660054,6.32,0,http://www.openphacts.org/units/Nanomolar,2534598,=,37,1,=,,IC50,nM,,484.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,484.0,PAK4
,222594,17611189,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)COc1c(Br)ccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '15.69', 'le': '0.34', 'lle': '2.62', 'sei': '8.54'}",CHEMBL3660055,,CHEMBL3660055,6.69,0,http://www.openphacts.org/units/Nanomolar,2534599,=,37,1,=,,IC50,nM,,204.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,204.0,PAK4
,222595,17611190,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc2nnc(-c3ccc4cccc(OC5CCNCC5F)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '14.53', 'le': '0.27', 'lle': '2.38', 'sei': '8.61'}",CHEMBL3660056,,CHEMBL3660056,5.54,0,http://www.openphacts.org/units/Nanomolar,2534600,=,37,1,=,,IC50,nM,,2866.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2866.0,PAK4
,222596,17611191,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccn2c(-c3ccc4cccc(OC5CCNCC5F)c4n3)nnc2c1,,,CHEMBL3639321,,2013,"{'bei': '15.09', 'le': '0.28', 'lle': '2.59', 'sei': '8.94'}",CHEMBL3660057,,CHEMBL3660057,5.75,0,http://www.openphacts.org/units/Nanomolar,2534601,=,37,1,=,,IC50,nM,,1760.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1760.0,PAK4
,222597,17611192,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OC[C@@H]2CCCN2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '14.48', 'le': '0.26', 'lle': '1.92', 'sei': '7.77'}",CHEMBL3660058,,CHEMBL3660058,5.00,0,http://www.openphacts.org/units/Nanomolar,2534602,=,37,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,222598,17611193,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,OCC(O)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '17.14', 'le': '0.31', 'lle': '4.08', 'sei': '6.21'}",CHEMBL3660059,,CHEMBL3660059,5.76,0,http://www.openphacts.org/units/Nanomolar,2534603,=,37,1,=,,IC50,nM,,1721.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1721.0,PAK4
,222599,17611194,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)COc1cccc2ccc(-c3nnc4ccc(Br)cn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '16.41', 'le': '0.35', 'lle': '2.93', 'sei': '8.93'}",CHEMBL3660060,,CHEMBL3660060,7.00,0,http://www.openphacts.org/units/Nanomolar,2534604,=,37,1,=,,IC50,nM,,101.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,101.0,PAK4
,222600,17611195,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)COc1cccc2ccc(-c3nnc4ccc(C5CC5)cn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '16.75', 'le': '0.31', 'lle': '2.30', 'sei': '8.29'}",CHEMBL3660061,,CHEMBL3660061,6.49,0,http://www.openphacts.org/units/Nanomolar,2534605,=,37,1,=,,IC50,nM,,323.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,323.0,PAK4
,222601,17611196,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CN)COc1cccc2ccc(-c3nnc4ccc(-c5ccccc5)cn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '15.96', 'le': '0.29', 'lle': '1.78', 'sei': '8.63'}",CHEMBL3660062,,CHEMBL3660062,6.76,0,http://www.openphacts.org/units/Nanomolar,2534606,=,37,1,=,,IC50,nM,,174.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,174.0,PAK4
,222602,17611197,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '19.30', 'le': '0.36', 'lle': '3.86', 'sei': '11.32'}",CHEMBL3664634,,CHEMBL3664634,7.28,0,http://www.openphacts.org/units/Nanomolar,2539586,=,37,1,=,,IC50,nM,,52.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,52.0,PAK4
,222603,17611198,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '19.18', 'le': '0.35', 'lle': '3.45', 'sei': '11.13'}",CHEMBL3660063,,CHEMBL3660063,7.16,0,http://www.openphacts.org/units/Nanomolar,2534607,=,37,1,=,,IC50,nM,,69.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,69.0,PAK4
,222604,17611199,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '17.81', 'le': '0.32', 'lle': '2.80', 'sei': '10.72'}",CHEMBL3660064,,CHEMBL3660064,6.90,0,http://www.openphacts.org/units/Nanomolar,2534608,=,37,1,=,,IC50,nM,,126.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,126.0,PAK4
,222605,17611200,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OCC2(CC3CC3)CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.98', 'le': '0.31', 'lle': '2.53', 'sei': '10.91'}",CHEMBL3660065,,CHEMBL3660065,7.02,0,http://www.openphacts.org/units/Nanomolar,2534609,=,37,1,=,,IC50,nM,,95.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,95.0,PAK4
,222606,17611201,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '17.87', 'le': '0.33', 'lle': '2.82', 'sei': '11.15'}",CHEMBL3660066,,CHEMBL3660066,7.17,0,http://www.openphacts.org/units/Nanomolar,2534610,=,37,1,=,,IC50,nM,,67.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,67.0,PAK4
,222607,17611202,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,OC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN(Cc2ccccc2)CC1,,,CHEMBL3639321,,2013,"{'bei': '10.74', 'le': '0.20', 'lle': '0.65', 'sei': '6.60'}",CHEMBL3660067,,CHEMBL3660067,5.00,0,http://www.openphacts.org/units/Nanomolar,2534611,=,37,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,222608,17611203,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,OC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '16.60', 'le': '0.30', 'lle': '3.79', 'sei': '7.37'}",CHEMBL3660068,,CHEMBL3660068,6.23,0,http://www.openphacts.org/units/Nanomolar,2534612,=,37,1,=,,IC50,nM,,588.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,588.0,PAK4
,222609,17611204,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '18.24', 'le': '0.33', 'lle': '4.01', 'sei': '9.65'}",CHEMBL3660069,,CHEMBL3660069,7.10,0,http://www.openphacts.org/units/Nanomolar,2534613,=,37,1,=,,IC50,nM,,79.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,79.0,PAK4
,222610,17611205,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(Oc2ccncc2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.80', 'le': '0.30', 'lle': '1.57', 'sei': '8.74'}",CHEMBL3660070,,CHEMBL3660070,5.70,0,http://www.openphacts.org/units/Nanomolar,2534614,=,37,1,=,,IC50,nM,,1994.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1994.0,PAK4
,222611,17611206,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)ccn1,,,CHEMBL3639321,,2013,"{'bei': '14.25', 'le': '0.26', 'lle': '1.34', 'sei': '5.53'}",CHEMBL3660071,,CHEMBL3660071,5.05,0,http://www.openphacts.org/units/Nanomolar,2534615,=,37,1,=,,IC50,nM,,8935.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8935.0,PAK4
,222612,17611207,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nccc(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)n1,,,CHEMBL3639321,,2013,"{'bei': '14.07', 'le': '0.25', 'lle': '1.89', 'sei': '4.80'}",CHEMBL3660072,,CHEMBL3660072,5.00,0,http://www.openphacts.org/units/Nanomolar,2534616,=,37,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,222613,17611208,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1(COc2cccc3ccc(-c4nnc5ccc(Br)cn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '12.84', 'le': '0.28', 'lle': '1.68', 'sei': '9.10'}",CHEMBL3660073,,CHEMBL3660073,5.86,0,http://www.openphacts.org/units/Nanomolar,2534617,=,37,1,=,,IC50,nM,,1389.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1389.0,PAK4
,222614,17611209,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccc(Br)cn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '13.32', 'le': '0.29', 'lle': '2.10', 'sei': '9.16'}",CHEMBL3660074,,CHEMBL3660074,5.89,0,http://www.openphacts.org/units/Nanomolar,2534618,=,37,1,=,,IC50,nM,,1278.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1278.0,PAK4
,222615,17611210,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1(COc2cccc3ccc(-c4nnc5ccc(C6CC6)cn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '17.39', 'le': '0.32', 'lle': '2.97', 'sei': '11.28'}",CHEMBL3660075,,CHEMBL3660075,7.26,0,http://www.openphacts.org/units/Nanomolar,2534619,=,37,1,=,,IC50,nM,,55.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,55.0,PAK4
,222616,17611211,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccc(C5CC5)cn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '14.71', 'le': '0.27', 'lle': '2.03', 'sei': '9.22'}",CHEMBL3660076,,CHEMBL3660076,5.93,0,http://www.openphacts.org/units/Nanomolar,2534620,=,37,1,=,,IC50,nM,,1163.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1163.0,PAK4
,222617,17611212,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1(COc2cccc3ccc(-c4nnc5ccc(-c6ccccc6)cn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '15.10', 'le': '0.28', 'lle': '1.77', 'sei': '10.64'}",CHEMBL3660077,,CHEMBL3660077,6.85,0,http://www.openphacts.org/units/Nanomolar,2534621,=,37,1,=,,IC50,nM,,142.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,142.0,PAK4
,222618,17611213,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccc(-c5ccccc5)cn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '13.62', 'le': '0.25', 'lle': '1.30', 'sei': '9.30'}",CHEMBL3660078,,CHEMBL3660078,5.99,0,http://www.openphacts.org/units/Nanomolar,2534622,=,37,1,=,,IC50,nM,,1035.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1035.0,PAK4
,222619,17611214,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)CN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '15.45', 'le': '0.29', 'lle': '4.10', 'sei': '6.81'}",CHEMBL3660079,,CHEMBL3660079,6.71,0,http://www.openphacts.org/units/Nanomolar,2534623,=,37,1,=,,IC50,nM,,193.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,193.0,PAK4
,222620,17611215,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '18.23', 'le': '0.34', 'lle': '3.38', 'sei': '12.85'}",CHEMBL3660080,,CHEMBL3660080,7.14,0,http://www.openphacts.org/units/Nanomolar,2534624,=,37,1,=,,IC50,nM,,73.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,73.0,PAK4
,222621,17611216,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,OCCN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '16.56', 'le': '0.31', 'lle': '3.86', 'sei': '9.21'}",CHEMBL3660081,,CHEMBL3660081,6.98,0,http://www.openphacts.org/units/Nanomolar,2534625,=,37,1,=,,IC50,nM,,105.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,105.0,PAK4
,222622,17611217,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCN(CCO)CC1,,,CHEMBL3639321,,2013,"{'bei': '16.40', 'le': '0.30', 'lle': '3.43', 'sei': '9.04'}",CHEMBL3660082,,CHEMBL3660082,6.85,0,http://www.openphacts.org/units/Nanomolar,2534626,=,37,1,=,,IC50,nM,,142.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,142.0,PAK4
,222623,17611218,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OC2CCNCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.52', 'le': '0.31', 'lle': '3.14', 'sei': '9.79'}",CHEMBL3660084,,CHEMBL3660084,6.30,0,http://www.openphacts.org/units/Nanomolar,2534628,=,37,1,=,,IC50,nM,,502.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,502.0,PAK4
,222624,17611219,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OC2CCNCCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '17.41', 'le': '0.32', 'lle': '3.33', 'sei': '10.70'}",CHEMBL3660085,,CHEMBL3660085,6.88,0,http://www.openphacts.org/units/Nanomolar,2534629,=,37,1,=,,IC50,nM,,131.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,131.0,PAK4
,222625,17611220,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OC2CCNCCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '18.74', 'le': '0.35', 'lle': '3.86', 'sei': '11.52'}",CHEMBL3660085,,CHEMBL3660085,7.41,0,http://www.openphacts.org/units/Nanomolar,2534629,=,37,1,=,,IC50,nM,,39.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,39.0,PAK4
,222626,17611221,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn2c(-c3ccc4cccc(OC5CCNCCC5F)c4n3)nnc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.89', 'le': '0.31', 'lle': '2.89', 'sei': '10.28'}",CHEMBL3660086,,CHEMBL3660086,6.61,0,http://www.openphacts.org/units/Nanomolar,2534630,=,37,1,=,,IC50,nM,,244.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,244.0,PAK4
,222627,17611222,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OC2CCNCC2(F)F)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '15.76', 'le': '0.30', 'lle': '2.84', 'sei': '9.79'}",CHEMBL3660087,,CHEMBL3660087,6.30,0,http://www.openphacts.org/units/Nanomolar,2534631,=,37,1,=,,IC50,nM,,506.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,506.0,PAK4
,222628,17611223,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '16.51', 'le': '0.30', 'lle': '2.98', 'sei': '9.33'}",CHEMBL3660088,,CHEMBL3660088,6.00,0,http://www.openphacts.org/units/Nanomolar,2534632,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222629,17611224,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '17.38', 'le': '0.32', 'lle': '3.30', 'sei': '9.82'}",CHEMBL3660088,,CHEMBL3660088,6.32,0,http://www.openphacts.org/units/Nanomolar,2534632,=,37,1,=,,IC50,nM,,481.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,481.8,PAK4
,222630,17611225,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '16.51', 'le': '0.30', 'lle': '2.98', 'sei': '9.33'}",CHEMBL3660088,,CHEMBL3660088,6.00,0,http://www.openphacts.org/units/Nanomolar,2534632,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222631,17611226,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CNCCC1Oc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '16.51', 'le': '0.30', 'lle': '2.98', 'sei': '9.33'}",CHEMBL3660088,,CHEMBL3660088,6.00,0,http://www.openphacts.org/units/Nanomolar,2534632,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222632,17611227,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1CCNCCC1Oc1cccc2ccc(-c3nnc4ccc(C5CC5)cn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '14.80', 'le': '0.27', 'lle': '1.89', 'sei': '9.60'}",CHEMBL3660089,,CHEMBL3660089,6.18,0,http://www.openphacts.org/units/Nanomolar,2534633,=,37,1,=,,IC50,nM,,661.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,661.3,PAK4
,222633,17611228,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2nnc(-c3ccc4cccc(OC5CCNCCC5F)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '15.33', 'le': '0.28', 'lle': '2.28', 'sei': '9.33'}",CHEMBL3660090,,CHEMBL3660090,6.00,0,http://www.openphacts.org/units/Nanomolar,2534634,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222634,17611229,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2nnc(-c3ccc4cccc(OC5CCNCCC5F)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '16.49', 'le': '0.30', 'lle': '2.73', 'sei': '10.03'}",CHEMBL3660090,,CHEMBL3660090,6.45,0,http://www.openphacts.org/units/Nanomolar,2534634,=,37,1,=,,IC50,nM,,351.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,351.9,PAK4
,222635,17611230,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1ccc2nnc(-c3ccc4cccc(OC5CCNCCC5F)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '14.91', 'le': '0.27', 'lle': '2.04', 'sei': '8.73'}",CHEMBL3660091,,CHEMBL3660091,6.00,0,http://www.openphacts.org/units/Nanomolar,2534635,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222636,17611231,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc2nnc(-c3ccc4cccc(OC5CCNCCC5F)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '16.08', 'le': '0.30', 'lle': '2.81', 'sei': '9.88'}",CHEMBL3660092,,CHEMBL3660092,6.36,0,http://www.openphacts.org/units/Nanomolar,2534636,=,37,1,=,,IC50,nM,,439.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,439.6,PAK4
,222637,17611232,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc2nnc(-c3ccc4cccc(OCC5(F)CCNCC5)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '18.17', 'le': '0.34', 'lle': '3.63', 'sei': '11.16'}",CHEMBL3660093,,CHEMBL3660093,7.18,0,http://www.openphacts.org/units/Nanomolar,2534637,=,37,1,=,,IC50,nM,,65.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,65.6,PAK4
,222638,17611233,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '16.57', 'le': '0.31', 'lle': '2.57', 'sei': '12.09'}",CHEMBL3660094,,CHEMBL3660094,6.72,0,http://www.openphacts.org/units/Nanomolar,2534638,=,37,1,=,,IC50,nM,,191.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,191.2,PAK4
,222639,17611234,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FCCN1CCC(F)(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '15.09', 'le': '0.28', 'lle': '2.29', 'sei': '11.50'}",CHEMBL3660095,,CHEMBL3660095,6.39,0,http://www.openphacts.org/units/Nanomolar,2534639,=,37,1,=,,IC50,nM,,409.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,409.0,PAK4
,222640,17611235,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OCC2(F)CCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '19.21', 'le': '0.36', 'lle': '4.05', 'sei': '11.80'}",CHEMBL3660096,,CHEMBL3660096,7.59,0,http://www.openphacts.org/units/Nanomolar,2534640,=,37,1,=,,IC50,nM,,25.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.4,PAK4
,222641,17611236,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CNC1,,,CHEMBL3639321,,2013,"{'bei': '17.17', 'le': '0.32', 'lle': '3.37', 'sei': '9.33'}",CHEMBL3660097,,CHEMBL3660097,6.00,0,http://www.openphacts.org/units/Nanomolar,2534641,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222642,17611237,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OCC2(F)CNC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '17.18', 'le': '0.32', 'lle': '3.54', 'sei': '9.81'}",CHEMBL3664611,,CHEMBL3664611,6.31,0,http://www.openphacts.org/units/Nanomolar,2539563,=,37,1,=,,IC50,nM,,489.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,489.2,PAK4
,222643,17611238,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2nnc(-c3ccc4cccc(OCC5(F)CCNCC5)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '15.75', 'le': '0.29', 'lle': '3.00', 'sei': '8.72'}",CHEMBL3664612,,CHEMBL3664612,6.42,0,http://www.openphacts.org/units/Nanomolar,2539564,=,37,1,=,,IC50,nM,,384.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,384.1,PAK4
,222644,17611239,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2nnc(-c3ccc4cc(F)cc(OCC5(F)CCNCC5)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '15.95', 'le': '0.30', 'lle': '3.23', 'sei': '9.22'}",CHEMBL3664613,,CHEMBL3664613,6.79,0,http://www.openphacts.org/units/Nanomolar,2539565,=,37,1,=,,IC50,nM,,163.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,163.4,PAK4
,222645,17611240,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOc1ccc2nnc(-c3ccc4cccc(OCC5(F)CCNCC5)c4n3)n2c1,,,CHEMBL3639321,,2013,"{'bei': '13.29', 'le': '0.25', 'lle': '2.56', 'sei': '7.25'}",CHEMBL3664614,,CHEMBL3664614,6.00,0,http://www.openphacts.org/units/Nanomolar,2539566,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222646,17611241,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(COc1cc(F)cc2ccc(-c3nnc4ccccn34)nc12)[C@@H](O)CO,,,CHEMBL3639321,,2013,"{'bei': '16.45', 'le': '0.31', 'lle': '3.68', 'sei': '7.03'}",CHEMBL3664615,,CHEMBL3664615,6.52,0,http://www.openphacts.org/units/Nanomolar,2539567,=,37,1,=,,IC50,nM,,299.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,299.9,PAK4
,222647,17611242,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(COc1cccc2ccc(-c3nnc4ccccn34)nc12)[C@@H](O)CO,,,CHEMBL3639321,,2013,"{'bei': '17.91', 'le': '0.33', 'lle': '4.08', 'sei': '7.31'}",CHEMBL3664616,,CHEMBL3664616,6.78,0,http://www.openphacts.org/units/Nanomolar,2539568,=,37,1,=,,IC50,nM,,166.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,166.9,PAK4
,222648,17611243,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(COc2cc(F)cc3ccc(-c4nnc5ccccn45)nc23)CCCNCC1,,,CHEMBL3639321,,2013,"{'bei': '16.76', 'le': '0.31', 'lle': '3.45', 'sei': '9.60'}",CHEMBL3664617,,CHEMBL3664617,7.07,0,http://www.openphacts.org/units/Nanomolar,2539569,=,37,1,=,,IC50,nM,,86.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,86.0,PAK4
,222649,17611244,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(COc2cc(F)cc3ccc(-c4nnc5ccccn45)nc23)CCCN(CCO)CC1,,,CHEMBL3639321,,2013,"{'bei': '14.29', 'le': '0.27', 'lle': '3.32', 'sei': '7.83'}",CHEMBL3664618,,CHEMBL3664618,6.65,0,http://www.openphacts.org/units/Nanomolar,2539570,=,37,1,=,,IC50,nM,,222.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,222.4,PAK4
,222650,17611245,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,OC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCCNCC1,,,CHEMBL3639321,,2013,"{'bei': '15.41', 'le': '0.28', 'lle': '3.17', 'sei': '7.09'}",CHEMBL3664619,,CHEMBL3664619,6.00,0,http://www.openphacts.org/units/Nanomolar,2539571,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222651,17611246,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCCNCC1,,,CHEMBL3639321,,2013,"{'bei': '17.44', 'le': '0.32', 'lle': '3.56', 'sei': '9.57'}",CHEMBL3664620,,CHEMBL3664620,7.04,0,http://www.openphacts.org/units/Nanomolar,2539572,=,37,1,=,,IC50,nM,,91.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,91.5,PAK4
,222652,17611247,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(F)C(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '16.56', 'le': '0.31', 'lle': '2.72', 'sei': '11.67'}",CHEMBL3664621,,CHEMBL3664621,6.48,0,http://www.openphacts.org/units/Nanomolar,2539573,=,37,1,=,,IC50,nM,,330.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,330.0,PAK4
,222653,17611248,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(F)C(Oc2cccc3ccc(-c4nnc5ccccn45)nc23)CC1,,,CHEMBL3639321,,2013,"{'bei': '15.94', 'le': '0.29', 'lle': '2.48', 'sei': '11.24'}",CHEMBL3664621,,CHEMBL3664621,6.24,0,http://www.openphacts.org/units/Nanomolar,2539573,=,37,1,=,,IC50,nM,,573.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,573.8,PAK4
,222654,17611249,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OC2CCNCCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '15.22', 'le': '0.28', 'lle': '2.47', 'sei': '9.35'}",CHEMBL3660085,,CHEMBL3660085,6.02,0,http://www.openphacts.org/units/Nanomolar,2534629,=,37,1,=,,IC50,nM,,958.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,958.6,PAK4
,222655,17611250,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cc(OC2CCNCCC2F)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '15.89', 'le': '0.30', 'lle': '2.73', 'sei': '9.77'}",CHEMBL3660085,,CHEMBL3660085,6.28,0,http://www.openphacts.org/units/Nanomolar,2534629,=,37,1,=,,IC50,nM,,520.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,520.2,PAK4
,222656,17611251,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn2c(-c3ccc4cccc(OC5CCNCCC5F)c4n3)nnc2c1,,,CHEMBL3639321,,2013,"{'bei': '15.33', 'le': '0.28', 'lle': '2.28', 'sei': '9.33'}",CHEMBL3660086,,CHEMBL3660086,6.00,0,http://www.openphacts.org/units/Nanomolar,2534630,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222657,17611252,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn2c(-c3ccc4cccc(OCC(C)(C)CN)c4n3)nnc2c1,,,CHEMBL3639321,,2013,"{'bei': '18.83', 'le': '0.34', 'lle': '3.19', 'sei': '8.69'}",CHEMBL3664622,,CHEMBL3664622,6.81,0,http://www.openphacts.org/units/Nanomolar,2539574,=,37,1,=,,IC50,nM,,156.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,156.0,PAK4
,222658,17611253,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,F[C@@H]1CNCCC1Oc1cccc2ccc(-c3nnc4cc(Cl)ccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '15.08', 'le': '0.29', 'lle': '2.32', 'sei': '9.33'}",CHEMBL3664623,,CHEMBL3664623,6.00,0,http://www.openphacts.org/units/Nanomolar,2539575,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222659,17611254,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1(COc2cccc3ccc(-c4nnc5cc(C)ccn45)nc23)CCNCC1,,,CHEMBL3639321,,2013,"{'bei': '15.78', 'le': '0.29', 'lle': '2.97', 'sei': '8.65'}",CHEMBL3664624,,CHEMBL3664624,6.37,0,http://www.openphacts.org/units/Nanomolar,2539576,=,37,1,=,,IC50,nM,,429.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,429.1,PAK4
,222660,17611255,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OCC2CNCCO2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '17.85', 'le': '0.33', 'lle': '4.14', 'sei': '8.77'}",CHEMBL3664625,,CHEMBL3664625,6.45,0,http://www.openphacts.org/units/Nanomolar,2539577,=,37,1,=,,IC50,nM,,353.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,353.7,PAK4
,222661,17611256,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OC2CCCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '17.69', 'le': '0.32', 'lle': '2.89', 'sei': '9.88'}",CHEMBL3660050,,CHEMBL3660050,6.36,0,http://www.openphacts.org/units/Nanomolar,2534594,=,37,1,=,,IC50,nM,,437.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,437.7,PAK4
,222662,17611257,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(OC2CCCNCC2)c2nc(-c3nnc4ccccn34)ccc2c1,,,CHEMBL3639321,,2013,"{'bei': '16.69', 'le': '0.30', 'lle': '2.53', 'sei': '9.33'}",CHEMBL3660050,,CHEMBL3660050,6.00,0,http://www.openphacts.org/units/Nanomolar,2534594,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222663,17611258,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCCC1,,,CHEMBL3639321,,2013,"{'bei': '16.07', 'le': '0.29', 'lle': '2.16', 'sei': '7.66'}",CHEMBL3664626,,CHEMBL3664626,6.00,0,http://www.openphacts.org/units/Nanomolar,2539578,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222664,17611259,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(CO)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '17.22', 'le': '0.32', 'lle': '2.66', 'sei': '8.27'}",CHEMBL3664627,,CHEMBL3664627,6.00,0,http://www.openphacts.org/units/Nanomolar,2539579,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222665,17611260,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(CC)(CO)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '15.94', 'le': '0.29', 'lle': '1.88', 'sei': '8.27'}",CHEMBL3664628,,CHEMBL3664628,6.00,0,http://www.openphacts.org/units/Nanomolar,2539580,=,37,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,222666,17611261,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CCN)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '19.69', 'le': '0.36', 'lle': '3.42', 'sei': '9.09'}",CHEMBL3664629,,CHEMBL3664629,7.12,0,http://www.openphacts.org/units/Nanomolar,2539581,=,37,1,=,,IC50,nM,,76.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,76.5,PAK4
,222667,17611262,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCCNC1,,,CHEMBL3639321,,2013,"{'bei': '18.15', 'le': '0.33', 'lle': '3.43', 'sei': '10.64'}",CHEMBL3664630,,CHEMBL3664630,6.85,0,http://www.openphacts.org/units/Nanomolar,2539582,=,37,1,=,,IC50,nM,,141.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,141.6,PAK4
,222668,17611263,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CNC(=O)CF)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '14.78', 'le': '0.27', 'lle': '2.58', 'sei': '7.40'}",CHEMBL3664631,,CHEMBL3664631,6.02,0,http://www.openphacts.org/units/Nanomolar,2539583,=,37,1,=,,IC50,nM,,951.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,951.8,PAK4
,222669,17611264,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CNCC(F)F)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '15.30', 'le': '0.29', 'lle': '2.10', 'sei': '9.79'}",CHEMBL3664632,,CHEMBL3664632,6.30,0,http://www.openphacts.org/units/Nanomolar,2539584,=,37,1,=,,IC50,nM,,506.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,506.2,PAK4
,222670,17611265,[],CHEMBL3705115,"PIM-2 Enzyme Assay: The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 4 uM [gamma-33P] ATP (20 uCi/mL), 1.0 uM PIM2tide and 1.5 nM PIM-2 in place of PIM-1.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CNCC(F)(F)F)COc1cccc2ccc(-c3nnc4ccccn34)nc12,,,CHEMBL3639321,,2013,"{'bei': '15.00', 'le': '0.28', 'lle': '1.94', 'sei': '10.01'}",CHEMBL3664633,,CHEMBL3664633,6.44,0,http://www.openphacts.org/units/Nanomolar,2539585,=,37,1,=,,IC50,nM,,361.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,361.9,PAK4
,254199,17637022,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1C=C(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CCC1,,,CHEMBL3638844,,2014,"{'bei': '14.92', 'le': '0.27', 'lle': '0.80', 'sei': '8.35'}",CHEMBL3685734,,CHEMBL3685734,6.41,0,http://www.openphacts.org/units/Nanomolar,2561986,=,37,1,=,,IC50,nM,,392.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,392.0,PAK4
,254200,17637023,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CC[C@@H]1O,,,CHEMBL3638844,,2014,"{'bei': '15.71', 'le': '0.29', 'lle': '3.44', 'sei': '7.03'}",CHEMBL3685735,,CHEMBL3685735,7.05,0,http://www.openphacts.org/units/Nanomolar,2561987,=,37,1,=,,IC50,nM,,90.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,90.0,PAK4
,254201,17637024,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CC[C@H]1O,,,CHEMBL3638844,,2014,"{'bei': '14.80', 'le': '0.27', 'lle': '3.03', 'sei': '6.63'}",CHEMBL3685736,,CHEMBL3685736,6.64,0,http://www.openphacts.org/units/Nanomolar,2561988,=,37,1,=,,IC50,nM,,230.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,230.0,PAK4
,254202,17637025,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](O)CN(c2ccncc2Nc2cccc3ccc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '14.06', 'le': '0.26', 'lle': '2.07', 'sei': '7.21'}",CHEMBL3685737,,CHEMBL3685737,6.29,0,http://www.openphacts.org/units/Nanomolar,2561989,=,37,1,=,,IC50,nM,,512.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,512.0,PAK4
,254203,17637026,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](CO)CN(c2ccncc2Nc2cccc3ccc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '14.18', 'le': '0.26', 'lle': '2.08', 'sei': '7.50'}",CHEMBL3685738,,CHEMBL3685738,6.54,0,http://www.openphacts.org/units/Nanomolar,2561990,=,37,1,=,,IC50,nM,,286.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,286.0,PAK4
,254204,17637027,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CCO[C@@H]1C[C@H](N)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '13.30', 'le': '0.25', 'lle': '1.68', 'sei': '7.11'}",CHEMBL3685739,,CHEMBL3685739,6.34,0,http://www.openphacts.org/units/Nanomolar,2561991,=,37,1,=,,IC50,nM,,460.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,460.0,PAK4
,254205,17637028,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '12.59', 'le': '0.23', 'lle': '0.80', 'sei': '6.81'}",CHEMBL3685740,,CHEMBL3685740,5.44,0,http://www.openphacts.org/units/Nanomolar,2561992,=,37,1,=,,IC50,nM,,3600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3600.0,PAK4
,254206,17637029,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CC(N)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '12.52', 'le': '0.23', 'lle': '2.02', 'sei': '5.29'}",CHEMBL3685741,,CHEMBL3685741,5.60,0,http://www.openphacts.org/units/Nanomolar,2561993,=,37,1,=,,IC50,nM,,2500.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2500.0,PAK4
,254207,17637030,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CC[C@H]1F,,,CHEMBL3638844,,2014,"{'bei': '13.99', 'le': '0.26', 'lle': '1.71', 'sei': '7.88'}",CHEMBL3685742,,CHEMBL3685742,6.30,0,http://www.openphacts.org/units/Nanomolar,2561994,=,37,1,=,,IC50,nM,,498.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,498.0,PAK4
,254208,17637031,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)CC[C@@H]1F,,,CHEMBL3638844,,2014,,CHEMBL3685743,,CHEMBL3685743,,0,http://www.openphacts.org/units/Nanomolar,2561995,>,37,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25000.0,PAK4
,254209,17637032,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCCN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,,CHEMBL3685744,,CHEMBL3685744,,0,http://www.openphacts.org/units/Nanomolar,2561996,>,37,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25000.0,PAK4
,254210,17637033,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ncncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,,CHEMBL3639846,,CHEMBL3639846,,0,http://www.openphacts.org/units/Nanomolar,2561997,>,37,1,>,,IC50,nM,,25000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25000.0,PAK4
,254211,17637034,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](CF)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '16.57', 'le': '0.31', 'lle': '2.86', 'sei': '9.63'}",CHEMBL3685745,,CHEMBL3685745,7.70,0,http://www.openphacts.org/units/Nanomolar,2561998,=,37,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.0,PAK4
,254212,17637035,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](N)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '13.59', 'le': '0.25', 'lle': '1.18', 'sei': '7.59'}",CHEMBL3685746,,CHEMBL3685746,6.07,0,http://www.openphacts.org/units/Nanomolar,2561999,=,37,1,=,,IC50,nM,,852.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,852.0,PAK4
,254213,17637036,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '18.02', 'le': '0.33', 'lle': '3.16', 'sei': '10.06'}",CHEMBL3685747,,CHEMBL3685747,8.05,0,http://www.openphacts.org/units/Nanomolar,2562000,=,37,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,254214,17637037,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCN(c2ccncc2Nc2cccc3cnc(-c4nccs4)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '14.18', 'le': '0.27', 'lle': '1.90', 'sei': '6.16'}",CHEMBL3685748,,CHEMBL3685748,5.72,0,http://www.openphacts.org/units/Nanomolar,2562001,=,37,1,=,,IC50,nM,,1900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1900.0,PAK4
,254215,17637038,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2cccc3cnc(-c4c(F)cccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '17.36', 'le': '0.32', 'lle': '2.87', 'sei': '9.39'}",CHEMBL3685749,,CHEMBL3685749,7.51,0,http://www.openphacts.org/units/Nanomolar,2562002,=,37,1,=,,IC50,nM,,31.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,31.0,PAK4
,254216,17637039,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2cccc3cnc(-c4ccccc4F)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '16.61', 'le': '0.30', 'lle': '2.38', 'sei': '8.61'}",CHEMBL3685750,,CHEMBL3685750,6.88,0,http://www.openphacts.org/units/Nanomolar,2562003,=,37,1,=,,IC50,nM,,131.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,131.0,PAK4
,254217,17637040,[],CHEMBL3705221,"ATP Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 ul per well. To start the reaction, 10 ul of 10 nM Pim2 kinase and 20 uM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 ul of 8 uM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 uM ATP, 10 uM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 ul KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2cccc3cnc(-c4cccc(-c5nccs5)c4)nc23)C1,,,CHEMBL3638844,,2014,"{'bei': '11.88', 'le': '0.22', 'lle': '0.21', 'sei': '6.14'}",CHEMBL3685751,,CHEMBL3685751,5.70,0,http://www.openphacts.org/units/Nanomolar,2562004,=,37,1,=,,IC50,nM,,2000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2000.0,PAK4
,263961,17646453,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '19.49', 'le': '0.38', 'lle': '4.44', 'sei': '9.62'}",CHEMBL3676258,,CHEMBL3676258,8.10,0,http://www.openphacts.org/units/Nanomolar,2551998,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,263962,17646454,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@H]1O,,,CHEMBL3638819,,2014,"{'bei': '18.45', 'le': '0.36', 'lle': '5.33', 'sei': '7.63'}",CHEMBL3676259,,CHEMBL3676259,7.96,0,http://www.openphacts.org/units/Nanomolar,2551999,=,37,1,=,,IC50,nM,,11.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.0,PAK4
,263963,17646455,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@H]1F,,,CHEMBL3638819,,2014,"{'bei': '17.62', 'le': '0.35', 'lle': '4.03', 'sei': '9.08'}",CHEMBL3676260,,CHEMBL3676260,7.64,0,http://www.openphacts.org/units/Nanomolar,2552000,=,37,1,=,,IC50,nM,,23.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,23.0,PAK4
,263964,17646456,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](O)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '16.49', 'le': '0.32', 'lle': '4.48', 'sei': '6.82'}",CHEMBL3676261,,CHEMBL3676261,7.11,0,http://www.openphacts.org/units/Nanomolar,2552001,=,37,1,=,,IC50,nM,,77.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,77.0,PAK4
,263965,17646457,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@@H]1O,,,CHEMBL3638819,,2014,"{'bei': '19.75', 'le': '0.39', 'lle': '5.89', 'sei': '8.17'}",CHEMBL3676262,,CHEMBL3676262,8.52,0,http://www.openphacts.org/units/Nanomolar,2552002,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,263966,17646458,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,COC1CCN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC1N,,,CHEMBL3638819,,2014,"{'bei': '14.85', 'le': '0.29', 'lle': '3.32', 'sei': '7.08'}",CHEMBL3676263,,CHEMBL3676263,6.61,0,http://www.openphacts.org/units/Nanomolar,2552003,=,37,1,=,,IC50,nM,,243.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,243.0,PAK4
,263967,17646459,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '16.47', 'le': '0.32', 'lle': '4.05', 'sei': '7.86'}",CHEMBL3676264,,CHEMBL3676264,7.34,0,http://www.openphacts.org/units/Nanomolar,2552004,=,37,1,=,,IC50,nM,,46.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,46.0,PAK4
,263968,17646460,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@H](O)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '13.50', 'le': '0.27', 'lle': '3.19', 'sei': '5.58'}",CHEMBL3676265,,CHEMBL3676265,5.82,0,http://www.openphacts.org/units/Nanomolar,2552005,=,37,1,=,,IC50,nM,,1502.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1502.0,PAK4
,263969,17646461,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@H](OC(=O)c2ccccc2)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '11.80', 'le': '0.23', 'lle': '1.82', 'sei': '5.72'}",CHEMBL3676266,,CHEMBL3676266,6.32,0,http://www.openphacts.org/units/Nanomolar,2552006,=,37,1,=,,IC50,nM,,479.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,479.0,PAK4
,263970,17646462,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '16.75', 'le': '0.33', 'lle': '3.65', 'sei': '8.63'}",CHEMBL3676267,,CHEMBL3676267,7.26,0,http://www.openphacts.org/units/Nanomolar,2552007,=,37,1,=,,IC50,nM,,55.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,55.0,PAK4
,263971,17646463,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '17.33', 'le': '0.34', 'lle': '2.91', 'sei': '7.94'}",CHEMBL3676268,,CHEMBL3676268,6.68,0,http://www.openphacts.org/units/Nanomolar,2552008,=,37,1,=,,IC50,nM,,208.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,208.0,PAK4
,263972,17646464,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CC(CO)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '16.24', 'le': '0.32', 'lle': '4.36', 'sei': '6.93'}",CHEMBL3676269,,CHEMBL3676269,7.24,0,http://www.openphacts.org/units/Nanomolar,2552009,=,37,1,=,,IC50,nM,,58.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,58.0,PAK4
,263973,17646465,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CC(N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '19.55', 'le': '0.38', 'lle': '4.49', 'sei': '9.98'}",CHEMBL3676270,,CHEMBL3676270,8.40,0,http://www.openphacts.org/units/Nanomolar,2552010,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,263974,17646466,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CC(C(F)(F)F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '17.63', 'le': '0.35', 'lle': '4.07', 'sei': '10.13'}",CHEMBL3676271,,CHEMBL3676271,8.52,0,http://www.openphacts.org/units/Nanomolar,2552011,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,263975,17646467,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CC(CF)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '19.05', 'le': '0.38', 'lle': '4.66', 'sei': '10.13'}",CHEMBL3676272,,CHEMBL3676272,8.52,0,http://www.openphacts.org/units/Nanomolar,2552012,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,263976,17646468,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@H](F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '16.51', 'le': '0.33', 'lle': '3.54', 'sei': '8.50'}",CHEMBL3676273,,CHEMBL3676273,7.16,0,http://www.openphacts.org/units/Nanomolar,2552013,=,37,1,=,,IC50,nM,,70.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,70.0,PAK4
,263977,17646469,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CCC1Cl,,,CHEMBL3638819,,2014,"{'bei': '16.15', 'le': '0.33', 'lle': '3.39', 'sei': '8.64'}",CHEMBL3676274,,CHEMBL3676274,7.27,0,http://www.openphacts.org/units/Nanomolar,2552014,=,37,1,=,,IC50,nM,,54.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,54.0,PAK4
,263978,17646470,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC1N,,,CHEMBL3638819,,2014,"{'bei': '18.85', 'le': '0.37', 'lle': '4.19', 'sei': '9.62'}",CHEMBL3676275,,CHEMBL3676275,8.10,0,http://www.openphacts.org/units/Nanomolar,2552015,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,263979,17646471,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CC(N)CN(c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '19.38', 'le': '0.38', 'lle': '3.73', 'sei': '9.20'}",CHEMBL3676276,,CHEMBL3676276,7.75,0,http://www.openphacts.org/units/Nanomolar,2552016,=,37,1,=,,IC50,nM,,18.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,18.0,PAK4
,263980,17646472,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CC(C(F)(F)F)CN(c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '16.93', 'le': '0.34', 'lle': '3.13', 'sei': '9.13'}",CHEMBL3676277,,CHEMBL3676277,7.68,0,http://www.openphacts.org/units/Nanomolar,2552017,=,37,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.0,PAK4
,263981,17646473,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '14.42', 'le': '0.28', 'lle': '3.13', 'sei': '6.88'}",CHEMBL3676278,,CHEMBL3676278,6.42,0,http://www.openphacts.org/units/Nanomolar,2552018,=,37,1,=,,IC50,nM,,378.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,378.0,PAK4
,263982,17646474,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CCO[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '15.39', 'le': '0.30', 'lle': '3.39', 'sei': '7.57'}",CHEMBL3676279,,CHEMBL3676279,7.07,0,http://www.openphacts.org/units/Nanomolar,2552019,=,37,1,=,,IC50,nM,,85.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,85.0,PAK4
,263983,17646475,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC(F)(F)C1,,,CHEMBL3638819,,2014,"{'bei': '16.44', 'le': '0.33', 'lle': '3.51', 'sei': '8.82'}",CHEMBL3676280,,CHEMBL3676280,7.42,0,http://www.openphacts.org/units/Nanomolar,2552020,=,37,1,=,,IC50,nM,,38.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,38.0,PAK4
,263984,17646476,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '19.22', 'le': '0.38', 'lle': '4.22', 'sei': '10.13'}",CHEMBL3676281,,CHEMBL3676281,8.52,0,http://www.openphacts.org/units/Nanomolar,2552021,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,263985,17646477,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@@H](C(F)(F)F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '14.77', 'le': '0.30', 'lle': '2.69', 'sei': '8.49'}",CHEMBL3676282,,CHEMBL3676282,7.14,0,http://www.openphacts.org/units/Nanomolar,2552022,=,37,1,=,,IC50,nM,,72.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,72.0,PAK4
,263986,17646478,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](C(F)(F)F)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '17.63', 'le': '0.35', 'lle': '4.07', 'sei': '10.13'}",CHEMBL3676283,,CHEMBL3676283,8.52,0,http://www.openphacts.org/units/Nanomolar,2552023,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,263987,17646479,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '20.25', 'le': '0.40', 'lle': '4.79', 'sei': '10.34'}",CHEMBL3676284,,CHEMBL3676284,8.70,0,http://www.openphacts.org/units/Nanomolar,2552024,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,263988,17646480,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1N1CCC[C@H](N)C1,,,CHEMBL3638819,,2014,"{'bei': '20.21', 'le': '0.40', 'lle': '5.45', 'sei': '7.90'}",CHEMBL3676285,,CHEMBL3676285,8.70,0,http://www.openphacts.org/units/Nanomolar,2552025,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,263989,17646481,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1N1CCC(F)CC1,,,CHEMBL3638819,,2014,"{'bei': '16.75', 'le': '0.33', 'lle': '3.00', 'sei': '8.63'}",CHEMBL3676286,,CHEMBL3676286,7.26,0,http://www.openphacts.org/units/Nanomolar,2552026,=,37,1,=,,IC50,nM,,55.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,55.0,PAK4
,263990,17646482,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](O)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '16.40', 'le': '0.32', 'lle': '2.05', 'sei': '9.38'}",CHEMBL3676287,,CHEMBL3676287,7.05,0,http://www.openphacts.org/units/Nanomolar,2552027,=,37,1,=,,IC50,nM,,90.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,90.0,PAK4
,263991,17646483,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](O)C[C@H](c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)sc2N)C1,,,CHEMBL3638819,,2014,"{'bei': '18.67', 'le': '0.37', 'lle': '3.72', 'sei': '8.21'}",CHEMBL3676288,,CHEMBL3676288,8.30,0,http://www.openphacts.org/units/Nanomolar,2552028,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,263992,17646484,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CCC[C@H](N)C1,,,CHEMBL3638819,,2014,"{'bei': '19.84', 'le': '0.39', 'lle': '4.22', 'sei': '7.97'}",CHEMBL3676289,,CHEMBL3676289,8.52,0,http://www.openphacts.org/units/Nanomolar,2552029,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,263993,17646485,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '18.19', 'le': '0.35', 'lle': '2.82', 'sei': '9.32'}",CHEMBL3676290,,CHEMBL3676290,7.54,0,http://www.openphacts.org/units/Nanomolar,2552030,=,37,1,=,,IC50,nM,,29.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.0,PAK4
,263994,17646486,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,,,CHEMBL3638819,,2014,"{'bei': '15.50', 'le': '0.30', 'lle': '4.02', 'sei': '6.61'}",CHEMBL3676291,,CHEMBL3676291,6.90,0,http://www.openphacts.org/units/Nanomolar,2552031,=,37,1,=,,IC50,nM,,125.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,125.0,PAK4
,263995,17646487,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638819,,2014,"{'bei': '19.13', 'le': '0.38', 'lle': '5.64', 'sei': '8.17'}",CHEMBL3676292,,CHEMBL3676292,8.52,0,http://www.openphacts.org/units/Nanomolar,2552032,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,263996,17646488,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@@H]1O,,,CHEMBL3638819,,2014,"{'bei': '16.28', 'le': '0.32', 'lle': '3.32', 'sei': '6.93'}",CHEMBL3676293,,CHEMBL3676293,7.01,0,http://www.openphacts.org/units/Nanomolar,2552033,=,37,1,=,,IC50,nM,,98.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,98.0,PAK4
,263997,17646489,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1sc(-c2c(F)cccc2F)nc1C(=O)Nc1cnccc1[C@@H]1CC[C@H](O)[C@H](N)C1,,,CHEMBL3638819,,2014,"{'bei': '18.85', 'le': '0.37', 'lle': '5.13', 'sei': '6.60'}",CHEMBL3676294,,CHEMBL3676294,8.40,0,http://www.openphacts.org/units/Nanomolar,2552034,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,263998,17646490,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)CC[C@H]1O,,,CHEMBL3638819,,2014,"{'bei': '16.31', 'le': '0.32', 'lle': '3.33', 'sei': '6.94'}",CHEMBL3676295,,CHEMBL3676295,7.02,0,http://www.openphacts.org/units/Nanomolar,2552035,=,37,1,=,,IC50,nM,,95.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,95.0,PAK4
,263999,17646491,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '17.60', 'le': '0.34', 'lle': '1.94', 'sei': '8.67'}",CHEMBL3676296,,CHEMBL3676296,7.01,0,http://www.openphacts.org/units/Nanomolar,2552036,=,37,1,=,,IC50,nM,,97.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,97.0,PAK4
,264000,17646492,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@@H]1O,,,CHEMBL3638819,,2014,"{'bei': '17.03', 'le': '0.33', 'lle': '3.63', 'sei': '7.48'}",CHEMBL3676297,,CHEMBL3676297,7.57,0,http://www.openphacts.org/units/Nanomolar,2552037,=,37,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,264001,17646493,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C[C@H](c2ccncc2NC(=O)c2csc(C3CCCCC3)n2)C[C@H](N)[C@H]1O,,,CHEMBL3638819,,2014,"{'bei': '15.89', 'le': '0.31', 'lle': '3.87', 'sei': '5.19'}",CHEMBL3676298,,CHEMBL3676298,6.60,0,http://www.openphacts.org/units/Nanomolar,2552038,=,37,1,=,,IC50,nM,,250.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,250.0,PAK4
,264002,17646494,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1O,,,CHEMBL3638819,,2014,"{'bei': '16.51', 'le': '0.32', 'lle': '3.40', 'sei': '7.26'}",CHEMBL3676299,,CHEMBL3676299,7.34,0,http://www.openphacts.org/units/Nanomolar,2552039,=,37,1,=,,IC50,nM,,46.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,46.0,PAK4
,264003,17646495,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '19.03', 'le': '0.37', 'lle': '3.18', 'sei': '10.08'}",CHEMBL3676300,,CHEMBL3676300,8.15,0,http://www.openphacts.org/units/Nanomolar,2552040,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,264004,17646496,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '17.62', 'le': '0.34', 'lle': '2.44', 'sei': '9.64'}",CHEMBL3676301,,CHEMBL3676301,7.80,0,http://www.openphacts.org/units/Nanomolar,2552041,=,37,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.0,PAK4
,264005,17646497,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(-c3ccccc3)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '20.43', 'le': '0.39', 'lle': '4.37', 'sei': '9.21'}",CHEMBL3676302,,CHEMBL3676302,7.75,0,http://www.openphacts.org/units/Nanomolar,2552042,=,37,1,=,,IC50,nM,,17.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.7,PAK4
,264006,17646498,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2NC(=O)c2csc(-c3ccccc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '20.14', 'le': '0.39', 'lle': '4.48', 'sei': '9.51'}",CHEMBL3676303,,CHEMBL3676303,8.00,0,http://www.openphacts.org/units/Nanomolar,2552043,=,37,1,=,,IC50,nM,,9.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.9,PAK4
,264007,17646499,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)NC(=O)c1ccc(F)c(-c2nc(C(=O)Nc3cnccc3N3CCC[C@H](N)C3)cs2)c1,,,CHEMBL3638819,,2014,"{'bei': '14.66', 'le': '0.28', 'lle': '3.42', 'sei': '6.25'}",CHEMBL3676304,,CHEMBL3676304,7.08,0,http://www.openphacts.org/units/Nanomolar,2552044,=,37,1,=,,IC50,nM,,83.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,83.8,PAK4
,264008,17646500,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)cs2)c1F,,,CHEMBL3638819,,2014,"{'bei': '18.31', 'le': '0.36', 'lle': '3.42', 'sei': '9.32'}",CHEMBL3676305,,CHEMBL3676305,8.40,0,http://www.openphacts.org/units/Nanomolar,2552045,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,264009,17646501,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)cs2)c1F,,,CHEMBL3638819,,2014,"{'bei': '15.82', 'le': '0.31', 'lle': '1.95', 'sei': '8.54'}",CHEMBL3676306,,CHEMBL3676306,7.70,0,http://www.openphacts.org/units/Nanomolar,2552046,=,37,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.0,PAK4
,264010,17646502,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(F)c(-c2nc(C(=O)Nc3cnccc3[C@@H]3C[C@H](C)C[C@H](N)C3)cs2)c1F,,,CHEMBL3638819,,2014,"{'bei': '17.03', 'le': '0.33', 'lle': '2.68', 'sei': '8.93'}",CHEMBL3676307,,CHEMBL3676307,8.05,0,http://www.openphacts.org/units/Nanomolar,2552047,=,37,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,264011,17646503,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)ccc(F)c3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '17.52', 'le': '0.34', 'lle': '2.71', 'sei': '9.67'}",CHEMBL3676308,,CHEMBL3676308,7.82,0,http://www.openphacts.org/units/Nanomolar,2552048,=,37,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.0,PAK4
,264012,17646504,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)ccc(Cl)c3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '17.11', 'le': '0.35', 'lle': '2.30', 'sei': '9.79'}",CHEMBL3676309,,CHEMBL3676309,7.92,0,http://www.openphacts.org/units/Nanomolar,2552049,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,264013,17646505,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2csc(-c3c(F)cc(O)cc3F)n2)C1,,,CHEMBL3638819,,2014,"{'bei': '18.89', 'le': '0.37', 'lle': '3.73', 'sei': '8.30'}",CHEMBL3676310,,CHEMBL3676310,8.40,0,http://www.openphacts.org/units/Nanomolar,2552050,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,264014,17646506,[],CHEMBL3706072,"Depletion Assay: The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed into white 384-well plates at 0.5 piper well. To start the reaction, 10 μl of 10 nM Pim2 kinase and 20 μM BAD peptide (RSRHSSYPAGT-OH) in assay buffer (50 mM HEPES pH 7.5, 5 mM MgCl2, and 1 mM DTT, 0.05% BSA) is added into each well. After 15 minutes, 10 μl of 8 μM ATP in assay buffer is added. Final assay concentrations are 5 nM PIM2, 4 μM ATP, 10 μM BAD peptide and 2.5% DMSO. The reaction is performed until approximately 50% of the ATP is depleted, then stopped with the addition of 20 μl KinaseGlo Plus (Promega Corporation) solution. The stopped reaction is incubated for 10 minutes and the remaining ATP detected via luminescence on the Victor2 (Perkin Elmer).",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](c2ccncc2NC(=O)c2csc(-c3c(F)cccc3F)n2)C[C@@H](N)[C@H]1F,,,CHEMBL3638819,,2014,"{'bei': '16.41', 'le': '0.32', 'lle': '2.42', 'sei': '9.06'}",CHEMBL3676311,,CHEMBL3676311,7.33,0,http://www.openphacts.org/units/Nanomolar,2552051,=,37,1,=,,IC50,nM,,47.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,47.0,PAK4
,330368,17708958,[],CHEMBL3887311,"Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28 ii. Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5Â  uM ATP=4 uM.Â  33P gamma ATP=1 nM iii. Robotized Dowex AssaySee above: same procedure as described for PIM1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3886268,,2015,"{'bei': '14.51', 'le': '0.28', 'lle': '3.63', 'sei': '10.68'}",CHEMBL3297762,,CHEMBL3297762,7.43,0,http://www.openphacts.org/units/Nanomolar,2841125,=,37,1,=,,IC50,nM,,37.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,37.0,PAK4
,330369,17708959,[],CHEMBL3887311,"Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28 ii. Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5Â  uM ATP=4 uM.Â  33P gamma ATP=1 nM iii. Robotized Dowex AssaySee above: same procedure as described for PIM1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4ccc(F)c(F)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3886268,,2015,"{'bei': '12.49', 'le': '0.24', 'lle': '2.57', 'sei': '9.72'}",CHEMBL3916318,,CHEMBL3916318,6.77,0,http://www.openphacts.org/units/Nanomolar,2841126,=,37,1,=,,IC50,nM,,171.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,171.0,PAK4
,330370,17708960,[],CHEMBL3887311,"Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28 ii. Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5Â  uM ATP=4 uM.Â  33P gamma ATP=1 nM iii. Robotized Dowex AssaySee above: same procedure as described for PIM1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4ccnc(F)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3886268,,2015,"{'bei': '13.81', 'le': '0.26', 'lle': '3.79', 'sei': '8.78'}",CHEMBL3961921,,CHEMBL3961921,7.24,0,http://www.openphacts.org/units/Nanomolar,2841127,=,37,1,=,,IC50,nM,,57.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,57.0,PAK4
,330371,17708961,[],CHEMBL3887311,"Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28 ii. Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5Â  uM ATP=4 uM.Â  33P gamma ATP=1 nM iii. Robotized Dowex AssaySee above: same procedure as described for PIM1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1,,,CHEMBL3886268,,2015,"{'bei': '13.78', 'le': '0.27', 'lle': '2.87', 'sei': '10.69'}",CHEMBL3297766,,CHEMBL3297766,7.44,1,http://www.openphacts.org/units/Nanomolar,2841128,=,37,1,=,,IC50,nM,,36.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,36.0,PAK4
,330372,17708962,[],CHEMBL3887311,"Kinase Inhibition Assay: Method for PIM2 Kinase Inhibition Assay: Dowex Technique i. Kinase Buffer (KB)The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28 ii. Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5Â  uM ATP=4 uM.Â  33P gamma ATP=1 nM iii. Robotized Dowex AssaySee above: same procedure as described for PIM1.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cc(Cl)ccc4F)cn32)C2CCCCC2)CC1,,,CHEMBL3886268,,2015,"{'bei': '12.98', 'le': '0.25', 'lle': '2.95', 'sei': '9.88'}",CHEMBL3297764,,CHEMBL3297764,6.88,1,http://www.openphacts.org/units/Nanomolar,2841129,=,37,1,=,,IC50,nM,,132.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,132.0,PAK4
,341741,17719276,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,,,CHEMBL3886350,,2015,"{'bei': '17.48', 'le': '0.33', 'lle': '2.91', 'sei': '10.48'}",CHEMBL3921910,,CHEMBL3921910,7.26,0,http://www.openphacts.org/units/Nanomolar,2848504,=,37,1,=,,IC50,nM,,55.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,55.0,PAK4
,341742,17719277,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccsc3)n21,,,CHEMBL3886350,,2015,"{'bei': '16.24', 'le': '0.32', 'lle': '2.42', 'sei': '9.88'}",CHEMBL3973086,,CHEMBL3973086,6.84,0,http://www.openphacts.org/units/Nanomolar,2848505,=,37,1,=,,IC50,nM,,143.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,143.0,PAK4
,341743,17719278,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cc(Cl)ccc3F)c(-c3ccsc3)n21,,,CHEMBL3886350,,2015,"{'bei': '18.25', 'le': '0.37', 'lle': '2.80', 'sei': '11.85'}",CHEMBL3896585,,CHEMBL3896585,7.11,0,http://www.openphacts.org/units/Nanomolar,2848506,=,37,1,=,,IC50,nM,,77.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,77.0,PAK4
,341744,17719279,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cc(Cl)ccc3F)c(-c3ccccc3)n21,,,CHEMBL3886350,,2015,"{'bei': '19.53', 'le': '0.38', 'lle': '3.24', 'sei': '12.48'}",CHEMBL3967769,,CHEMBL3967769,7.50,0,http://www.openphacts.org/units/Nanomolar,2848507,=,37,1,=,,IC50,nM,,32.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,32.0,PAK4
,341745,17719280,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3C(CCOC(=O)C(F)(F)F)CNC4=O)cc2)CC1,,,CHEMBL3886350,,2015,"{'bei': '11.94', 'le': '0.23', 'lle': '2.21', 'sei': '9.81'}",CHEMBL3903884,,CHEMBL3903884,7.46,0,http://www.openphacts.org/units/Nanomolar,2848508,=,37,1,=,,IC50,nM,,35.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.0,PAK4
,341746,17719281,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCOC(=O)C(F)(F)F)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '13.03', 'le': '0.25', 'lle': '1.86', 'sei': '10.19'}",CHEMBL3966701,,CHEMBL3966701,7.42,0,http://www.openphacts.org/units/Nanomolar,2848509,=,37,1,=,,IC50,nM,,38.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,38.0,PAK4
,341747,17719282,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccsc3)n21,,,CHEMBL3886350,,2015,"{'bei': '16.99', 'le': '0.34', 'lle': '2.74', 'sei': '10.34'}",CHEMBL3911078,,CHEMBL3911078,7.16,0,http://www.openphacts.org/units/Nanomolar,2848510,=,37,1,=,,IC50,nM,,69.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,69.0,PAK4
,341748,17719283,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,,,CHEMBL3886350,,2015,"{'bei': '17.86', 'le': '0.34', 'lle': '3.07', 'sei': '10.71'}",CHEMBL3981107,,CHEMBL3981107,7.42,0,http://www.openphacts.org/units/Nanomolar,2848511,=,37,1,=,,IC50,nM,,38.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,38.0,PAK4
,341749,17719284,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)c1,,,CHEMBL3886350,,2015,"{'bei': '18.22', 'le': '0.34', 'lle': '3.16', 'sei': '11.29'}",CHEMBL3935063,,CHEMBL3935063,7.82,0,http://www.openphacts.org/units/Nanomolar,2848512,=,37,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.0,PAK4
,341750,17719285,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cccc(Cl)c3)c(-c3ccccc3)n21,,,CHEMBL3886350,,2015,"{'bei': '18.95', 'le': '0.36', 'lle': '2.82', 'sei': '11.54'}",CHEMBL3980052,,CHEMBL3980052,6.93,0,http://www.openphacts.org/units/Nanomolar,2848513,=,37,1,=,,IC50,nM,,117.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,117.0,PAK4
,341751,17719286,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCN)CNC3=O)c1,,,CHEMBL3886350,,2015,"{'bei': '16.98', 'le': '0.32', 'lle': '2.63', 'sei': '10.53'}",CHEMBL3966555,,CHEMBL3966555,7.29,0,http://www.openphacts.org/units/Nanomolar,2848514,=,37,1,=,,IC50,nM,,51.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,51.0,PAK4
,341752,17719287,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3cccc(N)c3)n21,,,CHEMBL3886350,,2015,"{'bei': '16.64', 'le': '0.32', 'lle': '3.22', 'sei': '7.51'}",CHEMBL3891696,,CHEMBL3891696,7.16,0,http://www.openphacts.org/units/Nanomolar,2848515,=,37,1,=,,IC50,nM,,69.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,69.0,PAK4
,341753,17719288,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c(-c3cc(Cl)ccc3F)cc3n2C(CCN)CNC3=O)c1,,,CHEMBL3886350,,2015,"{'bei': '17.45', 'le': '0.34', 'lle': '2.38', 'sei': '11.56'}",CHEMBL3952009,,CHEMBL3952009,6.94,0,http://www.openphacts.org/units/Nanomolar,2848516,=,37,1,=,,IC50,nM,,114.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,114.0,PAK4
,341754,17719289,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(CO)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '17.56', 'le': '0.33', 'lle': '3.97', 'sei': '8.74'}",CHEMBL3980874,,CHEMBL3980874,7.82,0,http://www.openphacts.org/units/Nanomolar,2848517,=,37,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.0,PAK4
,341755,17719290,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)c(-c3ccc(CO)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '16.28', 'le': '0.31', 'lle': '3.02', 'sei': '8.71'}",CHEMBL3943279,,CHEMBL3943279,6.99,0,http://www.openphacts.org/units/Nanomolar,2848518,=,37,1,=,,IC50,nM,,102.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,102.0,PAK4
,341756,17719291,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)c(-c3ccsc3)n21,,,CHEMBL3886350,,2015,"{'bei': '16.80', 'le': '0.33', 'lle': '2.27', 'sei': '11.34'}",CHEMBL3919956,,CHEMBL3919956,6.81,0,http://www.openphacts.org/units/Nanomolar,2848519,=,37,1,=,,IC50,nM,,155.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,155.0,PAK4
,341757,17719292,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3ccnc(Cl)c3)c(-c3ccc(CO)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '17.53', 'le': '0.34', 'lle': '3.96', 'sei': '7.47'}",CHEMBL3917379,,CHEMBL3917379,6.96,0,http://www.openphacts.org/units/Nanomolar,2848520,=,37,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,110.0,PAK4
,341758,17719293,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c(-c3ccnc(Cl)c3)cc3n2C(CCN)CNC3=O)c1,,,CHEMBL3886350,,2015,"{'bei': '18.36', 'le': '0.35', 'lle': '3.18', 'sei': '9.59'}",CHEMBL3967508,,CHEMBL3967508,6.99,0,http://www.openphacts.org/units/Nanomolar,2848521,=,37,1,=,,IC50,nM,,102.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,102.0,PAK4
,341759,17719294,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC1CNC(=O)c2cc(-c3cccc(C(F)(F)F)c3)c(-c3ccc(O)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '18.48', 'le': '0.35', 'lle': '3.50', 'sei': '9.56'}",CHEMBL3928863,,CHEMBL3928863,7.68,0,http://www.openphacts.org/units/Nanomolar,2848522,=,37,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.0,PAK4
,341760,17719295,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCO)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '15.75', 'le': '0.30', 'lle': '3.75', 'sei': '6.79'}",CHEMBL3953089,,CHEMBL3953089,7.24,0,http://www.openphacts.org/units/Nanomolar,2848523,=,37,1,=,,IC50,nM,,58.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,58.0,PAK4
,341761,17719296,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCO)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '14.42', 'le': '0.27', 'lle': '2.94', 'sei': '8.39'}",CHEMBL3914356,,CHEMBL3914356,7.03,0,http://www.openphacts.org/units/Nanomolar,2848524,=,37,1,=,,IC50,nM,,93.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,93.0,PAK4
,341762,17719297,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCO)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '13.28', 'le': '0.25', 'lle': '3.37', 'sei': '7.35'}",CHEMBL3984169,,CHEMBL3984169,7.05,0,http://www.openphacts.org/units/Nanomolar,2848525,=,37,1,=,,IC50,nM,,90.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,90.0,PAK4
,341763,17719298,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3C(CCO)CNC4=O)cc2)CC1,,,CHEMBL3886350,,2015,"{'bei': '12.87', 'le': '0.24', 'lle': '2.95', 'sei': '7.47'}",CHEMBL3923364,,CHEMBL3923364,7.16,0,http://www.openphacts.org/units/Nanomolar,2848526,=,37,1,=,,IC50,nM,,69.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,69.0,PAK4
,341764,17719299,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCO)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '15.05', 'le': '0.29', 'lle': '3.37', 'sei': '7.70'}",CHEMBL3898842,,CHEMBL3898842,7.12,0,http://www.openphacts.org/units/Nanomolar,2848527,=,37,1,=,,IC50,nM,,75.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,75.0,PAK4
,341765,17719300,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCC(CCO)n2c1cc(-c1cccc(OC(F)(F)F)c1)c2-c1ccc(CO)cc1,,,CHEMBL3886350,,2015,"{'bei': '15.78', 'le': '0.30', 'lle': '3.17', 'sei': '8.42'}",CHEMBL3952159,,CHEMBL3952159,7.05,0,http://www.openphacts.org/units/Nanomolar,2848528,=,37,1,=,,IC50,nM,,90.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,90.0,PAK4
,341766,17719301,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(O)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '18.07', 'le': '0.34', 'lle': '3.74', 'sei': '8.71'}",CHEMBL3971118,,CHEMBL3971118,7.80,0,http://www.openphacts.org/units/Nanomolar,2848529,=,37,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.0,PAK4
,341767,17719302,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2C(CCCl)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '14.12', 'le': '0.28', 'lle': '1.25', 'sei': '14.94'}",CHEMBL3909000,,CHEMBL3909000,6.95,0,http://www.openphacts.org/units/Nanomolar,2848530,=,37,1,=,,IC50,nM,,113.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,113.0,PAK4
,341768,17719303,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3C(CCCl)CNC4=O)cc2)CC1,,,CHEMBL3886350,,2015,"{'bei': '13.45', 'le': '0.26', 'lle': '1.98', 'sei': '14.79'}",CHEMBL3976139,,CHEMBL3976139,7.36,0,http://www.openphacts.org/units/Nanomolar,2848531,=,37,1,=,,IC50,nM,,44.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,44.0,PAK4
,341769,17719304,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(F)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '17.46', 'le': '0.33', 'lle': '3.08', 'sei': '10.92'}",CHEMBL3963636,,CHEMBL3963636,7.57,0,http://www.openphacts.org/units/Nanomolar,2848532,=,37,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,341770,17719305,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '16.98', 'le': '0.32', 'lle': '3.21', 'sei': '9.00'}",CHEMBL3970295,,CHEMBL3970295,7.77,0,http://www.openphacts.org/units/Nanomolar,2848533,=,37,1,=,,IC50,nM,,17.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.0,PAK4
,341771,17719306,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '17.27', 'le': '0.34', 'lle': '4.76', 'sei': '8.24'}",CHEMBL3949477,,CHEMBL3949477,8.52,0,http://www.openphacts.org/units/Nanomolar,2848534,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,341772,17719307,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(C=O)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '17.27', 'le': '0.33', 'lle': '3.49', 'sei': '8.87'}",CHEMBL3925205,,CHEMBL3925205,7.66,0,http://www.openphacts.org/units/Nanomolar,2848535,=,37,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.0,PAK4
,341773,17719308,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(CN4CCOCC4)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '15.85', 'le': '0.30', 'lle': '3.96', 'sei': '9.98'}",CHEMBL3940702,,CHEMBL3940702,8.15,0,http://www.openphacts.org/units/Nanomolar,2848536,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,341774,17719309,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3[C@@H](CCN)CNC4=O)cc2)CC1,,,CHEMBL3886350,,2015,"{'bei': '16.49', 'le': '0.31', 'lle': '4.60', 'sei': '11.48'}",CHEMBL3912707,,CHEMBL3912707,8.70,0,http://www.openphacts.org/units/Nanomolar,2848537,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,341775,17719310,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '17.03', 'le': '0.32', 'lle': '3.63', 'sei': '11.09'}",CHEMBL3935180,,CHEMBL3935180,8.05,0,http://www.openphacts.org/units/Nanomolar,2848538,=,37,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,341776,17719311,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,,,CHEMBL3886350,,2015,"{'bei': '15.85', 'le': '0.30', 'lle': '2.07', 'sei': '9.83'}",CHEMBL3903697,,CHEMBL3903697,6.81,0,http://www.openphacts.org/units/Nanomolar,2848539,=,37,1,=,,IC50,nM,,156.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,156.0,PAK4
,341777,17719312,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccsc3)n21,,,CHEMBL3886350,,2015,"{'bei': '15.65', 'le': '0.31', 'lle': '2.01', 'sei': '9.84'}",CHEMBL3926281,,CHEMBL3926281,6.82,0,http://www.openphacts.org/units/Nanomolar,2848540,=,37,1,=,,IC50,nM,,153.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,153.0,PAK4
,341778,17719313,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(O)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '16.43', 'le': '0.31', 'lle': '2.87', 'sei': '8.18'}",CHEMBL3898204,,CHEMBL3898204,7.32,0,http://www.openphacts.org/units/Nanomolar,2848541,=,37,1,=,,IC50,nM,,48.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,48.0,PAK4
,341779,17719314,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(CO)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '15.15', 'le': '0.29', 'lle': '2.72', 'sei': '7.78'}",CHEMBL3937689,,CHEMBL3937689,6.96,0,http://www.openphacts.org/units/Nanomolar,2848542,=,37,1,=,,IC50,nM,,109.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,109.0,PAK4
,341780,17719315,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '17.19', 'le': '0.33', 'lle': '3.30', 'sei': '9.75'}",CHEMBL3987026,,CHEMBL3987026,7.66,0,http://www.openphacts.org/units/Nanomolar,2848543,=,37,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.0,PAK4
,341781,17719316,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '16.00', 'le': '0.30', 'lle': '2.92', 'sei': '10.12'}",CHEMBL3951026,,CHEMBL3951026,7.34,0,http://www.openphacts.org/units/Nanomolar,2848544,=,37,1,=,,IC50,nM,,46.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,46.0,PAK4
,341782,17719317,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '14.61', 'le': '0.28', 'lle': '1.94', 'sei': '7.98'}",CHEMBL3979978,,CHEMBL3979978,6.89,0,http://www.openphacts.org/units/Nanomolar,2848545,=,37,1,=,,IC50,nM,,129.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,129.0,PAK4
,341783,17719318,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '13.96', 'le': '0.28', 'lle': '2.94', 'sei': '6.85'}",CHEMBL3956295,,CHEMBL3956295,7.09,0,http://www.openphacts.org/units/Nanomolar,2848546,=,37,1,=,,IC50,nM,,82.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,82.0,PAK4
,341784,17719319,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '14.76', 'le': '0.28', 'lle': '2.37', 'sei': '9.90'}",CHEMBL3890672,,CHEMBL3890672,7.18,0,http://www.openphacts.org/units/Nanomolar,2848547,=,37,1,=,,IC50,nM,,66.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,66.0,PAK4
,341785,17719320,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3[C@@H](CCCN)CNC4=O)cc2)CC1,,,CHEMBL3886350,,2015,"{'bei': '14.56', 'le': '0.28', 'lle': '3.40', 'sei': '10.41'}",CHEMBL3967392,,CHEMBL3967392,7.89,0,http://www.openphacts.org/units/Nanomolar,2848548,=,37,1,=,,IC50,nM,,13.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.0,PAK4
,341786,17719321,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,,,CHEMBL3886350,,2015,"{'bei': '13.71', 'le': '0.27', 'lle': '2.82', 'sei': '7.56'}",CHEMBL3896150,,CHEMBL3896150,6.76,0,http://www.openphacts.org/units/Nanomolar,2848549,=,37,1,=,,IC50,nM,,172.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,172.0,PAK4
,341787,17719322,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccccc3)n21,,,CHEMBL3886350,,2015,"{'bei': '14.78', 'le': '0.28', 'lle': '2.23', 'sei': '9.34'}",CHEMBL3979034,,CHEMBL3979034,6.76,0,http://www.openphacts.org/units/Nanomolar,2848550,=,37,1,=,,IC50,nM,,174.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,174.0,PAK4
,341788,17719323,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc4c(c3)OCO4)n21,,,CHEMBL3886350,,2015,"{'bei': '16.97', 'le': '0.32', 'lle': '3.72', 'sei': '8.89'}",CHEMBL3905102,,CHEMBL3905102,7.80,0,http://www.openphacts.org/units/Nanomolar,2848551,=,37,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.0,PAK4
,341789,17719324,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc4ccccc4c3)n21,,,CHEMBL3886350,,2015,"{'bei': '14.65', 'le': '0.27', 'lle': '1.31', 'sei': '9.84'}",CHEMBL3943493,,CHEMBL3943493,6.82,0,http://www.openphacts.org/units/Nanomolar,2848552,=,37,1,=,,IC50,nM,,152.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,152.0,PAK4
,341790,17719325,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(S(N)(=O)=O)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '17.24', 'le': '0.34', 'lle': '5.52', 'sei': '6.58'}",CHEMBL3973012,,CHEMBL3973012,8.52,0,http://www.openphacts.org/units/Nanomolar,2848553,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,341791,17719326,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1Cl,,,CHEMBL3886350,,2015,"{'bei': '16.00', 'le': '0.32', 'lle': '2.66', 'sei': '9.78'}",CHEMBL3979444,,CHEMBL3979444,7.68,0,http://www.openphacts.org/units/Nanomolar,2848554,=,37,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.0,PAK4
,341792,17719327,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1F,,,CHEMBL3886350,,2015,"{'bei': '15.96', 'le': '0.31', 'lle': '2.73', 'sei': '9.71'}",CHEMBL3963827,,CHEMBL3963827,7.62,0,http://www.openphacts.org/units/Nanomolar,2848555,=,37,1,=,,IC50,nM,,24.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.0,PAK4
,341793,17719328,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(C)cc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1C,,,CHEMBL3886350,,2015,"{'bei': '15.83', 'le': '0.30', 'lle': '2.51', 'sei': '9.55'}",CHEMBL3959008,,CHEMBL3959008,7.50,0,http://www.openphacts.org/units/Nanomolar,2848556,=,37,1,=,,IC50,nM,,32.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,32.0,PAK4
,341794,17719329,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '15.92', 'le': '0.31', 'lle': '2.27', 'sei': '10.60'}",CHEMBL3935023,,CHEMBL3935023,7.35,0,http://www.openphacts.org/units/Nanomolar,2848557,=,37,1,=,,IC50,nM,,45.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,45.0,PAK4
,341795,17719330,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '14.41', 'le': '0.27', 'lle': '1.15', 'sei': '9.81'}",CHEMBL3966069,,CHEMBL3966069,6.80,0,http://www.openphacts.org/units/Nanomolar,2848558,=,37,1,=,,IC50,nM,,160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,160.0,PAK4
,341796,17719331,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3cccc(C(F)(F)F)c3)n21,,,CHEMBL3886350,,2015,"{'bei': '14.51', 'le': '0.28', 'lle': '1.64', 'sei': '10.12'}",CHEMBL3936239,,CHEMBL3936239,7.01,0,http://www.openphacts.org/units/Nanomolar,2848559,=,37,1,=,,IC50,nM,,97.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,97.0,PAK4
,341797,17719332,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3cccc(F)c3)n21,,,CHEMBL3886350,,2015,"{'bei': '18.28', 'le': '0.35', 'lle': '3.43', 'sei': '11.43'}",CHEMBL3974585,,CHEMBL3974585,7.92,0,http://www.openphacts.org/units/Nanomolar,2848560,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,341798,17719333,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)ccc1F,,,CHEMBL3886350,,2015,"{'bei': '15.79', 'le': '0.30', 'lle': '2.27', 'sei': '10.20'}",CHEMBL3910416,,CHEMBL3910416,7.07,0,http://www.openphacts.org/units/Nanomolar,2848561,=,37,1,=,,IC50,nM,,86.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,86.0,PAK4
,341799,17719334,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1Cl,,,CHEMBL3886350,,2015,"{'bei': '16.51', 'le': '0.33', 'lle': '2.90', 'sei': '10.09'}",CHEMBL3979444,,CHEMBL3979444,7.92,0,http://www.openphacts.org/units/Nanomolar,2848554,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,341800,17719335,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,NCC[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(C4(N)CC4)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '18.11', 'le': '0.34', 'lle': '4.22', 'sei': '8.94'}",CHEMBL3957977,,CHEMBL3957977,8.52,0,http://www.openphacts.org/units/Nanomolar,2848562,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,341801,17719336,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(Cc2ccc(-c3c(-c4cccc(OC(F)(F)F)c4)cc4n3[C@@H](CCCl)CNC4=O)cc2)CC1,,,CHEMBL3886350,,2015,"{'bei': '12.80', 'le': '0.25', 'lle': '1.62', 'sei': '14.08'}",CHEMBL3925655,,CHEMBL3925655,7.00,0,http://www.openphacts.org/units/Nanomolar,2848563,=,37,1,=,,IC50,nM,,99.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,99.0,PAK4
,341802,17719337,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1CNC(=O)c2cc(-c3cccc(OC(F)(F)F)c3)c(-c3ccc(CN)cc3)n21,,,CHEMBL3886350,,2015,"{'bei': '15.25', 'le': '0.29', 'lle': '1.64', 'sei': '9.76'}",CHEMBL3949873,,CHEMBL3949873,6.76,0,http://www.openphacts.org/units/Nanomolar,2848564,=,37,1,=,,IC50,nM,,173.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,173.0,PAK4
,341803,17719338,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCNC(=N)N)CNC3=O)c1,,,CHEMBL3886350,,2015,"{'bei': '16.80', 'le': '0.32', 'lle': '3.73', 'sei': '7.53'}",CHEMBL3941232,,CHEMBL3941232,7.92,0,http://www.openphacts.org/units/Nanomolar,2848565,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,341804,17719339,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCNC(=N)N)CNC3=O)cc1,,,CHEMBL3886350,,2015,"{'bei': '14.42', 'le': '0.29', 'lle': '4.44', 'sei': '5.54'}",CHEMBL3970786,,CHEMBL3970786,7.72,0,http://www.openphacts.org/units/Nanomolar,2848566,=,37,1,=,,IC50,nM,,19.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.0,PAK4
,341805,17719340,[],CHEMBL3887520,"Trans-Phosphorylation Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.Specific peptide or protein substrates were trans-phosphorylated by their specific ser-thr or tyr kinase in the presence of ATP traced with 33P-gamma-ATP, and in the presence of their own optimal buffer and cofactors. At the end of the phosphorylation reaction, more than 98% unlabeled ATP and radioactive ATP were captured by an excess of the ion exchange dowex resin; the resin then settled down to the bottom of the reaction plate by gravity. Supernatant was subsequently withdrawn and transferred into a counting plate, then evaluated by beta-counting. Kinase Buffer (KB):The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Â  Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(-c3cccc(OC(F)(F)F)c3)cc3n2[C@@H](CCN)CNC3=O)cc1F,,,CHEMBL3886350,,2015,"{'bei': '16.06', 'le': '0.31', 'lle': '2.94', 'sei': '9.48'}",CHEMBL3932237,,CHEMBL3932237,7.44,0,http://www.openphacts.org/units/Nanomolar,2848567,=,37,1,=,,IC50,nM,,36.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,36.0,PAK4
,344531,17721549,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '22.07', 'le': '0.41', 'lle': '5.56', 'sei': '11.02'}",CHEMBL3919646,,CHEMBL3919646,9.30,0,http://www.openphacts.org/units/Nanomolar,2849643,=,37,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,344532,17721550,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2cnc(Nc3cnccc3N3CCNCC3)n2n1,,,CHEMBL3886376,,2015,"{'bei': '16.93', 'le': '0.31', 'lle': '3.68', 'sei': '9.80'}",CHEMBL3936842,,CHEMBL3936842,6.90,0,http://www.openphacts.org/units/Nanomolar,2849644,=,37,1,=,,IC50,nM,,126.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,126.0,PAK4
,344533,17721551,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(N2CCNCC2)c(Nc2ncc3ccc(-c4nccs4)nn23)cn1,,,CHEMBL3886376,,2015,"{'bei': '18.00', 'le': '0.34', 'lle': '4.41', 'sei': '8.18'}",CHEMBL3960752,,CHEMBL3960752,6.81,0,http://www.openphacts.org/units/Nanomolar,2849645,=,37,1,=,,IC50,nM,,154.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,154.0,PAK4
,344534,17721552,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4Cl)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '20.30', 'le': '0.39', 'lle': '4.40', 'sei': '10.10'}",CHEMBL3924352,,CHEMBL3924352,8.52,0,http://www.openphacts.org/units/Nanomolar,2849646,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,344535,17721553,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1-c1ccc2cnc(Nc3cnccc3N3CCNCC3)n2n1,,,CHEMBL3886376,,2015,"{'bei': '15.26', 'le': '0.29', 'lle': '2.59', 'sei': '8.80'}",CHEMBL3952051,,CHEMBL3952051,6.19,0,http://www.openphacts.org/units/Nanomolar,2849647,=,37,1,=,,IC50,nM,,640.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,640.0,PAK4
,344536,17721554,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4cccnc4Cl)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '16.90', 'le': '0.32', 'lle': '3.60', 'sei': '7.31'}",CHEMBL3915354,,CHEMBL3915354,7.11,0,http://www.openphacts.org/units/Nanomolar,2849648,=,37,1,=,,IC50,nM,,77.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,77.0,PAK4
,344537,17721555,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4cccnc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '19.58', 'le': '0.36', 'lle': '4.92', 'sei': '8.14'}",CHEMBL3905239,,CHEMBL3905239,7.92,0,http://www.openphacts.org/units/Nanomolar,2849649,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,344538,17721556,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '21.71', 'le': '0.42', 'lle': '5.60', 'sei': '8.76'}",CHEMBL3910008,,CHEMBL3910008,8.52,0,http://www.openphacts.org/units/Nanomolar,2849650,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,344539,17721557,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2cnc(Nc3cnccc3OC3CNC3)n2n1,,,CHEMBL3886376,,2015,"{'bei': '17.76', 'le': '0.33', 'lle': '3.84', 'sei': '9.17'}",CHEMBL3937943,,CHEMBL3937943,7.00,0,http://www.openphacts.org/units/Nanomolar,2849651,=,37,1,=,,IC50,nM,,99.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,99.0,PAK4
,344540,17721558,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1-c1ccc2cnc(Nc3cnccc3O[C@@H]3CCCNC3)n2n1,,,CHEMBL3886376,,2015,,CHEMBL4109914,,CHEMBL4109914,,0,http://www.openphacts.org/units/Nanomolar,2849652,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344541,17721559,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccc(Cl)cc4Cl)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '17.52', 'le': '0.35', 'lle': '3.19', 'sei': '9.43'}",CHEMBL3970651,,CHEMBL3970651,7.96,0,http://www.openphacts.org/units/Nanomolar,2849653,=,37,1,=,,IC50,nM,,11.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.0,PAK4
,344542,17721560,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccc(F)cc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '20.22', 'le': '0.38', 'lle': '4.78', 'sei': '10.10'}",CHEMBL3931386,,CHEMBL3931386,8.52,0,http://www.openphacts.org/units/Nanomolar,2849654,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,344543,17721561,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,,CHEMBL3928490,,CHEMBL3928490,,0,http://www.openphacts.org/units/Nanomolar,2849655,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344544,17721562,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ncncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '16.80', 'le': '0.31', 'lle': '3.80', 'sei': '6.99'}",CHEMBL3959100,,CHEMBL3959100,6.80,0,http://www.openphacts.org/units/Nanomolar,2849656,=,37,1,=,,IC50,nM,,160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,160.0,PAK4
,344545,17721563,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '21.56', 'le': '0.40', 'lle': '5.10', 'sei': '10.31'}",CHEMBL3922469,,CHEMBL3922469,8.70,0,http://www.openphacts.org/units/Nanomolar,2849657,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,344546,17721564,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccccc1-c1ccc2cnc(Nc3cnccc3O[C@H]3CCCNC3)n2n1,,,CHEMBL3886376,,2015,"{'bei': '15.50', 'le': '0.30', 'lle': '2.21', 'sei': '8.54'}",CHEMBL3942758,,CHEMBL3942758,6.53,0,http://www.openphacts.org/units/Nanomolar,2849658,=,37,1,=,,IC50,nM,,298.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,298.0,PAK4
,344547,17721565,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,O[C@@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccc4Cl)nn23)C1,,,CHEMBL3886376,,2015,,CHEMBL4107589,,CHEMBL4107589,,0,http://www.openphacts.org/units/Nanomolar,2849659,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344548,17721566,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,O[C@@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C1,,,CHEMBL3886376,,2015,,CHEMBL4113806,,CHEMBL4113806,,0,http://www.openphacts.org/units/Nanomolar,2849660,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344549,17721567,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,O[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '17.81', 'le': '0.33', 'lle': '3.75', 'sei': '9.57'}",CHEMBL3920197,,CHEMBL3920197,7.52,0,http://www.openphacts.org/units/Nanomolar,2849661,=,37,1,=,,IC50,nM,,30.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.0,PAK4
,344550,17721568,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H](N)[C@@H]1O,,,CHEMBL3886376,,2015,"{'bei': '22.36', 'le': '0.42', 'lle': '7.14', 'sei': '9.65'}",CHEMBL3966732,,CHEMBL3966732,10.10,0,http://www.openphacts.org/units/Nanomolar,2849662,=,37,1,=,,IC50,nM,,0.08,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.08,PAK4
,344551,17721569,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C[C@@H](N)[C@@H]1O,,,CHEMBL3886376,,2015,"{'bei': '21.83', 'le': '0.42', 'lle': '7.08', 'sei': '7.85'}",CHEMBL3936992,,CHEMBL3936992,9.22,0,http://www.openphacts.org/units/Nanomolar,2849663,=,37,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,344552,17721570,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2ccc3cnc(Nc4cnccc4N4CCC[C@H](N)C4)n3n2)c(F)c1,,,CHEMBL3886376,,2015,"{'bei': '16.70', 'le': '0.32', 'lle': '5.04', 'sei': '6.79'}",CHEMBL3957474,,CHEMBL3957474,8.04,0,http://www.openphacts.org/units/Nanomolar,2849664,=,37,1,=,,IC50,nM,,9.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.1,PAK4
,344553,17721571,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4ccc(S(C)(=O)=O)cc4F)nn23)C[C@@H](N)[C@@H]1O,,,CHEMBL3886376,,2015,"{'bei': '18.18', 'le': '0.35', 'lle': '7.08', 'sei': '6.70'}",CHEMBL3986154,,CHEMBL3986154,9.30,0,http://www.openphacts.org/units/Nanomolar,2849665,=,37,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,344554,17721572,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(Cl)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '20.37', 'le': '0.40', 'lle': '4.55', 'sei': '8.30'}",CHEMBL3950192,,CHEMBL3950192,7.00,0,http://www.openphacts.org/units/Nanomolar,2849666,=,37,1,=,,IC50,nM,,99.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,99.0,PAK4
,344555,17721573,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,O[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H]1O,,,CHEMBL3886376,,2015,"{'bei': '18.47', 'le': '0.35', 'lle': '5.35', 'sei': '8.19'}",CHEMBL3892307,,CHEMBL3892307,8.10,0,http://www.openphacts.org/units/Nanomolar,2849667,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,344556,17721574,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,,CHEMBL3944210,,CHEMBL3944210,,0,http://www.openphacts.org/units/Nanomolar,2849668,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344557,17721575,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)c1,,,CHEMBL3886376,,2015,"{'bei': '16.69', 'le': '0.30', 'lle': '1.86', 'sei': '8.53'}",CHEMBL3973689,,CHEMBL3973689,6.92,0,http://www.openphacts.org/units/Nanomolar,2849669,=,37,1,=,,IC50,nM,,121.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,121.0,PAK4
,344558,17721576,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1ccc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)c[nH]1,,,CHEMBL3886376,,2015,"{'bei': '15.73', 'le': '0.29', 'lle': '2.38', 'sei': '7.45'}",CHEMBL3902922,,CHEMBL3902922,6.55,0,http://www.openphacts.org/units/Nanomolar,2849670,=,37,1,=,,IC50,nM,,281.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,281.0,PAK4
,344559,17721577,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cncc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)c1,,,CHEMBL3886376,,2015,,CHEMBL3981694,,CHEMBL3981694,,0,http://www.openphacts.org/units/Nanomolar,2849671,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344560,17721578,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)ccn1,,,CHEMBL3886376,,2015,"{'bei': '16.21', 'le': '0.30', 'lle': '2.27', 'sei': '7.16'}",CHEMBL3922101,,CHEMBL3922101,6.73,0,http://www.openphacts.org/units/Nanomolar,2849672,=,37,1,=,,IC50,nM,,185.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,185.0,PAK4
,344561,17721579,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2sncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '16.06', 'le': '0.31', 'lle': '3.07', 'sei': '8.14'}",CHEMBL3935874,,CHEMBL3935874,6.87,0,http://www.openphacts.org/units/Nanomolar,2849673,=,37,1,=,,IC50,nM,,136.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,136.0,PAK4
,344562,17721580,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '18.00', 'le': '0.33', 'lle': '2.77', 'sei': '9.33'}",CHEMBL3948849,,CHEMBL3948849,7.57,0,http://www.openphacts.org/units/Nanomolar,2849674,=,37,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,344633,17721651,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '20.89', 'le': '0.39', 'lle': '5.11', 'sei': '10.78'}",CHEMBL3897323,,CHEMBL3897323,9.10,0,http://www.openphacts.org/units/Nanomolar,2849675,=,37,1,=,,IC50,nM,,0.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.8,PAK4
,344634,17721652,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,O[C@@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1O,,,CHEMBL3886376,,2015,"{'bei': '18.37', 'le': '0.34', 'lle': '5.31', 'sei': '8.15'}",CHEMBL4109810,,CHEMBL4109810,8.06,0,http://www.openphacts.org/units/Nanomolar,2849676,=,37,1,=,,IC50,nM,,8.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.8,PAK4
,344635,17721653,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ncncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '16.47', 'le': '0.31', 'lle': '3.82', 'sei': '7.15'}",CHEMBL3941443,,CHEMBL3941443,6.96,0,http://www.openphacts.org/units/Nanomolar,2849677,=,37,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,110.0,PAK4
,344636,17721654,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '22.27', 'le': '0.41', 'lle': '5.71', 'sei': '11.50'}",CHEMBL3942186,,CHEMBL3942186,9.70,0,http://www.openphacts.org/units/Nanomolar,2849678,=,37,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,344637,17721655,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '22.96', 'le': '0.43', 'lle': '6.01', 'sei': '11.85'}",CHEMBL3965946,,CHEMBL3965946,10.00,0,http://www.openphacts.org/units/Nanomolar,2849679,=,37,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,344638,17721656,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '18.62', 'le': '0.35', 'lle': '4.12', 'sei': '9.61'}",CHEMBL3942186,,CHEMBL3942186,8.11,0,http://www.openphacts.org/units/Nanomolar,2849678,=,37,1,=,,IC50,nM,,7.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.8,PAK4
,344639,17721657,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '22.15', 'le': '0.41', 'lle': '5.96', 'sei': '9.21'}",CHEMBL3914287,,CHEMBL3914287,8.96,0,http://www.openphacts.org/units/Nanomolar,2849680,=,37,1,=,,IC50,nM,,1.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.1,PAK4
,344640,17721658,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H](N)[C@H]1O,,,CHEMBL3886376,,2015,"{'bei': '20.60', 'le': '0.38', 'lle': '6.34', 'sei': '8.89'}",CHEMBL4109503,,CHEMBL4109503,9.30,0,http://www.openphacts.org/units/Nanomolar,2849681,=,37,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,344641,17721659,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N)cc(-c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)c1,,,CHEMBL3886376,,2015,"{'bei': '17.42', 'le': '0.32', 'lle': '2.09', 'sei': '9.20'}",CHEMBL3949500,,CHEMBL3949500,7.46,0,http://www.openphacts.org/units/Nanomolar,2849682,=,37,1,=,,IC50,nM,,34.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.4,PAK4
,344642,17721660,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CC[C@@H]1F,,,CHEMBL3886376,,2015,"{'bei': '20.39', 'le': '0.38', 'lle': '5.27', 'sei': '10.62'}",CHEMBL3898611,,CHEMBL3898611,8.96,0,http://www.openphacts.org/units/Nanomolar,2849683,=,37,1,=,,IC50,nM,,1.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.1,PAK4
,344643,17721661,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CC[C@H]1F,,,CHEMBL3886376,,2015,"{'bei': '16.64', 'le': '0.31', 'lle': '3.62', 'sei': '8.67'}",CHEMBL3973432,,CHEMBL3973432,7.31,0,http://www.openphacts.org/units/Nanomolar,2849684,=,37,1,=,,IC50,nM,,48.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,48.8,PAK4
,344644,17721662,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCC1F,,,CHEMBL3886376,,2015,"{'bei': '20.39', 'le': '0.38', 'lle': '5.27', 'sei': '10.62'}",CHEMBL3909297,,CHEMBL3909297,8.96,0,http://www.openphacts.org/units/Nanomolar,2849685,=,37,1,=,,IC50,nM,,1.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.1,PAK4
,344645,17721663,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '23.95', 'le': '0.44', 'lle': '6.15', 'sei': '11.85'}",CHEMBL3930148,,CHEMBL3930148,10.00,0,http://www.openphacts.org/units/Nanomolar,2849686,=,37,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,344646,17721664,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ccccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '17.40', 'le': '0.32', 'lle': '3.42', 'sei': '8.61'}",CHEMBL4113731,,CHEMBL4113731,7.27,0,http://www.openphacts.org/units/Nanomolar,2849687,=,37,1,=,,IC50,nM,,54.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,54.2,PAK4
,344647,17721665,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](F)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '19.33', 'le': '0.36', 'lle': '4.80', 'sei': '10.07'}",CHEMBL3913112,,CHEMBL3913112,8.49,0,http://www.openphacts.org/units/Nanomolar,2849688,=,37,1,=,,IC50,nM,,3.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.2,PAK4
,344648,17721666,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)[C@@H](C)CN1,,,CHEMBL3886376,,2015,"{'bei': '15.95', 'le': '0.30', 'lle': '2.95', 'sei': '9.87'}",CHEMBL3971547,,CHEMBL3971547,6.95,0,http://www.openphacts.org/units/Nanomolar,2849689,=,37,1,=,,IC50,nM,,113.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,113.0,PAK4
,344649,17721667,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)[C@@H](C)CN1,,,CHEMBL3886376,,2015,"{'bei': '15.59', 'le': '0.29', 'lle': '2.79', 'sei': '9.65'}",CHEMBL4108465,,CHEMBL4108465,6.79,0,http://www.openphacts.org/units/Nanomolar,2849690,=,37,1,=,,IC50,nM,,162.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,162.0,PAK4
,344650,17721668,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN[C@@H](C)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '16.60', 'le': '0.31', 'lle': '3.23', 'sei': '10.27'}",CHEMBL3920138,,CHEMBL3920138,7.23,0,http://www.openphacts.org/units/Nanomolar,2849691,=,37,1,=,,IC50,nM,,59.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,59.0,PAK4
,344651,17721669,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C(C)CN1,,,CHEMBL3886376,,2015,"{'bei': '16.03', 'le': '0.30', 'lle': '2.98', 'sei': '9.92'}",CHEMBL3899655,,CHEMBL3899655,6.98,0,http://www.openphacts.org/units/Nanomolar,2849692,=,37,1,=,,IC50,nM,,105.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,105.0,PAK4
,344652,17721670,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C[C@@H](F)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '18.85', 'le': '0.35', 'lle': '5.02', 'sei': '8.19'}",CHEMBL4111268,,CHEMBL4111268,7.96,0,http://www.openphacts.org/units/Nanomolar,2849693,=,37,1,=,,IC50,nM,,10.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.9,PAK4
,344653,17721671,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '21.87', 'le': '0.41', 'lle': '5.39', 'sei': '11.29'}",CHEMBL3905194,,CHEMBL3905194,9.52,0,http://www.openphacts.org/units/Nanomolar,2849694,=,37,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,344654,17721672,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '15.24', 'le': '0.28', 'lle': '2.51', 'sei': '7.87'}",CHEMBL3956489,,CHEMBL3956489,6.64,0,http://www.openphacts.org/units/Nanomolar,2849695,=,37,1,=,,IC50,nM,,231.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,231.0,PAK4
,344655,17721673,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1[C@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '18.28', 'le': '0.34', 'lle': '3.83', 'sei': '9.44'}",CHEMBL4115547,,CHEMBL4115547,7.96,0,http://www.openphacts.org/units/Nanomolar,2849696,=,37,1,=,,IC50,nM,,10.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.9,PAK4
,344656,17721674,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1[C@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '18.99', 'le': '0.35', 'lle': '4.14', 'sei': '9.80'}",CHEMBL3900795,,CHEMBL3900795,8.27,0,http://www.openphacts.org/units/Nanomolar,2849697,=,37,1,=,,IC50,nM,,5.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.4,PAK4
,344657,17721675,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCN1,,,CHEMBL3886376,,2015,"{'bei': '17.04', 'le': '0.32', 'lle': '3.57', 'sei': '10.20'}",CHEMBL3972742,,CHEMBL3972742,7.18,0,http://www.openphacts.org/units/Nanomolar,2849698,=,37,1,=,,IC50,nM,,65.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,65.9,PAK4
,344658,17721676,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '17.24', 'le': '0.32', 'lle': '3.51', 'sei': '10.67'}",CHEMBL3912242,,CHEMBL3912242,7.51,0,http://www.openphacts.org/units/Nanomolar,2849699,=,37,1,=,,IC50,nM,,31.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,31.0,PAK4
,344659,17721677,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '21.87', 'le': '0.41', 'lle': '5.53', 'sei': '11.29'}",CHEMBL3942186,,CHEMBL3942186,9.52,0,http://www.openphacts.org/units/Nanomolar,2849678,=,37,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,344660,17721678,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '20.33', 'le': '0.38', 'lle': '4.86', 'sei': '10.49'}",CHEMBL3897323,,CHEMBL3897323,8.85,0,http://www.openphacts.org/units/Nanomolar,2849675,=,37,1,=,,IC50,nM,,1.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.4,PAK4
,344661,17721679,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4nccs4)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '23.12', 'le': '0.44', 'lle': '6.24', 'sei': '9.66'}",CHEMBL4109688,,CHEMBL4109688,9.40,0,http://www.openphacts.org/units/Nanomolar,2849700,=,37,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,344662,17721680,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ccccn4)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '22.19', 'le': '0.40', 'lle': '5.79', 'sei': '9.14'}",CHEMBL4109355,,CHEMBL4109355,8.89,0,http://www.openphacts.org/units/Nanomolar,2849701,=,37,1,=,,IC50,nM,,1.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.3,PAK4
,344663,17721681,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ccccn4)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '21.20', 'le': '0.39', 'lle': '5.33', 'sei': '8.42'}",CHEMBL3937423,,CHEMBL3937423,8.19,0,http://www.openphacts.org/units/Nanomolar,2849702,=,37,1,=,,IC50,nM,,6.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.4,PAK4
,344664,17721682,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '22.46', 'le': '0.41', 'lle': '6.16', 'sei': '9.66'}",CHEMBL3913540,,CHEMBL3913540,9.40,0,http://www.openphacts.org/units/Nanomolar,2849703,=,37,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,344665,17721683,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4F)nn23)C[C@@H](N)[C@@H]1O,,,CHEMBL3886376,,2015,"{'bei': '20.45', 'le': '0.38', 'lle': '6.68', 'sei': '7.56'}",CHEMBL3942827,,CHEMBL3942827,8.89,0,http://www.openphacts.org/units/Nanomolar,2849704,=,37,1,=,,IC50,nM,,1.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.3,PAK4
,344666,17721684,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2nnc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '17.64', 'le': '0.33', 'lle': '4.31', 'sei': '7.66'}",CHEMBL3914834,,CHEMBL3914834,7.45,0,http://www.openphacts.org/units/Nanomolar,2849705,=,37,1,=,,IC50,nM,,35.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.4,PAK4
,344667,17721685,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2nnc3ccccn23)C1,,,CHEMBL3886376,,2015,"{'bei': '23.05', 'le': '0.42', 'lle': '5.33', 'sei': '8.45'}",CHEMBL3969621,,CHEMBL3969621,7.13,0,http://www.openphacts.org/units/Nanomolar,2849706,=,37,1,=,,IC50,nM,,73.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,73.7,PAK4
,344668,17721686,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '17.68', 'le': '0.33', 'lle': '3.71', 'sei': '8.83'}",CHEMBL3911258,,CHEMBL3911258,7.45,0,http://www.openphacts.org/units/Nanomolar,2849707,=,37,1,=,,IC50,nM,,35.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.2,PAK4
,344669,17721687,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4cc(C(=O)NC5CC5)ccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '19.98', 'le': '0.37', 'lle': '6.26', 'sei': '8.81'}",CHEMBL4110951,,CHEMBL4110951,10.00,0,http://www.openphacts.org/units/Nanomolar,2849710,=,37,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,344670,17721688,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccccc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '19.47', 'le': '0.36', 'lle': '3.84', 'sei': '11.45'}",CHEMBL3921064,,CHEMBL3921064,8.19,0,http://www.openphacts.org/units/Nanomolar,2849711,=,37,1,=,,IC50,nM,,6.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.5,PAK4
,344671,17721689,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4cc(C(=O)NC5CC5)ccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '19.12', 'le': '0.35', 'lle': '5.81', 'sei': '8.20'}",CHEMBL3918076,,CHEMBL3918076,9.30,0,http://www.openphacts.org/units/Nanomolar,2849712,=,37,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,344672,17721690,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '17.95', 'le': '0.33', 'lle': '4.12', 'sei': '7.72'}",CHEMBL3965074,,CHEMBL3965074,7.51,0,http://www.openphacts.org/units/Nanomolar,2849713,=,37,1,=,,IC50,nM,,30.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.9,PAK4
,344673,17721691,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1[C@@H](N)CCCN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '20.90', 'le': '0.39', 'lle': '5.35', 'sei': '8.99'}",CHEMBL4115235,,CHEMBL4115235,8.74,0,http://www.openphacts.org/units/Nanomolar,2849714,=,37,1,=,,IC50,nM,,1.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.8,PAK4
,344674,17721692,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(C)CN(C)c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,,CHEMBL3963604,,CHEMBL3963604,,0,http://www.openphacts.org/units/Nanomolar,2849715,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344675,17721693,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4ncccc4Cl)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '20.40', 'le': '0.39', 'lle': '5.08', 'sei': '8.83'}",CHEMBL3920733,,CHEMBL3920733,8.59,0,http://www.openphacts.org/units/Nanomolar,2849716,=,37,1,=,,IC50,nM,,2.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.6,PAK4
,344676,17721694,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4ncccc4Cl)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '21.38', 'le': '0.41', 'lle': '5.54', 'sei': '9.56'}",CHEMBL4115280,,CHEMBL4115280,9.30,0,http://www.openphacts.org/units/Nanomolar,2849717,=,37,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,344677,17721695,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2cnccc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,,CHEMBL3904472,,CHEMBL3904472,,0,http://www.openphacts.org/units/Nanomolar,2849718,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344678,17721696,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C=C(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCC1,,,CHEMBL3886376,,2015,"{'bei': '19.18', 'le': '0.35', 'lle': '3.32', 'sei': '9.89'}",CHEMBL3940201,,CHEMBL3940201,8.03,0,http://www.openphacts.org/units/Nanomolar,2849720,=,37,1,=,,IC50,nM,,9.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.4,PAK4
,344679,17721697,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1C=C(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCC1,,,CHEMBL3886376,,2015,"{'bei': '19.60', 'le': '0.36', 'lle': '3.49', 'sei': '10.11'}",CHEMBL4115439,,CHEMBL4115439,8.20,0,http://www.openphacts.org/units/Nanomolar,2849721,=,37,1,=,,IC50,nM,,6.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.3,PAK4
,344680,17721698,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,NC1C=C(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CCC1,,,CHEMBL3886376,,2015,"{'bei': '16.07', 'le': '0.30', 'lle': '2.01', 'sei': '8.29'}",CHEMBL3946175,,CHEMBL3946175,6.72,0,http://www.openphacts.org/units/Nanomolar,2849722,=,37,1,=,,IC50,nM,,189.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,189.0,PAK4
,344681,17721699,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '17.02', 'le': '0.32', 'lle': '3.28', 'sei': '8.79'}",CHEMBL3900646,,CHEMBL3900646,7.41,0,http://www.openphacts.org/units/Nanomolar,2849723,=,37,1,=,,IC50,nM,,38.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,38.7,PAK4
,344682,17721700,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '20.67', 'le': '0.38', 'lle': '4.87', 'sei': '10.67'}",CHEMBL4112982,,CHEMBL4112982,9.00,0,http://www.openphacts.org/units/Nanomolar,2849724,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,344683,17721701,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '21.87', 'le': '0.41', 'lle': '5.39', 'sei': '11.29'}",CHEMBL3965757,,CHEMBL3965757,9.52,0,http://www.openphacts.org/units/Nanomolar,2849725,=,37,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,344684,17721702,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CC[C@@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '17.31', 'le': '0.32', 'lle': '3.41', 'sei': '8.93'}",CHEMBL3925861,,CHEMBL3925861,7.54,0,http://www.openphacts.org/units/Nanomolar,2849726,=,37,1,=,,IC50,nM,,29.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.0,PAK4
,344685,17721703,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)C(=O)c1ccc(F)c(-c2ccc3cnc(Nc4cnccc4N4CCC[C@H](N)C4)n3n2)c1,,,CHEMBL3886376,,2015,"{'bei': '17.44', 'le': '0.32', 'lle': '4.98', 'sei': '7.91'}",CHEMBL3916248,,CHEMBL3916248,8.28,0,http://www.openphacts.org/units/Nanomolar,2849727,=,37,1,=,,IC50,nM,,5.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.3,PAK4
,344686,17721704,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2nnc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '19.27', 'le': '0.36', 'lle': '5.03', 'sei': '8.65'}",CHEMBL4108287,,CHEMBL4108287,8.41,0,http://www.openphacts.org/units/Nanomolar,2849728,=,37,1,=,,IC50,nM,,3.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.9,PAK4
,344687,17721705,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2ccncc2Nc2nnc3ccc(-c4ncccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '18.54', 'le': '0.34', 'lle': '5.13', 'sei': '6.82'}",CHEMBL3919837,,CHEMBL3919837,7.52,0,http://www.openphacts.org/units/Nanomolar,2849729,=,37,1,=,,IC50,nM,,30.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.5,PAK4
,344688,17721706,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2nnc3ccc(-c4ncccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '19.01', 'le': '0.35', 'lle': '5.33', 'sei': '7.24'}",CHEMBL4113226,,CHEMBL4113226,7.97,0,http://www.openphacts.org/units/Nanomolar,2849730,=,37,1,=,,IC50,nM,,10.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.6,PAK4
,344689,17721707,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1C=C(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)CC[C@H]1F,,,CHEMBL3886376,,2015,"{'bei': '17.89', 'le': '0.33', 'lle': '3.15', 'sei': '9.63'}",CHEMBL4109687,,CHEMBL4109687,7.81,0,http://www.openphacts.org/units/Nanomolar,2849731,=,37,1,=,,IC50,nM,,15.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.5,PAK4
,344690,17721708,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '16.71', 'le': '0.31', 'lle': '3.60', 'sei': '7.19'}",CHEMBL3923683,,CHEMBL3923683,6.99,0,http://www.openphacts.org/units/Nanomolar,2849732,=,37,1,=,,IC50,nM,,102.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,102.0,PAK4
,344691,17721709,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '21.23', 'le': '0.39', 'lle': '5.50', 'sei': '9.14'}",CHEMBL4107310,,CHEMBL4107310,8.89,0,http://www.openphacts.org/units/Nanomolar,2849733,=,37,1,=,,IC50,nM,,1.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.3,PAK4
,344692,17721710,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CC[C@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '16.41', 'le': '0.30', 'lle': '3.48', 'sei': '7.06'}",CHEMBL3963283,,CHEMBL3963283,6.87,0,http://www.openphacts.org/units/Nanomolar,2849734,=,37,1,=,,IC50,nM,,136.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,136.0,PAK4
,344693,17721711,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CC[C@@H](N)CN1c1ccncc1Nc1ncc2ccc(-c3ncccc3F)nn12,,,CHEMBL3886376,,2015,"{'bei': '20.44', 'le': '0.38', 'lle': '5.16', 'sei': '8.79'}",CHEMBL3933147,,CHEMBL3933147,8.55,0,http://www.openphacts.org/units/Nanomolar,2849735,=,37,1,=,,IC50,nM,,2.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.8,PAK4
,344694,17721712,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1N,,,CHEMBL3886376,,2015,"{'bei': '17.92', 'le': '0.33', 'lle': '3.81', 'sei': '9.25'}",CHEMBL3902228,,CHEMBL3902228,7.80,0,http://www.openphacts.org/units/Nanomolar,2849736,=,37,1,=,,IC50,nM,,15.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.7,PAK4
,344695,17721713,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H]1N,,,CHEMBL3886376,,2015,"{'bei': '20.20', 'le': '0.38', 'lle': '4.81', 'sei': '10.43'}",CHEMBL4107702,,CHEMBL4107702,8.80,0,http://www.openphacts.org/units/Nanomolar,2849737,=,37,1,=,,IC50,nM,,1.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.6,PAK4
,344696,17721714,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@H]1N,,,CHEMBL3886376,,2015,"{'bei': '22.27', 'le': '0.41', 'lle': '5.71', 'sei': '11.50'}",CHEMBL3896244,,CHEMBL3896244,9.70,0,http://www.openphacts.org/units/Nanomolar,2849738,=,37,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,344697,17721715,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C[C@@H]1N,,,CHEMBL3886376,,2015,"{'bei': '17.20', 'le': '0.32', 'lle': '3.50', 'sei': '8.88'}",CHEMBL3931390,,CHEMBL3931390,7.49,0,http://www.openphacts.org/units/Nanomolar,2849739,=,37,1,=,,IC50,nM,,32.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,32.4,PAK4
,344698,17721716,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oncc1-c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,,CHEMBL3903273,,CHEMBL3903273,,0,http://www.openphacts.org/units/Nanomolar,2849741,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,344699,17721717,[],CHEMBL3887609,"PIM Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(N)CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1,,,CHEMBL3886376,,2015,"{'bei': '18.41', 'le': '0.34', 'lle': '3.89', 'sei': '9.50'}",CHEMBL3974415,,CHEMBL3974415,8.02,0,http://www.openphacts.org/units/Nanomolar,2849740,=,37,1,=,,IC50,nM,,9.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.6,PAK4
,344702,17721720,[],CHEMBL3887611,"PIM-Mn Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate [Costar 3658].",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(F)c1-c1ccc2cnc(Nc3cnccc3C3=CCNCC3)n2n1,,,CHEMBL3886376,,2015,"{'bei': '14.78', 'le': '0.27', 'lle': '1.79', 'sei': '8.90'}",CHEMBL3931404,,CHEMBL3931404,5.98,0,http://www.openphacts.org/units/Nanomolar,2849742,=,37,1,=,,IC50,nM,,1050.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1050.0,PAK4
,344703,17721721,[],CHEMBL3887611,"PIM-Mn Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate [Costar 3658].",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C)c1-c1ccncc1Nc1ncc2ccc(-c3c(F)cccc3F)nn12,,,CHEMBL3886376,,2015,,CHEMBL3906955,,CHEMBL3906955,,0,http://www.openphacts.org/units/Nanomolar,2849743,>,37,1,>,,IC50,nM,,5000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5000.0,PAK4
,375858,17750082,[],CHEMBL3888142,"PIM2 Activity Assay: Kinase Buffer (KB) The buffer for PIM2 assay was composed of HEPES 50 mM, at pH 7.5, with 1 mM MgCl2, 1 mM DTT, 3 uM Na3VO4, and 0.2 mg/mL BSA.Full-length human PIM2 was expressed and purified as described in Fedorov O, et al., PNAS 2007 104, 51, 20523-28.ii. Assay Conditions (Final Concentrations)Enzyme concentration=1.5 nMAktide substrate (Chemical Abstract Service Registry Number 324029-01-8)=5 uMATP=4 uM 33P-gamma-ATP=1 nMiii. Robotized Dowex AssayThe test mix consisted of: 1) 3x Enzyme mix (done in Kinase Buffer 3x), 5 uL/well 2) 3x substrate and ATP mix (done in ddH2O), together with 33P-gamma-ATP, 5 uL/well 3) 3x test compounds (diluted into ddH2O-3% DMSO)-5 uL/well.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1nccc(-c2cc(C(N)=O)nn2C2CCNCC2)n1,,,CHEMBL3886598,,2016,,CHEMBL3981760,,CHEMBL3981760,,0,http://www.openphacts.org/units/Nanomolar,2868098,<,37,1,<,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,393025,17763911,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCCCN1c1cncc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '23.13', 'le': '0.42', 'lle': '5.05', 'sei': '7.91'}",CHEMBL3980131,,CHEMBL3980131,8.69,0,http://www.openphacts.org/units/Nanomolar,2877417,=,37,1,=,,IC50,nM,,2.063,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.063,PAK4
,393026,17763912,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCC(F)(F)CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.76', 'le': '0.41', 'lle': '5.16', 'sei': '7.88'}",CHEMBL3904783,,CHEMBL3904783,8.65,0,http://www.openphacts.org/units/Nanomolar,2877418,=,37,1,=,,IC50,nM,,2.256,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.256,PAK4
,393027,17763913,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '23.07', 'le': '0.42', 'lle': '5.02', 'sei': '7.89'}",CHEMBL3932794,,CHEMBL3932794,8.66,0,http://www.openphacts.org/units/Nanomolar,2877419,=,37,1,=,,IC50,nM,,2.186,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.186,PAK4
,393028,17763914,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '24.07', 'le': '0.44', 'lle': '5.09', 'sei': '7.34'}",CHEMBL3917311,,CHEMBL3917311,8.70,0,http://www.openphacts.org/units/Nanomolar,2877420,=,37,1,=,,IC50,nM,,1.997,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.997,PAK4
,393029,17763915,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '25.79', 'le': '0.47', 'lle': '5.57', 'sei': '7.30'}",CHEMBL3908000,,CHEMBL3908000,8.65,0,http://www.openphacts.org/units/Nanomolar,2877421,=,37,1,=,,IC50,nM,,2.236,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.236,PAK4
,393030,17763916,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.20', 'le': '0.39', 'lle': '4.98', 'sei': '7.24'}",CHEMBL3890347,,CHEMBL3890347,7.68,0,http://www.openphacts.org/units/Nanomolar,2877422,=,37,1,=,,IC50,nM,,20.77,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.769,PAK4
,393031,17763917,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccc(F)cc5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.80', 'le': '0.36', 'lle': '3.31', 'sei': '6.92'}",CHEMBL3918394,,CHEMBL3918394,7.37,0,http://www.openphacts.org/units/Nanomolar,2877423,=,37,1,=,,IC50,nM,,42.48,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,42.476,PAK4
,393032,17763918,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5F)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.90', 'le': '0.40', 'lle': '4.09', 'sei': '7.66'}",CHEMBL3904737,,CHEMBL3904737,8.15,0,http://www.openphacts.org/units/Nanomolar,2877424,=,37,1,=,,IC50,nM,,7.002,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.002,PAK4
,393033,17763919,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3n2)o1,,,CHEMBL3886684,,2016,"{'bei': '20.81', 'le': '0.38', 'lle': '3.14', 'sei': '6.56'}",CHEMBL3927342,,CHEMBL3927342,6.14,0,http://www.openphacts.org/units/Nanomolar,2877425,=,37,1,=,,IC50,nM,,717.26,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,717.262,PAK4
,393034,17763920,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cncc(-c2c[nH]c3ccc(-c4nnc(N)o4)nc23)c1,,,CHEMBL3886684,,2016,"{'bei': '20.25', 'le': '0.37', 'lle': '3.97', 'sei': '5.40'}",CHEMBL3922191,,CHEMBL3922191,6.24,0,http://www.openphacts.org/units/Nanomolar,2877426,=,37,1,=,,IC50,nM,,569.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,569.603,PAK4
,393035,17763921,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '21.25', 'le': '0.41', 'lle': '5.50', 'sei': '7.62'}",CHEMBL3899208,,CHEMBL3899208,8.06,0,http://www.openphacts.org/units/Nanomolar,2877427,=,37,1,=,,IC50,nM,,8.613,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.613,PAK4
,393036,17763922,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,NCCCNc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.54', 'le': '0.36', 'lle': '2.56', 'sei': '8.55'}",CHEMBL3925503,,CHEMBL3925503,6.81,0,http://www.openphacts.org/units/Nanomolar,2877428,=,37,1,=,,IC50,nM,,154.61,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,154.614,PAK4
,393037,17763923,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1,,,CHEMBL3886684,,2016,"{'bei': '20.34', 'le': '0.39', 'lle': '4.88', 'sei': '9.16'}",CHEMBL3962808,,CHEMBL3962808,7.96,0,http://www.openphacts.org/units/Nanomolar,2877429,=,37,1,=,,IC50,nM,,10.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.897,PAK4
,393038,17763924,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.35', 'le': '0.39', 'lle': '3.45', 'sei': '8.81'}",CHEMBL3394066,,CHEMBL3394066,7.38,0,http://www.openphacts.org/units/Nanomolar,2877430,=,37,1,=,,IC50,nM,,41.98,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,41.983,PAK4
,393039,17763925,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '22.03', 'le': '0.42', 'lle': '4.40', 'sei': '7.30'}",CHEMBL3986124,,CHEMBL3986124,7.70,0,http://www.openphacts.org/units/Nanomolar,2877431,=,37,1,=,,IC50,nM,,20.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.071,PAK4
,393040,17763926,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.39', 'le': '0.39', 'lle': '2.99', 'sei': '8.30'}",CHEMBL3394069,,CHEMBL3394069,7.68,0,http://www.openphacts.org/units/Nanomolar,2877432,=,37,1,=,,IC50,nM,,21.11,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.109,PAK4
,393041,17763927,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '21.80', 'le': '0.42', 'lle': '4.15', 'sei': '7.81'}",CHEMBL3394164,,CHEMBL3394164,8.23,0,http://www.openphacts.org/units/Nanomolar,2877433,=,37,1,=,,IC50,nM,,5.923,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.923,PAK4
,393042,17763928,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cncc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1=O,,,CHEMBL3886684,,2016,"{'bei': '17.34', 'le': '0.33', 'lle': '5.05', 'sei': '6.03'}",CHEMBL3957441,,CHEMBL3957441,7.05,0,http://www.openphacts.org/units/Nanomolar,2877434,=,37,1,=,,IC50,nM,,89.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,89.205,PAK4
,393043,17763929,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.33', 'le': '0.43', 'lle': '4.44', 'sei': '7.36'}",CHEMBL3394170,,CHEMBL3394170,7.56,0,http://www.openphacts.org/units/Nanomolar,2877435,=,37,1,=,,IC50,nM,,27.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.785,PAK4
,393044,17763930,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '16.26', 'le': '0.30', 'lle': '0.48', 'sei': '8.24'}",CHEMBL3394060,,CHEMBL3394060,5.57,0,http://www.openphacts.org/units/Nanomolar,2877436,=,37,1,=,,IC50,nM,,2708.96,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2708.963,PAK4
,393045,17763931,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.46', 'le': '0.33', 'lle': '1.52', 'sei': '7.45'}",CHEMBL3394061,,CHEMBL3394061,6.00,0,http://www.openphacts.org/units/Nanomolar,2877437,=,37,1,=,,IC50,nM,,1006.03,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1006.029,PAK4
,393046,17763932,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(-c5ccccc5)c4)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3939931,,CHEMBL3939931,,0,http://www.openphacts.org/units/Nanomolar,2877438,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393047,17763933,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4ccc(F)cc4F)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '16.97', 'le': '0.33', 'lle': '1.14', 'sei': '10.84'}",CHEMBL3915388,,CHEMBL3915388,5.81,0,http://www.openphacts.org/units/Nanomolar,2877439,=,37,1,=,,IC50,nM,,1552.41,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1552.408,PAK4
,393048,17763934,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.11', 'le': '0.37', 'lle': '4.06', 'sei': '7.78'}",CHEMBL3394067,,CHEMBL3394067,7.23,0,http://www.openphacts.org/units/Nanomolar,2877440,=,37,1,=,,IC50,nM,,58.69,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,58.685,PAK4
,393049,17763935,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc2n1CCN(c1cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n1)C2,,,CHEMBL3886684,,2016,"{'bei': '16.42', 'le': '0.31', 'lle': '3.80', 'sei': '6.16'}",CHEMBL3930916,,CHEMBL3930916,7.05,0,http://www.openphacts.org/units/Nanomolar,2877441,=,37,1,=,,IC50,nM,,88.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,88.684,PAK4
,393050,17763936,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nnc(-c2ccc3[nH]cc(-c4ccc(F)cc4F)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3902931,,CHEMBL3902931,,0,http://www.openphacts.org/units/Nanomolar,2877442,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393051,17763937,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Brc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3958501,,CHEMBL3958501,,0,http://www.openphacts.org/units/Nanomolar,2877443,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393052,17763938,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2c[nH]c3ccc(-c4nncs4)cc23)nc(N2CCOCC2)c1,,,CHEMBL3886684,,2016,"{'bei': '18.72', 'le': '0.36', 'lle': '3.22', 'sei': '10.17'}",CHEMBL3927492,,CHEMBL3927492,6.80,0,http://www.openphacts.org/units/Nanomolar,2877444,=,37,1,=,,IC50,nM,,156.65,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,156.647,PAK4
,393053,17763939,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Oc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.38', 'le': '0.33', 'lle': '3.31', 'sei': '7.57'}",CHEMBL3977709,,CHEMBL3977709,6.60,0,http://www.openphacts.org/units/Nanomolar,2877445,=,37,1,=,,IC50,nM,,253.57,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,253.572,PAK4
,393054,17763940,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1=O,,,CHEMBL3886684,,2016,"{'bei': '17.95', 'le': '0.34', 'lle': '4.67', 'sei': '7.00'}",CHEMBL3910677,,CHEMBL3910677,7.28,0,http://www.openphacts.org/units/Nanomolar,2877446,=,37,1,=,,IC50,nM,,52.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,52.679,PAK4
,393055,17763941,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-c5ccc(Cl)cc5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.63', 'le': '0.35', 'lle': '1.47', 'sei': '8.85'}",CHEMBL3972727,,CHEMBL3972727,7.12,0,http://www.openphacts.org/units/Nanomolar,2877447,=,37,1,=,,IC50,nM,,75.51,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,75.509,PAK4
,393056,17763942,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(NC5CCCNC5)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '17.72', 'le': '0.34', 'lle': '3.00', 'sei': '8.77'}",CHEMBL3901647,,CHEMBL3901647,7.70,0,http://www.openphacts.org/units/Nanomolar,2877448,=,37,1,=,,IC50,nM,,20.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.998,PAK4
,393057,17763943,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N5CC[C@@H](N)C5)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '18.49', 'le': '0.35', 'lle': '3.71', 'sei': '8.37'}",CHEMBL3900578,,CHEMBL3900578,7.78,0,http://www.openphacts.org/units/Nanomolar,2877449,=,37,1,=,,IC50,nM,,16.71,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.713,PAK4
,393058,17763944,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N5CC[C@H](N)C5)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '18.09', 'le': '0.35', 'lle': '3.54', 'sei': '8.18'}",CHEMBL3925087,,CHEMBL3925087,7.61,0,http://www.openphacts.org/units/Nanomolar,2877450,=,37,1,=,,IC50,nM,,24.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.798,PAK4
,393059,17763945,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N[C@@H]5CCCNC5)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '18.22', 'le': '0.35', 'lle': '3.22', 'sei': '9.02'}",CHEMBL3985841,,CHEMBL3985841,7.92,0,http://www.openphacts.org/units/Nanomolar,2877451,=,37,1,=,,IC50,nM,,12.14,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.136,PAK4
,393060,17763946,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNc2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)o2)cc1,,,CHEMBL3886684,,2016,"{'bei': '15.22', 'le': '0.28', 'lle': '1.50', 'sei': '6.56'}",CHEMBL3916074,,CHEMBL3916074,6.67,0,http://www.openphacts.org/units/Nanomolar,2877452,=,37,1,=,,IC50,nM,,211.59,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,211.593,PAK4
,393061,17763947,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(N2CCCC2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.05', 'le': '0.35', 'lle': '2.95', 'sei': '8.48'}",CHEMBL3914961,,CHEMBL3914961,7.10,0,http://www.openphacts.org/units/Nanomolar,2877453,=,37,1,=,,IC50,nM,,80.05,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,80.051,PAK4
,393062,17763948,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]nc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.75', 'le': '0.41', 'lle': '4.41', 'sei': '7.23'}",CHEMBL3975848,,CHEMBL3975848,7.26,0,http://www.openphacts.org/units/Nanomolar,2877454,=,37,1,=,,IC50,nM,,54.54,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,54.541,PAK4
,393063,17763949,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(-c2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)o2)[nH]n1,,,CHEMBL3886684,,2016,"{'bei': '18.41', 'le': '0.33', 'lle': '2.86', 'sei': '6.23'}",CHEMBL3933275,,CHEMBL3933275,6.80,0,http://www.openphacts.org/units/Nanomolar,2877455,=,37,1,=,,IC50,nM,,158.31,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,158.312,PAK4
,393064,17763950,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(Nc2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)o2)cc1,,,CHEMBL3886684,,2016,"{'bei': '16.91', 'le': '0.30', 'lle': '1.37', 'sei': '7.21'}",CHEMBL3926288,,CHEMBL3926288,6.67,0,http://www.openphacts.org/units/Nanomolar,2877456,=,37,1,=,,IC50,nM,,214.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,214.684,PAK4
,393065,17763951,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(OC(C)C)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.06', 'le': '0.40', 'lle': '3.60', 'sei': '8.67'}",CHEMBL3942256,,CHEMBL3942256,7.71,0,http://www.openphacts.org/units/Nanomolar,2877457,=,37,1,=,,IC50,nM,,19.58,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.579,PAK4
,393066,17763952,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(-c2ccc3[nH]cc(-c4cccc(OC(C)C)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.17', 'le': '0.40', 'lle': '3.03', 'sei': '9.65'}",CHEMBL3910838,,CHEMBL3910838,7.41,0,http://www.openphacts.org/units/Nanomolar,2877458,=,37,1,=,,IC50,nM,,38.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,38.604,PAK4
,393067,17763953,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(C2CC2)nc(-c2c[nH]c3ccc(-c4nnc(C5CC5)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '24.36', 'le': '0.44', 'lle': '3.93', 'sei': '10.39'}",CHEMBL3947565,,CHEMBL3947565,8.37,0,http://www.openphacts.org/units/Nanomolar,2877459,=,37,1,=,,IC50,nM,,4.317,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.317,PAK4
,393068,17763954,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(C2CC2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.09', 'le': '0.40', 'lle': '3.15', 'sei': '9.42'}",CHEMBL3970104,,CHEMBL3970104,7.58,0,http://www.openphacts.org/units/Nanomolar,2877460,=,37,1,=,,IC50,nM,,26.01,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,26.01,PAK4
,393069,17763955,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccnc(-c2c[nH]c3ccc(-c4nnc(NCC#N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '23.79', 'le': '0.43', 'lle': '4.82', 'sei': '7.35'}",CHEMBL3956256,,CHEMBL3956256,8.55,0,http://www.openphacts.org/units/Nanomolar,2877461,=,37,1,=,,IC50,nM,,2.826,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.826,PAK4
,393070,17763956,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '23.23', 'le': '0.42', 'lle': '4.00', 'sei': '9.05'}",CHEMBL3932201,,CHEMBL3932201,8.37,0,http://www.openphacts.org/units/Nanomolar,2877462,=,37,1,=,,IC50,nM,,4.252,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.252,PAK4
,393071,17763957,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nc(C(=O)O)cc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.10', 'le': '0.41', 'lle': '4.87', 'sei': '6.88'}",CHEMBL3970756,,CHEMBL3970756,8.94,0,http://www.openphacts.org/units/Nanomolar,2877463,=,37,1,=,,IC50,nM,,1.156,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.156,PAK4
,393072,17763958,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nc(C(N)=O)cc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.14', 'le': '0.39', 'lle': '5.06', 'sei': '6.29'}",CHEMBL3941198,,CHEMBL3941198,8.53,0,http://www.openphacts.org/units/Nanomolar,2877464,=,37,1,=,,IC50,nM,,2.959,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.959,PAK4
,393073,17763959,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(NC2CC2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.65', 'le': '0.41', 'lle': '3.99', 'sei': '8.77'}",CHEMBL3892732,,CHEMBL3892732,8.12,0,http://www.openphacts.org/units/Nanomolar,2877465,=,37,1,=,,IC50,nM,,7.641,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.641,PAK4
,393074,17763960,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1)c1ccccc1,,,CHEMBL3886684,,2016,"{'bei': '14.94', 'le': '0.27', 'lle': '0.62', 'sei': '7.05'}",CHEMBL3956673,,CHEMBL3956673,6.52,0,http://www.openphacts.org/units/Nanomolar,2877466,=,37,1,=,,IC50,nM,,302.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,302.102,PAK4
,393075,17763961,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Cc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '20.90', 'le': '0.38', 'lle': '2.76', 'sei': '9.33'}",CHEMBL3958986,,CHEMBL3958986,7.51,0,http://www.openphacts.org/units/Nanomolar,2877467,=,37,1,=,,IC50,nM,,30.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.789,PAK4
,393076,17763962,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Nc1nnc(-c2ccc3[nH]cc(-c4ncccn4)c3c2)o1)c1ccccc1,,,CHEMBL3886684,,2016,"{'bei': '16.56', 'le': '0.30', 'lle': '1.55', 'sei': '7.10'}",CHEMBL3962369,,CHEMBL3962369,6.57,0,http://www.openphacts.org/units/Nanomolar,2877468,=,37,1,=,,IC50,nM,,271.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,271.1,PAK4
,393077,17763963,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)CNc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.97', 'le': '0.43', 'lle': '4.67', 'sei': '9.94'}",CHEMBL3940389,,CHEMBL3940389,9.20,0,http://www.openphacts.org/units/Nanomolar,2877469,=,37,1,=,,IC50,nM,,0.638,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.638,PAK4
,393078,17763964,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '23.02', 'le': '0.42', 'lle': '3.86', 'sei': '9.32'}",CHEMBL3969942,,CHEMBL3969942,8.62,0,http://www.openphacts.org/units/Nanomolar,2877470,=,37,1,=,,IC50,nM,,2.395,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.395,PAK4
,393079,17763965,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1nc(-c2cn(S(=O)(=O)c3ccc(C)cc3)c3ccc(-c4nnc(NC(C)(C)C)o4)cc23)ncc1F,,,CHEMBL3886684,,2016,"{'bei': '14.06', 'le': '0.27', 'lle': '2.49', 'sei': '6.03'}",CHEMBL3964497,,CHEMBL3964497,7.54,0,http://www.openphacts.org/units/Nanomolar,2877471,=,37,1,=,,IC50,nM,,28.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,28.681,PAK4
,393080,17763966,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(F)c(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '20.53', 'le': '0.38', 'lle': '3.15', 'sei': '8.71'}",CHEMBL3978285,,CHEMBL3978285,8.05,0,http://www.openphacts.org/units/Nanomolar,2877472,=,37,1,=,,IC50,nM,,8.813,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.813,PAK4
,393081,17763967,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)(C)C)o4)cc23)ncc1F,,,CHEMBL3886684,,2016,"{'bei': '20.18', 'le': '0.37', 'lle': '3.09', 'sei': '8.30'}",CHEMBL3918188,,CHEMBL3918188,7.68,0,http://www.openphacts.org/units/Nanomolar,2877473,=,37,1,=,,IC50,nM,,20.95,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.951,PAK4
,393082,17763968,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)s2)cc1,,,CHEMBL3886684,,2016,,CHEMBL3946064,,CHEMBL3946064,,0,http://www.openphacts.org/units/Nanomolar,2877474,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,393083,17763969,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccnc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.20', 'le': '0.41', 'lle': '4.28', 'sei': '7.64'}",CHEMBL3961854,,CHEMBL3961854,7.78,0,http://www.openphacts.org/units/Nanomolar,2877475,=,37,1,=,,IC50,nM,,16.67,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.673,PAK4
,393084,17763970,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(OC(C)C)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '20.80', 'le': '0.38', 'lle': '3.59', 'sei': '7.74'}",CHEMBL3937933,,CHEMBL3937933,7.87,0,http://www.openphacts.org/units/Nanomolar,2877476,=,37,1,=,,IC50,nM,,13.46,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.459,PAK4
,393085,17763971,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCN(C)C(=O)C5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '16.95', 'le': '0.31', 'lle': '4.56', 'sei': '6.32'}",CHEMBL3953116,,CHEMBL3953116,7.33,0,http://www.openphacts.org/units/Nanomolar,2877477,=,37,1,=,,IC50,nM,,46.75,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,46.752,PAK4
,393086,17763972,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(OC5CCCN(C)C5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '15.42', 'le': '0.29', 'lle': '2.71', 'sei': '6.37'}",CHEMBL3925450,,CHEMBL3925450,6.68,0,http://www.openphacts.org/units/Nanomolar,2877478,=,37,1,=,,IC50,nM,,206.54,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,206.538,PAK4
,393087,17763973,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nc(N)ns4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '18.20', 'le': '0.35', 'lle': '2.28', 'sei': '7.13'}",CHEMBL3947790,,CHEMBL3947790,6.40,0,http://www.openphacts.org/units/Nanomolar,2877479,=,37,1,=,,IC50,nM,,400.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,400.037,PAK4
,393088,17763974,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nc(N)ns4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '20.58', 'le': '0.40', 'lle': '3.68', 'sei': '6.86'}",CHEMBL3944528,,CHEMBL3944528,7.23,0,http://www.openphacts.org/units/Nanomolar,2877480,=,37,1,=,,IC50,nM,,58.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,58.701,PAK4
,393089,17763975,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nsc(N)n4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '17.61', 'le': '0.34', 'lle': '2.64', 'sei': '5.87'}",CHEMBL3939130,,CHEMBL3939130,6.19,0,http://www.openphacts.org/units/Nanomolar,2877482,=,37,1,=,,IC50,nM,,649.23,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,649.232,PAK4
,393090,17763976,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nc(N)no4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.56', 'le': '0.39', 'lle': '4.15', 'sei': '6.10'}",CHEMBL3954270,,CHEMBL3954270,7.23,0,http://www.openphacts.org/units/Nanomolar,2877483,=,37,1,=,,IC50,nM,,58.88,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,58.884,PAK4
,393091,17763977,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nc(N)no4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.17', 'le': '0.39', 'lle': '3.45', 'sei': '6.90'}",CHEMBL3930132,,CHEMBL3930132,7.10,0,http://www.openphacts.org/units/Nanomolar,2877484,=,37,1,=,,IC50,nM,,79.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,79.744,PAK4
,393092,17763978,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4noc(N)n4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '18.41', 'le': '0.34', 'lle': '2.53', 'sei': '6.00'}",CHEMBL3897123,,CHEMBL3897123,6.17,0,http://www.openphacts.org/units/Nanomolar,2877485,=,37,1,=,,IC50,nM,,668.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,668.036,PAK4
,393093,17763979,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4noc(N)n4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '19.21', 'le': '0.35', 'lle': '3.36', 'sei': '5.43'}",CHEMBL3899451,,CHEMBL3899451,6.44,0,http://www.openphacts.org/units/Nanomolar,2877486,=,37,1,=,,IC50,nM,,361.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,361.743,PAK4
,393094,17763980,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4noc(N)n4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '18.64', 'le': '0.34', 'lle': '3.23', 'sei': '5.42'}",CHEMBL3936450,,CHEMBL3936450,6.27,0,http://www.openphacts.org/units/Nanomolar,2877487,=,37,1,=,,IC50,nM,,538.27,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,538.27,PAK4
,393095,17763981,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nc(-c2ccc3[nH]cc(-c4cncc(OC(C)C)n4)c3c2)no1,,,CHEMBL3886684,,2016,"{'bei': '18.88', 'le': '0.35', 'lle': '3.12', 'sei': '6.50'}",CHEMBL3904923,,CHEMBL3904923,6.62,0,http://www.openphacts.org/units/Nanomolar,2877488,=,37,1,=,,IC50,nM,,242.33,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,242.326,PAK4
,393096,17763982,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nc(-c2ccc3[nH]cc(-c4cncc(OC(C)C)n4)c3c2)no1,,,CHEMBL3886684,,2016,"{'bei': '16.64', 'le': '0.31', 'lle': '2.02', 'sei': '6.19'}",CHEMBL3941897,,CHEMBL3941897,6.30,0,http://www.openphacts.org/units/Nanomolar,2877489,=,37,1,=,,IC50,nM,,504.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,504.197,PAK4
,393097,17763983,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1nc(-c2ccc3[nH]cc(-c4cncc(OC(C)C)n4)c3c2)no1,,,CHEMBL3886684,,2016,,CHEMBL3913921,,CHEMBL3913921,,0,http://www.openphacts.org/units/Nanomolar,2877490,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,393098,17763984,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)CC1,,,CHEMBL3886684,,2016,"{'bei': '21.74', 'le': '0.40', 'lle': '5.55', 'sei': '8.15'}",CHEMBL3960298,,CHEMBL3960298,8.16,0,http://www.openphacts.org/units/Nanomolar,2877491,=,37,1,=,,IC50,nM,,6.871,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.871,PAK4
,393099,17763985,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '24.63', 'le': '0.45', 'lle': '5.25', 'sei': '7.16'}",CHEMBL3965218,,CHEMBL3965218,8.29,0,http://www.openphacts.org/units/Nanomolar,2877492,=,37,1,=,,IC50,nM,,5.177,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.177,PAK4
,393100,17763986,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5cccn5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.90', 'le': '0.41', 'lle': '4.81', 'sei': '7.05'}",CHEMBL3981772,,CHEMBL3981772,7.86,0,http://www.openphacts.org/units/Nanomolar,2877493,=,37,1,=,,IC50,nM,,13.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.744,PAK4
,393101,17763987,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(F)c4F)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.72', 'le': '0.40', 'lle': '3.03', 'sei': '8.40'}",CHEMBL3900255,,CHEMBL3900255,6.78,0,http://www.openphacts.org/units/Nanomolar,2877494,=,37,1,=,,IC50,nM,,164.41,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,164.405,PAK4
,393102,17763988,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc(F)cc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)c1,,,CHEMBL3886684,,2016,"{'bei': '19.11', 'le': '0.35', 'lle': '2.34', 'sei': '7.48'}",CHEMBL3951344,,CHEMBL3951344,6.73,0,http://www.openphacts.org/units/Nanomolar,2877495,=,37,1,=,,IC50,nM,,184.89,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,184.887,PAK4
,393103,17763989,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Cn1cc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)cn1,,,CHEMBL3886684,,2016,"{'bei': '22.05', 'le': '0.40', 'lle': '3.79', 'sei': '7.21'}",CHEMBL3960832,,CHEMBL3960832,7.11,0,http://www.openphacts.org/units/Nanomolar,2877496,=,37,1,=,,IC50,nM,,77.98,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,77.984,PAK4
,393104,17763990,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cnn(CCN5CCOCC5)c4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '17.30', 'le': '0.32', 'lle': '4.56', 'sei': '5.91'}",CHEMBL3889658,,CHEMBL3889658,6.56,0,http://www.openphacts.org/units/Nanomolar,2877497,=,37,1,=,,IC50,nM,,272.78,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,272.784,PAK4
,393105,17763991,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C(=O)N5CCOCC5)c4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '14.73', 'le': '0.27', 'lle': '3.42', 'sei': '4.67'}",CHEMBL3962189,,CHEMBL3962189,5.75,0,http://www.openphacts.org/units/Nanomolar,2877498,=,37,1,=,,IC50,nM,,1777.29,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1777.29,PAK4
,393106,17763992,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc(F)c(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)c1,,,CHEMBL3886684,,2016,"{'bei': '19.05', 'le': '0.35', 'lle': '2.32', 'sei': '7.46'}",CHEMBL3894390,,CHEMBL3894390,6.71,0,http://www.openphacts.org/units/Nanomolar,2877499,=,37,1,=,,IC50,nM,,193.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,193.387,PAK4
,393107,17763993,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '23.29', 'le': '0.43', 'lle': '3.24', 'sei': '8.49'}",CHEMBL3965804,,CHEMBL3965804,6.85,0,http://www.openphacts.org/units/Nanomolar,2877500,=,37,1,=,,IC50,nM,,139.93,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,139.925,PAK4
,393108,17763994,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)c1,,,CHEMBL3886684,,2016,"{'bei': '19.18', 'le': '0.35', 'lle': '2.16', 'sei': '7.13'}",CHEMBL3974156,,CHEMBL3974156,6.42,0,http://www.openphacts.org/units/Nanomolar,2877501,=,37,1,=,,IC50,nM,,384.94,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,384.935,PAK4
,393109,17763995,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)cn1,,,CHEMBL3886684,,2016,"{'bei': '20.13', 'le': '0.37', 'lle': '3.83', 'sei': '5.61'}",CHEMBL3970964,,CHEMBL3970964,6.49,0,http://www.openphacts.org/units/Nanomolar,2877502,=,37,1,=,,IC50,nM,,324.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,324.238,PAK4
,393110,17763996,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '24.64', 'le': '0.45', 'lle': '4.61', 'sei': '8.03'}",CHEMBL3901441,,CHEMBL3901441,8.26,0,http://www.openphacts.org/units/Nanomolar,2877503,=,37,1,=,,IC50,nM,,5.458,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.458,PAK4
,393111,17763997,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCC(F)(F)C5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.37', 'le': '0.40', 'lle': '5.09', 'sei': '7.46'}",CHEMBL3942435,,CHEMBL3942435,8.19,0,http://www.openphacts.org/units/Nanomolar,2877504,=,37,1,=,,IC50,nM,,6.435,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.435,PAK4
,393112,17763998,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCCC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '23.03', 'le': '0.42', 'lle': '5.07', 'sei': '7.58'}",CHEMBL3930832,,CHEMBL3930832,8.32,0,http://www.openphacts.org/units/Nanomolar,2877505,=,37,1,=,,IC50,nM,,4.765,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.765,PAK4
,393113,17763999,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCOCC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.66', 'le': '0.40', 'lle': '5.78', 'sei': '6.62'}",CHEMBL3964669,,CHEMBL3964669,7.87,0,http://www.openphacts.org/units/Nanomolar,2877506,=,37,1,=,,IC50,nM,,13.45,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.445,PAK4
,393114,17764000,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '23.77', 'le': '0.44', 'lle': '6.49', 'sei': '7.54'}",CHEMBL3937011,,CHEMBL3937011,8.97,0,http://www.openphacts.org/units/Nanomolar,2877507,=,37,1,=,,IC50,nM,,1.069,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.069,PAK4
,393115,17764001,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(Oc5ccccc5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.80', 'le': '0.36', 'lle': '3.28', 'sei': '6.33'}",CHEMBL3895619,,CHEMBL3895619,7.33,0,http://www.openphacts.org/units/Nanomolar,2877508,=,37,1,=,,IC50,nM,,46.56,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,46.563,PAK4
,393116,17764002,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4ncccn4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '24.99', 'le': '0.45', 'lle': '4.69', 'sei': '6.53'}",CHEMBL3984537,,CHEMBL3984537,6.96,0,http://www.openphacts.org/units/Nanomolar,2877509,=,37,1,=,,IC50,nM,,110.99,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,110.993,PAK4
,393117,17764003,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '28.29', 'le': '0.51', 'lle': '5.88', 'sei': '8.46'}",CHEMBL3893588,,CHEMBL3893588,9.01,0,http://www.openphacts.org/units/Nanomolar,2877510,=,37,1,=,,IC50,nM,,0.984,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.984,PAK4
,393118,17764004,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cc(C(F)(F)F)ncn4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '17.55', 'le': '0.33', 'lle': '2.80', 'sei': '5.71'}",CHEMBL3903651,,CHEMBL3903651,6.08,0,http://www.openphacts.org/units/Nanomolar,2877511,=,37,1,=,,IC50,nM,,838.03,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,838.03,PAK4
,393119,17764005,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C(F)(F)F)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.65', 'le': '0.41', 'lle': '4.22', 'sei': '7.04'}",CHEMBL3909365,,CHEMBL3909365,7.50,0,http://www.openphacts.org/units/Nanomolar,2877512,=,37,1,=,,IC50,nM,,31.88,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,31.88,PAK4
,393120,17764006,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '24.26', 'le': '0.44', 'lle': '5.52', 'sei': '7.99'}",CHEMBL3971473,,CHEMBL3971473,8.77,0,http://www.openphacts.org/units/Nanomolar,2877513,=,37,1,=,,IC50,nM,,1.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.7,PAK4
,393121,17764007,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '26.12', 'le': '0.47', 'lle': '5.18', 'sei': '7.81'}",CHEMBL3896794,,CHEMBL3896794,8.31,0,http://www.openphacts.org/units/Nanomolar,2877514,=,37,1,=,,IC50,nM,,4.849,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.849,PAK4
,393122,17764008,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(O[C@@H]5CCCNC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '20.90', 'le': '0.38', 'lle': '5.50', 'sei': '6.17'}",CHEMBL4108940,,CHEMBL4108940,7.89,0,http://www.openphacts.org/units/Nanomolar,2877515,=,37,1,=,,IC50,nM,,12.91,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.915,PAK4
,393123,17764009,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NCC5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '25.00', 'le': '0.46', 'lle': '5.60', 'sei': '7.33'}",CHEMBL3890140,,CHEMBL3890140,8.69,0,http://www.openphacts.org/units/Nanomolar,2877516,=,37,1,=,,IC50,nM,,2.067,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.067,PAK4
,393124,17764010,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '25.03', 'le': '0.46', 'lle': '5.32', 'sei': '7.08'}",CHEMBL3912741,,CHEMBL3912741,8.39,0,http://www.openphacts.org/units/Nanomolar,2877517,=,37,1,=,,IC50,nM,,4.025,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.025,PAK4
,393125,17764011,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(Cl)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.86', 'le': '0.42', 'lle': '3.93', 'sei': '6.42'}",CHEMBL3982628,,CHEMBL3982628,6.83,0,http://www.openphacts.org/units/Nanomolar,2877518,=,37,1,=,,IC50,nM,,146.12,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,146.123,PAK4
,393126,17764012,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '25.79', 'le': '0.47', 'lle': '5.57', 'sei': '7.30'}",CHEMBL3908000,,CHEMBL3908000,8.65,0,http://www.openphacts.org/units/Nanomolar,2877421,=,37,1,=,,IC50,nM,,2.236,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.236,PAK4
,393127,17764013,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCC[C@@H](O)C5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.49', 'le': '0.40', 'lle': '5.89', 'sei': '6.24'}",CHEMBL4113485,,CHEMBL4113485,8.11,0,http://www.openphacts.org/units/Nanomolar,2877519,=,37,1,=,,IC50,nM,,7.727,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.727,PAK4
,393128,17764014,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CCCN(c2ccnc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)C1,,,CHEMBL3886684,,2016,"{'bei': '22.16', 'le': '0.41', 'lle': '4.83', 'sei': '7.58'}",CHEMBL3970168,,CHEMBL3970168,8.32,0,http://www.openphacts.org/units/Nanomolar,2877520,=,37,1,=,,IC50,nM,,4.807,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.807,PAK4
,393129,17764015,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(Oc5ccccc5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.12', 'le': '0.40', 'lle': '4.14', 'sei': '7.08'}",CHEMBL3951570,,CHEMBL3951570,8.19,0,http://www.openphacts.org/units/Nanomolar,2877521,=,37,1,=,,IC50,nM,,6.391,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.391,PAK4
,393130,17764016,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H]1CCCN(c2ccnc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)C1,,,CHEMBL3886684,,2016,"{'bei': '20.99', 'le': '0.39', 'lle': '5.70', 'sei': '7.51'}",CHEMBL3973417,,CHEMBL3973417,8.49,0,http://www.openphacts.org/units/Nanomolar,2877522,=,37,1,=,,IC50,nM,,3.243,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.243,PAK4
,393131,17764017,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(Nc5ccccc5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '23.03', 'le': '0.42', 'lle': '4.51', 'sei': '7.18'}",CHEMBL3899404,,CHEMBL3899404,8.51,0,http://www.openphacts.org/units/Nanomolar,2877523,=,37,1,=,,IC50,nM,,3.099,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.099,PAK4
,393132,17764018,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@@H]1CCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '19.34', 'le': '0.36', 'lle': '4.70', 'sei': '6.36'}",CHEMBL3894736,,CHEMBL3894736,7.57,0,http://www.openphacts.org/units/Nanomolar,2877524,=,37,1,=,,IC50,nM,,26.78,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,26.776,PAK4
,393133,17764019,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(OCC(F)(F)F)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.92', 'le': '0.44', 'lle': '5.42', 'sei': '7.45'}",CHEMBL3971664,,CHEMBL3971664,8.62,0,http://www.openphacts.org/units/Nanomolar,2877525,=,37,1,=,,IC50,nM,,2.378,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.378,PAK4
,393134,17764020,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCC(Nc2ccnc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)C1,,,CHEMBL3886684,,2016,"{'bei': '20.95', 'le': '0.39', 'lle': '5.42', 'sei': '6.72'}",CHEMBL3900527,,CHEMBL3900527,8.18,0,http://www.openphacts.org/units/Nanomolar,2877526,=,37,1,=,,IC50,nM,,6.595,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.595,PAK4
,393135,17764021,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCC(Oc2ccnc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)C1,,,CHEMBL3886684,,2016,"{'bei': '21.83', 'le': '0.40', 'lle': '5.81', 'sei': '7.18'}",CHEMBL3912113,,CHEMBL3912113,8.54,0,http://www.openphacts.org/units/Nanomolar,2877527,=,37,1,=,,IC50,nM,,2.853,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.853,PAK4
,393136,17764022,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1CCCN1c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '19.39', 'le': '0.36', 'lle': '4.72', 'sei': '6.38'}",CHEMBL4109812,,CHEMBL4109812,7.59,0,http://www.openphacts.org/units/Nanomolar,2877528,=,37,1,=,,IC50,nM,,25.65,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.652,PAK4
,393137,17764023,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccc(Cl)cc5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.54', 'le': '0.37', 'lle': '3.02', 'sei': '7.13'}",CHEMBL3922724,,CHEMBL3922724,7.60,0,http://www.openphacts.org/units/Nanomolar,2877529,=,37,1,=,,IC50,nM,,25.15,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.149,PAK4
,393138,17764024,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccccc5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.16', 'le': '0.40', 'lle': '3.93', 'sei': '7.37'}",CHEMBL3967996,,CHEMBL3967996,7.85,0,http://www.openphacts.org/units/Nanomolar,2877530,=,37,1,=,,IC50,nM,,14.02,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.024,PAK4
,393139,17764025,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccccc5F)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '20.70', 'le': '0.38', 'lle': '3.65', 'sei': '7.24'}",CHEMBL3938446,,CHEMBL3938446,7.71,0,http://www.openphacts.org/units/Nanomolar,2877531,=,37,1,=,,IC50,nM,,19.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.602,PAK4
,393140,17764026,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5ccccc5Cl)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '18.63', 'le': '0.35', 'lle': '2.66', 'sei': '6.80'}",CHEMBL3976511,,CHEMBL3976511,7.24,0,http://www.openphacts.org/units/Nanomolar,2877532,=,37,1,=,,IC50,nM,,57.26,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,57.257,PAK4
,393141,17764027,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5Cl)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.85', 'le': '0.38', 'lle': '3.14', 'sei': '7.25'}",CHEMBL3943843,,CHEMBL3943843,7.72,0,http://www.openphacts.org/units/Nanomolar,2877533,=,37,1,=,,IC50,nM,,19.17,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.167,PAK4
,393142,17764028,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5cccc(F)c5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.40', 'le': '0.39', 'lle': '3.91', 'sei': '7.48'}",CHEMBL3981344,,CHEMBL3981344,7.97,0,http://www.openphacts.org/units/Nanomolar,2877534,=,37,1,=,,IC50,nM,,10.73,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.731,PAK4
,393143,17764029,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(-c5cccc(Cl)c5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.65', 'le': '0.37', 'lle': '3.06', 'sei': '7.17'}",CHEMBL3952591,,CHEMBL3952591,7.64,0,http://www.openphacts.org/units/Nanomolar,2877535,=,37,1,=,,IC50,nM,,22.91,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.908,PAK4
,393144,17764030,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2cncc(-c3c[nH]c4ccc(-c5nnc(N)o5)cc34)n2)cn1,,,CHEMBL3886684,,2016,"{'bei': '20.82', 'le': '0.38', 'lle': '4.80', 'sei': '6.00'}",CHEMBL3892287,,CHEMBL3892287,7.46,0,http://www.openphacts.org/units/Nanomolar,2877536,=,37,1,=,,IC50,nM,,34.59,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.593,PAK4
,393145,17764031,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '23.74', 'le': '0.43', 'lle': '4.49', 'sei': '7.90'}",CHEMBL3965031,,CHEMBL3965031,8.41,0,http://www.openphacts.org/units/Nanomolar,2877537,=,37,1,=,,IC50,nM,,3.866,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.866,PAK4
,393146,17764032,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5F)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.90', 'le': '0.40', 'lle': '4.09', 'sei': '7.66'}",CHEMBL3904737,,CHEMBL3904737,8.15,0,http://www.openphacts.org/units/Nanomolar,2877424,=,37,1,=,,IC50,nM,,7.002,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.002,PAK4
,393147,17764033,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1ccnc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '20.29', 'le': '0.36', 'lle': '3.25', 'sei': '7.02'}",CHEMBL3975552,,CHEMBL3975552,7.48,0,http://www.openphacts.org/units/Nanomolar,2877538,=,37,1,=,,IC50,nM,,33.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,33.396,PAK4
,393148,17764034,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc(F)c(-c2c[nH]c3ccc(-c4nnc(N)o4)nc23)c1,,,CHEMBL3886684,,2016,"{'bei': '20.50', 'le': '0.38', 'lle': '3.45', 'sei': '7.04'}",CHEMBL3923772,,CHEMBL3923772,7.24,0,http://www.openphacts.org/units/Nanomolar,2877539,=,37,1,=,,IC50,nM,,57.03,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,57.029,PAK4
,393149,17764035,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)o4)nc23)c1,,,CHEMBL3886684,,2016,"{'bei': '19.72', 'le': '0.36', 'lle': '2.96', 'sei': '6.43'}",CHEMBL3954897,,CHEMBL3954897,6.61,0,http://www.openphacts.org/units/Nanomolar,2877540,=,37,1,=,,IC50,nM,,243.69,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,243.694,PAK4
,393150,17764036,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Cn1cc(-c2c[nH]c3ccc(-c4nnc(N)o4)nc23)cn1,,,CHEMBL3886684,,2016,"{'bei': '20.22', 'le': '0.37', 'lle': '3.83', 'sei': '5.87'}",CHEMBL3918311,,CHEMBL3918311,6.54,0,http://www.openphacts.org/units/Nanomolar,2877541,=,37,1,=,,IC50,nM,,289.38,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,289.382,PAK4
,393151,17764037,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCC[C@H](N)C5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '21.69', 'le': '0.42', 'lle': '5.71', 'sei': '8.12'}",CHEMBL3946212,,CHEMBL3946212,8.82,0,http://www.openphacts.org/units/Nanomolar,2877542,=,37,1,=,,IC50,nM,,1.527,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.527,PAK4
,393152,17764038,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4ccnc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.00', 'le': '0.35', 'lle': '4.06', 'sei': '7.71'}",CHEMBL3945136,,CHEMBL3945136,7.08,0,http://www.openphacts.org/units/Nanomolar,2877543,=,37,1,=,,IC50,nM,,82.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,82.389,PAK4
,393153,17764039,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-c5ccccc5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.05', 'le': '0.37', 'lle': '2.41', 'sei': '9.21'}",CHEMBL3981152,,CHEMBL3981152,7.41,0,http://www.openphacts.org/units/Nanomolar,2877544,=,37,1,=,,IC50,nM,,39.01,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,39.005,PAK4
,393154,17764040,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(-c5ccccc5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.37', 'le': '0.36', 'lle': '2.60', 'sei': '9.38'}",CHEMBL3932720,,CHEMBL3932720,7.45,0,http://www.openphacts.org/units/Nanomolar,2877545,=,37,1,=,,IC50,nM,,35.77,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.771,PAK4
,393155,17764041,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCN(C)CC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.38', 'le': '0.35', 'lle': '4.53', 'sei': '8.70'}",CHEMBL3960208,,CHEMBL3960208,7.47,0,http://www.openphacts.org/units/Nanomolar,2877546,=,37,1,=,,IC50,nM,,33.61,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,33.607,PAK4
,393156,17764042,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4ccnc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.32', 'le': '0.39', 'lle': '5.15', 'sei': '7.29'}",CHEMBL3959112,,CHEMBL3959112,7.71,0,http://www.openphacts.org/units/Nanomolar,2877547,=,37,1,=,,IC50,nM,,19.41,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.407,PAK4
,393157,17764043,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.79', 'le': '0.38', 'lle': '4.77', 'sei': '8.48'}",CHEMBL3962494,,CHEMBL3962494,7.79,0,http://www.openphacts.org/units/Nanomolar,2877548,=,37,1,=,,IC50,nM,,16.31,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.31,PAK4
,393158,17764044,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4nccc(N5CCCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.45', 'le': '0.35', 'lle': '3.04', 'sei': '8.74'}",CHEMBL3921252,,CHEMBL3921252,7.22,0,http://www.openphacts.org/units/Nanomolar,2877549,=,37,1,=,,IC50,nM,,59.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,59.704,PAK4
,393159,17764045,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '23.27', 'le': '0.45', 'lle': '3.15', 'sei': '10.68'}",CHEMBL3896741,,CHEMBL3896741,7.22,0,http://www.openphacts.org/units/Nanomolar,2877550,=,37,1,=,,IC50,nM,,59.99,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,59.994,PAK4
,393160,17764046,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cc(C(=O)Nc5ccccc5)ccc4F)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '15.43', 'le': '0.29', 'lle': '1.30', 'sei': '6.85'}",CHEMBL3912306,,CHEMBL3912306,6.63,0,http://www.openphacts.org/units/Nanomolar,2877551,=,37,1,=,,IC50,nM,,236.82,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,236.817,PAK4
,393161,17764047,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4c(F)cccc4F)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.67', 'le': '0.38', 'lle': '2.25', 'sei': '9.56'}",CHEMBL3394064,,CHEMBL3394064,6.46,0,http://www.openphacts.org/units/Nanomolar,2877552,=,37,1,=,,IC50,nM,,347.65,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,347.647,PAK4
,393162,17764048,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(N[C@H]4CCCNC4)s3)cc12,,,CHEMBL3886684,,2016,"{'bei': '17.73', 'le': '0.34', 'lle': '2.32', 'sei': '10.63'}",CHEMBL3982237,,CHEMBL3982237,6.98,0,http://www.openphacts.org/units/Nanomolar,2877553,=,37,1,=,,IC50,nM,,105.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,105.803,PAK4
,393163,17764049,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCN(c2nnc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)s2)C1,,,CHEMBL3886684,,2016,"{'bei': '17.42', 'le': '0.33', 'lle': '2.58', 'sei': '9.33'}",CHEMBL3944661,,CHEMBL3944661,6.61,0,http://www.openphacts.org/units/Nanomolar,2877554,=,37,1,=,,IC50,nM,,244.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,244.472,PAK4
,393164,17764050,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(NCC[C@H]4CCCCN4)s3)cc12,,,CHEMBL3886684,,2016,"{'bei': '14.99', 'le': '0.29', 'lle': '0.88', 'sei': '9.63'}",CHEMBL4108073,,CHEMBL4108073,6.32,0,http://www.openphacts.org/units/Nanomolar,2877555,=,37,1,=,,IC50,nM,,480.06,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,480.061,PAK4
,393165,17764051,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(NCc4ccc5[nH]ccc5c4)s3)cc12,,,CHEMBL3886684,,2016,"{'bei': '13.27', 'le': '0.25', 'lle': '-0.76', 'sei': '8.40'}",CHEMBL3930311,,CHEMBL3930311,5.83,0,http://www.openphacts.org/units/Nanomolar,2877556,=,37,1,=,,IC50,nM,,1478.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1478.127,PAK4
,393166,17764052,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(NCc4cccc5[nH]ccc45)s3)cc12,,,CHEMBL3886684,,2016,"{'bei': '12.56', 'le': '0.24', 'lle': '-1.07', 'sei': '7.95'}",CHEMBL3919198,,CHEMBL3919198,5.52,0,http://www.openphacts.org/units/Nanomolar,2877557,=,37,1,=,,IC50,nM,,3021.02,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3021.023,PAK4
,393167,17764053,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCN(c2nnc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)s2)CC1,,,CHEMBL3886684,,2016,"{'bei': '14.66', 'le': '0.28', 'lle': '1.35', 'sei': '8.15'}",CHEMBL3946988,,CHEMBL3946988,5.77,0,http://www.openphacts.org/units/Nanomolar,2877558,=,37,1,=,,IC50,nM,,1697.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1697.159,PAK4
,393168,17764054,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc(CNc2nnc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)s2)c1,,,CHEMBL3886684,,2016,"{'bei': '12.38', 'le': '0.23', 'lle': '-0.40', 'sei': '6.85'}",CHEMBL3924622,,CHEMBL3924622,5.66,0,http://www.openphacts.org/units/Nanomolar,2877559,=,37,1,=,,IC50,nM,,2167.72,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2167.722,PAK4
,393169,17764055,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COCC(=O)Nc1cccc(CNc2nnc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)s2)c1,,,CHEMBL3886684,,2016,"{'bei': '11.49', 'le': '0.22', 'lle': '-0.09', 'sei': '6.09'}",CHEMBL3984463,,CHEMBL3984463,5.60,0,http://www.openphacts.org/units/Nanomolar,2877560,=,37,1,=,,IC50,nM,,2513.75,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2513.75,PAK4
,393170,17764056,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]c2ccc(CNc3nnc(-c4ccc5[nH]cc(-c6ccc(F)cc6F)c5c4)s3)cc2c1C,,,CHEMBL3886684,,2016,,CHEMBL3961142,,CHEMBL3961142,,0,http://www.openphacts.org/units/Nanomolar,2877561,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393171,17764057,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(CNc2nnc(-c3ccc4[nH]cc(-c5ccc(F)cc5F)c4c3)s2)cc1,,,CHEMBL3886684,,2016,,CHEMBL3892162,,CHEMBL3892162,,0,http://www.openphacts.org/units/Nanomolar,2877562,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393172,17764058,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1-c1c[nH]c2ccc(-c3nnc(NCc4ccccc4)s3)cc12,,,CHEMBL3886684,,2016,,CHEMBL3975438,,CHEMBL3975438,,0,http://www.openphacts.org/units/Nanomolar,2877563,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393173,17764059,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1ccc(CNc2nnc(-c3ccc4[nH]cc(-c5ccc(F)cc5F)c4c3)s2)cc1,,,CHEMBL3886684,,2016,,CHEMBL3901121,,CHEMBL3901121,,0,http://www.openphacts.org/units/Nanomolar,2877564,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393174,17764060,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4ccc5nccnc5c4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.86', 'le': '0.37', 'lle': '2.96', 'sei': '7.33'}",CHEMBL3981312,,CHEMBL3981312,6.84,0,http://www.openphacts.org/units/Nanomolar,2877565,=,37,1,=,,IC50,nM,,144.17,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,144.172,PAK4
,393175,17764061,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC[C@@H]5N)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '21.54', 'le': '0.41', 'lle': '4.82', 'sei': '7.68'}",CHEMBL4108864,,CHEMBL4108864,8.43,0,http://www.openphacts.org/units/Nanomolar,2877566,=,37,1,=,,IC50,nM,,3.702,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.702,PAK4
,393176,17764062,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CCCCN1c1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '20.52', 'le': '0.39', 'lle': '3.30', 'sei': '9.57'}",CHEMBL3900171,,CHEMBL3900171,8.01,0,http://www.openphacts.org/units/Nanomolar,2877567,=,37,1,=,,IC50,nM,,9.735,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.735,PAK4
,393177,17764063,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)c1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.06', 'le': '0.40', 'lle': '4.13', 'sei': '7.97'}",CHEMBL3892029,,CHEMBL3892029,7.70,0,http://www.openphacts.org/units/Nanomolar,2877568,=,37,1,=,,IC50,nM,,20.03,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.026,PAK4
,393178,17764064,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn(-c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)cn1,,,CHEMBL3886684,,2016,"{'bei': '23.15', 'le': '0.44', 'lle': '4.83', 'sei': '8.80'}",CHEMBL3901582,,CHEMBL3901582,8.65,0,http://www.openphacts.org/units/Nanomolar,2877569,=,37,1,=,,IC50,nM,,2.254,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.254,PAK4
,393179,17764065,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.85', 'le': '0.40', 'lle': '5.35', 'sei': '7.47'}",CHEMBL3394073,,CHEMBL3394073,7.91,0,http://www.openphacts.org/units/Nanomolar,2877570,=,37,1,=,,IC50,nM,,12.31,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.314,PAK4
,393180,17764066,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.75', 'le': '0.44', 'lle': '3.88', 'sei': '8.91'}",CHEMBL3394167,,CHEMBL3394167,8.00,0,http://www.openphacts.org/units/Nanomolar,2877571,=,37,1,=,,IC50,nM,,10.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.073,PAK4
,393181,17764067,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.37', 'le': '0.43', 'lle': '4.76', 'sei': '7.81'}",CHEMBL3922231,,CHEMBL3922231,7.55,0,http://www.openphacts.org/units/Nanomolar,2877572,=,37,1,=,,IC50,nM,,28.22,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,28.224,PAK4
,393182,17764068,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.08', 'le': '0.43', 'lle': '4.27', 'sei': '7.58'}",CHEMBL3394171,,CHEMBL3394171,7.78,0,http://www.openphacts.org/units/Nanomolar,2877573,=,37,1,=,,IC50,nM,,16.58,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.581,PAK4
,393183,17764069,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(OC5CCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.10', 'le': '0.38', 'lle': '3.56', 'sei': '7.42'}",CHEMBL3394172,,CHEMBL3394172,7.61,0,http://www.openphacts.org/units/Nanomolar,2877574,=,37,1,=,,IC50,nM,,24.63,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.633,PAK4
,393184,17764070,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '21.39', 'le': '0.41', 'lle': '3.51', 'sei': '8.67'}",CHEMBL3914520,,CHEMBL3914520,7.77,0,http://www.openphacts.org/units/Nanomolar,2877575,=,37,1,=,,IC50,nM,,16.83,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.833,PAK4
,393185,17764071,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCN(c2cncc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1,,,CHEMBL3886684,,2016,"{'bei': '18.66', 'le': '0.36', 'lle': '3.35', 'sei': '7.56'}",CHEMBL3965029,,CHEMBL3965029,7.31,0,http://www.openphacts.org/units/Nanomolar,2877576,=,37,1,=,,IC50,nM,,49.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,49.388,PAK4
,393186,17764072,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.58', 'le': '0.37', 'lle': '2.74', 'sei': '8.24'}",CHEMBL3394168,,CHEMBL3394168,7.39,0,http://www.openphacts.org/units/Nanomolar,2877577,=,37,1,=,,IC50,nM,,40.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,40.791,PAK4
,393187,17764073,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.72', 'le': '0.44', 'lle': '3.94', 'sei': '8.55'}",CHEMBL3394166,,CHEMBL3394166,7.67,0,http://www.openphacts.org/units/Nanomolar,2877578,=,37,1,=,,IC50,nM,,21.56,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.562,PAK4
,393188,17764074,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCCOc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.21', 'le': '0.41', 'lle': '3.33', 'sei': '8.31'}",CHEMBL3933697,,CHEMBL3933697,7.45,0,http://www.openphacts.org/units/Nanomolar,2877579,=,37,1,=,,IC50,nM,,35.27,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.27,PAK4
,393189,17764075,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5=O)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.70', 'le': '0.38', 'lle': '3.96', 'sei': '7.36'}",CHEMBL3896735,,CHEMBL3896735,7.42,0,http://www.openphacts.org/units/Nanomolar,2877580,=,37,1,=,,IC50,nM,,38.33,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,38.334,PAK4
,393190,17764076,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CCCCN1c1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '18.41', 'le': '0.35', 'lle': '2.48', 'sei': '8.59'}",CHEMBL3900171,,CHEMBL3900171,7.19,0,http://www.openphacts.org/units/Nanomolar,2877567,=,37,1,=,,IC50,nM,,64.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,64.403,PAK4
,393191,17764077,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)nc1OC,,,CHEMBL3886684,,2016,"{'bei': '20.81', 'le': '0.40', 'lle': '4.01', 'sei': '7.43'}",CHEMBL3948227,,CHEMBL3948227,7.36,0,http://www.openphacts.org/units/Nanomolar,2877581,=,37,1,=,,IC50,nM,,44.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,44.071,PAK4
,393192,17764078,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nccn1-c1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '20.41', 'le': '0.39', 'lle': '3.80', 'sei': '7.76'}",CHEMBL3936230,,CHEMBL3936230,7.62,0,http://www.openphacts.org/units/Nanomolar,2877582,=,37,1,=,,IC50,nM,,23.77,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,23.773,PAK4
,393193,17764079,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn(-c2nc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)cs2)cn1,,,CHEMBL3886684,,2016,"{'bei': '18.44', 'le': '0.37', 'lle': '3.11', 'sei': '7.12'}",CHEMBL3911843,,CHEMBL3911843,7.00,0,http://www.openphacts.org/units/Nanomolar,2877583,=,37,1,=,,IC50,nM,,100.42,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,100.419,PAK4
,393194,17764080,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4ccc5cn[nH]c5c4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '21.76', 'le': '0.41', 'lle': '3.42', 'sei': '7.51'}",CHEMBL3939836,,CHEMBL3939836,7.23,0,http://www.openphacts.org/units/Nanomolar,2877584,=,37,1,=,,IC50,nM,,58.33,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,58.333,PAK4
,393195,17764081,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.02', 'le': '0.36', 'lle': '2.84', 'sei': '8.56'}",CHEMBL3913009,,CHEMBL3913009,7.16,0,http://www.openphacts.org/units/Nanomolar,2877585,=,37,1,=,,IC50,nM,,68.81,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,68.807,PAK4
,393196,17764082,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.73', 'le': '0.34', 'lle': '1.90', 'sei': '7.74'}",CHEMBL3394169,,CHEMBL3394169,6.94,0,http://www.openphacts.org/units/Nanomolar,2877586,=,37,1,=,,IC50,nM,,114.43,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,114.434,PAK4
,393197,17764083,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CCCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)C1,,,CHEMBL3886684,,2016,"{'bei': '17.41', 'le': '0.33', 'lle': '2.23', 'sei': '8.12'}",CHEMBL4110013,,CHEMBL4110013,6.80,0,http://www.openphacts.org/units/Nanomolar,2877587,=,37,1,=,,IC50,nM,,158.91,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,158.913,PAK4
,393198,17764084,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CCN(c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)CC1,,,CHEMBL3886684,,2016,"{'bei': '17.75', 'le': '0.34', 'lle': '2.36', 'sei': '8.28'}",CHEMBL3964167,,CHEMBL3964167,6.93,0,http://www.openphacts.org/units/Nanomolar,2877588,=,37,1,=,,IC50,nM,,117.31,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,117.311,PAK4
,393199,17764085,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.26', 'le': '0.37', 'lle': '3.05', 'sei': '8.34'}",CHEMBL3394066,,CHEMBL3394066,6.98,0,http://www.openphacts.org/units/Nanomolar,2877430,=,37,1,=,,IC50,nM,,104.38,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,104.384,PAK4
,393200,17764086,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4csc(-n5ccccc5=O)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.94', 'le': '0.36', 'lle': '3.50', 'sei': '6.87'}",CHEMBL3919558,,CHEMBL3919558,7.04,0,http://www.openphacts.org/units/Nanomolar,2877589,=,37,1,=,,IC50,nM,,91.22,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,91.216,PAK4
,393201,17764087,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2cnc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)cn2)CC1,,,CHEMBL3886684,,2016,"{'bei': '16.15', 'le': '0.31', 'lle': '3.86', 'sei': '6.35'}",CHEMBL3891490,,CHEMBL3891490,6.34,0,http://www.openphacts.org/units/Nanomolar,2877590,=,37,1,=,,IC50,nM,,459.37,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,459.372,PAK4
,393202,17764088,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn(-c2cccc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)n2)n1,,,CHEMBL3886684,,2016,"{'bei': '19.25', 'le': '0.36', 'lle': '3.37', 'sei': '7.31'}",CHEMBL3921475,,CHEMBL3921475,7.19,0,http://www.openphacts.org/units/Nanomolar,2877591,=,37,1,=,,IC50,nM,,64.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,64.601,PAK4
,393203,17764089,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5cccn5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.33', 'le': '0.38', 'lle': '3.79', 'sei': '7.43'}",CHEMBL3942496,,CHEMBL3942496,7.31,0,http://www.openphacts.org/units/Nanomolar,2877592,=,37,1,=,,IC50,nM,,49.46,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,49.459,PAK4
,393204,17764090,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCCC5=O)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.04', 'le': '0.32', 'lle': '2.80', 'sei': '6.60'}",CHEMBL3972469,,CHEMBL3972469,6.65,0,http://www.openphacts.org/units/Nanomolar,2877593,=,37,1,=,,IC50,nM,,222.97,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,222.97,PAK4
,393205,17764091,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(C(F)(F)F)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.01', 'le': '0.38', 'lle': '2.52', 'sei': '8.54'}",CHEMBL3912927,,CHEMBL3912927,6.87,0,http://www.openphacts.org/units/Nanomolar,2877594,=,37,1,=,,IC50,nM,,134.76,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,134.76,PAK4
,393206,17764092,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.23', 'le': '0.40', 'lle': '3.56', 'sei': '6.48'}",CHEMBL3984864,,CHEMBL3984864,6.76,0,http://www.openphacts.org/units/Nanomolar,2877595,=,37,1,=,,IC50,nM,,174.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,174.198,PAK4
,393207,17764093,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1CCCCN1c1nc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cs1,,,CHEMBL3886684,,2016,"{'bei': '15.69', 'le': '0.31', 'lle': '1.45', 'sei': '7.43'}",CHEMBL3910525,,CHEMBL3910525,6.22,0,http://www.openphacts.org/units/Nanomolar,2877596,=,37,1,=,,IC50,nM,,601.87,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,601.866,PAK4
,393208,17764094,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5ccccc5=O)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.11', 'le': '0.32', 'lle': '3.13', 'sei': '6.45'}",CHEMBL3903410,,CHEMBL3903410,6.61,0,http://www.openphacts.org/units/Nanomolar,2877597,=,37,1,=,,IC50,nM,,243.75,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,243.747,PAK4
,393209,17764095,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)ccn1,,,CHEMBL3886684,,2016,"{'bei': '21.30', 'le': '0.41', 'lle': '3.66', 'sei': '6.17'}",CHEMBL3985653,,CHEMBL3985653,6.57,0,http://www.openphacts.org/units/Nanomolar,2877598,=,37,1,=,,IC50,nM,,270.03,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,270.032,PAK4
,393210,17764096,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '16.71', 'le': '0.32', 'lle': '2.38', 'sei': '5.74'}",CHEMBL3394171,,CHEMBL3394171,5.89,0,http://www.openphacts.org/units/Nanomolar,2877573,=,37,1,=,,IC50,nM,,1294.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1294.157,PAK4
,393211,17764097,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(C)c1cnc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cn1,,,CHEMBL3886684,,2016,"{'bei': '16.83', 'le': '0.32', 'lle': '2.73', 'sei': '6.12'}",CHEMBL3915900,,CHEMBL3915900,5.91,0,http://www.openphacts.org/units/Nanomolar,2877599,=,37,1,=,,IC50,nM,,1218.57,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1218.571,PAK4
,393212,17764098,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cnc(N5CCCC5)cn4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '16.95', 'le': '0.32', 'lle': '2.83', 'sei': '6.38'}",CHEMBL3930502,,CHEMBL3930502,6.16,0,http://www.openphacts.org/units/Nanomolar,2877600,=,37,1,=,,IC50,nM,,689.91,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,689.915,PAK4
,393213,17764099,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '19.49', 'le': '0.37', 'lle': '3.10', 'sei': '5.64'}",CHEMBL3394065,,CHEMBL3394065,6.01,0,http://www.openphacts.org/units/Nanomolar,2877601,=,37,1,=,,IC50,nM,,977.36,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,977.359,PAK4
,393214,17764100,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)ccc1F,,,CHEMBL3886684,,2016,"{'bei': '18.70', 'le': '0.36', 'lle': '2.31', 'sei': '7.56'}",CHEMBL3891145,,CHEMBL3891145,6.08,0,http://www.openphacts.org/units/Nanomolar,2877602,=,37,1,=,,IC50,nM,,821.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,821.737,PAK4
,393215,17764101,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cnc(N5CCOCC5)cn4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '14.81', 'le': '0.28', 'lle': '3.06', 'sei': '5.31'}",CHEMBL3963322,,CHEMBL3963322,5.62,0,http://www.openphacts.org/units/Nanomolar,2877603,=,37,1,=,,IC50,nM,,2404.78,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2404.779,PAK4
,393216,17764102,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCCCOc1cnc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)cn1,,,CHEMBL3886684,,2016,"{'bei': '15.86', 'le': '0.31', 'lle': '1.91', 'sei': '5.66'}",CHEMBL3898134,,CHEMBL3898134,5.81,0,http://www.openphacts.org/units/Nanomolar,2877604,=,37,1,=,,IC50,nM,,1546.83,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1546.829,PAK4
,393217,17764103,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cnc(N5CCCC5=O)cn4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '15.85', 'le': '0.30', 'lle': '3.13', 'sei': '5.26'}",CHEMBL3985673,,CHEMBL3985673,5.98,0,http://www.openphacts.org/units/Nanomolar,2877605,=,37,1,=,,IC50,nM,,1042.57,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1042.567,PAK4
,393218,17764104,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cnc(OC5CCCC5)cn4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '15.52', 'le': '0.30', 'lle': '1.82', 'sei': '5.72'}",CHEMBL3953669,,CHEMBL3953669,5.87,0,http://www.openphacts.org/units/Nanomolar,2877606,=,37,1,=,,IC50,nM,,1343.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1343.13,PAK4
,393219,17764105,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(O)n4)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3977572,,CHEMBL3977572,,0,http://www.openphacts.org/units/Nanomolar,2877607,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393220,17764106,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccn(-c2cnc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)cn2)n1,,,CHEMBL3886684,,2016,"{'bei': '14.79', 'le': '0.28', 'lle': '2.32', 'sei': '4.98'}",CHEMBL3963678,,CHEMBL3963678,5.54,0,http://www.openphacts.org/units/Nanomolar,2877608,=,37,1,=,,IC50,nM,,2903.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2903.676,PAK4
,393221,17764107,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '21.09', 'le': '0.40', 'lle': '4.24', 'sei': '8.24'}",CHEMBL3967959,,CHEMBL3967959,7.96,0,http://www.openphacts.org/units/Nanomolar,2877609,=,37,1,=,,IC50,nM,,10.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.897,PAK4
,393222,17764108,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)c1,,,CHEMBL3886684,,2016,"{'bei': '19.20', 'le': '0.37', 'lle': '2.87', 'sei': '6.92'}",CHEMBL3941886,,CHEMBL3941886,6.21,0,http://www.openphacts.org/units/Nanomolar,2877610,=,37,1,=,,IC50,nM,,618.48,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,618.48,PAK4
,393223,17764109,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)nc(OC(C)C)n1,,,CHEMBL3886684,,2016,"{'bei': '19.67', 'le': '0.38', 'lle': '4.00', 'sei': '6.73'}",CHEMBL3904314,,CHEMBL3904314,7.52,0,http://www.openphacts.org/units/Nanomolar,2877611,=,37,1,=,,IC50,nM,,30.09,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.092,PAK4
,393224,17764110,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CNc2ncc(-c3c[nH]c4ccc(-c5nnc(N)s5)cc34)nc21,,,CHEMBL3886684,,2016,"{'bei': '20.61', 'le': '0.39', 'lle': '4.06', 'sei': '7.11'}",CHEMBL3935173,,CHEMBL3935173,7.49,0,http://www.openphacts.org/units/Nanomolar,2877612,=,37,1,=,,IC50,nM,,32.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,32.392,PAK4
,393225,17764111,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)nc(NC(C)C)n1,,,CHEMBL3886684,,2016,"{'bei': '18.50', 'le': '0.36', 'lle': '3.51', 'sei': '6.16'}",CHEMBL3898847,,CHEMBL3898847,7.06,0,http://www.openphacts.org/units/Nanomolar,2877613,=,37,1,=,,IC50,nM,,87.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,87.466,PAK4
,393226,17764112,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cccc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.20', 'le': '0.41', 'lle': '3.28', 'sei': '8.03'}",CHEMBL3394068,,CHEMBL3394068,7.43,0,http://www.openphacts.org/units/Nanomolar,2877614,=,37,1,=,,IC50,nM,,37.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,37.164,PAK4
,393227,17764113,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NCC5CC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.87', 'le': '0.36', 'lle': '2.69', 'sei': '7.39'}",CHEMBL3918913,,CHEMBL3918913,6.84,0,http://www.openphacts.org/units/Nanomolar,2877615,=,37,1,=,,IC50,nM,,144.67,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,144.668,PAK4
,393228,17764114,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(NC5CCCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.01', 'le': '0.32', 'lle': '1.56', 'sei': '7.18'}",CHEMBL3394070,,CHEMBL3394070,6.64,0,http://www.openphacts.org/units/Nanomolar,2877616,=,37,1,=,,IC50,nM,,226.69,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,226.694,PAK4
,393229,17764115,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.81', 'le': '0.44', 'lle': '4.47', 'sei': '7.60'}",CHEMBL3394074,,CHEMBL3394074,8.02,0,http://www.openphacts.org/units/Nanomolar,2877617,=,37,1,=,,IC50,nM,,9.654,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.654,PAK4
,393230,17764116,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NCC5CC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '22.32', 'le': '0.43', 'lle': '4.56', 'sei': '7.70'}",CHEMBL3925863,,CHEMBL3925863,8.11,0,http://www.openphacts.org/units/Nanomolar,2877618,=,37,1,=,,IC50,nM,,7.705,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.705,PAK4
,393231,17764117,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cncc(NC5CCCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.78', 'le': '0.38', 'lle': '3.27', 'sei': '7.35'}",CHEMBL3394165,,CHEMBL3394165,7.74,0,http://www.openphacts.org/units/Nanomolar,2877619,=,37,1,=,,IC50,nM,,18.07,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,18.07,PAK4
,393232,17764118,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(F)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.08', 'le': '0.39', 'lle': '2.78', 'sei': '7.77'}",CHEMBL3950062,,CHEMBL3950062,6.25,0,http://www.openphacts.org/units/Nanomolar,2877620,=,37,1,=,,IC50,nM,,557.99,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,557.988,PAK4
,393233,17764119,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.71', 'le': '0.42', 'lle': '4.41', 'sei': '5.63'}",CHEMBL3394071,,CHEMBL3394071,6.72,0,http://www.openphacts.org/units/Nanomolar,2877621,=,37,1,=,,IC50,nM,,192.34,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,192.339,PAK4
,393234,17764120,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(Oc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1)C(F)(F)F,,,CHEMBL3886684,,2016,"{'bei': '17.89', 'le': '0.35', 'lle': '3.21', 'sei': '7.09'}",CHEMBL3934994,,CHEMBL3934994,7.27,0,http://www.openphacts.org/units/Nanomolar,2877622,=,37,1,=,,IC50,nM,,53.74,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,53.742,PAK4
,393235,17764121,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cncc(-c2c[nH]c3ccc(-c4nnc(N)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '23.18', 'le': '0.45', 'lle': '4.79', 'sei': '7.33'}",CHEMBL3907899,,CHEMBL3907899,7.52,0,http://www.openphacts.org/units/Nanomolar,2877623,=,37,1,=,,IC50,nM,,30.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.178,PAK4
,393236,17764122,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '16.22', 'le': '0.31', 'lle': '2.97', 'sei': '6.60'}",CHEMBL3394067,,CHEMBL3394067,6.14,0,http://www.openphacts.org/units/Nanomolar,2877440,=,37,1,=,,IC50,nM,,729.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,729.8,PAK4
,393237,17764123,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.93', 'le': '0.34', 'lle': '3.41', 'sei': '8.91'}",CHEMBL3940277,,CHEMBL3940277,7.04,0,http://www.openphacts.org/units/Nanomolar,2877624,=,37,1,=,,IC50,nM,,91.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,91.896,PAK4
,393238,17764124,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '11.45', 'le': '0.23', 'lle': '2.07', 'sei': '5.00'}",CHEMBL3943596,,CHEMBL3943596,5.06,0,http://www.openphacts.org/units/Nanomolar,2877625,=,37,1,=,,IC50,nM,,8780.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8780.0,PAK4
,393239,17764125,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4ccc5c(c4)OC(C)(C)C5)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '15.23', 'le': '0.29', 'lle': '0.62', 'sei': '9.13'}",CHEMBL3965530,,CHEMBL3965530,5.74,0,http://www.openphacts.org/units/Nanomolar,2877626,=,37,1,=,,IC50,nM,,1841.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1841.035,PAK4
,393240,17764126,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cnc5ccccc5c4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '16.19', 'le': '0.30', 'lle': '0.85', 'sei': '8.70'}",CHEMBL3394062,,CHEMBL3394062,5.79,0,http://www.openphacts.org/units/Nanomolar,2877627,=,37,1,=,,IC50,nM,,1632.17,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1632.168,PAK4
,393241,17764127,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cn[nH]c4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.94', 'le': '0.40', 'lle': '3.09', 'sei': '7.54'}",CHEMBL3906121,,CHEMBL3906121,6.21,0,http://www.openphacts.org/units/Nanomolar,2877628,=,37,1,=,,IC50,nM,,622.52,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,622.523,PAK4
,393242,17764128,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4ccncc4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.05', 'le': '0.38', 'lle': '2.37', 'sei': '9.27'}",CHEMBL3918784,,CHEMBL3918784,6.16,0,http://www.openphacts.org/units/Nanomolar,2877629,=,37,1,=,,IC50,nM,,686.35,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,686.352,PAK4
,393243,17764129,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccnc4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.23', 'le': '0.37', 'lle': '2.12', 'sei': '8.89'}",CHEMBL3911670,,CHEMBL3911670,5.91,0,http://www.openphacts.org/units/Nanomolar,2877630,=,37,1,=,,IC50,nM,,1231.23,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1231.235,PAK4
,393244,17764130,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(N)c4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.13', 'le': '0.35', 'lle': '1.85', 'sei': '7.32'}",CHEMBL3948403,,CHEMBL3948403,5.83,0,http://www.openphacts.org/units/Nanomolar,2877631,=,37,1,=,,IC50,nM,,1491.22,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1491.218,PAK4
,393245,17764131,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4ccn[nH]4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.71', 'le': '0.38', 'lle': '2.72', 'sei': '7.10'}",CHEMBL3920604,,CHEMBL3920604,5.84,0,http://www.openphacts.org/units/Nanomolar,2877632,=,37,1,=,,IC50,nM,,1436.73,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1436.727,PAK4
,393246,17764132,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4ccccc4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.64', 'le': '0.35', 'lle': '1.31', 'sei': '10.65'}",CHEMBL3957078,,CHEMBL3957078,5.71,0,http://www.openphacts.org/units/Nanomolar,2877633,=,37,1,=,,IC50,nM,,1948.12,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1948.12,PAK4
,393247,17764133,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(C(F)(F)F)c4)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3955578,,CHEMBL3955578,,0,http://www.openphacts.org/units/Nanomolar,2877634,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393248,17764134,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(OC(F)(F)F)c4)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3916044,,CHEMBL3916044,,0,http://www.openphacts.org/units/Nanomolar,2877635,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393249,17764135,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(OC)c4)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3942045,,CHEMBL3942045,,0,http://www.openphacts.org/units/Nanomolar,2877636,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393250,17764136,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cncc(N5CCCCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.87', 'le': '0.36', 'lle': '3.21', 'sei': '8.94'}",CHEMBL3930004,,CHEMBL3930004,7.39,0,http://www.openphacts.org/units/Nanomolar,2877637,=,37,1,=,,IC50,nM,,40.97,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,40.974,PAK4
,393251,17764137,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5cnc(C)c5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '20.86', 'le': '0.39', 'lle': '3.80', 'sei': '9.59'}",CHEMBL3957552,,CHEMBL3957552,8.08,0,http://www.openphacts.org/units/Nanomolar,2877638,=,37,1,=,,IC50,nM,,8.279,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.279,PAK4
,393252,17764138,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCC5=O)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.17', 'le': '0.35', 'lle': '3.17', 'sei': '8.17'}",CHEMBL3942495,,CHEMBL3942495,7.09,0,http://www.openphacts.org/units/Nanomolar,2877639,=,37,1,=,,IC50,nM,,80.44,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,80.438,PAK4
,393253,17764139,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cccc(-c2c[nH]c3ccc(-c4nnc(NC)s4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '20.49', 'le': '0.39', 'lle': '3.01', 'sei': '9.51'}",CHEMBL3968565,,CHEMBL3968565,7.20,0,http://www.openphacts.org/units/Nanomolar,2877640,=,37,1,=,,IC50,nM,,63.12,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,63.115,PAK4
,393254,17764140,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1nnc(-c2ccc3[nH]cc(-c4cncc(N(C)C)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '19.58', 'le': '0.37', 'lle': '3.09', 'sei': '9.72'}",CHEMBL3915618,,CHEMBL3915618,6.86,0,http://www.openphacts.org/units/Nanomolar,2877641,=,37,1,=,,IC50,nM,,137.46,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,137.462,PAK4
,393255,17764141,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(OC5CCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.50', 'le': '0.35', 'lle': '2.26', 'sei': '9.22'}",CHEMBL3890422,,CHEMBL3890422,6.98,0,http://www.openphacts.org/units/Nanomolar,2877642,=,37,1,=,,IC50,nM,,104.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,104.13,PAK4
,393256,17764142,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4csc(-n5cnc(C)c5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '16.01', 'le': '0.32', 'lle': '1.95', 'sei': '7.47'}",CHEMBL3921086,,CHEMBL3921086,6.30,0,http://www.openphacts.org/units/Nanomolar,2877643,=,37,1,=,,IC50,nM,,502.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,502.395,PAK4
,393257,17764143,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5ccnc5C)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.84', 'le': '0.34', 'lle': '2.63', 'sei': '8.20'}",CHEMBL3952291,,CHEMBL3952291,6.91,0,http://www.openphacts.org/units/Nanomolar,2877644,=,37,1,=,,IC50,nM,,122.62,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,122.625,PAK4
,393258,17764144,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.83', 'le': '0.36', 'lle': '1.58', 'sei': '11.39'}",CHEMBL3937821,,CHEMBL3937821,6.11,0,http://www.openphacts.org/units/Nanomolar,2877645,=,37,1,=,,IC50,nM,,781.82,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,781.823,PAK4
,393259,17764145,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCCCC5=O)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '15.50', 'le': '0.30', 'lle': '1.96', 'sei': '7.22'}",CHEMBL3967448,,CHEMBL3967448,6.27,0,http://www.openphacts.org/units/Nanomolar,2877646,=,37,1,=,,IC50,nM,,538.32,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,538.316,PAK4
,393260,17764146,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4c(F)cccc4F)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '17.27', 'le': '0.34', 'lle': '1.24', 'sei': '11.03'}",CHEMBL3969190,,CHEMBL3969190,5.91,0,http://www.openphacts.org/units/Nanomolar,2877647,=,37,1,=,,IC50,nM,,1219.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1219.163,PAK4
,393261,17764147,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(-n5ccccc5=O)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '15.15', 'le': '0.29', 'lle': '2.13', 'sei': '6.86'}",CHEMBL3947592,,CHEMBL3947592,6.07,0,http://www.openphacts.org/units/Nanomolar,2877648,=,37,1,=,,IC50,nM,,855.58,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,855.584,PAK4
,393262,17764148,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4cccc(F)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '18.84', 'le': '0.36', 'lle': '2.20', 'sei': '9.22'}",CHEMBL3986966,,CHEMBL3986966,6.13,0,http://www.openphacts.org/units/Nanomolar,2877649,=,37,1,=,,IC50,nM,,739.49,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,739.487,PAK4
,393263,17764149,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4csc(-c5ccoc5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '14.70', 'le': '0.29', 'lle': '0.47', 'sei': '7.01'}",CHEMBL3958260,,CHEMBL3958260,5.58,0,http://www.openphacts.org/units/Nanomolar,2877650,=,37,1,=,,IC50,nM,,2635.25,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2635.252,PAK4
,393264,17764150,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nnc(-c2ccc3[nH]cc(-c4ccc(-c5cccs5)s4)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3982420,,CHEMBL3982420,,0,http://www.openphacts.org/units/Nanomolar,2877651,>,37,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,393265,17764151,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,,CHEMBL3957081,,CHEMBL3957081,,0,http://www.openphacts.org/units/Nanomolar,2877652,>,37,1,>,,IC50,nM,,3000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3000.0,PAK4
,393266,17764152,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1nnc(-c2ccc3[nH]cc(-c4cccc(N5CCOCC5)n4)c3c2)s1,,,CHEMBL3886684,,2016,"{'bei': '13.55', 'le': '0.27', 'lle': '1.24', 'sei': '8.29'}",CHEMBL3974432,,CHEMBL3974432,5.55,0,http://www.openphacts.org/units/Nanomolar,2877653,=,37,1,=,,IC50,nM,,2818.32,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2818.316,PAK4
,393267,17764153,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc(-c2c[nH]c3ccc(-c4nnco4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.07', 'le': '0.40', 'lle': '3.00', 'sei': '9.20'}",CHEMBL3945003,,CHEMBL3945003,7.07,0,http://www.openphacts.org/units/Nanomolar,2877654,=,37,1,=,,IC50,nM,,85.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,85.392,PAK4
,393268,17764154,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(N2CCOCC2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.17', 'le': '0.35', 'lle': '4.06', 'sei': '8.01'}",CHEMBL3959316,,CHEMBL3959316,7.45,0,http://www.openphacts.org/units/Nanomolar,2877655,=,37,1,=,,IC50,nM,,35.77,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.769,PAK4
,393269,17764155,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(N2CCNCC2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.79', 'le': '0.36', 'lle': '4.71', 'sei': '8.01'}",CHEMBL3927004,,CHEMBL3927004,7.67,0,http://www.openphacts.org/units/Nanomolar,2877656,=,37,1,=,,IC50,nM,,21.53,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.526,PAK4
,393270,17764156,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(NC2CNC2)o1,,,CHEMBL3886684,,2016,"{'bei': '24.04', 'le': '0.44', 'lle': '6.04', 'sei': '8.59'}",CHEMBL3905618,,CHEMBL3905618,8.98,0,http://www.openphacts.org/units/Nanomolar,2877657,=,37,1,=,,IC50,nM,,1.051,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.051,PAK4
,393271,17764157,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.08', 'le': '0.35', 'lle': '3.90', 'sei': '8.26'}",CHEMBL3930142,,CHEMBL3930142,7.68,0,http://www.openphacts.org/units/Nanomolar,2877658,=,37,1,=,,IC50,nM,,20.86,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.864,PAK4
,393272,17764158,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '18.16', 'le': '0.33', 'lle': '3.53', 'sei': '7.86'}",CHEMBL3930142,,CHEMBL3930142,7.31,0,http://www.openphacts.org/units/Nanomolar,2877658,=,37,1,=,,IC50,nM,,48.95,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,48.948,PAK4
,393273,17764159,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '17.93', 'le': '0.33', 'lle': '3.44', 'sei': '7.76'}",CHEMBL3930142,,CHEMBL3930142,7.21,0,http://www.openphacts.org/units/Nanomolar,2877658,=,37,1,=,,IC50,nM,,60.94,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,60.938,PAK4
,393274,17764160,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc2[nH]cc(-c3cncc(C4CC4)n3)c2cc1-c1nnc(NC2COC2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.99', 'le': '0.40', 'lle': '4.87', 'sei': '8.09'}",CHEMBL3982185,,CHEMBL3982185,8.23,0,http://www.openphacts.org/units/Nanomolar,2877659,=,37,1,=,,IC50,nM,,5.842,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.842,PAK4
,393275,17764161,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '18.07', 'le': '0.33', 'lle': '3.36', 'sei': '8.10'}",CHEMBL4115309,,CHEMBL4115309,7.53,0,http://www.openphacts.org/units/Nanomolar,2877660,=,37,1,=,,IC50,nM,,29.82,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.819,PAK4
,393276,17764162,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)COCCN1c1nnc(-c2ccc3[nH]cc(-c4cncc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '16.45', 'le': '0.30', 'lle': '2.68', 'sei': '7.37'}",CHEMBL3906747,,CHEMBL3906747,6.85,0,http://www.openphacts.org/units/Nanomolar,2877661,=,37,1,=,,IC50,nM,,140.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,140.902,PAK4
,393277,17764163,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc(-c3ccc4[nH]cc(-c5cncc(C6CC6)n5)c4c3)o2)cc1,,,CHEMBL3886684,,2016,,CHEMBL3981095,,CHEMBL3981095,,0,http://www.openphacts.org/units/Nanomolar,2877662,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,393278,17764164,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(-c2nnc(-c3ccc4[nH]cc(-c5nccc(C6CC6)n5)c4c3)o2)cc1,,,CHEMBL3886684,,2016,"{'bei': '16.26', 'le': '0.29', 'lle': '0.95', 'sei': '7.66'}",CHEMBL3963493,,CHEMBL3963493,6.17,0,http://www.openphacts.org/units/Nanomolar,2877663,=,37,1,=,,IC50,nM,,676.86,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,676.86,PAK4
,393279,17764165,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(C2CC2)nc(-c2c[nH]c3ccc(-c4nnc(NC5COC5)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '22.69', 'le': '0.41', 'lle': '5.13', 'sei': '8.35'}",CHEMBL3952561,,CHEMBL3952561,8.49,0,http://www.openphacts.org/units/Nanomolar,2877664,=,37,1,=,,IC50,nM,,3.204,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.204,PAK4
,393280,17764166,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,c1cc(C2CC2)nc(-c2c[nH]c3ccc(-c4nnc(NC5CC5)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '24.69', 'le': '0.45', 'lle': '4.72', 'sei': '9.57'}",CHEMBL3924862,,CHEMBL3924862,8.85,0,http://www.openphacts.org/units/Nanomolar,2877665,=,37,1,=,,IC50,nM,,1.41,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.41,PAK4
,393281,17764167,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C(F)(F)F)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.56', 'le': '0.37', 'lle': '3.09', 'sei': '8.21'}",CHEMBL3961249,,CHEMBL3961249,7.60,0,http://www.openphacts.org/units/Nanomolar,2877666,=,37,1,=,,IC50,nM,,25.25,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.247,PAK4
,393282,17764168,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)ncc1F,,,CHEMBL3886684,,2016,"{'bei': '19.44', 'le': '0.36', 'lle': '3.40', 'sei': '7.30'}",CHEMBL3937321,,CHEMBL3937321,7.43,0,http://www.openphacts.org/units/Nanomolar,2877667,=,37,1,=,,IC50,nM,,36.95,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,36.949,PAK4
,393283,17764169,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)nc(C)c1F,,,CHEMBL3886684,,2016,"{'bei': '18.24', 'le': '0.34', 'lle': '3.02', 'sei': '6.85'}",CHEMBL3938424,,CHEMBL3938424,6.97,0,http://www.openphacts.org/units/Nanomolar,2877668,=,37,1,=,,IC50,nM,,106.12,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,106.121,PAK4
,393284,17764170,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccnc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '19.73', 'le': '0.36', 'lle': '3.45', 'sei': '6.52'}",CHEMBL3910491,,CHEMBL3910491,7.15,0,http://www.openphacts.org/units/Nanomolar,2877669,=,37,1,=,,IC50,nM,,70.78,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,70.778,PAK4
,393285,17764171,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(F)c(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.61', 'le': '0.42', 'lle': '4.05', 'sei': '9.25'}",CHEMBL3947201,,CHEMBL3947201,8.56,0,http://www.openphacts.org/units/Nanomolar,2877670,=,37,1,=,,IC50,nM,,2.77,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.77,PAK4
,393286,17764172,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nc(C5CC5)n[nH]4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '18.36', 'le': '0.34', 'lle': '2.72', 'sei': '5.92'}",CHEMBL3915869,,CHEMBL3915869,6.42,0,http://www.openphacts.org/units/Nanomolar,2877671,=,37,1,=,,IC50,nM,,383.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,383.178,PAK4
,393287,17764173,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '24.57', 'le': '0.45', 'lle': '4.49', 'sei': '9.57'}",CHEMBL3919337,,CHEMBL3919337,8.86,0,http://www.openphacts.org/units/Nanomolar,2877672,=,37,1,=,,IC50,nM,,1.394,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.394,PAK4
,393288,17764174,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '20.23', 'le': '0.37', 'lle': '2.92', 'sei': '7.88'}",CHEMBL3919337,,CHEMBL3919337,7.29,0,http://www.openphacts.org/units/Nanomolar,2877672,=,37,1,=,,IC50,nM,,50.99,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,50.995,PAK4
,393289,17764175,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nnc(-c2ccc3[nH]cc(-c4ncccn4)c3c2)o1)c1ccccc1,,,CHEMBL3886684,,2016,"{'bei': '17.36', 'le': '0.31', 'lle': '1.79', 'sei': '7.18'}",CHEMBL3952167,,CHEMBL3952167,6.64,0,http://www.openphacts.org/units/Nanomolar,2877673,=,37,1,=,,IC50,nM,,228.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,228.802,PAK4
,393290,17764176,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nnc(-c2ccc3[nH]cc(-c4ccccn4)c3c2)o1)c1ccccc1,,,CHEMBL3886684,,2016,"{'bei': '17.40', 'le': '0.31', 'lle': '1.19', 'sei': '8.34'}",CHEMBL3980995,,CHEMBL3980995,6.64,0,http://www.openphacts.org/units/Nanomolar,2877674,=,37,1,=,,IC50,nM,,230.51,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,230.511,PAK4
,393291,17764177,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nnc(-c2ccc3[nH]cc(-c4cnccn4)c3c2)o1)c1ccccc1,,,CHEMBL3886684,,2016,"{'bei': '16.35', 'le': '0.29', 'lle': '1.40', 'sei': '6.76'}",CHEMBL3951087,,CHEMBL3951087,6.25,0,http://www.openphacts.org/units/Nanomolar,2877675,=,37,1,=,,IC50,nM,,559.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,559.298,PAK4
,393292,17764178,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Fc1cccc(Nc2nnc(-c3ccc4[nH]cc(-c5nccc(C6CC6)n5)c4c3)o2)c1,,,CHEMBL3886684,,2016,"{'bei': '15.39', 'le': '0.28', 'lle': '0.91', 'sei': '6.86'}",CHEMBL3891857,,CHEMBL3891857,6.35,0,http://www.openphacts.org/units/Nanomolar,2877676,=,37,1,=,,IC50,nM,,449.78,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,449.78,PAK4
,393293,17764179,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccnc(-c2c[nH]c3ccc(-c4nnc(NC(C)(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.41', 'le': '0.39', 'lle': '3.27', 'sei': '8.06'}",CHEMBL3968456,,CHEMBL3968456,7.46,0,http://www.openphacts.org/units/Nanomolar,2877677,=,37,1,=,,IC50,nM,,34.83,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.834,PAK4
,393294,17764180,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(C4=CCOCC4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '18.12', 'le': '0.33', 'lle': '1.90', 'sei': '8.07'}",CHEMBL3897313,,CHEMBL3897313,6.13,0,http://www.openphacts.org/units/Nanomolar,2877678,=,37,1,=,,IC50,nM,,737.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,737.904,PAK4
,393295,17764181,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N)nc(-c2c[nH]c3ccc(-c4nnc(NC(C)(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '17.76', 'le': '0.33', 'lle': '2.67', 'sei': '5.45'}",CHEMBL3950989,,CHEMBL3950989,6.46,0,http://www.openphacts.org/units/Nanomolar,2877679,=,37,1,=,,IC50,nM,,350.99,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,350.994,PAK4
,393296,17764182,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C(N)=O)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.99', 'le': '0.37', 'lle': '4.57', 'sei': '5.56'}",CHEMBL3976832,,CHEMBL3976832,7.54,0,http://www.openphacts.org/units/Nanomolar,2877680,=,37,1,=,,IC50,nM,,28.51,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,28.508,PAK4
,393297,17764183,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cncc(-c2c[nH]c3ccc(-c4nnc(-c5ccccc5)o4)cc23)n1,,,CHEMBL3886684,,2016,,CHEMBL3959708,,CHEMBL3959708,,0,http://www.openphacts.org/units/Nanomolar,2877681,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,393298,17764184,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(C(=O)NC5CC5)s4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '15.06', 'le': '0.29', 'lle': '2.10', 'sei': '5.66'}",CHEMBL3931494,,CHEMBL3931494,6.15,0,http://www.openphacts.org/units/Nanomolar,2877682,=,37,1,=,,IC50,nM,,705.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,705.0,PAK4
,393299,17764185,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(C(N)=O)s4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '17.65', 'le': '0.34', 'lle': '3.24', 'sei': '5.30'}",CHEMBL3898788,,CHEMBL3898788,6.50,0,http://www.openphacts.org/units/Nanomolar,2877683,=,37,1,=,,IC50,nM,,315.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,315.0,PAK4
,393300,17764186,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(C(N)=O)s4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '16.75', 'le': '0.32', 'lle': '2.76', 'sei': '5.22'}",CHEMBL3947675,,CHEMBL3947675,6.41,0,http://www.openphacts.org/units/Nanomolar,2877684,=,37,1,=,,IC50,nM,,393.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,393.0,PAK4
,393301,17764187,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nc(C(=O)NC5CC5)cs4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '15.64', 'le': '0.30', 'lle': '2.34', 'sei': '5.88'}",CHEMBL3949902,,CHEMBL3949902,6.39,0,http://www.openphacts.org/units/Nanomolar,2877685,=,37,1,=,,IC50,nM,,408.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,408.0,PAK4
,393302,17764188,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2cc3c(-c4nccc(C5CC5)n4)c[nH]c3cc2F)o1,,,CHEMBL3886684,,2016,"{'bei': '23.06', 'le': '0.43', 'lle': '4.22', 'sei': '9.43'}",CHEMBL3965588,,CHEMBL3965588,8.73,0,http://www.openphacts.org/units/Nanomolar,2877686,=,37,1,=,,IC50,nM,,1.88,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.88,PAK4
,393303,17764189,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2cc3c(-c4nccc(C5CC5)n4)c[nH]c3cc2F)o1,,,CHEMBL3886684,,2016,"{'bei': '21.39', 'le': '0.39', 'lle': '3.58', 'sei': '8.75'}",CHEMBL3965588,,CHEMBL3965588,8.10,0,http://www.openphacts.org/units/Nanomolar,2877686,=,37,1,=,,IC50,nM,,8.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.04,PAK4
,393304,17764190,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ncc(C(N)=O)c(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '21.48', 'le': '0.39', 'lle': '5.20', 'sei': '6.39'}",CHEMBL3981514,,CHEMBL3981514,8.67,0,http://www.openphacts.org/units/Nanomolar,2877687,=,37,1,=,,IC50,nM,,2.15,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.15,PAK4
,393305,17764191,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccnc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '16.39', 'le': '0.30', 'lle': '3.34', 'sei': '5.09'}",CHEMBL3889589,,CHEMBL3889589,6.19,0,http://www.openphacts.org/units/Nanomolar,2877688,=,37,1,=,,IC50,nM,,652.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,652.0,PAK4
,393306,17764192,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4nccc(C(=O)NC5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '15.72', 'le': '0.29', 'lle': '2.95', 'sei': '5.22'}",CHEMBL3943672,,CHEMBL3943672,6.34,0,http://www.openphacts.org/units/Nanomolar,2877689,=,37,1,=,,IC50,nM,,453.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,453.0,PAK4
,393307,17764193,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2c[nH]c3ccc(-c4nnc(N)o4)cc23)nc1,,,CHEMBL3886684,,2016,"{'bei': '17.60', 'le': '0.34', 'lle': '3.99', 'sei': '4.90'}",CHEMBL3951600,,CHEMBL3951600,6.26,0,http://www.openphacts.org/units/Nanomolar,2877690,=,37,1,=,,IC50,nM,,555.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,555.0,PAK4
,393308,17764194,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '16.26', 'le': '0.30', 'lle': '2.66', 'sei': '5.63'}",CHEMBL3910718,,CHEMBL3910718,6.12,0,http://www.openphacts.org/units/Nanomolar,2877691,=,37,1,=,,IC50,nM,,760.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,760.0,PAK4
,393309,17764195,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cncc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)c1,,,CHEMBL3886684,,2016,"{'bei': '16.14', 'le': '0.30', 'lle': '2.61', 'sei': '5.59'}",CHEMBL3983984,,CHEMBL3983984,6.07,0,http://www.openphacts.org/units/Nanomolar,2877692,=,37,1,=,,IC50,nM,,843.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,843.0,PAK4
,393310,17764196,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nccc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '21.07', 'le': '0.39', 'lle': '3.63', 'sei': '7.61'}",CHEMBL3950988,,CHEMBL3950988,7.96,0,http://www.openphacts.org/units/Nanomolar,2877693,=,37,1,=,,IC50,nM,,11.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.1,PAK4
,393311,17764197,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)cc(=O)[nH]1,,,CHEMBL3886684,,2016,"{'bei': '19.94', 'le': '0.37', 'lle': '4.23', 'sei': '6.30'}",CHEMBL3965556,,CHEMBL3965556,7.84,0,http://www.openphacts.org/units/Nanomolar,2877694,=,37,1,=,,IC50,nM,,14.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.3,PAK4
,393312,17764198,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ncc(F)c(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '16.49', 'le': '0.31', 'lle': '3.53', 'sei': '5.36'}",CHEMBL3957476,,CHEMBL3957476,6.52,0,http://www.openphacts.org/units/Nanomolar,2877695,=,37,1,=,,IC50,nM,,301.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,301.0,PAK4
,393313,17764199,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccc(F)c(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)c1,,,CHEMBL3886684,,2016,"{'bei': '16.84', 'le': '0.31', 'lle': '2.42', 'sei': '6.91'}",CHEMBL3913664,,CHEMBL3913664,6.62,0,http://www.openphacts.org/units/Nanomolar,2877696,=,37,1,=,,IC50,nM,,238.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,238.0,PAK4
,393314,17764200,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(NC(=O)C4CC4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '23.33', 'le': '0.43', 'lle': '4.20', 'sei': '7.92'}",CHEMBL3935080,,CHEMBL3935080,7.59,0,http://www.openphacts.org/units/Nanomolar,2877697,=,37,1,=,,IC50,nM,,25.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.6,PAK4
,393315,17764201,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cccc(C(=O)N(C)C)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '16.05', 'le': '0.30', 'lle': '2.47', 'sei': '6.27'}",CHEMBL3956364,,CHEMBL3956364,6.27,0,http://www.openphacts.org/units/Nanomolar,2877698,=,37,1,=,,IC50,nM,,541.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,541.0,PAK4
,393316,17764202,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C(=O)N(C)C)c4)c3c2)o1,,,CHEMBL3886684,,2016,,CHEMBL3985000,,CHEMBL3985000,,0,http://www.openphacts.org/units/Nanomolar,2877701,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,393317,17764203,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1nccc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)n1,,,CHEMBL3886684,,2016,"{'bei': '20.35', 'le': '0.37', 'lle': '3.63', 'sei': '7.01'}",CHEMBL3959910,,CHEMBL3959910,7.13,0,http://www.openphacts.org/units/Nanomolar,2877702,=,37,1,=,,IC50,nM,,73.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,73.8,PAK4
,393318,17764204,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,COc1nc(-c2c[nH]c3ccc(-c4nnc(NC(C)C)o4)cc23)cc(=O)[nH]1,,,CHEMBL3886684,,2016,"{'bei': '20.78', 'le': '0.39', 'lle': '4.81', 'sei': '6.25'}",CHEMBL3945846,,CHEMBL3945846,7.61,0,http://www.openphacts.org/units/Nanomolar,2877703,=,37,1,=,,IC50,nM,,24.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.4,PAK4
,393319,17764205,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cncc(C(=O)NC5CC5)c4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '16.21', 'le': '0.30', 'lle': '2.53', 'sei': '6.00'}",CHEMBL3983191,,CHEMBL3983191,6.52,0,http://www.openphacts.org/units/Nanomolar,2877704,=,37,1,=,,IC50,nM,,299.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,299.0,PAK4
,393320,17764206,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4cc(=O)[nH]c(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '22.98', 'le': '0.42', 'lle': '4.98', 'sei': '7.69'}",CHEMBL3913006,,CHEMBL3913006,8.65,0,http://www.openphacts.org/units/Nanomolar,2877705,=,37,1,=,,IC50,nM,,2.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.24,PAK4
,393321,17764207,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(-c4ccnc(C5CC5)n4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '23.12', 'le': '0.42', 'lle': '3.96', 'sei': '9.01'}",CHEMBL3895040,,CHEMBL3895040,8.33,0,http://www.openphacts.org/units/Nanomolar,2877706,=,37,1,=,,IC50,nM,,4.65,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.65,PAK4
,393322,17764208,[],CHEMBL3888378,"Enzyme Assay: The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction.Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 uM. A reference compound was included on each assay plate in order to validate that plate; on",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nnc(-c2ccc3[nH]cc(NC(=O)c4ccncc4)c3c2)o1,,,CHEMBL3886684,,2016,"{'bei': '19.15', 'le': '0.35', 'lle': '3.25', 'sei': '6.38'}",CHEMBL3908883,,CHEMBL3908883,6.94,0,http://www.openphacts.org/units/Nanomolar,2877709,=,37,1,=,,IC50,nM,,115.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,115.0,PAK4
,416153,17779664,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Cl)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '20.81', 'le': '0.40', 'lle': '3.03', 'sei': '10.72'}",CHEMBL3938933,,CHEMBL3938933,6.20,0,http://www.openphacts.org/units/Nanomolar,2887737,=,37,1,=,,IC50,nM,,636.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,636.0,PAK4
,416154,17779665,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '22.85', 'le': '0.41', 'lle': '3.84', 'sei': '11.60'}",CHEMBL3942833,,CHEMBL3942833,8.10,0,http://www.openphacts.org/units/Nanomolar,2887738,=,37,1,=,,IC50,nM,,8.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.0,PAK4
,416155,17779666,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Cc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.03', 'le': '0.38', 'lle': '3.32', 'sei': '12.86'}",CHEMBL3943939,,CHEMBL3943939,7.43,0,http://www.openphacts.org/units/Nanomolar,2887739,=,37,1,=,,IC50,nM,,37.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,37.0,PAK4
,416156,17779667,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '22.17', 'le': '0.40', 'lle': '3.89', 'sei': '13.38'}",CHEMBL3947727,,CHEMBL3947727,8.17,0,http://www.openphacts.org/units/Nanomolar,2887740,=,37,1,=,,IC50,nM,,6.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.8,PAK4
,416157,17779668,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Sc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.37', 'le': '0.40', 'lle': '3.27', 'sei': '13.74'}",CHEMBL3976993,,CHEMBL3976993,7.94,0,http://www.openphacts.org/units/Nanomolar,2887741,=,37,1,=,,IC50,nM,,11.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.5,PAK4
,416158,17779669,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5ccccc5F)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '22.39', 'le': '0.41', 'lle': '3.94', 'sei': '11.94'}",CHEMBL3968570,,CHEMBL3968570,8.34,0,http://www.openphacts.org/units/Nanomolar,2887742,=,37,1,=,,IC50,nM,,4.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.6,PAK4
,416159,17779670,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5c(F)cccc5Cl)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '20.36', 'le': '0.39', 'lle': '3.23', 'sei': '11.87'}",CHEMBL3939032,,CHEMBL3939032,8.28,0,http://www.openphacts.org/units/Nanomolar,2887743,=,37,1,=,,IC50,nM,,5.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.2,PAK4
,416160,17779671,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5ccc(F)cc5F)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '20.23', 'le': '0.37', 'lle': '3.36', 'sei': '11.31'}",CHEMBL3977073,,CHEMBL3977073,7.90,0,http://www.openphacts.org/units/Nanomolar,2887744,=,37,1,=,,IC50,nM,,12.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.7,PAK4
,416161,17779672,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5c(F)cccc5Cl)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '19.78', 'le': '0.38', 'lle': '2.97', 'sei': '12.04'}",CHEMBL3944428,,CHEMBL3944428,8.07,0,http://www.openphacts.org/units/Nanomolar,2887745,=,37,1,=,,IC50,nM,,8.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.6,PAK4
,416162,17779673,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccc(F)cc5F)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '19.61', 'le': '0.36', 'lle': '3.09', 'sei': '11.45'}",CHEMBL3981885,,CHEMBL3981885,7.68,0,http://www.openphacts.org/units/Nanomolar,2887746,=,37,1,=,,IC50,nM,,21.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.1,PAK4
,416163,17779674,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccccc5F)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.39', 'le': '0.39', 'lle': '3.54', 'sei': '11.92'}",CHEMBL3953144,,CHEMBL3953144,7.99,0,http://www.openphacts.org/units/Nanomolar,2887747,=,37,1,=,,IC50,nM,,10.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.3,PAK4
,416164,17779675,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]ccc2[nH]c(-c3cccc4ccc(Nc5c(F)cccc5Cl)nc34)cc12,,,CHEMBL3886836,,2016,"{'bei': '19.66', 'le': '0.37', 'lle': '2.35', 'sei': '10.82'}",CHEMBL3892866,,CHEMBL3892866,7.96,0,http://www.openphacts.org/units/Nanomolar,2887748,=,37,1,=,,IC50,nM,,11.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.0,PAK4
,416165,17779676,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5cncnc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '24.00', 'le': '0.43', 'lle': '5.50', 'sei': '8.95'}",CHEMBL3967572,,CHEMBL3967572,8.55,0,http://www.openphacts.org/units/Nanomolar,2887749,=,37,1,=,,IC50,nM,,2.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.8,PAK4
,416166,17779677,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '21.50', 'le': '0.39', 'lle': '3.55', 'sei': '13.47'}",CHEMBL3903003,,CHEMBL3903003,8.22,0,http://www.openphacts.org/units/Nanomolar,2887750,=,37,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,416167,17779678,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]cnc2[nH]c(-c3cccc4ccc(Nc5ccc(Cl)cc5)nc34)cc12,,,CHEMBL3886836,,2016,"{'bei': '19.83', 'le': '0.38', 'lle': '2.83', 'sei': '8.89'}",CHEMBL3973961,,CHEMBL3973961,7.69,0,http://www.openphacts.org/units/Nanomolar,2887751,=,37,1,=,,IC50,nM,,20.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.4,PAK4
,416168,17779679,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]cnc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc12,,,CHEMBL3886836,,2016,"{'bei': '22.27', 'le': '0.40', 'lle': '3.66', 'sei': '9.10'}",CHEMBL3934975,,CHEMBL3934975,7.87,0,http://www.openphacts.org/units/Nanomolar,2887752,=,37,1,=,,IC50,nM,,13.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.5,PAK4
,416169,17779680,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]cnc2[nH]c(-c3cccc4ccc(Oc5ccccc5)nc34)cc12,,,CHEMBL3886836,,2016,"{'bei': '20.02', 'le': '0.36', 'lle': '2.84', 'sei': '8.48'}",CHEMBL3968103,,CHEMBL3968103,7.10,0,http://www.openphacts.org/units/Nanomolar,2887753,=,37,1,=,,IC50,nM,,80.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,80.2,PAK4
,416170,17779681,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccc(Cl)cc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '18.85', 'le': '0.36', 'lle': '2.39', 'sei': '10.97'}",CHEMBL3929510,,CHEMBL3929510,7.35,0,http://www.openphacts.org/units/Nanomolar,2887754,=,37,1,=,,IC50,nM,,44.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,44.9,PAK4
,416171,17779682,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]cnc2[nH]c(-c3cccc4ccc(Cl)nc34)cc12,,,CHEMBL3886836,,2016,"{'bei': '20.36', 'le': '0.39', 'lle': '2.92', 'sei': '8.12'}",CHEMBL3973448,,CHEMBL3973448,6.04,0,http://www.openphacts.org/units/Nanomolar,2887755,=,37,1,=,,IC50,nM,,908.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,908.0,PAK4
,416172,17779683,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(OCc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '18.97', 'le': '0.34', 'lle': '2.92', 'sei': '10.46'}",CHEMBL3957082,,CHEMBL3957082,7.01,0,http://www.openphacts.org/units/Nanomolar,2887756,=,37,1,=,,IC50,nM,,98.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,98.4,PAK4
,416173,17779684,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(NCc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '20.81', 'le': '0.37', 'lle': '3.54', 'sei': '10.98'}",CHEMBL3970144,,CHEMBL3970144,7.67,0,http://www.openphacts.org/units/Nanomolar,2887757,=,37,1,=,,IC50,nM,,21.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.6,PAK4
,416174,17779685,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1CNC(=O)c2cc(-c3cccc4ccc(Cl)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '20.27', 'le': '0.39', 'lle': '2.49', 'sei': '11.43'}",CHEMBL3956063,,CHEMBL3956063,6.61,0,http://www.openphacts.org/units/Nanomolar,2887758,=,37,1,=,,IC50,nM,,248.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,248.0,PAK4
,416175,17779686,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1CNC(=O)c2cc(-c3cccc4ccc(Oc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '18.96', 'le': '0.34', 'lle': '2.01', 'sei': '10.85'}",CHEMBL3981435,,CHEMBL3981435,7.27,0,http://www.openphacts.org/units/Nanomolar,2887759,=,37,1,=,,IC50,nM,,53.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,53.6,PAK4
,416176,17779687,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.54', 'le': '0.41', 'lle': '3.41', 'sei': '12.35'}",CHEMBL3902525,,CHEMBL3902525,8.62,0,http://www.openphacts.org/units/Nanomolar,2887760,=,37,1,=,,IC50,nM,,2.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.4,PAK4
,416177,17779688,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '19.68', 'le': '0.35', 'lle': '2.32', 'sei': '10.78'}",CHEMBL3917922,,CHEMBL3917922,7.53,0,http://www.openphacts.org/units/Nanomolar,2887761,=,37,1,=,,IC50,nM,,29.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.7,PAK4
,416178,17779689,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CNC(=O)c2cc(-c3cccc4ccc(Cl)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '20.65', 'le': '0.40', 'lle': '2.71', 'sei': '11.14'}",CHEMBL3942347,,CHEMBL3942347,6.44,0,http://www.openphacts.org/units/Nanomolar,2887762,=,37,1,=,,IC50,nM,,366.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,366.0,PAK4
,416179,17779690,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CNC(=O)c2cc(-c3cccc4ccc(Oc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '19.53', 'le': '0.35', 'lle': '2.34', 'sei': '10.77'}",CHEMBL3905357,,CHEMBL3905357,7.21,0,http://www.openphacts.org/units/Nanomolar,2887763,=,37,1,=,,IC50,nM,,61.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,61.0,PAK4
,416180,17779691,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '23.40', 'le': '0.42', 'lle': '3.80', 'sei': '12.35'}",CHEMBL3933369,,CHEMBL3933369,8.62,0,http://www.openphacts.org/units/Nanomolar,2887764,=,37,1,=,,IC50,nM,,2.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.4,PAK4
,416181,17779692,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '20.70', 'le': '0.37', 'lle': '2.81', 'sei': '10.92'}",CHEMBL3933369,,CHEMBL3933369,7.62,0,http://www.openphacts.org/units/Nanomolar,2887764,=,37,1,=,,IC50,nM,,23.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,23.7,PAK4
,416182,17779693,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(c1cccnc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '24.05', 'le': '0.43', 'lle': '5.15', 'sei': '12.48'}",CHEMBL3971351,,CHEMBL3971351,9.22,0,http://www.openphacts.org/units/Nanomolar,2887766,=,37,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,416183,17779694,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1Cc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc2C(=O)N1,,,CHEMBL3886836,,2016,"{'bei': '20.23', 'le': '0.36', 'lle': '2.80', 'sei': '10.68'}",CHEMBL3946958,,CHEMBL3946958,7.45,0,http://www.openphacts.org/units/Nanomolar,2887767,=,37,1,=,,IC50,nM,,35.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.3,PAK4
,416184,17779695,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1Cc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc2C(=O)N1,,,CHEMBL3886836,,2016,"{'bei': '19.37', 'le': '0.35', 'lle': '2.48', 'sei': '10.22'}",CHEMBL3946958,,CHEMBL3946958,7.13,0,http://www.openphacts.org/units/Nanomolar,2887767,=,37,1,=,,IC50,nM,,73.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,73.3,PAK4
,416185,17779696,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '22.11', 'le': '0.40', 'lle': '3.55', 'sei': '11.73'}",CHEMBL3966805,,CHEMBL3966805,7.86,0,http://www.openphacts.org/units/Nanomolar,2887768,=,37,1,=,,IC50,nM,,13.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.9,PAK4
,416186,17779697,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5cccnc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '25.76', 'le': '0.46', 'lle': '5.50', 'sei': '11.07'}",CHEMBL3937054,,CHEMBL3937054,9.15,0,http://www.openphacts.org/units/Nanomolar,2887769,=,37,1,=,,IC50,nM,,0.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.7,PAK4
,416187,17779698,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5cccnc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '23.39', 'le': '0.42', 'lle': '4.64', 'sei': '10.43'}",CHEMBL3975293,,CHEMBL3975293,8.34,0,http://www.openphacts.org/units/Nanomolar,2887770,=,37,1,=,,IC50,nM,,4.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.6,PAK4
,416188,17779699,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5cccc(Cl)c5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '20.17', 'le': '0.38', 'lle': '2.93', 'sei': '11.24'}",CHEMBL3949372,,CHEMBL3949372,7.84,0,http://www.openphacts.org/units/Nanomolar,2887771,=,37,1,=,,IC50,nM,,14.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.3,PAK4
,416189,17779700,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5cccc(Cl)c5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '18.39', 'le': '0.35', 'lle': '2.21', 'sei': '10.70'}",CHEMBL3937446,,CHEMBL3937446,7.17,0,http://www.openphacts.org/units/Nanomolar,2887772,=,37,1,=,,IC50,nM,,68.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,68.0,PAK4
,416190,17779701,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5cccc(F)c5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.54', 'le': '0.39', 'lle': '3.59', 'sei': '12.00'}",CHEMBL3950494,,CHEMBL3950494,8.04,0,http://www.openphacts.org/units/Nanomolar,2887773,=,37,1,=,,IC50,nM,,9.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.1,PAK4
,416191,17779702,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(Oc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c1,,,CHEMBL3886836,,2016,"{'bei': '19.82', 'le': '0.36', 'lle': '2.70', 'sei': '10.92'}",CHEMBL3959074,,CHEMBL3959074,7.32,0,http://www.openphacts.org/units/Nanomolar,2887774,=,37,1,=,,IC50,nM,,47.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,47.8,PAK4
,416192,17779703,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c1,,,CHEMBL3886836,,2016,"{'bei': '20.45', 'le': '0.37', 'lle': '2.96', 'sei': '10.79'}",CHEMBL3891519,,CHEMBL3891519,7.54,0,http://www.openphacts.org/units/Nanomolar,2887775,=,37,1,=,,IC50,nM,,29.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.2,PAK4
,416193,17779704,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5cccc(F)c5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.79', 'le': '0.40', 'lle': '3.71', 'sei': '11.62'}",CHEMBL3906206,,CHEMBL3906206,8.11,0,http://www.openphacts.org/units/Nanomolar,2887776,=,37,1,=,,IC50,nM,,7.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.7,PAK4
,416194,17779705,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)N(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '16.74', 'le': '0.30', 'lle': '2.48', 'sei': '7.91'}",CHEMBL3929257,,CHEMBL3929257,6.90,0,http://www.openphacts.org/units/Nanomolar,2887777,=,37,1,=,,IC50,nM,,125.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,125.0,PAK4
,416195,17779706,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(NC5CCCC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '22.29', 'le': '0.41', 'lle': '3.85', 'sei': '11.06'}",CHEMBL3958651,,CHEMBL3958651,7.72,0,http://www.openphacts.org/units/Nanomolar,2887778,=,37,1,=,,IC50,nM,,19.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.0,PAK4
,416196,17779707,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(Oc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)C(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '17.82', 'le': '0.34', 'lle': '2.84', 'sei': '9.98'}",CHEMBL3898550,,CHEMBL3898550,6.69,0,http://www.openphacts.org/units/Nanomolar,2887779,=,37,1,=,,IC50,nM,,204.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,204.0,PAK4
,416197,17779708,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(OC5CCCC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.63', 'le': '0.39', 'lle': '3.68', 'sei': '11.22'}",CHEMBL3966407,,CHEMBL3966407,7.52,0,http://www.openphacts.org/units/Nanomolar,2887780,=,37,1,=,,IC50,nM,,30.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.5,PAK4
,416198,17779709,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(OC5CCNCC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '19.37', 'le': '0.36', 'lle': '4.37', 'sei': '8.88'}",CHEMBL3904025,,CHEMBL3904025,7.02,0,http://www.openphacts.org/units/Nanomolar,2887781,=,37,1,=,,IC50,nM,,95.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,95.6,PAK4
,416199,17779710,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(N[C@H]5CC[C@H](O)CC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '19.24', 'le': '0.35', 'lle': '4.01', 'sei': '8.04'}",CHEMBL3974903,,CHEMBL3974903,7.24,0,http://www.openphacts.org/units/Nanomolar,2887782,=,37,1,=,,IC50,nM,,57.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,57.2,PAK4
,416200,17779711,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(NC5CCCCC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.71', 'le': '0.40', 'lle': '3.56', 'sei': '11.21'}",CHEMBL3933170,,CHEMBL3933170,7.82,0,http://www.openphacts.org/units/Nanomolar,2887783,=,37,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.0,PAK4
,416201,17779712,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(N5CCOCC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '19.92', 'le': '0.36', 'lle': '4.59', 'sei': '9.88'}",CHEMBL3986310,,CHEMBL3986310,6.94,0,http://www.openphacts.org/units/Nanomolar,2887784,=,37,1,=,,IC50,nM,,115.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,115.0,PAK4
,416202,17779713,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(NC5CCOCC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.10', 'le': '0.39', 'lle': '4.54', 'sei': '9.67'}",CHEMBL3925557,,CHEMBL3925557,7.65,0,http://www.openphacts.org/units/Nanomolar,2887785,=,37,1,=,,IC50,nM,,22.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.6,PAK4
,416203,17779714,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccc(-c2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c(F)c1,,,CHEMBL3886836,,2016,"{'bei': '15.72', 'le': '0.30', 'lle': '3.11', 'sei': '7.45'}",CHEMBL3897474,,CHEMBL3897474,6.84,0,http://www.openphacts.org/units/Nanomolar,2887786,=,37,1,=,,IC50,nM,,143.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,143.0,PAK4
,416204,17779715,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c(F)n1,,,CHEMBL3886836,,2016,"{'bei': '20.98', 'le': '0.38', 'lle': '4.53', 'sei': '8.10'}",CHEMBL3983324,,CHEMBL3983324,7.83,0,http://www.openphacts.org/units/Nanomolar,2887787,=,37,1,=,,IC50,nM,,14.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.7,PAK4
,416205,17779716,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cl)cc1-c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '16.79', 'le': '0.32', 'lle': '1.94', 'sei': '10.12'}",CHEMBL3913508,,CHEMBL3913508,6.78,0,http://www.openphacts.org/units/Nanomolar,2887788,=,37,1,=,,IC50,nM,,166.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,166.0,PAK4
,416206,17779717,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(O[C@@H]5CCCNC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '17.85', 'le': '0.33', 'lle': '3.82', 'sei': '8.18'}",CHEMBL3940639,,CHEMBL3940639,6.47,0,http://www.openphacts.org/units/Nanomolar,2887789,=,37,1,=,,IC50,nM,,340.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,340.0,PAK4
,416207,17779718,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(-c2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c(F)c1,,,CHEMBL3886836,,2016,"{'bei': '19.70', 'le': '0.36', 'lle': '3.44', 'sei': '8.75'}",CHEMBL3970213,,CHEMBL3970213,7.34,0,http://www.openphacts.org/units/Nanomolar,2887791,=,37,1,=,,IC50,nM,,46.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,46.1,PAK4
,416208,17779719,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(O[C@H]5CCCNC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '19.89', 'le': '0.36', 'lle': '4.56', 'sei': '9.12'}",CHEMBL3899011,,CHEMBL3899011,7.21,0,http://www.openphacts.org/units/Nanomolar,2887792,=,37,1,=,,IC50,nM,,62.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,62.0,PAK4
,416209,17779720,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C)c1Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '18.54', 'le': '0.33', 'lle': '2.21', 'sei': '10.16'}",CHEMBL3942200,,CHEMBL3942200,7.09,0,http://www.openphacts.org/units/Nanomolar,2887797,=,37,1,=,,IC50,nM,,80.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,80.9,PAK4
,416210,17779721,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C)c1Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '18.65', 'le': '0.34', 'lle': '2.25', 'sei': '10.22'}",CHEMBL3942200,,CHEMBL3942200,7.13,0,http://www.openphacts.org/units/Nanomolar,2887797,=,37,1,=,,IC50,nM,,73.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,73.9,PAK4
,416211,17779722,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5ccccc5Cl)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '19.86', 'le': '0.38', 'lle': '2.78', 'sei': '11.55'}",CHEMBL3937510,,CHEMBL3937510,7.74,0,http://www.openphacts.org/units/Nanomolar,2887798,=,37,1,=,,IC50,nM,,18.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,18.1,PAK4
,416212,17779723,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Oc1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '21.78', 'le': '0.39', 'lle': '3.43', 'sei': '12.01'}",CHEMBL3913032,,CHEMBL3913032,8.05,0,http://www.openphacts.org/units/Nanomolar,2887799,=,37,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,416213,17779724,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '24.21', 'le': '0.44', 'lle': '4.35', 'sei': '12.78'}",CHEMBL3928492,,CHEMBL3928492,8.92,0,http://www.openphacts.org/units/Nanomolar,2887800,=,37,1,=,,IC50,nM,,1.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.2,PAK4
,416214,17779725,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccc(Br)cc1,,,CHEMBL3886836,,2016,"{'bei': '17.84', 'le': '0.38', 'lle': '2.65', 'sei': '11.43'}",CHEMBL3900533,,CHEMBL3900533,7.98,0,http://www.openphacts.org/units/Nanomolar,2887801,=,37,1,=,,IC50,nM,,10.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.5,PAK4
,416215,17779726,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]ccc2[nH]c(-c3cccc4ccc(Nc5ccccc5Cl)nc34)cc12,,,CHEMBL3886836,,2016,"{'bei': '19.37', 'le': '0.37', 'lle': '2.02', 'sei': '10.18'}",CHEMBL3915285,,CHEMBL3915285,7.49,0,http://www.openphacts.org/units/Nanomolar,2887802,=,37,1,=,,IC50,nM,,32.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,32.2,PAK4
,416216,17779727,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5ccccc5Cl)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '20.25', 'le': '0.38', 'lle': '2.96', 'sei': '11.28'}",CHEMBL3981805,,CHEMBL3981805,7.87,0,http://www.openphacts.org/units/Nanomolar,2887803,=,37,1,=,,IC50,nM,,13.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.4,PAK4
,416217,17779728,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5cccc(O)c5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.01', 'le': '0.38', 'lle': '3.79', 'sei': '8.94'}",CHEMBL3972504,,CHEMBL3972504,7.80,0,http://www.openphacts.org/units/Nanomolar,2887804,=,37,1,=,,IC50,nM,,15.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.8,PAK4
,416218,17779729,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc(Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)c1,,,CHEMBL3886836,,2016,"{'bei': '23.11', 'le': '0.42', 'lle': '4.70', 'sei': '8.91'}",CHEMBL3986342,,CHEMBL3986342,8.54,0,http://www.openphacts.org/units/Nanomolar,2887805,=,37,1,=,,IC50,nM,,2.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.9,PAK4
,416219,17779730,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)c1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '17.63', 'le': '0.32', 'lle': '2.05', 'sei': '9.66'}",CHEMBL3913060,,CHEMBL3913060,6.74,0,http://www.openphacts.org/units/Nanomolar,2887806,=,37,1,=,,IC50,nM,,181.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,181.0,PAK4
,416220,17779731,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)c1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '17.62', 'le': '0.32', 'lle': '2.05', 'sei': '9.65'}",CHEMBL3974958,,CHEMBL3974958,6.74,0,http://www.openphacts.org/units/Nanomolar,2887807,=,37,1,=,,IC50,nM,,182.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,182.0,PAK4
,416221,17779732,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C=C(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '22.14', 'le': '0.39', 'lle': '3.51', 'sei': '14.00'}",CHEMBL3964505,,CHEMBL3964505,8.09,0,http://www.openphacts.org/units/Nanomolar,2887808,=,37,1,=,,IC50,nM,,8.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.1,PAK4
,416222,17779733,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(C5(c6ccccc6)CC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.22', 'le': '0.38', 'lle': '3.45', 'sei': '13.93'}",CHEMBL3966443,,CHEMBL3966443,8.05,0,http://www.openphacts.org/units/Nanomolar,2887809,=,37,1,=,,IC50,nM,,8.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.9,PAK4
,416223,17779734,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '18.82', 'le': '0.34', 'lle': '2.24', 'sei': '11.97'}",CHEMBL3898587,,CHEMBL3898587,6.91,0,http://www.openphacts.org/units/Nanomolar,2887810,=,37,1,=,,IC50,nM,,122.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,122.0,PAK4
,416224,17779735,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '21.09', 'le': '0.38', 'lle': '3.08', 'sei': '13.41'}",CHEMBL3898587,,CHEMBL3898587,7.75,0,http://www.openphacts.org/units/Nanomolar,2887810,=,37,1,=,,IC50,nM,,17.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.8,PAK4
,416225,17779736,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1CNC(=O)c2cc(-c3cccc4cc(C)c(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.81', 'le': '0.41', 'lle': '3.53', 'sei': '12.96'}",CHEMBL3889660,,CHEMBL3889660,9.05,0,http://www.openphacts.org/units/Nanomolar,2887811,=,37,1,=,,IC50,nM,,0.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.9,PAK4
,416226,17779737,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1CNC(=O)c2cc(-c3cccc4cc(C)c(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '19.66', 'le': '0.35', 'lle': '2.27', 'sei': '11.16'}",CHEMBL3889660,,CHEMBL3889660,7.79,0,http://www.openphacts.org/units/Nanomolar,2887811,=,37,1,=,,IC50,nM,,16.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.1,PAK4
,416227,17779738,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCC(Cc2ccccc2)c2[nH]c(-c3cccc4cccnc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '18.92', 'le': '0.34', 'lle': '2.39', 'sei': '11.57'}",CHEMBL3927283,,CHEMBL3927283,6.69,0,http://www.openphacts.org/units/Nanomolar,2887812,=,37,1,=,,IC50,nM,,206.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,206.0,PAK4
,416228,17779739,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCC[C@@H](Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)C1,,,CHEMBL3886836,,2016,"{'bei': '22.20', 'le': '0.41', 'lle': '5.14', 'sei': '8.70'}",CHEMBL3935691,,CHEMBL3935691,8.34,0,http://www.openphacts.org/units/Nanomolar,2887813,=,37,1,=,,IC50,nM,,4.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.6,PAK4
,416229,17779740,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)C1,,,CHEMBL3886836,,2016,"{'bei': '20.36', 'le': '0.37', 'lle': '4.45', 'sei': '7.98'}",CHEMBL3907732,,CHEMBL3907732,7.65,0,http://www.openphacts.org/units/Nanomolar,2887814,=,37,1,=,,IC50,nM,,22.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.6,PAK4
,416230,17779741,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCC[C@@H](Nc2ccc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)C1,,,CHEMBL3886836,,2016,"{'bei': '25.36', 'le': '0.46', 'lle': '6.32', 'sei': '9.94'}",CHEMBL3907732,,CHEMBL3907732,9.52,0,http://www.openphacts.org/units/Nanomolar,2887814,=,37,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,416231,17779742,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(N[C@H]5CCCNC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.91', 'le': '0.40', 'lle': '5.24', 'sei': '9.68'}",CHEMBL3920246,,CHEMBL3920246,7.92,0,http://www.openphacts.org/units/Nanomolar,2887815,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,416232,17779743,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(N[C@@H]5CCCNC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '18.95', 'le': '0.35', 'lle': '4.17', 'sei': '8.37'}",CHEMBL3921312,,CHEMBL3921312,6.85,0,http://www.openphacts.org/units/Nanomolar,2887816,=,37,1,=,,IC50,nM,,141.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,141.0,PAK4
,416233,17779744,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1F,,,CHEMBL3886836,,2016,,CHEMBL3930282,,CHEMBL3930282,,0,http://www.openphacts.org/units/Nanomolar,2887875,>,37,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,416234,17779745,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCOCC1,,,CHEMBL3886836,,2016,"{'bei': '20.93', 'le': '0.39', 'lle': '5.09', 'sei': '8.59'}",CHEMBL3898719,,CHEMBL3898719,7.90,0,http://www.openphacts.org/units/Nanomolar,2887818,=,37,1,=,,IC50,nM,,12.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.6,PAK4
,416235,17779746,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H](C)C(N)=O,,,CHEMBL3886836,,2016,"{'bei': '18.26', 'le': '0.34', 'lle': '5.15', 'sei': '5.29'}",CHEMBL3902209,,CHEMBL3902209,6.65,0,http://www.openphacts.org/units/Nanomolar,2887819,=,37,1,=,,IC50,nM,,222.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,222.0,PAK4
,416236,17779747,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H](C)C(N)=O,,,CHEMBL3886836,,2016,"{'bei': '18.23', 'le': '0.34', 'lle': '5.14', 'sei': '5.28'}",CHEMBL3973242,,CHEMBL3973242,6.64,0,http://www.openphacts.org/units/Nanomolar,2887820,=,37,1,=,,IC50,nM,,227.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,227.0,PAK4
,416237,17779748,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCC1,,,CHEMBL3886836,,2016,"{'bei': '22.85', 'le': '0.42', 'lle': '4.69', 'sei': '9.99'}",CHEMBL3925905,,CHEMBL3925905,8.26,0,http://www.openphacts.org/units/Nanomolar,2887821,=,37,1,=,,IC50,nM,,5.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.5,PAK4
,416238,17779749,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC1,,,CHEMBL3886836,,2016,"{'bei': '24.71', 'le': '0.45', 'lle': '5.41', 'sei': '10.38'}",CHEMBL3960320,,CHEMBL3960320,8.59,0,http://www.openphacts.org/units/Nanomolar,2887822,=,37,1,=,,IC50,nM,,2.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.6,PAK4
,416239,17779750,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCCC1,,,CHEMBL3886836,,2016,"{'bei': '22.13', 'le': '0.41', 'lle': '4.35', 'sei': '10.05'}",CHEMBL3986516,,CHEMBL3986516,8.31,0,http://www.openphacts.org/units/Nanomolar,2887823,=,37,1,=,,IC50,nM,,4.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.9,PAK4
,416240,17779751,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CCOCC1,,,CHEMBL3886836,,2016,"{'bei': '19.26', 'le': '0.35', 'lle': '4.94', 'sei': '8.42'}",CHEMBL3957810,,CHEMBL3957810,7.00,0,http://www.openphacts.org/units/Nanomolar,2887824,=,37,1,=,,IC50,nM,,99.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,99.8,PAK4
,416241,17779752,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCCCC1,,,CHEMBL3886836,,2016,"{'bei': '20.17', 'le': '0.37', 'lle': '3.51', 'sei': '9.50'}",CHEMBL3981339,,CHEMBL3981339,7.86,0,http://www.openphacts.org/units/Nanomolar,2887825,=,37,1,=,,IC50,nM,,13.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.9,PAK4
,416242,17779753,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C=C(C)CNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '23.97', 'le': '0.44', 'lle': '5.12', 'sei': '10.07'}",CHEMBL3949181,,CHEMBL3949181,8.33,0,http://www.openphacts.org/units/Nanomolar,2887826,=,37,1,=,,IC50,nM,,4.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.7,PAK4
,416243,17779754,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)[C@H](C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '17.95', 'le': '0.33', 'lle': '4.62', 'sei': '6.25'}",CHEMBL3973354,,CHEMBL3973354,6.81,0,http://www.openphacts.org/units/Nanomolar,2887827,=,37,1,=,,IC50,nM,,154.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,154.0,PAK4
,416244,17779755,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)[C@@H](C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '18.79', 'le': '0.35', 'lle': '4.94', 'sei': '6.54'}",CHEMBL3923254,,CHEMBL3923254,7.13,0,http://www.openphacts.org/units/Nanomolar,2887828,=,37,1,=,,IC50,nM,,74.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,74.1,PAK4
,416245,17779756,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CCCC1,,,CHEMBL3886836,,2016,"{'bei': '21.65', 'le': '0.40', 'lle': '4.70', 'sei': '10.18'}",CHEMBL3961180,,CHEMBL3961180,7.52,0,http://www.openphacts.org/units/Nanomolar,2887829,=,37,1,=,,IC50,nM,,30.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,30.1,PAK4
,416246,17779757,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CCC1,,,CHEMBL3886836,,2016,"{'bei': '23.38', 'le': '0.43', 'lle': '5.37', 'sei': '10.55'}",CHEMBL3937248,,CHEMBL3937248,7.80,0,http://www.openphacts.org/units/Nanomolar,2887830,=,37,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.0,PAK4
,416247,17779758,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCC[C@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '24.84', 'le': '0.46', 'lle': '6.80', 'sei': '8.92'}",CHEMBL3958307,,CHEMBL3958307,9.70,0,http://www.openphacts.org/units/Nanomolar,2887831,=,37,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,416248,17779759,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCC[C@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '20.57', 'le': '0.38', 'lle': '5.13', 'sei': '7.39'}",CHEMBL3958307,,CHEMBL3958307,8.03,0,http://www.openphacts.org/units/Nanomolar,2887831,=,37,1,=,,IC50,nM,,9.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.3,PAK4
,416249,17779760,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '21.98', 'le': '0.40', 'lle': '5.77', 'sei': '7.61'}",CHEMBL3966072,,CHEMBL3966072,8.28,0,http://www.openphacts.org/units/Nanomolar,2887832,=,37,1,=,,IC50,nM,,5.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.3,PAK4
,416250,17779761,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '24.16', 'le': '0.44', 'lle': '6.59', 'sei': '8.37'}",CHEMBL3966072,,CHEMBL3966072,9.10,0,http://www.openphacts.org/units/Nanomolar,2887832,=,37,1,=,,IC50,nM,,0.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.8,PAK4
,416251,17779762,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCC1,,,CHEMBL3886836,,2016,"{'bei': '24.33', 'le': '0.44', 'lle': '5.23', 'sei': '10.64'}",CHEMBL3904282,,CHEMBL3904282,8.80,0,http://www.openphacts.org/units/Nanomolar,2887833,=,37,1,=,,IC50,nM,,1.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.6,PAK4
,416252,17779763,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CC(F)(F)C1,,,CHEMBL3886836,,2016,"{'bei': '21.00', 'le': '0.39', 'lle': '4.62', 'sei': '9.73'}",CHEMBL3903663,,CHEMBL3903663,8.05,0,http://www.openphacts.org/units/Nanomolar,2887834,=,37,1,=,,IC50,nM,,8.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.9,PAK4
,416253,17779764,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(CO)CCC1,,,CHEMBL3886836,,2016,"{'bei': '21.47', 'le': '0.40', 'lle': '5.55', 'sei': '7.87'}",CHEMBL3916316,,CHEMBL3916316,8.10,0,http://www.openphacts.org/units/Nanomolar,2887835,=,37,1,=,,IC50,nM,,7.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.9,PAK4
,416254,17779765,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.36', 'le': '0.45', 'lle': '5.17', 'sei': '10.71'}",CHEMBL3940808,,CHEMBL3940808,8.85,0,http://www.openphacts.org/units/Nanomolar,2887836,=,37,1,=,,IC50,nM,,1.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.4,PAK4
,416255,17779766,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2cc(-c3cccc4ccc(Nc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.86', 'le': '0.39', 'lle': '3.56', 'sei': '13.14'}",CHEMBL3897895,,CHEMBL3897895,7.75,0,http://www.openphacts.org/units/Nanomolar,2887838,=,37,1,=,,IC50,nM,,17.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.9,PAK4
,416256,17779767,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2cc(-c3cccc4ccc(Nc5cccnc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '24.36', 'le': '0.44', 'lle': '5.07', 'sei': '12.05'}",CHEMBL3906821,,CHEMBL3906821,8.66,0,http://www.openphacts.org/units/Nanomolar,2887839,=,37,1,=,,IC50,nM,,2.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.2,PAK4
,416257,17779768,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCn2cc(-c3cccc4ccc(C(=O)N5CCOCC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '16.41', 'le': '0.30', 'lle': '4.26', 'sei': '8.08'}",CHEMBL3931277,,CHEMBL3931277,6.18,0,http://www.openphacts.org/units/Nanomolar,2887840,=,37,1,=,,IC50,nM,,667.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,667.0,PAK4
,416258,17779769,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Nc5c(F)cccc5F)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.76', 'le': '0.40', 'lle': '3.95', 'sei': '12.17'}",CHEMBL3916900,,CHEMBL3916900,8.49,0,http://www.openphacts.org/units/Nanomolar,2887842,=,37,1,=,,IC50,nM,,3.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.2,PAK4
,416259,17779770,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(Oc5c(F)cccc5F)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.28', 'le': '0.39', 'lle': '3.74', 'sei': '12.43'}",CHEMBL3908049,,CHEMBL3908049,8.33,0,http://www.openphacts.org/units/Nanomolar,2887843,=,37,1,=,,IC50,nM,,4.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.7,PAK4
,416260,17779771,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ncc(Oc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.70', 'le': '0.39', 'lle': '4.04', 'sei': '9.68'}",CHEMBL3985018,,CHEMBL3985018,7.74,0,http://www.openphacts.org/units/Nanomolar,2887844,=,37,1,=,,IC50,nM,,18.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,18.4,PAK4
,416261,17779772,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ncc(Nc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '24.07', 'le': '0.43', 'lle': '4.90', 'sei': '10.34'}",CHEMBL3899005,,CHEMBL3899005,8.55,0,http://www.openphacts.org/units/Nanomolar,2887845,=,37,1,=,,IC50,nM,,2.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.8,PAK4
,416262,17779773,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '23.81', 'le': '0.43', 'lle': '4.84', 'sei': '10.64'}",CHEMBL3810085,,CHEMBL3810085,8.80,0,http://www.openphacts.org/units/Nanomolar,2887846,=,37,1,=,,IC50,nM,,1.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.6,PAK4
,416263,17779774,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(c1ccccc1)c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '21.82', 'le': '0.39', 'lle': '4.30', 'sei': '11.32'}",CHEMBL3983065,,CHEMBL3983065,8.37,0,http://www.openphacts.org/units/Nanomolar,2887847,=,37,1,=,,IC50,nM,,4.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.3,PAK4
,416264,17779775,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CNC(=O)c2cc(-c3cccc4ncc(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.65', 'le': '0.41', 'lle': '4.15', 'sei': '10.12'}",CHEMBL3980066,,CHEMBL3980066,8.37,0,http://www.openphacts.org/units/Nanomolar,2887848,=,37,1,=,,IC50,nM,,4.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.3,PAK4
,416265,17779776,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1ccccc1)c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '22.62', 'le': '0.41', 'lle': '4.68', 'sei': '11.31'}",CHEMBL3904349,,CHEMBL3904349,8.36,0,http://www.openphacts.org/units/Nanomolar,2887849,=,37,1,=,,IC50,nM,,4.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.4,PAK4
,416266,17779777,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]ccc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)nc12,,,CHEMBL3886836,,2016,"{'bei': '20.22', 'le': '0.36', 'lle': '2.93', 'sei': '8.26'}",CHEMBL3975214,,CHEMBL3975214,7.14,0,http://www.openphacts.org/units/Nanomolar,2887850,=,37,1,=,,IC50,nM,,71.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,71.8,PAK4
,416267,17779778,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Nc1ccccn1,,,CHEMBL3886836,,2016,"{'bei': '20.93', 'le': '0.38', 'lle': '4.39', 'sei': '8.11'}",CHEMBL3899619,,CHEMBL3899619,7.75,0,http://www.openphacts.org/units/Nanomolar,2887851,=,37,1,=,,IC50,nM,,17.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.6,PAK4
,416268,17779779,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '24.39', 'le': '0.45', 'lle': '5.14', 'sei': '9.89'}",CHEMBL3808459,,CHEMBL3808459,8.18,0,http://www.openphacts.org/units/Nanomolar,2887852,=,37,1,=,,IC50,nM,,6.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.6,PAK4
,416269,17779780,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.78', 'le': '0.45', 'lle': '5.27', 'sei': '10.05'}",CHEMBL3890648,,CHEMBL3890648,8.31,0,http://www.openphacts.org/units/Nanomolar,2887853,=,37,1,=,,IC50,nM,,4.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.9,PAK4
,416270,17779781,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '25.43', 'le': '0.47', 'lle': '5.46', 'sei': '10.74'}",CHEMBL3959725,,CHEMBL3959725,8.89,0,http://www.openphacts.org/units/Nanomolar,2887854,=,37,1,=,,IC50,nM,,1.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.3,PAK4
,416271,17779782,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '26.09', 'le': '0.48', 'lle': '5.91', 'sei': '10.52'}",CHEMBL3976162,,CHEMBL3976162,8.70,0,http://www.openphacts.org/units/Nanomolar,2887855,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,416272,17779783,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC(=O)N(C)C1,,,CHEMBL3886836,,2016,"{'bei': '16.69', 'le': '0.31', 'lle': '4.50', 'sei': '6.55'}",CHEMBL3921045,,CHEMBL3921045,6.75,0,http://www.openphacts.org/units/Nanomolar,2887856,=,37,1,=,,IC50,nM,,177.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,177.0,PAK4
,416273,17779784,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1COC1,,,CHEMBL3886836,,2016,"{'bei': '22.73', 'le': '0.42', 'lle': '5.91', 'sei': '8.64'}",CHEMBL3969001,,CHEMBL3969001,7.94,0,http://www.openphacts.org/units/Nanomolar,2887857,=,37,1,=,,IC50,nM,,11.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.4,PAK4
,416274,17779785,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)COC1,,,CHEMBL3886836,,2016,"{'bei': '22.68', 'le': '0.42', 'lle': '5.82', 'sei': '8.97'}",CHEMBL3897814,,CHEMBL3897814,8.24,0,http://www.openphacts.org/units/Nanomolar,2887858,=,37,1,=,,IC50,nM,,5.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.7,PAK4
,416275,17779786,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCOC1,,,CHEMBL3886836,,2016,"{'bei': '21.36', 'le': '0.39', 'lle': '5.25', 'sei': '8.77'}",CHEMBL3980526,,CHEMBL3980526,8.06,0,http://www.openphacts.org/units/Nanomolar,2887859,=,37,1,=,,IC50,nM,,8.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.7,PAK4
,416276,17779787,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC(=O)NC1,,,CHEMBL3886836,,2016,"{'bei': '18.70', 'le': '0.34', 'lle': '5.39', 'sei': '6.53'}",CHEMBL3906819,,CHEMBL3906819,7.30,0,http://www.openphacts.org/units/Nanomolar,2887860,=,37,1,=,,IC50,nM,,50.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,50.0,PAK4
,416277,17779788,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCNC1=O,,,CHEMBL3886836,,2016,"{'bei': '18.10', 'le': '0.33', 'lle': '5.16', 'sei': '6.32'}",CHEMBL3952715,,CHEMBL3952715,7.07,0,http://www.openphacts.org/units/Nanomolar,2887861,=,37,1,=,,IC50,nM,,85.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,85.7,PAK4
,416278,17779789,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CO,,,CHEMBL3886836,,2016,"{'bei': '23.40', 'le': '0.43', 'lle': '6.15', 'sei': '8.31'}",CHEMBL3963838,,CHEMBL3963838,8.55,0,http://www.openphacts.org/units/Nanomolar,2887862,=,37,1,=,,IC50,nM,,2.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.8,PAK4
,416279,17779790,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]ccc2[nH]c(-c3cccc4ccc(Oc5ccccc5)nc34)cc12,,,CHEMBL3886836,,2016,"{'bei': '20.83', 'le': '0.37', 'lle': '2.50', 'sei': '10.40'}",CHEMBL3915073,,CHEMBL3915073,7.36,0,http://www.openphacts.org/units/Nanomolar,2887863,=,37,1,=,,IC50,nM,,43.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,43.7,PAK4
,416280,17779791,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(-c5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '21.86', 'le': '0.39', 'lle': '3.24', 'sei': '12.84'}",CHEMBL3918521,,CHEMBL3918521,7.42,0,http://www.openphacts.org/units/Nanomolar,2887864,=,37,1,=,,IC50,nM,,38.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,38.1,PAK4
,416281,17779792,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3c(F)ccc4ccc(Nc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '22.58', 'le': '0.41', 'lle': '4.01', 'sei': '12.05'}",CHEMBL3964527,,CHEMBL3964527,8.41,0,http://www.openphacts.org/units/Nanomolar,2887865,=,37,1,=,,IC50,nM,,3.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.9,PAK4
,416282,17779793,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3c(F)ccc4ccc(Nc5cccnc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '24.23', 'le': '0.44', 'lle': '5.26', 'sei': '10.94'}",CHEMBL3978196,,CHEMBL3978196,9.05,0,http://www.openphacts.org/units/Nanomolar,2887866,=,37,1,=,,IC50,nM,,0.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.9,PAK4
,416283,17779794,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2ccc3ccc(F)c(-c4cc5c([nH]4)CCNC5=O)c3n2)cn1,,,CHEMBL3886836,,2016,"{'bei': '19.47', 'le': '0.36', 'lle': '3.98', 'sei': '9.31'}",CHEMBL3895191,,CHEMBL3895191,7.04,0,http://www.openphacts.org/units/Nanomolar,2887867,=,37,1,=,,IC50,nM,,92.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,92.0,PAK4
,416284,17779795,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(-c5c(F)cccc5F)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '18.75', 'le': '0.34', 'lle': '2.58', 'sei': '12.18'}",CHEMBL3966499,,CHEMBL3966499,7.04,0,http://www.openphacts.org/units/Nanomolar,2887868,=,37,1,=,,IC50,nM,,91.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,91.9,PAK4
,416285,17779796,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(N)=O)cc1-c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '18.35', 'le': '0.33', 'lle': '3.69', 'sei': '7.21'}",CHEMBL3889720,,CHEMBL3889720,7.28,0,http://www.openphacts.org/units/Nanomolar,2887869,=,37,1,=,,IC50,nM,,52.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,52.9,PAK4
,416286,17779797,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '23.35', 'le': '0.43', 'lle': '5.07', 'sei': '10.84'}",CHEMBL3927624,,CHEMBL3927624,7.79,0,http://www.openphacts.org/units/Nanomolar,2887870,=,37,1,=,,IC50,nM,,16.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.4,PAK4
,416287,17779798,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4cnc(Oc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '20.75', 'le': '0.37', 'lle': '3.70', 'sei': '9.26'}",CHEMBL3922211,,CHEMBL3922211,7.40,0,http://www.openphacts.org/units/Nanomolar,2887871,=,37,1,=,,IC50,nM,,40.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,40.2,PAK4
,416288,17779799,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1Cc2[nH]c(-c3cccc4ccc(Nc5ccccc5)nc34)cc2C(=O)N1,,,CHEMBL3886836,,2016,"{'bei': '20.26', 'le': '0.36', 'lle': '2.82', 'sei': '10.69'}",CHEMBL3946958,,CHEMBL3946958,7.47,0,http://www.openphacts.org/units/Nanomolar,2887767,=,37,1,=,,IC50,nM,,34.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.2,PAK4
,416289,17779800,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.79', 'le': '0.41', 'lle': '3.58', 'sei': '12.03'}",CHEMBL3933369,,CHEMBL3933369,8.40,0,http://www.openphacts.org/units/Nanomolar,2887764,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,416290,17779801,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1CNC(=O)c2cc(-c3cccc4ccc(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.36', 'le': '0.40', 'lle': '3.34', 'sei': '12.25'}",CHEMBL3973604,,CHEMBL3973604,8.55,0,http://www.openphacts.org/units/Nanomolar,2887872,=,37,1,=,,IC50,nM,,2.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.8,PAK4
,416291,17779802,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4cnc(C5(c6ccccc6)CC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '20.36', 'le': '0.36', 'lle': '3.76', 'sei': '10.96'}",CHEMBL3945081,,CHEMBL3945081,7.75,0,http://www.openphacts.org/units/Nanomolar,2887873,=,37,1,=,,IC50,nM,,17.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.9,PAK4
,416292,17779803,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(c1ccccc1)c1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '20.76', 'le': '0.37', 'lle': '2.96', 'sei': '13.20'}",CHEMBL3898587,,CHEMBL3898587,7.63,0,http://www.openphacts.org/units/Nanomolar,2887810,=,37,1,=,,IC50,nM,,23.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,23.6,PAK4
,416293,17779804,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC1CNC(=O)c2cc(-c3cccc4cc(C)c(Nc5ccccc5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.00', 'le': '0.40', 'lle': '3.20', 'sei': '12.49'}",CHEMBL3889660,,CHEMBL3889660,8.72,0,http://www.openphacts.org/units/Nanomolar,2887811,=,37,1,=,,IC50,nM,,1.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.9,PAK4
,416294,17779805,[],CHEMBL3888798,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 96-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 10-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The final buffer conditions were as follows: 60 mM Hepes, pH 7.0, 0.05% BSA, 2 mM DTT. Incubations were carried out at RT (22° C.) for 2 h for Pim-1, 1 hour and 30 min for Pim-3, and 45 min for Pim-2. The reaction was stopped by the addition of 3 mM EDTA, and fluorescence was measured by an HTRF® Rubystar microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4cnc(Nc5ccccc5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '22.14', 'le': '0.40', 'lle': '4.22', 'sei': '9.52'}",CHEMBL3936246,,CHEMBL3936246,7.87,0,http://www.openphacts.org/units/Nanomolar,2887874,=,37,1,=,,IC50,nM,,13.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.5,PAK4
,416617,17780128,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Oc1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '23.55', 'le': '0.43', 'lle': '5.45', 'sei': '8.26'}",CHEMBL3934584,,CHEMBL3934584,8.74,0,http://www.openphacts.org/units/Nanomolar,2887876,=,37,1,=,,IC50,nM,,1.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.8,PAK4
,416618,17780129,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCN(C(=O)OC(C)(C)C)CC1,,,CHEMBL3886836,,2016,"{'bei': '15.65', 'le': '0.29', 'lle': '3.43', 'sei': '6.64'}",CHEMBL3943561,,CHEMBL3943561,7.46,0,http://www.openphacts.org/units/Nanomolar,2887877,=,37,1,=,,IC50,nM,,34.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.9,PAK4
,416619,17780130,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCN(C(=O)OC(C)(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '14.99', 'le': '0.28', 'lle': '3.30', 'sei': '6.18'}",CHEMBL3963379,,CHEMBL3963379,6.94,0,http://www.openphacts.org/units/Nanomolar,2887878,=,37,1,=,,IC50,nM,,116.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,116.0,PAK4
,416620,17780131,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CCN(C(=O)OC(C)(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '14.79', 'le': '0.27', 'lle': '3.20', 'sei': '6.10'}",CHEMBL3948887,,CHEMBL3948887,6.84,0,http://www.openphacts.org/units/Nanomolar,2887879,=,37,1,=,,IC50,nM,,144.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,144.0,PAK4
,416621,17780132,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC(Nc2nc3c(-c4cc5c([nH]4)CCNC5=O)cccc3nc2C)CC1,,,CHEMBL3886836,,2016,"{'bei': '18.19', 'le': '0.34', 'lle': '4.97', 'sei': '7.39'}",CHEMBL3948078,,CHEMBL3948078,7.61,0,http://www.openphacts.org/units/Nanomolar,2887880,=,37,1,=,,IC50,nM,,24.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,24.4,PAK4
,416622,17780133,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CCCN(C(=O)OC(C)(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '13.97', 'le': '0.26', 'lle': '2.63', 'sei': '5.93'}",CHEMBL3957539,,CHEMBL3957539,6.66,0,http://www.openphacts.org/units/Nanomolar,2887881,=,37,1,=,,IC50,nM,,220.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,220.0,PAK4
,416623,17780134,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCCN(C(=O)OC(C)(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '13.42', 'le': '0.25', 'lle': '2.36', 'sei': '5.70'}",CHEMBL3986236,,CHEMBL3986236,6.39,0,http://www.openphacts.org/units/Nanomolar,2887882,=,37,1,=,,IC50,nM,,403.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,403.0,PAK4
,416624,17780135,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCNCC1,,,CHEMBL3886836,,2016,"{'bei': '22.90', 'le': '0.42', 'lle': '6.24', 'sei': '9.10'}",CHEMBL3901085,,CHEMBL3901085,8.62,0,http://www.openphacts.org/units/Nanomolar,2887883,=,37,1,=,,IC50,nM,,2.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.4,PAK4
,416625,17780136,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@@H]1N,,,CHEMBL3886836,,2016,"{'bei': '23.56', 'le': '0.43', 'lle': '6.42', 'sei': '7.85'}",CHEMBL3910979,,CHEMBL3910979,8.54,0,http://www.openphacts.org/units/Nanomolar,2887884,=,37,1,=,,IC50,nM,,2.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.9,PAK4
,416626,17780137,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CCNC1,,,CHEMBL3886836,,2016,"{'bei': '23.52', 'le': '0.43', 'lle': '6.53', 'sei': '9.00'}",CHEMBL3910145,,CHEMBL3910145,8.52,0,http://www.openphacts.org/units/Nanomolar,2887885,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,416627,17780138,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1CC[C@@H]1Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '18.34', 'le': '0.34', 'lle': '5.12', 'sei': '6.63'}",CHEMBL3986065,,CHEMBL3986065,7.42,0,http://www.openphacts.org/units/Nanomolar,2887886,=,37,1,=,,IC50,nM,,38.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,38.3,PAK4
,416628,17780139,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)C(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '18.47', 'le': '0.34', 'lle': '4.69', 'sei': '6.67'}",CHEMBL3956734,,CHEMBL3956734,7.26,0,http://www.openphacts.org/units/Nanomolar,2887887,=,37,1,=,,IC50,nM,,54.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,54.3,PAK4
,416629,17780140,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1CC[C@@H]1Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '16.68', 'le': '0.31', 'lle': '4.44', 'sei': '6.03'}",CHEMBL3986065,,CHEMBL3986065,6.75,0,http://www.openphacts.org/units/Nanomolar,2887886,=,37,1,=,,IC50,nM,,180.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,180.0,PAK4
,416630,17780141,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1CC[C@@H]1Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '18.77', 'le': '0.35', 'lle': '5.29', 'sei': '6.79'}",CHEMBL3986065,,CHEMBL3986065,7.59,0,http://www.openphacts.org/units/Nanomolar,2887886,=,37,1,=,,IC50,nM,,25.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,25.7,PAK4
,416631,17780142,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C(=O)O,,,CHEMBL3886836,,2016,"{'bei': '17.71', 'le': '0.33', 'lle': '4.23', 'sei': '5.60'}",CHEMBL3892131,,CHEMBL3892131,6.72,0,http://www.openphacts.org/units/Nanomolar,2887888,=,37,1,=,,IC50,nM,,191.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,191.0,PAK4
,416632,17780143,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCNC1,,,CHEMBL3886836,,2016,"{'bei': '20.91', 'le': '0.38', 'lle': '5.59', 'sei': '8.00'}",CHEMBL3914616,,CHEMBL3914616,7.58,0,http://www.openphacts.org/units/Nanomolar,2887889,=,37,1,=,,IC50,nM,,26.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,26.4,PAK4
,416633,17780144,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C(N)=O,,,CHEMBL3886836,,2016,"{'bei': '20.20', 'le': '0.37', 'lle': '5.74', 'sei': '6.08'}",CHEMBL3981216,,CHEMBL3981216,7.64,0,http://www.openphacts.org/units/Nanomolar,2887890,=,37,1,=,,IC50,nM,,22.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.7,PAK4
,416634,17780145,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COCC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '21.79', 'le': '0.40', 'lle': '5.21', 'sei': '8.99'}",CHEMBL3965003,,CHEMBL3965003,8.27,0,http://www.openphacts.org/units/Nanomolar,2887891,=,37,1,=,,IC50,nM,,5.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.4,PAK4
,416635,17780146,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C=C(c1cc2c([nH]1)CCNC2=O)c1nc(N[C@@H]2CCN(C(C)=O)C2)c(C)nc1C,,,CHEMBL3886836,,2016,"{'bei': '18.92', 'le': '0.35', 'lle': '5.66', 'sei': '7.24'}",CHEMBL3976384,,CHEMBL3976384,7.46,0,http://www.openphacts.org/units/Nanomolar,2887892,=,37,1,=,,IC50,nM,,34.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.5,PAK4
,416636,17780147,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CC[C@H](Nc2nc3c(-c4cc5c([nH]4)CCNC5=O)cccc3nc2C)C1,,,CHEMBL3886836,,2016,"{'bei': '17.65', 'le': '0.32', 'lle': '4.89', 'sei': '6.93'}",CHEMBL3895552,,CHEMBL3895552,7.14,0,http://www.openphacts.org/units/Nanomolar,2887893,=,37,1,=,,IC50,nM,,72.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,72.8,PAK4
,416637,17780148,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)C,,,CHEMBL3886836,,2016,"{'bei': '26.20', 'le': '0.48', 'lle': '5.86', 'sei': '11.07'}",CHEMBL3970207,,CHEMBL3970207,9.15,0,http://www.openphacts.org/units/Nanomolar,2887894,=,37,1,=,,IC50,nM,,0.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.7,PAK4
,416638,17780149,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCCC1,,,CHEMBL3886836,,2016,"{'bei': '24.56', 'le': '0.45', 'lle': '5.26', 'sei': '11.15'}",CHEMBL3956884,,CHEMBL3956884,9.22,0,http://www.openphacts.org/units/Nanomolar,2887895,=,37,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,416639,17780150,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N(C)C(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.51', 'le': '0.43', 'lle': '5.15', 'sei': '11.11'}",CHEMBL3891287,,CHEMBL3891287,8.21,0,http://www.openphacts.org/units/Nanomolar,2887896,=,37,1,=,,IC50,nM,,6.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.1,PAK4
,416640,17780151,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '27.29', 'le': '0.50', 'lle': '6.12', 'sei': '10.60'}",CHEMBL3951627,,CHEMBL3951627,8.77,0,http://www.openphacts.org/units/Nanomolar,2887897,=,37,1,=,,IC50,nM,,1.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.7,PAK4
,416641,17780152,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)(C)N,,,CHEMBL3886836,,2016,"{'bei': '22.50', 'le': '0.41', 'lle': '5.83', 'sei': '7.54'}",CHEMBL3980532,,CHEMBL3980532,8.20,0,http://www.openphacts.org/units/Nanomolar,2887898,=,37,1,=,,IC50,nM,,6.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.3,PAK4
,416642,17780153,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCOC1,,,CHEMBL3886836,,2016,"{'bei': '22.60', 'le': '0.42', 'lle': '5.79', 'sei': '8.94'}",CHEMBL3979545,,CHEMBL3979545,8.21,0,http://www.openphacts.org/units/Nanomolar,2887899,=,37,1,=,,IC50,nM,,6.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.1,PAK4
,416643,17780154,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CC(O)C1,,,CHEMBL3886836,,2016,"{'bei': '24.00', 'le': '0.44', 'lle': '6.57', 'sei': '8.47'}",CHEMBL3905697,,CHEMBL3905697,8.72,0,http://www.openphacts.org/units/Nanomolar,2887900,=,37,1,=,,IC50,nM,,1.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.9,PAK4
,416644,17780155,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)C(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.06', 'le': '0.44', 'lle': '5.06', 'sei': '10.57'}",CHEMBL3967917,,CHEMBL3967917,8.74,0,http://www.openphacts.org/units/Nanomolar,2887901,=,37,1,=,,IC50,nM,,1.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.8,PAK4
,416645,17780156,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCS(=O)(=O)C1,,,CHEMBL3886836,,2016,"{'bei': '18.68', 'le': '0.36', 'lle': '5.87', 'sei': '6.58'}",CHEMBL3896761,,CHEMBL3896761,7.69,0,http://www.openphacts.org/units/Nanomolar,2887902,=,37,1,=,,IC50,nM,,20.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.5,PAK4
,416646,17780157,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCCNC1,,,CHEMBL3886836,,2016,"{'bei': '23.70', 'le': '0.44', 'lle': '6.54', 'sei': '9.42'}",CHEMBL3926862,,CHEMBL3926862,8.92,0,http://www.openphacts.org/units/Nanomolar,2887903,=,37,1,=,,IC50,nM,,1.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.2,PAK4
,416647,17780158,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CCCNC1,,,CHEMBL3886836,,2016,"{'bei': '20.10', 'le': '0.37', 'lle': '5.19', 'sei': '7.99'}",CHEMBL3899021,,CHEMBL3899021,7.57,0,http://www.openphacts.org/units/Nanomolar,2887904,=,37,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,416648,17780159,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)CNC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '23.43', 'le': '0.43', 'lle': '5.14', 'sei': '10.18'}",CHEMBL3889626,,CHEMBL3889626,8.42,0,http://www.openphacts.org/units/Nanomolar,2887905,=,37,1,=,,IC50,nM,,3.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.8,PAK4
,416649,17780160,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCc2[nH]c(-c3cccc4ccc(NC5CC5)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '25.61', 'le': '0.46', 'lle': '5.06', 'sei': '11.68'}",CHEMBL3923078,,CHEMBL3923078,8.15,0,http://www.openphacts.org/units/Nanomolar,2887906,=,37,1,=,,IC50,nM,,7.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.0,PAK4
,416650,17780161,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '25.95', 'le': '0.47', 'lle': '5.91', 'sei': '12.55'}",CHEMBL3978475,,CHEMBL3978475,9.02,0,http://www.openphacts.org/units/Nanomolar,2887907,=,37,1,=,,IC50,nM,,0.961,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.961,PAK4
,416651,17780162,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CC1CNC(=O)c2cc(-c3cccc4cccnc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '20.53', 'le': '0.37', 'lle': '2.46', 'sei': '11.35'}",CHEMBL3893318,,CHEMBL3893318,6.56,0,http://www.openphacts.org/units/Nanomolar,2887817,=,37,1,=,,IC50,nM,,278.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,278.0,PAK4
,416652,17780163,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC1,,,CHEMBL3886836,,2016,"{'bei': '26.18', 'le': '0.48', 'lle': '5.92', 'sei': '11.00'}",CHEMBL3960320,,CHEMBL3960320,9.10,0,http://www.openphacts.org/units/Nanomolar,2887822,=,37,1,=,,IC50,nM,,0.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.8,PAK4
,416653,17780164,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CCC1,,,CHEMBL3886836,,2016,"{'bei': '23.11', 'le': '0.42', 'lle': '5.28', 'sei': '10.43'}",CHEMBL3937248,,CHEMBL3937248,7.71,0,http://www.openphacts.org/units/Nanomolar,2887830,=,37,1,=,,IC50,nM,,19.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.7,PAK4
,416654,17780165,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCC[C@H](N)C1,,,CHEMBL3886836,,2016,,CHEMBL3958307,,CHEMBL3958307,,0,http://www.openphacts.org/units/Nanomolar,2887831,<,37,1,<,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,416655,17780166,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CCC[C@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '21.65', 'le': '0.40', 'lle': '5.56', 'sei': '7.78'}",CHEMBL3958307,,CHEMBL3958307,8.46,0,http://www.openphacts.org/units/Nanomolar,2887831,=,37,1,=,,IC50,nM,,3.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.5,PAK4
,416656,17780167,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '23.52', 'le': '0.43', 'lle': '6.34', 'sei': '8.14'}",CHEMBL3966072,,CHEMBL3966072,8.85,0,http://www.openphacts.org/units/Nanomolar,2887832,=,37,1,=,,IC50,nM,,1.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.4,PAK4
,416657,17780168,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H]1CC[C@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '24.96', 'le': '0.46', 'lle': '6.89', 'sei': '8.64'}",CHEMBL3966072,,CHEMBL3966072,9.40,0,http://www.openphacts.org/units/Nanomolar,2887832,=,37,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,416658,17780169,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCC1,,,CHEMBL3886836,,2016,"{'bei': '25.51', 'le': '0.47', 'lle': '5.65', 'sei': '11.15'}",CHEMBL3904282,,CHEMBL3904282,9.22,0,http://www.openphacts.org/units/Nanomolar,2887833,=,37,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,416659,17780170,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CC(F)(F)C1,,,CHEMBL3886836,,2016,"{'bei': '21.75', 'le': '0.41', 'lle': '4.91', 'sei': '10.08'}",CHEMBL3903663,,CHEMBL3903663,8.34,0,http://www.openphacts.org/units/Nanomolar,2887834,=,37,1,=,,IC50,nM,,4.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.6,PAK4
,416660,17780171,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(CO)CCC1,,,CHEMBL3886836,,2016,"{'bei': '22.58', 'le': '0.42', 'lle': '5.97', 'sei': '8.28'}",CHEMBL3916316,,CHEMBL3916316,8.52,0,http://www.openphacts.org/units/Nanomolar,2887835,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,416661,17780172,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '25.37', 'le': '0.47', 'lle': '5.54', 'sei': '11.15'}",CHEMBL3940808,,CHEMBL3940808,9.22,0,http://www.openphacts.org/units/Nanomolar,2887836,=,37,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,416662,17780173,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(C)(C)O,,,CHEMBL3886836,,2016,"{'bei': '22.06', 'le': '0.41', 'lle': '5.66', 'sei': '7.83'}",CHEMBL3925309,,CHEMBL3925309,8.06,0,http://www.openphacts.org/units/Nanomolar,2887908,=,37,1,=,,IC50,nM,,8.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.7,PAK4
,416663,17780174,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CN(C(=O)OC(C)(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '16.68', 'le': '0.31', 'lle': '4.23', 'sei': '6.67'}",CHEMBL3952993,,CHEMBL3952993,7.48,0,http://www.openphacts.org/units/Nanomolar,2887909,=,37,1,=,,IC50,nM,,33.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,33.0,PAK4
,416664,17780175,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CNC1,,,CHEMBL3886836,,2016,"{'bei': '23.62', 'le': '0.43', 'lle': '6.63', 'sei': '8.69'}",CHEMBL3933668,,CHEMBL3933668,8.23,0,http://www.openphacts.org/units/Nanomolar,2887910,=,37,1,=,,IC50,nM,,5.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.9,PAK4
,416665,17780176,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1OC1CCC1,,,CHEMBL3886836,,2016,"{'bei': '22.70', 'le': '0.42', 'lle': '4.76', 'sei': '9.90'}",CHEMBL3905644,,CHEMBL3905644,7.91,0,http://www.openphacts.org/units/Nanomolar,2887911,=,37,1,=,,IC50,nM,,12.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.3,PAK4
,416666,17780177,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1OCC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '20.17', 'le': '0.37', 'lle': '3.71', 'sei': '9.20'}",CHEMBL3942637,,CHEMBL3942637,7.35,0,http://www.openphacts.org/units/Nanomolar,2887912,=,37,1,=,,IC50,nM,,44.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,44.7,PAK4
,416667,17780178,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCCCC1,,,CHEMBL3886836,,2016,"{'bei': '22.65', 'le': '0.42', 'lle': '4.47', 'sei': '10.67'}",CHEMBL3918209,,CHEMBL3918209,8.82,0,http://www.openphacts.org/units/Nanomolar,2887913,=,37,1,=,,IC50,nM,,1.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.5,PAK4
,416668,17780179,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(C)CNC4=O)c2nc1F,,,CHEMBL3886836,,2016,"{'bei': '19.72', 'le': '0.36', 'lle': '3.20', 'sei': '8.66'}",CHEMBL3947213,,CHEMBL3947213,6.12,0,http://www.openphacts.org/units/Nanomolar,2887914,=,37,1,=,,IC50,nM,,758.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,758.0,PAK4
,416669,17780180,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCCNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '25.10', 'le': '0.46', 'lle': '5.34', 'sei': '10.60'}",CHEMBL3809623,,CHEMBL3809623,8.77,0,http://www.openphacts.org/units/Nanomolar,2887915,=,37,1,=,,IC50,nM,,1.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.7,PAK4
,416670,17780181,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(C)CNC4=O)c2nc1F,,,CHEMBL3886836,,2016,"{'bei': '29.97', 'le': '0.55', 'lle': '6.38', 'sei': '13.16'}",CHEMBL3947213,,CHEMBL3947213,9.30,0,http://www.openphacts.org/units/Nanomolar,2887914,=,37,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,416671,17780182,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(C)CNC4=O)c2nc1F,,,CHEMBL3886836,,2016,"{'bei': '29.50', 'le': '0.54', 'lle': '6.23', 'sei': '12.95'}",CHEMBL3947213,,CHEMBL3947213,9.15,0,http://www.openphacts.org/units/Nanomolar,2887914,=,37,1,=,,IC50,nM,,0.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.7,PAK4
,416672,17780183,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1cnc2cccc(-c3cc4n(c3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '26.40', 'le': '0.48', 'lle': '5.80', 'sei': '12.32'}",CHEMBL3922362,,CHEMBL3922362,8.85,0,http://www.openphacts.org/units/Nanomolar,2887916,=,37,1,=,,IC50,nM,,1.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.4,PAK4
,416673,17780184,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.20', 'le': '0.44', 'lle': '5.10', 'sei': '11.77'}",CHEMBL3913500,,CHEMBL3913500,8.46,0,http://www.openphacts.org/units/Nanomolar,2887917,=,37,1,=,,IC50,nM,,3.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.5,PAK4
,416674,17780185,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCOC1,,,CHEMBL3886836,,2016,"{'bei': '22.66', 'le': '0.42', 'lle': '5.74', 'sei': '9.30'}",CHEMBL3980526,,CHEMBL3980526,8.55,0,http://www.openphacts.org/units/Nanomolar,2887859,=,37,1,=,,IC50,nM,,2.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.8,PAK4
,416675,17780186,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCC(=O)NC1,,,CHEMBL3886836,,2016,"{'bei': '19.42', 'le': '0.36', 'lle': '5.67', 'sei': '6.78'}",CHEMBL3906819,,CHEMBL3906819,7.58,0,http://www.openphacts.org/units/Nanomolar,2887860,=,37,1,=,,IC50,nM,,26.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,26.2,PAK4
,416676,17780187,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCNC1=O,,,CHEMBL3886836,,2016,"{'bei': '18.90', 'le': '0.35', 'lle': '5.47', 'sei': '6.60'}",CHEMBL3952715,,CHEMBL3952715,7.38,0,http://www.openphacts.org/units/Nanomolar,2887861,=,37,1,=,,IC50,nM,,41.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,41.8,PAK4
,416677,17780188,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CO,,,CHEMBL3886836,,2016,"{'bei': '24.00', 'le': '0.44', 'lle': '6.37', 'sei': '8.52'}",CHEMBL3963838,,CHEMBL3963838,8.77,0,http://www.openphacts.org/units/Nanomolar,2887862,=,37,1,=,,IC50,nM,,1.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.7,PAK4
,416678,17780189,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '27.41', 'le': '0.50', 'lle': '6.34', 'sei': '11.51'}",CHEMBL3957954,,CHEMBL3957954,9.52,0,http://www.openphacts.org/units/Nanomolar,2887918,=,37,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,416679,17780190,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCOCC1,,,CHEMBL3886836,,2016,"{'bei': '21.08', 'le': '0.39', 'lle': '5.05', 'sei': '8.98'}",CHEMBL3892409,,CHEMBL3892409,8.25,0,http://www.openphacts.org/units/Nanomolar,2887919,=,37,1,=,,IC50,nM,,5.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.6,PAK4
,416680,17780191,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCC(O)C1,,,CHEMBL3886836,,2016,"{'bei': '21.60', 'le': '0.40', 'lle': '5.53', 'sei': '8.22'}",CHEMBL3976306,,CHEMBL3976306,8.46,0,http://www.openphacts.org/units/Nanomolar,2887920,=,37,1,=,,IC50,nM,,3.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.5,PAK4
,416681,17780192,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCCC1O,,,CHEMBL3886836,,2016,"{'bei': '21.32', 'le': '0.39', 'lle': '5.42', 'sei': '8.11'}",CHEMBL3964978,,CHEMBL3964978,8.35,0,http://www.openphacts.org/units/Nanomolar,2887921,=,37,1,=,,IC50,nM,,4.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.5,PAK4
,416682,17780193,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1CC[C@H](O)CC1,,,CHEMBL3886836,,2016,"{'bei': '21.45', 'le': '0.40', 'lle': '5.47', 'sei': '8.16'}",CHEMBL3949174,,CHEMBL3949174,8.40,0,http://www.openphacts.org/units/Nanomolar,2887922,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,416683,17780194,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCOC1,,,CHEMBL3886836,,2016,"{'bei': '22.99', 'le': '0.42', 'lle': '5.87', 'sei': '9.44'}",CHEMBL3980526,,CHEMBL3980526,8.68,0,http://www.openphacts.org/units/Nanomolar,2887859,=,37,1,=,,IC50,nM,,2.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.1,PAK4
,416684,17780195,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CCCOC1,,,CHEMBL3886836,,2016,"{'bei': '22.25', 'le': '0.41', 'lle': '5.59', 'sei': '9.14'}",CHEMBL3980526,,CHEMBL3980526,8.40,0,http://www.openphacts.org/units/Nanomolar,2887859,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,416685,17780196,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '28.39', 'le': '0.52', 'lle': '6.40', 'sei': '11.51'}",CHEMBL3926782,,CHEMBL3926782,9.52,0,http://www.openphacts.org/units/Nanomolar,2887923,=,37,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,416686,17780197,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(Nc2cnc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)CC1,,,CHEMBL3886836,,2016,"{'bei': '28.56', 'le': '0.52', 'lle': '6.64', 'sei': '11.51'}",CHEMBL3965643,,CHEMBL3965643,9.52,0,http://www.openphacts.org/units/Nanomolar,2887924,=,37,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,416687,17780198,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCCCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '23.01', 'le': '0.42', 'lle': '4.96', 'sei': '11.69'}",CHEMBL3935709,,CHEMBL3935709,8.64,0,http://www.openphacts.org/units/Nanomolar,2887925,=,37,1,=,,IC50,nM,,2.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.3,PAK4
,416688,17780199,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)COCCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '22.51', 'le': '0.41', 'lle': '5.96', 'sei': '10.22'}",CHEMBL3963777,,CHEMBL3963777,8.49,0,http://www.openphacts.org/units/Nanomolar,2887926,=,37,1,=,,IC50,nM,,3.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.2,PAK4
,416689,17780200,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CN(c2cnc3cccc(-c4cc5c([nH]4)CCNC5=O)c3n2)CCN1,,,CHEMBL3886836,,2016,"{'bei': '19.22', 'le': '0.35', 'lle': '5.14', 'sei': '8.42'}",CHEMBL3948083,,CHEMBL3948083,7.24,0,http://www.openphacts.org/units/Nanomolar,2887927,=,37,1,=,,IC50,nM,,58.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,58.0,PAK4
,416690,17780201,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)C(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '26.20', 'le': '0.48', 'lle': '6.00', 'sei': '12.39'}",CHEMBL3985398,,CHEMBL3985398,9.15,0,http://www.openphacts.org/units/Nanomolar,2887928,=,37,1,=,,IC50,nM,,0.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.7,PAK4
,416691,17780202,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '25.17', 'le': '0.46', 'lle': '5.81', 'sei': '12.31'}",CHEMBL3956736,,CHEMBL3956736,9.10,0,http://www.openphacts.org/units/Nanomolar,2887929,=,37,1,=,,IC50,nM,,0.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.8,PAK4
,416692,17780203,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CNCCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '21.98', 'le': '0.40', 'lle': '6.18', 'sei': '9.63'}",CHEMBL3977800,,CHEMBL3977800,8.28,0,http://www.openphacts.org/units/Nanomolar,2887930,=,37,1,=,,IC50,nM,,5.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.3,PAK4
,416693,17780204,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N,,,CHEMBL3886836,,2016,"{'bei': '26.45', 'le': '0.48', 'lle': '5.96', 'sei': '8.03'}",CHEMBL3910799,,CHEMBL3910799,7.76,0,http://www.openphacts.org/units/Nanomolar,2887931,=,37,1,=,,IC50,nM,,17.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.4,PAK4
,416694,17780205,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '27.29', 'le': '0.50', 'lle': '6.13', 'sei': '10.14'}",CHEMBL3972842,,CHEMBL3972842,8.39,0,http://www.openphacts.org/units/Nanomolar,2887932,=,37,1,=,,IC50,nM,,4.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.1,PAK4
,416695,17780206,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)C(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '27.51', 'le': '0.51', 'lle': '6.46', 'sei': '13.53'}",CHEMBL3901766,,CHEMBL3901766,10.00,0,http://www.openphacts.org/units/Nanomolar,2887933,=,37,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,416696,17780207,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1SC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '22.83', 'le': '0.44', 'lle': '4.26', 'sei': '11.84'}",CHEMBL3900670,,CHEMBL3900670,8.37,0,http://www.openphacts.org/units/Nanomolar,2887934,=,37,1,=,,IC50,nM,,4.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.3,PAK4
,416697,17780208,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N(C)C(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.87', 'le': '0.44', 'lle': '5.23', 'sei': '11.74'}",CHEMBL3925198,,CHEMBL3925198,8.68,0,http://www.openphacts.org/units/Nanomolar,2887935,=,37,1,=,,IC50,nM,,2.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.1,PAK4
,416698,17780209,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)CCN1c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '26.18', 'le': '0.48', 'lle': '6.20', 'sei': '12.31'}",CHEMBL3985959,,CHEMBL3985959,9.10,0,http://www.openphacts.org/units/Nanomolar,2887936,=,37,1,=,,IC50,nM,,0.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.8,PAK4
,416699,17780210,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '21.20', 'le': '0.40', 'lle': '4.41', 'sei': '10.34'}",CHEMBL3916196,,CHEMBL3916196,8.55,0,http://www.openphacts.org/units/Nanomolar,2887937,=,37,1,=,,IC50,nM,,2.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.8,PAK4
,416700,17780211,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '24.48', 'le': '0.45', 'lle': '5.44', 'sei': '11.36'}",CHEMBL3927624,,CHEMBL3927624,8.16,0,http://www.openphacts.org/units/Nanomolar,2887870,=,37,1,=,,IC50,nM,,6.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.9,PAK4
,416701,17780212,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(c3)C(CCO)CNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '19.92', 'le': '0.37', 'lle': '4.56', 'sei': '8.51'}",CHEMBL3949953,,CHEMBL3949953,7.84,0,http://www.openphacts.org/units/Nanomolar,2887938,=,37,1,=,,IC50,nM,,14.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.5,PAK4
,416702,17780213,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NS(C)(=O)=O,,,CHEMBL3886836,,2016,"{'bei': '21.59', 'le': '0.42', 'lle': '6.43', 'sei': '6.86'}",CHEMBL3902617,,CHEMBL3902617,8.02,0,http://www.openphacts.org/units/Nanomolar,2887939,=,37,1,=,,IC50,nM,,9.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.6,PAK4
,416703,17780214,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC[C@@H](Nc2nc3c(-c4cc5c([nH]4)CCNC5=O)cccc3nc2C)C1,,,CHEMBL3886836,,2016,"{'bei': '17.12', 'le': '0.32', 'lle': '4.52', 'sei': '6.96'}",CHEMBL3978539,,CHEMBL3978539,7.17,0,http://www.openphacts.org/units/Nanomolar,2887940,=,37,1,=,,IC50,nM,,68.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,68.4,PAK4
,416704,17780215,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCC[C@H](Nc2nc3c(-c4cc5c([nH]4)CCNC5=O)cccc3nc2C)C1,,,CHEMBL3886836,,2016,"{'bei': '16.40', 'le': '0.30', 'lle': '4.22', 'sei': '6.66'}",CHEMBL3939749,,CHEMBL3939749,6.86,0,http://www.openphacts.org/units/Nanomolar,2887941,=,37,1,=,,IC50,nM,,137.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,137.0,PAK4
,416705,17780216,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1CN(C)C1,,,CHEMBL3886836,,2016,"{'bei': '16.50', 'le': '0.30', 'lle': '4.03', 'sei': '6.96'}",CHEMBL3917176,,CHEMBL3917176,5.98,0,http://www.openphacts.org/units/Nanomolar,2887942,=,37,1,=,,IC50,nM,,1050.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1050.0,PAK4
,416706,17780217,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '21.44', 'le': '0.41', 'lle': '4.68', 'sei': '10.46'}",CHEMBL3966076,,CHEMBL3966076,8.65,0,http://www.openphacts.org/units/Nanomolar,2887943,=,37,1,=,,IC50,nM,,2.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.24,PAK4
,416707,17780218,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H](C)C(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '19.43', 'le': '0.37', 'lle': '3.99', 'sei': '9.15'}",CHEMBL3949234,,CHEMBL3949234,7.57,0,http://www.openphacts.org/units/Nanomolar,2887944,=,37,1,=,,IC50,nM,,27.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.2,PAK4
,416708,17780219,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H](C)C(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '21.48', 'le': '0.41', 'lle': '4.78', 'sei': '10.11'}",CHEMBL3978345,,CHEMBL3978345,8.37,0,http://www.openphacts.org/units/Nanomolar,2887945,=,37,1,=,,IC50,nM,,4.32,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.32,PAK4
,416709,17780220,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C(F)(F)F)CC1,,,CHEMBL3886836,,2016,"{'bei': '23.60', 'le': '0.45', 'lle': '5.74', 'sei': '11.45'}",CHEMBL3961328,,CHEMBL3961328,9.47,0,http://www.openphacts.org/units/Nanomolar,2887946,=,37,1,=,,IC50,nM,,0.338,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.338,PAK4
,416710,17780221,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1NC1CCC1,,,CHEMBL3886836,,2016,"{'bei': '25.72', 'le': '0.47', 'lle': '5.78', 'sei': '8.97'}",CHEMBL3986567,,CHEMBL3986567,8.91,0,http://www.openphacts.org/units/Nanomolar,2887947,=,37,1,=,,IC50,nM,,1.23,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.23,PAK4
,416711,17780222,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '25.51', 'le': '0.47', 'lle': '5.51', 'sei': '8.95'}",CHEMBL3934918,,CHEMBL3934918,8.89,0,http://www.openphacts.org/units/Nanomolar,2887948,=,37,1,=,,IC50,nM,,1.29,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.29,PAK4
,416712,17780223,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1N,,,CHEMBL3886836,,2016,"{'bei': '26.27', 'le': '0.48', 'lle': '5.93', 'sei': '6.77'}",CHEMBL3962427,,CHEMBL3962427,7.68,0,http://www.openphacts.org/units/Nanomolar,2887949,=,37,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.0,PAK4
,416713,17780224,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1NC(C)(C)CO,,,CHEMBL3886836,,2016,"{'bei': '22.60', 'le': '0.42', 'lle': '5.89', 'sei': '6.89'}",CHEMBL3940464,,CHEMBL3940464,8.24,0,http://www.openphacts.org/units/Nanomolar,2887950,=,37,1,=,,IC50,nM,,5.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.8,PAK4
,416714,17780225,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(=O)[nH]cnc4[nH]3)c2nc1F,,,CHEMBL3886836,,2016,"{'bei': '19.55', 'le': '0.36', 'lle': '3.46', 'sei': '6.61'}",CHEMBL3973409,,CHEMBL3973409,5.77,0,http://www.openphacts.org/units/Nanomolar,2887951,=,37,1,=,,IC50,nM,,1690.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1690.0,PAK4
,416715,17780226,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1C,,,CHEMBL3886836,,2016,"{'bei': '23.28', 'le': '0.45', 'lle': '5.98', 'sei': '9.93'}",CHEMBL3983220,,CHEMBL3983220,7.92,0,http://www.openphacts.org/units/Nanomolar,2887952,=,37,1,=,,IC50,nM,,11.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.9,PAK4
,416716,17780227,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(Nc2ccccc2)nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '22.57', 'le': '0.41', 'lle': '5.74', 'sei': '9.47'}",CHEMBL3913376,,CHEMBL3913376,8.70,0,http://www.openphacts.org/units/Nanomolar,2887953,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,416717,17780228,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1OCCC(C)(C)N,,,CHEMBL3886836,,2016,"{'bei': '18.94', 'le': '0.35', 'lle': '4.46', 'sei': '6.78'}",CHEMBL3913792,,CHEMBL3913792,7.18,0,http://www.openphacts.org/units/Nanomolar,2887954,=,37,1,=,,IC50,nM,,65.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,65.3,PAK4
,416718,17780229,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@@H](C)C1CC1,,,CHEMBL3886836,,2016,"{'bei': '24.50', 'le': '0.45', 'lle': '5.42', 'sei': '10.71'}",CHEMBL3980483,,CHEMBL3980483,8.85,0,http://www.openphacts.org/units/Nanomolar,2887955,=,37,1,=,,IC50,nM,,1.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.4,PAK4
,416719,17780230,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H](C)C1CC1,,,CHEMBL3886836,,2016,"{'bei': '24.07', 'le': '0.44', 'lle': '5.27', 'sei': '10.52'}",CHEMBL3904800,,CHEMBL3904800,8.70,0,http://www.openphacts.org/units/Nanomolar,2887956,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,416720,17780231,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1CC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.27', 'le': '0.43', 'lle': '4.30', 'sei': '11.47'}",CHEMBL3975613,,CHEMBL3975613,8.11,0,http://www.openphacts.org/units/Nanomolar,2887957,=,37,1,=,,IC50,nM,,7.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.8,PAK4
,416721,17780232,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(Cc3ccc(Cl)cc3)CNC4=O)c2nc1N,,,CHEMBL3886836,,2016,"{'bei': '18.47', 'le': '0.35', 'lle': '3.48', 'sei': '7.98'}",CHEMBL3941086,,CHEMBL3941086,7.72,0,http://www.openphacts.org/units/Nanomolar,2887958,=,37,1,=,,IC50,nM,,19.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,19.1,PAK4
,416722,17780233,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CS(C)(=O)=O,,,CHEMBL3886836,,2016,"{'bei': '17.32', 'le': '0.34', 'lle': '4.95', 'sei': '6.34'}",CHEMBL3903730,,CHEMBL3903730,7.40,0,http://www.openphacts.org/units/Nanomolar,2887959,=,37,1,=,,IC50,nM,,39.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,39.5,PAK4
,416723,17780234,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '22.72', 'le': '0.42', 'lle': '5.17', 'sei': '9.03'}",CHEMBL3919294,,CHEMBL3919294,8.30,0,http://www.openphacts.org/units/Nanomolar,2887960,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,416724,17780235,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(CO)CC1,,,CHEMBL3886836,,2016,"{'bei': '25.86', 'le': '0.48', 'lle': '7.24', 'sei': '9.13'}",CHEMBL3891210,,CHEMBL3891210,9.40,0,http://www.openphacts.org/units/Nanomolar,2887961,=,37,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,416725,17780236,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC#CCC1CNC(=O)c2cc(-c3cccc4nc(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '19.87', 'le': '0.36', 'lle': '3.60', 'sei': '9.65'}",CHEMBL3931746,,CHEMBL3931746,7.98,0,http://www.openphacts.org/units/Nanomolar,2887962,=,37,1,=,,IC50,nM,,10.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.5,PAK4
,416726,17780237,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CCO,,,CHEMBL3886836,,2016,"{'bei': '23.72', 'le': '0.44', 'lle': '6.21', 'sei': '8.74'}",CHEMBL3918196,,CHEMBL3918196,9.00,0,http://www.openphacts.org/units/Nanomolar,2887963,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,416727,17780238,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC#CCC1CNC(=O)c2cc(-c3cccc4nc(C)c(F)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '17.66', 'le': '0.32', 'lle': '2.84', 'sei': '8.70'}",CHEMBL3897388,,CHEMBL3897388,6.15,0,http://www.openphacts.org/units/Nanomolar,2887964,=,37,1,=,,IC50,nM,,706.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,706.0,PAK4
,416728,17780239,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC1(C)COC1,,,CHEMBL3886836,,2016,"{'bei': '22.66', 'le': '0.42', 'lle': '5.88', 'sei': '9.30'}",CHEMBL3894496,,CHEMBL3894496,8.55,0,http://www.openphacts.org/units/Nanomolar,2887965,=,37,1,=,,IC50,nM,,2.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.8,PAK4
,416729,17780240,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C=O,,,CHEMBL3886836,,2016,"{'bei': '21.82', 'le': '0.40', 'lle': '5.00', 'sei': '7.95'}",CHEMBL3891942,,CHEMBL3891942,7.93,0,http://www.openphacts.org/units/Nanomolar,2887966,=,37,1,=,,IC50,nM,,11.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.8,PAK4
,416730,17780241,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2nccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '25.96', 'le': '0.48', 'lle': '6.28', 'sei': '9.52'}",CHEMBL3919994,,CHEMBL3919994,9.10,0,http://www.openphacts.org/units/Nanomolar,2887967,=,37,1,=,,IC50,nM,,0.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.8,PAK4
,416731,17780242,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N,,,CHEMBL3886836,,2016,"{'bei': '23.71', 'le': '0.44', 'lle': '5.61', 'sei': '7.64'}",CHEMBL3943301,,CHEMBL3943301,8.31,0,http://www.openphacts.org/units/Nanomolar,2887969,=,37,1,=,,IC50,nM,,4.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.9,PAK4
,416732,17780243,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2nccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '27.27', 'le': '0.50', 'lle': '6.74', 'sei': '10.00'}",CHEMBL3919994,,CHEMBL3919994,9.56,0,http://www.openphacts.org/units/Nanomolar,2887967,=,37,1,=,,IC50,nM,,0.278,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.278,PAK4
,416733,17780244,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2[nH]c1=O,,,CHEMBL3886836,,2016,"{'bei': '29.66', 'le': '0.55', 'lle': '8.01', 'sei': '10.15'}",CHEMBL3918907,,CHEMBL3918907,10.42,0,http://www.openphacts.org/units/Nanomolar,2887968,=,37,1,=,,IC50,nM,,0.0378,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.0378,PAK4
,416734,17780245,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '25.02', 'le': '0.46', 'lle': '5.61', 'sei': '10.94'}",CHEMBL3906357,,CHEMBL3906357,9.04,0,http://www.openphacts.org/units/Nanomolar,2887970,=,37,1,=,,IC50,nM,,0.902,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.902,PAK4
,416735,17780246,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N,,,CHEMBL3886836,,2016,"{'bei': '27.15', 'le': '0.50', 'lle': '6.82', 'sei': '8.75'}",CHEMBL3943301,,CHEMBL3943301,9.52,0,http://www.openphacts.org/units/Nanomolar,2887969,=,37,1,=,,IC50,nM,,0.305,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.305,PAK4
,416736,17780247,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)C,,,CHEMBL3886836,,2016,"{'bei': '26.19', 'le': '0.48', 'lle': '5.23', 'sei': '10.62'}",CHEMBL3934338,,CHEMBL3934338,8.79,0,http://www.openphacts.org/units/Nanomolar,2887971,=,37,1,=,,IC50,nM,,1.64,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.64,PAK4
,416737,17780248,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C[C@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.12', 'le': '0.43', 'lle': '4.58', 'sei': '10.16'}",CHEMBL3930939,,CHEMBL3930939,8.40,0,http://www.openphacts.org/units/Nanomolar,2887972,=,37,1,=,,IC50,nM,,3.96,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.96,PAK4
,416738,17780249,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C[C@@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.31', 'le': '0.43', 'lle': '4.65', 'sei': '10.24'}",CHEMBL3959102,,CHEMBL3959102,8.47,0,http://www.openphacts.org/units/Nanomolar,2887973,=,37,1,=,,IC50,nM,,3.37,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.37,PAK4
,416739,17780250,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(n3C(=O)OC(C)(C)C)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '16.56', 'le': '0.31', 'lle': '2.76', 'sei': '7.59'}",CHEMBL3985049,,CHEMBL3985049,7.45,0,http://www.openphacts.org/units/Nanomolar,2887974,=,37,1,=,,IC50,nM,,35.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,35.8,PAK4
,416740,17780251,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCN(C(=O)OC(C)(C)C)C4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '15.98', 'le': '0.30', 'lle': '2.11', 'sei': '7.17'}",CHEMBL3913905,,CHEMBL3913905,7.19,0,http://www.openphacts.org/units/Nanomolar,2887975,=,37,1,=,,IC50,nM,,65.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,65.2,PAK4
,416741,17780252,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=S)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.52', 'le': '0.45', 'lle': '4.64', 'sei': '13.10'}",CHEMBL3934590,,CHEMBL3934590,8.60,0,http://www.openphacts.org/units/Nanomolar,2887976,=,37,1,=,,IC50,nM,,2.54,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.54,PAK4
,416742,17780253,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NCC(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '21.90', 'le': '0.42', 'lle': '4.51', 'sei': '9.94'}",CHEMBL3965960,,CHEMBL3965960,8.22,0,http://www.openphacts.org/units/Nanomolar,2887977,=,37,1,=,,IC50,nM,,6.02,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.02,PAK4
,416743,17780254,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NCC(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '23.05', 'le': '0.44', 'lle': '4.94', 'sei': '10.46'}",CHEMBL3903517,,CHEMBL3903517,8.65,0,http://www.openphacts.org/units/Nanomolar,2887978,=,37,1,=,,IC50,nM,,2.23,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.23,PAK4
,416744,17780255,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.47', 'le': '0.45', 'lle': '5.26', 'sei': '11.23'}",CHEMBL3974455,,CHEMBL3974455,9.28,0,http://www.openphacts.org/units/Nanomolar,2887979,=,37,1,=,,IC50,nM,,0.52,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.52,PAK4
,416745,17780256,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '26.32', 'le': '0.49', 'lle': '5.77', 'sei': '11.25'}",CHEMBL3944136,,CHEMBL3944136,9.30,0,http://www.openphacts.org/units/Nanomolar,2887980,=,37,1,=,,IC50,nM,,0.501,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.501,PAK4
,416746,17780257,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '27.11', 'le': '0.50', 'lle': '5.87', 'sei': '12.05'}",CHEMBL3979182,,CHEMBL3979182,9.96,0,http://www.openphacts.org/units/Nanomolar,2887981,=,37,1,=,,IC50,nM,,0.109,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.109,PAK4
,416747,17780258,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '26.39', 'le': '0.49', 'lle': '5.61', 'sei': '11.73'}",CHEMBL3940707,,CHEMBL3940707,9.70,0,http://www.openphacts.org/units/Nanomolar,2887982,=,37,1,=,,IC50,nM,,0.201,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.201,PAK4
,416748,17780259,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCN(CO)C4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '21.20', 'le': '0.39', 'lle': '4.96', 'sei': '8.55'}",CHEMBL3894660,,CHEMBL3894660,8.05,0,http://www.openphacts.org/units/Nanomolar,2887983,=,37,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,416749,17780260,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCN/C4=N/O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '21.73', 'le': '0.40', 'lle': '4.49', 'sei': '8.06'}",CHEMBL3934276,,CHEMBL3934276,7.92,0,http://www.openphacts.org/units/Nanomolar,2887984,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,416750,17780261,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NCC(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '24.13', 'le': '0.46', 'lle': '5.57', 'sei': '10.54'}",CHEMBL3961776,,CHEMBL3961776,8.72,0,http://www.openphacts.org/units/Nanomolar,2887985,=,37,1,=,,IC50,nM,,1.91,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.91,PAK4
,416751,17780262,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)CO,,,CHEMBL3886836,,2016,"{'bei': '24.19', 'le': '0.45', 'lle': '5.92', 'sei': '8.59'}",CHEMBL3939819,,CHEMBL3939819,8.84,0,http://www.openphacts.org/units/Nanomolar,2887986,=,37,1,=,,IC50,nM,,1.45,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.45,PAK4
,416752,17780263,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCCC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '25.35', 'le': '0.46', 'lle': '4.17', 'sei': '12.50'}",CHEMBL3901863,,CHEMBL3901863,8.83,0,http://www.openphacts.org/units/Nanomolar,2887987,=,37,1,=,,IC50,nM,,1.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.47,PAK4
,416753,17780264,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N,,,CHEMBL3886836,,2016,"{'bei': '26.73', 'le': '0.49', 'lle': '6.67', 'sei': '8.62'}",CHEMBL3943301,,CHEMBL3943301,9.37,0,http://www.openphacts.org/units/Nanomolar,2887969,=,37,1,=,,IC50,nM,,0.429,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.429,PAK4
,416754,17780265,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '22.26', 'le': '0.41', 'lle': '4.27', 'sei': '9.78'}",CHEMBL3907325,,CHEMBL3907325,8.09,1,http://www.openphacts.org/units/Nanomolar,2887988,=,37,1,=,,IC50,nM,,8.14,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.14,PAK4
,416755,17780266,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1CO,,,CHEMBL3886836,,2016,"{'bei': '23.66', 'le': '0.44', 'lle': '6.04', 'sei': '8.40'}",CHEMBL3891786,,CHEMBL3891786,8.65,0,http://www.openphacts.org/units/Nanomolar,2887989,=,37,1,=,,IC50,nM,,2.26,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.26,PAK4
,416756,17780267,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C#Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.59', 'le': '0.45', 'lle': '5.74', 'sei': '10.69'}",CHEMBL3929651,,CHEMBL3929651,8.84,0,http://www.openphacts.org/units/Nanomolar,2887990,=,37,1,=,,IC50,nM,,1.45,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.45,PAK4
,416757,17780268,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1/C=N/O,,,CHEMBL3886836,,2016,"{'bei': '23.51', 'le': '0.43', 'lle': '5.97', 'sei': '7.72'}",CHEMBL3898395,,CHEMBL3898395,8.90,0,http://www.openphacts.org/units/Nanomolar,2887991,=,37,1,=,,IC50,nM,,1.27,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.27,PAK4
,416758,17780269,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C#N,,,CHEMBL3886836,,2016,"{'bei': '23.37', 'le': '0.43', 'lle': '5.43', 'sei': '7.91'}",CHEMBL3926451,,CHEMBL3926451,8.43,0,http://www.openphacts.org/units/Nanomolar,2887992,=,37,1,=,,IC50,nM,,3.76,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.76,PAK4
,416759,17780270,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](O)c1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '22.46', 'le': '0.42', 'lle': '5.35', 'sei': '8.28'}",CHEMBL3923557,,CHEMBL3923557,8.52,0,http://www.openphacts.org/units/Nanomolar,2887993,=,37,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
,416760,17780271,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](O)c1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '22.95', 'le': '0.42', 'lle': '5.54', 'sei': '8.46'}",CHEMBL3899014,,CHEMBL3899014,8.71,0,http://www.openphacts.org/units/Nanomolar,2887994,=,37,1,=,,IC50,nM,,1.95,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.95,PAK4
,416761,17780272,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '26.71', 'le': '0.49', 'lle': '6.03', 'sei': '11.74'}",CHEMBL3914535,,CHEMBL3914535,9.71,0,http://www.openphacts.org/units/Nanomolar,2887995,=,37,1,=,,IC50,nM,,0.195,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.195,PAK4
,416762,17780273,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(n3C)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '22.19', 'le': '0.41', 'lle': '4.63', 'sei': '11.23'}",CHEMBL3984361,,CHEMBL3984361,8.07,0,http://www.openphacts.org/units/Nanomolar,2887996,=,37,1,=,,IC50,nM,,8.58,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.58,PAK4
,416763,17780274,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCc2[nH]c(-c3cccc4nc(C)c(NC(C)(C)C)nc34)cc2C1=O,,,CHEMBL3886836,,2016,"{'bei': '18.76', 'le': '0.35', 'lle': '3.65', 'sei': '8.07'}",CHEMBL3909184,,CHEMBL3909184,7.34,0,http://www.openphacts.org/units/Nanomolar,2887997,=,37,1,=,,IC50,nM,,45.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,45.4,PAK4
,416764,17780275,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(C)N(C(=O)OC(C)(C)C)C4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '15.85', 'le': '0.29', 'lle': '1.52', 'sei': '7.11'}",CHEMBL3946889,,CHEMBL3946889,7.12,0,http://www.openphacts.org/units/Nanomolar,2887998,=,37,1,=,,IC50,nM,,75.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,75.0,PAK4
,416765,17780276,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOCC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '18.49', 'le': '0.35', 'lle': '4.76', 'sei': '7.74'}",CHEMBL3971171,,CHEMBL3971171,7.83,0,http://www.openphacts.org/units/Nanomolar,2887999,=,37,1,=,,IC50,nM,,14.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,14.7,PAK4
,416766,17780277,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CC(S(C)(=O)=O)C1,,,CHEMBL3886836,,2016,"{'bei': '18.41', 'le': '0.36', 'lle': '6.12', 'sei': '7.01'}",CHEMBL3941570,,CHEMBL3941570,7.57,0,http://www.openphacts.org/units/Nanomolar,2888000,=,37,1,=,,IC50,nM,,26.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,26.7,PAK4
,416767,17780278,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N1CC(S(C)(=O)=O)C1,,,CHEMBL3886836,,2016,"{'bei': '15.96', 'le': '0.31', 'lle': '5.12', 'sei': '6.08'}",CHEMBL3941570,,CHEMBL3941570,6.57,0,http://www.openphacts.org/units/Nanomolar,2888000,=,37,1,=,,IC50,nM,,272.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,272.0,PAK4
,416768,17780279,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)c1ccccn1,,,CHEMBL3886836,,2016,"{'bei': '17.08', 'le': '0.31', 'lle': '3.02', 'sei': '7.12'}",CHEMBL3932604,,CHEMBL3932604,6.81,0,http://www.openphacts.org/units/Nanomolar,2888001,=,37,1,=,,IC50,nM,,156.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,156.0,PAK4
,416769,17780280,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)c1cnccn1,,,CHEMBL3886836,,2016,"{'bei': '16.99', 'le': '0.31', 'lle': '3.61', 'sei': '6.26'}",CHEMBL3908673,,CHEMBL3908673,6.79,0,http://www.openphacts.org/units/Nanomolar,2888002,=,37,1,=,,IC50,nM,,163.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,163.0,PAK4
,416770,17780281,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)c1ccncn1,,,CHEMBL3886836,,2016,"{'bei': '18.03', 'le': '0.33', 'lle': '4.02', 'sei': '6.64'}",CHEMBL3933088,,CHEMBL3933088,7.20,0,http://www.openphacts.org/units/Nanomolar,2888003,=,37,1,=,,IC50,nM,,62.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,62.7,PAK4
,416771,17780282,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '26.70', 'le': '0.49', 'lle': '5.77', 'sei': '11.67'}",CHEMBL3896124,,CHEMBL3896124,9.65,0,http://www.openphacts.org/units/Nanomolar,2888004,=,37,1,=,,IC50,nM,,0.223,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.223,PAK4
,416772,17780283,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '27.84', 'le': '0.51', 'lle': '6.38', 'sei': '11.63'}",CHEMBL3924143,,CHEMBL3924143,9.62,0,http://www.openphacts.org/units/Nanomolar,2888005,=,37,1,=,,IC50,nM,,0.242,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.242,PAK4
,416773,17780284,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '26.48', 'le': '0.49', 'lle': '5.30', 'sei': '11.19'}",CHEMBL3974543,,CHEMBL3974543,9.25,0,http://www.openphacts.org/units/Nanomolar,2888006,=,37,1,=,,IC50,nM,,0.559,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.559,PAK4
,416774,17780285,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.88', 'le': '0.46', 'lle': '4.74', 'sei': '10.51'}",CHEMBL3918714,,CHEMBL3918714,8.70,0,http://www.openphacts.org/units/Nanomolar,2888007,=,37,1,=,,IC50,nM,,2.02,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.02,PAK4
,416775,17780286,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '27.91', 'le': '0.51', 'lle': '6.00', 'sei': '11.73'}",CHEMBL3979954,,CHEMBL3979954,9.70,0,http://www.openphacts.org/units/Nanomolar,2888008,=,37,1,=,,IC50,nM,,0.201,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.201,PAK4
,416776,17780287,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '26.18', 'le': '0.48', 'lle': '5.78', 'sei': '11.38'}",CHEMBL3909785,,CHEMBL3909785,9.41,0,http://www.openphacts.org/units/Nanomolar,2888009,=,37,1,=,,IC50,nM,,0.39,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.39,PAK4
,416777,17780288,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.44', 'le': '0.45', 'lle': '5.30', 'sei': '10.80'}",CHEMBL3974046,,CHEMBL3974046,8.93,0,http://www.openphacts.org/units/Nanomolar,2888010,=,37,1,=,,IC50,nM,,1.17,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.17,PAK4
,416778,17780289,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NCC(F)F,,,CHEMBL3886836,,2016,"{'bei': '24.23', 'le': '0.45', 'lle': '5.61', 'sei': '10.82'}",CHEMBL3899535,,CHEMBL3899535,8.95,0,http://www.openphacts.org/units/Nanomolar,2888011,=,37,1,=,,IC50,nM,,1.12,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.12,PAK4
,416779,17780290,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=S)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.42', 'le': '0.45', 'lle': '4.08', 'sei': '13.04'}",CHEMBL3931370,,CHEMBL3931370,8.56,0,http://www.openphacts.org/units/Nanomolar,2888012,=,37,1,=,,IC50,nM,,2.76,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.76,PAK4
,416780,17780291,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '28.03', 'le': '0.51', 'lle': '6.04', 'sei': '11.77'}",CHEMBL3903402,,CHEMBL3903402,9.74,0,http://www.openphacts.org/units/Nanomolar,2888013,=,37,1,=,,IC50,nM,,0.183,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.183,PAK4
,416781,17780292,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '27.00', 'le': '0.49', 'lle': '5.66', 'sei': '10.95'}",CHEMBL3940411,,CHEMBL3940411,9.05,1,http://www.openphacts.org/units/Nanomolar,2888014,=,37,1,=,,IC50,nM,,0.882,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.882,PAK4
,416782,17780293,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '24.90', 'le': '0.46', 'lle': '5.57', 'sei': '10.88'}",CHEMBL3906357,,CHEMBL3906357,9.00,0,http://www.openphacts.org/units/Nanomolar,2887970,=,37,1,=,,IC50,nM,,0.996,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.996,PAK4
,416783,17780294,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NCC(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '23.66', 'le': '0.45', 'lle': '5.69', 'sei': '10.74'}",CHEMBL3916993,,CHEMBL3916993,8.88,0,http://www.openphacts.org/units/Nanomolar,2888015,=,37,1,=,,IC50,nM,,1.32,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.32,PAK4
,416784,17780295,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '23.55', 'le': '0.43', 'lle': '4.95', 'sei': '9.09'}",CHEMBL3986733,,CHEMBL3986733,7.26,0,http://www.openphacts.org/units/Nanomolar,2888016,=,37,1,=,,IC50,nM,,54.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,54.6,PAK4
,416785,17780296,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CCS(C)(=O)=O,,,CHEMBL3886836,,2016,"{'bei': '15.87', 'le': '0.31', 'lle': '4.17', 'sei': '6.00'}",CHEMBL3925989,,CHEMBL3925989,7.01,0,http://www.openphacts.org/units/Nanomolar,2888017,=,37,1,=,,IC50,nM,,98.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,98.6,PAK4
,416786,17780297,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CNC(=O)OC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '15.52', 'le': '0.29', 'lle': '3.28', 'sei': '5.96'}",CHEMBL3894442,,CHEMBL3894442,7.21,0,http://www.openphacts.org/units/Nanomolar,2888018,=,37,1,=,,IC50,nM,,61.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,61.8,PAK4
,416787,17780298,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1ccc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '26.78', 'le': '0.49', 'lle': '5.22', 'sei': '12.83'}",CHEMBL3897826,,CHEMBL3897826,8.96,0,http://www.openphacts.org/units/Nanomolar,2888019,=,37,1,=,,IC50,nM,,1.11,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.11,PAK4
,416788,17780299,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CN,,,CHEMBL3886836,,2016,"{'bei': '21.87', 'le': '0.40', 'lle': '5.60', 'sei': '7.33'}",CHEMBL3969013,,CHEMBL3969013,7.97,0,http://www.openphacts.org/units/Nanomolar,2888020,=,37,1,=,,IC50,nM,,10.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.7,PAK4
,416789,17780300,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CNCCS(C)(=O)=O,,,CHEMBL3886836,,2016,"{'bei': '16.34', 'le': '0.32', 'lle': '5.65', 'sei': '5.97'}",CHEMBL3979464,,CHEMBL3979464,7.69,0,http://www.openphacts.org/units/Nanomolar,2888021,=,37,1,=,,IC50,nM,,20.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.4,PAK4
,416790,17780301,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1F,,,CHEMBL3886836,,2016,"{'bei': '24.21', 'le': '0.45', 'lle': '5.30', 'sei': '10.35'}",CHEMBL3909227,,CHEMBL3909227,8.56,0,http://www.openphacts.org/units/Nanomolar,2888022,=,37,1,=,,IC50,nM,,2.78,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.78,PAK4
,416791,17780302,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CNc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '22.64', 'le': '0.42', 'lle': '5.09', 'sei': '8.71'}",CHEMBL3893675,,CHEMBL3893675,8.25,0,http://www.openphacts.org/units/Nanomolar,2888023,=,37,1,=,,IC50,nM,,5.61,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.61,PAK4
,416792,17780303,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1Cl,,,CHEMBL3886836,,2016,"{'bei': '23.38', 'le': '0.45', 'lle': '4.88', 'sei': '10.46'}",CHEMBL3918158,,CHEMBL3918158,8.65,0,http://www.openphacts.org/units/Nanomolar,2888024,=,37,1,=,,IC50,nM,,2.25,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.25,PAK4
,416793,17780304,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N1CC(O)C1,,,CHEMBL3886836,,2016,"{'bei': '19.60', 'le': '0.36', 'lle': '5.67', 'sei': '7.50'}",CHEMBL3966109,,CHEMBL3966109,7.97,0,http://www.openphacts.org/units/Nanomolar,2888025,=,37,1,=,,IC50,nM,,10.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.8,PAK4
,416794,17780305,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1N1CCC1,,,CHEMBL3886836,,2016,"{'bei': '20.43', 'le': '0.38', 'lle': '4.65', 'sei': '9.28'}",CHEMBL3894757,,CHEMBL3894757,7.98,0,http://www.openphacts.org/units/Nanomolar,2888026,=,37,1,=,,IC50,nM,,10.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.5,PAK4
,416795,17780306,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)NCC4)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.34', 'le': '0.47', 'lle': '5.26', 'sei': '11.30'}",CHEMBL3971342,,CHEMBL3971342,9.34,0,http://www.openphacts.org/units/Nanomolar,2888027,=,37,1,=,,IC50,nM,,0.454,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.454,PAK4
,416796,17780307,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3[nH]c4c(c3Br)C(=O)NCC4)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '21.15', 'le': '0.46', 'lle': '4.87', 'sei': '10.95'}",CHEMBL3964367,,CHEMBL3964367,9.06,0,http://www.openphacts.org/units/Nanomolar,2888028,=,37,1,=,,IC50,nM,,0.874,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.874,PAK4
,416797,17780308,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3[nH]c4c(c3C)C(=O)NCC4)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.31', 'le': '0.43', 'lle': '4.73', 'sei': '10.24'}",CHEMBL3986680,,CHEMBL3986680,8.47,0,http://www.openphacts.org/units/Nanomolar,2888029,=,37,1,=,,IC50,nM,,3.38,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.38,PAK4
,416798,17780309,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COC1=NCCc2[nH]c(-c3cccc4nc(C)c(NC(C)(C)C)nc34)cc21,,,CHEMBL3886836,,2016,"{'bei': '22.15', 'le': '0.41', 'lle': '3.96', 'sei': '10.71'}",CHEMBL3916951,,CHEMBL3916951,8.05,0,http://www.openphacts.org/units/Nanomolar,2888030,=,37,1,=,,IC50,nM,,8.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.9,PAK4
,416799,17780310,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@H]([C@@H](C)O)NC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '22.58', 'le': '0.42', 'lle': '5.80', 'sei': '8.37'}",CHEMBL3918771,,CHEMBL3918771,8.61,0,http://www.openphacts.org/units/Nanomolar,2888031,=,37,1,=,,IC50,nM,,2.45,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.45,PAK4
,416800,17780311,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@@H]([C@H](C)O)NC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '22.65', 'le': '0.42', 'lle': '5.83', 'sei': '8.39'}",CHEMBL3939783,,CHEMBL3939783,8.64,0,http://www.openphacts.org/units/Nanomolar,2888032,=,37,1,=,,IC50,nM,,2.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.3,PAK4
,416801,17780312,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@H]([C@@H](C)O)NC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '20.41', 'le': '0.38', 'lle': '4.98', 'sei': '7.56'}",CHEMBL3918771,,CHEMBL3918771,7.79,0,http://www.openphacts.org/units/Nanomolar,2888031,=,37,1,=,,IC50,nM,,16.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.4,PAK4
,416802,17780313,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(COCc3ccccc3)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '19.25', 'le': '0.35', 'lle': '3.83', 'sei': '9.50'}",CHEMBL3934242,,CHEMBL3934242,8.73,0,http://www.openphacts.org/units/Nanomolar,2888033,=,37,1,=,,IC50,nM,,1.86,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.86,PAK4
,416803,17780314,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '27.73', 'le': '0.50', 'lle': '6.10', 'sei': '11.18'}",CHEMBL3957073,,CHEMBL3957073,9.24,0,http://www.openphacts.org/units/Nanomolar,2888034,=,37,1,=,,IC50,nM,,0.57,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.57,PAK4
,416804,17780315,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)NC4)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '27.47', 'le': '0.53', 'lle': '6.32', 'sei': '12.22'}",CHEMBL3933056,,CHEMBL3933056,10.11,0,http://www.openphacts.org/units/Nanomolar,2888035,=,37,1,=,,IC50,nM,,0.0783,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.0783,PAK4
,416805,17780316,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(CO)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '24.39', 'le': '0.45', 'lle': '6.19', 'sei': '8.61'}",CHEMBL3948398,,CHEMBL3948398,8.86,0,http://www.openphacts.org/units/Nanomolar,2888036,=,37,1,=,,IC50,nM,,1.37,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.37,PAK4
,416806,17780317,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](CO)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '25.52', 'le': '0.47', 'lle': '6.61', 'sei': '9.01'}",CHEMBL3920600,,CHEMBL3920600,9.28,0,http://www.openphacts.org/units/Nanomolar,2888037,=,37,1,=,,IC50,nM,,0.53,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.53,PAK4
,416807,17780318,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](CO)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '24.05', 'le': '0.44', 'lle': '6.07', 'sei': '8.49'}",CHEMBL3935312,,CHEMBL3935312,8.74,0,http://www.openphacts.org/units/Nanomolar,2888038,=,37,1,=,,IC50,nM,,1.82,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.82,PAK4
,416808,17780319,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '29.83', 'le': '0.54', 'lle': '6.78', 'sei': '11.52'}",CHEMBL3903837,,CHEMBL3903837,9.53,0,http://www.openphacts.org/units/Nanomolar,2888039,=,37,1,=,,IC50,nM,,0.297,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.297,PAK4
,416809,17780320,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(COCc3ccccc3)NC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '19.71', 'le': '0.36', 'lle': '4.15', 'sei': '9.42'}",CHEMBL3933159,,CHEMBL3933159,8.66,0,http://www.openphacts.org/units/Nanomolar,2888040,=,37,1,=,,IC50,nM,,2.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.18,PAK4
,416810,17780321,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(CO)NC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '27.69', 'le': '0.51', 'lle': '7.39', 'sei': '9.40'}",CHEMBL3905144,,CHEMBL3905144,9.67,0,http://www.openphacts.org/units/Nanomolar,2888041,=,37,1,=,,IC50,nM,,0.212,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.212,PAK4
,416811,17780322,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](CO)NC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '27.91', 'le': '0.51', 'lle': '7.47', 'sei': '9.47'}",CHEMBL3942145,,CHEMBL3942145,9.75,0,http://www.openphacts.org/units/Nanomolar,2888042,=,37,1,=,,IC50,nM,,0.177,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.177,PAK4
,416812,17780323,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](CO)NC4=O)c2nc1NC1CC1,,,CHEMBL3886836,,2016,"{'bei': '24.14', 'le': '0.44', 'lle': '6.15', 'sei': '8.19'}",CHEMBL3917695,,CHEMBL3917695,8.43,0,http://www.openphacts.org/units/Nanomolar,2888043,=,37,1,=,,IC50,nM,,3.68,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.68,PAK4
,416813,17780324,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccnc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '21.32', 'le': '0.39', 'lle': '4.65', 'sei': '7.82'}",CHEMBL3918795,,CHEMBL3918795,7.47,0,http://www.openphacts.org/units/Nanomolar,2888044,=,37,1,=,,IC50,nM,,33.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,33.7,PAK4
,416814,17780325,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '26.79', 'le': '0.50', 'lle': '6.47', 'sei': '11.84'}",CHEMBL3890727,,CHEMBL3890727,9.79,0,http://www.openphacts.org/units/Nanomolar,2888045,=,37,1,=,,IC50,nM,,0.162,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.162,PAK4
,416815,17780326,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CO,,,CHEMBL3886836,,2016,"{'bei': '24.95', 'le': '0.47', 'lle': '7.03', 'sei': '9.29'}",CHEMBL3927716,,CHEMBL3927716,9.56,0,http://www.openphacts.org/units/Nanomolar,2888046,=,37,1,=,,IC50,nM,,0.272,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.272,PAK4
,416816,17780327,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c(=O)[nH]ccc4[nH]3)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '27.85', 'le': '0.51', 'lle': '6.06', 'sei': '11.77'}",CHEMBL3896195,,CHEMBL3896195,10.18,0,http://www.openphacts.org/units/Nanomolar,2888047,=,37,1,=,,IC50,nM,,0.0667,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.0667,PAK4
,416817,17780328,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(-c2nc3cccc(-c4cc5c([nH]4)CCNC5=O)c3nc2NC(C)(C)C)o1,,,CHEMBL3886836,,2016,"{'bei': '17.07', 'le': '0.31', 'lle': '3.65', 'sei': '5.86'}",CHEMBL3950282,,CHEMBL3950282,7.13,0,http://www.openphacts.org/units/Nanomolar,2888048,=,37,1,=,,IC50,nM,,74.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,74.8,PAK4
,416818,17780329,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.87', 'le': '0.46', 'lle': '5.61', 'sei': '10.63'}",CHEMBL3970766,,CHEMBL3970766,8.79,0,http://www.openphacts.org/units/Nanomolar,2888049,=,37,1,=,,IC50,nM,,1.63,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.63,PAK4
,416819,17780330,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1ncc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '25.17', 'le': '0.46', 'lle': '5.32', 'sei': '10.21'}",CHEMBL3972296,,CHEMBL3972296,8.44,0,http://www.openphacts.org/units/Nanomolar,2888050,=,37,1,=,,IC50,nM,,3.62,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.62,PAK4
,416820,17780331,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)c(F)ccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '25.06', 'le': '0.47', 'lle': '5.60', 'sei': '11.56'}",CHEMBL3897606,,CHEMBL3897606,9.56,0,http://www.openphacts.org/units/Nanomolar,2888051,=,37,1,=,,IC50,nM,,0.275,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.275,PAK4
,416821,17780332,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC1(C)CCC1,,,CHEMBL3886836,,2016,"{'bei': '26.00', 'le': '0.48', 'lle': '6.16', 'sei': '11.93'}",CHEMBL3957722,,CHEMBL3957722,9.87,0,http://www.openphacts.org/units/Nanomolar,2888052,=,37,1,=,,IC50,nM,,0.136,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.136,PAK4
,416822,17780333,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CN(c1ncc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1)C(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.26', 'le': '0.45', 'lle': '5.33', 'sei': '11.47'}",CHEMBL3982591,,CHEMBL3982591,8.48,0,http://www.openphacts.org/units/Nanomolar,2888053,=,37,1,=,,IC50,nM,,3.32,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.32,PAK4
,416823,17780334,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '27.69', 'le': '0.51', 'lle': '6.68', 'sei': '12.64'}",CHEMBL3949102,,CHEMBL3949102,10.45,0,http://www.openphacts.org/units/Nanomolar,2888054,=,37,1,=,,IC50,nM,,0.0354,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.0354,PAK4
,416824,17780335,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '28.23', 'le': '0.52', 'lle': '6.48', 'sei': '12.47'}",CHEMBL3949318,,CHEMBL3949318,10.32,0,http://www.openphacts.org/units/Nanomolar,2888055,=,37,1,=,,IC50,nM,,0.0484,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.0484,PAK4
,416825,17780336,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '25.76', 'le': '0.48', 'lle': '5.57', 'sei': '11.38'}",CHEMBL3943763,,CHEMBL3943763,9.41,0,http://www.openphacts.org/units/Nanomolar,2888056,=,37,1,=,,IC50,nM,,0.385,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.385,PAK4
,416826,17780337,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NCC(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '22.89', 'le': '0.43', 'lle': '5.23', 'sei': '10.72'}",CHEMBL3973280,,CHEMBL3973280,8.87,0,http://www.openphacts.org/units/Nanomolar,2888057,=,37,1,=,,IC50,nM,,1.36,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.36,PAK4
,416827,17780338,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NCC(F)F,,,CHEMBL3886836,,2016,"{'bei': '26.89', 'le': '0.50', 'lle': '6.20', 'sei': '11.62'}",CHEMBL3937161,,CHEMBL3937161,9.61,0,http://www.openphacts.org/units/Nanomolar,2888058,=,37,1,=,,IC50,nM,,0.246,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.246,PAK4
,416828,17780339,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NCC(F)F,,,CHEMBL3886836,,2016,"{'bei': '23.34', 'le': '0.44', 'lle': '4.93', 'sei': '10.08'}",CHEMBL3961097,,CHEMBL3961097,8.34,0,http://www.openphacts.org/units/Nanomolar,2888059,=,37,1,=,,IC50,nM,,4.57,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.57,PAK4
,416829,17780340,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(C)c1-c1cnc2cccc(-c3cc4c([nH]3)CCNC4=O)c2n1,,,CHEMBL3886836,,2016,"{'bei': '20.24', 'le': '0.36', 'lle': '3.27', 'sei': '10.55'}",CHEMBL3916586,,CHEMBL3916586,7.46,0,http://www.openphacts.org/units/Nanomolar,2888060,=,37,1,=,,IC50,nM,,34.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.9,PAK4
,416830,17780341,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1-c1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '19.91', 'le': '0.36', 'lle': '4.74', 'sei': '8.97'}",CHEMBL3892102,,CHEMBL3892102,8.23,0,http://www.openphacts.org/units/Nanomolar,2888061,=,37,1,=,,IC50,nM,,5.87,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.87,PAK4
,416831,17780342,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1-c1cccnc1,,,CHEMBL3886836,,2016,"{'bei': '18.78', 'le': '0.34', 'lle': '4.91', 'sei': '7.44'}",CHEMBL3907606,,CHEMBL3907606,7.79,0,http://www.openphacts.org/units/Nanomolar,2888062,=,37,1,=,,IC50,nM,,16.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,16.4,PAK4
,416832,17780343,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1-c1cccnc1,,,CHEMBL3886836,,2016,"{'bei': '20.04', 'le': '0.37', 'lle': '5.32', 'sei': '8.20'}",CHEMBL3978132,,CHEMBL3978132,8.59,0,http://www.openphacts.org/units/Nanomolar,2888063,=,37,1,=,,IC50,nM,,2.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.6,PAK4
,416833,17780344,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '28.48', 'le': '0.53', 'lle': '7.84', 'sei': '11.90'}",CHEMBL3902148,,CHEMBL3902148,10.92,0,http://www.openphacts.org/units/Nanomolar,2888064,=,37,1,=,,IC50,nM,,0.012,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.012,PAK4
,416834,17780345,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)n1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '27.75', 'le': '0.51', 'lle': '6.93', 'sei': '11.90'}",CHEMBL3940091,,CHEMBL3940091,10.92,0,http://www.openphacts.org/units/Nanomolar,2888065,=,37,1,=,,IC50,nM,,0.012,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.012,PAK4
,416835,17780346,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)[nH]c(N(C)C(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '25.72', 'le': '0.48', 'lle': '6.44', 'sei': '10.01'}",CHEMBL3962064,,CHEMBL3962064,9.40,0,http://www.openphacts.org/units/Nanomolar,2888066,=,37,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,416836,17780347,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)[nH]c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '27.37', 'le': '0.51', 'lle': '6.69', 'sei': '9.37'}",CHEMBL3934565,,CHEMBL3934565,9.62,0,http://www.openphacts.org/units/Nanomolar,2888067,=,37,1,=,,IC50,nM,,0.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.24,PAK4
,416837,17780348,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CCOCC3)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '17.76', 'le': '0.33', 'lle': '3.31', 'sei': '7.84'}",CHEMBL3949896,,CHEMBL3949896,7.20,0,http://www.openphacts.org/units/Nanomolar,2888068,=,37,1,=,,IC50,nM,,62.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,62.6,PAK4
,416838,17780349,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1cccnc1Cl,,,CHEMBL3886836,,2016,"{'bei': '17.26', 'le': '0.33', 'lle': '2.80', 'sei': '8.05'}",CHEMBL3925684,,CHEMBL3925684,6.73,0,http://www.openphacts.org/units/Nanomolar,2888069,=,37,1,=,,IC50,nM,,187.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,187.0,PAK4
,416839,17780350,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccncc1Cl,,,CHEMBL3886836,,2016,"{'bei': '16.98', 'le': '0.32', 'lle': '2.69', 'sei': '7.92'}",CHEMBL3933867,,CHEMBL3933867,6.62,0,http://www.openphacts.org/units/Nanomolar,2888070,=,37,1,=,,IC50,nM,,239.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,239.0,PAK4
,416840,17780351,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1cnccc1Cl,,,CHEMBL3886836,,2016,"{'bei': '18.43', 'le': '0.35', 'lle': '3.25', 'sei': '8.60'}",CHEMBL3961358,,CHEMBL3961358,7.18,0,http://www.openphacts.org/units/Nanomolar,2888071,=,37,1,=,,IC50,nM,,65.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,65.6,PAK4
,416841,17780352,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccc(N)cc1Cl,,,CHEMBL3886836,,2016,"{'bei': '18.51', 'le': '0.35', 'lle': '3.36', 'sei': '7.73'}",CHEMBL3939400,,CHEMBL3939400,7.48,0,http://www.openphacts.org/units/Nanomolar,2888072,=,37,1,=,,IC50,nM,,33.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,33.4,PAK4
,416842,17780353,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1c(F)cccc1Cl,,,CHEMBL3886836,,2016,"{'bei': '18.79', 'le': '0.36', 'lle': '2.97', 'sei': '10.82'}",CHEMBL3901445,,CHEMBL3901445,7.65,0,http://www.openphacts.org/units/Nanomolar,2888073,=,37,1,=,,IC50,nM,,22.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.6,PAK4
,416843,17780354,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c(=O)n1-c1ccccn1,,,CHEMBL3886836,,2016,"{'bei': '18.17', 'le': '0.33', 'lle': '4.65', 'sei': '7.19'}",CHEMBL3977535,,CHEMBL3977535,7.53,0,http://www.openphacts.org/units/Nanomolar,2888074,=,37,1,=,,IC50,nM,,29.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.4,PAK4
,416844,17780355,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(=O)[nH]nc(C)c4[nH]3)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '21.52', 'le': '0.39', 'lle': '4.11', 'sei': '7.85'}",CHEMBL3906911,,CHEMBL3906911,7.80,0,http://www.openphacts.org/units/Nanomolar,2888075,=,37,1,=,,IC50,nM,,15.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.8,PAK4
,416845,17780356,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc(C(N)=O)c(C)[nH]3)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '23.91', 'le': '0.44', 'lle': '5.01', 'sei': '8.74'}",CHEMBL3891362,,CHEMBL3891362,8.45,0,http://www.openphacts.org/units/Nanomolar,2888076,=,37,1,=,,IC50,nM,,3.56,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.56,PAK4
,416846,17780357,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc(C(N)=O)c(C4CC4)[nH]3)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '22.31', 'le': '0.41', 'lle': '3.99', 'sei': '8.39'}",CHEMBL3915882,,CHEMBL3915882,8.11,0,http://www.openphacts.org/units/Nanomolar,2888077,=,37,1,=,,IC50,nM,,7.79,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.79,PAK4
,416847,17780358,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)CNC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '27.64', 'le': '0.51', 'lle': '7.33', 'sei': '10.58'}",CHEMBL3897988,,CHEMBL3897988,9.71,0,http://www.openphacts.org/units/Nanomolar,2888078,=,37,1,=,,IC50,nM,,0.193,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.193,PAK4
,416848,17780359,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3c[nH]c(C(N)=O)c3)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.06', 'le': '0.42', 'lle': '4.22', 'sei': '7.71'}",CHEMBL3926062,,CHEMBL3926062,7.46,0,http://www.openphacts.org/units/Nanomolar,2888079,=,37,1,=,,IC50,nM,,34.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,34.8,PAK4
,416849,17780360,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(c3)C(=O)NC4)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '20.05', 'le': '0.37', 'lle': '3.03', 'sei': '9.36'}",CHEMBL3940085,,CHEMBL3940085,6.72,0,http://www.openphacts.org/units/Nanomolar,2888080,=,37,1,=,,IC50,nM,,189.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,189.0,PAK4
,416850,17780361,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(c3)C(=O)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '21.27', 'le': '0.39', 'lle': '4.10', 'sei': '8.36'}",CHEMBL3912094,,CHEMBL3912094,7.43,0,http://www.openphacts.org/units/Nanomolar,2888081,=,37,1,=,,IC50,nM,,37.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,37.1,PAK4
,416851,17780362,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(=O)[nH]ncc4[nH]3)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.20', 'le': '0.44', 'lle': '5.05', 'sei': '8.49'}",CHEMBL3953807,,CHEMBL3953807,8.43,0,http://www.openphacts.org/units/Nanomolar,2888082,=,37,1,=,,IC50,nM,,3.71,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.71,PAK4
,416852,17780363,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '19.99', 'le': '0.36', 'lle': '3.20', 'sei': '10.03'}",CHEMBL3917533,,CHEMBL3917533,7.09,0,http://www.openphacts.org/units/Nanomolar,2888083,=,37,1,=,,IC50,nM,,82.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,82.1,PAK4
,416853,17780364,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1Cl,,,CHEMBL3886836,,2016,"{'bei': '20.09', 'le': '0.39', 'lle': '3.41', 'sei': '8.89'}",CHEMBL3954143,,CHEMBL3954143,6.28,0,http://www.openphacts.org/units/Nanomolar,2888084,=,37,1,=,,IC50,nM,,521.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,521.0,PAK4
,416854,17780365,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '18.72', 'le': '0.34', 'lle': '2.71', 'sei': '9.76'}",CHEMBL3926513,,CHEMBL3926513,6.90,0,http://www.openphacts.org/units/Nanomolar,2888085,=,37,1,=,,IC50,nM,,127.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,127.0,PAK4
,416855,17780366,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccccc1Cl,,,CHEMBL3886836,,2016,"{'bei': '18.22', 'le': '0.35', 'lle': '2.55', 'sei': '10.03'}",CHEMBL3962883,,CHEMBL3962883,7.09,0,http://www.openphacts.org/units/Nanomolar,2888086,=,37,1,=,,IC50,nM,,82.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,82.0,PAK4
,416856,17780367,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccccc1F,,,CHEMBL3886836,,2016,"{'bei': '19.67', 'le': '0.36', 'lle': '3.29', 'sei': '10.36'}",CHEMBL3938995,,CHEMBL3938995,7.32,0,http://www.openphacts.org/units/Nanomolar,2888087,=,37,1,=,,IC50,nM,,47.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,47.4,PAK4
,416857,17780368,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccccn1,,,CHEMBL3886836,,2016,"{'bei': '19.07', 'le': '0.34', 'lle': '3.50', 'sei': '8.11'}",CHEMBL3974890,,CHEMBL3974890,6.78,0,http://www.openphacts.org/units/Nanomolar,2888088,=,37,1,=,,IC50,nM,,167.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,167.0,PAK4
,416858,17780369,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccnc1-c1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '17.84', 'le': '0.32', 'lle': '3.00', 'sei': '7.89'}",CHEMBL3945507,,CHEMBL3945507,6.59,0,http://www.openphacts.org/units/Nanomolar,2888089,=,37,1,=,,IC50,nM,,257.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,257.0,PAK4
,416859,17780370,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccoc1,,,CHEMBL3886836,,2016,"{'bei': '20.93', 'le': '0.38', 'lle': '3.73', 'sei': '8.60'}",CHEMBL3943059,,CHEMBL3943059,7.21,0,http://www.openphacts.org/units/Nanomolar,2888090,=,37,1,=,,IC50,nM,,61.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,61.9,PAK4
,416860,17780371,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1nccn1C,,,CHEMBL3886836,,2016,"{'bei': '18.45', 'le': '0.33', 'lle': '3.99', 'sei': '7.47'}",CHEMBL3975814,,CHEMBL3975814,6.61,0,http://www.openphacts.org/units/Nanomolar,2888091,=,37,1,=,,IC50,nM,,244.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,244.0,PAK4
,416861,17780372,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1-c1ccoc1C,,,CHEMBL3886836,,2016,"{'bei': '20.61', 'le': '0.37', 'lle': '3.60', 'sei': '8.82'}",CHEMBL3937682,,CHEMBL3937682,7.39,0,http://www.openphacts.org/units/Nanomolar,2888092,=,37,1,=,,IC50,nM,,40.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,40.9,PAK4
,416862,17780373,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](NC(=O)OC(C)(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '16.79', 'le': '0.31', 'lle': '4.07', 'sei': '6.42'}",CHEMBL3967337,,CHEMBL3967337,7.76,0,http://www.openphacts.org/units/Nanomolar,2888093,=,37,1,=,,IC50,nM,,17.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.2,PAK4
,416863,17780374,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '26.27', 'le': '0.48', 'lle': '7.40', 'sei': '8.76'}",CHEMBL3966363,,CHEMBL3966363,9.52,0,http://www.openphacts.org/units/Nanomolar,2888094,=,37,1,=,,IC50,nM,,0.301,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.301,PAK4
,416864,17780375,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@H](NC(=O)OC(C)(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '17.48', 'le': '0.32', 'lle': '4.40', 'sei': '6.68'}",CHEMBL3891457,,CHEMBL3891457,8.09,0,http://www.openphacts.org/units/Nanomolar,2888095,=,37,1,=,,IC50,nM,,8.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.2,PAK4
,416865,17780376,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '25.93', 'le': '0.48', 'lle': '7.28', 'sei': '8.64'}",CHEMBL3928595,,CHEMBL3928595,9.40,0,http://www.openphacts.org/units/Nanomolar,2888096,=,37,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,416866,17780377,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1-c1ccccc1,,,CHEMBL3886836,,2016,"{'bei': '19.25', 'le': '0.35', 'lle': '3.13', 'sei': '9.58'}",CHEMBL3980680,,CHEMBL3980680,7.92,0,http://www.openphacts.org/units/Nanomolar,2888097,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,416867,17780378,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](O)C1,,,CHEMBL3886836,,2016,"{'bei': '24.36', 'le': '0.45', 'lle': '6.70', 'sei': '8.60'}",CHEMBL3977692,,CHEMBL3977692,8.85,0,http://www.openphacts.org/units/Nanomolar,2888098,=,37,1,=,,IC50,nM,,1.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.4,PAK4
,416868,17780379,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](NCCS(C)(=O)=O)C1,,,CHEMBL3886836,,2016,"{'bei': '18.96', 'le': '0.37', 'lle': '7.09', 'sei': '6.90'}",CHEMBL3918797,,CHEMBL3918797,8.89,0,http://www.openphacts.org/units/Nanomolar,2888099,=,37,1,=,,IC50,nM,,1.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.3,PAK4
,416869,17780380,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@H](O)C1,,,CHEMBL3886836,,2016,"{'bei': '24.11', 'le': '0.44', 'lle': '6.61', 'sei': '8.51'}",CHEMBL3974822,,CHEMBL3974822,8.76,0,http://www.openphacts.org/units/Nanomolar,2888100,=,37,1,=,,IC50,nM,,1.73,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.73,PAK4
,416870,17780381,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2nc1C,,,CHEMBL3886836,,2016,"{'bei': '22.95', 'le': '0.42', 'lle': '5.52', 'sei': '7.71'}",CHEMBL3941979,,CHEMBL3941979,7.70,0,http://www.openphacts.org/units/Nanomolar,2888101,=,37,1,=,,IC50,nM,,20.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,20.1,PAK4
,416871,17780382,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(=O)C1CC1,,,CHEMBL3886836,,2016,"{'bei': '19.04', 'le': '0.35', 'lle': '4.31', 'sei': '6.90'}",CHEMBL3966323,,CHEMBL3966323,6.88,0,http://www.openphacts.org/units/Nanomolar,2888102,=,37,1,=,,IC50,nM,,131.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,131.0,PAK4
,416872,17780383,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(=N)N,,,CHEMBL3886836,,2016,"{'bei': '20.45', 'le': '0.37', 'lle': '5.34', 'sei': '5.17'}",CHEMBL3936529,,CHEMBL3936529,6.86,0,http://www.openphacts.org/units/Nanomolar,2888103,=,37,1,=,,IC50,nM,,139.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,139.0,PAK4
,416873,17780384,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)CCNC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '26.74', 'le': '0.49', 'lle': '7.35', 'sei': '10.64'}",CHEMBL3890346,,CHEMBL3890346,9.77,0,http://www.openphacts.org/units/Nanomolar,2888104,=,37,1,=,,IC50,nM,,0.169,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.169,PAK4
,416874,17780385,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(NC(C)(C)C)nc2c(-c3cc4n(c3)CCNC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '22.97', 'le': '0.42', 'lle': '6.03', 'sei': '10.37'}",CHEMBL3962885,,CHEMBL3962885,8.39,0,http://www.openphacts.org/units/Nanomolar,2888105,=,37,1,=,,IC50,nM,,4.05,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.05,PAK4
,416875,17780386,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '24.86', 'le': '0.46', 'lle': '6.14', 'sei': '9.89'}",CHEMBL3979678,,CHEMBL3979678,9.08,0,http://www.openphacts.org/units/Nanomolar,2888106,=,37,1,=,,IC50,nM,,0.826,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.826,PAK4
,416876,17780387,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '25.97', 'le': '0.48', 'lle': '6.74', 'sei': '10.28'}",CHEMBL3950704,,CHEMBL3950704,9.44,0,http://www.openphacts.org/units/Nanomolar,2888107,=,37,1,=,,IC50,nM,,0.364,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.364,PAK4
,416877,17780388,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1O[C@H](C)C(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '19.18', 'le': '0.37', 'lle': '3.42', 'sei': '9.37'}",CHEMBL3899758,,CHEMBL3899758,7.49,0,http://www.openphacts.org/units/Nanomolar,2888108,=,37,1,=,,IC50,nM,,32.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,32.5,PAK4
,416878,17780389,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1O[C@H](C)C(F)(F)F,,,CHEMBL3886836,,2016,"{'bei': '16.88', 'le': '0.32', 'lle': '2.52', 'sei': '8.25'}",CHEMBL3899758,,CHEMBL3899758,6.59,0,http://www.openphacts.org/units/Nanomolar,2888108,=,37,1,=,,IC50,nM,,258.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,258.0,PAK4
,416879,17780390,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)N[C@@H]4C)c2nc1NC1(C)CC1,,,CHEMBL3886836,,2016,"{'bei': '24.15', 'le': '0.47', 'lle': '4.86', 'sei': '11.15'}",CHEMBL3933719,,CHEMBL3933719,9.22,0,http://www.openphacts.org/units/Nanomolar,2888109,=,37,1,=,,IC50,nM,,0.599,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.599,PAK4
,416880,17780391,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)N[C@@H]4C)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.04', 'le': '0.45', 'lle': '4.24', 'sei': '10.69'}",CHEMBL3932879,,CHEMBL3932879,8.85,0,http://www.openphacts.org/units/Nanomolar,2888110,=,37,1,=,,IC50,nM,,1.43,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.43,PAK4
,416881,17780392,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)C3(CC3)NC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '24.88', 'le': '0.46', 'lle': '6.52', 'sei': '10.23'}",CHEMBL3946152,,CHEMBL3946152,9.39,0,http://www.openphacts.org/units/Nanomolar,2888111,=,37,1,=,,IC50,nM,,0.407,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.407,PAK4
,416882,17780393,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CN1CCOCC1,,,CHEMBL3886836,,2016,"{'bei': '15.82', 'le': '0.29', 'lle': '4.13', 'sei': '7.22'}",CHEMBL3986937,,CHEMBL3986937,6.87,0,http://www.openphacts.org/units/Nanomolar,2888112,=,37,1,=,,IC50,nM,,134.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,134.0,PAK4
,416883,17780394,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)CNC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '24.43', 'le': '0.46', 'lle': '7.17', 'sei': '9.56'}",CHEMBL3919362,,CHEMBL3919362,9.66,0,http://www.openphacts.org/units/Nanomolar,2888113,=,37,1,=,,IC50,nM,,0.218,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.218,PAK4
,416884,17780395,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '23.72', 'le': '0.44', 'lle': '6.66', 'sei': '9.61'}",CHEMBL3947143,,CHEMBL3947143,9.71,0,http://www.openphacts.org/units/Nanomolar,2888114,=,37,1,=,,IC50,nM,,0.193,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.193,PAK4
,416885,17780396,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(OC5(C)CC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '24.69', 'le': '0.46', 'lle': '6.34', 'sei': '10.11'}",CHEMBL3983621,,CHEMBL3983621,9.00,0,http://www.openphacts.org/units/Nanomolar,2888115,=,37,1,=,,IC50,nM,,1.01,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.01,PAK4
,416886,17780397,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(CCO)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.58', 'le': '0.45', 'lle': '6.02', 'sei': '9.06'}",CHEMBL3955880,,CHEMBL3955880,9.33,0,http://www.openphacts.org/units/Nanomolar,2888116,=,37,1,=,,IC50,nM,,0.47,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.47,PAK4
,416887,17780398,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC5(C)CCC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '26.19', 'le': '0.48', 'lle': '6.80', 'sei': '10.77'}",CHEMBL3968854,,CHEMBL3968854,9.89,0,http://www.openphacts.org/units/Nanomolar,2888117,=,37,1,=,,IC50,nM,,0.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.13,PAK4
,416888,17780399,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(C)(C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.98', 'le': '0.44', 'lle': '4.59', 'sei': '10.54'}",CHEMBL3897690,,CHEMBL3897690,8.71,0,http://www.openphacts.org/units/Nanomolar,2888118,=,37,1,=,,IC50,nM,,1.93,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.93,PAK4
,416889,17780400,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc(C(N)=O)n[nH]3)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.82', 'le': '0.46', 'lle': '5.41', 'sei': '7.35'}",CHEMBL3927458,,CHEMBL3927458,8.05,0,http://www.openphacts.org/units/Nanomolar,2888119,=,37,1,=,,IC50,nM,,8.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.9,PAK4
,416890,17780401,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](COCc3ccccc3)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '17.78', 'le': '0.33', 'lle': '2.95', 'sei': '8.81'}",CHEMBL3899420,,CHEMBL3899420,8.10,0,http://www.openphacts.org/units/Nanomolar,2888120,=,37,1,=,,IC50,nM,,7.94,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.94,PAK4
,416891,17780402,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C(CO)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '23.71', 'le': '0.44', 'lle': '5.75', 'sei': '8.42'}",CHEMBL3936412,,CHEMBL3936412,8.67,0,http://www.openphacts.org/units/Nanomolar,2888121,=,37,1,=,,IC50,nM,,2.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.16,PAK4
,416892,17780403,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(n3C)C(CO)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '21.37', 'le': '0.40', 'lle': '5.18', 'sei': '8.81'}",CHEMBL3912000,,CHEMBL3912000,8.11,0,http://www.openphacts.org/units/Nanomolar,2888122,=,37,1,=,,IC50,nM,,7.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.8,PAK4
,416893,17780404,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(n3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL3886836,,2016,"{'bei': '17.77', 'le': '0.33', 'lle': '3.47', 'sei': '7.35'}",CHEMBL3941161,,CHEMBL3941161,6.23,0,http://www.openphacts.org/units/Nanomolar,2888123,=,37,1,=,,IC50,nM,,593.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,593.0,PAK4
,416894,17780405,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '24.80', 'le': '0.46', 'lle': '6.12', 'sei': '9.87'}",CHEMBL3913164,,CHEMBL3913164,9.06,0,http://www.openphacts.org/units/Nanomolar,2888124,=,37,1,=,,IC50,nM,,0.864,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.864,PAK4
,416895,17780406,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(CCOC)CCC(C)(C)Nc1nc2c(-c3cc4c([nH]3)CNC4=O)cccc2c(=O)n1C,,,CHEMBL3886836,,2016,"{'bei': '14.99', 'le': '0.28', 'lle': '5.09', 'sei': '6.56'}",CHEMBL3922035,,CHEMBL3922035,7.44,0,http://www.openphacts.org/units/Nanomolar,2888125,=,37,1,=,,IC50,nM,,36.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,36.0,PAK4
,416896,17780407,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCOCCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '19.93', 'le': '0.37', 'lle': '5.97', 'sei': '8.20'}",CHEMBL3918647,,CHEMBL3918647,9.04,0,http://www.openphacts.org/units/Nanomolar,2888126,=,37,1,=,,IC50,nM,,0.917,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.917,PAK4
,416897,17780408,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '25.85', 'le': '0.48', 'lle': '6.38', 'sei': '11.02'}",CHEMBL3919725,,CHEMBL3919725,10.12,0,http://www.openphacts.org/units/Nanomolar,2888127,=,37,1,=,,IC50,nM,,0.076,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.076,PAK4
,416898,17780409,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](N(CCF)CCF)C1,,,CHEMBL3886836,,2016,"{'bei': '17.43', 'le': '0.33', 'lle': '4.52', 'sei': '9.22'}",CHEMBL3891675,,CHEMBL3891675,7.92,0,http://www.openphacts.org/units/Nanomolar,2888128,=,37,1,=,,IC50,nM,,12.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,12.0,PAK4
,416899,17780410,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](NCCF)C1,,,CHEMBL3886836,,2016,"{'bei': '22.03', 'le': '0.41', 'lle': '6.28', 'sei': '9.50'}",CHEMBL3902504,,CHEMBL3902504,9.00,0,http://www.openphacts.org/units/Nanomolar,2888129,=,37,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,416900,17780411,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](NCC(F)F)C1,,,CHEMBL3886836,,2016,"{'bei': '20.40', 'le': '0.38', 'lle': '5.68', 'sei': '9.18'}",CHEMBL3926975,,CHEMBL3926975,8.70,0,http://www.openphacts.org/units/Nanomolar,2888130,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,416901,17780412,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](N(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '21.51', 'le': '0.40', 'lle': '5.68', 'sei': '9.77'}",CHEMBL3889998,,CHEMBL3889998,8.40,0,http://www.openphacts.org/units/Nanomolar,2888131,=,37,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,416902,17780413,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1N[C@H]1C[C@@H](N2CCOCC2)C1,,,CHEMBL3886836,,2016,"{'bei': '19.01', 'le': '0.35', 'lle': '5.73', 'sei': '8.64'}",CHEMBL3918021,,CHEMBL3918021,8.22,0,http://www.openphacts.org/units/Nanomolar,2888132,=,37,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,416903,17780414,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '26.65', 'le': '0.49', 'lle': '6.68', 'sei': '11.02'}",CHEMBL3909217,,CHEMBL3909217,10.11,0,http://www.openphacts.org/units/Nanomolar,2888133,=,37,1,=,,IC50,nM,,0.077,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.077,PAK4
,416904,17780415,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(-c5cccnc5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '19.97', 'le': '0.37', 'lle': '4.77', 'sei': '8.17'}",CHEMBL3912577,,CHEMBL3912577,8.56,0,http://www.openphacts.org/units/Nanomolar,2888134,=,37,1,=,,IC50,nM,,2.77,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.77,PAK4
,416905,17780416,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](N)C1,,,CHEMBL3886836,,2016,"{'bei': '26.75', 'le': '0.49', 'lle': '7.03', 'sei': '9.61'}",CHEMBL3903686,,CHEMBL3903686,10.45,0,http://www.openphacts.org/units/Nanomolar,2888135,=,37,1,=,,IC50,nM,,0.0358,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.0358,PAK4
,416906,17780417,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(N)nc(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '23.16', 'le': '0.43', 'lle': '4.90', 'sei': '7.46'}",CHEMBL3931685,,CHEMBL3931685,8.12,0,http://www.openphacts.org/units/Nanomolar,2888136,=,37,1,=,,IC50,nM,,7.66,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.66,PAK4
,416907,17780418,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COCC1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '21.51', 'le': '0.40', 'lle': '5.94', 'sei': '8.42'}",CHEMBL3894748,,CHEMBL3894748,8.51,0,http://www.openphacts.org/units/Nanomolar,2888137,=,37,1,=,,IC50,nM,,3.12,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.12,PAK4
,416908,17780419,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1CCC[C@H](Nc2nc3c(-c4cc5c([nH]4)[C@@H](C)NC5=O)cccc3nc2C)C1,,,CHEMBL3886836,,2016,"{'bei': '19.94', 'le': '0.37', 'lle': '5.02', 'sei': '7.71'}",CHEMBL3919258,,CHEMBL3919258,8.62,0,http://www.openphacts.org/units/Nanomolar,2888138,=,37,1,=,,IC50,nM,,2.38,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.38,PAK4
,416909,17780420,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](NCC(F)(F)F)C1,,,CHEMBL3886836,,2016,"{'bei': '20.26', 'le': '0.38', 'lle': '4.96', 'sei': '10.11'}",CHEMBL3913446,,CHEMBL3913446,9.57,0,http://www.openphacts.org/units/Nanomolar,2888139,=,37,1,=,,IC50,nM,,0.267,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.267,PAK4
,416910,17780421,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCN(c1nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c(=O)[nH]1)C(C)C,,,CHEMBL3886836,,2016,"{'bei': '24.11', 'le': '0.45', 'lle': '5.85', 'sei': '9.39'}",CHEMBL3944889,,CHEMBL3944889,8.81,0,http://www.openphacts.org/units/Nanomolar,2888140,=,37,1,=,,IC50,nM,,1.54,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.54,PAK4
,416911,17780422,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](NS(C)(=O)=O)C1,,,CHEMBL3886836,,2016,"{'bei': '18.56', 'le': '0.36', 'lle': '5.69', 'sei': '6.75'}",CHEMBL3907991,,CHEMBL3907991,8.70,0,http://www.openphacts.org/units/Nanomolar,2888141,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,416912,17780423,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c(F)ccc2c(=O)n1C1CC1,,,CHEMBL3886836,,2016,"{'bei': '24.53', 'le': '0.46', 'lle': '6.21', 'sei': '10.56'}",CHEMBL3984961,,CHEMBL3984961,9.70,0,http://www.openphacts.org/units/Nanomolar,2888142,=,37,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,416913,17780424,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](NC(=O)[C@@H](CO)NC(=O)OC(C)(C)C)C1,,,CHEMBL3886836,,2016,"{'bei': '13.85', 'le': '0.26', 'lle': '4.54', 'sei': '4.70'}",CHEMBL3934853,,CHEMBL3934853,8.00,0,http://www.openphacts.org/units/Nanomolar,2888143,=,37,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,416914,17780425,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '25.68', 'le': '0.47', 'lle': '6.50', 'sei': '10.89'}",CHEMBL3958862,,CHEMBL3958862,10.00,0,http://www.openphacts.org/units/Nanomolar,2888144,=,37,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,416915,17780426,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '20.99', 'le': '0.39', 'lle': '5.73', 'sei': '8.22'}",CHEMBL3922440,,CHEMBL3922440,8.30,0,http://www.openphacts.org/units/Nanomolar,2888145,=,37,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,416916,17780427,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,COC[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.00', 'le': '0.41', 'lle': '6.13', 'sei': '8.61'}",CHEMBL3961876,,CHEMBL3961876,8.70,0,http://www.openphacts.org/units/Nanomolar,2888146,=,37,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
,416917,17780428,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c3N=C(NC3(C)CC3)N(C3CC3)C4)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '25.98', 'le': '0.48', 'lle': '6.49', 'sei': '14.10'}",CHEMBL3949175,,CHEMBL3949175,10.22,0,http://www.openphacts.org/units/Nanomolar,2888147,=,37,1,=,,IC50,nM,,0.06,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.06,PAK4
,416918,17780429,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC5(C)CCC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '24.04', 'le': '0.44', 'lle': '5.81', 'sei': '10.56'}",CHEMBL3911461,,CHEMBL3911461,9.70,0,http://www.openphacts.org/units/Nanomolar,2888148,=,37,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,416919,17780430,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1N[C@H]1CCC[C@@H](NC(=O)[C@H](N)CO)C1,,,CHEMBL3886836,,2016,"{'bei': '20.51', 'le': '0.38', 'lle': '7.90', 'sei': '6.20'}",CHEMBL3910446,,CHEMBL3910446,9.80,0,http://www.openphacts.org/units/Nanomolar,2888149,=,37,1,=,,IC50,nM,,0.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.16,PAK4
,416920,17780431,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C5CC5)c(NC5(C)CCC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '23.73', 'le': '0.44', 'lle': '5.98', 'sei': '10.89'}",CHEMBL3944421,,CHEMBL3944421,10.00,0,http://www.openphacts.org/units/Nanomolar,2888150,=,37,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,416921,17780432,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4cnc(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '26.38', 'le': '0.48', 'lle': '5.41', 'sei': '10.64'}",CHEMBL3935407,,CHEMBL3935407,8.80,0,http://www.openphacts.org/units/Nanomolar,2888151,=,37,1,=,,IC50,nM,,1.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.6,PAK4
,416922,17780433,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CCCO)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '24.32', 'le': '0.45', 'lle': '7.17', 'sei': '8.89'}",CHEMBL3919616,,CHEMBL3919616,9.96,0,http://www.openphacts.org/units/Nanomolar,2888152,=,37,1,=,,IC50,nM,,0.11,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.11,PAK4
,416923,17780434,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC(F)(F)F)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.43', 'le': '0.43', 'lle': '5.75', 'sei': '10.59'}",CHEMBL3924828,,CHEMBL3924828,9.72,0,http://www.openphacts.org/units/Nanomolar,2888153,=,37,1,=,,IC50,nM,,0.19,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.19,PAK4
,416924,17780435,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C)c(NC5(C)CCC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '24.53', 'le': '0.46', 'lle': '6.47', 'sei': '10.56'}",CHEMBL3896782,,CHEMBL3896782,9.70,0,http://www.openphacts.org/units/Nanomolar,2888154,=,37,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,416925,17780436,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](CCO)NC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '23.52', 'le': '0.44', 'lle': '6.99', 'sei': '8.30'}",CHEMBL3933742,,CHEMBL3933742,9.30,0,http://www.openphacts.org/units/Nanomolar,2888155,=,37,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,416926,17780437,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](CCN)NC4=O)cccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '27.12', 'le': '0.50', 'lle': '8.43', 'sei': '9.08'}",CHEMBL3909351,,CHEMBL3909351,10.70,0,http://www.openphacts.org/units/Nanomolar,2888156,=,37,1,=,,IC50,nM,,0.02,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.02,PAK4
,416927,17780438,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '23.97', 'le': '0.44', 'lle': '5.77', 'sei': '9.91'}",CHEMBL3946176,,CHEMBL3946176,9.10,0,http://www.openphacts.org/units/Nanomolar,2888157,=,37,1,=,,IC50,nM,,0.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.8,PAK4
,416928,17780439,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(N[C@H]5CCC[C@@H](N)C5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '24.60', 'le': '0.46', 'lle': '7.59', 'sei': '8.49'}",CHEMBL3918273,,CHEMBL3918273,10.00,0,http://www.openphacts.org/units/Nanomolar,2888158,=,37,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,416929,17780440,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CCC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.74', 'le': '0.42', 'lle': '5.09', 'sei': '10.04'}",CHEMBL3904050,,CHEMBL3904050,9.22,0,http://www.openphacts.org/units/Nanomolar,2888159,=,37,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,416930,17780441,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CCCS(C)(=O)=O)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '20.19', 'le': '0.39', 'lle': '6.68', 'sei': '7.56'}",CHEMBL3932047,,CHEMBL3932047,9.52,0,http://www.openphacts.org/units/Nanomolar,2888160,=,37,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,416931,17780442,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(N[C@@H]5CCC[C@H](NC(=O)OC(C)(C)C)C5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '15.44', 'le': '0.29', 'lle': '3.84', 'sei': '6.01'}",CHEMBL3916569,,CHEMBL3916569,7.82,0,http://www.openphacts.org/units/Nanomolar,2888161,=,37,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.0,PAK4
,416932,17780443,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '26.22', 'le': '0.49', 'lle': '7.16', 'sei': '10.89'}",CHEMBL3941050,,CHEMBL3941050,10.00,0,http://www.openphacts.org/units/Nanomolar,2888162,=,37,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,416933,17780444,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '22.58', 'le': '0.42', 'lle': '5.02', 'sei': '9.97'}",CHEMBL3948310,,CHEMBL3948310,9.15,0,http://www.openphacts.org/units/Nanomolar,2888163,=,37,1,=,,IC50,nM,,0.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.7,PAK4
,416934,17780445,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c(F)ccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '25.49', 'le': '0.48', 'lle': '6.56', 'sei': '11.03'}",CHEMBL3960373,,CHEMBL3960373,10.13,0,http://www.openphacts.org/units/Nanomolar,2888164,=,37,1,=,,IC50,nM,,0.0741,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.0741,PAK4
,416935,17780446,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(NC2(C)CC2)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c(F)ccc2c1=O,,,CHEMBL3886836,,2016,"{'bei': '26.36', 'le': '0.49', 'lle': '7.10', 'sei': '11.35'}",CHEMBL3895124,,CHEMBL3895124,10.42,0,http://www.openphacts.org/units/Nanomolar,2888165,=,37,1,=,,IC50,nM,,0.0378,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.0378,PAK4
,416936,17780447,[],CHEMBL3888800,"Homogeneous Time Resolved Fluorescence Assay (HTRF): The assay for the determination of Pim activity is based on the formation of phosphorylated biotinylated-BAD peptide at the Serine 112 residue (S112) and employs HTRF® (homogeneous time resolved fluorescence) technology to detect the product in a 384-well plate format. The phosphorylation of biotinylated-BAD (S112) peptide by full length recombinant Pim-1, Pim-2, or Pim-3 protein was detected with streptavidin:Allophycocyanin (APC) conjugate and a europium (Eu) labeled antibody directed against phosphorylated-BAD (S112). Excitation of Eu by a high energy laser light (337 nm) leads to a transfer of energy to the APC molecule, and results in an emission at 665 nm. The fluorescence is directly proportional to the amount of phosphorylated BAD peptide present in the reaction. Compounds were prepared in DMSO by conducting 3-fold serial dilutions to give a 22-point dosing curve having a high dose of 1 μM. A reference compound was included on each assay plate [Costar 3658] in order to validate that plate; on one plate of every assay run, two additional reference compounds were included. The Reaction Buffer consisted of 45 mM Hepes, pH 7.0, 15 mM NaCl, and 1 mM MgCl. The quench/detection buffer consisted of 50 mM Tris, 100 mM NaCl, 0.05% BSA, 0.1% Tween and 3 mM EDTA. Biotinylated BAD peptide (Biopeptide), 10 mM ATP (Sigma), Labeled p-BAD (S112) mAb (Cell Signalling and Perkin Elmer) [with 0.05% BSA and 2 mM DTT added] streptavidin:Allophycocyanin [Perkin Elmer]. Final concentrations either Pim-1 enzyme [5 pM], or Pim-2 enzyme [0.5 pM], DMSO [1%], BLC BAD (S112) [0.5 μM], ATP [1.5 μM], streptavidin:Allophycocyanin [0.002 mg/mL] and biotinylated-BAD (S112) mAb [100 pM]. Initial incubations were carried out at RT (22° C.) for 30 min for both Pim-1 and for Pim-2. Pim enzyme is added to compound in buffer, and plates are incubated of 30 min. Biotinylated BAD and ATP are added and plates are incubated for 1 h. A mixture of labeled p-BAD (S112) mAb and quench/detection buffer are added and incubated for 2 h. Fluorescence was measured by an HTRF® Envision microplate reader.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CCOCC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL3886836,,2016,"{'bei': '21.06', 'le': '0.39', 'lle': '5.41', 'sei': '9.08'}",CHEMBL3926620,,CHEMBL3926620,9.17,0,http://www.openphacts.org/units/Nanomolar,2888166,=,37,1,=,,IC50,nM,,0.671,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.671,PAK4
,438365,17798110,[],CHEMBL3889161,"In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors, the activity of PIM2 was measured using an in vitro Caliper kinase assay. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The 384 well microtiter assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, 25 uM ATP, and 2 uM S6 peptide) and 4.5 ul per well of enzyme solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, and 0.6 nM PIM2 enzyme).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1cnccc1N1CCCC(N)C1,,,CHEMBL3886971,,2016,"{'bei': '13.79', 'le': '0.26', 'lle': '2.99', 'sei': '5.13'}",CHEMBL3949162,,CHEMBL3949162,6.31,0,http://www.openphacts.org/units/Nanomolar,2898835,=,37,1,=,,IC50,nM,,490.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,490.0,PAK4
,438366,17798111,[],CHEMBL3889161,"In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors, the activity of PIM2 was measured using an in vitro Caliper kinase assay. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The 384 well microtiter assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, 25 uM ATP, and 2 uM S6 peptide) and 4.5 ul per well of enzyme solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, and 0.6 nM PIM2 enzyme).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCC(N)CC1,,,CHEMBL3886971,,2016,"{'bei': '21.73', 'le': '0.40', 'lle': '6.41', 'sei': '7.20'}",CHEMBL3895998,,CHEMBL3895998,8.85,0,http://www.openphacts.org/units/Nanomolar,2898836,=,37,1,=,,IC50,nM,,1.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.4,PAK4
,438367,17798112,[],CHEMBL3889161,"In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors, the activity of PIM2 was measured using an in vitro Caliper kinase assay. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The 384 well microtiter assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, 25 uM ATP, and 2 uM S6 peptide) and 4.5 ul per well of enzyme solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, and 0.6 nM PIM2 enzyme).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ccccc2)nc1C(=O)Nc1ccccc1N1CCC(N)CC1,,,CHEMBL3886971,,2016,"{'bei': '15.74', 'le': '0.29', 'lle': '3.20', 'sei': '5.55'}",CHEMBL3943813,,CHEMBL3943813,6.11,0,http://www.openphacts.org/units/Nanomolar,2898837,=,37,1,=,,IC50,nM,,770.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,770.0,PAK4
,438368,17798113,[],CHEMBL3889161,"In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors, the activity of PIM2 was measured using an in vitro Caliper kinase assay. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The 384 well microtiter assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, 25 uM ATP, and 2 uM S6 peptide) and 4.5 ul per well of enzyme solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, and 0.6 nM PIM2 enzyme).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ccccc2)nc1C(=O)Nc1cnccc1N1CCC(N)CC1,,,CHEMBL3886971,,2016,"{'bei': '20.54', 'le': '0.38', 'lle': '5.70', 'sei': '6.50'}",CHEMBL3963605,,CHEMBL3963605,8.00,0,http://www.openphacts.org/units/Nanomolar,2898838,=,37,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.0,PAK4
,438369,17798114,[],CHEMBL3889161,"In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors, the activity of PIM2 was measured using an in vitro Caliper kinase assay. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The 384 well microtiter assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, 25 uM ATP, and 2 uM S6 peptide) and 4.5 ul per well of enzyme solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, and 0.6 nM PIM2 enzyme).",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC(N)CC3)n2)cc1,,,CHEMBL3886971,,2016,"{'bei': '18.80', 'le': '0.35', 'lle': '5.58', 'sei': '5.96'}",CHEMBL3942619,,CHEMBL3942619,7.89,0,http://www.openphacts.org/units/Nanomolar,2898839,=,37,1,=,,IC50,nM,,13.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.0,PAK4
,438370,17798115,[],CHEMBL3889161,"In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors, the activity of PIM2 was measured using an in vitro Caliper kinase assay. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The 384 well microtiter assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, 25 uM ATP, and 2 uM S6 peptide) and 4.5 ul per well of enzyme solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, and 0.6 nM PIM2 enzyme).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCNCC1,,,CHEMBL3886971,,2016,"{'bei': '18.07', 'le': '0.33', 'lle': '5.19', 'sei': '6.52'}",CHEMBL3957649,,CHEMBL3957649,7.11,0,http://www.openphacts.org/units/Nanomolar,2898840,=,37,1,=,,IC50,nM,,78.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,78.0,PAK4
,438371,17798116,[],CHEMBL3889161,"In Vitro Caliper Kinase Assay: For comparison between certain PKC inhibitors of the present application and structurally comparable PIM kinase inhibitors, the activity of PIM2 was measured using an in vitro Caliper kinase assay. Liquid handling and incubation steps were done on an Innovadyne Nanodrop Express equipped with a robotic arm (Thermo CatX, Caliper Twister II) and an incubator (Liconic STX40, Thermo Cytomat 2C450). The 384 well microtiter assay plates were prepared by addition of 50 nl per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition of 4.5 ul per well of peptide/ATP-solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, 25 uM ATP, and 2 uM S6 peptide) and 4.5 ul per well of enzyme solution (50 mM HEPES, pH 7.5, 1 mM DTT, 0.02% Tween20, 0.02% BSA, 0.6% DMSO, 10 mM beta-glycerophosphate, and 10 uM sodium orthovanadate, 1 mM MgCl2, and 0.6 nM PIM2 enzyme).",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1,,,CHEMBL3886971,,2016,,CHEMBL3890986,,CHEMBL3890986,,0,http://www.openphacts.org/units/Nanomolar,2898725,>,37,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,,17978417,[],CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1/C(=C/c2c[nH]c3nc(Cl)ccc23)Oc2c1ccc(O)c2CN1CCNCC1,,,CHEMBL3994673,ACS Med Chem Lett,2017,"{'bei': '16.68', 'le': '0.32', 'lle': '3.91', 'sei': '7.58'}",CHEMBL4061176,,CHEMBL4061176,6.85,0,http://www.openphacts.org/units/Nanomolar,2978583,=,1,1,=,,IC50,nM,,140.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,140.0,PAK4
,,17978418,[],CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2c(/C=C3\Oc4c(ccc(O)c4CN4CCNCC4)C3=O)c[nH]c2n1,,,CHEMBL3994673,ACS Med Chem Lett,2017,"{'bei': '16.12', 'le': '0.30', 'lle': '3.69', 'sei': '6.95'}",CHEMBL4084953,,CHEMBL4084953,6.29,0,http://www.openphacts.org/units/Nanomolar,2978580,=,1,1,=,,IC50,nM,,510.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,510.0,PAK4
,,17978419,[],CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1/C(=C/c2c[nH]c3ncccc23)Oc2c1ccc(O)c2CN1CCNCC1,,,CHEMBL3994673,ACS Med Chem Lett,2017,"{'bei': '16.94', 'le': '0.31', 'lle': '4.09', 'sei': '7.05'}",CHEMBL4102902,,CHEMBL4102902,6.38,0,http://www.openphacts.org/units/Nanomolar,2978579,=,1,1,=,,IC50,nM,,420.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,420.0,PAK4
,,17978420,[],CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(Cl)ccc13)C2=O,,,CHEMBL3994673,ACS Med Chem Lett,2017,"{'bei': '16.13', 'le': '0.31', 'lle': '3.60', 'sei': '8.62'}",CHEMBL4062256,,CHEMBL4062256,6.85,0,http://www.openphacts.org/units/Nanomolar,2978578,=,1,1,=,,IC50,nM,,140.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,140.0,PAK4
,,17978421,[],CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc2c(/C=C3\Oc4c(ccc(OC)c4CN4CCNCC4)C3=O)c[nH]c2n1,,,CHEMBL3994673,ACS Med Chem Lett,2017,"{'bei': '15.62', 'le': '0.29', 'lle': '3.38', 'sei': '8.23'}",CHEMBL4074201,,CHEMBL4074201,6.54,0,http://www.openphacts.org/units/Nanomolar,2978573,=,1,1,=,,IC50,nM,,290.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,290.0,PAK4
,,17978422,[],CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(C)ccc13)C2=O,,,CHEMBL3994673,ACS Med Chem Lett,2017,"{'bei': '16.13', 'le': '0.30', 'lle': '3.62', 'sei': '8.21'}",CHEMBL4060711,,CHEMBL4060711,6.52,0,http://www.openphacts.org/units/Nanomolar,2978572,=,1,1,=,,IC50,nM,,300.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,300.0,PAK4
,,17978423,[],CHEMBL3997632,Inhibition of full length recombinant human N-terminal GST-tagged PIM2 (1 to 311 residues) expressed in baculovirus infected sf21 cells using S6K2 peptide as substrate by electrophoretic mobility shift assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O,,,CHEMBL3994673,ACS Med Chem Lett,2017,"{'bei': '16.41', 'le': '0.30', 'lle': '3.82', 'sei': '8.06'}",CHEMBL2147767,,CHEMBL2147767,6.41,0,http://www.openphacts.org/units/Nanomolar,2978571,=,1,1,=,,IC50,nM,,390.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,390.0,PAK4
,,18031828,[],CHEMBL4007735,Inhibition of PIM2 (unknown origin) after 60 mins by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21,,,CHEMBL4007384,Bioorg Med Chem Lett,2016,,CHEMBL4069365,,CHEMBL4069365,,0,http://www.openphacts.org/units/Nanomolar,2987739,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18200526,[],CHEMBL4043032,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system by Z'-Lyte assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(-n2c(=O)ccc3ccc4ccc(-c5cnn(C)c5)cc4c32)cc1NC(=O)/C=C/CN(C)C,,,CHEMBL4041550,ACS Med Chem Lett,2017,,CHEMBL4064534,,CHEMBL4064534,,0,http://www.openphacts.org/units/Nanomolar,3019438,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,,18219256,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C(F)(F)F)n(C3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '19.94', 'le': '0.43', 'lle': '4.21', 'sei': '10.42'}",CHEMBL4078609,,CHEMBL4078609,7.60,0,http://www.openphacts.org/units/Nanomolar,3023070,=,1,1,=,,IC50,nM,,25.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.025,PAK4
,,18219257,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC/C=C/c1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1C1CCCNC1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '18.90', 'le': '0.40', 'lle': '4.21', 'sei': '8.82'}",CHEMBL4096630,,CHEMBL4096630,7.24,0,http://www.openphacts.org/units/Nanomolar,3023071,=,1,1,=,,IC50,nM,,57.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.057,PAK4
,,18219262,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(-c3cc4c(Cl)cc(C(N)=O)nc4n3C)cc2)CC1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,,CHEMBL4098659,,CHEMBL4098659,,0,http://www.openphacts.org/units/Nanomolar,3023040,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18219263,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2ccc(N3CCN(C)CC3)cc2)n(C)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '14.35', 'le': '0.28', 'lle': '2.66', 'sei': '8.47'}",CHEMBL4083330,,CHEMBL4083330,5.71,0,http://www.openphacts.org/units/Nanomolar,3023041,=,1,1,=,,IC50,nM,,1950.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.95,PAK4
,,18219264,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(CC3CCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '17.40', 'le': '0.50', 'lle': '4.98', 'sei': '10.47'}",CHEMBL4093592,,CHEMBL4093592,7.64,0,http://www.openphacts.org/units/Nanomolar,3023042,=,1,1,=,,IC50,nM,,23.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.023,PAK4
,,18219265,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(CC3CCNCC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '15.46', 'le': '0.43', 'lle': '3.95', 'sei': '9.60'}",CHEMBL4072887,,CHEMBL4072887,7.00,0,http://www.openphacts.org/units/Nanomolar,3023043,=,1,1,=,,IC50,nM,,99.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.099,PAK4
,,18219266,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(CC3CCCN3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '14.61', 'le': '0.42', 'lle': '3.62', 'sei': '8.80'}",CHEMBL4085846,,CHEMBL4085846,6.42,0,http://www.openphacts.org/units/Nanomolar,3023044,=,1,1,=,,IC50,nM,,383.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.383,PAK4
,,18219267,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(CCC3CCNCC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '14.62', 'le': '0.41', 'lle': '3.39', 'sei': '9.36'}",CHEMBL4064302,,CHEMBL4064302,6.83,0,http://www.openphacts.org/units/Nanomolar,3023045,=,1,1,=,,IC50,nM,,148.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.148,PAK4
,,18219268,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CCNCC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '17.20', 'le': '0.49', 'lle': '4.58', 'sei': '10.35'}",CHEMBL4077977,,CHEMBL4077977,7.55,0,http://www.openphacts.org/units/Nanomolar,3023046,=,1,1,=,,IC50,nM,,28.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.028,PAK4
,,18219269,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '18.73', 'le': '0.53', 'lle': '5.25', 'sei': '11.27'}",CHEMBL4084988,,CHEMBL4084988,8.22,0,http://www.openphacts.org/units/Nanomolar,3023047,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,18219270,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(n2c(I)c(Cl)c3c(Cl)cc(C(N)=O)nc32)CC1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '16.48', 'le': '0.46', 'lle': '4.16', 'sei': '11.64'}",CHEMBL4070019,,CHEMBL4070019,7.47,0,http://www.openphacts.org/units/Nanomolar,3023048,=,1,1,=,,IC50,nM,,34.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.034,PAK4
,,18219271,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CCC(N)CC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '18.15', 'le': '0.51', 'lle': '4.73', 'sei': '9.46'}",CHEMBL4070441,,CHEMBL4070441,8.22,0,http://www.openphacts.org/units/Nanomolar,3023049,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,18219272,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CCCC(N)C3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '17.66', 'le': '0.50', 'lle': '4.51', 'sei': '9.20'}",CHEMBL4095220,,CHEMBL4095220,8.00,0,http://www.openphacts.org/units/Nanomolar,3023050,=,1,1,=,,IC50,nM,,10.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.01,PAK4
,,18219273,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CCCNCC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '17.27', 'le': '0.49', 'lle': '4.46', 'sei': '10.73'}",CHEMBL4067797,,CHEMBL4067797,7.82,0,http://www.openphacts.org/units/Nanomolar,3023051,=,1,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.015,PAK4
,,18219274,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NCC1CCC(n2c(I)c(Cl)c3c(Cl)cc(C(N)=O)nc32)CC1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '17.22', 'le': '0.48', 'lle': '4.31', 'sei': '9.26'}",CHEMBL4087517,,CHEMBL4087517,8.05,0,http://www.openphacts.org/units/Nanomolar,3023052,=,1,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.009,PAK4
,,18219275,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CN4CCC3CC4)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '15.06', 'le': '0.42', 'lle': '3.69', 'sei': '10.92'}",CHEMBL4105379,,CHEMBL4105379,7.00,0,http://www.openphacts.org/units/Nanomolar,3023053,=,1,1,=,,IC50,nM,,99.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.099,PAK4
,,18219276,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CCC(O)CC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '15.27', 'le': '0.43', 'lle': '3.42', 'sei': '8.55'}",CHEMBL4065094,,CHEMBL4065094,6.94,0,http://www.openphacts.org/units/Nanomolar,3023054,=,1,1,=,,IC50,nM,,116.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.116,PAK4
,,18219277,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CCCC(O)C3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '15.53', 'le': '0.44', 'lle': '3.53', 'sei': '8.69'}",CHEMBL4086532,,CHEMBL4086532,7.05,0,http://www.openphacts.org/units/Nanomolar,3023055,=,1,1,=,,IC50,nM,,89.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.089,PAK4
,,18219278,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CCNC(=O)C3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '13.64', 'le': '0.38', 'lle': '3.68', 'sei': '6.87'}",CHEMBL4089255,,CHEMBL4089255,6.18,0,http://www.openphacts.org/units/Nanomolar,3023056,=,1,1,=,,IC50,nM,,660.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.66,PAK4
,,18219279,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(I)n(C3CNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '13.08', 'le': '0.39', 'lle': '3.18', 'sei': '7.37'}",CHEMBL4078687,,CHEMBL4078687,5.38,0,http://www.openphacts.org/units/Nanomolar,3023057,=,1,1,=,,IC50,nM,,4220.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,4.22,PAK4
,,18219280,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)CCn1c(I)c(Cl)c2c(Cl)cc(C(N)=O)nc21,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '11.27', 'le': '0.32', 'lle': '1.74', 'sei': '8.00'}",CHEMBL4102030,,CHEMBL4102030,5.13,0,http://www.openphacts.org/units/Nanomolar,3023059,=,1,1,=,,IC50,nM,,7410.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,7.41,PAK4
,,18219281,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(I)c(Cl)c2c(Cl)cc(C(N)=O)nc21,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '16.74', 'le': '0.53', 'lle': '3.61', 'sei': '10.17'}",CHEMBL4061455,,CHEMBL4061455,6.19,0,http://www.openphacts.org/units/Nanomolar,3023060,=,1,1,=,,IC50,nM,,640.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.64,PAK4
,,18219282,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1C1CCCNC1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '21.78', 'le': '0.49', 'lle': '4.73', 'sei': '10.73'}",CHEMBL4075702,,CHEMBL4075702,7.82,0,http://www.openphacts.org/units/Nanomolar,3023061,=,1,1,=,,IC50,nM,,15.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.015,PAK4
,,18219283,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(-c3ccccc3)n(C3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '17.89', 'le': '0.37', 'lle': '2.93', 'sei': '9.55'}",CHEMBL4092706,,CHEMBL4092706,6.96,0,http://www.openphacts.org/units/Nanomolar,3023062,=,1,1,=,,IC50,nM,,109.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.109,PAK4
,,18219284,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)=Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1C1CCCNC1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '20.75', 'le': '0.43', 'lle': '3.83', 'sei': '10.45'}",CHEMBL4071926,,CHEMBL4071926,7.62,0,http://www.openphacts.org/units/Nanomolar,3023063,=,1,1,=,,IC50,nM,,24.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.024,PAK4
,,18219285,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CC3)n(C3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '21.79', 'le': '0.45', 'lle': '5.09', 'sei': '11.27'}",CHEMBL4100435,,CHEMBL4100435,8.22,0,http://www.openphacts.org/units/Nanomolar,3023064,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.006,PAK4
,,18219286,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C3CC3)n(C3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '22.32', 'le': '0.47', 'lle': '4.65', 'sei': '10.81'}",CHEMBL4082422,,CHEMBL4082422,7.89,0,http://www.openphacts.org/units/Nanomolar,3023065,=,1,1,=,,IC50,nM,,13.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.013,PAK4
,,18219287,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1cc(-c2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2C2CCCNC2)cn1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '19.82', 'le': '0.41', 'lle': '5.03', 'sei': '8.59'}",CHEMBL4062258,,CHEMBL4062258,7.80,0,http://www.openphacts.org/units/Nanomolar,3023066,=,1,1,=,,IC50,nM,,16.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.016,PAK4
,,18219288,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCC1CC1c1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1C1CCCNC1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '16.42', 'le': '0.34', 'lle': '3.41', 'sei': '7.94'}",CHEMBL4090269,,CHEMBL4090269,6.53,0,http://www.openphacts.org/units/Nanomolar,3023067,=,1,1,=,,IC50,nM,,298.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.298,PAK4
,,18219289,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C3CCCO3)n(C3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '17.92', 'le': '0.38', 'lle': '3.65', 'sei': '8.36'}",CHEMBL4073332,,CHEMBL4073332,6.87,0,http://www.openphacts.org/units/Nanomolar,3023068,=,1,1,=,,IC50,nM,,135.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.135,PAK4
,,18219290,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C3=CCOCC3)n(C3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '17.07', 'le': '0.35', 'lle': '3.58', 'sei': '8.21'}",CHEMBL4101554,,CHEMBL4101554,6.75,0,http://www.openphacts.org/units/Nanomolar,3023069,=,1,1,=,,IC50,nM,,179.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.179,PAK4
,,18219369,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C3CC3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '23.27', 'le': '0.49', 'lle': '4.98', 'sei': '11.27'}",CHEMBL4104355,,CHEMBL4104355,8.22,0,http://www.openphacts.org/units/Nanomolar,3023073,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,,18219370,[],CHEMBL4047363,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C3CC3)n([C@@H]3CCCNC3)c2n1,,,CHEMBL4043238,Bioorg Med Chem Lett,2017,"{'bei': '21.68', 'le': '0.45', 'lle': '4.42', 'sei': '10.50'}",CHEMBL4086461,,CHEMBL4086461,7.66,0,http://www.openphacts.org/units/Nanomolar,3023072,=,1,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.0,PAK4
,,18221077,[],CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccc(N3CCNCC3)cc2)cc2c(Cl)ccnc21,,,CHEMBL4043256,Bioorg Med Chem Lett,2017,,CHEMBL4102376,,CHEMBL4102376,,0,http://www.openphacts.org/units/Nanomolar,3023496,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18221078,[],CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(NC(=O)c2ccc(-c3c(-c4ccc(N5CCN(C)CC5)cc4)n(C)c4nccc(Cl)c34)cc2)CC1,,,CHEMBL4043256,Bioorg Med Chem Lett,2017,"{'bei': '10.88', 'le': '0.21', 'lle': '0.92', 'sei': '10.70'}",CHEMBL4065485,,CHEMBL4065485,6.06,0,http://www.openphacts.org/units/Nanomolar,3023499,=,1,1,=,,IC50,nM,,872.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,872.0,PAK4
,,18221079,[],CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1ccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)n(C)c3nccc(Cl)c23)cc1,,,CHEMBL4043256,Bioorg Med Chem Lett,2017,"{'bei': '11.56', 'le': '0.22', 'lle': '0.11', 'sei': '19.90'}",CHEMBL4086917,,CHEMBL4086917,5.48,0,http://www.openphacts.org/units/Nanomolar,3023500,=,1,1,=,,IC50,nM,,3300.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3300.0,PAK4
,,18221080,[],CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccc(N3CCNCC3)cc2)cc2c(Cl)cc(C(N)=O)nc21,,,CHEMBL4043256,Bioorg Med Chem Lett,2017,,CHEMBL4079062,,CHEMBL4079062,,0,http://www.openphacts.org/units/Nanomolar,3023502,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18221081,[],CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1ccc(-c2c(-c3ccc(N4CCNCC4)cc3)n(C)c3nc(C(N)=O)cc(Cl)c23)cc1,,,CHEMBL4043256,Bioorg Med Chem Lett,2017,,CHEMBL4088490,,CHEMBL4088490,,0,http://www.openphacts.org/units/Nanomolar,3023503,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18221082,[],CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2ccc(N3CCNCC3)cc2)n(C)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4043256,Bioorg Med Chem Lett,2017,"{'bei': '15.36', 'le': '0.30', 'lle': '3.19', 'sei': '7.74'}",CHEMBL4060267,,CHEMBL4060267,5.90,0,http://www.openphacts.org/units/Nanomolar,3023504,=,1,1,=,,IC50,nM,,1270.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.27,PAK4
,,18221083,[],CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(-c2ccc(N3CCNCC3)cc2)c(-c2ccc(CO)cc2)c2c(Cl)ccnc21,,,CHEMBL4043256,Bioorg Med Chem Lett,2017,"{'bei': '11.23', 'le': '0.21', 'lle': '0.40', 'sei': '9.12'}",CHEMBL4080621,,CHEMBL4080621,4.86,0,http://www.openphacts.org/units/Nanomolar,3023505,=,1,1,=,,IC50,nM,,13800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,13.8,PAK4
,,18221084,[],CHEMBL4047686,Inhibition of PIM2 (unknown origin) assessed as reduction in full length human BAD phosphorylation at Ser112 residues by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(c2ccc(-c3cc4c(Cl)cc(C(N)=O)nc4n3C)cc2)CC1,,,CHEMBL4043256,Bioorg Med Chem Lett,2017,,CHEMBL4098659,,CHEMBL4098659,,1,http://www.openphacts.org/units/Nanomolar,3023506,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18300191,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '18.58', 'le': '0.34', 'lle': '4.32', 'sei': '6.41'}",CHEMBL3264257,,CHEMBL3264257,6.96,1,http://www.openphacts.org/units/Nanomolar,3037991,=,1,1,=,,IC50,nM,,110.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.11,PAK4
,,18300193,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cncc(-c2ccc3[nH]cc(-c4ccccc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,,CHEMBL4128811,,CHEMBL4128811,,0,http://www.openphacts.org/units/Nanomolar,3037993,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18300194,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)cc1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.46', 'le': '0.28', 'lle': '1.17', 'sei': '10.11'}",CHEMBL4130169,,CHEMBL4130169,5.75,0,http://www.openphacts.org/units/Nanomolar,3037994,=,1,1,=,,IC50,nM,,1800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.8,PAK4
,,18300195,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)c1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '16.37', 'le': '0.30', 'lle': '1.51', 'sei': '10.70'}",CHEMBL4130257,,CHEMBL4130257,6.08,0,http://www.openphacts.org/units/Nanomolar,3037995,=,1,1,=,,IC50,nM,,830.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.83,PAK4
,,18300196,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '12.31', 'le': '0.23', 'lle': '-0.04', 'sei': '9.21'}",CHEMBL4126252,,CHEMBL4126252,5.24,0,http://www.openphacts.org/units/Nanomolar,3037996,=,1,1,=,,IC50,nM,,5800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,5.8,PAK4
,,18300197,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(C(F)(F)F)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '13.27', 'le': '0.25', 'lle': '0.37', 'sei': '9.93'}",CHEMBL4126847,,CHEMBL4126847,5.65,0,http://www.openphacts.org/units/Nanomolar,3037997,=,1,1,=,,IC50,nM,,2260.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.26,PAK4
,,18300198,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '17.01', 'le': '0.31', 'lle': '2.49', 'sei': '7.65'}",CHEMBL4130104,,CHEMBL4130104,6.34,0,http://www.openphacts.org/units/Nanomolar,3037998,=,1,1,=,,IC50,nM,,460.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.46,PAK4
,,18300199,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(N)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '16.34', 'le': '0.30', 'lle': '2.24', 'sei': '7.35'}",CHEMBL4125999,,CHEMBL4125999,6.09,0,http://www.openphacts.org/units/Nanomolar,3037999,=,1,1,=,,IC50,nM,,820.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.82,PAK4
,,18300200,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(C#N)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '14.63', 'le': '0.26', 'lle': '1.46', 'sei': '6.94'}",CHEMBL4126689,,CHEMBL4126689,5.59,0,http://www.openphacts.org/units/Nanomolar,3038000,=,1,1,=,,IC50,nM,,2540.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.54,PAK4
,,18300201,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(C#N)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.98', 'le': '0.29', 'lle': '1.97', 'sei': '7.58'}",CHEMBL4128740,,CHEMBL4128740,6.11,0,http://www.openphacts.org/units/Nanomolar,3038001,=,1,1,=,,IC50,nM,,770.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.77,PAK4
,,18300202,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)cc1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.64', 'le': '0.29', 'lle': '1.79', 'sei': '9.17'}",CHEMBL4129779,,CHEMBL4129779,6.06,0,http://www.openphacts.org/units/Nanomolar,3038002,=,1,1,=,,IC50,nM,,870.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.87,PAK4
,,18300203,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)c1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '16.13', 'le': '0.29', 'lle': '1.98', 'sei': '9.46'}",CHEMBL4128290,,CHEMBL4128290,6.25,0,http://www.openphacts.org/units/Nanomolar,3038003,=,1,1,=,,IC50,nM,,560.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.56,PAK4
,,18300204,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(OC(F)(F)F)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '12.12', 'le': '0.23', 'lle': '0.19', 'sei': '8.10'}",CHEMBL4129352,,CHEMBL4129352,5.35,0,http://www.openphacts.org/units/Nanomolar,3038004,=,1,1,=,,IC50,nM,,4440.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,4.44,PAK4
,,18300205,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(OC(F)(F)F)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '12.59', 'le': '0.24', 'lle': '0.40', 'sei': '8.41'}",CHEMBL4128901,,CHEMBL4128901,5.56,0,http://www.openphacts.org/units/Nanomolar,3038005,=,1,1,=,,IC50,nM,,2780.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.78,PAK4
,,18300206,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(F)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.42', 'le': '0.28', 'lle': '1.39', 'sei': '10.19'}",CHEMBL4129891,,CHEMBL4129891,5.79,0,http://www.openphacts.org/units/Nanomolar,3038006,=,1,1,=,,IC50,nM,,1620.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.62,PAK4
,,18300207,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(F)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '16.48', 'le': '0.30', 'lle': '1.79', 'sei': '10.89'}",CHEMBL4129023,,CHEMBL4129023,6.19,0,http://www.openphacts.org/units/Nanomolar,3038007,=,1,1,=,,IC50,nM,,650.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.65,PAK4
,,18300208,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '17.13', 'le': '0.31', 'lle': '2.03', 'sei': '11.32'}",CHEMBL4126848,,CHEMBL4126848,6.43,0,http://www.openphacts.org/units/Nanomolar,3038008,=,1,1,=,,IC50,nM,,370.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.37,PAK4
,,18300209,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(-c5ccccc5)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '12.16', 'le': '0.22', 'lle': '-0.66', 'sei': '9.28'}",CHEMBL4130297,,CHEMBL4130297,5.27,0,http://www.openphacts.org/units/Nanomolar,3038009,=,1,1,=,,IC50,nM,,5330.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,5.33,PAK4
,,18300210,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(S(C)(=O)=O)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '13.01', 'le': '0.25', 'lle': '2.00', 'sei': '6.23'}",CHEMBL4129118,,CHEMBL4129118,5.67,0,http://www.openphacts.org/units/Nanomolar,3038010,=,1,1,=,,IC50,nM,,2160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.16,PAK4
,,18300211,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(S(N)(=O)=O)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '14.10', 'le': '0.27', 'lle': '3.24', 'sei': '5.26'}",CHEMBL4127644,,CHEMBL4127644,6.16,0,http://www.openphacts.org/units/Nanomolar,3038011,=,1,1,=,,IC50,nM,,700.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.7,PAK4
,,18300212,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)c1ccc(-c2c[nH]c3ccc(-c4cncc(N5CCNCC5)n4)cc23)cc1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '13.40', 'le': '0.25', 'lle': '0.95', 'sei': '9.98'}",CHEMBL4129044,,CHEMBL4129044,5.67,0,http://www.openphacts.org/units/Nanomolar,3038012,=,1,1,=,,IC50,nM,,2120.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.12,PAK4
,,18300213,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCOc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,,CHEMBL4129166,,CHEMBL4129166,,0,http://www.openphacts.org/units/Nanomolar,3038013,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18300214,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCOc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,,CHEMBL4126838,,CHEMBL4126838,,0,http://www.openphacts.org/units/Nanomolar,3038014,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18300215,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,FC(F)(F)c1ccc(-c2c[nH]c3ccc(-c4cncc(OC5CCNCC5)n4)cc23)cc1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '12.23', 'le': '0.23', 'lle': '-0.08', 'sei': '8.53'}",CHEMBL4130071,,CHEMBL4130071,5.36,0,http://www.openphacts.org/units/Nanomolar,3038015,=,1,1,=,,IC50,nM,,4350.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,4.35,PAK4
,,18300216,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCNc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,,CHEMBL4128705,,CHEMBL4128705,,0,http://www.openphacts.org/units/Nanomolar,3038016,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18300217,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCN(C)c1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,,CHEMBL4130160,,CHEMBL4130160,,0,http://www.openphacts.org/units/Nanomolar,3038017,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18300218,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCN(C)c1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)cc4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,,CHEMBL4127463,,CHEMBL4127463,,0,http://www.openphacts.org/units/Nanomolar,3038018,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18300219,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCCN1c1cncc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,,CHEMBL4127890,,CHEMBL4127890,,0,http://www.openphacts.org/units/Nanomolar,3038019,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18300220,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,OCCc1cncc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,,CHEMBL4126500,,CHEMBL4126500,,0,http://www.openphacts.org/units/Nanomolar,3038020,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18300221,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccccc1-c1c[nH]c2ccc(-c3cncc(N4CCCNCC4)n3)cc12,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '16.18', 'le': '0.30', 'lle': '2.04', 'sei': '11.03'}",CHEMBL4126656,,CHEMBL4126656,6.27,0,http://www.openphacts.org/units/Nanomolar,3038021,=,1,1,=,,IC50,nM,,537.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.537,PAK4
,,18300222,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCCN(c2cncc(-c3ccc4[nH]cc(-c5ccccc5F)c4c3)n2)C1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.12', 'le': '0.28', 'lle': '1.50', 'sei': '8.27'}",CHEMBL4129929,,CHEMBL4129929,5.86,0,http://www.openphacts.org/units/Nanomolar,3038022,=,1,1,=,,IC50,nM,,1380.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.38,PAK4
,,18300223,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NCCNc1cncc(-c2ccc3[nH]cc(-c4ccccc4F)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '19.11', 'le': '0.35', 'lle': '2.84', 'sei': '8.34'}",CHEMBL4125725,,CHEMBL4125725,6.64,0,http://www.openphacts.org/units/Nanomolar,3038023,=,1,1,=,,IC50,nM,,230.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.23,PAK4
,,18300224,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(F)c(C(F)(F)F)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '12.10', 'le': '0.23', 'lle': '-0.06', 'sei': '9.44'}",CHEMBL4126778,,CHEMBL4126778,5.37,0,http://www.openphacts.org/units/Nanomolar,3038024,=,1,1,=,,IC50,nM,,4320.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,4.32,PAK4
,,18300225,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(C(F)(F)F)c(F)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '11.50', 'le': '0.22', 'lle': '-0.32', 'sei': '8.97'}",CHEMBL4126344,,CHEMBL4126344,5.10,0,http://www.openphacts.org/units/Nanomolar,3038025,=,1,1,=,,IC50,nM,,7950.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,7.95,PAK4
,,18300226,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)c(C#N)c4)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '16.57', 'le': '0.30', 'lle': '2.87', 'sei': '6.18'}",CHEMBL4126750,,CHEMBL4126750,6.59,0,http://www.openphacts.org/units/Nanomolar,3038026,=,1,1,=,,IC50,nM,,259.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.259,PAK4
,,18300227,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cc(C#N)ccc4F)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.17', 'le': '0.28', 'lle': '1.80', 'sei': '7.53'}",CHEMBL4128288,,CHEMBL4128288,6.08,0,http://www.openphacts.org/units/Nanomolar,3038027,=,1,1,=,,IC50,nM,,841.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.841,PAK4
,,18300228,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cc(C(=O)O)ccc4F)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '13.94', 'le': '0.26', 'lle': '1.75', 'sei': '6.21'}",CHEMBL4130159,,CHEMBL4130159,5.85,0,http://www.openphacts.org/units/Nanomolar,3038028,=,1,1,=,,IC50,nM,,1426.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.426,PAK4
,,18300229,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1ccc(F)c(-c2c[nH]c3ccc(-c4cncc(NCCN(C)C)n4)cc23)c1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.95', 'le': '0.29', 'lle': '2.05', 'sei': '9.01'}",CHEMBL4125914,,CHEMBL4125914,6.66,0,http://www.openphacts.org/units/Nanomolar,3038029,=,1,1,=,,IC50,nM,,220.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.22,PAK4
,,18300230,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4cccc(F)c4F)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.73', 'le': '0.29', 'lle': '1.65', 'sei': '10.89'}",CHEMBL4128205,,CHEMBL4128205,6.19,0,http://www.openphacts.org/units/Nanomolar,3038030,=,1,1,=,,IC50,nM,,645.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.645,PAK4
,,18300231,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)cc4F)c3c2)n1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '16.83', 'le': '0.31', 'lle': '2.58', 'sei': '7.93'}",CHEMBL4129087,,CHEMBL4129087,6.57,0,http://www.openphacts.org/units/Nanomolar,3038031,=,1,1,=,,IC50,nM,,267.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.267,PAK4
,,18300232,[],CHEMBL4124627,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,,,CHEMBL4118246,Bioorg Med Chem Lett,2018,"{'bei': '15.88', 'le': '0.30', 'lle': '2.39', 'sei': '11.78'}",CHEMBL1952329,SGI-1776,CHEMBL1952329,6.44,1,http://www.openphacts.org/units/Nanomolar,3038032,=,1,1,=,,IC50,nM,,363.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.363,PAK4
,,18580228,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4csc(C(=O)O)c4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4228394,,CHEMBL4228394,,0,http://www.openphacts.org/units/Nanomolar,3085398,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580229,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4cccc(C(=O)O)c4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4227556,,CHEMBL4227556,,0,http://www.openphacts.org/units/Nanomolar,3085399,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580230,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '15.68', 'le': '0.29', 'lle': '1.85', 'sei': '6.30'}",CHEMBL4228654,,CHEMBL4228654,5.85,0,http://www.openphacts.org/units/Nanomolar,3085400,=,1,1,=,,IC50,nM,,1400.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.4,PAK4
,,18580231,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4F)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '12.94', 'le': '0.24', 'lle': '0.93', 'sei': '5.45'}",CHEMBL4227817,,CHEMBL4227817,5.07,0,http://www.openphacts.org/units/Nanomolar,3085401,=,1,1,=,,IC50,nM,,8600.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,8.6,PAK4
,,18580232,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4Cl)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '11.24', 'le': '0.22', 'lle': '-0.06', 'sei': '4.93'}",CHEMBL4227886,,CHEMBL4227886,4.58,0,http://www.openphacts.org/units/Nanomolar,3085402,=,1,1,=,,IC50,nM,,26000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,26.0,PAK4
,,18580233,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)O)ccc1-c1cncc(-n2ncc3ccc(NC(C)C)cc32)n1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4227028,,CHEMBL4227028,,0,http://www.openphacts.org/units/Nanomolar,3085403,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580234,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)c(F)c4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '14.19', 'le': '0.26', 'lle': '1.41', 'sei': '5.98'}",CHEMBL4224859,,CHEMBL4224859,5.55,0,http://www.openphacts.org/units/Nanomolar,3085404,=,1,1,=,,IC50,nM,,2800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,2.8,PAK4
,,18580235,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cncc(-n3ncc4ccc(NC(C)C)cc43)n2)ccc1C(=O)O,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4225330,,CHEMBL4225330,,0,http://www.openphacts.org/units/Nanomolar,3085405,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580236,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)nc4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4225224,,CHEMBL4225224,,0,http://www.openphacts.org/units/Nanomolar,3085406,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580237,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cn4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '13.79', 'le': '0.25', 'lle': '1.76', 'sei': '4.88'}",CHEMBL4228363,,CHEMBL4228363,5.16,0,http://www.openphacts.org/units/Nanomolar,3085407,=,1,1,=,,IC50,nM,,6900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,6.9,PAK4
,,18580238,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(-c5nnn[nH]5)cc4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4224959,,CHEMBL4224959,,0,http://www.openphacts.org/units/Nanomolar,3085408,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580239,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(O)C(F)(F)F)cc4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4228564,,CHEMBL4228564,,0,http://www.openphacts.org/units/Nanomolar,3085409,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580240,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)NS(C)(=O)=O)cc4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4224693,,CHEMBL4224693,,0,http://www.openphacts.org/units/Nanomolar,3085410,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580241,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCc1ccc(-c2cncc(-n3ncc4ccc(NC(C)C)cc43)n2)cc1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4225206,,CHEMBL4225206,,0,http://www.openphacts.org/units/Nanomolar,3085411,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580242,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(CN)cc4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4227791,,CHEMBL4227791,,0,http://www.openphacts.org/units/Nanomolar,3085412,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580243,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2ccn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '13.43', 'le': '0.24', 'lle': '0.39', 'sei': '6.25'}",CHEMBL4225287,,CHEMBL4225287,5.00,0,http://www.openphacts.org/units/Nanomolar,3085413,=,1,1,=,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18580244,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc(-c2ccc3cnn(-c4cncc(C#N)n4)c3c2)c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4225896,,CHEMBL4225896,,0,http://www.openphacts.org/units/Nanomolar,3085414,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580245,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCCC(=O)Nc1ccc2cnn(-c3cncc(C#N)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4225046,,CHEMBL4225046,,0,http://www.openphacts.org/units/Nanomolar,3085415,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580246,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCCCC(=O)Nc1ccc2cnn(-c3cncc(C#N)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4225633,,CHEMBL4225633,,0,http://www.openphacts.org/units/Nanomolar,3085416,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580247,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCC(=O)Nc1ccc2cnn(-c3cncc(C#N)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4224786,,CHEMBL4224786,,0,http://www.openphacts.org/units/Nanomolar,3085417,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580248,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NCCCNc1cncc(-n2ncc3ccc(NC(C)C)cc32)n1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,,CHEMBL4225378,,CHEMBL4225378,,0,http://www.openphacts.org/units/Nanomolar,3085418,>,1,1,>,,IC50,nM,,30000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,30.0,PAK4
,,18580249,[],CHEMBL4222673,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Nc1ccc2cnn(-c3cncc(NCCCN)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '21.06', 'le': '0.39', 'lle': '4.45', 'sei': '7.32'}",CHEMBL4229130,,CHEMBL4229130,6.85,0,http://www.openphacts.org/units/Nanomolar,3085419,=,1,1,=,,IC50,nM,,140.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.14,PAK4
,,18580302,[],CHEMBL4222695,Inhibition of PIM2 (unknown origin) expressed in human U2OS cells assessed as reduction in BAD substrate phosphorylation by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4F)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '11.90', 'le': '0.22', 'lle': '0.52', 'sei': '5.01'}",CHEMBL4227817,,CHEMBL4227817,4.66,0,http://www.openphacts.org/units/Nanomolar,3085401,=,1,1,=,,IC50,nM,,22000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,22.0,PAK4
,,18580303,[],CHEMBL4222695,Inhibition of PIM2 (unknown origin) expressed in human U2OS cells assessed as reduction in BAD substrate phosphorylation by ELISA,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1ccc2cnn(-c3cncc(NCCCN)n3)c2c1,,,CHEMBL4219163,Bioorg Med Chem Lett,2018,"{'bei': '17.58', 'le': '0.33', 'lle': '3.32', 'sei': '6.11'}",CHEMBL4229130,,CHEMBL4229130,5.72,0,http://www.openphacts.org/units/Nanomolar,3085419,=,1,1,=,,IC50,nM,,1900.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.9,PAK4
,,18665427,[],CHEMBL4233381,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,,,CHEMBL4229420,Bioorg Med Chem Lett,2018,,CHEMBL4245507,,CHEMBL4245507,,0,http://www.openphacts.org/units/Nanomolar,3100083,>,1,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,,18851339,[],CHEMBL4305831,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,,,CHEMBL4304763,Eur J Med Chem,2019,"{'bei': '13.33', 'le': '0.25', 'lle': '2.03', 'sei': '9.00'}",CHEMBL4448494,,CHEMBL4448494,6.75,0,http://www.openphacts.org/units/Nanomolar,3146778,=,1,1,=,,IC50,nM,,177.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,177.0,PAK4
,,18939057,[],CHEMBL4328556,Inhibition of human PIM2 using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4325871,Eur J Med Chem,2019,"{'bei': '16.43', 'le': '0.30', 'lle': '3.31', 'sei': '11.03'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,7.66,0,http://www.openphacts.org/units/Nanomolar,3159540,=,1,1,=,,IC50,nM,,21.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,10'-8M,UO_0000065,,2.17,PAK4
,,18952508,[],CHEMBL4331756,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL4330088,Eur J Med Chem,2019,"{'bei': '24.39', 'le': '0.46', 'lle': '5.70', 'sei': '13.28'}",CHEMBL3651966,LGH-447,CHEMBL3651966,10.74,0,http://www.openphacts.org/units/Nanomolar,3161687,=,1,1,=,,IC50,nM,,0.018,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,pM,UO_0000065,,18.0,PAK4
,,18952509,[],CHEMBL4331756,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,,,CHEMBL4330088,Eur J Med Chem,2019,"{'bei': '21.87', 'le': '0.42', 'lle': '4.69', 'sei': '11.00'}",CHEMBL2048872,,CHEMBL2048872,8.30,1,http://www.openphacts.org/units/Nanomolar,3161686,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,,18952510,[],CHEMBL4331756,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,,,CHEMBL4330088,Eur J Med Chem,2019,"{'bei': '15.88', 'le': '0.30', 'lle': '2.39', 'sei': '11.78'}",CHEMBL1952329,SGI-1776,CHEMBL1952329,6.44,1,http://www.openphacts.org/units/Nanomolar,3161685,=,1,1,=,,IC50,nM,,363.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,363.0,PAK4
,,18975992,[],CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12,,,CHEMBL4334516,J Med Chem,2019,,CHEMBL4555884,,CHEMBL4555884,,0,http://www.openphacts.org/units/Nanomolar,3165564,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18975993,[],CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12,,,CHEMBL4334516,J Med Chem,2019,,CHEMBL4475097,,CHEMBL4475097,,0,http://www.openphacts.org/units/Nanomolar,3165565,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18975994,[],CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br,,,CHEMBL4334516,J Med Chem,2019,"{'bei': '13.84', 'le': '0.31', 'lle': '0.37', 'sei': '7.42'}",CHEMBL4564337,,CHEMBL4564337,4.96,0,http://www.openphacts.org/units/Nanomolar,3165566,=,1,1,=,,IC50,nM,,11000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,11.0,PAK4
,,18975995,[],CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12,,,CHEMBL4334516,J Med Chem,2019,"{'bei': '13.00', 'le': '0.29', 'lle': '0.07', 'sei': '6.97'}",CHEMBL4446434,,CHEMBL4446434,4.66,0,http://www.openphacts.org/units/Nanomolar,3165567,=,1,1,=,,IC50,nM,,22000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,22.0,PAK4
,,18975996,[],CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12,,,CHEMBL4334516,J Med Chem,2019,,CHEMBL4476426,,CHEMBL4476426,,0,http://www.openphacts.org/units/Nanomolar,3165568,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18975997,[],CHEMBL4338190,Inhibition of PIM2 (unknown origin) by [33P]-ATP filter binding kinase assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12,,,CHEMBL4334516,J Med Chem,2019,,CHEMBL4548361,,CHEMBL4548361,,0,http://www.openphacts.org/units/Nanomolar,3165569,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,18989751,[],CHEMBL4340988,Inhibition of human recombinant PIM2 using KKRNRTLTV as substrate in presence of [gamma-33P]ATP incubated for 40 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '15.89', 'le': '0.30', 'lle': '2.39', 'sei': '11.78'}",CHEMBL1952329,SGI-1776,CHEMBL1952329,6.44,0,http://www.openphacts.org/units/Nanomolar,3167979,=,1,1,=,,IC50,nM,,362.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,363.0,362.0,PAK4
,,18989794,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(N5CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,,CHEMBL4561045,,CHEMBL4561045,,0,http://www.openphacts.org/units/Nanomolar,3167990,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,,18989795,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.47', 'le': '0.23', 'lle': '2.79', 'sei': '5.81'}",CHEMBL4577938,,CHEMBL4577938,5.37,0,http://www.openphacts.org/units/Nanomolar,3167991,=,1,1,=,,IC50,nM,,4260.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4260.0,PAK4
,,18989796,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC(=O)C5CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.21', 'le': '0.22', 'lle': '3.32', 'sei': '4.95'}",CHEMBL4573369,,CHEMBL4573369,5.43,0,http://www.openphacts.org/units/Nanomolar,3167992,=,1,1,=,,IC50,nM,,3740.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3740.0,PAK4
,,18989797,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '14.79', 'le': '0.27', 'lle': '3.83', 'sei': '6.66'}",CHEMBL4584365,,CHEMBL4584365,6.16,0,http://www.openphacts.org/units/Nanomolar,3167993,=,1,1,=,,IC50,nM,,690.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,690.0,PAK4
,,18989798,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(Nc2cccc3ccc(-c4nnc5c6c(cnn45)N(C)CCO6)nc23)CC1,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.87', 'le': '0.24', 'lle': '2.87', 'sei': '6.62'}",CHEMBL4468395,,CHEMBL4468395,5.54,0,http://www.openphacts.org/units/Nanomolar,3167994,=,1,1,=,,IC50,nM,,2870.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2870.0,PAK4
,,18989799,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2cccc3ccc(-c4nnc5c6c(cnn45)N(C)CCO6)nc23)CC1,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.08', 'le': '0.22', 'lle': '2.45', 'sei': '6.42'}",CHEMBL4543342,,CHEMBL4543342,5.37,0,http://www.openphacts.org/units/Nanomolar,3167995,=,1,1,=,,IC50,nM,,4250.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4250.0,PAK4
,,18989800,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5(F)CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '11.72', 'le': '0.22', 'lle': '2.59', 'sei': '5.68'}",CHEMBL4576509,,CHEMBL4576509,5.26,0,http://www.openphacts.org/units/Nanomolar,3167996,=,1,1,=,,IC50,nM,,5530.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5530.0,PAK4
,,18989801,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCOCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '13.43', 'le': '0.25', 'lle': '2.85', 'sei': '6.25'}",CHEMBL4461326,,CHEMBL4461326,5.61,0,http://www.openphacts.org/units/Nanomolar,3167997,=,1,1,=,,IC50,nM,,2470.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2470.0,PAK4
,,18989802,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCOCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.07', 'le': '0.22', 'lle': '2.20', 'sei': '5.80'}",CHEMBL4513415,,CHEMBL4513415,5.21,0,http://www.openphacts.org/units/Nanomolar,3167998,=,1,1,=,,IC50,nM,,6210.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6210.0,PAK4
,,18989803,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCCCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '13.18', 'le': '0.24', 'lle': '1.57', 'sei': '6.81'}",CHEMBL4547383,,CHEMBL4547383,5.48,0,http://www.openphacts.org/units/Nanomolar,3167999,=,1,1,=,,IC50,nM,,3330.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3330.0,PAK4
,,18989804,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(N5CCC(N)CC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '13.61', 'le': '0.25', 'lle': '3.57', 'sei': '5.80'}",CHEMBL4521605,,CHEMBL4521605,5.67,0,http://www.openphacts.org/units/Nanomolar,3168000,=,1,1,=,,IC50,nM,,2140.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2140.0,PAK4
,,18989805,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCC(C)(C)CC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,,CHEMBL4526234,,CHEMBL4526234,,0,http://www.openphacts.org/units/Nanomolar,3168001,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,,18989806,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCCCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,,CHEMBL4461970,,CHEMBL4461970,,0,http://www.openphacts.org/units/Nanomolar,3168002,>,1,1,>,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1000.0,PAK4
,,18989807,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(OCCN2CCOc3c2cnn2c(-c4ccc5cccc(NCC6CCNCC6)c5n4)nnc32)cc1,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '9.93', 'le': '0.18', 'lle': '1.30', 'sei': '5.24'}",CHEMBL4467003,,CHEMBL4467003,5.33,0,http://www.openphacts.org/units/Nanomolar,3168003,=,1,1,=,,IC50,nM,,4690.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4690.0,PAK4
,,18989808,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '11.77', 'le': '0.22', 'lle': '2.04', 'sei': '5.83'}",CHEMBL4517926,,CHEMBL4517926,5.40,0,http://www.openphacts.org/units/Nanomolar,3168004,=,1,1,=,,IC50,nM,,4010.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4010.0,PAK4
,,18989809,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.85', 'le': '0.24', 'lle': '2.74', 'sei': '6.18'}",CHEMBL4446938,,CHEMBL4446938,5.71,0,http://www.openphacts.org/units/Nanomolar,3168005,=,1,1,=,,IC50,nM,,1930.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1930.0,PAK4
,,18989810,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '11.08', 'le': '0.21', 'lle': '2.66', 'sei': '5.17'}",CHEMBL4556293,,CHEMBL4556293,5.26,0,http://www.openphacts.org/units/Nanomolar,3168006,=,1,1,=,,IC50,nM,,5530.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5530.0,PAK4
,,18989811,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)N1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.61', 'le': '0.23', 'lle': '2.42', 'sei': '6.25'}",CHEMBL4567516,,CHEMBL4567516,5.78,0,http://www.openphacts.org/units/Nanomolar,3168007,=,1,1,=,,IC50,nM,,1650.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1650.0,PAK4
,,18989812,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cc(F)cc(NCC5(F)CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '13.00', 'le': '0.24', 'lle': '3.26', 'sei': '6.56'}",CHEMBL4564783,,CHEMBL4564783,6.07,0,http://www.openphacts.org/units/Nanomolar,3168008,=,1,1,=,,IC50,nM,,858.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,858.0,PAK4
,,18989813,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4ccc(Cl)c(NCC5(F)CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.75', 'le': '0.25', 'lle': '2.83', 'sei': '6.66'}",CHEMBL4483071,,CHEMBL4483071,6.16,0,http://www.openphacts.org/units/Nanomolar,3168009,=,1,1,=,,IC50,nM,,696.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,696.0,PAK4
,,18989814,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4c(F)c(F)cc(NCC5(F)CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '11.24', 'le': '0.21', 'lle': '2.49', 'sei': '5.89'}",CHEMBL4526558,,CHEMBL4526558,5.45,0,http://www.openphacts.org/units/Nanomolar,3168010,=,1,1,=,,IC50,nM,,3590.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3590.0,PAK4
,,18989815,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cc(Cl)cc(NCC5(F)CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.21', 'le': '0.24', 'lle': '2.57', 'sei': '6.37'}",CHEMBL4457634,,CHEMBL4457634,5.90,0,http://www.openphacts.org/units/Nanomolar,3168011,=,1,1,=,,IC50,nM,,1270.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1270.0,PAK4
,,18989816,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4c(F)ccc(NCC5(F)CCNCC5)c4n3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '11.84', 'le': '0.22', 'lle': '2.71', 'sei': '5.97'}",CHEMBL4527736,,CHEMBL4527736,5.52,0,http://www.openphacts.org/units/Nanomolar,3168012,=,1,1,=,,IC50,nM,,3010.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3010.0,PAK4
,,18989817,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(NCC2(F)CCNCC2)c2nc(-c3nnc4c5c(cnn34)N(C)CCO5)ccc2c1,,,CHEMBL4340512,Eur J Med Chem,2019,,CHEMBL4455041,,CHEMBL4455041,,0,http://www.openphacts.org/units/Nanomolar,3168013,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
,,18989818,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4ccnc(NCC5CCNCC5)c4c3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '17.58', 'le': '0.32', 'lle': '4.99', 'sei': '8.18'}",CHEMBL4555990,,CHEMBL4555990,7.57,0,http://www.openphacts.org/units/Nanomolar,3168014,=,1,1,=,,IC50,nM,,27.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,27.0,PAK4
,,18989819,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4ccnc(NCC5(F)CCNCC5)c4c3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '15.41', 'le': '0.29', 'lle': '4.24', 'sei': '7.47'}",CHEMBL4460019,,CHEMBL4460019,6.91,0,http://www.openphacts.org/units/Nanomolar,3168015,=,1,1,=,,IC50,nM,,122.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,122.0,PAK4
,,18989820,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4ccnc(NC5CCCCC5)c4c3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '14.34', 'le': '0.26', 'lle': '2.05', 'sei': '7.40'}",CHEMBL4521827,,CHEMBL4521827,5.96,0,http://www.openphacts.org/units/Nanomolar,3168016,=,1,1,=,,IC50,nM,,1100.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1100.0,PAK4
,,18989821,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4c3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.37', 'le': '0.23', 'lle': '2.13', 'sei': '6.67'}",CHEMBL4440880,,CHEMBL4440880,5.31,0,http://www.openphacts.org/units/Nanomolar,3168017,=,1,1,=,,IC50,nM,,4870.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4870.0,PAK4
,,18989822,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCOCC5)c4c3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '11.62', 'le': '0.21', 'lle': '1.39', 'sei': '6.51'}",CHEMBL4562507,,CHEMBL4562507,5.00,0,http://www.openphacts.org/units/Nanomolar,3168018,=,1,1,=,,IC50,nM,,9940.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9940.0,PAK4
,,18989823,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCOc2c1cnn1c(-c3ccc4cccc(NC5CCCCC5)c4c3)nnc21,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '12.29', 'le': '0.22', 'lle': '0.57', 'sei': '7.54'}",CHEMBL4449598,,CHEMBL4449598,5.09,0,http://www.openphacts.org/units/Nanomolar,3168019,=,1,1,=,,IC50,nM,,8040.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8040.0,PAK4
,,18989824,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(NCC2CCNCC2)nc2c1nnn2-c1cccc(OC(F)(F)F)c1,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '17.84', 'le': '0.34', 'lle': '4.41', 'sei': '8.75'}",CHEMBL1952142,,CHEMBL1952142,7.54,1,http://www.openphacts.org/units/Nanomolar,3167986,=,1,1,=,,IC50,nM,,29.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.0,PAK4
,,18990089,[],CHEMBL4340984,Inhibition of His tagged human recombinant PIM2 using PIM tide (ARKRRRHPSGPPTA) as substrate incubated for 1 hr by fluorescence based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,,,CHEMBL4340512,Eur J Med Chem,2019,"{'bei': '15.32', 'le': '0.29', 'lle': '2.16', 'sei': '11.35'}",CHEMBL1952329,SGI-1776,CHEMBL1952329,6.21,0,http://www.openphacts.org/units/Nanomolar,3167979,=,1,1,=,,IC50,nM,,618.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,618.0,PAK4
,,19067289,[],CHEMBL4360607,Inhibition of human Pim-2 expressed in Escherichia coli cells using KKRNRTLTV as substrate after 40 mins by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,,,CHEMBL4359824,Eur J Med Chem,2019,"{'bei': '15.88', 'le': '0.30', 'lle': '2.39', 'sei': '11.78'}",CHEMBL1952329,SGI-1776,CHEMBL1952329,6.44,1,http://www.openphacts.org/units/Nanomolar,3181149,=,1,1,=,,IC50,nM,,363.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nmol/L,UO_0000065,,363.0,PAK4
,,19109641,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C[C@H]5CCCO5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '22.70', 'le': '0.42', 'lle': '6.30', 'sei': '9.78'}",CHEMBL4461181,,CHEMBL4461181,9.89,0,http://www.openphacts.org/units/Nanomolar,3188501,=,1,1,=,,IC50,nM,,0.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.13,PAK4
,,19109649,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5COC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '21.88', 'le': '0.41', 'lle': '6.17', 'sei': '9.13'}",CHEMBL4472803,,CHEMBL4472803,9.22,0,http://www.openphacts.org/units/Nanomolar,3188500,=,1,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,,19109657,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC(C)(C)N)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '20.49', 'le': '0.38', 'lle': '5.52', 'sei': '7.35'}",CHEMBL4445845,,CHEMBL4445845,8.66,0,http://www.openphacts.org/units/Nanomolar,3188499,=,1,1,=,,IC50,nM,,2.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.2,PAK4
,,19109665,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(N)CC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '22.88', 'le': '0.42', 'lle': '6.72', 'sei': '8.16'}",CHEMBL4468122,,CHEMBL4468122,9.62,0,http://www.openphacts.org/units/Nanomolar,3188498,=,1,1,=,,IC50,nM,,0.24,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.24,PAK4
,,19109673,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(O)CC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '22.87', 'le': '0.42', 'lle': '6.71', 'sei': '8.60'}",CHEMBL4591512,,CHEMBL4591512,9.64,0,http://www.openphacts.org/units/Nanomolar,3188497,=,1,1,=,,IC50,nM,,0.23,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.23,PAK4
,,19109681,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5CC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '24.90', 'le': '0.46', 'lle': '6.28', 'sei': '11.00'}",CHEMBL4441708,,CHEMBL4441708,10.10,0,http://www.openphacts.org/units/Nanomolar,3188496,=,1,1,=,,IC50,nM,,0.08,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.08,PAK4
,,19109684,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '25.78', 'le': '0.48', 'lle': '6.48', 'sei': '10.26'}",CHEMBL3979678,,CHEMBL3979678,9.42,0,http://www.openphacts.org/units/Nanomolar,3188491,=,1,1,=,,IC50,nM,,0.38,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.38,PAK4
,,19109703,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)n1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '25.12', 'le': '0.47', 'lle': '5.90', 'sei': '10.77'}",CHEMBL3940091,,CHEMBL3940091,9.89,0,http://www.openphacts.org/units/Nanomolar,3188492,=,1,1,=,,IC50,nM,,0.13,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.13,PAK4
,,19109711,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '25.34', 'le': '0.47', 'lle': '6.18', 'sei': '10.81'}",CHEMBL3919725,,CHEMBL3919725,9.92,0,http://www.openphacts.org/units/Nanomolar,3188493,=,1,1,=,,IC50,nM,,0.12,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.12,PAK4
,,19109719,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5(C)CC5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '24.16', 'le': '0.45', 'lle': '5.88', 'sei': '10.67'}",CHEMBL4456165,,CHEMBL4456165,9.80,0,http://www.openphacts.org/units/Nanomolar,3188494,=,1,1,=,,IC50,nM,,0.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.16,PAK4
,,19109727,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C(C)(C)C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '22.28', 'le': '0.41', 'lle': '4.92', 'sei': '9.89'}",CHEMBL4436502,,CHEMBL4436502,9.08,0,http://www.openphacts.org/units/Nanomolar,3188495,=,1,1,=,,IC50,nM,,0.83,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.83,PAK4
,,19109734,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C[C@@H]5CCCO5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '20.57', 'le': '0.38', 'lle': '5.37', 'sei': '8.87'}",CHEMBL4556760,,CHEMBL4556760,8.96,0,http://www.openphacts.org/units/Nanomolar,3188502,=,1,1,=,,IC50,nM,,1.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.1,PAK4
,,19109742,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C[C@H]5CN(C)CCO5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '18.93', 'le': '0.35', 'lle': '6.06', 'sei': '8.43'}",CHEMBL4443684,,CHEMBL4443684,8.80,0,http://www.openphacts.org/units/Nanomolar,3188503,=,1,1,=,,IC50,nM,,1.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.6,PAK4
,,19109750,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C[C@@H]5CN(C)CCO5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '20.21', 'le': '0.38', 'lle': '6.65', 'sei': '9.00'}",CHEMBL4476513,,CHEMBL4476513,9.39,0,http://www.openphacts.org/units/Nanomolar,3188504,=,1,1,=,,IC50,nM,,0.41,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.41,PAK4
,,19109758,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(Cc5cn(C)cn5)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '21.99', 'le': '0.41', 'lle': '6.61', 'sei': '8.94'}",CHEMBL4563904,,CHEMBL4563904,9.80,0,http://www.openphacts.org/units/Nanomolar,3188505,=,1,1,=,,IC50,nM,,0.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.16,PAK4
,,19109766,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(c1cn(C)cn1)n1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '19.92', 'le': '0.37', 'lle': '5.40', 'sei': '8.35'}",CHEMBL4464030,,CHEMBL4464030,9.15,0,http://www.openphacts.org/units/Nanomolar,3188506,=,1,1,=,,IC50,nM,,0.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.7,PAK4
,,19109774,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '25.92', 'le': '0.48', 'lle': '6.72', 'sei': '10.26'}",CHEMBL3950704,,CHEMBL3950704,9.42,0,http://www.openphacts.org/units/Nanomolar,3188507,=,1,1,=,,IC50,nM,,0.38,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.38,PAK4
,,19109788,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CC5)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '25.79', 'le': '0.47', 'lle': '6.55', 'sei': '10.94'}",CHEMBL3958862,,CHEMBL3958862,10.05,0,http://www.openphacts.org/units/Nanomolar,3188508,=,1,1,=,,IC50,nM,,0.09,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.09,PAK4
,,19109802,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5CCC5)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '24.15', 'le': '0.44', 'lle': '5.85', 'sei': '10.61'}",CHEMBL4470271,,CHEMBL4470271,9.74,0,http://www.openphacts.org/units/Nanomolar,3188509,=,1,1,=,,IC50,nM,,0.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.18,PAK4
,,19109810,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C5(C)CC5)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '25.53', 'le': '0.47', 'lle': '6.63', 'sei': '11.22'}",CHEMBL4568404,,CHEMBL4568404,10.30,0,http://www.openphacts.org/units/Nanomolar,3188510,=,1,1,=,,IC50,nM,,0.05,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.05,PAK4
,,19109857,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C(C)(C)C)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '20.85', 'le': '0.38', 'lle': '4.54', 'sei': '9.21'}",CHEMBL4573829,,CHEMBL4573829,8.46,0,http://www.openphacts.org/units/Nanomolar,3188511,=,1,1,=,,IC50,nM,,3.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.5,PAK4
,,19109865,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5CC5)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '24.59', 'le': '0.45', 'lle': '6.35', 'sei': '10.81'}",CHEMBL4436404,,CHEMBL4436404,9.92,0,http://www.openphacts.org/units/Nanomolar,3188512,=,1,1,=,,IC50,nM,,0.12,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.12,PAK4
,,19109873,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(O)CC5)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '23.23', 'le': '0.43', 'lle': '7.05', 'sei': '8.70'}",CHEMBL4446411,,CHEMBL4446411,9.74,0,http://www.openphacts.org/units/Nanomolar,3188513,=,1,1,=,,IC50,nM,,0.18,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.18,PAK4
,,19109881,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(CC5(N)CC5)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '23.41', 'le': '0.43', 'lle': '7.15', 'sei': '8.31'}",CHEMBL4513589,,CHEMBL4513589,9.80,0,http://www.openphacts.org/units/Nanomolar,3188514,=,1,1,=,,IC50,nM,,0.16,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.16,PAK4
,,19109889,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(c1cn(C)cn1)n1c(NC2(C)CC2)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '21.77', 'le': '0.40', 'lle': '6.46', 'sei': '9.08'}",CHEMBL4471849,,CHEMBL4471849,9.96,0,http://www.openphacts.org/units/Nanomolar,3188515,=,1,1,=,,IC50,nM,,0.11,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.11,PAK4
,,19109897,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](c1cn(C)cn1)n1c(NC2(C)CC2)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccc2c1=O,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '18.57', 'le': '0.34', 'lle': '4.99', 'sei': '7.75'}",CHEMBL4463004,,CHEMBL4463004,8.49,0,http://www.openphacts.org/units/Nanomolar,3188516,=,1,1,=,,IC50,nM,,3.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.2,PAK4
,,19109905,[],CHEMBL4370146,Inhibition of full length recombinant PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser112 residues preincubated for 30 mins followed by biotinylated BAD addition and measured after 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n([C@@H](C)c5cn(C)cn5)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4368910,J Med Chem,2019,"{'bei': '21.47', 'le': '0.39', 'lle': '6.32', 'sei': '8.96'}",CHEMBL4450494,,CHEMBL4450494,9.82,0,http://www.openphacts.org/units/Nanomolar,3188517,=,1,1,=,,IC50,nM,,0.15,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.15,PAK4
,,19121769,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CC3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '21.33', 'le': '0.44', 'lle': '4.92', 'sei': '11.03'}",CHEMBL4564586,,CHEMBL4564586,8.05,0,http://www.openphacts.org/units/Nanomolar,3191097,=,1,1,=,,IC50,nM,,9.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.0,PAK4
,,19121770,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CCO)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '21.67', 'le': '0.45', 'lle': '6.25', 'sei': '8.54'}",CHEMBL4466080,,CHEMBL4466080,7.96,0,http://www.openphacts.org/units/Nanomolar,3191098,=,1,1,=,,IC50,nM,,11.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,11.0,PAK4
,,19121771,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)C#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '21.07', 'le': '0.44', 'lle': '5.93', 'sei': '8.62'}",CHEMBL4593810,,CHEMBL4593810,8.03,0,http://www.openphacts.org/units/Nanomolar,3191099,=,1,1,=,,IC50,nM,,9.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.3,PAK4
,,19121772,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(O)C#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '20.25', 'le': '0.42', 'lle': '5.51', 'sei': '8.59'}",CHEMBL4587382,,CHEMBL4587382,8.00,0,http://www.openphacts.org/units/Nanomolar,3191100,=,1,1,=,,IC50,nM,,9.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,9.9,PAK4
,,19121773,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CCCO)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '22.47', 'le': '0.47', 'lle': '6.47', 'sei': '9.20'}",CHEMBL4448325,,CHEMBL4448325,8.57,0,http://www.openphacts.org/units/Nanomolar,3191101,=,1,1,=,,IC50,nM,,2.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.7,PAK4
,,19121774,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(O)CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '20.78', 'le': '0.43', 'lle': '5.72', 'sei': '8.82'}",CHEMBL4588948,,CHEMBL4588948,8.21,0,http://www.openphacts.org/units/Nanomolar,3191102,=,1,1,=,,IC50,nM,,6.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.1,PAK4
,,19121775,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '20.98', 'le': '0.44', 'lle': '5.54', 'sei': '10.09'}",CHEMBL4540910,,CHEMBL4540910,8.29,0,http://www.openphacts.org/units/Nanomolar,3191103,=,1,1,=,,IC50,nM,,5.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.1,PAK4
,,19121776,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,COCC(C)(C)C#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '19.84', 'le': '0.41', 'lle': '5.01', 'sei': '10.22'}",CHEMBL4457529,,CHEMBL4457529,8.40,0,http://www.openphacts.org/units/Nanomolar,3191104,=,1,1,=,,IC50,nM,,4.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.0,PAK4
,,19121777,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,COC(C)(C)CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '18.86', 'le': '0.39', 'lle': '4.45', 'sei': '9.72'}",CHEMBL4541837,,CHEMBL4541837,7.98,0,http://www.openphacts.org/units/Nanomolar,3191105,=,1,1,=,,IC50,nM,,10.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.4,PAK4
,,19121778,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCCO3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '18.85', 'le': '0.39', 'lle': '4.78', 'sei': '9.34'}",CHEMBL4518492,,CHEMBL4518492,7.68,0,http://www.openphacts.org/units/Nanomolar,3191106,=,1,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.0,PAK4
,,19121779,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCCO3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '19.96', 'le': '0.41', 'lle': '5.23', 'sei': '9.90'}",CHEMBL4518492,,CHEMBL4518492,8.13,0,http://www.openphacts.org/units/Nanomolar,3191107,=,1,1,=,,IC50,nM,,7.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.4,PAK4
,,19121780,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CCOCC3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '18.97', 'le': '0.39', 'lle': '4.85', 'sei': '9.73'}",CHEMBL4528544,,CHEMBL4528544,7.99,0,http://www.openphacts.org/units/Nanomolar,3191108,=,1,1,=,,IC50,nM,,10.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10.2,PAK4
,,19121781,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3COCCO3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '19.03', 'le': '0.39', 'lle': '5.93', 'sei': '8.81'}",CHEMBL4466764,,CHEMBL4466764,8.06,0,http://www.openphacts.org/units/Nanomolar,3191109,=,1,1,=,,IC50,nM,,8.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.8,PAK4
,,19121782,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3COCCO3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '19.42', 'le': '0.40', 'lle': '6.09', 'sei': '9.00'}",CHEMBL4466764,,CHEMBL4466764,8.22,0,http://www.openphacts.org/units/Nanomolar,3191110,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
,,19121783,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)COC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '20.24', 'le': '0.42', 'lle': '5.49', 'sei': '10.03'}",CHEMBL4470576,,CHEMBL4470576,8.24,0,http://www.openphacts.org/units/Nanomolar,3191111,=,1,1,=,,IC50,nM,,5.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.7,PAK4
,,19121784,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC1(CC#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)COC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '18.52', 'le': '0.38', 'lle': '4.66', 'sei': '9.50'}",CHEMBL4457389,,CHEMBL4457389,7.80,0,http://www.openphacts.org/units/Nanomolar,3191112,=,1,1,=,,IC50,nM,,15.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,15.7,PAK4
,,19121785,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CC(C#Cc2c(Cl)c3c(Cl)cc(C(N)=O)nc3n2[C@H]2CCCNC2)CC1=O,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '17.86', 'le': '0.37', 'lle': '5.56', 'sei': '8.32'}",CHEMBL4563802,,CHEMBL4563802,7.76,0,http://www.openphacts.org/units/Nanomolar,3191113,=,1,1,=,,IC50,nM,,17.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,17.5,PAK4
,,19121786,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CCN3CCCC3=O)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '18.82', 'le': '0.38', 'lle': '5.83', 'sei': '8.77'}",CHEMBL4446498,,CHEMBL4446498,8.17,0,http://www.openphacts.org/units/Nanomolar,3191114,=,1,1,=,,IC50,nM,,6.7,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.7,PAK4
,,19121787,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C#N)CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '18.00', 'le': '0.37', 'lle': '3.87', 'sei': '7.79'}",CHEMBL4445116,,CHEMBL4445116,7.53,0,http://www.openphacts.org/units/Nanomolar,3191115,=,1,1,=,,IC50,nM,,29.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,29.4,PAK4
,,19121788,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(CC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1)C(N)=O,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '17.60', 'le': '0.36', 'lle': '5.06', 'sei': '6.62'}",CHEMBL4533366,,CHEMBL4533366,7.68,0,http://www.openphacts.org/units/Nanomolar,3191116,=,1,1,=,,IC50,nM,,21.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,21.0,PAK4
,,19121789,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CNCCO3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '19.45', 'le': '0.40', 'lle': '6.50', 'sei': '8.72'}",CHEMBL4583118,,CHEMBL4583118,8.21,0,http://www.openphacts.org/units/Nanomolar,3191117,=,1,1,=,,IC50,nM,,6.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.1,PAK4
,,19121790,[],CHEMBL4373003,Inhibition of PIM2 (unknown origin) assessed as reduction in BAD phosphorylation at Ser-112 residue by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cc(Cl)c2c(Cl)c(C#CC3CNCCO3)n([C@H]3CCCNC3)c2n1,,,CHEMBL4371067,Bioorg Med Chem Lett,2019,"{'bei': '19.23', 'le': '0.40', 'lle': '6.41', 'sei': '8.62'}",CHEMBL4583118,,CHEMBL4583118,8.12,0,http://www.openphacts.org/units/Nanomolar,3191118,=,1,1,=,,IC50,nM,,7.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.6,PAK4
,,19147988,[],CHEMBL4379285,Inhibition of recombinant human Pim2 (2 to end residues) using RSRHSSYPAGT as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1,,,CHEMBL4376834,J Med Chem,2019,,CHEMBL4438748,,CHEMBL4438748,,0,http://www.openphacts.org/units/Nanomolar,3195750,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,19470220,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '25.92', 'le': '0.48', 'lle': '5.95', 'sei': '11.51'}",CHEMBL4587596,,CHEMBL4587596,9.52,0,http://www.openphacts.org/units/Nanomolar,3255722,=,1,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,,19470221,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '26.39', 'le': '0.48', 'lle': '5.79', 'sei': '11.15'}",CHEMBL3959725,,CHEMBL3959725,9.22,0,http://www.openphacts.org/units/Nanomolar,3255723,=,1,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,,19470222,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4n(c3)CCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '23.51', 'le': '0.43', 'lle': '4.85', 'sei': '11.43'}",CHEMBL3913500,,CHEMBL3913500,8.21,0,http://www.openphacts.org/units/Nanomolar,3255724,=,1,1,=,,IC50,nM,,6.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.1,PAK4
,,19470223,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CCCNC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '22.26', 'le': '0.41', 'lle': '4.27', 'sei': '9.78'}",CHEMBL3907325,,CHEMBL3907325,8.09,0,http://www.openphacts.org/units/Nanomolar,3255725,=,1,1,=,,IC50,nM,,8.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.1,PAK4
,,19470224,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)CNC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '26.97', 'le': '0.49', 'lle': '5.66', 'sei': '10.94'}",CHEMBL3940411,,CHEMBL3940411,9.05,0,http://www.openphacts.org/units/Nanomolar,3255726,=,1,1,=,,IC50,nM,,0.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.9,PAK4
,,19470225,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '25.02', 'le': '0.46', 'lle': '4.79', 'sei': '10.57'}",CHEMBL3918714,,CHEMBL3918714,8.74,0,http://www.openphacts.org/units/Nanomolar,3255727,=,1,1,=,,IC50,nM,,1.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.8,PAK4
,,19470226,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '25.76', 'le': '0.47', 'lle': '5.05', 'sei': '10.88'}",CHEMBL3974543,,CHEMBL3974543,9.00,0,http://www.openphacts.org/units/Nanomolar,3255728,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,,19470227,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)[C@@H](CCN)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '25.16', 'le': '0.46', 'lle': '6.24', 'sei': '8.76'}",CHEMBL4541192,,CHEMBL4541192,9.52,0,http://www.openphacts.org/units/Nanomolar,3255729,=,1,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,,19470228,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CC3)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '25.73', 'le': '0.47', 'lle': '5.42', 'sei': '11.25'}",CHEMBL3896124,,CHEMBL3896124,9.30,0,http://www.openphacts.org/units/Nanomolar,3255730,=,1,1,=,,IC50,nM,,0.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.5,PAK4
,,19470229,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c([nH]3)C3(CCOCC3)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '17.09', 'le': '0.32', 'lle': '3.04', 'sei': '7.54'}",CHEMBL3949896,,CHEMBL3949896,6.93,0,http://www.openphacts.org/units/Nanomolar,3255731,=,1,1,=,,IC50,nM,,117.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,117.0,PAK4
,,19470230,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3[nH]c4c(c3Cl)C(=O)N[C@@H]4C)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '23.44', 'le': '0.46', 'lle': '4.40', 'sei': '10.88'}",CHEMBL3932879,,CHEMBL3932879,9.00,0,http://www.openphacts.org/units/Nanomolar,3255732,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,,19470231,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(s3)CNC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '23.17', 'le': '0.45', 'lle': '4.05', 'sei': '12.21'}",CHEMBL4514782,,CHEMBL4514782,8.17,0,http://www.openphacts.org/units/Nanomolar,3255733,=,1,1,=,,IC50,nM,,6.8,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.8,PAK4
,,19470232,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cccc(-c3cc4c(s3)C(=O)NC4)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '24.41', 'le': '0.47', 'lle': '4.48', 'sei': '12.86'}",CHEMBL4527131,,CHEMBL4527131,8.60,0,http://www.openphacts.org/units/Nanomolar,3255734,=,1,1,=,,IC50,nM,,2.5,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.5,PAK4
,,19470233,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)[C@@H](C)NC4=O)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '27.22', 'le': '0.51', 'lle': '5.91', 'sei': '12.09'}",CHEMBL3979182,,CHEMBL3979182,10.00,0,http://www.openphacts.org/units/Nanomolar,3255735,=,1,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,,19470234,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(NC(C)(C)C)nc2c(-c3cc4c([nH]3)[C@@H](C)NC4=O)cccn2c1=O,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '23.75', 'le': '0.44', 'lle': '5.67', 'sei': '9.51'}",CHEMBL4522524,,CHEMBL4522524,8.68,0,http://www.openphacts.org/units/Nanomolar,3255736,=,1,1,=,,IC50,nM,,2.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.1,PAK4
,,19470235,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '26.54', 'le': '0.49', 'lle': '6.76', 'sei': '10.56'}",CHEMBL3979678,,CHEMBL3979678,9.70,0,http://www.openphacts.org/units/Nanomolar,3255737,=,1,1,=,,IC50,nM,,0.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.2,PAK4
,,19470236,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3c(F)ccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '26.08', 'le': '0.49', 'lle': '6.92', 'sei': '10.89'}",CHEMBL3902148,,CHEMBL3902148,10.00,0,http://www.openphacts.org/units/Nanomolar,3255738,=,1,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,,19470237,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3nccc4c(=O)n(C)c(NC(C)(C)C)nc34)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '22.19', 'le': '0.41', 'lle': '5.79', 'sei': '7.77'}",CHEMBL4530924,,CHEMBL4530924,8.13,0,http://www.openphacts.org/units/Nanomolar,3255739,=,1,1,=,,IC50,nM,,7.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,7.4,PAK4
,,19470238,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(CC(C)(C)C)nc34)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '22.80', 'le': '0.42', 'lle': '4.99', 'sei': '10.42'}",CHEMBL4559238,,CHEMBL4559238,8.31,0,http://www.openphacts.org/units/Nanomolar,3255740,=,1,1,=,,IC50,nM,,4.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,4.9,PAK4
,,19470239,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c3N=C(NC(C)(C)C)N(C)S4(=O)=O)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '20.63', 'le': '0.40', 'lle': '5.78', 'sei': '7.77'}",CHEMBL4546373,,CHEMBL4546373,8.28,0,http://www.openphacts.org/units/Nanomolar,3255741,=,1,1,=,,IC50,nM,,5.2,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.2,PAK4
,,19470240,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC5(C)CC5)nc34)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '25.86', 'le': '0.48', 'lle': '6.70', 'sei': '10.24'}",CHEMBL3950704,,CHEMBL3950704,9.40,0,http://www.openphacts.org/units/Nanomolar,3255742,=,1,1,=,,IC50,nM,,0.4,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.4,PAK4
,,19470241,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(NC(C)(C)CO)nc34)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '23.71', 'le': '0.44', 'lle': '7.13', 'sei': '8.07'}",CHEMBL4587256,,CHEMBL4587256,9.05,0,http://www.openphacts.org/units/Nanomolar,3255743,=,1,1,=,,IC50,nM,,0.9,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.9,PAK4
,,19470242,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(N(C)C(C)(C)C)nc34)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '23.72', 'le': '0.44', 'lle': '6.03', 'sei': '10.84'}",CHEMBL4589855,,CHEMBL4589855,9.00,0,http://www.openphacts.org/units/Nanomolar,3255744,=,1,1,=,,IC50,nM,,1.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1.0,PAK4
,,19470243,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1NC(=O)c2cc(-c3cccc4c(=O)n(C)c(N5CCCC5(C)C)nc34)[nH]c21,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '23.56', 'le': '0.43', 'lle': '6.11', 'sei': '11.11'}",CHEMBL4572195,,CHEMBL4572195,9.22,0,http://www.openphacts.org/units/Nanomolar,3255745,=,1,1,=,,IC50,nM,,0.6,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.6,PAK4
,,19470244,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c([nH]3)CCNC4=O)c2nc1NC(C)(C)CO,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '24.84', 'le': '0.46', 'lle': '6.98', 'sei': '9.25'}",CHEMBL3927716,,CHEMBL3927716,9.52,0,http://www.openphacts.org/units/Nanomolar,3255746,=,1,1,=,,IC50,nM,,0.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.3,PAK4
,,19470245,[],CHEMBL4478465,Inhibition of full length recombinant Pim-2 (unknown origin) assessed as reduction in phosphorylation of biotinylated-BAD peptide at Serine 112 residue preincubated for 30 mins followed by substrate addition for 1 hr by HTRF assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(F)c(-c3cc4c(=O)[nH]ccc4[nH]3)c2nc1NC(C)(C)C,,,CHEMBL4477213,J Med Chem,2016,"{'bei': '27.37', 'le': '0.51', 'lle': '5.88', 'sei': '11.57'}",CHEMBL3896195,,CHEMBL3896195,10.00,0,http://www.openphacts.org/units/Nanomolar,3255747,=,1,1,=,,IC50,nM,,0.1,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,0.1,PAK4
,,20600630,[],CHEMBL4603582,Inhibition of recombinant full length GST-tagged human PIM2 expressed in baculovirus expression system using Ser/Thr 07 as substrate after 1 hr in presence of ATP by Z'-LYTE assay,B,,,BAO_0000190,BAO_0000019,assay format,C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C,,,CHEMBL4602617,Bioorg Med Chem Lett,2020,,CHEMBL4634634,,CHEMBL4634634,,0,http://www.openphacts.org/units/Nanomolar,3465297,>,1,1,>,,IC50,nM,,100000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,100.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22482667,[],CHEMBL4687873,Inhibition of human PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1,,,CHEMBL4680285,Bioorg Med Chem,2020,"{'bei': '14.64', 'le': '0.30', 'lle': '2.46', 'sei': '10.57'}",CHEMBL4757567,,CHEMBL4757567,7.07,0,http://www.openphacts.org/units/Nanomolar,3524193,=,1,1,=,,IC50,nM,,86.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,86.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22482711,[],CHEMBL4687897,Inhibition of human PIM2 using full length BAD peptide substrate in presence of ATP at Km concentration,B,,,BAO_0000190,BAO_0000357,single protein format,N[C@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,,,CHEMBL4680285,Bioorg Med Chem,2020,"{'bei': '21.87', 'le': '0.42', 'lle': '4.69', 'sei': '11.00'}",CHEMBL4793492,,CHEMBL4793492,8.30,0,http://www.openphacts.org/units/Nanomolar,3524203,=,1,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22482714,[],CHEMBL4687900,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1C[C@H](N)C[C@H](c2ccccc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL4680285,Bioorg Med Chem,2020,"{'bei': '24.45', 'le': '0.46', 'lle': '5.09', 'sei': '15.80'}",CHEMBL4741714,,CHEMBL4741714,10.74,0,http://www.openphacts.org/units/Nanomolar,3524204,=,1,1,=,,IC50,nM,,0.018,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,pM,UO_0000065,,18.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22770340,[],CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@H](C)[C@@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4699590,Bioorg Med Chem Lett,2020,"{'bei': '17.70', 'le': '0.36', 'lle': '3.39', 'sei': '7.88'}",CHEMBL4765208,,CHEMBL4765208,5.75,0,http://www.openphacts.org/units/Nanomolar,3535096,=,1,1,=,,IC50,nM,,1780.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,1780.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22770341,[],CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@@H](C)[C@@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4699590,Bioorg Med Chem Lett,2020,"{'bei': '20.92', 'le': '0.42', 'lle': '4.44', 'sei': '9.32'}",CHEMBL4796578,,CHEMBL4796578,6.80,0,http://www.openphacts.org/units/Nanomolar,3535097,=,1,1,=,,IC50,nM,,160.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,160.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22770342,[],CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4699590,Bioorg Med Chem Lett,2020,"{'bei': '25.31', 'le': '0.51', 'lle': '5.86', 'sei': '11.27'}",CHEMBL4778578,,CHEMBL4778578,8.22,0,http://www.openphacts.org/units/Nanomolar,3535098,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22770343,[],CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4699590,Bioorg Med Chem Lett,2020,"{'bei': '19.36', 'le': '0.39', 'lle': '3.93', 'sei': '8.62'}",CHEMBL4781364,,CHEMBL4781364,6.29,0,http://www.openphacts.org/units/Nanomolar,3535099,=,1,1,=,,IC50,nM,,515.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,515.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22770344,[],CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@H](C)[C@H]2CCNC[C@@H]2F)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4699590,Bioorg Med Chem Lett,2020,"{'bei': '25.68', 'le': '0.52', 'lle': '6.09', 'sei': '11.93'}",CHEMBL4750046,,CHEMBL4750046,8.70,0,http://www.openphacts.org/units/Nanomolar,3535100,=,1,1,=,,IC50,nM,,2.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,2.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22770345,[],CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@H](C)[C@@H]2CCNC[C@H]2F)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4699590,Bioorg Med Chem Lett,2020,"{'bei': '25.16', 'le': '0.51', 'lle': '5.91', 'sei': '11.68'}",CHEMBL4745141,,CHEMBL4745141,8.52,0,http://www.openphacts.org/units/Nanomolar,3535101,=,1,1,=,,IC50,nM,,3.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,3.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22770346,[],CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@@H](C)[C@H]2CCNC[C@H]2F)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4699590,Bioorg Med Chem Lett,2020,"{'bei': '24.27', 'le': '0.49', 'lle': '5.61', 'sei': '11.27'}",CHEMBL4759685,,CHEMBL4759685,8.22,0,http://www.openphacts.org/units/Nanomolar,3535102,=,1,1,=,,IC50,nM,,6.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,6.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22770347,[],CHEMBL4704282,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@@H](C)[C@@H]2CCNC[C@@H]2F)c2nc(C(N)=O)cc(Cl)c12,,,CHEMBL4699590,Bioorg Med Chem Lett,2020,"{'bei': '22.60', 'le': '0.45', 'lle': '5.05', 'sei': '10.50'}",CHEMBL4746428,,CHEMBL4746428,7.66,0,http://www.openphacts.org/units/Nanomolar,3535103,=,1,1,=,,IC50,nM,,22.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,22.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22843615,[],CHEMBL4720601,Inhibition of human PIM2 using RSRHSSYPAGT as substrate by [gamma-33P]-ATP assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,,,CHEMBL4715818,Bioorg Med Chem,2018,"{'bei': '17.84', 'le': '0.32', 'lle': '3.98', 'sei': '11.99'}",CHEMBL388978,STAUROSPORINE,CHEMBL388978,8.32,0,http://www.openphacts.org/units/Nanomolar,3546983,=,1,1,=,,IC50,nM,,4.73,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,10^-9M,UO_0000065,,4.73,PAK4
,,22851529,[],CHEMBL4723785,Inhibition of human PIM2 in presence of ATP at Km level,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12,,,CHEMBL4715866,J Med Chem,2020,,CHEMBL4752776,,CHEMBL4752776,,0,http://www.openphacts.org/units/Nanomolar,3548114,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23236814,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.6667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '40.0'}]",CHEMBL4828265,Inhibition of recombinant human Pim2 (2 to end residues) using RSRHSSYPAGT as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cc(F)ccc1Nc1ncnc2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nc12,,,CHEMBL4825757,J Med Chem,2021,"{'bei': '13.64', 'le': '0.25', 'lle': '2.22', 'sei': '7.19'}",CHEMBL4869634,,CHEMBL4869634,6.63,0,http://www.openphacts.org/units/Nanomolar,3614795,=,1,1,=,,IC50,nM,,232.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,232.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23317114,[],CHEMBL4845577,Inhibition of PIM2 (unknown origin) using ARKRRRHPSGPPTA as peptide substrate by ADP Hunter Plus assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ncc2cc1NS(=O)(=O)c1cccc(c1)C(=O)NCc1ccc(s1)-c1ncnc3c(C)c-2sc13,,,CHEMBL4842397,ACS Med Chem Lett,2021,"{'bei': '14.33', 'le': '0.29', 'lle': '3.04', 'sei': '6.39'}",CHEMBL4860369,,CHEMBL4860369,7.88,0,http://www.openphacts.org/units/Nanomolar,3629136,=,1,1,=,,IC50,nM,,13.3,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,13.3,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23317115,[],CHEMBL4845577,Inhibition of PIM2 (unknown origin) using ARKRRRHPSGPPTA as peptide substrate by ADP Hunter Plus assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ncc2cc1NS(=O)(=O)c1ccc(F)c(c1)C(=O)NCc1ccc(s1)-c1ncnc3c(C)c-2sc13,,,CHEMBL4842397,ACS Med Chem Lett,2021,"{'bei': '14.26', 'le': '0.29', 'lle': '3.11', 'sei': '6.57'}",CHEMBL4878958,,CHEMBL4878958,8.10,0,http://www.openphacts.org/units/Nanomolar,3629139,=,1,1,=,,IC50,nM,,8.04,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,8.04,PAK4
,,23372845,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'uM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'uM', 'value': '1.0'}]",CHEMBL4884810,Pim2(PIM2LHY1) Takeda global kinase panel,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21,,,CHEMBL4507327,,2021,"{'bei': '14.91', 'le': '0.27', 'lle': '3.65', 'sei': '8.87'}",CHEMBL4088216,TP-030-1,CHEMBL4088216,6.00,0,http://www.openphacts.org/units/Nanomolar,3359782,=,54,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,pIC50,,UO_0000065,,6.0,PAK4
,,23373254,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'uM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'uM', 'value': '1.0'}]",CHEMBL4885101,Pim2(PIM2LHY1) Takeda global kinase panel,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21,,,CHEMBL4507326,,2021,"{'bei': '12.46', 'le': '0.26', 'lle': '2.88', 'sei': '8.87'}",CHEMBL4549667,TP-030-2,CHEMBL4549667,6.00,0,http://www.openphacts.org/units/Nanomolar,3359780,=,54,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,pIC50,,UO_0000065,,6.0,PAK4
,,23373611,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'uM', 'standard_value': '1.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'uM', 'value': '1.0'}]",CHEMBL4885388,Pim2(PIM2LHY1) Takeda global kinase panel,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21,,,CHEMBL4507327,,2021,"{'bei': '13.09', 'le': '0.26', 'lle': '4.87', 'sei': '5.89'}",CHEMBL4097778,TP-030n,CHEMBL4097778,6.00,0,http://www.openphacts.org/units/Nanomolar,3489319,=,54,1,=,,IC50,nM,,1000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,pIC50,,UO_0000065,,6.0,PAK4
,,24391706,[],CHEMBL5041384,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)c1cnc2ccc(-c3nc(Nc4ccc(N5CCNCC5)cn4)ncc3F)cc2n1,,,CHEMBL5038637,J Med Chem,2022,,CHEMBL5079648,,CHEMBL5079648,,0,http://www.openphacts.org/units/Nanomolar,3779106,>,1,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,10000.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25013367,[],CHEMBL5237490,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1,,,CHEMBL5236558,Eur J Med Chem,2021,"{'bei': '18.75', 'le': '0.34', 'lle': '2.32', 'sei': '9.69'}",CHEMBL200528,,CHEMBL200528,5.75,0,http://www.openphacts.org/units/Nanomolar,3915121,=,1,1,=,,IC50,nM,,1800.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,1.8,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25013368,[],CHEMBL5237490,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,,,CHEMBL5236558,Eur J Med Chem,2021,"{'bei': '15.88', 'le': '0.30', 'lle': '2.39', 'sei': '11.78'}",CHEMBL1952329,SGI-1776,CHEMBL1952329,6.44,1,http://www.openphacts.org/units/Nanomolar,3915122,=,1,1,=,,IC50,nM,,363.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,363.0,PAK4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25690644,[],CHEMBL5382181,Inhibition of PIM2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(=O)oc2cc3c([N+](=O)[O-])c(O)ccc3cc12,,,CHEMBL5380797,J Med Chem,2023,"{'bei': '23.85', 'le': '0.44', 'lle': '3.60', 'sei': '6.91'}",CHEMBL270722,,CHEMBL270722,6.47,0,http://www.openphacts.org/units/Nanomolar,4003810,=,1,1,=,,IC50,nM,,340.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,0.34,PAK4
,,25755605,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01275', 'standard_type': 'Affinity Phenotypic Cellular Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01275', 'type': 'Affinity Phenotypic Cellular Source Knowledge', 'units': None, 'value': None}]",CHEMBL5445203,"Affinity Phenotypic Cellular interaction: (Cell Titer-Gloxc2xae assay (proliferation in KMS11luc pS6RP cells, Promega)) EUB0001581a PIM2",F,,,BAO_0000190,BAO_0000219,cell-based format,C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1,,,CHEMBL5444388,,2024,,CHEMBL3651966,LGH-447,CHEMBL3651966,6.75,0,http://www.openphacts.org/units/Nanomolar,4018303,=,65,1,=,,IC50,nM,,180.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,180.0,PAK4
,,25755717,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://ashpublications.org/blood/article/123/6/905/32601/AZD1208-a-potent-and-selective-pan-Pim-kinase', 'standard_type': 'Affinity On-target Cellular Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://ashpublications.org/blood/article/123/6/905/32601/AZD1208-a-potent-and-selective-pan-Pim-kinase', 'type': 'Affinity On-target Cellular Source Knowledge', 'units': None, 'value': None}]",CHEMBL5446059,Affinity On-target Cellular interaction: (Enzyme-linked immunosorbent assay (phosphorylation of BAD in U2OS cells)) EUB0001547a PIM2,B,,,BAO_0000190,BAO_0000219,cell-based format,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,,,CHEMBL5445981,,2024,"{'bei': '17.97', 'le': '0.35', 'lle': '3.21', 'sei': '9.04'}",CHEMBL2048872,,CHEMBL2048872,6.82,0,http://www.openphacts.org/units/Nanomolar,4018376,=,65,1,=,,IC50,nM,,151.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,151.0,PAK4
,,25755876,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://ashpublications.org/blood/article/123/6/905/32601/AZD1208-a-potent-and-selective-pan-Pim-kinase', 'standard_type': 'Affinity Biochemical Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://ashpublications.org/blood/article/123/6/905/32601/AZD1208-a-potent-and-selective-pan-Pim-kinase', 'type': 'Affinity Biochemical Source Knowledge', 'units': None, 'value': None}]",CHEMBL5446218,"Affinity Biochemical interaction: (Mobility shift assay (Caliper Life Sciences, conc. ATP = Km)) EUB0001547a PIM2",B,,,BAO_0000190,BAO_0000357,single protein format,N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1,,,CHEMBL5446079,,2024,"{'bei': '21.87', 'le': '0.42', 'lle': '4.69', 'sei': '11.00'}",CHEMBL2048872,,CHEMBL2048872,8.30,0,http://www.openphacts.org/units/Nanomolar,4018467,=,65,1,=,,IC50,nM,,5.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,nM,UO_0000065,,5.0,PAK4
,,25782255,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Selectivity number of off-targets', 'standard_units': None, 'standard_value': '1.0', 'text_value': None, 'type': 'Selectivity number of off-targets', 'units': None, 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Selectivity number of targets', 'standard_units': None, 'standard_value': '60.0', 'text_value': None, 'type': 'Selectivity number of targets', 'units': None, 'value': '60.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'In-vitro potency', 'standard_type': 'Selectivity Remarks', 'standard_units': None, 'standard_value': None, 'text_value': 'In-vitro potency', 'type': 'Selectivity Remarks', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://pubmed.ncbi.nlm.nih.gov/21159646/', 'standard_type': 'Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://pubmed.ncbi.nlm.nih.gov/21159646/', 'type': 'Source Knowledge', 'units': None, 'value': None}]",CHEMBL5467305,Selectivity interaction (Kinase panel (Enzyme activity assay)) EUB0000612a PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2,,,CHEMBL5465560,,2024,,CHEMBL1236095,,CHEMBL1236095,,0,http://www.openphacts.org/units/Nanomolar,4018625,>,65,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,25785153,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Selectivity number of off-targets', 'standard_units': None, 'standard_value': '0.0', 'text_value': None, 'type': 'Selectivity number of off-targets', 'units': None, 'value': '0.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Selectivity number of targets', 'standard_units': None, 'standard_value': '85.0', 'text_value': None, 'type': 'Selectivity number of targets', 'units': None, 'value': '85.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'In-vitro potency', 'standard_type': 'Selectivity Remarks', 'standard_units': None, 'standard_value': None, 'text_value': 'In-vitro potency', 'type': 'Selectivity Remarks', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://pubmed.ncbi.nlm.nih.gov/30886973/', 'standard_type': 'Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://pubmed.ncbi.nlm.nih.gov/30886973/', 'type': 'Source Knowledge', 'units': None, 'value': None}]",CHEMBL5472001,Selectivity interaction (TR-FRET binding assay) EUB0000644a PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,,,CHEMBL5465560,,2024,,CHEMBL3622821,UPADACITINIB,CHEMBL3622821,,0,http://www.openphacts.org/units/Nanomolar,4018635,>,65,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,25786795,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Strong effect toward FGFR3 mutants K650E and S249C with IC50s of ~5 nM (PMID:  21936542)', 'standard_type': 'Selectivity Comments', 'standard_units': None, 'standard_value': None, 'text_value': 'Strong effect toward FGFR3 mutants K650E and S249C with IC50s of ~5 nM (PMID:  21936542)', 'type': 'Selectivity Comments', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Selectivity number of off-targets', 'standard_units': None, 'standard_value': '4.0', 'text_value': None, 'type': 'Selectivity number of off-targets', 'units': None, 'value': '4.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Selectivity number of targets', 'standard_units': None, 'standard_value': '67.0', 'text_value': None, 'type': 'Selectivity number of targets', 'units': None, 'value': '67.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'In-vitro potency', 'standard_type': 'Selectivity Remarks', 'standard_units': None, 'standard_value': None, 'text_value': 'In-vitro potency', 'type': 'Selectivity Remarks', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://pubmed.ncbi.nlm.nih.gov/21936542/', 'standard_type': 'Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://pubmed.ncbi.nlm.nih.gov/21936542/', 'type': 'Source Knowledge', 'units': None, 'value': None}]",CHEMBL5473719,"Selectivity interaction (Kinase panel (Enzymatic assay, microfluidic mobility shift readout, Caliper lifesciences, conc.  ATP = Km for each kinase)) EUB0000678a PIM2",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1,,,CHEMBL5465560,,2024,,CHEMBL1852688,INFIGRATINIB,CHEMBL1852688,,0,http://www.openphacts.org/units/Nanomolar,4018642,>,65,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
,,25787758,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'In-vitro potency', 'standard_type': 'Selectivity Remarks', 'standard_units': None, 'standard_value': None, 'text_value': 'In-vitro potency', 'type': 'Selectivity Remarks', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673624/', 'standard_type': 'Source Knowledge', 'standard_units': None, 'standard_value': None, 'text_value': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673624/', 'type': 'Source Knowledge', 'units': None, 'value': None}]",CHEMBL5474885,Selectivity interaction (Enzymatic assay (Eurofins)) EUB0001049a PIM2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(Nc2nc(C)cc(-c3cnn4nc(OC)ccc34)n2)cc(C(F)(F)F)c1,,,CHEMBL5465560,,2024,,CHEMBL5076478,,CHEMBL5076478,,0,http://www.openphacts.org/units/Nanomolar,4018650,>,65,1,>,,IC50,nM,,10000.0,CHEMBL4523,Homo sapiens,Serine/threonine-protein kinase PIM2,9606,,,IC50,uM,UO_0000065,,10.0,PAK4
